Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cytarabine'
(id=6869656 ; fe=en:cytarabine ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=124446 creation date=2017-06-25 touchdate=2025-07-25 16:29:30.000)
≈ 2952 relations sortantes

  1. en:cytarabine -- r_associated #0: 80 / 1 -> cytosine arabinoside
    n1=en:cytarabine | n2=cytosine arabinoside | rel=r_associated | relid=0 | w=80
  2. en:cytarabine -- r_associated #0: 79 / 0.988 -> ARA-C
    n1=en:cytarabine | n2=ARA-C | rel=r_associated | relid=0 | w=79
  3. en:cytarabine -- r_associated #0: 79 / 0.988 -> chimie
    n1=en:cytarabine | n2=chimie | rel=r_associated | relid=0 | w=79
  4. en:cytarabine -- r_associated #0: 71 / 0.888 -> en:nucleoside metabolic inhibitor [epc]
    n1=en:cytarabine | n2=en:nucleoside metabolic inhibitor [epc] | rel=r_associated | relid=0 | w=71
  5. en:cytarabine -- r_associated #0: 69 / 0.863 -> en:ancitabine hydrochloride
    n1=en:cytarabine | n2=en:ancitabine hydrochloride | rel=r_associated | relid=0 | w=69
  6. en:cytarabine -- r_associated #0: 68 / 0.85 -> en:arabinonucleosides
    n1=en:cytarabine | n2=en:arabinonucleosides | rel=r_associated | relid=0 | w=68
  7. en:cytarabine -- r_associated #0: 68 / 0.85 -> en:cytarabine 2gm/vil inj
    n1=en:cytarabine | n2=en:cytarabine 2gm/vil inj | rel=r_associated | relid=0 | w=68
  8. en:cytarabine -- r_associated #0: 67 / 0.838 -> en:1(beta)-arabinofuranosylcytosine 5'-diphosphate-1,2-distearin
    n1=en:cytarabine | n2=en:1(beta)-arabinofuranosylcytosine 5'-diphosphate-1,2-distearin | rel=r_associated | relid=0 | w=67
  9. en:cytarabine -- r_associated #0: 67 / 0.838 -> en:teratogen
    n1=en:cytarabine | n2=en:teratogen | rel=r_associated | relid=0 | w=67
  10. en:cytarabine -- r_associated #0: 66 / 0.825 -> en:antiviral agent
    n1=en:cytarabine | n2=en:antiviral agent | rel=r_associated | relid=0 | w=66
  11. en:cytarabine -- r_associated #0: 60 / 0.75 -> en:beta-ara c
    n1=en:cytarabine | n2=en:beta-ara c | rel=r_associated | relid=0 | w=60
  12. en:cytarabine -- r_associated #0: 59 / 0.738 -> 1-bêta-d-arabinofuranosylcytosine
    n1=en:cytarabine | n2=1-bêta-d-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=59
  13. en:cytarabine -- r_associated #0: 59 / 0.738 -> en:cytonal
    n1=en:cytarabine | n2=en:cytonal | rel=r_associated | relid=0 | w=59
  14. en:cytarabine -- r_associated #0: 59 / 0.738 -> médicament
    n1=en:cytarabine | n2=médicament | rel=r_associated | relid=0 | w=59
  15. en:cytarabine -- r_associated #0: 58 / 0.725 -> arabinosylcytosine
    n1=en:cytarabine | n2=arabinosylcytosine | rel=r_associated | relid=0 | w=58
  16. en:cytarabine -- r_associated #0: 58 / 0.725 -> aracytine
    n1=en:cytarabine | n2=aracytine | rel=r_associated | relid=0 | w=58
  17. en:cytarabine -- r_associated #0: 49 / 0.613 -> cytosine-arabinoside
    n1=en:cytarabine | n2=cytosine-arabinoside | rel=r_associated | relid=0 | w=49
  18. en:cytarabine -- r_associated #0: 44 / 0.55 -> cytarabine
    n1=en:cytarabine | n2=cytarabine | rel=r_associated | relid=0 | w=44
  19. en:cytarabine -- r_associated #0: 40 / 0.5 -> cytarabines
    n1=en:cytarabine | n2=cytarabines | rel=r_associated | relid=0 | w=40
  20. en:cytarabine -- r_associated #0: 37 / 0.463 -> ara-c
    n1=en:cytarabine | n2=ara-c | rel=r_associated | relid=0 | w=37
  21. en:cytarabine -- r_associated #0: 31 / 0.388 -> en:(18f)1-(2'-deoxy-2'-arabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:(18f)1-(2'-deoxy-2'-arabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=31
  22. en:cytarabine -- r_associated #0: 30 / 0.375 -> en:cytarabine injection
    n1=en:cytarabine | n2=en:cytarabine injection | rel=r_associated | relid=0 | w=30
  23. en:cytarabine -- r_associated #0: 30 / 0.375 -> en:dalteparin
    n1=en:cytarabine | n2=en:dalteparin | rel=r_associated | relid=0 | w=30
  24. en:cytarabine -- r_associated #0: 30 / 0.375 -> en:exposure as collected domain
    n1=en:cytarabine | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=30
  25. en:cytarabine -- r_associated #0: 30 / 0.375 -> en:rhenium re 188 p2045
    n1=en:cytarabine | n2=en:rhenium re 188 p2045 | rel=r_associated | relid=0 | w=30
  26. en:cytarabine -- r_associated #0: 30 / 0.375 -> en:yttrium y 90 resin microspheres
    n1=en:cytarabine | n2=en:yttrium y 90 resin microspheres | rel=r_associated | relid=0 | w=30
  27. en:cytarabine -- r_associated #0: 29 / 0.363 -> cytosine
    n1=en:cytarabine | n2=cytosine | rel=r_associated | relid=0 | w=29
  28. en:cytarabine -- r_associated #0: 29 / 0.363 -> en:fluorouracil
    n1=en:cytarabine | n2=en:fluorouracil | rel=r_associated | relid=0 | w=29
  29. en:cytarabine -- r_associated #0: 29 / 0.363 -> en:rar-alpha agonist vtp195183
    n1=en:cytarabine | n2=en:rar-alpha agonist vtp195183 | rel=r_associated | relid=0 | w=29
  30. en:cytarabine -- r_associated #0: 29 / 0.363 -> en:talc
    n1=en:cytarabine | n2=en:talc | rel=r_associated | relid=0 | w=29
  31. en:cytarabine -- r_associated #0: 29 / 0.363 -> en:vardenafil hydrochloride trihydrate
    n1=en:cytarabine | n2=en:vardenafil hydrochloride trihydrate | rel=r_associated | relid=0 | w=29
  32. en:cytarabine -- r_associated #0: 28 / 0.35 -> en:agonists
    n1=en:cytarabine | n2=en:agonists | rel=r_associated | relid=0 | w=28
  33. en:cytarabine -- r_associated #0: 28 / 0.35 -> en:cytarabine 50 mg/ml
    n1=en:cytarabine | n2=en:cytarabine 50 mg/ml | rel=r_associated | relid=0 | w=28
  34. en:cytarabine -- r_associated #0: 28 / 0.35 -> en:standards characteristics
    n1=en:cytarabine | n2=en:standards characteristics | rel=r_associated | relid=0 | w=28
  35. en:cytarabine -- r_associated #0: 27 / 0.338 -> arabinoside
    n1=en:cytarabine | n2=arabinoside | rel=r_associated | relid=0 | w=27
  36. en:cytarabine -- r_associated #0: 27 / 0.338 -> en:gastroenteral dosage form product
    n1=en:cytarabine | n2=en:gastroenteral dosage form product | rel=r_associated | relid=0 | w=27
  37. en:cytarabine -- r_associated #0: 27 / 0.338 -> en:immunology aspects
    n1=en:cytarabine | n2=en:immunology aspects | rel=r_associated | relid=0 | w=27
  38. en:cytarabine -- r_associated #0: 27 / 0.338 -> en:injection, cytarabine, 100 mg
    n1=en:cytarabine | n2=en:injection, cytarabine, 100 mg | rel=r_associated | relid=0 | w=27
  39. en:cytarabine -- r_associated #0: 27 / 0.338 -> en:meclocycline sulfosalicylate
    n1=en:cytarabine | n2=en:meclocycline sulfosalicylate | rel=r_associated | relid=0 | w=27
  40. en:cytarabine -- r_associated #0: 27 / 0.338 -> en:nadroparin calcium
    n1=en:cytarabine | n2=en:nadroparin calcium | rel=r_associated | relid=0 | w=27
  41. en:cytarabine -- r_associated #0: 27 / 0.338 -> préparation pharmaceutique
    n1=en:cytarabine | n2=préparation pharmaceutique | rel=r_associated | relid=0 | w=27
  42. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:cytarabine 50mg injection suspension
    n1=en:cytarabine | n2=en:cytarabine 50mg injection suspension | rel=r_associated | relid=0 | w=26
  43. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:cytosine arabinoside
    n1=en:cytarabine | n2=en:cytosine arabinoside | rel=r_associated | relid=0 | w=26
  44. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:hydromorphone hydrochloride
    n1=en:cytarabine | n2=en:hydromorphone hydrochloride | rel=r_associated | relid=0 | w=26
  45. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:raloxifene
    n1=en:cytarabine | n2=en:raloxifene | rel=r_associated | relid=0 | w=26
  46. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:saxagliptin hydrochloride
    n1=en:cytarabine | n2=en:saxagliptin hydrochloride | rel=r_associated | relid=0 | w=26
  47. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:t4n5 liposomal lotion
    n1=en:cytarabine | n2=en:t4n5 liposomal lotion | rel=r_associated | relid=0 | w=26
  48. en:cytarabine -- r_associated #0: 26 / 0.325 -> en:topoisomerase i/ii inhibitor nev-801
    n1=en:cytarabine | n2=en:topoisomerase i/ii inhibitor nev-801 | rel=r_associated | relid=0 | w=26
  49. en:cytarabine -- r_associated #0: 25 / 0.313 -> en:cytarabine 100mg/ml injection solution 10ml vial
    n1=en:cytarabine | n2=en:cytarabine 100mg/ml injection solution 10ml vial | rel=r_associated | relid=0 | w=25
  50. en:cytarabine -- r_associated #0: 25 / 0.313 -> en:valacyclovir
    n1=en:cytarabine | n2=en:valacyclovir | rel=r_associated | relid=0 | w=25
  51. en:cytarabine -- r_associated #0: 24 / 0.3 -> en:cytarabine 50 mg/ml [cytosar]
    n1=en:cytarabine | n2=en:cytarabine 50 mg/ml [cytosar] | rel=r_associated | relid=0 | w=24
  52. en:cytarabine -- r_associated #0: 24 / 0.3 -> en:haemato fu
    n1=en:cytarabine | n2=en:haemato fu | rel=r_associated | relid=0 | w=24
  53. en:cytarabine -- r_associated #0: 23 / 0.288 -> en:cytarabine 100 mg/ml
    n1=en:cytarabine | n2=en:cytarabine 100 mg/ml | rel=r_associated | relid=0 | w=23
  54. en:cytarabine -- r_associated #0: 23 / 0.288 -> en:mechanism of action qualifier
    n1=en:cytarabine | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=23
  55. en:cytarabine -- r_associated #0: 23 / 0.288 -> en:therapeutic use - qualifier
    n1=en:cytarabine | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=23
  56. en:cytarabine -- r_associated #0: 22 / 0.275 -> en:acyclovir sodium
    n1=en:cytarabine | n2=en:acyclovir sodium | rel=r_associated | relid=0 | w=22
  57. en:cytarabine -- r_associated #0: 22 / 0.275 -> en:iodine i-125
    n1=en:cytarabine | n2=en:iodine i-125 | rel=r_associated | relid=0 | w=22
  58. en:cytarabine -- r_associated #0: 22 / 0.275 -> en:sotagliflozin
    n1=en:cytarabine | n2=en:sotagliflozin | rel=r_associated | relid=0 | w=22
  59. en:cytarabine -- r_associated #0: 21 / 0.263 -> en:5-ht3 receptor antagonist
    n1=en:cytarabine | n2=en:5-ht3 receptor antagonist | rel=r_associated | relid=0 | w=21
  60. en:cytarabine -- r_associated #0: 21 / 0.263 -> en:hypoglycemic agents
    n1=en:cytarabine | n2=en:hypoglycemic agents | rel=r_associated | relid=0 | w=21
  61. en:cytarabine -- r_associated #0: 21 / 0.263 -> en:medication
    n1=en:cytarabine | n2=en:medication | rel=r_associated | relid=0 | w=21
  62. en:cytarabine -- r_associated #0: 21 / 0.263 -> en:pharmacokinetic aspects
    n1=en:cytarabine | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=21
  63. en:cytarabine -- r_associated #0: 21 / 0.263 -> fluorouracile
    n1=en:cytarabine | n2=fluorouracile | rel=r_associated | relid=0 | w=21
  64. en:cytarabine -- r_associated #0: 20 / 0.25 -> 3TC
    n1=en:cytarabine | n2=3TC | rel=r_associated | relid=0 | w=20
  65. en:cytarabine -- r_associated #0: 20 / 0.25 -> abatacept
    n1=en:cytarabine | n2=abatacept | rel=r_associated | relid=0 | w=20
  66. en:cytarabine -- r_associated #0: 20 / 0.25 -> acarbose
    n1=en:cytarabine | n2=acarbose | rel=r_associated | relid=0 | w=20
  67. en:cytarabine -- r_associated #0: 20 / 0.25 -> acénocoumarol
    n1=en:cytarabine | n2=acénocoumarol | rel=r_associated | relid=0 | w=20
  68. en:cytarabine -- r_associated #0: 20 / 0.25 -> acétaminophène
    n1=en:cytarabine | n2=acétaminophène | rel=r_associated | relid=0 | w=20
  69. en:cytarabine -- r_associated #0: 20 / 0.25 -> acétylcystéine
    n1=en:cytarabine | n2=acétylcystéine | rel=r_associated | relid=0 | w=20
  70. en:cytarabine -- r_associated #0: 20 / 0.25 -> acide docosahexaènoïque
    n1=en:cytarabine | n2=acide docosahexaènoïque | rel=r_associated | relid=0 | w=20
  71. en:cytarabine -- r_associated #0: 20 / 0.25 -> acide docosahexaénoïque
    n1=en:cytarabine | n2=acide docosahexaénoïque | rel=r_associated | relid=0 | w=20
  72. en:cytarabine -- r_associated #0: 20 / 0.25 -> acide tranexamique
    n1=en:cytarabine | n2=acide tranexamique | rel=r_associated | relid=0 | w=20
  73. en:cytarabine -- r_associated #0: 20 / 0.25 -> acitrétine
    n1=en:cytarabine | n2=acitrétine | rel=r_associated | relid=0 | w=20
  74. en:cytarabine -- r_associated #0: 20 / 0.25 -> agent antibactérien
    n1=en:cytarabine | n2=agent antibactérien | rel=r_associated | relid=0 | w=20
  75. en:cytarabine -- r_associated #0: 20 / 0.25 -> agent antinéoplasique
    n1=en:cytarabine | n2=agent antinéoplasique | rel=r_associated | relid=0 | w=20
  76. en:cytarabine -- r_associated #0: 20 / 0.25 -> agent biologique
    n1=en:cytarabine | n2=agent biologique | rel=r_associated | relid=0 | w=20
  77. en:cytarabine -- r_associated #0: 20 / 0.25 -> agent tensioactif
    n1=en:cytarabine | n2=agent tensioactif | rel=r_associated | relid=0 | w=20
  78. en:cytarabine -- r_associated #0: 20 / 0.25 -> aller ensemble
    n1=en:cytarabine | n2=aller ensemble | rel=r_associated | relid=0 | w=20
  79. en:cytarabine -- r_associated #0: 20 / 0.25 -> allergie à un médicament
    n1=en:cytarabine | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
  80. en:cytarabine -- r_associated #0: 20 / 0.25 -> allergie aux médicaments
    n1=en:cytarabine | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
  81. en:cytarabine -- r_associated #0: 20 / 0.25 -> allergie médicamenteuse
    n1=en:cytarabine | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
  82. en:cytarabine -- r_associated #0: 20 / 0.25 -> amifampridine
    n1=en:cytarabine | n2=amifampridine | rel=r_associated | relid=0 | w=20
  83. en:cytarabine -- r_associated #0: 20 / 0.25 -> amifostine
    n1=en:cytarabine | n2=amifostine | rel=r_associated | relid=0 | w=20
  84. en:cytarabine -- r_associated #0: 20 / 0.25 -> anæsthésique
    n1=en:cytarabine | n2=anæsthésique | rel=r_associated | relid=0 | w=20
  85. en:cytarabine -- r_associated #0: 20 / 0.25 -> anesthésique
    n1=en:cytarabine | n2=anesthésique | rel=r_associated | relid=0 | w=20
  86. en:cytarabine -- r_associated #0: 20 / 0.25 -> angiostatine
    n1=en:cytarabine | n2=angiostatine | rel=r_associated | relid=0 | w=20
  87. en:cytarabine -- r_associated #0: 20 / 0.25 -> anhydride arsénieux
    n1=en:cytarabine | n2=anhydride arsénieux | rel=r_associated | relid=0 | w=20
  88. en:cytarabine -- r_associated #0: 20 / 0.25 -> antibiotique
    n1=en:cytarabine | n2=antibiotique | rel=r_associated | relid=0 | w=20
  89. en:cytarabine -- r_associated #0: 20 / 0.25 -> antienzyme
    n1=en:cytarabine | n2=antienzyme | rel=r_associated | relid=0 | w=20
  90. en:cytarabine -- r_associated #0: 20 / 0.25 -> antimétabolite
    n1=en:cytarabine | n2=antimétabolite | rel=r_associated | relid=0 | w=20
  91. en:cytarabine -- r_associated #0: 20 / 0.25 -> apixaban
    n1=en:cytarabine | n2=apixaban | rel=r_associated | relid=0 | w=20
  92. en:cytarabine -- r_associated #0: 20 / 0.25 -> arsenic blanc
    n1=en:cytarabine | n2=arsenic blanc | rel=r_associated | relid=0 | w=20
  93. en:cytarabine -- r_associated #0: 20 / 0.25 -> asparaginase
    n1=en:cytarabine | n2=asparaginase | rel=r_associated | relid=0 | w=20
  94. en:cytarabine -- r_associated #0: 20 / 0.25 -> astringente
    n1=en:cytarabine | n2=astringente | rel=r_associated | relid=0 | w=20
  95. en:cytarabine -- r_associated #0: 20 / 0.25 -> aténolol
    n1=en:cytarabine | n2=aténolol | rel=r_associated | relid=0 | w=20
  96. en:cytarabine -- r_associated #0: 20 / 0.25 -> auranofine
    n1=en:cytarabine | n2=auranofine | rel=r_associated | relid=0 | w=20
  97. en:cytarabine -- r_associated #0: 20 / 0.25 -> axitinib
    n1=en:cytarabine | n2=axitinib | rel=r_associated | relid=0 | w=20
  98. en:cytarabine -- r_associated #0: 20 / 0.25 -> Azadirachta indica
    n1=en:cytarabine | n2=Azadirachta indica | rel=r_associated | relid=0 | w=20
  99. en:cytarabine -- r_associated #0: 20 / 0.25 -> baclofen
    n1=en:cytarabine | n2=baclofen | rel=r_associated | relid=0 | w=20
  100. en:cytarabine -- r_associated #0: 20 / 0.25 -> baclofène
    n1=en:cytarabine | n2=baclofène | rel=r_associated | relid=0 | w=20
  101. en:cytarabine -- r_associated #0: 20 / 0.25 -> barbe de maïs
    n1=en:cytarabine | n2=barbe de maïs | rel=r_associated | relid=0 | w=20
  102. en:cytarabine -- r_associated #0: 20 / 0.25 -> baricitinib
    n1=en:cytarabine | n2=baricitinib | rel=r_associated | relid=0 | w=20
  103. en:cytarabine -- r_associated #0: 20 / 0.25 -> baryte
    n1=en:cytarabine | n2=baryte | rel=r_associated | relid=0 | w=20
  104. en:cytarabine -- r_associated #0: 20 / 0.25 -> belimumab
    n1=en:cytarabine | n2=belimumab | rel=r_associated | relid=0 | w=20
  105. en:cytarabine -- r_associated #0: 20 / 0.25 -> bevacizumab
    n1=en:cytarabine | n2=bevacizumab | rel=r_associated | relid=0 | w=20
  106. en:cytarabine -- r_associated #0: 20 / 0.25 -> bléomycine sulfate
    n1=en:cytarabine | n2=bléomycine sulfate | rel=r_associated | relid=0 | w=20
  107. en:cytarabine -- r_associated #0: 20 / 0.25 -> busulfan
    n1=en:cytarabine | n2=busulfan | rel=r_associated | relid=0 | w=20
  108. en:cytarabine -- r_associated #0: 20 / 0.25 -> cabergoline
    n1=en:cytarabine | n2=cabergoline | rel=r_associated | relid=0 | w=20
  109. en:cytarabine -- r_associated #0: 20 / 0.25 -> cancérigène
    n1=en:cytarabine | n2=cancérigène | rel=r_associated | relid=0 | w=20
  110. en:cytarabine -- r_associated #0: 20 / 0.25 -> cannabidiol
    n1=en:cytarabine | n2=cannabidiol | rel=r_associated | relid=0 | w=20
  111. en:cytarabine -- r_associated #0: 20 / 0.25 -> cannabinol
    n1=en:cytarabine | n2=cannabinol | rel=r_associated | relid=0 | w=20
  112. en:cytarabine -- r_associated #0: 20 / 0.25 -> capécitabine
    n1=en:cytarabine | n2=capécitabine | rel=r_associated | relid=0 | w=20
  113. en:cytarabine -- r_associated #0: 20 / 0.25 -> capsaïcine
    n1=en:cytarabine | n2=capsaïcine | rel=r_associated | relid=0 | w=20
  114. en:cytarabine -- r_associated #0: 20 / 0.25 -> carbendazime
    n1=en:cytarabine | n2=carbendazime | rel=r_associated | relid=0 | w=20
  115. en:cytarabine -- r_associated #0: 20 / 0.25 -> carbonate lithium
    n1=en:cytarabine | n2=carbonate lithium | rel=r_associated | relid=0 | w=20
  116. en:cytarabine -- r_associated #0: 20 / 0.25 -> carcinogène
    n1=en:cytarabine | n2=carcinogène | rel=r_associated | relid=0 | w=20
  117. en:cytarabine -- r_associated #0: 20 / 0.25 -> carmustine
    n1=en:cytarabine | n2=carmustine | rel=r_associated | relid=0 | w=20
  118. en:cytarabine -- r_associated #0: 20 / 0.25 -> cefpodoxime proxétil
    n1=en:cytarabine | n2=cefpodoxime proxétil | rel=r_associated | relid=0 | w=20
  119. en:cytarabine -- r_associated #0: 20 / 0.25 -> ceritinib
    n1=en:cytarabine | n2=ceritinib | rel=r_associated | relid=0 | w=20
  120. en:cytarabine -- r_associated #0: 20 / 0.25 -> certolizumab
    n1=en:cytarabine | n2=certolizumab | rel=r_associated | relid=0 | w=20
  121. en:cytarabine -- r_associated #0: 20 / 0.25 -> cétirizine
    n1=en:cytarabine | n2=cétirizine | rel=r_associated | relid=0 | w=20
  122. en:cytarabine -- r_associated #0: 20 / 0.25 -> cetuximab
    n1=en:cytarabine | n2=cetuximab | rel=r_associated | relid=0 | w=20
  123. en:cytarabine -- r_associated #0: 20 / 0.25 -> chélateur
    n1=en:cytarabine | n2=chélateur | rel=r_associated | relid=0 | w=20
  124. en:cytarabine -- r_associated #0: 20 / 0.25 -> chlorhydrate de doxorubicine
    n1=en:cytarabine | n2=chlorhydrate de doxorubicine | rel=r_associated | relid=0 | w=20
  125. en:cytarabine -- r_associated #0: 20 / 0.25 -> chlorhydrate de métronidazole
    n1=en:cytarabine | n2=chlorhydrate de métronidazole | rel=r_associated | relid=0 | w=20
  126. en:cytarabine -- r_associated #0: 20 / 0.25 -> cimétidine
    n1=en:cytarabine | n2=cimétidine | rel=r_associated | relid=0 | w=20
  127. en:cytarabine -- r_associated #0: 20 / 0.25 -> cis-diaminedichloroplatine
    n1=en:cytarabine | n2=cis-diaminedichloroplatine | rel=r_associated | relid=0 | w=20
  128. en:cytarabine -- r_associated #0: 20 / 0.25 -> cisatracurium
    n1=en:cytarabine | n2=cisatracurium | rel=r_associated | relid=0 | w=20
  129. en:cytarabine -- r_associated #0: 20 / 0.25 -> cisplatine
    n1=en:cytarabine | n2=cisplatine | rel=r_associated | relid=0 | w=20
  130. en:cytarabine -- r_associated #0: 20 / 0.25 -> citrate de clomifène
    n1=en:cytarabine | n2=citrate de clomifène | rel=r_associated | relid=0 | w=20
  131. en:cytarabine -- r_associated #0: 20 / 0.25 -> citrate de clomiphène
    n1=en:cytarabine | n2=citrate de clomiphène | rel=r_associated | relid=0 | w=20
  132. en:cytarabine -- r_associated #0: 20 / 0.25 -> citrate de magnésium
    n1=en:cytarabine | n2=citrate de magnésium | rel=r_associated | relid=0 | w=20
  133. en:cytarabine -- r_associated #0: 20 / 0.25 -> citrulline
    n1=en:cytarabine | n2=citrulline | rel=r_associated | relid=0 | w=20
  134. en:cytarabine -- r_associated #0: 20 / 0.25 -> clarithromycine
    n1=en:cytarabine | n2=clarithromycine | rel=r_associated | relid=0 | w=20
  135. en:cytarabine -- r_associated #0: 20 / 0.25 -> clé à fourche
    n1=en:cytarabine | n2=clé à fourche | rel=r_associated | relid=0 | w=20
  136. en:cytarabine -- r_associated #0: 20 / 0.25 -> clé à fourches
    n1=en:cytarabine | n2=clé à fourches | rel=r_associated | relid=0 | w=20
  137. en:cytarabine -- r_associated #0: 20 / 0.25 -> clé à molette
    n1=en:cytarabine | n2=clé à molette | rel=r_associated | relid=0 | w=20
  138. en:cytarabine -- r_associated #0: 20 / 0.25 -> clé ouverte
    n1=en:cytarabine | n2=clé ouverte | rel=r_associated | relid=0 | w=20
  139. en:cytarabine -- r_associated #0: 20 / 0.25 -> clef
    n1=en:cytarabine | n2=clef | rel=r_associated | relid=0 | w=20
  140. en:cytarabine -- r_associated #0: 20 / 0.25 -> clef à fourche
    n1=en:cytarabine | n2=clef à fourche | rel=r_associated | relid=0 | w=20
  141. en:cytarabine -- r_associated #0: 20 / 0.25 -> clef à fourches
    n1=en:cytarabine | n2=clef à fourches | rel=r_associated | relid=0 | w=20
  142. en:cytarabine -- r_associated #0: 20 / 0.25 -> clef ouverte
    n1=en:cytarabine | n2=clef ouverte | rel=r_associated | relid=0 | w=20
  143. en:cytarabine -- r_associated #0: 20 / 0.25 -> cobalamine
    n1=en:cytarabine | n2=cobalamine | rel=r_associated | relid=0 | w=20
  144. en:cytarabine -- r_associated #0: 20 / 0.25 -> cortisol
    n1=en:cytarabine | n2=cortisol | rel=r_associated | relid=0 | w=20
  145. en:cytarabine -- r_associated #0: 20 / 0.25 -> coumaphène
    n1=en:cytarabine | n2=coumaphène | rel=r_associated | relid=0 | w=20
  146. en:cytarabine -- r_associated #0: 20 / 0.25 -> créatine phosphate
    n1=en:cytarabine | n2=créatine phosphate | rel=r_associated | relid=0 | w=20
  147. en:cytarabine -- r_associated #0: 20 / 0.25 -> curcumine
    n1=en:cytarabine | n2=curcumine | rel=r_associated | relid=0 | w=20
  148. en:cytarabine -- r_associated #0: 20 / 0.25 -> cycloleucine
    n1=en:cytarabine | n2=cycloleucine | rel=r_associated | relid=0 | w=20
  149. en:cytarabine -- r_associated #0: 20 / 0.25 -> cyclophosphamide
    n1=en:cytarabine | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
  150. en:cytarabine -- r_associated #0: 20 / 0.25 -> dabrafenib
    n1=en:cytarabine | n2=dabrafenib | rel=r_associated | relid=0 | w=20
  151. en:cytarabine -- r_associated #0: 20 / 0.25 -> daclatasvir
    n1=en:cytarabine | n2=daclatasvir | rel=r_associated | relid=0 | w=20
  152. en:cytarabine -- r_associated #0: 20 / 0.25 -> dapsone
    n1=en:cytarabine | n2=dapsone | rel=r_associated | relid=0 | w=20
  153. en:cytarabine -- r_associated #0: 20 / 0.25 -> dasatinib
    n1=en:cytarabine | n2=dasatinib | rel=r_associated | relid=0 | w=20
  154. en:cytarabine -- r_associated #0: 20 / 0.25 -> désincrustant
    n1=en:cytarabine | n2=désincrustant | rel=r_associated | relid=0 | w=20
  155. en:cytarabine -- r_associated #0: 20 / 0.25 -> dextran
    n1=en:cytarabine | n2=dextran | rel=r_associated | relid=0 | w=20
  156. en:cytarabine -- r_associated #0: 20 / 0.25 -> dextrane
    n1=en:cytarabine | n2=dextrane | rel=r_associated | relid=0 | w=20
  157. en:cytarabine -- r_associated #0: 20 / 0.25 -> dichlorhydrate d'histamine
    n1=en:cytarabine | n2=dichlorhydrate d'histamine | rel=r_associated | relid=0 | w=20
  158. en:cytarabine -- r_associated #0: 20 / 0.25 -> dicumarol
    n1=en:cytarabine | n2=dicumarol | rel=r_associated | relid=0 | w=20
  159. en:cytarabine -- r_associated #0: 20 / 0.25 -> diéthylstilbestrol
    n1=en:cytarabine | n2=diéthylstilbestrol | rel=r_associated | relid=0 | w=20
  160. en:cytarabine -- r_associated #0: 20 / 0.25 -> diéthylstilboestrol
    n1=en:cytarabine | n2=diéthylstilboestrol | rel=r_associated | relid=0 | w=20
  161. en:cytarabine -- r_associated #0: 20 / 0.25 -> digitoxine
    n1=en:cytarabine | n2=digitoxine | rel=r_associated | relid=0 | w=20
  162. en:cytarabine -- r_associated #0: 20 / 0.25 -> dobutamine
    n1=en:cytarabine | n2=dobutamine | rel=r_associated | relid=0 | w=20
  163. en:cytarabine -- r_associated #0: 20 / 0.25 -> docusate
    n1=en:cytarabine | n2=docusate | rel=r_associated | relid=0 | w=20
  164. en:cytarabine -- r_associated #0: 20 / 0.25 -> E100
    n1=en:cytarabine | n2=E100 | rel=r_associated | relid=0 | w=20
  165. en:cytarabine -- r_associated #0: 20 / 0.25 -> E100(i)
    n1=en:cytarabine | n2=E100(i) | rel=r_associated | relid=0 | w=20
  166. en:cytarabine -- r_associated #0: 20 / 0.25 -> E1200
    n1=en:cytarabine | n2=E1200 | rel=r_associated | relid=0 | w=20
  167. en:cytarabine -- r_associated #0: 20 / 0.25 -> E1521
    n1=en:cytarabine | n2=E1521 | rel=r_associated | relid=0 | w=20
  168. en:cytarabine -- r_associated #0: 20 / 0.25 -> E553(iii)
    n1=en:cytarabine | n2=E553(iii) | rel=r_associated | relid=0 | w=20
  169. en:cytarabine -- r_associated #0: 20 / 0.25 -> eau distillée
    n1=en:cytarabine | n2=eau distillée | rel=r_associated | relid=0 | w=20
  170. en:cytarabine -- r_associated #0: 20 / 0.25 -> échinomycine
    n1=en:cytarabine | n2=échinomycine | rel=r_associated | relid=0 | w=20
  171. en:cytarabine -- r_associated #0: 20 / 0.25 -> emtricitabine
    n1=en:cytarabine | n2=emtricitabine | rel=r_associated | relid=0 | w=20
  172. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:(99m)tc-n4-(hydrazinonicotinoyl)-1-beta-arabinofuranosyl cytosine
    n1=en:cytarabine | n2=en:(99m)tc-n4-(hydrazinonicotinoyl)-1-beta-arabinofuranosyl cytosine | rel=r_associated | relid=0 | w=20
  173. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:[18f]-labeled substance p antagonist receptor quantifier
    n1=en:cytarabine | n2=en:[18f]-labeled substance p antagonist receptor quantifier | rel=r_associated | relid=0 | w=20
  174. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:[18f]l-fac
    n1=en:cytarabine | n2=en:[18f]l-fac | rel=r_associated | relid=0 | w=20
  175. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1 beta-arabinofuranosylcytosine 5'-diphosphate-1,2-diolein
    n1=en:cytarabine | n2=en:1 beta-arabinofuranosylcytosine 5'-diphosphate-1,2-diolein | rel=r_associated | relid=0 | w=20
  176. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin
    n1=en:cytarabine | n2=en:1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin | rel=r_associated | relid=0 | w=20
  177. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1 beta-d-arabinofuranosylcytosine diphosphate choline
    n1=en:cytarabine | n2=en:1 beta-d-arabinofuranosylcytosine diphosphate choline | rel=r_associated | relid=0 | w=20
  178. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1 beta-d-arabinofuranosylcytosine-5'-diphosphatecortisol
    n1=en:cytarabine | n2=en:1 beta-d-arabinofuranosylcytosine-5'-diphosphatecortisol | rel=r_associated | relid=0 | w=20
  179. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2-chloro-2-deoxy-d-arabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2-chloro-2-deoxy-d-arabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  180. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2-deoxy-2-c-fluoromethylarabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2-deoxy-2-c-fluoromethylarabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  181. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2-deoxy-2-c-hydroxymethylarabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2-deoxy-2-c-hydroxymethylarabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  182. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2-deoxy-2-fluoro-4-thio-arabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2-deoxy-2-fluoro-4-thio-arabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  183. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2-o-methyl-beta-d-arabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2-o-methyl-beta-d-arabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  184. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2-o-nitro-beta-d-arabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2-o-nitro-beta-d-arabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  185. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(2'-deoxy-2'-fluoro-arabinofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(2'-deoxy-2'-fluoro-arabinofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  186. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(3-deoxypentofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(3-deoxypentofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  187. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-(5-deoxy-beta-d-hexofuranosyl)cytosine
    n1=en:cytarabine | n2=en:1-(5-deoxy-beta-d-hexofuranosyl)cytosine | rel=r_associated | relid=0 | w=20
  188. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-arabinofuranosyl-5-ethynylcytosine
    n1=en:cytarabine | n2=en:1-arabinofuranosyl-5-ethynylcytosine | rel=r_associated | relid=0 | w=20
  189. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1-beta-4-selenoarabinofuranosyl cytosine
    n1=en:cytarabine | n2=en:1-beta-4-selenoarabinofuranosyl cytosine | rel=r_associated | relid=0 | w=20
  190. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1,2-carbon c 13-labeled glucose
    n1=en:cytarabine | n2=en:1,2-carbon c 13-labeled glucose | rel=r_associated | relid=0 | w=20
  191. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:1(beta)-d-arabinofuranosylcytosine-5'-diphosphate prednisolone
    n1=en:cytarabine | n2=en:1(beta)-d-arabinofuranosylcytosine-5'-diphosphate prednisolone | rel=r_associated | relid=0 | w=20
  192. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:11 epicortisol
    n1=en:cytarabine | n2=en:11 epicortisol | rel=r_associated | relid=0 | w=20
  193. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:13-deoxydoxorubicin
    n1=en:cytarabine | n2=en:13-deoxydoxorubicin | rel=r_associated | relid=0 | w=20
  194. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:14c bms-275183
    n1=en:cytarabine | n2=en:14c bms-275183 | rel=r_associated | relid=0 | w=20
  195. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:16,16-dimethyl prostaglandin e2
    n1=en:cytarabine | n2=en:16,16-dimethyl prostaglandin e2 | rel=r_associated | relid=0 | w=20
  196. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:17-hydroxycorticosterone
    n1=en:cytarabine | n2=en:17-hydroxycorticosterone | rel=r_associated | relid=0 | w=20
  197. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:18-f-fluoroacetate
    n1=en:cytarabine | n2=en:18-f-fluoroacetate | rel=r_associated | relid=0 | w=20
  198. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:18f-fhbg
    n1=en:cytarabine | n2=en:18f-fhbg | rel=r_associated | relid=0 | w=20
  199. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:18f-fluoroazomycin arabinoside
    n1=en:cytarabine | n2=en:18f-fluoroazomycin arabinoside | rel=r_associated | relid=0 | w=20
  200. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:18f-labeled mini-peg spacered rgd dimer
    n1=en:cytarabine | n2=en:18f-labeled mini-peg spacered rgd dimer | rel=r_associated | relid=0 | w=20
  201. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide
    n1=en:cytarabine | n2=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | rel=r_associated | relid=0 | w=20
  202. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2-hydroxyoleic acid
    n1=en:cytarabine | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=20
  203. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2-methoxyestradiol
    n1=en:cytarabine | n2=en:2-methoxyestradiol | rel=r_associated | relid=0 | w=20
  204. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2-methoxyestradiol nanocrystal colloidal dispersion
    n1=en:cytarabine | n2=en:2-methoxyestradiol nanocrystal colloidal dispersion | rel=r_associated | relid=0 | w=20
  205. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2,2'-anhydro-1-(3'-o-acetyl-beta-arabinofuranosyl)-5-iodocytosine hydrochloride
    n1=en:cytarabine | n2=en:2,2'-anhydro-1-(3'-o-acetyl-beta-arabinofuranosyl)-5-iodocytosine hydrochloride | rel=r_associated | relid=0 | w=20
  206. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2,2'-anhydro-1-(3'-o-acetyl-beta-d-arabinofuranosyl)-5-iodocytosine hydrochloride
    n1=en:cytarabine | n2=en:2,2'-anhydro-1-(3'-o-acetyl-beta-d-arabinofuranosyl)-5-iodocytosine hydrochloride | rel=r_associated | relid=0 | w=20
  207. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2'-deoxy-2'-fluoro-4'-selenoarabinofuranosylcytosine
    n1=en:cytarabine | n2=en:2'-deoxy-2'-fluoro-4'-selenoarabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  208. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2'-deoxy-5-fluorouridylyl-(5'-5')-n(4)-octadecyl-1-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:2'-deoxy-5-fluorouridylyl-(5'-5')-n(4)-octadecyl-1-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  209. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2'-f-ara-deoxyuridine
    n1=en:cytarabine | n2=en:2'-f-ara-deoxyuridine | rel=r_associated | relid=0 | w=20
  210. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2'-fluoro-5-bromo-1-beta-d-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:2'-fluoro-5-bromo-1-beta-d-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  211. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2'-fluoro-5-chloro-1-beta-d-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:2'-fluoro-5-chloro-1-beta-d-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  212. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2'-fluoro-5-methylarabino-furanosylcytosine
    n1=en:cytarabine | n2=en:2'-fluoro-5-methylarabino-furanosylcytosine | rel=r_associated | relid=0 | w=20
  213. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2',5'-arabinosylcytidine monophosphate
    n1=en:cytarabine | n2=en:2',5'-arabinosylcytidine monophosphate | rel=r_associated | relid=0 | w=20
  214. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:2g-1 tcr retroviral vector-transduced lymphocytes
    n1=en:cytarabine | n2=en:2g-1 tcr retroviral vector-transduced lymphocytes | rel=r_associated | relid=0 | w=20
  215. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:3-deazauridine
    n1=en:cytarabine | n2=en:3-deazauridine | rel=r_associated | relid=0 | w=20
  216. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine
    n1=en:cytarabine | n2=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | rel=r_associated | relid=0 | w=20
  217. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:3'-c-ethynylcytidine
    n1=en:cytarabine | n2=en:3'-c-ethynylcytidine | rel=r_associated | relid=0 | w=20
  218. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:3'-o-galactopyranosyl-1-4-o-galactopyranosylcytarabine
    n1=en:cytarabine | n2=en:3'-o-galactopyranosyl-1-4-o-galactopyranosylcytarabine | rel=r_associated | relid=0 | w=20
  219. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:3'-o-galactopyranosylcytarabine
    n1=en:cytarabine | n2=en:3'-o-galactopyranosylcytarabine | rel=r_associated | relid=0 | w=20
  220. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:4-1bb agonist monoclonal antibody pf-05082566
    n1=en:cytarabine | n2=en:4-1bb agonist monoclonal antibody pf-05082566 | rel=r_associated | relid=0 | w=20
  221. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:4-amino-1-(5-o-(2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl)arabinofuranosyl)-2(1h)-pyrimidinone
    n1=en:cytarabine | n2=en:4-amino-1-(5-o-(2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl)arabinofuranosyl)-2(1h)-pyrimidinone | rel=r_associated | relid=0 | w=20
  222. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:4-peptide melanoma vaccine
    n1=en:cytarabine | n2=en:4-peptide melanoma vaccine | rel=r_associated | relid=0 | w=20
  223. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:4'-azidoarabinocytidine
    n1=en:cytarabine | n2=en:4'-azidoarabinocytidine | rel=r_associated | relid=0 | w=20
  224. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5-fitc-labeled gi-heptapeptide
    n1=en:cytarabine | n2=en:5-fitc-labeled gi-heptapeptide | rel=r_associated | relid=0 | w=20
  225. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5-fluoro-2'-deoxyuridylyl-(3'-5')-arabinocytidine
    n1=en:cytarabine | n2=en:5-fluoro-2'-deoxyuridylyl-(3'-5')-arabinocytidine | rel=r_associated | relid=0 | w=20
  226. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5-fluorouracil/salicylic acid topical solution
    n1=en:cytarabine | n2=en:5-fluorouracil/salicylic acid topical solution | rel=r_associated | relid=0 | w=20
  227. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5-methyl ara-c
    n1=en:cytarabine | n2=en:5-methyl ara-c | rel=r_associated | relid=0 | w=20
  228. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5'-chloro-5'-deoxyarabinosylcytosine
    n1=en:cytarabine | n2=en:5'-chloro-5'-deoxyarabinosylcytosine | rel=r_associated | relid=0 | w=20
  229. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5'-oleoyl cytarabine
    n1=en:cytarabine | n2=en:5'-oleoyl cytarabine | rel=r_associated | relid=0 | w=20
  230. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:5'-palmitoyl cytarabine
    n1=en:cytarabine | n2=en:5'-palmitoyl cytarabine | rel=r_associated | relid=0 | w=20
  231. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158
    n1=en:cytarabine | n2=en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 | rel=r_associated | relid=0 | w=20
  232. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:6,8-bis(benzylthio)octanoic acid
    n1=en:cytarabine | n2=en:6,8-bis(benzylthio)octanoic acid | rel=r_associated | relid=0 | w=20
  233. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:7-cyanoquinocarcinol
    n1=en:cytarabine | n2=en:7-cyanoquinocarcinol | rel=r_associated | relid=0 | w=20
  234. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:7-hydroxystaurosporine
    n1=en:cytarabine | n2=en:7-hydroxystaurosporine | rel=r_associated | relid=0 | w=20
  235. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:7+3 protocol
    n1=en:cytarabine | n2=en:7+3 protocol | rel=r_associated | relid=0 | w=20
  236. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:8-hydroxyquinoline sulfate ointment
    n1=en:cytarabine | n2=en:8-hydroxyquinoline sulfate ointment | rel=r_associated | relid=0 | w=20
  237. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:80-035 protocol
    n1=en:cytarabine | n2=en:80-035 protocol | rel=r_associated | relid=0 | w=20
  238. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:a-triple-v protocol
    n1=en:cytarabine | n2=en:a-triple-v protocol | rel=r_associated | relid=0 | w=20
  239. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aa2 protocol
    n1=en:cytarabine | n2=en:aa2 protocol | rel=r_associated | relid=0 | w=20
  240. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aa3 protocol
    n1=en:cytarabine | n2=en:aa3 protocol | rel=r_associated | relid=0 | w=20
  241. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aaabc protocol
    n1=en:cytarabine | n2=en:aaabc protocol | rel=r_associated | relid=0 | w=20
  242. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ab-triple v protocol
    n1=en:cytarabine | n2=en:ab-triple v protocol | rel=r_associated | relid=0 | w=20
  243. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abagovomab
    n1=en:cytarabine | n2=en:abagovomab | rel=r_associated | relid=0 | w=20
  244. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abarelix
    n1=en:cytarabine | n2=en:abarelix | rel=r_associated | relid=0 | w=20
  245. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abatacept
    n1=en:cytarabine | n2=en:abatacept | rel=r_associated | relid=0 | w=20
  246. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abbv-221
    n1=en:cytarabine | n2=en:abbv-221 | rel=r_associated | relid=0 | w=20
  247. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abcdv protocol
    n1=en:cytarabine | n2=en:abcdv protocol | rel=r_associated | relid=0 | w=20
  248. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abep protocol 1
    n1=en:cytarabine | n2=en:abep protocol 1 | rel=r_associated | relid=0 | w=20
  249. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abexinostat
    n1=en:cytarabine | n2=en:abexinostat | rel=r_associated | relid=0 | w=20
  250. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abiraterone acetate
    n1=en:cytarabine | n2=en:abiraterone acetate | rel=r_associated | relid=0 | w=20
  251. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abortifacient agents
    n1=en:cytarabine | n2=en:abortifacient agents | rel=r_associated | relid=0 | w=20
  252. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abr-217620
    n1=en:cytarabine | n2=en:abr-217620 | rel=r_associated | relid=0 | w=20
  253. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:absorbable adhesion barrier gel
    n1=en:cytarabine | n2=en:absorbable adhesion barrier gel | rel=r_associated | relid=0 | w=20
  254. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:absorbable fibrin sealant patch
    n1=en:cytarabine | n2=en:absorbable fibrin sealant patch | rel=r_associated | relid=0 | w=20
  255. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:absorbable gelatin sponge
    n1=en:cytarabine | n2=en:absorbable gelatin sponge | rel=r_associated | relid=0 | w=20
  256. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:absorbable modified polymer hemostatic powder
    n1=en:cytarabine | n2=en:absorbable modified polymer hemostatic powder | rel=r_associated | relid=0 | w=20
  257. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abt-751
    n1=en:cytarabine | n2=en:abt-751 | rel=r_associated | relid=0 | w=20
  258. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abvd regimen
    n1=en:cytarabine | n2=en:abvd regimen | rel=r_associated | relid=0 | w=20
  259. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:abve regimen
    n1=en:cytarabine | n2=en:abve regimen | rel=r_associated | relid=0 | w=20
  260. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ac regimen
    n1=en:cytarabine | n2=en:ac regimen | rel=r_associated | relid=0 | w=20
  261. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acai berry juice
    n1=en:cytarabine | n2=en:acai berry juice | rel=r_associated | relid=0 | w=20
  262. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acalabrutinib
    n1=en:cytarabine | n2=en:acalabrutinib | rel=r_associated | relid=0 | w=20
  263. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acarbose
    n1=en:cytarabine | n2=en:acarbose | rel=r_associated | relid=0 | w=20
  264. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acellular cadaveric dermal matrix
    n1=en:cytarabine | n2=en:acellular cadaveric dermal matrix | rel=r_associated | relid=0 | w=20
  265. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acenocoumarol
    n1=en:cytarabine | n2=en:acenocoumarol | rel=r_associated | relid=0 | w=20
  266. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acetaminophen
    n1=en:cytarabine | n2=en:acetaminophen | rel=r_associated | relid=0 | w=20
  267. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acetylcysteine
    n1=en:cytarabine | n2=en:acetylcysteine | rel=r_associated | relid=0 | w=20
  268. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acitretin
    n1=en:cytarabine | n2=en:acitretin | rel=r_associated | relid=0 | w=20
  269. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acivicin
    n1=en:cytarabine | n2=en:acivicin | rel=r_associated | relid=0 | w=20
  270. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acmp protocol
    n1=en:cytarabine | n2=en:acmp protocol | rel=r_associated | relid=0 | w=20
  271. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acodazole
    n1=en:cytarabine | n2=en:acodazole | rel=r_associated | relid=0 | w=20
  272. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acolbifene hydrochloride
    n1=en:cytarabine | n2=en:acolbifene hydrochloride | rel=r_associated | relid=0 | w=20
  273. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:acomla protocol
    n1=en:cytarabine | n2=en:acomla protocol | rel=r_associated | relid=0 | w=20
  274. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:act protocol
    n1=en:cytarabine | n2=en:act protocol | rel=r_associated | relid=0 | w=20
  275. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:activin type 2b receptor fc fusion protein stm 434
    n1=en:cytarabine | n2=en:activin type 2b receptor fc fusion protein stm 434 | rel=r_associated | relid=0 | w=20
  276. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ad-hcmv-flt3l
    n1=en:cytarabine | n2=en:ad-hcmv-flt3l | rel=r_associated | relid=0 | w=20
  277. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ad-isf35
    n1=en:cytarabine | n2=en:ad-isf35 | rel=r_associated | relid=0 | w=20
  278. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ad-sig-hmuc-1/ecdcd40l vaccine
    n1=en:cytarabine | n2=en:ad-sig-hmuc-1/ecdcd40l vaccine | rel=r_associated | relid=0 | w=20
  279. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ad5-ycd/muttk(sr39)rep-adp
    n1=en:cytarabine | n2=en:ad5-ycd/muttk(sr39)rep-adp | rel=r_associated | relid=0 | w=20
  280. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ad5.sstr/tk.rgd
    n1=en:cytarabine | n2=en:ad5.sstr/tk.rgd | rel=r_associated | relid=0 | w=20
  281. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ad5cmv-p53 gene
    n1=en:cytarabine | n2=en:ad5cmv-p53 gene | rel=r_associated | relid=0 | w=20
  282. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ada protocol
    n1=en:cytarabine | n2=en:ada protocol | rel=r_associated | relid=0 | w=20
  283. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adamantoylcytarabine
    n1=en:cytarabine | n2=en:adamantoylcytarabine | rel=r_associated | relid=0 | w=20
  284. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adecatumumab
    n1=en:cytarabine | n2=en:adecatumumab | rel=r_associated | relid=0 | w=20
  285. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adefovir dipivoxil
    n1=en:cytarabine | n2=en:adefovir dipivoxil | rel=r_associated | relid=0 | w=20
  286. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenosine a2a receptor antagonist pbf-509
    n1=en:cytarabine | n2=en:adenosine a2a receptor antagonist pbf-509 | rel=r_associated | relid=0 | w=20
  287. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovector encoding mda7
    n1=en:cytarabine | n2=en:adenovector encoding mda7 | rel=r_associated | relid=0 | w=20
  288. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201
    n1=en:cytarabine | n2=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | rel=r_associated | relid=0 | w=20
  289. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus 5-cd40 ligand
    n1=en:cytarabine | n2=en:adenovirus 5-cd40 ligand | rel=r_associated | relid=0 | w=20
  290. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus 5-human guanylyl cyclase c-padre vaccine
    n1=en:cytarabine | n2=en:adenovirus 5-human guanylyl cyclase c-padre vaccine | rel=r_associated | relid=0 | w=20
  291. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus b7-1
    n1=en:cytarabine | n2=en:adenovirus b7-1 | rel=r_associated | relid=0 | w=20
  292. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus encoding rat her-2/neu
    n1=en:cytarabine | n2=en:adenovirus encoding rat her-2/neu | rel=r_associated | relid=0 | w=20
  293. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus encoding recombinant human endostatin
    n1=en:cytarabine | n2=en:adenovirus encoding recombinant human endostatin | rel=r_associated | relid=0 | w=20
  294. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus-mediated human interleukin-12
    n1=en:cytarabine | n2=en:adenovirus-mediated human interleukin-12 | rel=r_associated | relid=0 | w=20
  295. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001
    n1=en:cytarabine | n2=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=20
  296. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus-p53 transduced dendritic cell vaccine
    n1=en:cytarabine | n2=en:adenovirus-p53 transduced dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  297. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes
    n1=en:cytarabine | n2=en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=20
  298. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adgmcaix-transduced autologous dendritic cells
    n1=en:cytarabine | n2=en:adgmcaix-transduced autologous dendritic cells | rel=r_associated | relid=0 | w=20
  299. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adh-1
    n1=en:cytarabine | n2=en:adh-1 | rel=r_associated | relid=0 | w=20
  300. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adipose-derived regenerative cells
    n1=en:cytarabine | n2=en:adipose-derived regenerative cells | rel=r_associated | relid=0 | w=20
  301. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:adrtvp-1-transduced prostate cancer cell-based vaccine
    n1=en:cytarabine | n2=en:adrtvp-1-transduced prostate cancer cell-based vaccine | rel=r_associated | relid=0 | w=20
  302. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ae37 peptide/gm-csf vaccine
    n1=en:cytarabine | n2=en:ae37 peptide/gm-csf vaccine | rel=r_associated | relid=0 | w=20
  303. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aee788
    n1=en:cytarabine | n2=en:aee788 | rel=r_associated | relid=0 | w=20
  304. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aeg35156
    n1=en:cytarabine | n2=en:aeg35156 | rel=r_associated | relid=0 | w=20
  305. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aerosol gemcitabine
    n1=en:cytarabine | n2=en:aerosol gemcitabine | rel=r_associated | relid=0 | w=20
  306. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:afatinib dimaleate
    n1=en:cytarabine | n2=en:afatinib dimaleate | rel=r_associated | relid=0 | w=20
  307. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:afc regimen
    n1=en:cytarabine | n2=en:afc regimen | rel=r_associated | relid=0 | w=20
  308. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:afimoxifene
    n1=en:cytarabine | n2=en:afimoxifene | rel=r_associated | relid=0 | w=20
  309. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:afp gene hepatocellular carcinoma vaccine
    n1=en:cytarabine | n2=en:afp gene hepatocellular carcinoma vaccine | rel=r_associated | relid=0 | w=20
  310. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:afp464
    n1=en:cytarabine | n2=en:afp464 | rel=r_associated | relid=0 | w=20
  311. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:afuresertib
    n1=en:cytarabine | n2=en:afuresertib | rel=r_associated | relid=0 | w=20
  312. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ag-024322
    n1=en:cytarabine | n2=en:ag-024322 | rel=r_associated | relid=0 | w=20
  313. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:agatolimod sodium
    n1=en:cytarabine | n2=en:agatolimod sodium | rel=r_associated | relid=0 | w=20
  314. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:agerafenib
    n1=en:cytarabine | n2=en:agerafenib | rel=r_associated | relid=0 | w=20
  315. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aie regimen
    n1=en:cytarabine | n2=en:aie regimen | rel=r_associated | relid=0 | w=20
  316. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aieop 8801 low-risk all protocol
    n1=en:cytarabine | n2=en:aieop 8801 low-risk all protocol | rel=r_associated | relid=0 | w=20
  317. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aieop 8802 standard-risk all protocol
    n1=en:cytarabine | n2=en:aieop 8802 standard-risk all protocol | rel=r_associated | relid=0 | w=20
  318. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aieop 8803 high-risk all protocol
    n1=en:cytarabine | n2=en:aieop 8803 high-risk all protocol | rel=r_associated | relid=0 | w=20
  319. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aieop acute lymphoblastic leukemia protocol
    n1=en:cytarabine | n2=en:aieop acute lymphoblastic leukemia protocol | rel=r_associated | relid=0 | w=20
  320. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aieop all protocol
    n1=en:cytarabine | n2=en:aieop all protocol | rel=r_associated | relid=0 | w=20
  321. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ak 3012
    n1=en:cytarabine | n2=en:ak 3012 | rel=r_associated | relid=0 | w=20
  322. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt 1/2 inhibitor bay1125976
    n1=en:cytarabine | n2=en:akt 1/2 inhibitor bay1125976 | rel=r_associated | relid=0 | w=20
  323. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt inhibitor azd5363
    n1=en:cytarabine | n2=en:akt inhibitor azd5363 | rel=r_associated | relid=0 | w=20
  324. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt inhibitor gsk2141795
    n1=en:cytarabine | n2=en:akt inhibitor gsk2141795 | rel=r_associated | relid=0 | w=20
  325. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt inhibitor ly2780301
    n1=en:cytarabine | n2=en:akt inhibitor ly2780301 | rel=r_associated | relid=0 | w=20
  326. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt inhibitor mk2206
    n1=en:cytarabine | n2=en:akt inhibitor mk2206 | rel=r_associated | relid=0 | w=20
  327. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt inhibitor sr13668
    n1=en:cytarabine | n2=en:akt inhibitor sr13668 | rel=r_associated | relid=0 | w=20
  328. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:akt/erk inhibitor onc201
    n1=en:cytarabine | n2=en:akt/erk inhibitor onc201 | rel=r_associated | relid=0 | w=20
  329. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:al-721
    n1=en:cytarabine | n2=en:al-721 | rel=r_associated | relid=0 | w=20
  330. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:al721
    n1=en:cytarabine | n2=en:al721 | rel=r_associated | relid=0 | w=20
  331. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:albuterol sulfate
    n1=en:cytarabine | n2=en:albuterol sulfate | rel=r_associated | relid=0 | w=20
  332. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aldesleukin
    n1=en:cytarabine | n2=en:aldesleukin | rel=r_associated | relid=0 | w=20
  333. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aldoxorubicin
    n1=en:cytarabine | n2=en:aldoxorubicin | rel=r_associated | relid=0 | w=20
  334. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alectinib
    n1=en:cytarabine | n2=en:alectinib | rel=r_associated | relid=0 | w=20
  335. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alefacept
    n1=en:cytarabine | n2=en:alefacept | rel=r_associated | relid=0 | w=20
  336. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alfuzosin hydrochloride
    n1=en:cytarabine | n2=en:alfuzosin hydrochloride | rel=r_associated | relid=0 | w=20
  337. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:algenpantucel-l
    n1=en:cytarabine | n2=en:algenpantucel-l | rel=r_associated | relid=0 | w=20
  338. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alhr88 protocol
    n1=en:cytarabine | n2=en:alhr88 protocol | rel=r_associated | relid=0 | w=20
  339. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alisertib
    n1=en:cytarabine | n2=en:alisertib | rel=r_associated | relid=0 | w=20
  340. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alk inhibitor x-396
    n1=en:cytarabine | n2=en:alk inhibitor x-396 | rel=r_associated | relid=0 | w=20
  341. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alk/ros1 inhibitor pf-06463922
    n1=en:cytarabine | n2=en:alk/ros1 inhibitor pf-06463922 | rel=r_associated | relid=0 | w=20
  342. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alk/trk inhibitor tsr-011
    n1=en:cytarabine | n2=en:alk/trk inhibitor tsr-011 | rel=r_associated | relid=0 | w=20
  343. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alk5 inhibitor tew-7197
    n1=en:cytarabine | n2=en:alk5 inhibitor tew-7197 | rel=r_associated | relid=0 | w=20
  344. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:all-82 protocol
    n1=en:cytarabine | n2=en:all-82 protocol | rel=r_associated | relid=0 | w=20
  345. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:all-bfm-90 protocol
    n1=en:cytarabine | n2=en:all-bfm-90 protocol | rel=r_associated | relid=0 | w=20
  346. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:all-bfm-95 protocol
    n1=en:cytarabine | n2=en:all-bfm-95 protocol | rel=r_associated | relid=0 | w=20
  347. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allodepleted haploidentical t cells-expressing inducible caspase 9
    n1=en:cytarabine | n2=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | rel=r_associated | relid=0 | w=20
  348. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allodepleted t cell immunotherapeutic atir101
    n1=en:cytarabine | n2=en:allodepleted t cell immunotherapeutic atir101 | rel=r_associated | relid=0 | w=20
  349. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic aml antigen-expressing dendritic cell vaccine
    n1=en:cytarabine | n2=en:allogeneic aml antigen-expressing dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  350. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine
    n1=en:cytarabine | n2=en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine | rel=r_associated | relid=0 | w=20
  351. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells
    n1=en:cytarabine | n2=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | rel=r_associated | relid=0 | w=20
  352. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic cd56-positive cd3-negative natural killer cells
    n1=en:cytarabine | n2=en:allogeneic cd56-positive cd3-negative natural killer cells | rel=r_associated | relid=0 | w=20
  353. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic cmv/adv-specific cytotoxic t lymphocytes
    n1=en:cytarabine | n2=en:allogeneic cmv/adv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=20
  354. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes
    n1=en:cytarabine | n2=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=20
  355. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic dendritic cell vaccine combig-dc
    n1=en:cytarabine | n2=en:allogeneic dendritic cell vaccine combig-dc | rel=r_associated | relid=0 | w=20
  356. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic dendritic cell-myeloma idiotype vaccine
    n1=en:cytarabine | n2=en:allogeneic dendritic cell-myeloma idiotype vaccine | rel=r_associated | relid=0 | w=20
  357. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  358. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic gm-csf-based myeloma cell vaccine
    n1=en:cytarabine | n2=en:allogeneic gm-csf-based myeloma cell vaccine | rel=r_associated | relid=0 | w=20
  359. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine
    n1=en:cytarabine | n2=en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine | rel=r_associated | relid=0 | w=20
  360. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo
    n1=en:cytarabine | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=20
  361. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic large multivalent immunogen breast cancer vaccine
    n1=en:cytarabine | n2=en:allogeneic large multivalent immunogen breast cancer vaccine | rel=r_associated | relid=0 | w=20
  362. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  363. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  364. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic natural killer cell line mg4101
    n1=en:cytarabine | n2=en:allogeneic natural killer cell line mg4101 | rel=r_associated | relid=0 | w=20
  365. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic natural killer cell line nk-92
    n1=en:cytarabine | n2=en:allogeneic natural killer cell line nk-92 | rel=r_associated | relid=0 | w=20
  366. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allogeneic tumor cell vaccine
    n1=en:cytarabine | n2=en:allogeneic tumor cell vaccine | rel=r_associated | relid=0 | w=20
  367. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:allosteric bcr-abl tyrosine kinase inhibitor abl001
    n1=en:cytarabine | n2=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | rel=r_associated | relid=0 | w=20
  368. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aloe vera gel
    n1=en:cytarabine | n2=en:aloe vera gel | rel=r_associated | relid=0 | w=20
  369. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha fetoprotein adenoviral vector vaccine
    n1=en:cytarabine | n2=en:alpha fetoprotein adenoviral vector vaccine | rel=r_associated | relid=0 | w=20
  370. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha fetoprotein plasmid dna vaccine
    n1=en:cytarabine | n2=en:alpha fetoprotein plasmid dna vaccine | rel=r_associated | relid=0 | w=20
  371. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha galactosylceramide
    n1=en:cytarabine | n2=en:alpha galactosylceramide | rel=r_associated | relid=0 | w=20
  372. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-1-proteinase inhibitor human
    n1=en:cytarabine | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=20
  373. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine
    n1=en:cytarabine | n2=en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine | rel=r_associated | relid=0 | w=20
  374. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801
    n1=en:cytarabine | n2=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | rel=r_associated | relid=0 | w=20
  375. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-gal glycosphingolipids
    n1=en:cytarabine | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=20
  376. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-galactosylceramide-pulsed autologous dendritic cells
    n1=en:cytarabine | n2=en:alpha-galactosylceramide-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=20
  377. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-lipoic acid-palladium/vitamin/mineral supplement
    n1=en:cytarabine | n2=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | rel=r_associated | relid=0 | w=20
  378. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-tocopheryloxyacetic acid
    n1=en:cytarabine | n2=en:alpha-tocopheryloxyacetic acid | rel=r_associated | relid=0 | w=20
  379. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alpha-type-1 polarized dendritic cells
    n1=en:cytarabine | n2=en:alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=20
  380. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:altiratinib
    n1=en:cytarabine | n2=en:altiratinib | rel=r_associated | relid=0 | w=20
  381. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvac-cea b7.1 vaccine
    n1=en:cytarabine | n2=en:alvac-cea b7.1 vaccine | rel=r_associated | relid=0 | w=20
  382. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvac-eso-1 vaccine
    n1=en:cytarabine | n2=en:alvac-eso-1 vaccine | rel=r_associated | relid=0 | w=20
  383. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvac-hb7.1
    n1=en:cytarabine | n2=en:alvac-hb7.1 | rel=r_associated | relid=0 | w=20
  384. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvac-mart-1 vaccine
    n1=en:cytarabine | n2=en:alvac-mart-1 vaccine | rel=r_associated | relid=0 | w=20
  385. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvelestat
    n1=en:cytarabine | n2=en:alvelestat | rel=r_associated | relid=0 | w=20
  386. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvespimycin hydrochloride
    n1=en:cytarabine | n2=en:alvespimycin hydrochloride | rel=r_associated | relid=0 | w=20
  387. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:alvocidib hydrochloride
    n1=en:cytarabine | n2=en:alvocidib hydrochloride | rel=r_associated | relid=0 | w=20
  388. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amantadine hydrochloride
    n1=en:cytarabine | n2=en:amantadine hydrochloride | rel=r_associated | relid=0 | w=20
  389. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amatuximab
    n1=en:cytarabine | n2=en:amatuximab | rel=r_associated | relid=0 | w=20
  390. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:American ginseng
    n1=en:cytarabine | n2=en:American ginseng | rel=r_associated | relid=0 | w=20
  391. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:american ginseng
    n1=en:cytarabine | n2=en:american ginseng | rel=r_associated | relid=0 | w=20
  392. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ametantrone
    n1=en:cytarabine | n2=en:ametantrone | rel=r_associated | relid=0 | w=20
  393. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amifampridine
    n1=en:cytarabine | n2=en:amifampridine | rel=r_associated | relid=0 | w=20
  394. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amifostine
    n1=en:cytarabine | n2=en:amifostine | rel=r_associated | relid=0 | w=20
  395. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amikacin sulfate
    n1=en:cytarabine | n2=en:amikacin sulfate | rel=r_associated | relid=0 | w=20
  396. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aminobenzoate potassium
    n1=en:cytarabine | n2=en:aminobenzoate potassium | rel=r_associated | relid=0 | w=20
  397. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aminocamptothecin
    n1=en:cytarabine | n2=en:aminocamptothecin | rel=r_associated | relid=0 | w=20
  398. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aminocamptothecin colloidal dispersion
    n1=en:cytarabine | n2=en:aminocamptothecin colloidal dispersion | rel=r_associated | relid=0 | w=20
  399. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aminocaproic acid
    n1=en:cytarabine | n2=en:aminocaproic acid | rel=r_associated | relid=0 | w=20
  400. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aminosyn
    n1=en:cytarabine | n2=en:aminosyn | rel=r_associated | relid=0 | w=20
  401. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amitriptyline hydrochloride
    n1=en:cytarabine | n2=en:amitriptyline hydrochloride | rel=r_associated | relid=0 | w=20
  402. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aml-bfm 83 protocol
    n1=en:cytarabine | n2=en:aml-bfm 83 protocol | rel=r_associated | relid=0 | w=20
  403. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aml-bfm-87
    n1=en:cytarabine | n2=en:aml-bfm-87 | rel=r_associated | relid=0 | w=20
  404. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aml8a protocol
    n1=en:cytarabine | n2=en:aml8a protocol | rel=r_associated | relid=0 | w=20
  405. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aml91 protocol
    n1=en:cytarabine | n2=en:aml91 protocol | rel=r_associated | relid=0 | w=20
  406. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aml92 protocol
    n1=en:cytarabine | n2=en:aml92 protocol | rel=r_associated | relid=0 | w=20
  407. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ammonia n-13
    n1=en:cytarabine | n2=en:ammonia n-13 | rel=r_associated | relid=0 | w=20
  408. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ammonium glycyrrhizate
    n1=en:cytarabine | n2=en:ammonium glycyrrhizate | rel=r_associated | relid=0 | w=20
  409. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amnion-derived cellular cytokine solution
    n1=en:cytarabine | n2=en:amnion-derived cellular cytokine solution | rel=r_associated | relid=0 | w=20
  410. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amolimogene bepiplasmid
    n1=en:cytarabine | n2=en:amolimogene bepiplasmid | rel=r_associated | relid=0 | w=20
  411. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amonafide dihydrochloride
    n1=en:cytarabine | n2=en:amonafide dihydrochloride | rel=r_associated | relid=0 | w=20
  412. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amonafide l-malate
    n1=en:cytarabine | n2=en:amonafide l-malate | rel=r_associated | relid=0 | w=20
  413. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amphotericin b deoxycholate
    n1=en:cytarabine | n2=en:amphotericin b deoxycholate | rel=r_associated | relid=0 | w=20
  414. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amrubicin hydrochloride
    n1=en:cytarabine | n2=en:amrubicin hydrochloride | rel=r_associated | relid=0 | w=20
  415. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amsilarotene
    n1=en:cytarabine | n2=en:amsilarotene | rel=r_associated | relid=0 | w=20
  416. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:amuvatinib
    n1=en:cytarabine | n2=en:amuvatinib | rel=r_associated | relid=0 | w=20
  417. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anagrelide hydrochloride
    n1=en:cytarabine | n2=en:anagrelide hydrochloride | rel=r_associated | relid=0 | w=20
  418. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anagrelide prolonged-release formulation
    n1=en:cytarabine | n2=en:anagrelide prolonged-release formulation | rel=r_associated | relid=0 | w=20
  419. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:analgesic agent
    n1=en:cytarabine | n2=en:analgesic agent | rel=r_associated | relid=0 | w=20
  420. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anamorelin hydrochloride
    n1=en:cytarabine | n2=en:anamorelin hydrochloride | rel=r_associated | relid=0 | w=20
  421. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anaxirone
    n1=en:cytarabine | n2=en:anaxirone | rel=r_associated | relid=0 | w=20
  422. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ancestim
    n1=en:cytarabine | n2=en:ancestim | rel=r_associated | relid=0 | w=20
  423. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ancitabine
    n1=en:cytarabine | n2=en:ancitabine | rel=r_associated | relid=0 | w=20
  424. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androgen antagonist apc-100
    n1=en:cytarabine | n2=en:androgen antagonist apc-100 | rel=r_associated | relid=0 | w=20
  425. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androgen receptor antagonist arn-509
    n1=en:cytarabine | n2=en:androgen receptor antagonist arn-509 | rel=r_associated | relid=0 | w=20
  426. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androgen receptor antagonist shr3680
    n1=en:cytarabine | n2=en:androgen receptor antagonist shr3680 | rel=r_associated | relid=0 | w=20
  427. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androgen receptor antisense oligonucleotide azd5312
    n1=en:cytarabine | n2=en:androgen receptor antisense oligonucleotide azd5312 | rel=r_associated | relid=0 | w=20
  428. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androgen receptor antisense oligonucleotide ezn-4176
    n1=en:cytarabine | n2=en:androgen receptor antisense oligonucleotide ezn-4176 | rel=r_associated | relid=0 | w=20
  429. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androgen receptor inhibitor epi-506
    n1=en:cytarabine | n2=en:androgen receptor inhibitor epi-506 | rel=r_associated | relid=0 | w=20
  430. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:androstane steroid he3235
    n1=en:cytarabine | n2=en:androstane steroid he3235 | rel=r_associated | relid=0 | w=20
  431. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anesthetic agent
    n1=en:cytarabine | n2=en:anesthetic agent | rel=r_associated | relid=0 | w=20
  432. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:angiogenesis inhibitor gt-111
    n1=en:cytarabine | n2=en:angiogenesis inhibitor gt-111 | rel=r_associated | relid=0 | w=20
  433. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:angiogenesis inhibitor ji-101
    n1=en:cytarabine | n2=en:angiogenesis inhibitor ji-101 | rel=r_associated | relid=0 | w=20
  434. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:angiostatin
    n1=en:cytarabine | n2=en:angiostatin | rel=r_associated | relid=0 | w=20
  435. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anhydro-araic 3'-acetate
    n1=en:cytarabine | n2=en:anhydro-araic 3'-acetate | rel=r_associated | relid=0 | w=20
  436. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anhydrovinblastine
    n1=en:cytarabine | n2=en:anhydrovinblastine | rel=r_associated | relid=0 | w=20
  437. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aniline mustard
    n1=en:cytarabine | n2=en:aniline mustard | rel=r_associated | relid=0 | w=20
  438. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anll91 protocol
    n1=en:cytarabine | n2=en:anll91 protocol | rel=r_associated | relid=0 | w=20
  439. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:annamycin liposomal
    n1=en:cytarabine | n2=en:annamycin liposomal | rel=r_associated | relid=0 | w=20
  440. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:annonaceous acetogenins
    n1=en:cytarabine | n2=en:annonaceous acetogenins | rel=r_associated | relid=0 | w=20
  441. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:answer
    n1=en:cytarabine | n2=en:answer | rel=r_associated | relid=0 | w=20
  442. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:answer [sb] back
    n1=en:cytarabine | n2=en:answer [sb] back | rel=r_associated | relid=0 | w=20
  443. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:answer sb back
    n1=en:cytarabine | n2=en:answer sb back | rel=r_associated | relid=0 | w=20
  444. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:answer somebody back
    n1=en:cytarabine | n2=en:answer somebody back | rel=r_associated | relid=0 | w=20
  445. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anthocyanin-rich corn extract
    n1=en:cytarabine | n2=en:anthocyanin-rich corn extract | rel=r_associated | relid=0 | w=20
  446. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti c-kit antibody-drug conjugate lop628
    n1=en:cytarabine | n2=en:anti c-kit antibody-drug conjugate lop628 | rel=r_associated | relid=0 | w=20
  447. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-a33 monoclonal antibody krn330
    n1=en:cytarabine | n2=en:anti-a33 monoclonal antibody krn330 | rel=r_associated | relid=0 | w=20
  448. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-a5b1 integrin monoclonal antibody pf-04605412
    n1=en:cytarabine | n2=en:anti-a5b1 integrin monoclonal antibody pf-04605412 | rel=r_associated | relid=0 | w=20
  449. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ags-5 antibody-drug conjugate asg-5me
    n1=en:cytarabine | n2=en:anti-ags-5 antibody-drug conjugate asg-5me | rel=r_associated | relid=0 | w=20
  450. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ags-8 monoclonal antibody ags-8m4
    n1=en:cytarabine | n2=en:anti-ags-8 monoclonal antibody ags-8m4 | rel=r_associated | relid=0 | w=20
  451. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-alk-1 monoclonal antibody pf-03446962
    n1=en:cytarabine | n2=en:anti-alk-1 monoclonal antibody pf-03446962 | rel=r_associated | relid=0 | w=20
  452. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-allergic agents
    n1=en:cytarabine | n2=en:anti-allergic agents | rel=r_associated | relid=0 | w=20
  453. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-alpha5beta1 integrin antibody mint1526a
    n1=en:cytarabine | n2=en:anti-alpha5beta1 integrin antibody mint1526a | rel=r_associated | relid=0 | w=20
  454. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-alphavbeta3 monoclonal antibody emd 525797
    n1=en:cytarabine | n2=en:anti-alphavbeta3 monoclonal antibody emd 525797 | rel=r_associated | relid=0 | w=20
  455. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ang2 monoclonal antibody medi-3617
    n1=en:cytarabine | n2=en:anti-ang2 monoclonal antibody medi-3617 | rel=r_associated | relid=0 | w=20
  456. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-b4 blocked ricin immunotoxin
    n1=en:cytarabine | n2=en:anti-b4 blocked ricin immunotoxin | rel=r_associated | relid=0 | w=20
  457. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-c-fms monoclonal antibody amg 820
    n1=en:cytarabine | n2=en:anti-c-fms monoclonal antibody amg 820 | rel=r_associated | relid=0 | w=20
  458. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-c-kit monoclonal antibody ktn0158
    n1=en:cytarabine | n2=en:anti-c-kit monoclonal antibody ktn0158 | rel=r_associated | relid=0 | w=20
  459. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-c-met monoclonal antibody abt-700
    n1=en:cytarabine | n2=en:anti-c-met monoclonal antibody abt-700 | rel=r_associated | relid=0 | w=20
  460. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-c-met monoclonal antibody argx-111
    n1=en:cytarabine | n2=en:anti-c-met monoclonal antibody argx-111 | rel=r_associated | relid=0 | w=20
  461. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-c-met monoclonal antibody ly2875358
    n1=en:cytarabine | n2=en:anti-c-met monoclonal antibody ly2875358 | rel=r_associated | relid=0 | w=20
  462. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-c-met monoclonal antibody sait301
    n1=en:cytarabine | n2=en:anti-c-met monoclonal antibody sait301 | rel=r_associated | relid=0 | w=20
  463. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ca19-9 monoclonal antibody 5b1
    n1=en:cytarabine | n2=en:anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=20
  464. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ca6-dm4 immunoconjugate sar566658
    n1=en:cytarabine | n2=en:anti-ca6-dm4 immunoconjugate sar566658 | rel=r_associated | relid=0 | w=20
  465. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd123 monoclonal antibody csl360
    n1=en:cytarabine | n2=en:anti-cd123 monoclonal antibody csl360 | rel=r_associated | relid=0 | w=20
  466. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd123 monoclonal antibody csl362
    n1=en:cytarabine | n2=en:anti-cd123 monoclonal antibody csl362 | rel=r_associated | relid=0 | w=20
  467. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd123 x anti-cd3 bispecific antibody xmab1404
    n1=en:cytarabine | n2=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | rel=r_associated | relid=0 | w=20
  468. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd123/cd3 monoclonal antibody mgd006
    n1=en:cytarabine | n2=en:anti-cd123/cd3 monoclonal antibody mgd006 | rel=r_associated | relid=0 | w=20
  469. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd157 monoclonal antibody men1112
    n1=en:cytarabine | n2=en:anti-cd157 monoclonal antibody men1112 | rel=r_associated | relid=0 | w=20
  470. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19 monoclonal antibody mdx-1342
    n1=en:cytarabine | n2=en:anti-cd19 monoclonal antibody mdx-1342 | rel=r_associated | relid=0 | w=20
  471. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19 monoclonal antibody xmab5574
    n1=en:cytarabine | n2=en:anti-cd19 monoclonal antibody xmab5574 | rel=r_associated | relid=0 | w=20
  472. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes
    n1=en:cytarabine | n2=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=20
  473. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19-car retroviral vector-transduced autologous t cells
    n1=en:cytarabine | n2=en:anti-cd19-car retroviral vector-transduced autologous t cells | rel=r_associated | relid=0 | w=20
  474. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells
    n1=en:cytarabine | n2=en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells | rel=r_associated | relid=0 | w=20
  475. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19-dm4 immunoconjugate sar3419
    n1=en:cytarabine | n2=en:anti-cd19-dm4 immunoconjugate sar3419 | rel=r_associated | relid=0 | w=20
  476. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl
    n1=en:cytarabine | n2=en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl | rel=r_associated | relid=0 | w=20
  477. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd19/cd3 tetravalent antibody afm11
    n1=en:cytarabine | n2=en:anti-cd19/cd3 tetravalent antibody afm11 | rel=r_associated | relid=0 | w=20
  478. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20 b9e9 scfv-streptavidin fusion protein
    n1=en:cytarabine | n2=en:anti-cd20 b9e9 scfv-streptavidin fusion protein | rel=r_associated | relid=0 | w=20
  479. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20 monoclonal antibody pro131921
    n1=en:cytarabine | n2=en:anti-cd20 monoclonal antibody pro131921 | rel=r_associated | relid=0 | w=20
  480. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20 monoclonal antibody sct400
    n1=en:cytarabine | n2=en:anti-cd20 monoclonal antibody sct400 | rel=r_associated | relid=0 | w=20
  481. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20 monoclonal antibody tl011
    n1=en:cytarabine | n2=en:anti-cd20 monoclonal antibody tl011 | rel=r_associated | relid=0 | w=20
  482. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002
    n1=en:cytarabine | n2=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | rel=r_associated | relid=0 | w=20
  483. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells
    n1=en:cytarabine | n2=en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells | rel=r_associated | relid=0 | w=20
  484. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20-engineered toxin body mt-3724
    n1=en:cytarabine | n2=en:anti-cd20-engineered toxin body mt-3724 | rel=r_associated | relid=0 | w=20
  485. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd20/cd3 monoclonal antibody regn1979
    n1=en:cytarabine | n2=en:anti-cd20/cd3 monoclonal antibody regn1979 | rel=r_associated | relid=0 | w=20
  486. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd200 monoclonal antibody alxn6000
    n1=en:cytarabine | n2=en:anti-cd200 monoclonal antibody alxn6000 | rel=r_associated | relid=0 | w=20
  487. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd22 car-expressing t lymphocytes
    n1=en:cytarabine | n2=en:anti-cd22 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  488. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s
    n1=en:cytarabine | n2=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | rel=r_associated | relid=0 | w=20
  489. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes
    n1=en:cytarabine | n2=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  490. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd25-pbd antibody-drug conjugate adct-301
    n1=en:cytarabine | n2=en:anti-cd25-pbd antibody-drug conjugate adct-301 | rel=r_associated | relid=0 | w=20
  491. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd27l antibody-drug conjugate amg 172
    n1=en:cytarabine | n2=en:anti-cd27l antibody-drug conjugate amg 172 | rel=r_associated | relid=0 | w=20
  492. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1)
    n1=en:cytarabine | n2=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | rel=r_associated | relid=0 | w=20
  493. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes
    n1=en:cytarabine | n2=en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes | rel=r_associated | relid=0 | w=20
  494. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05
    n1=en:cytarabine | n2=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | rel=r_associated | relid=0 | w=20
  495. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes
    n1=en:cytarabine | n2=en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  496. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd30 monoclonal antibody mdx-1401
    n1=en:cytarabine | n2=en:anti-cd30 monoclonal antibody mdx-1401 | rel=r_associated | relid=0 | w=20
  497. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd33 antibody-drug conjugate imgn779
    n1=en:cytarabine | n2=en:anti-cd33 antibody-drug conjugate imgn779 | rel=r_associated | relid=0 | w=20
  498. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633
    n1=en:cytarabine | n2=en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 | rel=r_associated | relid=0 | w=20
  499. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd33/cd3 bite antibody amg 330
    n1=en:cytarabine | n2=en:anti-cd33/cd3 bite antibody amg 330 | rel=r_associated | relid=0 | w=20
  500. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd37 monoclonal antibody bi 836826
    n1=en:cytarabine | n2=en:anti-cd37 monoclonal antibody bi 836826 | rel=r_associated | relid=0 | w=20
  501. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd38 monoclonal antibody mor03087
    n1=en:cytarabine | n2=en:anti-cd38 monoclonal antibody mor03087 | rel=r_associated | relid=0 | w=20
  502. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd38 monoclonal antibody sar650984
    n1=en:cytarabine | n2=en:anti-cd38 monoclonal antibody sar650984 | rel=r_associated | relid=0 | w=20
  503. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd40 monoclonal antibody chi lob 7/4
    n1=en:cytarabine | n2=en:anti-cd40 monoclonal antibody chi lob 7/4 | rel=r_associated | relid=0 | w=20
  504. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd40 monoclonal antibody sea-cd40
    n1=en:cytarabine | n2=en:anti-cd40 monoclonal antibody sea-cd40 | rel=r_associated | relid=0 | w=20
  505. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd44 monoclonal antibody ro5429083
    n1=en:cytarabine | n2=en:anti-cd44 monoclonal antibody ro5429083 | rel=r_associated | relid=0 | w=20
  506. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate
    n1=en:cytarabine | n2=en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate | rel=r_associated | relid=0 | w=20
  507. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd45 monoclonal antibody bc8
    n1=en:cytarabine | n2=en:anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=20
  508. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd47 monoclonal antibody cc-90002
    n1=en:cytarabine | n2=en:anti-cd47 monoclonal antibody cc-90002 | rel=r_associated | relid=0 | w=20
  509. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd47 monoclonal antibody hu5f9-g4
    n1=en:cytarabine | n2=en:anti-cd47 monoclonal antibody hu5f9-g4 | rel=r_associated | relid=0 | w=20
  510. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd7 immunotoxin
    n1=en:cytarabine | n2=en:anti-cd7 immunotoxin | rel=r_associated | relid=0 | w=20
  511. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd70 antibody-drug conjugate mdx-1203
    n1=en:cytarabine | n2=en:anti-cd70 antibody-drug conjugate mdx-1203 | rel=r_associated | relid=0 | w=20
  512. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd70 antibody-drug conjugate sgn-cd70a
    n1=en:cytarabine | n2=en:anti-cd70 antibody-drug conjugate sgn-cd70a | rel=r_associated | relid=0 | w=20
  513. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd70 monoclonal antibody argx-110
    n1=en:cytarabine | n2=en:anti-cd70 monoclonal antibody argx-110 | rel=r_associated | relid=0 | w=20
  514. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd73 monoclonal antibody medi9447
    n1=en:cytarabine | n2=en:anti-cd73 monoclonal antibody medi9447 | rel=r_associated | relid=0 | w=20
  515. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cd98 monoclonal antibody ign523
    n1=en:cytarabine | n2=en:anti-cd98 monoclonal antibody ign523 | rel=r_associated | relid=0 | w=20
  516. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cea bite monoclonal antibody amg211
    n1=en:cytarabine | n2=en:anti-cea bite monoclonal antibody amg211 | rel=r_associated | relid=0 | w=20
  517. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cea igcd28tcr-transduced autologous t cells
    n1=en:cytarabine | n2=en:anti-cea igcd28tcr-transduced autologous t cells | rel=r_associated | relid=0 | w=20
  518. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  519. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cea-car autologous t lymphocytes
    n1=en:cytarabine | n2=en:anti-cea-car autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  520. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cea/anti-hsg bispecific monoclonal antibody tf2
    n1=en:cytarabine | n2=en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 | rel=r_associated | relid=0 | w=20
  521. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cea/cd3 bispecific antibody ro6958688
    n1=en:cytarabine | n2=en:anti-cea/cd3 bispecific antibody ro6958688 | rel=r_associated | relid=0 | w=20
  522. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ceacam1 monoclonal antibody cm-24
    n1=en:cytarabine | n2=en:anti-ceacam1 monoclonal antibody cm-24 | rel=r_associated | relid=0 | w=20
  523. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ceacam5 antibody-drug conjugate sar408701
    n1=en:cytarabine | n2=en:anti-ceacam5 antibody-drug conjugate sar408701 | rel=r_associated | relid=0 | w=20
  524. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-cldn6 monoclonal antibody imab027
    n1=en:cytarabine | n2=en:anti-cldn6 monoclonal antibody imab027 | rel=r_associated | relid=0 | w=20
  525. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-csf1r monoclonal antibody fpa008
    n1=en:cytarabine | n2=en:anti-csf1r monoclonal antibody fpa008 | rel=r_associated | relid=0 | w=20
  526. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-csf1r monoclonal antibody imc-cs4
    n1=en:cytarabine | n2=en:anti-csf1r monoclonal antibody imc-cs4 | rel=r_associated | relid=0 | w=20
  527. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ctgf monoclonal antibody fg-3019
    n1=en:cytarabine | n2=en:anti-ctgf monoclonal antibody fg-3019 | rel=r_associated | relid=0 | w=20
  528. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  529. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ctla-4 monoclonal antibody agen1884
    n1=en:cytarabine | n2=en:anti-ctla-4 monoclonal antibody agen1884 | rel=r_associated | relid=0 | w=20
  530. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  531. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-denatured collagen monoclonal antibody trc093
    n1=en:cytarabine | n2=en:anti-denatured collagen monoclonal antibody trc093 | rel=r_associated | relid=0 | w=20
  532. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-dkk-1 monoclonal antibody ly2812176
    n1=en:cytarabine | n2=en:anti-dkk-1 monoclonal antibody ly2812176 | rel=r_associated | relid=0 | w=20
  533. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-dkk1 monoclonal antibody bhq880
    n1=en:cytarabine | n2=en:anti-dkk1 monoclonal antibody bhq880 | rel=r_associated | relid=0 | w=20
  534. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-dll4 monoclonal antibody medi0639
    n1=en:cytarabine | n2=en:anti-dll4 monoclonal antibody medi0639 | rel=r_associated | relid=0 | w=20
  535. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83
    n1=en:cytarabine | n2=en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 | rel=r_associated | relid=0 | w=20
  536. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr monoclonal antibody gc1118
    n1=en:cytarabine | n2=en:anti-egfr monoclonal antibody gc1118 | rel=r_associated | relid=0 | w=20
  537. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr monoclonal antibody mixture mm-151
    n1=en:cytarabine | n2=en:anti-egfr monoclonal antibody mixture mm-151 | rel=r_associated | relid=0 | w=20
  538. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr monoclonal antibody mixture sym004
    n1=en:cytarabine | n2=en:anti-egfr monoclonal antibody mixture sym004 | rel=r_associated | relid=0 | w=20
  539. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr monoclonal antibody ro5083945
    n1=en:cytarabine | n2=en:anti-egfr monoclonal antibody ro5083945 | rel=r_associated | relid=0 | w=20
  540. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr monoclonal antibody sct200
    n1=en:cytarabine | n2=en:anti-egfr monoclonal antibody sct200 | rel=r_associated | relid=0 | w=20
  541. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr monoclonal antibody syn004
    n1=en:cytarabine | n2=en:anti-egfr monoclonal antibody syn004 | rel=r_associated | relid=0 | w=20
  542. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr tap antibody-drug conjugate imgn289
    n1=en:cytarabine | n2=en:anti-egfr tap antibody-drug conjugate imgn289 | rel=r_associated | relid=0 | w=20
  543. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfr/c-met bispecific antibody jnj-61186372
    n1=en:cytarabine | n2=en:anti-egfr/c-met bispecific antibody jnj-61186372 | rel=r_associated | relid=0 | w=20
  544. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfrviii antibody drug conjugate amg 595
    n1=en:cytarabine | n2=en:anti-egfrviii antibody drug conjugate amg 595 | rel=r_associated | relid=0 | w=20
  545. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfrviii car-transduced allogeneic t-lymphocytes
    n1=en:cytarabine | n2=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=20
  546. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-egfrviii immunotoxin mr1-1
    n1=en:cytarabine | n2=en:anti-egfrviii immunotoxin mr1-1 | rel=r_associated | relid=0 | w=20
  547. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-endosialin monoclonal antibody morab-004
    n1=en:cytarabine | n2=en:anti-endosialin monoclonal antibody morab-004 | rel=r_associated | relid=0 | w=20
  548. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-enpp3 antibody-drug conjugate ags-16c3f
    n1=en:cytarabine | n2=en:anti-enpp3 antibody-drug conjugate ags-16c3f | rel=r_associated | relid=0 | w=20
  549. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f
    n1=en:cytarabine | n2=en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f | rel=r_associated | relid=0 | w=20
  550. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein
    n1=en:cytarabine | n2=en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein | rel=r_associated | relid=0 | w=20
  551. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-epha2 monoclonal antibody ds-8895a
    n1=en:cytarabine | n2=en:anti-epha2 monoclonal antibody ds-8895a | rel=r_associated | relid=0 | w=20
  552. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547
    n1=en:cytarabine | n2=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | rel=r_associated | relid=0 | w=20
  553. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes
    n1=en:cytarabine | n2=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=20
  554. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111
    n1=en:cytarabine | n2=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | rel=r_associated | relid=0 | w=20
  555. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-erbb3 monoclonal antibody av-203
    n1=en:cytarabine | n2=en:anti-erbb3 monoclonal antibody av-203 | rel=r_associated | relid=0 | w=20
  556. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-erbb3 monoclonal antibody ktn3379
    n1=en:cytarabine | n2=en:anti-erbb3 monoclonal antibody ktn3379 | rel=r_associated | relid=0 | w=20
  557. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-etbr/mmae antibody-drug conjugate dedn6526a
    n1=en:cytarabine | n2=en:anti-etbr/mmae antibody-drug conjugate dedn6526a | rel=r_associated | relid=0 | w=20
  558. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fgf23 igg1 monoclonal antibody krn23
    n1=en:cytarabine | n2=en:anti-fgf23 igg1 monoclonal antibody krn23 | rel=r_associated | relid=0 | w=20
  559. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fgfr2 antibody bay1179470
    n1=en:cytarabine | n2=en:anti-fgfr2 antibody bay1179470 | rel=r_associated | relid=0 | w=20
  560. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fgfr2 antibody-drug conjugate bay1187982
    n1=en:cytarabine | n2=en:anti-fgfr2 antibody-drug conjugate bay1187982 | rel=r_associated | relid=0 | w=20
  561. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fgfr2 monoclonal antibody fpa144
    n1=en:cytarabine | n2=en:anti-fgfr2 monoclonal antibody fpa144 | rel=r_associated | relid=0 | w=20
  562. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fgfr3 antibody-drug conjugate ly3076226
    n1=en:cytarabine | n2=en:anti-fgfr3 antibody-drug conjugate ly3076226 | rel=r_associated | relid=0 | w=20
  563. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fgfr3 monoclonal antibody b-701
    n1=en:cytarabine | n2=en:anti-fgfr3 monoclonal antibody b-701 | rel=r_associated | relid=0 | w=20
  564. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-flt3 monoclonal antibody imc-eb10
    n1=en:cytarabine | n2=en:anti-flt3 monoclonal antibody imc-eb10 | rel=r_associated | relid=0 | w=20
  565. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-fucosyl-gm1 monoclonal antibody bms-986012
    n1=en:cytarabine | n2=en:anti-fucosyl-gm1 monoclonal antibody bms-986012 | rel=r_associated | relid=0 | w=20
  566. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ganglioside gm2 monoclonal antibody biw-8962
    n1=en:cytarabine | n2=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | rel=r_associated | relid=0 | w=20
  567. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gcc antibody-drug conjugate mln0264
    n1=en:cytarabine | n2=en:anti-gcc antibody-drug conjugate mln0264 | rel=r_associated | relid=0 | w=20
  568. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gd2 monoclonal antibody morab-028
    n1=en:cytarabine | n2=en:anti-gd2 monoclonal antibody morab-028 | rel=r_associated | relid=0 | w=20
  569. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gitr agonistic monoclonal antibody incagn01876
    n1=en:cytarabine | n2=en:anti-gitr agonistic monoclonal antibody incagn01876 | rel=r_associated | relid=0 | w=20
  570. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gitr monoclonal antibody gwn 323
    n1=en:cytarabine | n2=en:anti-gitr monoclonal antibody gwn 323 | rel=r_associated | relid=0 | w=20
  571. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gitr monoclonal antibody mk-4166
    n1=en:cytarabine | n2=en:anti-gitr monoclonal antibody mk-4166 | rel=r_associated | relid=0 | w=20
  572. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gnrh vaccine pep223
    n1=en:cytarabine | n2=en:anti-gnrh vaccine pep223 | rel=r_associated | relid=0 | w=20
  573. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gpa33/cd3 monoclonal antibody mgd007
    n1=en:cytarabine | n2=en:anti-gpa33/cd3 monoclonal antibody mgd007 | rel=r_associated | relid=0 | w=20
  574. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gpc3 monoclonal antibody gc33
    n1=en:cytarabine | n2=en:anti-gpc3 monoclonal antibody gc33 | rel=r_associated | relid=0 | w=20
  575. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-gpc3-car autologous t lymphocytes
    n1=en:cytarabine | n2=en:anti-gpc3-car autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  576. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-hb-egf monoclonal antibody khk2866
    n1=en:cytarabine | n2=en:anti-hb-egf monoclonal antibody khk2866 | rel=r_associated | relid=0 | w=20
  577. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-hbegf monoclonal antibody u3-1565
    n1=en:cytarabine | n2=en:anti-hbegf monoclonal antibody u3-1565 | rel=r_associated | relid=0 | w=20
  578. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  579. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-her2 antibody-drug conjugate arx788
    n1=en:cytarabine | n2=en:anti-her2 antibody-drug conjugate arx788 | rel=r_associated | relid=0 | w=20
  580. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-her2 monoclonal antibody ct-p6
    n1=en:cytarabine | n2=en:anti-her2 monoclonal antibody ct-p6 | rel=r_associated | relid=0 | w=20
  581. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  582. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-her3 monoclonal antibody gsk2849330
    n1=en:cytarabine | n2=en:anti-her3 monoclonal antibody gsk2849330 | rel=r_associated | relid=0 | w=20
  583. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-her3 monoclonal antibody ljm716
    n1=en:cytarabine | n2=en:anti-her3 monoclonal antibody ljm716 | rel=r_associated | relid=0 | w=20
  584. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-hgf monoclonal antibody tak-701
    n1=en:cytarabine | n2=en:anti-hgf monoclonal antibody tak-701 | rel=r_associated | relid=0 | w=20
  585. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968
    n1=en:cytarabine | n2=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | rel=r_associated | relid=0 | w=20
  586. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes
    n1=en:cytarabine | n2=en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  587. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-hla-dr monoclonal antibody immu-114
    n1=en:cytarabine | n2=en:anti-hla-dr monoclonal antibody immu-114 | rel=r_associated | relid=0 | w=20
  588. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-human chorionic gonadotropin vaccine
    n1=en:cytarabine | n2=en:anti-human chorionic gonadotropin vaccine | rel=r_associated | relid=0 | w=20
  589. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-human gitr monoclonal antibody trx518
    n1=en:cytarabine | n2=en:anti-human gitr monoclonal antibody trx518 | rel=r_associated | relid=0 | w=20
  590. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-icam-1 monoclonal antibody bi-505
    n1=en:cytarabine | n2=en:anti-icam-1 monoclonal antibody bi-505 | rel=r_associated | relid=0 | w=20
  591. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-icos agonist antibody gsk3359609
    n1=en:cytarabine | n2=en:anti-icos agonist antibody gsk3359609 | rel=r_associated | relid=0 | w=20
  592. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-icos monoclonal antibody medi-570
    n1=en:cytarabine | n2=en:anti-icos monoclonal antibody medi-570 | rel=r_associated | relid=0 | w=20
  593. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-igf-1r monoclonal antibody ave1642
    n1=en:cytarabine | n2=en:anti-igf-1r monoclonal antibody ave1642 | rel=r_associated | relid=0 | w=20
  594. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-igf-1r recombinant monoclonal antibody biib022
    n1=en:cytarabine | n2=en:anti-igf-1r recombinant monoclonal antibody biib022 | rel=r_associated | relid=0 | w=20
  595. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-igf1/2 monoclonal antibody medi-573
    n1=en:cytarabine | n2=en:anti-igf1/2 monoclonal antibody medi-573 | rel=r_associated | relid=0 | w=20
  596. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-il-1 alpha monoclonal antibody mabp1
    n1=en:cytarabine | n2=en:anti-il-1 alpha monoclonal antibody mabp1 | rel=r_associated | relid=0 | w=20
  597. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-il-13 humanized monoclonal antibody tnx-650
    n1=en:cytarabine | n2=en:anti-il-13 humanized monoclonal antibody tnx-650 | rel=r_associated | relid=0 | w=20
  598. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-il-4/il-13 combination agent qbx258
    n1=en:cytarabine | n2=en:anti-il-4/il-13 combination agent qbx258 | rel=r_associated | relid=0 | w=20
  599. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-il-8 monoclonal antibody humax-il8
    n1=en:cytarabine | n2=en:anti-il-8 monoclonal antibody humax-il8 | rel=r_associated | relid=0 | w=20
  600. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-inflammatory agents
    n1=en:cytarabine | n2=en:anti-inflammatory agents | rel=r_associated | relid=0 | w=20
  601. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388
    n1=en:cytarabine | n2=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | rel=r_associated | relid=0 | w=20
  602. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-kir monoclonal antibody iph 2101
    n1=en:cytarabine | n2=en:anti-kir monoclonal antibody iph 2101 | rel=r_associated | relid=0 | w=20
  603. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-lag-3 monoclonal antibody bms-986016
    n1=en:cytarabine | n2=en:anti-lag-3 monoclonal antibody bms-986016 | rel=r_associated | relid=0 | w=20
  604. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-lag-3 monoclonal antibody lag525
    n1=en:cytarabine | n2=en:anti-lag-3 monoclonal antibody lag525 | rel=r_associated | relid=0 | w=20
  605. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-lamp1 antibody-drug conjugate sar428926
    n1=en:cytarabine | n2=en:anti-lamp1 antibody-drug conjugate sar428926 | rel=r_associated | relid=0 | w=20
  606. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ly6e antibody-drug conjugate dlye5953a
    n1=en:cytarabine | n2=en:anti-ly6e antibody-drug conjugate dlye5953a | rel=r_associated | relid=0 | w=20
  607. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-masp-2 monoclonal antibody oms721
    n1=en:cytarabine | n2=en:anti-masp-2 monoclonal antibody oms721 | rel=r_associated | relid=0 | w=20
  608. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-melanin monoclonal antibody pti-6d2
    n1=en:cytarabine | n2=en:anti-melanin monoclonal antibody pti-6d2 | rel=r_associated | relid=0 | w=20
  609. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes
    n1=en:cytarabine | n2=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  610. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100
    n1=en:cytarabine | n2=en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | rel=r_associated | relid=0 | w=20
  611. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-met monoclonal antibody mixture sym015
    n1=en:cytarabine | n2=en:anti-met monoclonal antibody mixture sym015 | rel=r_associated | relid=0 | w=20
  612. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-met/egfr monoclonal antibody ly3164530
    n1=en:cytarabine | n2=en:anti-met/egfr monoclonal antibody ly3164530 | rel=r_associated | relid=0 | w=20
  613. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-mmp-9 monoclonal antibody gs-5745
    n1=en:cytarabine | n2=en:anti-mmp-9 monoclonal antibody gs-5745 | rel=r_associated | relid=0 | w=20
  614. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-muc1 car-transduced autologous t-lymphocytes
    n1=en:cytarabine | n2=en:anti-muc1 car-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  615. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-muc1 monoclonal antibody bth1704
    n1=en:cytarabine | n2=en:anti-muc1 monoclonal antibody bth1704 | rel=r_associated | relid=0 | w=20
  616. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062
    n1=en:cytarabine | n2=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | rel=r_associated | relid=0 | w=20
  617. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-myostatin monoclonal antibody ly2495655
    n1=en:cytarabine | n2=en:anti-myostatin monoclonal antibody ly2495655 | rel=r_associated | relid=0 | w=20
  618. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-napi2b/mmae antibody-drug conjugate dnib0600a
    n1=en:cytarabine | n2=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | rel=r_associated | relid=0 | w=20
  619. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-nectin 4 antibody-drug conjugate asg-22ce
    n1=en:cytarabine | n2=en:anti-nectin 4 antibody-drug conjugate asg-22ce | rel=r_associated | relid=0 | w=20
  620. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e
    n1=en:cytarabine | n2=en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e | rel=r_associated | relid=0 | w=20
  621. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-neuropilin-1 monoclonal antibody mnrp1685a
    n1=en:cytarabine | n2=en:anti-neuropilin-1 monoclonal antibody mnrp1685a | rel=r_associated | relid=0 | w=20
  622. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-nf-p2x7 antibody ointment bil-010t
    n1=en:cytarabine | n2=en:anti-nf-p2x7 antibody ointment bil-010t | rel=r_associated | relid=0 | w=20
  623. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-nucleolin aptamer as1411
    n1=en:cytarabine | n2=en:anti-nucleolin aptamer as1411 | rel=r_associated | relid=0 | w=20
  624. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ofa immunotherapeutic bb-mpi-03
    n1=en:cytarabine | n2=en:anti-ofa immunotherapeutic bb-mpi-03 | rel=r_associated | relid=0 | w=20
  625. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ox40 monoclonal antibody
    n1=en:cytarabine | n2=en:anti-ox40 monoclonal antibody | rel=r_associated | relid=0 | w=20
  626. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ox40 monoclonal antibody gsk3174998
    n1=en:cytarabine | n2=en:anti-ox40 monoclonal antibody gsk3174998 | rel=r_associated | relid=0 | w=20
  627. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ox40 monoclonal antibody medi0562
    n1=en:cytarabine | n2=en:anti-ox40 monoclonal antibody medi0562 | rel=r_associated | relid=0 | w=20
  628. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  629. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-1 fusion protein amp-224
    n1=en:cytarabine | n2=en:anti-pd-1 fusion protein amp-224 | rel=r_associated | relid=0 | w=20
  630. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-1 monoclonal antibody bgb-a317
    n1=en:cytarabine | n2=en:anti-pd-1 monoclonal antibody bgb-a317 | rel=r_associated | relid=0 | w=20
  631. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-1 monoclonal antibody medi0680
    n1=en:cytarabine | n2=en:anti-pd-1 monoclonal antibody medi0680 | rel=r_associated | relid=0 | w=20
  632. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-1 monoclonal antibody regn2810
    n1=en:cytarabine | n2=en:anti-pd-1 monoclonal antibody regn2810 | rel=r_associated | relid=0 | w=20
  633. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-1 monoclonal antibody shr-1210
    n1=en:cytarabine | n2=en:anti-pd-1 monoclonal antibody shr-1210 | rel=r_associated | relid=0 | w=20
  634. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-l1 monoclonal antibody ly3300054
    n1=en:cytarabine | n2=en:anti-pd-l1 monoclonal antibody ly3300054 | rel=r_associated | relid=0 | w=20
  635. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pd-l1/tgfbetarii fusion protein msb0011359c
    n1=en:cytarabine | n2=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | rel=r_associated | relid=0 | w=20
  636. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pdgfr alpha monoclonal antibody medi-575
    n1=en:cytarabine | n2=en:anti-pdgfr alpha monoclonal antibody medi-575 | rel=r_associated | relid=0 | w=20
  637. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pgf monoclonal antibody ro5323441
    n1=en:cytarabine | n2=en:anti-pgf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=20
  638. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-pkn3 sirna atu027
    n1=en:cytarabine | n2=en:anti-pkn3 sirna atu027 | rel=r_associated | relid=0 | w=20
  639. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-plgf monoclonal antibody tb-403
    n1=en:cytarabine | n2=en:anti-plgf monoclonal antibody tb-403 | rel=r_associated | relid=0 | w=20
  640. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes
    n1=en:cytarabine | n2=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=20
  641. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-prolactin receptor antibody lfa102
    n1=en:cytarabine | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=20
  642. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-psma monoclonal antibody mdx1201-a488
    n1=en:cytarabine | n2=en:anti-psma monoclonal antibody mdx1201-a488 | rel=r_associated | relid=0 | w=20
  643. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-psma monoclonal antibody-mmae conjugate
    n1=en:cytarabine | n2=en:anti-psma monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=20
  644. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-psma/cd3 bite monoclonal antibody mt112
    n1=en:cytarabine | n2=en:anti-psma/cd3 bite monoclonal antibody mt112 | rel=r_associated | relid=0 | w=20
  645. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-psma/cd3 monoclonal antibody mor209/es414
    n1=en:cytarabine | n2=en:anti-psma/cd3 monoclonal antibody mor209/es414 | rel=r_associated | relid=0 | w=20
  646. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-rspo3 monoclonal antibody omp-131r10
    n1=en:cytarabine | n2=en:anti-rspo3 monoclonal antibody omp-131r10 | rel=r_associated | relid=0 | w=20
  647. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-sclu monoclonal antibody ab-16b5
    n1=en:cytarabine | n2=en:anti-sclu monoclonal antibody ab-16b5 | rel=r_associated | relid=0 | w=20
  648. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-sema4d monoclonal antibody vx15/2503
    n1=en:cytarabine | n2=en:anti-sema4d monoclonal antibody vx15/2503 | rel=r_associated | relid=0 | w=20
  649. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e
    n1=en:cytarabine | n2=en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e | rel=r_associated | relid=0 | w=20
  650. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-ta-muc1 monoclonal antibody pankomab
    n1=en:cytarabine | n2=en:anti-ta-muc1 monoclonal antibody pankomab | rel=r_associated | relid=0 | w=20
  651. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-tf monoclonal antibody alt-836
    n1=en:cytarabine | n2=en:anti-tf monoclonal antibody alt-836 | rel=r_associated | relid=0 | w=20
  652. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-tgf-beta rii monoclonal antibody imc-tr1
    n1=en:cytarabine | n2=en:anti-tgf-beta rii monoclonal antibody imc-tr1 | rel=r_associated | relid=0 | w=20
  653. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  654. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-tim-3 monoclonal antibody mbg453
    n1=en:cytarabine | n2=en:anti-tim-3 monoclonal antibody mbg453 | rel=r_associated | relid=0 | w=20
  655. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-tumor necrosis factor alpha drug
    n1=en:cytarabine | n2=en:anti-tumor necrosis factor alpha drug | rel=r_associated | relid=0 | w=20
  656. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-tweak monoclonal antibody ro5458640
    n1=en:cytarabine | n2=en:anti-tweak monoclonal antibody ro5458640 | rel=r_associated | relid=0 | w=20
  657. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-vegf anticalin prs-050-peg40
    n1=en:cytarabine | n2=en:anti-vegf anticalin prs-050-peg40 | rel=r_associated | relid=0 | w=20
  658. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-vegf/ang2 nanobody bi 836880
    n1=en:cytarabine | n2=en:anti-vegf/ang2 nanobody bi 836880 | rel=r_associated | relid=0 | w=20
  659. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-vegfc monoclonal antibody vgx-100
    n1=en:cytarabine | n2=en:anti-vegfc monoclonal antibody vgx-100 | rel=r_associated | relid=0 | w=20
  660. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-vegfr3 monoclonal antibody imc-3c5
    n1=en:cytarabine | n2=en:anti-vegfr3 monoclonal antibody imc-3c5 | rel=r_associated | relid=0 | w=20
  661. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-vista monoclonal antibody jnj 61610588
    n1=en:cytarabine | n2=en:anti-vista monoclonal antibody jnj 61610588 | rel=r_associated | relid=0 | w=20
  662. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:anti-von willebrand factor nanobody
    n1=en:cytarabine | n2=en:anti-von willebrand factor nanobody | rel=r_associated | relid=0 | w=20
  663. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antiangiogenic drug combination tl-118
    n1=en:cytarabine | n2=en:antiangiogenic drug combination tl-118 | rel=r_associated | relid=0 | w=20
  664. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibacterial agent
    n1=en:cytarabine | n2=en:antibacterial agent | rel=r_associated | relid=0 | w=20
  665. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibiotic
    n1=en:cytarabine | n2=en:antibiotic | rel=r_associated | relid=0 | w=20
  666. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibiotic sq109
    n1=en:cytarabine | n2=en:antibiotic sq109 | rel=r_associated | relid=0 | w=20
  667. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate abbv-085
    n1=en:cytarabine | n2=en:antibody-drug conjugate abbv-085 | rel=r_associated | relid=0 | w=20
  668. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate abbv-399
    n1=en:cytarabine | n2=en:antibody-drug conjugate abbv-399 | rel=r_associated | relid=0 | w=20
  669. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate adct-402
    n1=en:cytarabine | n2=en:antibody-drug conjugate adct-402 | rel=r_associated | relid=0 | w=20
  670. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate bay79-4620
    n1=en:cytarabine | n2=en:antibody-drug conjugate bay79-4620 | rel=r_associated | relid=0 | w=20
  671. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate dfrf4539a
    n1=en:cytarabine | n2=en:antibody-drug conjugate dfrf4539a | rel=r_associated | relid=0 | w=20
  672. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate sc-002
    n1=en:cytarabine | n2=en:antibody-drug conjugate sc-002 | rel=r_associated | relid=0 | w=20
  673. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate sc-003
    n1=en:cytarabine | n2=en:antibody-drug conjugate sc-003 | rel=r_associated | relid=0 | w=20
  674. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antibody-drug conjugate sc16ld6.5
    n1=en:cytarabine | n2=en:antibody-drug conjugate sc16ld6.5 | rel=r_associated | relid=0 | w=20
  675. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antigen-targeted personalized breast cancer vaccine
    n1=en:cytarabine | n2=en:antigen-targeted personalized breast cancer vaccine | rel=r_associated | relid=0 | w=20
  676. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antihypertensive agent
    n1=en:cytarabine | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=20
  677. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antilipemic agent
    n1=en:cytarabine | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=20
  678. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antimetabolite
    n1=en:cytarabine | n2=en:antimetabolite | rel=r_associated | relid=0 | w=20
  679. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antimetabolite ff-10502
    n1=en:cytarabine | n2=en:antimetabolite ff-10502 | rel=r_associated | relid=0 | w=20
  680. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antineoplastic agent
    n1=en:cytarabine | n2=en:antineoplastic agent | rel=r_associated | relid=0 | w=20
  681. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antineoplastic agent combination sm-88
    n1=en:cytarabine | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=20
  682. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antineoplastic agent trx-818
    n1=en:cytarabine | n2=en:antineoplastic agent trx-818 | rel=r_associated | relid=0 | w=20
  683. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antineoplaston a10
    n1=en:cytarabine | n2=en:antineoplaston a10 | rel=r_associated | relid=0 | w=20
  684. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antineoplaston as2-1
    n1=en:cytarabine | n2=en:antineoplaston as2-1 | rel=r_associated | relid=0 | w=20
  685. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antiperspirant cream f511
    n1=en:cytarabine | n2=en:antiperspirant cream f511 | rel=r_associated | relid=0 | w=20
  686. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antirheumatic agents
    n1=en:cytarabine | n2=en:antirheumatic agents | rel=r_associated | relid=0 | w=20
  687. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antispasmodic agent
    n1=en:cytarabine | n2=en:antispasmodic agent | rel=r_associated | relid=0 | w=20
  688. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:antrodia cinnamomea supplement
    n1=en:cytarabine | n2=en:antrodia cinnamomea supplement | rel=r_associated | relid=0 | w=20
  689. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aoap protocol
    n1=en:cytarabine | n2=en:aoap protocol | rel=r_associated | relid=0 | w=20
  690. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apatinib
    n1=en:cytarabine | n2=en:apatinib | rel=r_associated | relid=0 | w=20
  691. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apatorsen
    n1=en:cytarabine | n2=en:apatorsen | rel=r_associated | relid=0 | w=20
  692. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apaziquone
    n1=en:cytarabine | n2=en:apaziquone | rel=r_associated | relid=0 | w=20
  693. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apc8015f
    n1=en:cytarabine | n2=en:apc8015f | rel=r_associated | relid=0 | w=20
  694. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apf530
    n1=en:cytarabine | n2=en:apf530 | rel=r_associated | relid=0 | w=20
  695. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apilimod dimesylate capsule
    n1=en:cytarabine | n2=en:apilimod dimesylate capsule | rel=r_associated | relid=0 | w=20
  696. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apixaban
    n1=en:cytarabine | n2=en:apixaban | rel=r_associated | relid=0 | w=20
  697. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apomab
    n1=en:cytarabine | n2=en:apomab | rel=r_associated | relid=0 | w=20
  698. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apomine
    n1=en:cytarabine | n2=en:apomine | rel=r_associated | relid=0 | w=20
  699. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apoptosis inducer bzl101
    n1=en:cytarabine | n2=en:apoptosis inducer bzl101 | rel=r_associated | relid=0 | w=20
  700. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apoptosis inducer mpc-2130
    n1=en:cytarabine | n2=en:apoptosis inducer mpc-2130 | rel=r_associated | relid=0 | w=20
  701. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells
    n1=en:cytarabine | n2=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=20
  702. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aprepitant
    n1=en:cytarabine | n2=en:aprepitant | rel=r_associated | relid=0 | w=20
  703. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:apricoxib
    n1=en:cytarabine | n2=en:apricoxib | rel=r_associated | relid=0 | w=20
  704. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ar antagonist bms-641988
    n1=en:cytarabine | n2=en:ar antagonist bms-641988 | rel=r_associated | relid=0 | w=20
  705. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ar antagonist odm-201
    n1=en:cytarabine | n2=en:ar antagonist odm-201 | rel=r_associated | relid=0 | w=20
  706. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-c 5'-benzoate
    n1=en:cytarabine | n2=en:ara-c 5'-benzoate | rel=r_associated | relid=0 | w=20
  707. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-c 5'octanoate
    n1=en:cytarabine | n2=en:ara-c 5'octanoate | rel=r_associated | relid=0 | w=20
  708. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-cdp-1-o-octadecyl-2-o-palmitoyl-sn-glycerol
    n1=en:cytarabine | n2=en:ara-cdp-1-o-octadecyl-2-o-palmitoyl-sn-glycerol | rel=r_associated | relid=0 | w=20
  709. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-cdp-1-s-hexadecyl-2-o-palmitoyl-1-thioglycerol
    n1=en:cytarabine | n2=en:ara-cdp-1-s-hexadecyl-2-o-palmitoyl-1-thioglycerol | rel=r_associated | relid=0 | w=20
  710. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-cdp-1-s-octadecyl-2-o-palmitoyl-1-thioglycerol
    n1=en:cytarabine | n2=en:ara-cdp-1-s-octadecyl-2-o-palmitoyl-1-thioglycerol | rel=r_associated | relid=0 | w=20
  711. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-cdp-cortisol
    n1=en:cytarabine | n2=en:ara-cdp-cortisol | rel=r_associated | relid=0 | w=20
  712. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-cdp-distearin
    n1=en:cytarabine | n2=en:ara-cdp-distearin | rel=r_associated | relid=0 | w=20
  713. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-cop protocol
    n1=en:cytarabine | n2=en:ara-cop protocol | rel=r_associated | relid=0 | w=20
  714. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ara-fluorocytosine
    n1=en:cytarabine | n2=en:ara-fluorocytosine | rel=r_associated | relid=0 | w=20
  715. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:arac-diphosphate diglyceride
    n1=en:cytarabine | n2=en:arac-diphosphate diglyceride | rel=r_associated | relid=0 | w=20
  716. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aracytidine-5'-hexadecylphosphonophosphate
    n1=en:cytarabine | n2=en:aracytidine-5'-hexadecylphosphonophosphate | rel=r_associated | relid=0 | w=20
  717. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:arginine butyrate
    n1=en:cytarabine | n2=en:arginine butyrate | rel=r_associated | relid=0 | w=20
  718. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:arginine/omega-3 fatty acids/nucleotides oral supplement
    n1=en:cytarabine | n2=en:arginine/omega-3 fatty acids/nucleotides oral supplement | rel=r_associated | relid=0 | w=20
  719. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:armodafinil
    n1=en:cytarabine | n2=en:armodafinil | rel=r_associated | relid=0 | w=20
  720. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:arnebia indigo jade pearl topical cream
    n1=en:cytarabine | n2=en:arnebia indigo jade pearl topical cream | rel=r_associated | relid=0 | w=20
  721. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:arsenic trioxide
    n1=en:cytarabine | n2=en:arsenic trioxide | rel=r_associated | relid=0 | w=20
  722. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:artemether sublingual spray
    n1=en:cytarabine | n2=en:artemether sublingual spray | rel=r_associated | relid=0 | w=20
  723. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:artesunate
    n1=en:cytarabine | n2=en:artesunate | rel=r_associated | relid=0 | w=20
  724. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:artichoke whole phytocomplex concentrate
    n1=en:cytarabine | n2=en:artichoke whole phytocomplex concentrate | rel=r_associated | relid=0 | w=20
  725. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:arzoxifene hydrochloride
    n1=en:cytarabine | n2=en:arzoxifene hydrochloride | rel=r_associated | relid=0 | w=20
  726. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:as03-adjuvanted h1n1 pandemic influenza vaccine
    n1=en:cytarabine | n2=en:as03-adjuvanted h1n1 pandemic influenza vaccine | rel=r_associated | relid=0 | w=20
  727. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asaley
    n1=en:cytarabine | n2=en:asaley | rel=r_associated | relid=0 | w=20
  728. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asfotase alfa
    n1=en:cytarabine | n2=en:asfotase alfa | rel=r_associated | relid=0 | w=20
  729. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ashwagandha root powder extract
    n1=en:cytarabine | n2=en:ashwagandha root powder extract | rel=r_associated | relid=0 | w=20
  730. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asian ginseng
    n1=en:cytarabine | n2=en:asian ginseng | rel=r_associated | relid=0 | w=20
  731. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ask1 inhibitor gs-4997
    n1=en:cytarabine | n2=en:ask1 inhibitor gs-4997 | rel=r_associated | relid=0 | w=20
  732. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asp4132
    n1=en:cytarabine | n2=en:asp4132 | rel=r_associated | relid=0 | w=20
  733. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asp9853
    n1=en:cytarabine | n2=en:asp9853 | rel=r_associated | relid=0 | w=20
  734. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asparaginase
    n1=en:cytarabine | n2=en:asparaginase | rel=r_associated | relid=0 | w=20
  735. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asparaginase erwinia chrysanthemi
    n1=en:cytarabine | n2=en:asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=20
  736. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:astringent
    n1=en:cytarabine | n2=en:astringent | rel=r_associated | relid=0 | w=20
  737. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:astuprotimut-r
    n1=en:cytarabine | n2=en:astuprotimut-r | rel=r_associated | relid=0 | w=20
  738. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:asulacrine isethionate
    n1=en:cytarabine | n2=en:asulacrine isethionate | rel=r_associated | relid=0 | w=20
  739. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atamestane
    n1=en:cytarabine | n2=en:atamestane | rel=r_associated | relid=0 | w=20
  740. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atenolol
    n1=en:cytarabine | n2=en:atenolol | rel=r_associated | relid=0 | w=20
  741. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atezolizumab
    n1=en:cytarabine | n2=en:atezolizumab | rel=r_associated | relid=0 | w=20
  742. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atiprimod
    n1=en:cytarabine | n2=en:atiprimod | rel=r_associated | relid=0 | w=20
  743. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atn-161
    n1=en:cytarabine | n2=en:atn-161 | rel=r_associated | relid=0 | w=20
  744. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atomoxetine hydrochloride
    n1=en:cytarabine | n2=en:atomoxetine hydrochloride | rel=r_associated | relid=0 | w=20
  745. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atorvastatin calcium
    n1=en:cytarabine | n2=en:atorvastatin calcium | rel=r_associated | relid=0 | w=20
  746. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atr kinase inhibitor azd6738
    n1=en:cytarabine | n2=en:atr kinase inhibitor azd6738 | rel=r_associated | relid=0 | w=20
  747. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atr kinase inhibitor vx-970
    n1=en:cytarabine | n2=en:atr kinase inhibitor vx-970 | rel=r_associated | relid=0 | w=20
  748. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atr-101
    n1=en:cytarabine | n2=en:atr-101 | rel=r_associated | relid=0 | w=20
  749. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:atrasentan hydrochloride
    n1=en:cytarabine | n2=en:atrasentan hydrochloride | rel=r_associated | relid=0 | w=20
  750. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:attenuated chimpanzee adenovirus 5t4 vaccine
    n1=en:cytarabine | n2=en:attenuated chimpanzee adenovirus 5t4 vaccine | rel=r_associated | relid=0 | w=20
  751. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:attenuated corynebacterium parvum
    n1=en:cytarabine | n2=en:attenuated corynebacterium parvum | rel=r_associated | relid=0 | w=20
  752. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:attenuated listeria monocytogenes crs-100
    n1=en:cytarabine | n2=en:attenuated listeria monocytogenes crs-100 | rel=r_associated | relid=0 | w=20
  753. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001
    n1=en:cytarabine | n2=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | rel=r_associated | relid=0 | w=20
  754. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:auranofin
    n1=en:cytarabine | n2=en:auranofin | rel=r_associated | relid=0 | w=20
  755. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora a kinase inhibitor tas-119
    n1=en:cytarabine | n2=en:aurora a kinase inhibitor tas-119 | rel=r_associated | relid=0 | w=20
  756. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora b serine/threonine kinase inhibitor tak-901
    n1=en:cytarabine | n2=en:aurora b serine/threonine kinase inhibitor tak-901 | rel=r_associated | relid=0 | w=20
  757. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora b/c kinase inhibitor gsk1070916a
    n1=en:cytarabine | n2=en:aurora b/c kinase inhibitor gsk1070916a | rel=r_associated | relid=0 | w=20
  758. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora kinase inhibitor amg 900
    n1=en:cytarabine | n2=en:aurora kinase inhibitor amg 900 | rel=r_associated | relid=0 | w=20
  759. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora kinase inhibitor bi 811283
    n1=en:cytarabine | n2=en:aurora kinase inhibitor bi 811283 | rel=r_associated | relid=0 | w=20
  760. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora kinase inhibitor mln8054
    n1=en:cytarabine | n2=en:aurora kinase inhibitor mln8054 | rel=r_associated | relid=0 | w=20
  761. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora kinase inhibitor ttp607
    n1=en:cytarabine | n2=en:aurora kinase inhibitor ttp607 | rel=r_associated | relid=0 | w=20
  762. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aurora kinase/vegfr2 inhibitor cyc116
    n1=en:cytarabine | n2=en:aurora kinase/vegfr2 inhibitor cyc116 | rel=r_associated | relid=0 | w=20
  763. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ad-cd154-transduced cll b cells
    n1=en:cytarabine | n2=en:autologous ad-cd154-transduced cll b cells | rel=r_associated | relid=0 | w=20
  764. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-cd19 car-expressing t lymphocytes
    n1=en:cytarabine | n2=en:autologous anti-cd19 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  765. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014
    n1=en:cytarabine | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 | rel=r_associated | relid=0 | w=20
  766. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017
    n1=en:cytarabine | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | rel=r_associated | relid=0 | w=20
  767. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes
    n1=en:cytarabine | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  768. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  769. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  770. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous anti-psma gene-modified t-lymphocytes
    n1=en:cytarabine | n2=en:autologous anti-psma gene-modified t-lymphocytes | rel=r_associated | relid=0 | w=20
  771. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes
    n1=en:cytarabine | n2=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  772. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  773. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes
    n1=en:cytarabine | n2=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  774. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes
    n1=en:cytarabine | n2=en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes | rel=r_associated | relid=0 | w=20
  775. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells
    n1=en:cytarabine | n2=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | rel=r_associated | relid=0 | w=20
  776. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides
    n1=en:cytarabine | n2=en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides | rel=r_associated | relid=0 | w=20
  777. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cd8+ melanoma specific t cells
    n1=en:cytarabine | n2=en:autologous cd8+ melanoma specific t cells | rel=r_associated | relid=0 | w=20
  778. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous colon cancer cell vaccine
    n1=en:cytarabine | n2=en:autologous colon cancer cell vaccine | rel=r_associated | relid=0 | w=20
  779. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  780. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells
    n1=en:cytarabine | n2=en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells | rel=r_associated | relid=0 | w=20
  781. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells
    n1=en:cytarabine | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | rel=r_associated | relid=0 | w=20
  782. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells
    n1=en:cytarabine | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells | rel=r_associated | relid=0 | w=20
  783. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dendritic cell vaccine act2001
    n1=en:cytarabine | n2=en:autologous dendritic cell vaccine act2001 | rel=r_associated | relid=0 | w=20
  784. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dendritic cell-adenovirus ccl21 vaccine
    n1=en:cytarabine | n2=en:autologous dendritic cell-adenovirus ccl21 vaccine | rel=r_associated | relid=0 | w=20
  785. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
    n1=en:cytarabine | n2=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | rel=r_associated | relid=0 | w=20
  786. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine
    n1=en:cytarabine | n2=en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine | rel=r_associated | relid=0 | w=20
  787. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dendritic cell-based immunotherapeutic av0113
    n1=en:cytarabine | n2=en:autologous dendritic cell-based immunotherapeutic av0113 | rel=r_associated | relid=0 | w=20
  788. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dendritic cell-tumor fusion vaccine
    n1=en:cytarabine | n2=en:autologous dendritic cell-tumor fusion vaccine | rel=r_associated | relid=0 | w=20
  789. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous dinitrophenyl-modified ovarian cancer vaccine
    n1=en:cytarabine | n2=en:autologous dinitrophenyl-modified ovarian cancer vaccine | rel=r_associated | relid=0 | w=20
  790. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ebv-ctl cd19car zeta
    n1=en:cytarabine | n2=en:autologous ebv-ctl cd19car zeta | rel=r_associated | relid=0 | w=20
  791. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine
    n1=en:cytarabine | n2=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | rel=r_associated | relid=0 | w=20
  792. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous glioma cell lysate
    n1=en:cytarabine | n2=en:autologous glioma cell lysate | rel=r_associated | relid=0 | w=20
  793. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine
    n1=en:cytarabine | n2=en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine | rel=r_associated | relid=0 | w=20
  794. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine
    n1=en:cytarabine | n2=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | rel=r_associated | relid=0 | w=20
  795. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous gm-csf-secreting melanoma vaccine
    n1=en:cytarabine | n2=en:autologous gm-csf-secreting melanoma vaccine | rel=r_associated | relid=0 | w=20
  796. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous heat-shock protein 70 peptide vaccine ag-858
    n1=en:cytarabine | n2=en:autologous heat-shock protein 70 peptide vaccine ag-858 | rel=r_associated | relid=0 | w=20
  797. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=en:cytarabine | n2=en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=20
  798. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes
    n1=en:cytarabine | n2=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | rel=r_associated | relid=0 | w=20
  799. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes
    n1=en:cytarabine | n2=en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes | rel=r_associated | relid=0 | w=20
  800. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous il-21-modulated cd8+ mart1-specific t cells
    n1=en:cytarabine | n2=en:autologous il-21-modulated cd8+ mart1-specific t cells | rel=r_associated | relid=0 | w=20
  801. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous immunoglobulin idiotype-klh conjugate vaccine
    n1=en:cytarabine | n2=en:autologous immunoglobulin idiotype-klh conjugate vaccine | rel=r_associated | relid=0 | w=20
  802. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous interferon-producing killer dendritic cells
    n1=en:cytarabine | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=20
  803. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  804. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  805. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
    n1=en:cytarabine | n2=en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=20
  806. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine
    n1=en:cytarabine | n2=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=20
  807. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine
    n1=en:cytarabine | n2=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | rel=r_associated | relid=0 | w=20
  808. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes
    n1=en:cytarabine | n2=en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes | rel=r_associated | relid=0 | w=20
  809. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  810. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  811. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  812. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous mesenchymal stem cells apceth_101
    n1=en:cytarabine | n2=en:autologous mesenchymal stem cells apceth_101 | rel=r_associated | relid=0 | w=20
  813. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  814. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=en:cytarabine | n2=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=20
  815. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous nsclc peptide-specific dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous nsclc peptide-specific dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  816. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes
    n1=en:cytarabine | n2=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=20
  817. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ofa-ilrp rna-transfected dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous ofa-ilrp rna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  818. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  819. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr
    n1=en:cytarabine | n2=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | rel=r_associated | relid=0 | w=20
  820. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous pluripotent aldhbr stem cells ald-451
    n1=en:cytarabine | n2=en:autologous pluripotent aldhbr stem cells ald-451 | rel=r_associated | relid=0 | w=20
  821. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  822. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous sarcoma lysate-pulsed dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  823. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors
    n1=en:cytarabine | n2=en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors | rel=r_associated | relid=0 | w=20
  824. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous tns9.3.55-transduced cd34-positive cells
    n1=en:cytarabine | n2=en:autologous tns9.3.55-transduced cd34-positive cells | rel=r_associated | relid=0 | w=20
  825. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine
    n1=en:cytarabine | n2=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | rel=r_associated | relid=0 | w=20
  826. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous tumor cell vaccine
    n1=en:cytarabine | n2=en:autologous tumor cell vaccine | rel=r_associated | relid=0 | w=20
  827. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous tumor infiltrating lymphocytes ln-144
    n1=en:cytarabine | n2=en:autologous tumor infiltrating lymphocytes ln-144 | rel=r_associated | relid=0 | w=20
  828. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine
    n1=en:cytarabine | n2=en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  829. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
    n1=en:cytarabine | n2=en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes | rel=r_associated | relid=0 | w=20
  830. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:avitinib maleate
    n1=en:cytarabine | n2=en:avitinib maleate | rel=r_associated | relid=0 | w=20
  831. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:avn944
    n1=en:cytarabine | n2=en:avn944 | rel=r_associated | relid=0 | w=20
  832. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:axitinib
    n1=en:cytarabine | n2=en:axitinib | rel=r_associated | relid=0 | w=20
  833. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:axl inhibitor bgb324
    n1=en:cytarabine | n2=en:axl inhibitor bgb324 | rel=r_associated | relid=0 | w=20
  834. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:axl inhibitor tp-0903
    n1=en:cytarabine | n2=en:axl inhibitor tp-0903 | rel=r_associated | relid=0 | w=20
  835. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:Azadirachta indica
    n1=en:cytarabine | n2=en:Azadirachta indica | rel=r_associated | relid=0 | w=20
  836. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:azadirachta indica
    n1=en:cytarabine | n2=en:azadirachta indica | rel=r_associated | relid=0 | w=20
  837. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:azapicyl
    n1=en:cytarabine | n2=en:azapicyl | rel=r_associated | relid=0 | w=20
  838. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:azathioprine sodium
    n1=en:cytarabine | n2=en:azathioprine sodium | rel=r_associated | relid=0 | w=20
  839. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:azd5438
    n1=en:cytarabine | n2=en:azd5438 | rel=r_associated | relid=0 | w=20
  840. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:azimexon
    n1=en:cytarabine | n2=en:azimexon | rel=r_associated | relid=0 | w=20
  841. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:aziridinylbenzoquinone rh1
    n1=en:cytarabine | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=20
  842. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:azurin:50-77 cell penetrating peptide p28
    n1=en:cytarabine | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=20
  843. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:b-8801 protocol
    n1=en:cytarabine | n2=en:b-8801 protocol | rel=r_associated | relid=0 | w=20
  844. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:b-domp protocol
    n1=en:cytarabine | n2=en:b-domp protocol | rel=r_associated | relid=0 | w=20
  845. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:b-raf/vegfr-2 inhibitor raf265
    n1=en:cytarabine | n2=en:b-raf/vegfr-2 inhibitor raf265 | rel=r_associated | relid=0 | w=20
  846. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:b-triple-v protocol
    n1=en:cytarabine | n2=en:b-triple-v protocol | rel=r_associated | relid=0 | w=20
  847. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:b16alphagal melanoma vaccine
    n1=en:cytarabine | n2=en:b16alphagal melanoma vaccine | rel=r_associated | relid=0 | w=20
  848. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:b43-pap immunotoxin
    n1=en:cytarabine | n2=en:b43-pap immunotoxin | rel=r_associated | relid=0 | w=20
  849. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:baclofen
    n1=en:cytarabine | n2=en:baclofen | rel=r_associated | relid=0 | w=20
  850. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bact protocol
    n1=en:cytarabine | n2=en:bact protocol | rel=r_associated | relid=0 | w=20
  851. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bafetinib
    n1=en:cytarabine | n2=en:bafetinib | rel=r_associated | relid=0 | w=20
  852. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:banoxantrone
    n1=en:cytarabine | n2=en:banoxantrone | rel=r_associated | relid=0 | w=20
  853. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:barasertib
    n1=en:cytarabine | n2=en:barasertib | rel=r_associated | relid=0 | w=20
  854. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bardoxolone
    n1=en:cytarabine | n2=en:bardoxolone | rel=r_associated | relid=0 | w=20
  855. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:baricitinib
    n1=en:cytarabine | n2=en:baricitinib | rel=r_associated | relid=0 | w=20
  856. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:barium meal
    n1=en:cytarabine | n2=en:barium meal | rel=r_associated | relid=0 | w=20
  857. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:barium sulfate
    n1=en:cytarabine | n2=en:barium sulfate | rel=r_associated | relid=0 | w=20
  858. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:batanopride
    n1=en:cytarabine | n2=en:batanopride | rel=r_associated | relid=0 | w=20
  859. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bavc protocol
    n1=en:cytarabine | n2=en:bavc protocol | rel=r_associated | relid=0 | w=20
  860. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bavituximab
    n1=en:cytarabine | n2=en:bavituximab | rel=r_associated | relid=0 | w=20
  861. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bay 56-3722
    n1=en:cytarabine | n2=en:bay 56-3722 | rel=r_associated | relid=0 | w=20
  862. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bazedoxifene
    n1=en:cytarabine | n2=en:bazedoxifene | rel=r_associated | relid=0 | w=20
  863. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bbr 3464
    n1=en:cytarabine | n2=en:bbr 3464 | rel=r_associated | relid=0 | w=20
  864. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bc-819 plasmid/polyethylenimine complex
    n1=en:cytarabine | n2=en:bc-819 plasmid/polyethylenimine complex | rel=r_associated | relid=0 | w=20
  865. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bcg solution
    n1=en:cytarabine | n2=en:bcg solution | rel=r_associated | relid=0 | w=20
  866. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bcl-2 inhibitor bcl201
    n1=en:cytarabine | n2=en:bcl-2 inhibitor bcl201 | rel=r_associated | relid=0 | w=20
  867. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bcma-specific car-expressing t lymphocytes
    n1=en:cytarabine | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=20
  868. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bcr-abl (b2a2)-derived peptide vaccine
    n1=en:cytarabine | n2=en:bcr-abl (b2a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=20
  869. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bcr-abl (b3a2)-derived peptide vaccine
    n1=en:cytarabine | n2=en:bcr-abl (b3a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=20
  870. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bcr-abl peptide vaccine
    n1=en:cytarabine | n2=en:bcr-abl peptide vaccine | rel=r_associated | relid=0 | w=20
  871. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:be a counterpart to something
    n1=en:cytarabine | n2=en:be a counterpart to something | rel=r_associated | relid=0 | w=20
  872. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:be the counterpart of
    n1=en:cytarabine | n2=en:be the counterpart of | rel=r_associated | relid=0 | w=20
  873. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beam protocol
    n1=en:cytarabine | n2=en:beam protocol | rel=r_associated | relid=0 | w=20
  874. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beam regimen
    n1=en:cytarabine | n2=en:beam regimen | rel=r_associated | relid=0 | w=20
  875. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:becatecarin
    n1=en:cytarabine | n2=en:becatecarin | rel=r_associated | relid=0 | w=20
  876. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beclomethasone dipropionate
    n1=en:cytarabine | n2=en:beclomethasone dipropionate | rel=r_associated | relid=0 | w=20
  877. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beetroot juice
    n1=en:cytarabine | n2=en:beetroot juice | rel=r_associated | relid=0 | w=20
  878. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:belagenpumatucel-l
    n1=en:cytarabine | n2=en:belagenpumatucel-l | rel=r_associated | relid=0 | w=20
  879. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:belimumab
    n1=en:cytarabine | n2=en:belimumab | rel=r_associated | relid=0 | w=20
  880. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:belinostat
    n1=en:cytarabine | n2=en:belinostat | rel=r_associated | relid=0 | w=20
  881. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:belotecan hydrochloride
    n1=en:cytarabine | n2=en:belotecan hydrochloride | rel=r_associated | relid=0 | w=20
  882. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:benazepril hydrochloride
    n1=en:cytarabine | n2=en:benazepril hydrochloride | rel=r_associated | relid=0 | w=20
  883. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bendamustine hydrochloride
    n1=en:cytarabine | n2=en:bendamustine hydrochloride | rel=r_associated | relid=0 | w=20
  884. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bendamustine-containing nanoparticle-based formulation rxdx-107
    n1=en:cytarabine | n2=en:bendamustine-containing nanoparticle-based formulation rxdx-107 | rel=r_associated | relid=0 | w=20
  885. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bendamustine-vorinostat fusion molecule edo-s101
    n1=en:cytarabine | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=20
  886. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:benzoylphenylurea
    n1=en:cytarabine | n2=en:benzoylphenylurea | rel=r_associated | relid=0 | w=20
  887. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bep regimen
    n1=en:cytarabine | n2=en:bep regimen | rel=r_associated | relid=0 | w=20
  888. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:berberine chloride
    n1=en:cytarabine | n2=en:berberine chloride | rel=r_associated | relid=0 | w=20
  889. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:berlin-frankfurt-muenster protocol ii
    n1=en:cytarabine | n2=en:berlin-frankfurt-muenster protocol ii | rel=r_associated | relid=0 | w=20
  890. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:berubicin hydrochloride
    n1=en:cytarabine | n2=en:berubicin hydrochloride | rel=r_associated | relid=0 | w=20
  891. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet bromodomain inhibitor zen-3694
    n1=en:cytarabine | n2=en:bet bromodomain inhibitor zen-3694 | rel=r_associated | relid=0 | w=20
  892. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet bromodomains 2/3/4 inhibitor mk-8628
    n1=en:cytarabine | n2=en:bet bromodomains 2/3/4 inhibitor mk-8628 | rel=r_associated | relid=0 | w=20
  893. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor bay1238097
    n1=en:cytarabine | n2=en:bet inhibitor bay1238097 | rel=r_associated | relid=0 | w=20
  894. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor bms-986158
    n1=en:cytarabine | n2=en:bet inhibitor bms-986158 | rel=r_associated | relid=0 | w=20
  895. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor cpi-0610
    n1=en:cytarabine | n2=en:bet inhibitor cpi-0610 | rel=r_associated | relid=0 | w=20
  896. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor ft-1101
    n1=en:cytarabine | n2=en:bet inhibitor ft-1101 | rel=r_associated | relid=0 | w=20
  897. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor gsk525762
    n1=en:cytarabine | n2=en:bet inhibitor gsk525762 | rel=r_associated | relid=0 | w=20
  898. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor incb057643
    n1=en:cytarabine | n2=en:bet inhibitor incb057643 | rel=r_associated | relid=0 | w=20
  899. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bet inhibitor ten-010
    n1=en:cytarabine | n2=en:bet inhibitor ten-010 | rel=r_associated | relid=0 | w=20
  900. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beta-elemene
    n1=en:cytarabine | n2=en:beta-elemene | rel=r_associated | relid=0 | w=20
  901. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beta-glucan mm-10-001
    n1=en:cytarabine | n2=en:beta-glucan mm-10-001 | rel=r_associated | relid=0 | w=20
  902. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion
    n1=en:cytarabine | n2=en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion | rel=r_associated | relid=0 | w=20
  903. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beta-lapachone prodrug arq 761
    n1=en:cytarabine | n2=en:beta-lapachone prodrug arq 761 | rel=r_associated | relid=0 | w=20
  904. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:beta-thioguanine deoxyriboside
    n1=en:cytarabine | n2=en:beta-thioguanine deoxyriboside | rel=r_associated | relid=0 | w=20
  905. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:betulinic acid
    n1=en:cytarabine | n2=en:betulinic acid | rel=r_associated | relid=0 | w=20
  906. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bevacizumab
    n1=en:cytarabine | n2=en:bevacizumab | rel=r_associated | relid=0 | w=20
  907. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bevacizumab-irdye 800cw
    n1=en:cytarabine | n2=en:bevacizumab-irdye 800cw | rel=r_associated | relid=0 | w=20
  908. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bexarotene
    n1=en:cytarabine | n2=en:bexarotene | rel=r_associated | relid=0 | w=20
  909. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bf-9 protocol
    n1=en:cytarabine | n2=en:bf-9 protocol | rel=r_associated | relid=0 | w=20
  910. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bf12 protocol
    n1=en:cytarabine | n2=en:bf12 protocol | rel=r_associated | relid=0 | w=20
  911. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bfm-78
    n1=en:cytarabine | n2=en:bfm-78 | rel=r_associated | relid=0 | w=20
  912. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bfm-86 protocol
    n1=en:cytarabine | n2=en:bfm-86 protocol | rel=r_associated | relid=0 | w=20
  913. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bfm-all 81 protocol
    n1=en:cytarabine | n2=en:bfm-all 81 protocol | rel=r_associated | relid=0 | w=20
  914. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bgm 84 protocol
    n1=en:cytarabine | n2=en:bgm 84 protocol | rel=r_associated | relid=0 | w=20
  915. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bh-ac-amp protocol
    n1=en:cytarabine | n2=en:bh-ac-amp protocol | rel=r_associated | relid=0 | w=20
  916. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bh-ac-dmp protocol
    n1=en:cytarabine | n2=en:bh-ac-dmp protocol | rel=r_associated | relid=0 | w=20
  917. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bh3 mimetic abt-737
    n1=en:cytarabine | n2=en:bh3 mimetic abt-737 | rel=r_associated | relid=0 | w=20
  918. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bhac-amp protocol
    n1=en:cytarabine | n2=en:bhac-amp protocol | rel=r_associated | relid=0 | w=20
  919. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bhac-dmpv protocol
    n1=en:cytarabine | n2=en:bhac-dmpv protocol | rel=r_associated | relid=0 | w=20
  920. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bi 2536
    n1=en:cytarabine | n2=en:bi 2536 | rel=r_associated | relid=0 | w=20
  921. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bi 831266
    n1=en:cytarabine | n2=en:bi 831266 | rel=r_associated | relid=0 | w=20
  922. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bi 894999
    n1=en:cytarabine | n2=en:bi 894999 | rel=r_associated | relid=0 | w=20
  923. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bi-functional alkylating agent val-083
    n1=en:cytarabine | n2=en:bi-functional alkylating agent val-083 | rel=r_associated | relid=0 | w=20
  924. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bi-layered skin substitute from keratinocytes and fibroblasts
    n1=en:cytarabine | n2=en:bi-layered skin substitute from keratinocytes and fibroblasts | rel=r_associated | relid=0 | w=20
  925. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine
    n1=en:cytarabine | n2=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | rel=r_associated | relid=0 | w=20
  926. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:biafine cream
    n1=en:cytarabine | n2=en:biafine cream | rel=r_associated | relid=0 | w=20
  927. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bibx 1382
    n1=en:cytarabine | n2=en:bibx 1382 | rel=r_associated | relid=0 | w=20
  928. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bicalutamide
    n1=en:cytarabine | n2=en:bicalutamide | rel=r_associated | relid=0 | w=20
  929. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement
    n1=en:cytarabine | n2=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | rel=r_associated | relid=0 | w=20
  930. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex
    n1=en:cytarabine | n2=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | rel=r_associated | relid=0 | w=20
  931. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:binetrakin
    n1=en:cytarabine | n2=en:binetrakin | rel=r_associated | relid=0 | w=20
  932. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:binimetinib
    n1=en:cytarabine | n2=en:binimetinib | rel=r_associated | relid=0 | w=20
  933. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:biological agent
    n1=en:cytarabine | n2=en:biological agent | rel=r_associated | relid=0 | w=20
  934. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:biological factors
    n1=en:cytarabine | n2=en:biological factors | rel=r_associated | relid=0 | w=20
  935. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:biomed 101
    n1=en:cytarabine | n2=en:biomed 101 | rel=r_associated | relid=0 | w=20
  936. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:birinapant
    n1=en:cytarabine | n2=en:birinapant | rel=r_associated | relid=0 | w=20
  937. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bis(choline)tetrathiomolybdate
    n1=en:cytarabine | n2=en:bis(choline)tetrathiomolybdate | rel=r_associated | relid=0 | w=20
  938. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bisantrene hydrochloride
    n1=en:cytarabine | n2=en:bisantrene hydrochloride | rel=r_associated | relid=0 | w=20
  939. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bismuth subsalicylate
    n1=en:cytarabine | n2=en:bismuth subsalicylate | rel=r_associated | relid=0 | w=20
  940. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bispecific antibody 2b1
    n1=en:cytarabine | n2=en:bispecific antibody 2b1 | rel=r_associated | relid=0 | w=20
  941. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bispecific antibody mdx-h210
    n1=en:cytarabine | n2=en:bispecific antibody mdx-h210 | rel=r_associated | relid=0 | w=20
  942. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bispecific antibody mdx447
    n1=en:cytarabine | n2=en:bispecific antibody mdx447 | rel=r_associated | relid=0 | w=20
  943. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bivalent hpv16/18 therapeutic cervical cancer vaccine
    n1=en:cytarabine | n2=en:bivalent hpv16/18 therapeutic cervical cancer vaccine | rel=r_associated | relid=0 | w=20
  944. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bizelesin
    n1=en:cytarabine | n2=en:bizelesin | rel=r_associated | relid=0 | w=20
  945. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bl22 immunotoxin
    n1=en:cytarabine | n2=en:bl22 immunotoxin | rel=r_associated | relid=0 | w=20
  946. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:black cohosh
    n1=en:cytarabine | n2=en:black cohosh | rel=r_associated | relid=0 | w=20
  947. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:black tea
    n1=en:cytarabine | n2=en:black tea | rel=r_associated | relid=0 | w=20
  948. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:blackberry allergenic extract
    n1=en:cytarabine | n2=en:blackberry allergenic extract | rel=r_associated | relid=0 | w=20
  949. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bleomycin sulfate
    n1=en:cytarabine | n2=en:bleomycin sulfate | rel=r_associated | relid=0 | w=20
  950. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:blex 404
    n1=en:cytarabine | n2=en:blex 404 | rel=r_associated | relid=0 | w=20
  951. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:blue citrus-based herbal capsule
    n1=en:cytarabine | n2=en:blue citrus-based herbal capsule | rel=r_associated | relid=0 | w=20
  952. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:blueberry powder supplement
    n1=en:cytarabine | n2=en:blueberry powder supplement | rel=r_associated | relid=0 | w=20
  953. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bmf phase ii protocol
    n1=en:cytarabine | n2=en:bmf phase ii protocol | rel=r_associated | relid=0 | w=20
  954. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bmft-all protocol
    n1=en:cytarabine | n2=en:bmft-all protocol | rel=r_associated | relid=0 | w=20
  955. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bms-188797
    n1=en:cytarabine | n2=en:bms-188797 | rel=r_associated | relid=0 | w=20
  956. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bms-214662
    n1=en:cytarabine | n2=en:bms-214662 | rel=r_associated | relid=0 | w=20
  957. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bms-275183
    n1=en:cytarabine | n2=en:bms-275183 | rel=r_associated | relid=0 | w=20
  958. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bms-817378
    n1=en:cytarabine | n2=en:bms-817378 | rel=r_associated | relid=0 | w=20
  959. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bmvc protocol
    n1=en:cytarabine | n2=en:bmvc protocol | rel=r_associated | relid=0 | w=20
  960. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:boanmycin hydrochloride
    n1=en:cytarabine | n2=en:boanmycin hydrochloride | rel=r_associated | relid=0 | w=20
  961. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:boronophenylalanine-fructose complex
    n1=en:cytarabine | n2=en:boronophenylalanine-fructose complex | rel=r_associated | relid=0 | w=20
  962. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bortezomib
    n1=en:cytarabine | n2=en:bortezomib | rel=r_associated | relid=0 | w=20
  963. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bosutinib
    n1=en:cytarabine | n2=en:bosutinib | rel=r_associated | relid=0 | w=20
  964. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:boswellia serrata extract
    n1=en:cytarabine | n2=en:boswellia serrata extract | rel=r_associated | relid=0 | w=20
  965. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:botulinum toxin type a
    n1=en:cytarabine | n2=en:botulinum toxin type a | rel=r_associated | relid=0 | w=20
  966. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bp-cx1-platinum complex bp-c1
    n1=en:cytarabine | n2=en:bp-cx1-platinum complex bp-c1 | rel=r_associated | relid=0 | w=20
  967. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:br96-doxorubicin immunoconjugate
    n1=en:cytarabine | n2=en:br96-doxorubicin immunoconjugate | rel=r_associated | relid=0 | w=20
  968. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:braf inhibitor arq 736
    n1=en:cytarabine | n2=en:braf inhibitor arq 736 | rel=r_associated | relid=0 | w=20
  969. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:braf inhibitor plx8394
    n1=en:cytarabine | n2=en:braf inhibitor plx8394 | rel=r_associated | relid=0 | w=20
  970. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:braf(v600e) inhibitor cep-32496
    n1=en:cytarabine | n2=en:braf(v600e) inhibitor cep-32496 | rel=r_associated | relid=0 | w=20
  971. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:braf(v600e) kinase inhibitor ro5212054
    n1=en:cytarabine | n2=en:braf(v600e) kinase inhibitor ro5212054 | rel=r_associated | relid=0 | w=20
  972. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:braf/egfr inhibitor bgb-283
    n1=en:cytarabine | n2=en:braf/egfr inhibitor bgb-283 | rel=r_associated | relid=0 | w=20
  973. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brain tumor initiating cell vaccine
    n1=en:cytarabine | n2=en:brain tumor initiating cell vaccine | rel=r_associated | relid=0 | w=20
  974. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:branched-chain amino acid supplement
    n1=en:cytarabine | n2=en:branched-chain amino acid supplement | rel=r_associated | relid=0 | w=20
  975. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brassica vegetable
    n1=en:cytarabine | n2=en:brassica vegetable | rel=r_associated | relid=0 | w=20
  976. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brd4 inhibitor plx51107
    n1=en:cytarabine | n2=en:brd4 inhibitor plx51107 | rel=r_associated | relid=0 | w=20
  977. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brequinar
    n1=en:cytarabine | n2=en:brequinar | rel=r_associated | relid=0 | w=20
  978. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brequinar sodium
    n1=en:cytarabine | n2=en:brequinar sodium | rel=r_associated | relid=0 | w=20
  979. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:briciclib sodium
    n1=en:cytarabine | n2=en:briciclib sodium | rel=r_associated | relid=0 | w=20
  980. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brigatinib
    n1=en:cytarabine | n2=en:brigatinib | rel=r_associated | relid=0 | w=20
  981. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brilacidin oral rinse
    n1=en:cytarabine | n2=en:brilacidin oral rinse | rel=r_associated | relid=0 | w=20
  982. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brivanib
    n1=en:cytarabine | n2=en:brivanib | rel=r_associated | relid=0 | w=20
  983. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brivanib alaninate
    n1=en:cytarabine | n2=en:brivanib alaninate | rel=r_associated | relid=0 | w=20
  984. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brivudine
    n1=en:cytarabine | n2=en:brivudine | rel=r_associated | relid=0 | w=20
  985. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brivudine phosphoramidate
    n1=en:cytarabine | n2=en:brivudine phosphoramidate | rel=r_associated | relid=0 | w=20
  986. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:broad-spectrum human papillomavirus vaccine v505
    n1=en:cytarabine | n2=en:broad-spectrum human papillomavirus vaccine v505 | rel=r_associated | relid=0 | w=20
  987. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bromelains
    n1=en:cytarabine | n2=en:bromelains | rel=r_associated | relid=0 | w=20
  988. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bromocriptine mesylate
    n1=en:cytarabine | n2=en:bromocriptine mesylate | rel=r_associated | relid=0 | w=20
  989. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:brostallicin
    n1=en:cytarabine | n2=en:brostallicin | rel=r_associated | relid=0 | w=20
  990. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bryostatin 1
    n1=en:cytarabine | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=20
  991. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:btk inhibitor gdc-0853
    n1=en:cytarabine | n2=en:btk inhibitor gdc-0853 | rel=r_associated | relid=0 | w=20
  992. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:budesonide/formoterol fumarate dihydrate inhalation aerosol
    n1=en:cytarabine | n2=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | rel=r_associated | relid=0 | w=20
  993. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:buparlisib
    n1=en:cytarabine | n2=en:buparlisib | rel=r_associated | relid=0 | w=20
  994. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bupivacaine hydrochloride
    n1=en:cytarabine | n2=en:bupivacaine hydrochloride | rel=r_associated | relid=0 | w=20
  995. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bupropion + naltrexone
    n1=en:cytarabine | n2=en:bupropion + naltrexone | rel=r_associated | relid=0 | w=20
  996. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:buspirone hydrochloride
    n1=en:cytarabine | n2=en:buspirone hydrochloride | rel=r_associated | relid=0 | w=20
  997. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:busulfan
    n1=en:cytarabine | n2=en:busulfan | rel=r_associated | relid=0 | w=20
  998. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:busulfan/melphalan regimen
    n1=en:cytarabine | n2=en:busulfan/melphalan regimen | rel=r_associated | relid=0 | w=20
  999. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:bvam protocol
    n1=en:cytarabine | n2=en:bvam protocol | rel=r_associated | relid=0 | w=20
  1000. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-ham regimen
    n1=en:cytarabine | n2=en:c-ham regimen | rel=r_associated | relid=0 | w=20
  1001. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-kit inhibitor plx9486
    n1=en:cytarabine | n2=en:c-kit inhibitor plx9486 | rel=r_associated | relid=0 | w=20
  1002. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-met inhibitor jnj-38877605
    n1=en:cytarabine | n2=en:c-met inhibitor jnj-38877605 | rel=r_associated | relid=0 | w=20
  1003. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-met inhibitor mk2461
    n1=en:cytarabine | n2=en:c-met inhibitor mk2461 | rel=r_associated | relid=0 | w=20
  1004. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-met inhibitor mk8033
    n1=en:cytarabine | n2=en:c-met inhibitor mk8033 | rel=r_associated | relid=0 | w=20
  1005. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-met inhibitor msc2156119j
    n1=en:cytarabine | n2=en:c-met inhibitor msc2156119j | rel=r_associated | relid=0 | w=20
  1006. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:c-myb antisense oligonucleotide g4460
    n1=en:cytarabine | n2=en:c-myb antisense oligonucleotide g4460 | rel=r_associated | relid=0 | w=20
  1007. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cabazitaxel
    n1=en:cytarabine | n2=en:cabazitaxel | rel=r_associated | relid=0 | w=20
  1008. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cabergoline
    n1=en:cytarabine | n2=en:cabergoline | rel=r_associated | relid=0 | w=20
  1009. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cace regimen
    n1=en:cytarabine | n2=en:cace regimen | rel=r_associated | relid=0 | w=20
  1010. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caffeine, ergotamine drug combination
    n1=en:cytarabine | n2=en:caffeine, ergotamine drug combination | rel=r_associated | relid=0 | w=20
  1011. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caffeine/cisplatin/cytarabine
    n1=en:cytarabine | n2=en:caffeine/cisplatin/cytarabine | rel=r_associated | relid=0 | w=20
  1012. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cag protocol
    n1=en:cytarabine | n2=en:cag protocol | rel=r_associated | relid=0 | w=20
  1013. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caix inhibitor dtp348
    n1=en:cytarabine | n2=en:caix inhibitor dtp348 | rel=r_associated | relid=0 | w=20
  1014. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calamine
    n1=en:cytarabine | n2=en:calamine | rel=r_associated | relid=0 | w=20
  1015. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calamine / pramoxine
    n1=en:cytarabine | n2=en:calamine / pramoxine | rel=r_associated | relid=0 | w=20
  1016. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calamine + zinc oxide
    n1=en:cytarabine | n2=en:calamine + zinc oxide | rel=r_associated | relid=0 | w=20
  1017. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calaspargase pegol
    n1=en:cytarabine | n2=en:calaspargase pegol | rel=r_associated | relid=0 | w=20
  1018. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcipotriene
    n1=en:cytarabine | n2=en:calcipotriene | rel=r_associated | relid=0 | w=20
  1019. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcitonin salmon
    n1=en:cytarabine | n2=en:calcitonin salmon | rel=r_associated | relid=0 | w=20
  1020. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium aluminosilicate anti-diarrheal
    n1=en:cytarabine | n2=en:calcium aluminosilicate anti-diarrheal | rel=r_associated | relid=0 | w=20
  1021. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium carbonate + famotidine + magnesium hydroxide
    n1=en:cytarabine | n2=en:calcium carbonate + famotidine + magnesium hydroxide | rel=r_associated | relid=0 | w=20
  1022. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium carbonate + simethicone
    n1=en:cytarabine | n2=en:calcium carbonate + simethicone | rel=r_associated | relid=0 | w=20
  1023. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium carbonate+magnesium carbonate
    n1=en:cytarabine | n2=en:calcium carbonate+magnesium carbonate | rel=r_associated | relid=0 | w=20
  1024. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium channel blocker
    n1=en:cytarabine | n2=en:calcium channel blocker | rel=r_associated | relid=0 | w=20
  1025. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium channel inhibitor
    n1=en:cytarabine | n2=en:calcium channel inhibitor | rel=r_associated | relid=0 | w=20
  1026. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium citrate
    n1=en:cytarabine | n2=en:calcium citrate | rel=r_associated | relid=0 | w=20
  1027. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium magnesium potassium carbonate chloride hydroxide
    n1=en:cytarabine | n2=en:calcium magnesium potassium carbonate chloride hydroxide | rel=r_associated | relid=0 | w=20
  1028. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium saccharate
    n1=en:cytarabine | n2=en:calcium saccharate | rel=r_associated | relid=0 | w=20
  1029. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calcium-46 chloride aqueous solution
    n1=en:cytarabine | n2=en:calcium-46 chloride aqueous solution | rel=r_associated | relid=0 | w=20
  1030. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:calendula preparation
    n1=en:cytarabine | n2=en:calendula preparation | rel=r_associated | relid=0 | w=20
  1031. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cameleon protocol
    n1=en:cytarabine | n2=en:cameleon protocol | rel=r_associated | relid=0 | w=20
  1032. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camp combination
    n1=en:cytarabine | n2=en:camp combination | rel=r_associated | relid=0 | w=20
  1033. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camphor / lidocaine / methyl salicylate
    n1=en:cytarabine | n2=en:camphor / lidocaine / methyl salicylate | rel=r_associated | relid=0 | w=20
  1034. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camphor / parachlorophenol
    n1=en:cytarabine | n2=en:camphor / parachlorophenol | rel=r_associated | relid=0 | w=20
  1035. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camphor / phenol
    n1=en:cytarabine | n2=en:camphor / phenol | rel=r_associated | relid=0 | w=20
  1036. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camphor + menthol
    n1=en:cytarabine | n2=en:camphor + menthol | rel=r_associated | relid=0 | w=20
  1037. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camphor + menthol + methyl salicylate
    n1=en:cytarabine | n2=en:camphor + menthol + methyl salicylate | rel=r_associated | relid=0 | w=20
  1038. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camphor + menthol + phenol
    n1=en:cytarabine | n2=en:camphor + menthol + phenol | rel=r_associated | relid=0 | w=20
  1039. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:camptothecin-20(s)-o-propionate hydrate
    n1=en:cytarabine | n2=en:camptothecin-20(s)-o-propionate hydrate | rel=r_associated | relid=0 | w=20
  1040. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cananga odorata extract
    n1=en:cytarabine | n2=en:cananga odorata extract | rel=r_associated | relid=0 | w=20
  1041. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:canarypox-hil-12 melanoma vaccine
    n1=en:cytarabine | n2=en:canarypox-hil-12 melanoma vaccine | rel=r_associated | relid=0 | w=20
  1042. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cancell
    n1=en:cytarabine | n2=en:cancell | rel=r_associated | relid=0 | w=20
  1043. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cancer stemness kinase inhibitor bbi503
    n1=en:cytarabine | n2=en:cancer stemness kinase inhibitor bbi503 | rel=r_associated | relid=0 | w=20
  1044. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:candelilla wax powder
    n1=en:cytarabine | n2=en:candelilla wax powder | rel=r_associated | relid=0 | w=20
  1045. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:candesartan cilexetil
    n1=en:cytarabine | n2=en:candesartan cilexetil | rel=r_associated | relid=0 | w=20
  1046. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:canfosfamide hydrochloride
    n1=en:cytarabine | n2=en:canfosfamide hydrochloride | rel=r_associated | relid=0 | w=20
  1047. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cannabidiol
    n1=en:cytarabine | n2=en:cannabidiol | rel=r_associated | relid=0 | w=20
  1048. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cannabinol
    n1=en:cytarabine | n2=en:cannabinol | rel=r_associated | relid=0 | w=20
  1049. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cannabis extract oil sr capsule
    n1=en:cytarabine | n2=en:cannabis extract oil sr capsule | rel=r_associated | relid=0 | w=20
  1050. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cantuzumab ravtansine
    n1=en:cytarabine | n2=en:cantuzumab ravtansine | rel=r_associated | relid=0 | w=20
  1051. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:capecitabine
    n1=en:cytarabine | n2=en:capecitabine | rel=r_associated | relid=0 | w=20
  1052. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:capecitabine rapidly disintegrating tablet
    n1=en:cytarabine | n2=en:capecitabine rapidly disintegrating tablet | rel=r_associated | relid=0 | w=20
  1053. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:capox regimen
    n1=en:cytarabine | n2=en:capox regimen | rel=r_associated | relid=0 | w=20
  1054. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caprylyl glucoside
    n1=en:cytarabine | n2=en:caprylyl glucoside | rel=r_associated | relid=0 | w=20
  1055. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:capsaicin
    n1=en:cytarabine | n2=en:capsaicin | rel=r_associated | relid=0 | w=20
  1056. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:capsaicin/diclofenac
    n1=en:cytarabine | n2=en:capsaicin/diclofenac | rel=r_associated | relid=0 | w=20
  1057. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:captopril, hydrochlorothiazide drug combination
    n1=en:cytarabine | n2=en:captopril, hydrochlorothiazide drug combination | rel=r_associated | relid=0 | w=20
  1058. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cara protocol
    n1=en:cytarabine | n2=en:cara protocol | rel=r_associated | relid=0 | w=20
  1059. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caracemide
    n1=en:cytarabine | n2=en:caracemide | rel=r_associated | relid=0 | w=20
  1060. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbendazim
    n1=en:cytarabine | n2=en:carbendazim | rel=r_associated | relid=0 | w=20
  1061. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbetimer
    n1=en:cytarabine | n2=en:carbetimer | rel=r_associated | relid=0 | w=20
  1062. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbidopa + entacapone + levodopa
    n1=en:cytarabine | n2=en:carbidopa + entacapone + levodopa | rel=r_associated | relid=0 | w=20
  1063. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbinoxamine, dextromethorphan, pseudoephedrine drug combination
    n1=en:cytarabine | n2=en:carbinoxamine, dextromethorphan, pseudoephedrine drug combination | rel=r_associated | relid=0 | w=20
  1064. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbogen
    n1=en:cytarabine | n2=en:carbogen | rel=r_associated | relid=0 | w=20
  1065. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 11 choline
    n1=en:cytarabine | n2=en:carbon c 11 choline | rel=r_associated | relid=0 | w=20
  1066. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 11 n-desmethyl-loperamide
    n1=en:cytarabine | n2=en:carbon c 11 n-desmethyl-loperamide | rel=r_associated | relid=0 | w=20
  1067. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 11 pbr-28
    n1=en:cytarabine | n2=en:carbon c 11 pbr-28 | rel=r_associated | relid=0 | w=20
  1068. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 13 acetate
    n1=en:cytarabine | n2=en:carbon c 13 acetate | rel=r_associated | relid=0 | w=20
  1069. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 13 lycopene
    n1=en:cytarabine | n2=en:carbon c 13 lycopene | rel=r_associated | relid=0 | w=20
  1070. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 13 phytofluene
    n1=en:cytarabine | n2=en:carbon c 13 phytofluene | rel=r_associated | relid=0 | w=20
  1071. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 13/nitrogen n 15-labeled valine
    n1=en:cytarabine | n2=en:carbon c 13/nitrogen n 15-labeled valine | rel=r_associated | relid=0 | w=20
  1072. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 14 anlotinib hydrochloride
    n1=en:cytarabine | n2=en:carbon c 14 anlotinib hydrochloride | rel=r_associated | relid=0 | w=20
  1073. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 14 ibrutinib
    n1=en:cytarabine | n2=en:carbon c 14 ibrutinib | rel=r_associated | relid=0 | w=20
  1074. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 14 lenvatinib mesylate
    n1=en:cytarabine | n2=en:carbon c 14 lenvatinib mesylate | rel=r_associated | relid=0 | w=20
  1075. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 14 oxaliplatin
    n1=en:cytarabine | n2=en:carbon c 14 oxaliplatin | rel=r_associated | relid=0 | w=20
  1076. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 14 telotristat etiprate
    n1=en:cytarabine | n2=en:carbon c 14 telotristat etiprate | rel=r_associated | relid=0 | w=20
  1077. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c 14 vemurafenib
    n1=en:cytarabine | n2=en:carbon c 14 vemurafenib | rel=r_associated | relid=0 | w=20
  1078. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c-13 dextromethorphan
    n1=en:cytarabine | n2=en:carbon c-13 dextromethorphan | rel=r_associated | relid=0 | w=20
  1079. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon c11 temozolomide
    n1=en:cytarabine | n2=en:carbon c11 temozolomide | rel=r_associated | relid=0 | w=20
  1080. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carbon-11 acetate
    n1=en:cytarabine | n2=en:carbon-11 acetate | rel=r_associated | relid=0 | w=20
  1081. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboplatin/etoposide/melphalan regimen
    n1=en:cytarabine | n2=en:carboplatin/etoposide/melphalan regimen | rel=r_associated | relid=0 | w=20
  1082. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboxyamidotriazole orotate
    n1=en:cytarabine | n2=en:carboxyamidotriazole orotate | rel=r_associated | relid=0 | w=20
  1083. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboxylesterase-expressing allogeneic neural stem cells
    n1=en:cytarabine | n2=en:carboxylesterase-expressing allogeneic neural stem cells | rel=r_associated | relid=0 | w=20
  1084. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboxymethyl-beta-glucan-cytarabine
    n1=en:cytarabine | n2=en:carboxymethyl-beta-glucan-cytarabine | rel=r_associated | relid=0 | w=20
  1085. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboxymethylcellulose / hypromellose
    n1=en:cytarabine | n2=en:carboxymethylcellulose / hypromellose | rel=r_associated | relid=0 | w=20
  1086. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboxymethylcellulose sodium
    n1=en:cytarabine | n2=en:carboxymethylcellulose sodium | rel=r_associated | relid=0 | w=20
  1087. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carboxyphenyl retinamide
    n1=en:cytarabine | n2=en:carboxyphenyl retinamide | rel=r_associated | relid=0 | w=20
  1088. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine
    n1=en:cytarabine | n2=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | rel=r_associated | relid=0 | w=20
  1089. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carcinoembryonic antigen rna-pulsed dc cancer vaccine
    n1=en:cytarabine | n2=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | rel=r_associated | relid=0 | w=20
  1090. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carcinoembryonic antigen-expressing measles virus
    n1=en:cytarabine | n2=en:carcinoembryonic antigen-expressing measles virus | rel=r_associated | relid=0 | w=20
  1091. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carcinogen
    n1=en:cytarabine | n2=en:carcinogen | rel=r_associated | relid=0 | w=20
  1092. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:care protocol
    n1=en:cytarabine | n2=en:care protocol | rel=r_associated | relid=0 | w=20
  1093. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carfilzomib
    n1=en:cytarabine | n2=en:carfilzomib | rel=r_associated | relid=0 | w=20
  1094. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caricotamide/tretazicar
    n1=en:cytarabine | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=20
  1095. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carmofur
    n1=en:cytarabine | n2=en:carmofur | rel=r_associated | relid=0 | w=20
  1096. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carmustine
    n1=en:cytarabine | n2=en:carmustine | rel=r_associated | relid=0 | w=20
  1097. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carmustine in ethanol
    n1=en:cytarabine | n2=en:carmustine in ethanol | rel=r_associated | relid=0 | w=20
  1098. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carmustine/cytarabine/etoposide/melphalan
    n1=en:cytarabine | n2=en:carmustine/cytarabine/etoposide/melphalan | rel=r_associated | relid=0 | w=20
  1099. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carrageenan-containing gel
    n1=en:cytarabine | n2=en:carrageenan-containing gel | rel=r_associated | relid=0 | w=20
  1100. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cart protocol
    n1=en:cytarabine | n2=en:cart protocol | rel=r_associated | relid=0 | w=20
  1101. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:carvedilol
    n1=en:cytarabine | n2=en:carvedilol | rel=r_associated | relid=0 | w=20
  1102. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:caseinate protein isolate
    n1=en:cytarabine | n2=en:caseinate protein isolate | rel=r_associated | relid=0 | w=20
  1103. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:casopitant mesylate
    n1=en:cytarabine | n2=en:casopitant mesylate | rel=r_associated | relid=0 | w=20
  1104. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cat combination
    n1=en:cytarabine | n2=en:cat combination | rel=r_associated | relid=0 | w=20
  1105. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cat-g protocol
    n1=en:cytarabine | n2=en:cat-g protocol | rel=r_associated | relid=0 | w=20
  1106. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cathelicidin ll-37
    n1=en:cytarabine | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=20
  1107. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cationic liposome-encapsulated paclitaxel
    n1=en:cytarabine | n2=en:cationic liposome-encapsulated paclitaxel | rel=r_associated | relid=0 | w=20
  1108. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:catumaxomab
    n1=en:cytarabine | n2=en:catumaxomab | rel=r_associated | relid=0 | w=20
  1109. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cb10-277
    n1=en:cytarabine | n2=en:cb10-277 | rel=r_associated | relid=0 | w=20
  1110. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cbp/beta-catenin antagonist pri-724
    n1=en:cytarabine | n2=en:cbp/beta-catenin antagonist pri-724 | rel=r_associated | relid=0 | w=20
  1111. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cc-1088
    n1=en:cytarabine | n2=en:cc-1088 | rel=r_associated | relid=0 | w=20
  1112. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cc-401
    n1=en:cytarabine | n2=en:cc-401 | rel=r_associated | relid=0 | w=20
  1113. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ccg-0922 apl regimen
    n1=en:cytarabine | n2=en:ccg-0922 apl regimen | rel=r_associated | relid=0 | w=20
  1114. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ccg-192p
    n1=en:cytarabine | n2=en:ccg-192p | rel=r_associated | relid=0 | w=20
  1115. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ccl21-expressing h1944 cell vaccine
    n1=en:cytarabine | n2=en:ccl21-expressing h1944 cell vaccine | rel=r_associated | relid=0 | w=20
  1116. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ccr2 antagonist pf-04136309
    n1=en:cytarabine | n2=en:ccr2 antagonist pf-04136309 | rel=r_associated | relid=0 | w=20
  1117. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
    n1=en:cytarabine | n2=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | rel=r_associated | relid=0 | w=20
  1118. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  1119. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd19/cd3 dual-affinity retargeting protein jnj-64052781
    n1=en:cytarabine | n2=en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 | rel=r_associated | relid=0 | w=20
  1120. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  1121. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  1122. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd19car-cd3zeta-expressing autologous t lymphocytes
    n1=en:cytarabine | n2=en:cd19car-cd3zeta-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  1123. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc
    n1=en:cytarabine | n2=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | rel=r_associated | relid=0 | w=20
  1124. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  1125. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd4+ cd25+ regulatory t cells
    n1=en:cytarabine | n2=en:cd4+ cd25+ regulatory t cells | rel=r_associated | relid=0 | w=20
  1126. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd40 agonist monoclonal antibody cp-870,893
    n1=en:cytarabine | n2=en:cd40 agonist monoclonal antibody cp-870,893 | rel=r_associated | relid=0 | w=20
  1127. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd40 agonist monoclonal antibody ro7009789
    n1=en:cytarabine | n2=en:cd40 agonist monoclonal antibody ro7009789 | rel=r_associated | relid=0 | w=20
  1128. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd40 agonistic monoclonal antibody apx005m
    n1=en:cytarabine | n2=en:cd40 agonistic monoclonal antibody apx005m | rel=r_associated | relid=0 | w=20
  1129. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cd95 ecd/igg-fc fusion protein apg101
    n1=en:cytarabine | n2=en:cd95 ecd/igg-fc fusion protein apg101 | rel=r_associated | relid=0 | w=20
  1130. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdc7 inhibitor tak-931
    n1=en:cytarabine | n2=en:cdc7 inhibitor tak-931 | rel=r_associated | relid=0 | w=20
  1131. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdc7 kinase inhibitor bms-863233
    n1=en:cytarabine | n2=en:cdc7 kinase inhibitor bms-863233 | rel=r_associated | relid=0 | w=20
  1132. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdk inhibitor p276-00
    n1=en:cytarabine | n2=en:cdk inhibitor p276-00 | rel=r_associated | relid=0 | w=20
  1133. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdk inhibitor sns-032
    n1=en:cytarabine | n2=en:cdk inhibitor sns-032 | rel=r_associated | relid=0 | w=20
  1134. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdk2/5/9 inhibitor cyc065
    n1=en:cytarabine | n2=en:cdk2/5/9 inhibitor cyc065 | rel=r_associated | relid=0 | w=20
  1135. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdk4 inhibitor p1446a-05
    n1=en:cytarabine | n2=en:cdk4 inhibitor p1446a-05 | rel=r_associated | relid=0 | w=20
  1136. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdk4/6 inhibitor g1t28
    n1=en:cytarabine | n2=en:cdk4/6 inhibitor g1t28 | rel=r_associated | relid=0 | w=20
  1137. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdki at7519
    n1=en:cytarabine | n2=en:cdki at7519 | rel=r_associated | relid=0 | w=20
  1138. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cdki r547
    n1=en:cytarabine | n2=en:cdki r547 | rel=r_associated | relid=0 | w=20
  1139. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine
    n1=en:cytarabine | n2=en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine | rel=r_associated | relid=0 | w=20
  1140. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cebpa-targeting sarna mtl-cebpa liposome
    n1=en:cytarabine | n2=en:cebpa-targeting sarna mtl-cebpa liposome | rel=r_associated | relid=0 | w=20
  1141. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cef regimen
    n1=en:cytarabine | n2=en:cef regimen | rel=r_associated | relid=0 | w=20
  1142. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cefepime hydrochloride
    n1=en:cytarabine | n2=en:cefepime hydrochloride | rel=r_associated | relid=0 | w=20
  1143. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cefpodoxime proxetil
    n1=en:cytarabine | n2=en:cefpodoxime proxetil | rel=r_associated | relid=0 | w=20
  1144. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ceftobiprole medocaril
    n1=en:cytarabine | n2=en:ceftobiprole medocaril | rel=r_associated | relid=0 | w=20
  1145. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ceftriaxone sodium
    n1=en:cytarabine | n2=en:ceftriaxone sodium | rel=r_associated | relid=0 | w=20
  1146. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:celecoxib/lidocaine/menthol
    n1=en:cytarabine | n2=en:celecoxib/lidocaine/menthol | rel=r_associated | relid=0 | w=20
  1147. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cell cycle checkpoint/dna repair antagonist ic83
    n1=en:cytarabine | n2=en:cell cycle checkpoint/dna repair antagonist ic83 | rel=r_associated | relid=0 | w=20
  1148. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cemadotin hydrochloride
    n1=en:cytarabine | n2=en:cemadotin hydrochloride | rel=r_associated | relid=0 | w=20
  1149. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cenersen
    n1=en:cytarabine | n2=en:cenersen | rel=r_associated | relid=0 | w=20
  1150. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cenisertib
    n1=en:cytarabine | n2=en:cenisertib | rel=r_associated | relid=0 | w=20
  1151. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:centaury preparation
    n1=en:cytarabine | n2=en:centaury preparation | rel=r_associated | relid=0 | w=20
  1152. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:central nervous system agents
    n1=en:cytarabine | n2=en:central nervous system agents | rel=r_associated | relid=0 | w=20
  1153. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cer-cyt protocol
    n1=en:cytarabine | n2=en:cer-cyt protocol | rel=r_associated | relid=0 | w=20
  1154. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ceritinib
    n1=en:cytarabine | n2=en:ceritinib | rel=r_associated | relid=0 | w=20
  1155. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cerium oxalate
    n1=en:cytarabine | n2=en:cerium oxalate | rel=r_associated | relid=0 | w=20
  1156. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:certolizumab
    n1=en:cytarabine | n2=en:certolizumab | rel=r_associated | relid=0 | w=20
  1157. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cesium cs-131
    n1=en:cytarabine | n2=en:cesium cs-131 | rel=r_associated | relid=0 | w=20
  1158. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cetearyl alcohol
    n1=en:cytarabine | n2=en:cetearyl alcohol | rel=r_associated | relid=0 | w=20
  1159. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cetirizine
    n1=en:cytarabine | n2=en:cetirizine | rel=r_associated | relid=0 | w=20
  1160. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cetuximab
    n1=en:cytarabine | n2=en:cetuximab | rel=r_associated | relid=0 | w=20
  1161. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cetylpyridinium chloride anhydrous
    n1=en:cytarabine | n2=en:cetylpyridinium chloride anhydrous | rel=r_associated | relid=0 | w=20
  1162. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cetylpyridinium+menthol
    n1=en:cytarabine | n2=en:cetylpyridinium+menthol | rel=r_associated | relid=0 | w=20
  1163. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cfms tyrosine kinase inhibitor arry-382
    n1=en:cytarabine | n2=en:cfms tyrosine kinase inhibitor arry-382 | rel=r_associated | relid=0 | w=20
  1164. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cgp-6809
    n1=en:cytarabine | n2=en:cgp-6809 | rel=r_associated | relid=0 | w=20
  1165. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chase protocol
    n1=en:cytarabine | n2=en:chase protocol | rel=r_associated | relid=0 | w=20
  1166. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chaste berry extract
    n1=en:cytarabine | n2=en:chaste berry extract | rel=r_associated | relid=0 | w=20
  1167. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:checkpoint kinase inhibitor azd7762
    n1=en:cytarabine | n2=en:checkpoint kinase inhibitor azd7762 | rel=r_associated | relid=0 | w=20
  1168. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:checkpoint kinase inhibitor xl844
    n1=en:cytarabine | n2=en:checkpoint kinase inhibitor xl844 | rel=r_associated | relid=0 | w=20
  1169. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chelating agent
    n1=en:cytarabine | n2=en:chelating agent | rel=r_associated | relid=0 | w=20
  1170. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chewing gum dosage form
    n1=en:cytarabine | n2=en:chewing gum dosage form | rel=r_associated | relid=0 | w=20
  1171. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chidamide
    n1=en:cytarabine | n2=en:chidamide | rel=r_associated | relid=0 | w=20
  1172. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chimeric fibril-reactive monoclonal antibody 111f4
    n1=en:cytarabine | n2=en:chimeric fibril-reactive monoclonal antibody 111f4 | rel=r_associated | relid=0 | w=20
  1173. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chimeric humanized anti-cd47 antibody
    n1=en:cytarabine | n2=en:chimeric humanized anti-cd47 antibody | rel=r_associated | relid=0 | w=20
  1174. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chinese herbal formulation changtai keli
    n1=en:cytarabine | n2=en:chinese herbal formulation changtai keli | rel=r_associated | relid=0 | w=20
  1175. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chinese herbal formulation phy906
    n1=en:cytarabine | n2=en:chinese herbal formulation phy906 | rel=r_associated | relid=0 | w=20
  1176. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chitosan-n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine conjugate
    n1=en:cytarabine | n2=en:chitosan-n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine conjugate | rel=r_associated | relid=0 | w=20
  1177. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chk1 inhibitor gdc-0425
    n1=en:cytarabine | n2=en:chk1 inhibitor gdc-0425 | rel=r_associated | relid=0 | w=20
  1178. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chk1 inhibitor gdc-0575
    n1=en:cytarabine | n2=en:chk1 inhibitor gdc-0575 | rel=r_associated | relid=0 | w=20
  1179. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chk1 inhibitor mk-8776
    n1=en:cytarabine | n2=en:chk1 inhibitor mk-8776 | rel=r_associated | relid=0 | w=20
  1180. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chk1 inhibitor pf-477736
    n1=en:cytarabine | n2=en:chk1 inhibitor pf-477736 | rel=r_associated | relid=0 | w=20
  1181. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorambucil-prednisone regimen
    n1=en:cytarabine | n2=en:chlorambucil-prednisone regimen | rel=r_associated | relid=0 | w=20
  1182. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlordiazepoxide, clidinium drug combination
    n1=en:cytarabine | n2=en:chlordiazepoxide, clidinium drug combination | rel=r_associated | relid=0 | w=20
  1183. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chloroquinoxaline sulfonamide
    n1=en:cytarabine | n2=en:chloroquinoxaline sulfonamide | rel=r_associated | relid=0 | w=20
  1184. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorothiazide + methyldopa
    n1=en:cytarabine | n2=en:chlorothiazide + methyldopa | rel=r_associated | relid=0 | w=20
  1185. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorothiazide + reserpine
    n1=en:cytarabine | n2=en:chlorothiazide + reserpine | rel=r_associated | relid=0 | w=20
  1186. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chloroxylenol / pramoxine
    n1=en:cytarabine | n2=en:chloroxylenol / pramoxine | rel=r_associated | relid=0 | w=20
  1187. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + carbetapentane
    n1=en:cytarabine | n2=en:chlorpheniramine + carbetapentane | rel=r_associated | relid=0 | w=20
  1188. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + ibuprofen + pseudoephedrine
    n1=en:cytarabine | n2=en:chlorpheniramine + ibuprofen + pseudoephedrine | rel=r_associated | relid=0 | w=20
  1189. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + phenylephrine
    n1=en:cytarabine | n2=en:chlorpheniramine + phenylephrine | rel=r_associated | relid=0 | w=20
  1190. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + pseudoephedrine
    n1=en:cytarabine | n2=en:chlorpheniramine + pseudoephedrine | rel=r_associated | relid=0 | w=20
  1191. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + pseudoephedrine + codeine
    n1=en:cytarabine | n2=en:chlorpheniramine + pseudoephedrine + codeine | rel=r_associated | relid=0 | w=20
  1192. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + pseudoephedrine + dextromethorphan
    n1=en:cytarabine | n2=en:chlorpheniramine + pseudoephedrine + dextromethorphan | rel=r_associated | relid=0 | w=20
  1193. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + pseudoephedrine + hydrocodone
    n1=en:cytarabine | n2=en:chlorpheniramine + pseudoephedrine + hydrocodone | rel=r_associated | relid=0 | w=20
  1194. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine + pyrilamine + phenylephrine
    n1=en:cytarabine | n2=en:chlorpheniramine + pyrilamine + phenylephrine | rel=r_associated | relid=0 | w=20
  1195. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine, ephedrine drug combination
    n1=en:cytarabine | n2=en:chlorpheniramine, ephedrine drug combination | rel=r_associated | relid=0 | w=20
  1196. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination
    n1=en:cytarabine | n2=en:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination | rel=r_associated | relid=0 | w=20
  1197. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chlorpheniramine, phenylpropanolamine drug combination
    n1=en:cytarabine | n2=en:chlorpheniramine, phenylpropanolamine drug combination | rel=r_associated | relid=0 | w=20
  1198. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:choleretic agent
    n1=en:cytarabine | n2=en:choleretic agent | rel=r_associated | relid=0 | w=20
  1199. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cholesterol test kit
    n1=en:cytarabine | n2=en:cholesterol test kit | rel=r_associated | relid=0 | w=20
  1200. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:choline / dexpanthenol
    n1=en:cytarabine | n2=en:choline / dexpanthenol | rel=r_associated | relid=0 | w=20
  1201. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:choline kinase alpha inhibitor tcd-717
    n1=en:cytarabine | n2=en:choline kinase alpha inhibitor tcd-717 | rel=r_associated | relid=0 | w=20
  1202. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chp-her-2 peptide vaccine
    n1=en:cytarabine | n2=en:chp-her-2 peptide vaccine | rel=r_associated | relid=0 | w=20
  1203. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:chp-ny-eso-1 peptide vaccine imf-001
    n1=en:cytarabine | n2=en:chp-ny-eso-1 peptide vaccine imf-001 | rel=r_associated | relid=0 | w=20
  1204. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ciclesonide
    n1=en:cytarabine | n2=en:ciclesonide | rel=r_associated | relid=0 | w=20
  1205. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ciclopirox olamine lotion
    n1=en:cytarabine | n2=en:ciclopirox olamine lotion | rel=r_associated | relid=0 | w=20
  1206. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cilengitide
    n1=en:cytarabine | n2=en:cilengitide | rel=r_associated | relid=0 | w=20
  1207. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cimetidine
    n1=en:cytarabine | n2=en:cimetidine | rel=r_associated | relid=0 | w=20
  1208. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cinacalcet hydrochloride
    n1=en:cytarabine | n2=en:cinacalcet hydrochloride | rel=r_associated | relid=0 | w=20
  1209. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cinobufagin
    n1=en:cytarabine | n2=en:cinobufagin | rel=r_associated | relid=0 | w=20
  1210. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ciprofloxacin+dexamethasone
    n1=en:cytarabine | n2=en:ciprofloxacin+dexamethasone | rel=r_associated | relid=0 | w=20
  1211. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cirmtuzumab
    n1=en:cytarabine | n2=en:cirmtuzumab | rel=r_associated | relid=0 | w=20
  1212. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cis-urocanic acid
    n1=en:cytarabine | n2=en:cis-urocanic acid | rel=r_associated | relid=0 | w=20
  1213. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cisatracurium
    n1=en:cytarabine | n2=en:cisatracurium | rel=r_associated | relid=0 | w=20
  1214. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cisplatin
    n1=en:cytarabine | n2=en:cisplatin | rel=r_associated | relid=0 | w=20
  1215. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cisplatin liposomal
    n1=en:cytarabine | n2=en:cisplatin liposomal | rel=r_associated | relid=0 | w=20
  1216. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cisplatin-e therapeutic implant
    n1=en:cytarabine | n2=en:cisplatin-e therapeutic implant | rel=r_associated | relid=0 | w=20
  1217. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:citatuzumab bogatox
    n1=en:cytarabine | n2=en:citatuzumab bogatox | rel=r_associated | relid=0 | w=20
  1218. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:citric acid + magnesium oxide + sodium picosulfate
    n1=en:cytarabine | n2=en:citric acid + magnesium oxide + sodium picosulfate | rel=r_associated | relid=0 | w=20
  1219. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:citrulline
    n1=en:cytarabine | n2=en:citrulline | rel=r_associated | relid=0 | w=20
  1220. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cixutumumab
    n1=en:cytarabine | n2=en:cixutumumab | rel=r_associated | relid=0 | w=20
  1221. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cjc-1295
    n1=en:cytarabine | n2=en:cjc-1295 | rel=r_associated | relid=0 | w=20
  1222. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ck2-targeting synthetic peptide cigb-300
    n1=en:cytarabine | n2=en:ck2-targeting synthetic peptide cigb-300 | rel=r_associated | relid=0 | w=20
  1223. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clag protocol
    n1=en:cytarabine | n2=en:clag protocol | rel=r_associated | relid=0 | w=20
  1224. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clag-m regimen
    n1=en:cytarabine | n2=en:clag-m regimen | rel=r_associated | relid=0 | w=20
  1225. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clarithromycin
    n1=en:cytarabine | n2=en:clarithromycin | rel=r_associated | relid=0 | w=20
  1226. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:claudiximab
    n1=en:cytarabine | n2=en:claudiximab | rel=r_associated | relid=0 | w=20
  1227. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cleanser
    n1=en:cytarabine | n2=en:cleanser | rel=r_associated | relid=0 | w=20
  1228. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clematis vitalba flower extract
    n1=en:cytarabine | n2=en:clematis vitalba flower extract | rel=r_associated | relid=0 | w=20
  1229. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clevudine
    n1=en:cytarabine | n2=en:clevudine | rel=r_associated | relid=0 | w=20
  1230. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clino-san vaginal lubricant
    n1=en:cytarabine | n2=en:clino-san vaginal lubricant | rel=r_associated | relid=0 | w=20
  1231. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clioquinol + hydrocortisone + pramoxine hydrochloride
    n1=en:cytarabine | n2=en:clioquinol + hydrocortisone + pramoxine hydrochloride | rel=r_associated | relid=0 | w=20
  1232. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clofarabine
    n1=en:cytarabine | n2=en:clofarabine | rel=r_associated | relid=0 | w=20
  1233. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clomiphen citrate
    n1=en:cytarabine | n2=en:clomiphen citrate | rel=r_associated | relid=0 | w=20
  1234. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clomiphene citrate
    n1=en:cytarabine | n2=en:clomiphene citrate | rel=r_associated | relid=0 | w=20
  1235. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clonidine-containing mucoadhesive buccal tablet
    n1=en:cytarabine | n2=en:clonidine-containing mucoadhesive buccal tablet | rel=r_associated | relid=0 | w=20
  1236. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clostridium butyricum-containing probiotic
    n1=en:cytarabine | n2=en:clostridium butyricum-containing probiotic | rel=r_associated | relid=0 | w=20
  1237. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clostridium novyi-nt spores
    n1=en:cytarabine | n2=en:clostridium novyi-nt spores | rel=r_associated | relid=0 | w=20
  1238. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clove preparation
    n1=en:cytarabine | n2=en:clove preparation | rel=r_associated | relid=0 | w=20
  1239. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:clozapine (actavis)
    n1=en:cytarabine | n2=en:clozapine (actavis) | rel=r_associated | relid=0 | w=20
  1240. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cmet car-mrna electroporated autologous t lymphocytes
    n1=en:cytarabine | n2=en:cmet car-mrna electroporated autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  1241. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cmv n495 peptide
    n1=en:cytarabine | n2=en:cmv n495 peptide | rel=r_associated | relid=0 | w=20
  1242. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  1243. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cmvpp65-a*0201 peptide vaccine
    n1=en:cytarabine | n2=en:cmvpp65-a*0201 peptide vaccine | rel=r_associated | relid=0 | w=20
  1244. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cngrc peptide-tnf alpha conjugate
    n1=en:cytarabine | n2=en:cngrc peptide-tnf alpha conjugate | rel=r_associated | relid=0 | w=20
  1245. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:coa protocol
    n1=en:cytarabine | n2=en:coa protocol | rel=r_associated | relid=0 | w=20
  1246. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cobalamin
    n1=en:cytarabine | n2=en:cobalamin | rel=r_associated | relid=0 | w=20
  1247. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cobimetinib
    n1=en:cytarabine | n2=en:cobimetinib | rel=r_associated | relid=0 | w=20
  1248. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cobiprostone
    n1=en:cytarabine | n2=en:cobiprostone | rel=r_associated | relid=0 | w=20
  1249. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:coccidioides immitis antigen
    n1=en:cytarabine | n2=en:coccidioides immitis antigen | rel=r_associated | relid=0 | w=20
  1250. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cocculus/nux vomica/tabacum/petroleum extract
    n1=en:cytarabine | n2=en:cocculus/nux vomica/tabacum/petroleum extract | rel=r_associated | relid=0 | w=20
  1251. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:code
    n1=en:cytarabine | n2=en:code | rel=r_associated | relid=0 | w=20
  1252. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:codeine / iodinated glycerol
    n1=en:cytarabine | n2=en:codeine / iodinated glycerol | rel=r_associated | relid=0 | w=20
  1253. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:codeine / potassium citrate
    n1=en:cytarabine | n2=en:codeine / potassium citrate | rel=r_associated | relid=0 | w=20
  1254. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:codeine + pseudoephedrine
    n1=en:cytarabine | n2=en:codeine + pseudoephedrine | rel=r_associated | relid=0 | w=20
  1255. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:codeine phosphate
    n1=en:cytarabine | n2=en:codeine phosphate | rel=r_associated | relid=0 | w=20
  1256. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:codox-m/ivac regimen
    n1=en:cytarabine | n2=en:codox-m/ivac regimen | rel=r_associated | relid=0 | w=20
  1257. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:coffee dietary supplement
    n1=en:cytarabine | n2=en:coffee dietary supplement | rel=r_associated | relid=0 | w=20
  1258. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cola
    n1=en:cytarabine | n2=en:cola | rel=r_associated | relid=0 | w=20
  1259. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cold contaminant-free iobenguane i-131
    n1=en:cytarabine | n2=en:cold contaminant-free iobenguane i-131 | rel=r_associated | relid=0 | w=20
  1260. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:colloidal gold-bound tumor necrosis factor
    n1=en:cytarabine | n2=en:colloidal gold-bound tumor necrosis factor | rel=r_associated | relid=0 | w=20
  1261. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:colorectal tumor-associated peptides vaccine ima910
    n1=en:cytarabine | n2=en:colorectal tumor-associated peptides vaccine ima910 | rel=r_associated | relid=0 | w=20
  1262. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:combretastatin a1 diphosphate
    n1=en:cytarabine | n2=en:combretastatin a1 diphosphate | rel=r_associated | relid=0 | w=20
  1263. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:comet-a protocol
    n1=en:cytarabine | n2=en:comet-a protocol | rel=r_associated | relid=0 | w=20
  1264. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:comla protocol
    n1=en:cytarabine | n2=en:comla protocol | rel=r_associated | relid=0 | w=20
  1265. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:complement c5 inhibitor alxn1210
    n1=en:cytarabine | n2=en:complement c5 inhibitor alxn1210 | rel=r_associated | relid=0 | w=20
  1266. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:compound kushen injection
    n1=en:cytarabine | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=20
  1267. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:compound sodium lactate solution
    n1=en:cytarabine | n2=en:compound sodium lactate solution | rel=r_associated | relid=0 | w=20
  1268. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:computer language
    n1=en:cytarabine | n2=en:computer language | rel=r_associated | relid=0 | w=20
  1269. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:conatumumab
    n1=en:cytarabine | n2=en:conatumumab | rel=r_associated | relid=0 | w=20
  1270. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:conb-a protocol
    n1=en:cytarabine | n2=en:conb-a protocol | rel=r_associated | relid=0 | w=20
  1271. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:concentrated beet crystals
    n1=en:cytarabine | n2=en:concentrated beet crystals | rel=r_associated | relid=0 | w=20
  1272. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:conditionally replicative adenovirus 5/3-delta24
    n1=en:cytarabine | n2=en:conditionally replicative adenovirus 5/3-delta24 | rel=r_associated | relid=0 | w=20
  1273. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:conium preparation
    n1=en:cytarabine | n2=en:conium preparation | rel=r_associated | relid=0 | w=20
  1274. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:conjugated estrogens/bazedoxifene
    n1=en:cytarabine | n2=en:conjugated estrogens/bazedoxifene | rel=r_associated | relid=0 | w=20
  1275. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:controlled substance
    n1=en:cytarabine | n2=en:controlled substance | rel=r_associated | relid=0 | w=20
  1276. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:copanlisib
    n1=en:cytarabine | n2=en:copanlisib | rel=r_associated | relid=0 | w=20
  1277. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:copovithane
    n1=en:cytarabine | n2=en:copovithane | rel=r_associated | relid=0 | w=20
  1278. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:copp regimen
    n1=en:cytarabine | n2=en:copp regimen | rel=r_associated | relid=0 | w=20
  1279. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:copper cu 62-atsm
    n1=en:cytarabine | n2=en:copper cu 62-atsm | rel=r_associated | relid=0 | w=20
  1280. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:copper gluconate
    n1=en:cytarabine | n2=en:copper gluconate | rel=r_associated | relid=0 | w=20
  1281. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:coptis extract
    n1=en:cytarabine | n2=en:coptis extract | rel=r_associated | relid=0 | w=20
  1282. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cord blood-derived expanded natural killer cell infusion pnk-007
    n1=en:cytarabine | n2=en:cord blood-derived expanded natural killer cell infusion pnk-007 | rel=r_associated | relid=0 | w=20
  1283. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cordycepin
    n1=en:cytarabine | n2=en:cordycepin | rel=r_associated | relid=0 | w=20
  1284. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cordyceps sinensis preparation
    n1=en:cytarabine | n2=en:cordyceps sinensis preparation | rel=r_associated | relid=0 | w=20
  1285. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:coriolus versicolor extract
    n1=en:cytarabine | n2=en:coriolus versicolor extract | rel=r_associated | relid=0 | w=20
  1286. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:corn tassel
    n1=en:cytarabine | n2=en:corn tassel | rel=r_associated | relid=0 | w=20
  1287. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cornsilk
    n1=en:cytarabine | n2=en:cornsilk | rel=r_associated | relid=0 | w=20
  1288. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:correspond to
    n1=en:cytarabine | n2=en:correspond to | rel=r_associated | relid=0 | w=20
  1289. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:corticorelin acetate
    n1=en:cytarabine | n2=en:corticorelin acetate | rel=r_associated | relid=0 | w=20
  1290. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cortifair
    n1=en:cytarabine | n2=en:cortifair | rel=r_associated | relid=0 | w=20
  1291. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cortisol
    n1=en:cytarabine | n2=en:cortisol | rel=r_associated | relid=0 | w=20
  1292. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cortisol-4-ara-c
    n1=en:cytarabine | n2=en:cortisol-4-ara-c | rel=r_associated | relid=0 | w=20
  1293. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cortisone-4-ara-c
    n1=en:cytarabine | n2=en:cortisone-4-ara-c | rel=r_associated | relid=0 | w=20
  1294. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:corynebacterium granulosum p40
    n1=en:cytarabine | n2=en:corynebacterium granulosum p40 | rel=r_associated | relid=0 | w=20
  1295. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:coxsackievirus a21
    n1=en:cytarabine | n2=en:coxsackievirus a21 | rel=r_associated | relid=0 | w=20
  1296. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cp 461
    n1=en:cytarabine | n2=en:cp 461 | rel=r_associated | relid=0 | w=20
  1297. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cp-609,754
    n1=en:cytarabine | n2=en:cp-609,754 | rel=r_associated | relid=0 | w=20
  1298. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cp-724,714
    n1=en:cytarabine | n2=en:cp-724,714 | rel=r_associated | relid=0 | w=20
  1299. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cpg-28 oligodeoxynucleotide
    n1=en:cytarabine | n2=en:cpg-28 oligodeoxynucleotide | rel=r_associated | relid=0 | w=20
  1300. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cr2-fh fusion protein tt30
    n1=en:cytarabine | n2=en:cr2-fh fusion protein tt30 | rel=r_associated | relid=0 | w=20
  1301. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:creatine monohydrate
    n1=en:cytarabine | n2=en:creatine monohydrate | rel=r_associated | relid=0 | w=20
  1302. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crenolanib
    n1=en:cytarabine | n2=en:crenolanib | rel=r_associated | relid=0 | w=20
  1303. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crenolanib besylate
    n1=en:cytarabine | n2=en:crenolanib besylate | rel=r_associated | relid=0 | w=20
  1304. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cridanimod sodium
    n1=en:cytarabine | n2=en:cridanimod sodium | rel=r_associated | relid=0 | w=20
  1305. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crisnatol mesylate
    n1=en:cytarabine | n2=en:crisnatol mesylate | rel=r_associated | relid=0 | w=20
  1306. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crl 1005
    n1=en:cytarabine | n2=en:crl 1005 | rel=r_associated | relid=0 | w=20
  1307. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crolibulin
    n1=en:cytarabine | n2=en:crolibulin | rel=r_associated | relid=0 | w=20
  1308. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crop protocol
    n1=en:cytarabine | n2=en:crop protocol | rel=r_associated | relid=0 | w=20
  1309. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cryoprotective agent
    n1=en:cytarabine | n2=en:cryoprotective agent | rel=r_associated | relid=0 | w=20
  1310. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:crystalline genistein formulation axp107-11
    n1=en:cytarabine | n2=en:crystalline genistein formulation axp107-11 | rel=r_associated | relid=0 | w=20
  1311. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ct protocol
    n1=en:cytarabine | n2=en:ct protocol | rel=r_associated | relid=0 | w=20
  1312. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ctp-37-dt vaccine
    n1=en:cytarabine | n2=en:ctp-37-dt vaccine | rel=r_associated | relid=0 | w=20
  1313. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ctr iii protocol
    n1=en:cytarabine | n2=en:ctr iii protocol | rel=r_associated | relid=0 | w=20
  1314. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ctriii
    n1=en:cytarabine | n2=en:ctriii | rel=r_associated | relid=0 | w=20
  1315. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ctrp terminology
    n1=en:cytarabine | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=20
  1316. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:curcumin
    n1=en:cytarabine | n2=en:curcumin | rel=r_associated | relid=0 | w=20
  1317. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule
    n1=en:cytarabine | n2=en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule | rel=r_associated | relid=0 | w=20
  1318. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:custirsen sodium
    n1=en:cytarabine | n2=en:custirsen sodium | rel=r_associated | relid=0 | w=20
  1319. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cutemol
    n1=en:cytarabine | n2=en:cutemol | rel=r_associated | relid=0 | w=20
  1320. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cvap-bleo
    n1=en:cytarabine | n2=en:cvap-bleo | rel=r_associated | relid=0 | w=20
  1321. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cxc chemokine receptor 2 antagonist azd5069
    n1=en:cytarabine | n2=en:cxc chemokine receptor 2 antagonist azd5069 | rel=r_associated | relid=0 | w=20
  1322. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cxcr4 antagonist bl-8040
    n1=en:cytarabine | n2=en:cxcr4 antagonist bl-8040 | rel=r_associated | relid=0 | w=20
  1323. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cxcr4 inhibitor x4p-001
    n1=en:cytarabine | n2=en:cxcr4 inhibitor x4p-001 | rel=r_associated | relid=0 | w=20
  1324. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyanocobalamin + folic acid
    n1=en:cytarabine | n2=en:cyanocobalamin + folic acid | rel=r_associated | relid=0 | w=20
  1325. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclic ara-cmp
    n1=en:cytarabine | n2=en:cyclic ara-cmp | rel=r_associated | relid=0 | w=20
  1326. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  1327. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclodextrin-based polymer-camptothecin crlx101
    n1=en:cytarabine | n2=en:cyclodextrin-based polymer-camptothecin crlx101 | rel=r_associated | relid=0 | w=20
  1328. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cycloleucine
    n1=en:cytarabine | n2=en:cycloleucine | rel=r_associated | relid=0 | w=20
  1329. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclomethicone
    n1=en:cytarabine | n2=en:cyclomethicone | rel=r_associated | relid=0 | w=20
  1330. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclopentenyl cytosine
    n1=en:cytarabine | n2=en:cyclopentenyl cytosine | rel=r_associated | relid=0 | w=20
  1331. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclopentolate+phenylephrine
    n1=en:cytarabine | n2=en:cyclopentolate+phenylephrine | rel=r_associated | relid=0 | w=20
  1332. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclophosphamide
    n1=en:cytarabine | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=20
  1333. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclophosphamide/dactinomycin/vincristine
    n1=en:cytarabine | n2=en:cyclophosphamide/dactinomycin/vincristine | rel=r_associated | relid=0 | w=20
  1334. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyclosporine ophthalmic emulsion
    n1=en:cytarabine | n2=en:cyclosporine ophthalmic emulsion | rel=r_associated | relid=0 | w=20
  1335. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyl-02 plasmid dna
    n1=en:cytarabine | n2=en:cyl-02 plasmid dna | rel=r_associated | relid=0 | w=20
  1336. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cym protocol
    n1=en:cytarabine | n2=en:cym protocol | rel=r_associated | relid=0 | w=20
  1337. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyp17 inhibitor cfg920
    n1=en:cytarabine | n2=en:cyp17 inhibitor cfg920 | rel=r_associated | relid=0 | w=20
  1338. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyp17 inhibitor vt-464
    n1=en:cytarabine | n2=en:cyp17 inhibitor vt-464 | rel=r_associated | relid=0 | w=20
  1339. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyp17 lyase inhibitor asn001
    n1=en:cytarabine | n2=en:cyp17 lyase inhibitor asn001 | rel=r_associated | relid=0 | w=20
  1340. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cyproheptadine hydrochloride
    n1=en:cytarabine | n2=en:cyproheptadine hydrochloride | rel=r_associated | relid=0 | w=20
  1341. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cystemustine
    n1=en:cytarabine | n2=en:cystemustine | rel=r_associated | relid=0 | w=20
  1342. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine 100mg/vil inj
    n1=en:cytarabine | n2=en:cytarabine 100mg/vil inj | rel=r_associated | relid=0 | w=20
  1343. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine 20 mg/ml injectable solution [cytosar]
    n1=en:cytarabine | n2=en:cytarabine 20 mg/ml injectable solution [cytosar] | rel=r_associated | relid=0 | w=20
  1344. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine 5'-methylphosphonate
    n1=en:cytarabine | n2=en:cytarabine 5'-methylphosphonate | rel=r_associated | relid=0 | w=20
  1345. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine liposome 10 mg/ml injection
    n1=en:cytarabine | n2=en:cytarabine liposome 10 mg/ml injection | rel=r_associated | relid=0 | w=20
  1346. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine-daunorubicin-etoposide regimen
    n1=en:cytarabine | n2=en:cytarabine-daunorubicin-etoposide regimen | rel=r_associated | relid=0 | w=20
  1347. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine-idarubicin regimen
    n1=en:cytarabine | n2=en:cytarabine-idarubicin regimen | rel=r_associated | relid=0 | w=20
  1348. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine-mitoxantrone regimen
    n1=en:cytarabine | n2=en:cytarabine-mitoxantrone regimen | rel=r_associated | relid=0 | w=20
  1349. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine/daunorubicin/mercaptopurine/prednisolone
    n1=en:cytarabine | n2=en:cytarabine/daunorubicin/mercaptopurine/prednisolone | rel=r_associated | relid=0 | w=20
  1350. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine/doxorubicin/prednisone/vincristine
    n1=en:cytarabine | n2=en:cytarabine/doxorubicin/prednisone/vincristine | rel=r_associated | relid=0 | w=20
  1351. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine/etoposide/mitoxantrone
    n1=en:cytarabine | n2=en:cytarabine/etoposide/mitoxantrone | rel=r_associated | relid=0 | w=20
  1352. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarabine/prednisone/vincristine
    n1=en:cytarabine | n2=en:cytarabine/prednisone/vincristine | rel=r_associated | relid=0 | w=20
  1353. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytaramin
    n1=en:cytarabine | n2=en:cytaramin | rel=r_associated | relid=0 | w=20
  1354. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytarazid
    n1=en:cytarabine | n2=en:cytarazid | rel=r_associated | relid=0 | w=20
  1355. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytembena
    n1=en:cytarabine | n2=en:cytembena | rel=r_associated | relid=0 | w=20
  1356. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytidine analog rx-3117
    n1=en:cytarabine | n2=en:cytidine analog rx-3117 | rel=r_associated | relid=0 | w=20
  1357. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytochlor
    n1=en:cytarabine | n2=en:cytochlor | rel=r_associated | relid=0 | w=20
  1358. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytokine-induced killer cells
    n1=en:cytarabine | n2=en:cytokine-induced killer cells | rel=r_associated | relid=0 | w=20
  1359. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytomegalovirus pp65-specific cytotoxic t lymphocytes
    n1=en:cytarabine | n2=en:cytomegalovirus pp65-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=20
  1360. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytoros
    n1=en:cytarabine | n2=en:cytoros | rel=r_associated | relid=0 | w=20
  1361. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytosine analog
    n1=en:cytarabine | n2=en:cytosine analog | rel=r_associated | relid=0 | w=20
  1362. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytosine arabinoside palmitate
    n1=en:cytarabine | n2=en:cytosine arabinoside palmitate | rel=r_associated | relid=0 | w=20
  1363. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:cytosine nucleoside
    n1=en:cytarabine | n2=en:cytosine nucleoside | rel=r_associated | relid=0 | w=20
  1364. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:d-zapo protocol
    n1=en:cytarabine | n2=en:d-zapo protocol | rel=r_associated | relid=0 | w=20
  1365. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:d(a)at protocol
    n1=en:cytarabine | n2=en:d(a)at protocol | rel=r_associated | relid=0 | w=20
  1366. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:d1/3-mage-3-his fusion protein
    n1=en:cytarabine | n2=en:d1/3-mage-3-his fusion protein | rel=r_associated | relid=0 | w=20
  1367. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dab389 epidermal growth factor
    n1=en:cytarabine | n2=en:dab389 epidermal growth factor | rel=r_associated | relid=0 | w=20
  1368. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dabrafenib
    n1=en:cytarabine | n2=en:dabrafenib | rel=r_associated | relid=0 | w=20
  1369. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dacetuzumab
    n1=en:cytarabine | n2=en:dacetuzumab | rel=r_associated | relid=0 | w=20
  1370. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dach polymer platinate ap5346
    n1=en:cytarabine | n2=en:dach polymer platinate ap5346 | rel=r_associated | relid=0 | w=20
  1371. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dach-platin micelle nc-4016
    n1=en:cytarabine | n2=en:dach-platin micelle nc-4016 | rel=r_associated | relid=0 | w=20
  1372. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daclatasvir
    n1=en:cytarabine | n2=en:daclatasvir | rel=r_associated | relid=0 | w=20
  1373. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daclizumab
    n1=en:cytarabine | n2=en:daclizumab | rel=r_associated | relid=0 | w=20
  1374. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dactinomycin
    n1=en:cytarabine | n2=en:dactinomycin | rel=r_associated | relid=0 | w=20
  1375. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dae protocol
    n1=en:cytarabine | n2=en:dae protocol | rel=r_associated | relid=0 | w=20
  1376. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daep protocol
    n1=en:cytarabine | n2=en:daep protocol | rel=r_associated | relid=0 | w=20
  1377. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daflon 500
    n1=en:cytarabine | n2=en:daflon 500 | rel=r_associated | relid=0 | w=20
  1378. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dakins solution
    n1=en:cytarabine | n2=en:dakins solution | rel=r_associated | relid=0 | w=20
  1379. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dalantercept
    n1=en:cytarabine | n2=en:dalantercept | rel=r_associated | relid=0 | w=20
  1380. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dalbavancin
    n1=en:cytarabine | n2=en:dalbavancin | rel=r_associated | relid=0 | w=20
  1381. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dam regimen
    n1=en:cytarabine | n2=en:dam regimen | rel=r_associated | relid=0 | w=20
  1382. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daniquidone
    n1=en:cytarabine | n2=en:daniquidone | rel=r_associated | relid=0 | w=20
  1383. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:danusertib
    n1=en:cytarabine | n2=en:danusertib | rel=r_associated | relid=0 | w=20
  1384. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dap protocol
    n1=en:cytarabine | n2=en:dap protocol | rel=r_associated | relid=0 | w=20
  1385. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daporinad
    n1=en:cytarabine | n2=en:daporinad | rel=r_associated | relid=0 | w=20
  1386. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dapsone
    n1=en:cytarabine | n2=en:dapsone | rel=r_associated | relid=0 | w=20
  1387. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:darbepoetin alfa
    n1=en:cytarabine | n2=en:darbepoetin alfa | rel=r_associated | relid=0 | w=20
  1388. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:darinaparsin
    n1=en:cytarabine | n2=en:darinaparsin | rel=r_associated | relid=0 | w=20
  1389. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dasatinib
    n1=en:cytarabine | n2=en:dasatinib | rel=r_associated | relid=0 | w=20
  1390. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dat i
    n1=en:cytarabine | n2=en:dat i | rel=r_associated | relid=0 | w=20
  1391. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dat-coap regimen
    n1=en:cytarabine | n2=en:dat-coap regimen | rel=r_associated | relid=0 | w=20
  1392. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:datv regimen
    n1=en:cytarabine | n2=en:datv regimen | rel=r_associated | relid=0 | w=20
  1393. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:daunorubicin hydrochloride
    n1=en:cytarabine | n2=en:daunorubicin hydrochloride | rel=r_associated | relid=0 | w=20
  1394. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dbve-pc regimen
    n1=en:cytarabine | n2=en:dbve-pc regimen | rel=r_associated | relid=0 | w=20
  1395. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dc-cholesterol liposome
    n1=en:cytarabine | n2=en:dc-cholesterol liposome | rel=r_associated | relid=0 | w=20
  1396. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dc-ova vaccine
    n1=en:cytarabine | n2=en:dc-ova vaccine | rel=r_associated | relid=0 | w=20
  1397. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dcds0780a
    n1=en:cytarabine | n2=en:dcds0780a | rel=r_associated | relid=0 | w=20
  1398. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dcter protocol
    n1=en:cytarabine | n2=en:dcter protocol | rel=r_associated | relid=0 | w=20
  1399. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dcter regimen
    n1=en:cytarabine | n2=en:dcter regimen | rel=r_associated | relid=0 | w=20
  1400. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dctp regimen
    n1=en:cytarabine | n2=en:dctp regimen | rel=r_associated | relid=0 | w=20
  1401. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dcvp-1-asp protocol
    n1=en:cytarabine | n2=en:dcvp-1-asp protocol | rel=r_associated | relid=0 | w=20
  1402. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dec-205/ny-eso-1 fusion protein cdx-1401
    n1=en:cytarabine | n2=en:dec-205/ny-eso-1 fusion protein cdx-1401 | rel=r_associated | relid=0 | w=20
  1403. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:deca regimen
    n1=en:cytarabine | n2=en:deca regimen | rel=r_associated | relid=0 | w=20
  1404. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:decitabine
    n1=en:cytarabine | n2=en:decitabine | rel=r_associated | relid=0 | w=20
  1405. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:defined green tea catechin extract
    n1=en:cytarabine | n2=en:defined green tea catechin extract | rel=r_associated | relid=0 | w=20
  1406. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:degarelix
    n1=en:cytarabine | n2=en:degarelix | rel=r_associated | relid=0 | w=20
  1407. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins
    n1=en:cytarabine | n2=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | rel=r_associated | relid=0 | w=20
  1408. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dehydrated human amnion/chorion membrane
    n1=en:cytarabine | n2=en:dehydrated human amnion/chorion membrane | rel=r_associated | relid=0 | w=20
  1409. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:delanzomib
    n1=en:cytarabine | n2=en:delanzomib | rel=r_associated | relid=0 | w=20
  1410. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:delta-8-tetrahydrocannabinol
    n1=en:cytarabine | n2=en:delta-8-tetrahydrocannabinol | rel=r_associated | relid=0 | w=20
  1411. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:delta-tocotrienol
    n1=en:cytarabine | n2=en:delta-tocotrienol | rel=r_associated | relid=0 | w=20
  1412. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dendritic cell-autologous lung tumor vaccine
    n1=en:cytarabine | n2=en:dendritic cell-autologous lung tumor vaccine | rel=r_associated | relid=0 | w=20
  1413. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dendritic cell-cea peptide vaccine
    n1=en:cytarabine | n2=en:dendritic cell-cea peptide vaccine | rel=r_associated | relid=0 | w=20
  1414. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dendritic cell-gp100-mart-1 antigen vaccine
    n1=en:cytarabine | n2=en:dendritic cell-gp100-mart-1 antigen vaccine | rel=r_associated | relid=0 | w=20
  1415. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
    n1=en:cytarabine | n2=en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine | rel=r_associated | relid=0 | w=20
  1416. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dendritic cell-precision multiple antigen t-lymphocytes
    n1=en:cytarabine | n2=en:dendritic cell-precision multiple antigen t-lymphocytes | rel=r_associated | relid=0 | w=20
  1417. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dendritic cell-targeting lentiviral vector id-lv305
    n1=en:cytarabine | n2=en:dendritic cell-targeting lentiviral vector id-lv305 | rel=r_associated | relid=0 | w=20
  1418. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:denenicokin
    n1=en:cytarabine | n2=en:denenicokin | rel=r_associated | relid=0 | w=20
  1419. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:denibulin hydrochloride
    n1=en:cytarabine | n2=en:denibulin hydrochloride | rel=r_associated | relid=0 | w=20
  1420. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:denileukin diftitox
    n1=en:cytarabine | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=20
  1421. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:denosumab
    n1=en:cytarabine | n2=en:denosumab | rel=r_associated | relid=0 | w=20
  1422. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:depatuxizumab
    n1=en:cytarabine | n2=en:depatuxizumab | rel=r_associated | relid=0 | w=20
  1423. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:depdc1/mphosh1 peptide vaccine
    n1=en:cytarabine | n2=en:depdc1/mphosh1 peptide vaccine | rel=r_associated | relid=0 | w=20
  1424. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:desmopressin acetate
    n1=en:cytarabine | n2=en:desmopressin acetate | rel=r_associated | relid=0 | w=20
  1425. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:detorubicin
    n1=en:cytarabine | n2=en:detorubicin | rel=r_associated | relid=0 | w=20
  1426. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dexa-beam protocol
    n1=en:cytarabine | n2=en:dexa-beam protocol | rel=r_associated | relid=0 | w=20
  1427. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dexa-pamb protocol
    n1=en:cytarabine | n2=en:dexa-pamb protocol | rel=r_associated | relid=0 | w=20
  1428. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dextran
    n1=en:cytarabine | n2=en:dextran | rel=r_associated | relid=0 | w=20
  1429. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dextroamphetamine-amphetamine
    n1=en:cytarabine | n2=en:dextroamphetamine-amphetamine | rel=r_associated | relid=0 | w=20
  1430. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dextromethorphan hydrobromide
    n1=en:cytarabine | n2=en:dextromethorphan hydrobromide | rel=r_associated | relid=0 | w=20
  1431. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dezaguanine
    n1=en:cytarabine | n2=en:dezaguanine | rel=r_associated | relid=0 | w=20
  1432. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dha-paclitaxel
    n1=en:cytarabine | n2=en:dha-paclitaxel | rel=r_associated | relid=0 | w=20
  1433. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dhact protocol
    n1=en:cytarabine | n2=en:dhact protocol | rel=r_associated | relid=0 | w=20
  1434. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dhact regimen
    n1=en:cytarabine | n2=en:dhact regimen | rel=r_associated | relid=0 | w=20
  1435. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dhaox protocol
    n1=en:cytarabine | n2=en:dhaox protocol | rel=r_associated | relid=0 | w=20
  1436. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dhap regimen
    n1=en:cytarabine | n2=en:dhap regimen | rel=r_associated | relid=0 | w=20
  1437. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dher2 vaccine+as15 adjuvant
    n1=en:cytarabine | n2=en:dher2 vaccine+as15 adjuvant | rel=r_associated | relid=0 | w=20
  1438. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:di-leu16-il2 immunocytokine
    n1=en:cytarabine | n2=en:di-leu16-il2 immunocytokine | rel=r_associated | relid=0 | w=20
  1439. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dianhydrogalactitol
    n1=en:cytarabine | n2=en:dianhydrogalactitol | rel=r_associated | relid=0 | w=20
  1440. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diaziquone
    n1=en:cytarabine | n2=en:diaziquone | rel=r_associated | relid=0 | w=20
  1441. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dichloroallyl lawsone
    n1=en:cytarabine | n2=en:dichloroallyl lawsone | rel=r_associated | relid=0 | w=20
  1442. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dichloromethotrexate
    n1=en:cytarabine | n2=en:dichloromethotrexate | rel=r_associated | relid=0 | w=20
  1443. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dicumarol
    n1=en:cytarabine | n2=en:dicumarol | rel=r_associated | relid=0 | w=20
  1444. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:didox
    n1=en:cytarabine | n2=en:didox | rel=r_associated | relid=0 | w=20
  1445. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dienogest
    n1=en:cytarabine | n2=en:dienogest | rel=r_associated | relid=0 | w=20
  1446. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diethylstilbestrol
    n1=en:cytarabine | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=20
  1447. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diflomotecan
    n1=en:cytarabine | n2=en:diflomotecan | rel=r_associated | relid=0 | w=20
  1448. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:digitoxin
    n1=en:cytarabine | n2=en:digitoxin | rel=r_associated | relid=0 | w=20
  1449. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dihydro-5-azacytidine
    n1=en:cytarabine | n2=en:dihydro-5-azacytidine | rel=r_associated | relid=0 | w=20
  1450. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diindolylmethane
    n1=en:cytarabine | n2=en:diindolylmethane | rel=r_associated | relid=0 | w=20
  1451. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dimethyl sulfoxide
    n1=en:cytarabine | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=20
  1452. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dimethylmyleran
    n1=en:cytarabine | n2=en:dimethylmyleran | rel=r_associated | relid=0 | w=20
  1453. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dinaciclib
    n1=en:cytarabine | n2=en:dinaciclib | rel=r_associated | relid=0 | w=20
  1454. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
    n1=en:cytarabine | n2=en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine | rel=r_associated | relid=0 | w=20
  1455. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diphenhydramine hydrochloride
    n1=en:cytarabine | n2=en:diphenhydramine hydrochloride | rel=r_associated | relid=0 | w=20
  1456. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diphtheria toxin fragment-interleukin-2 fusion protein e7777
    n1=en:cytarabine | n2=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | rel=r_associated | relid=0 | w=20
  1457. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed
    n1=en:cytarabine | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | rel=r_associated | relid=0 | w=20
  1458. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:distilled water
    n1=en:cytarabine | n2=en:distilled water | rel=r_associated | relid=0 | w=20
  1459. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dkk1-neutralizing monoclonal antibody dkn-01
    n1=en:cytarabine | n2=en:dkk1-neutralizing monoclonal antibody dkn-01 | rel=r_associated | relid=0 | w=20
  1460. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
    n1=en:cytarabine | n2=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  1461. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dm4-conjugated anti-cripto monoclonal antibody biib015
    n1=en:cytarabine | n2=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | rel=r_associated | relid=0 | w=20
  1462. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dmuc4064a
    n1=en:cytarabine | n2=en:dmuc4064a | rel=r_associated | relid=0 | w=20
  1463. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dn-101
    n1=en:cytarabine | n2=en:dn-101 | rel=r_associated | relid=0 | w=20
  1464. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dna interference oligonucleotide pnt2258
    n1=en:cytarabine | n2=en:dna interference oligonucleotide pnt2258 | rel=r_associated | relid=0 | w=20
  1465. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dna minor groove binding agent pm060184
    n1=en:cytarabine | n2=en:dna minor groove binding agent pm060184 | rel=r_associated | relid=0 | w=20
  1466. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dna minor groove binding agent sg2000
    n1=en:cytarabine | n2=en:dna minor groove binding agent sg2000 | rel=r_associated | relid=0 | w=20
  1467. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112
    n1=en:cytarabine | n2=en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 | rel=r_associated | relid=0 | w=20
  1468. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dna-pk inhibitor msc2490484a
    n1=en:cytarabine | n2=en:dna-pk inhibitor msc2490484a | rel=r_associated | relid=0 | w=20
  1469. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dna-pk/tor kinase inhibitor cc-115
    n1=en:cytarabine | n2=en:dna-pk/tor kinase inhibitor cc-115 | rel=r_associated | relid=0 | w=20
  1470. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doa protocol
    n1=en:cytarabine | n2=en:doa protocol | rel=r_associated | relid=0 | w=20
  1471. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doap protocol
    n1=en:cytarabine | n2=en:doap protocol | rel=r_associated | relid=0 | w=20
  1472. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doapp protocol
    n1=en:cytarabine | n2=en:doapp protocol | rel=r_associated | relid=0 | w=20
  1473. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dobutamine
    n1=en:cytarabine | n2=en:dobutamine | rel=r_associated | relid=0 | w=20
  1474. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:docetaxel emulsion anx-514
    n1=en:cytarabine | n2=en:docetaxel emulsion anx-514 | rel=r_associated | relid=0 | w=20
  1475. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:docetaxel formulation ckd-810
    n1=en:cytarabine | n2=en:docetaxel formulation ckd-810 | rel=r_associated | relid=0 | w=20
  1476. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:docetaxel lipid microspheres
    n1=en:cytarabine | n2=en:docetaxel lipid microspheres | rel=r_associated | relid=0 | w=20
  1477. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:docetaxel-loaded nanopharmaceutical crlx301
    n1=en:cytarabine | n2=en:docetaxel-loaded nanopharmaceutical crlx301 | rel=r_associated | relid=0 | w=20
  1478. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doconexent
    n1=en:cytarabine | n2=en:doconexent | rel=r_associated | relid=0 | w=20
  1479. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:docosahexaenoic acid
    n1=en:cytarabine | n2=en:docosahexaenoic acid | rel=r_associated | relid=0 | w=20
  1480. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:docusate
    n1=en:cytarabine | n2=en:docusate | rel=r_associated | relid=0 | w=20
  1481. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dolastatin 10
    n1=en:cytarabine | n2=en:dolastatin 10 | rel=r_associated | relid=0 | w=20
  1482. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:donafenib
    n1=en:cytarabine | n2=en:donafenib | rel=r_associated | relid=0 | w=20
  1483. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:donepezil + memantine
    n1=en:cytarabine | n2=en:donepezil + memantine | rel=r_associated | relid=0 | w=20
  1484. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:donor lymphocytes
    n1=en:cytarabine | n2=en:donor lymphocytes | rel=r_associated | relid=0 | w=20
  1485. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes
    n1=en:cytarabine | n2=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | rel=r_associated | relid=0 | w=20
  1486. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dopamine-somatostatin chimeric molecule bim-23a760
    n1=en:cytarabine | n2=en:dopamine-somatostatin chimeric molecule bim-23a760 | rel=r_associated | relid=0 | w=20
  1487. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dornase alfa
    n1=en:cytarabine | n2=en:dornase alfa | rel=r_associated | relid=0 | w=20
  1488. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dotap:cholesterol-fus1 liposome complex
    n1=en:cytarabine | n2=en:dotap:cholesterol-fus1 liposome complex | rel=r_associated | relid=0 | w=20
  1489. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dova protocol
    n1=en:cytarabine | n2=en:dova protocol | rel=r_associated | relid=0 | w=20
  1490. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dovitinib lactate
    n1=en:cytarabine | n2=en:dovitinib lactate | rel=r_associated | relid=0 | w=20
  1491. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doxercalciferol
    n1=en:cytarabine | n2=en:doxercalciferol | rel=r_associated | relid=0 | w=20
  1492. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doxorubicin hydrochloride
    n1=en:cytarabine | n2=en:doxorubicin hydrochloride | rel=r_associated | relid=0 | w=20
  1493. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:doxorubicin-hpma conjugate
    n1=en:cytarabine | n2=en:doxorubicin-hpma conjugate | rel=r_associated | relid=0 | w=20
  1494. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine
    n1=en:cytarabine | n2=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | rel=r_associated | relid=0 | w=20
  1495. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dr5-targeting tetrameric nanobody agonist tas266
    n1=en:cytarabine | n2=en:dr5-targeting tetrameric nanobody agonist tas266 | rel=r_associated | relid=0 | w=20
  1496. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:drotrecogin alfa (activated)
    n1=en:cytarabine | n2=en:drotrecogin alfa (activated) | rel=r_associated | relid=0 | w=20
  1497. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:drug allergy
    n1=en:cytarabine | n2=en:drug allergy | rel=r_associated | relid=0 | w=20
  1498. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:drug products by fda established pharmacologic class
    n1=en:cytarabine | n2=en:drug products by fda established pharmacologic class | rel=r_associated | relid=0 | w=20
  1499. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:drug products by va class
    n1=en:cytarabine | n2=en:drug products by va class | rel=r_associated | relid=0 | w=20
  1500. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:drugs, chinese herbal
    n1=en:cytarabine | n2=en:drugs, chinese herbal | rel=r_associated | relid=0 | w=20
  1501. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dt(388)il3 fusion protein sl-401
    n1=en:cytarabine | n2=en:dt(388)il3 fusion protein sl-401 | rel=r_associated | relid=0 | w=20
  1502. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dta-h19 plasmid
    n1=en:cytarabine | n2=en:dta-h19 plasmid | rel=r_associated | relid=0 | w=20
  1503. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dual igf-1r/insr inhibitor bms-754807
    n1=en:cytarabine | n2=en:dual igf-1r/insr inhibitor bms-754807 | rel=r_associated | relid=0 | w=20
  1504. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dual pi3 kinase/mtor inhibitor gdc-0980
    n1=en:cytarabine | n2=en:dual pi3 kinase/mtor inhibitor gdc-0980 | rel=r_associated | relid=0 | w=20
  1505. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dual variable domain immunoglobulin abt-165
    n1=en:cytarabine | n2=en:dual variable domain immunoglobulin abt-165 | rel=r_associated | relid=0 | w=20
  1506. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:duborimycin
    n1=en:cytarabine | n2=en:duborimycin | rel=r_associated | relid=0 | w=20
  1507. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dulanermin
    n1=en:cytarabine | n2=en:dulanermin | rel=r_associated | relid=0 | w=20
  1508. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:duligotuzumab
    n1=en:cytarabine | n2=en:duligotuzumab | rel=r_associated | relid=0 | w=20
  1509. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:durvalumab
    n1=en:cytarabine | n2=en:durvalumab | rel=r_associated | relid=0 | w=20
  1510. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:dutasteride
    n1=en:cytarabine | n2=en:dutasteride | rel=r_associated | relid=0 | w=20
  1511. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:e-selectin antagonist gmi-1271
    n1=en:cytarabine | n2=en:e-selectin antagonist gmi-1271 | rel=r_associated | relid=0 | w=20
  1512. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:e-z scrub
    n1=en:cytarabine | n2=en:e-z scrub | rel=r_associated | relid=0 | w=20
  1513. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:e1a lipid complex
    n1=en:cytarabine | n2=en:e1a lipid complex | rel=r_associated | relid=0 | w=20
  1514. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:e1m184v peptide vaccine
    n1=en:cytarabine | n2=en:e1m184v peptide vaccine | rel=r_associated | relid=0 | w=20
  1515. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:e7820
    n1=en:cytarabine | n2=en:e7820 | rel=r_associated | relid=0 | w=20
  1516. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:east indian sandalwood oil mouth rinse
    n1=en:cytarabine | n2=en:east indian sandalwood oil mouth rinse | rel=r_associated | relid=0 | w=20
  1517. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ebselen-containing oral capsule spi-1005
    n1=en:cytarabine | n2=en:ebselen-containing oral capsule spi-1005 | rel=r_associated | relid=0 | w=20
  1518. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:echinomycin
    n1=en:cytarabine | n2=en:echinomycin | rel=r_associated | relid=0 | w=20
  1519. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ecromeximab
    n1=en:cytarabine | n2=en:ecromeximab | rel=r_associated | relid=0 | w=20
  1520. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eculizumab
    n1=en:cytarabine | n2=en:eculizumab | rel=r_associated | relid=0 | w=20
  1521. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:edelfosine
    n1=en:cytarabine | n2=en:edelfosine | rel=r_associated | relid=0 | w=20
  1522. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:edetate calcium disodium
    n1=en:cytarabine | n2=en:edetate calcium disodium | rel=r_associated | relid=0 | w=20
  1523. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:edotecarin
    n1=en:cytarabine | n2=en:edotecarin | rel=r_associated | relid=0 | w=20
  1524. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:edrecolomab
    n1=en:cytarabine | n2=en:edrecolomab | rel=r_associated | relid=0 | w=20
  1525. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:efatutazone dihydrochloride
    n1=en:cytarabine | n2=en:efatutazone dihydrochloride | rel=r_associated | relid=0 | w=20
  1526. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eg5 kinesin-related motor protein inhibitor 4sc-205
    n1=en:cytarabine | n2=en:eg5 kinesin-related motor protein inhibitor 4sc-205 | rel=r_associated | relid=0 | w=20
  1527. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eg5 kinesin-related motor protein inhibitor arq 621
    n1=en:cytarabine | n2=en:eg5 kinesin-related motor protein inhibitor arq 621 | rel=r_associated | relid=0 | w=20
  1528. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr antagonist hemay022
    n1=en:cytarabine | n2=en:egfr antagonist hemay022 | rel=r_associated | relid=0 | w=20
  1529. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr antisense dna
    n1=en:cytarabine | n2=en:egfr antisense dna | rel=r_associated | relid=0 | w=20
  1530. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  1531. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr inhibitor abt-414
    n1=en:cytarabine | n2=en:egfr inhibitor abt-414 | rel=r_associated | relid=0 | w=20
  1532. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr inhibitor asp8273
    n1=en:cytarabine | n2=en:egfr inhibitor asp8273 | rel=r_associated | relid=0 | w=20
  1533. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr inhibitor azd3759
    n1=en:cytarabine | n2=en:egfr inhibitor azd3759 | rel=r_associated | relid=0 | w=20
  1534. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr inhibitor hm61713
    n1=en:cytarabine | n2=en:egfr inhibitor hm61713 | rel=r_associated | relid=0 | w=20
  1535. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr t790m inhibitor pf-06747775
    n1=en:cytarabine | n2=en:egfr t790m inhibitor pf-06747775 | rel=r_associated | relid=0 | w=20
  1536. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr/her2 inhibitor ap32788
    n1=en:cytarabine | n2=en:egfr/her2 inhibitor ap32788 | rel=r_associated | relid=0 | w=20
  1537. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr/her2 inhibitor av-412
    n1=en:cytarabine | n2=en:egfr/her2 inhibitor av-412 | rel=r_associated | relid=0 | w=20
  1538. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfr/her2 kinase inhibitor tak-285
    n1=en:cytarabine | n2=en:egfr/her2 kinase inhibitor tak-285 | rel=r_associated | relid=0 | w=20
  1539. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:egfrviii-specific car-transduced autologous t lymphocytes
    n1=en:cytarabine | n2=en:egfrviii-specific car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=20
  1540. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eicosapentaenoic acid
    n1=en:cytarabine | n2=en:eicosapentaenoic acid | rel=r_associated | relid=0 | w=20
  1541. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eicosapentaenoic acid-enriched nutritional supplement
    n1=en:cytarabine | n2=en:eicosapentaenoic acid-enriched nutritional supplement | rel=r_associated | relid=0 | w=20
  1542. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eif4e antisense oligonucleotide isis 183750
    n1=en:cytarabine | n2=en:eif4e antisense oligonucleotide isis 183750 | rel=r_associated | relid=0 | w=20
  1543. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elacytarabine
    n1=en:cytarabine | n2=en:elacytarabine | rel=r_associated | relid=0 | w=20
  1544. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elaidic acid-cytarabine
    n1=en:cytarabine | n2=en:elaidic acid-cytarabine | rel=r_associated | relid=0 | w=20
  1545. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:electrolyte-free parenteral nutrition emulsion
    n1=en:cytarabine | n2=en:electrolyte-free parenteral nutrition emulsion | rel=r_associated | relid=0 | w=20
  1546. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elesclomol
    n1=en:cytarabine | n2=en:elesclomol | rel=r_associated | relid=0 | w=20
  1547. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elesclomol sodium
    n1=en:cytarabine | n2=en:elesclomol sodium | rel=r_associated | relid=0 | w=20
  1548. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elinafide
    n1=en:cytarabine | n2=en:elinafide | rel=r_associated | relid=0 | w=20
  1549. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ellagic acid/annona muricata supplement
    n1=en:cytarabine | n2=en:ellagic acid/annona muricata supplement | rel=r_associated | relid=0 | w=20
  1550. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elliptinium acetate
    n1=en:cytarabine | n2=en:elliptinium acetate | rel=r_associated | relid=0 | w=20
  1551. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elotuzumab
    n1=en:cytarabine | n2=en:elotuzumab | rel=r_associated | relid=0 | w=20
  1552. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:elsamitrucin
    n1=en:cytarabine | n2=en:elsamitrucin | rel=r_associated | relid=0 | w=20
  1553. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eltrombopag olamine
    n1=en:cytarabine | n2=en:eltrombopag olamine | rel=r_associated | relid=0 | w=20
  1554. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:emepepimut-s
    n1=en:cytarabine | n2=en:emepepimut-s | rel=r_associated | relid=0 | w=20
  1555. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:emitefur
    n1=en:cytarabine | n2=en:emitefur | rel=r_associated | relid=0 | w=20
  1556. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:emricasan
    n1=en:cytarabine | n2=en:emricasan | rel=r_associated | relid=0 | w=20
  1557. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:emtricitabine
    n1=en:cytarabine | n2=en:emtricitabine | rel=r_associated | relid=0 | w=20
  1558. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enadenotucirev
    n1=en:cytarabine | n2=en:enadenotucirev | rel=r_associated | relid=0 | w=20
  1559. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enavatuzumab
    n1=en:cytarabine | n2=en:enavatuzumab | rel=r_associated | relid=0 | w=20
  1560. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enocitabine
    n1=en:cytarabine | n2=en:enocitabine | rel=r_associated | relid=0 | w=20
  1561. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ensituximab
    n1=en:cytarabine | n2=en:ensituximab | rel=r_associated | relid=0 | w=20
  1562. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:entecavir
    n1=en:cytarabine | n2=en:entecavir | rel=r_associated | relid=0 | w=20
  1563. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enteric-coated trpm8 agonist d-3263 hydrochloride
    n1=en:cytarabine | n2=en:enteric-coated trpm8 agonist d-3263 hydrochloride | rel=r_associated | relid=0 | w=20
  1564. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:entinostat
    n1=en:cytarabine | n2=en:entinostat | rel=r_associated | relid=0 | w=20
  1565. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:entolimod
    n1=en:cytarabine | n2=en:entolimod | rel=r_associated | relid=0 | w=20
  1566. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enzalutamide
    n1=en:cytarabine | n2=en:enzalutamide | rel=r_associated | relid=0 | w=20
  1567. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enzastaurin hydrochloride
    n1=en:cytarabine | n2=en:enzastaurin hydrochloride | rel=r_associated | relid=0 | w=20
  1568. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enzymatically-hydrolyzed whey protein-based nutritional supplement
    n1=en:cytarabine | n2=en:enzymatically-hydrolyzed whey protein-based nutritional supplement | rel=r_associated | relid=0 | w=20
  1569. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:enzyme inhibitor
    n1=en:cytarabine | n2=en:enzyme inhibitor | rel=r_associated | relid=0 | w=20
  1570. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eortc gimema aml-10 protocol
    n1=en:cytarabine | n2=en:eortc gimema aml-10 protocol | rel=r_associated | relid=0 | w=20
  1571. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eortc gimema aml-13 protocol
    n1=en:cytarabine | n2=en:eortc gimema aml-13 protocol | rel=r_associated | relid=0 | w=20
  1572. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ep4 receptor antagonist aat-007
    n1=en:cytarabine | n2=en:ep4 receptor antagonist aat-007 | rel=r_associated | relid=0 | w=20
  1573. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:epidermal growth factor ointment
    n1=en:cytarabine | n2=en:epidermal growth factor ointment | rel=r_associated | relid=0 | w=20
  1574. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:epinephrine + chlorpheniramine
    n1=en:cytarabine | n2=en:epinephrine + chlorpheniramine | rel=r_associated | relid=0 | w=20
  1575. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eplerenone
    n1=en:cytarabine | n2=en:eplerenone | rel=r_associated | relid=0 | w=20
  1576. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:epoetin alfa
    n1=en:cytarabine | n2=en:epoetin alfa | rel=r_associated | relid=0 | w=20
  1577. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:epothilone analog utd1
    n1=en:cytarabine | n2=en:epothilone analog utd1 | rel=r_associated | relid=0 | w=20
  1578. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:epratuzumab
    n1=en:cytarabine | n2=en:epratuzumab | rel=r_associated | relid=0 | w=20
  1579. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:Epsom salt
    n1=en:cytarabine | n2=en:Epsom salt | rel=r_associated | relid=0 | w=20
  1580. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:epsom salt
    n1=en:cytarabine | n2=en:epsom salt | rel=r_associated | relid=0 | w=20
  1581. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:era36 modulator icaritin
    n1=en:cytarabine | n2=en:era36 modulator icaritin | rel=r_associated | relid=0 | w=20
  1582. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:erastin analogue prlx 93936
    n1=en:cytarabine | n2=en:erastin analogue prlx 93936 | rel=r_associated | relid=0 | w=20
  1583. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:erbb-2 inhibitor arry-380
    n1=en:cytarabine | n2=en:erbb-2 inhibitor arry-380 | rel=r_associated | relid=0 | w=20
  1584. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eritoran tetrasodium
    n1=en:cytarabine | n2=en:eritoran tetrasodium | rel=r_associated | relid=0 | w=20
  1585. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:erk inhibitor cc-90003
    n1=en:cytarabine | n2=en:erk inhibitor cc-90003 | rel=r_associated | relid=0 | w=20
  1586. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:erk inhibitor gdc-0994
    n1=en:cytarabine | n2=en:erk inhibitor gdc-0994 | rel=r_associated | relid=0 | w=20
  1587. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:erk inhibitor ltt462
    n1=en:cytarabine | n2=en:erk inhibitor ltt462 | rel=r_associated | relid=0 | w=20
  1588. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:erk inhibitor mk-8353
    n1=en:cytarabine | n2=en:erk inhibitor mk-8353 | rel=r_associated | relid=0 | w=20
  1589. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:esa protocol
    n1=en:cytarabine | n2=en:esa protocol | rel=r_associated | relid=0 | w=20
  1590. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:esap protocol
    n1=en:cytarabine | n2=en:esap protocol | rel=r_associated | relid=0 | w=20
  1591. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eshap regimen
    n1=en:cytarabine | n2=en:eshap regimen | rel=r_associated | relid=0 | w=20
  1592. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:estradiol/norethindrone acetate tablet
    n1=en:cytarabine | n2=en:estradiol/norethindrone acetate tablet | rel=r_associated | relid=0 | w=20
  1593. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:estriol vaginal gel
    n1=en:cytarabine | n2=en:estriol vaginal gel | rel=r_associated | relid=0 | w=20
  1594. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:eszopiclone
    n1=en:cytarabine | n2=en:eszopiclone | rel=r_associated | relid=0 | w=20
  1595. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:etaracizumab
    n1=en:cytarabine | n2=en:etaracizumab | rel=r_associated | relid=0 | w=20
  1596. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ethaselen
    n1=en:cytarabine | n2=en:ethaselen | rel=r_associated | relid=0 | w=20
  1597. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ethinyl estradiol
    n1=en:cytarabine | n2=en:ethinyl estradiol | rel=r_associated | relid=0 | w=20
  1598. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ethosuximide
    n1=en:cytarabine | n2=en:ethosuximide | rel=r_associated | relid=0 | w=20
  1599. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ethylchlorformate vaccine
    n1=en:cytarabine | n2=en:ethylchlorformate vaccine | rel=r_associated | relid=0 | w=20
  1600. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:etoricoxib
    n1=en:cytarabine | n2=en:etoricoxib | rel=r_associated | relid=0 | w=20
  1601. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:evdac regimen
    n1=en:cytarabine | n2=en:evdac regimen | rel=r_associated | relid=0 | w=20
  1602. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:everolimus
    n1=en:cytarabine | n2=en:everolimus | rel=r_associated | relid=0 | w=20
  1603. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ex vivo-expanded her2-specific t cells
    n1=en:cytarabine | n2=en:ex vivo-expanded her2-specific t cells | rel=r_associated | relid=0 | w=20
  1604. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:exemestane
    n1=en:cytarabine | n2=en:exemestane | rel=r_associated | relid=0 | w=20
  1605. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:exenatide
    n1=en:cytarabine | n2=en:exenatide | rel=r_associated | relid=0 | w=20
  1606. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:extended release flucytosine
    n1=en:cytarabine | n2=en:extended release flucytosine | rel=r_associated | relid=0 | w=20
  1607. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ezatiostat hydrochloride
    n1=en:cytarabine | n2=en:ezatiostat hydrochloride | rel=r_associated | relid=0 | w=20
  1608. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ezetimibe
    n1=en:cytarabine | n2=en:ezetimibe | rel=r_associated | relid=0 | w=20
  1609. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ezetimibe/simvastatin
    n1=en:cytarabine | n2=en:ezetimibe/simvastatin | rel=r_associated | relid=0 | w=20
  1610. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:f-18 fluoroethyltyrosine
    n1=en:cytarabine | n2=en:f-18 fluoroethyltyrosine | rel=r_associated | relid=0 | w=20
  1611. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:f-machop protocol
    n1=en:cytarabine | n2=en:f-machop protocol | rel=r_associated | relid=0 | w=20
  1612. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:f16-il2 fusion protein
    n1=en:cytarabine | n2=en:f16-il2 fusion protein | rel=r_associated | relid=0 | w=20
  1613. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:factor viia inhibitor pci-27483
    n1=en:cytarabine | n2=en:factor viia inhibitor pci-27483 | rel=r_associated | relid=0 | w=20
  1614. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fak inhibitor gsk2256098
    n1=en:cytarabine | n2=en:fak inhibitor gsk2256098 | rel=r_associated | relid=0 | w=20
  1615. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fak inhibitor vs-4718
    n1=en:cytarabine | n2=en:fak inhibitor vs-4718 | rel=r_associated | relid=0 | w=20
  1616. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:famitinib
    n1=en:cytarabine | n2=en:famitinib | rel=r_associated | relid=0 | w=20
  1617. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fap-specific cd8-positive t cells
    n1=en:cytarabine | n2=en:fap-specific cd8-positive t cells | rel=r_associated | relid=0 | w=20
  1618. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:farletuzumab
    n1=en:cytarabine | n2=en:farletuzumab | rel=r_associated | relid=0 | w=20
  1619. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fas receptor agonist apo010
    n1=en:cytarabine | n2=en:fas receptor agonist apo010 | rel=r_associated | relid=0 | w=20
  1620. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111
    n1=en:cytarabine | n2=en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 | rel=r_associated | relid=0 | w=20
  1621. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fat emulsion
    n1=en:cytarabine | n2=en:fat emulsion | rel=r_associated | relid=0 | w=20
  1622. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fazarabine
    n1=en:cytarabine | n2=en:fazarabine | rel=r_associated | relid=0 | w=20
  1623. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fda established names and unique ingredient identifier codes terminology
    n1=en:cytarabine | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=20
  1624. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fenretinide lipid matrix
    n1=en:cytarabine | n2=en:fenretinide lipid matrix | rel=r_associated | relid=0 | w=20
  1625. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fermented wheat germ extract
    n1=en:cytarabine | n2=en:fermented wheat germ extract | rel=r_associated | relid=0 | w=20
  1626. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ferric carboxymaltose solution
    n1=en:cytarabine | n2=en:ferric carboxymaltose solution | rel=r_associated | relid=0 | w=20
  1627. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ferrous sulfate
    n1=en:cytarabine | n2=en:ferrous sulfate | rel=r_associated | relid=0 | w=20
  1628. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fgfr inhibitor asp5878
    n1=en:cytarabine | n2=en:fgfr inhibitor asp5878 | rel=r_associated | relid=0 | w=20
  1629. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fgfr inhibitor debio 1347
    n1=en:cytarabine | n2=en:fgfr inhibitor debio 1347 | rel=r_associated | relid=0 | w=20
  1630. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fgfr inhibitor incb054828
    n1=en:cytarabine | n2=en:fgfr inhibitor incb054828 | rel=r_associated | relid=0 | w=20
  1631. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fgfr inhibitor tas-120
    n1=en:cytarabine | n2=en:fgfr inhibitor tas-120 | rel=r_associated | relid=0 | w=20
  1632. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999
    n1=en:cytarabine | n2=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | rel=r_associated | relid=0 | w=20
  1633. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fiacitabine
    n1=en:cytarabine | n2=en:fiacitabine | rel=r_associated | relid=0 | w=20
  1634. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fibrin sealant
    n1=en:cytarabine | n2=en:fibrin sealant | rel=r_associated | relid=0 | w=20
  1635. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fidaxomicin
    n1=en:cytarabine | n2=en:fidaxomicin | rel=r_associated | relid=0 | w=20
  1636. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:filgrastim
    n1=en:cytarabine | n2=en:filgrastim | rel=r_associated | relid=0 | w=20
  1637. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:filgrastim-primed peripheral blood progenitor cells
    n1=en:cytarabine | n2=en:filgrastim-primed peripheral blood progenitor cells | rel=r_associated | relid=0 | w=20
  1638. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:finasteride
    n1=en:cytarabine | n2=en:finasteride | rel=r_associated | relid=0 | w=20
  1639. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fingolimod hydrochloride
    n1=en:cytarabine | n2=en:fingolimod hydrochloride | rel=r_associated | relid=0 | w=20
  1640. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:firtecan pegol
    n1=en:cytarabine | n2=en:firtecan pegol | rel=r_associated | relid=0 | w=20
  1641. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flag protocol
    n1=en:cytarabine | n2=en:flag protocol | rel=r_associated | relid=0 | w=20
  1642. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flam regimen
    n1=en:cytarabine | n2=en:flam regimen | rel=r_associated | relid=0 | w=20
  1643. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flang protocol
    n1=en:cytarabine | n2=en:flang protocol | rel=r_associated | relid=0 | w=20
  1644. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flaxseed
    n1=en:cytarabine | n2=en:flaxseed | rel=r_associated | relid=0 | w=20
  1645. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flt3/kit kinase inhibitor akn-028
    n1=en:cytarabine | n2=en:flt3/kit kinase inhibitor akn-028 | rel=r_associated | relid=0 | w=20
  1646. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flu matrix peptide p58-66
    n1=en:cytarabine | n2=en:flu matrix peptide p58-66 | rel=r_associated | relid=0 | w=20
  1647. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluciclatide f-18
    n1=en:cytarabine | n2=en:fluciclatide f-18 | rel=r_associated | relid=0 | w=20
  1648. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:flucytosine
    n1=en:cytarabine | n2=en:flucytosine | rel=r_associated | relid=0 | w=20
  1649. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fludap protocol
    n1=en:cytarabine | n2=en:fludap protocol | rel=r_associated | relid=0 | w=20
  1650. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fludarabine
    n1=en:cytarabine | n2=en:fludarabine | rel=r_associated | relid=0 | w=20
  1651. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fludarabine phosphate
    n1=en:cytarabine | n2=en:fludarabine phosphate | rel=r_associated | relid=0 | w=20
  1652. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 5-fluoro-2-deoxycytidine
    n1=en:cytarabine | n2=en:fluorine f 18 5-fluoro-2-deoxycytidine | rel=r_associated | relid=0 | w=20
  1653. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 alfatide ii
    n1=en:cytarabine | n2=en:fluorine f 18 alfatide ii | rel=r_associated | relid=0 | w=20
  1654. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 choline
    n1=en:cytarabine | n2=en:fluorine f 18 choline | rel=r_associated | relid=0 | w=20
  1655. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 dcfpyl
    n1=en:cytarabine | n2=en:fluorine f 18 dcfpyl | rel=r_associated | relid=0 | w=20
  1656. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 ef5
    n1=en:cytarabine | n2=en:fluorine f 18 ef5 | rel=r_associated | relid=0 | w=20
  1657. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 feqa
    n1=en:cytarabine | n2=en:fluorine f 18 feqa | rel=r_associated | relid=0 | w=20
  1658. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 fmdht
    n1=en:cytarabine | n2=en:fluorine f 18 fmdht | rel=r_associated | relid=0 | w=20
  1659. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 galacto-rgd peptide
    n1=en:cytarabine | n2=en:fluorine f 18 galacto-rgd peptide | rel=r_associated | relid=0 | w=20
  1660. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18 sodium fluoride
    n1=en:cytarabine | n2=en:fluorine f 18 sodium fluoride | rel=r_associated | relid=0 | w=20
  1661. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f 18-av-133
    n1=en:cytarabine | n2=en:fluorine f 18-av-133 | rel=r_associated | relid=0 | w=20
  1662. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f-18 6-fluorodopamine
    n1=en:cytarabine | n2=en:fluorine f-18 6-fluorodopamine | rel=r_associated | relid=0 | w=20
  1663. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluorine f-18 fluoropaclitaxel
    n1=en:cytarabine | n2=en:fluorine f-18 fluoropaclitaxel | rel=r_associated | relid=0 | w=20
  1664. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluoro-uracile
    n1=en:cytarabine | n2=en:fluoro-uracile | rel=r_associated | relid=0 | w=20
  1665. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluoropyrimidine
    n1=en:cytarabine | n2=en:fluoropyrimidine | rel=r_associated | relid=0 | w=20
  1666. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluvastatin sodium
    n1=en:cytarabine | n2=en:fluvastatin sodium | rel=r_associated | relid=0 | w=20
  1667. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fluzoparib
    n1=en:cytarabine | n2=en:fluzoparib | rel=r_associated | relid=0 | w=20
  1668. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:folate binding protein e39 peptide vaccine
    n1=en:cytarabine | n2=en:folate binding protein e39 peptide vaccine | rel=r_associated | relid=0 | w=20
  1669. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:folate binding protein j65 peptide vaccine
    n1=en:cytarabine | n2=en:folate binding protein j65 peptide vaccine | rel=r_associated | relid=0 | w=20
  1670. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:folate receptor-targeted tubulysin conjugate ec1456
    n1=en:cytarabine | n2=en:folate receptor-targeted tubulysin conjugate ec1456 | rel=r_associated | relid=0 | w=20
  1671. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225
    n1=en:cytarabine | n2=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | rel=r_associated | relid=0 | w=20
  1672. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:folic acid + pyridoxine + cyanocobalamin
    n1=en:cytarabine | n2=en:folic acid + pyridoxine + cyanocobalamin | rel=r_associated | relid=0 | w=20
  1673. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:foretinib
    n1=en:cytarabine | n2=en:foretinib | rel=r_associated | relid=0 | w=20
  1674. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fork wrench
    n1=en:cytarabine | n2=en:fork wrench | rel=r_associated | relid=0 | w=20
  1675. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:form a pair with something
    n1=en:cytarabine | n2=en:form a pair with something | rel=r_associated | relid=0 | w=20
  1676. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fosbretabulin disodium
    n1=en:cytarabine | n2=en:fosbretabulin disodium | rel=r_associated | relid=0 | w=20
  1677. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fosbretabulin tromethamine
    n1=en:cytarabine | n2=en:fosbretabulin tromethamine | rel=r_associated | relid=0 | w=20
  1678. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fostriecin
    n1=en:cytarabine | n2=en:fostriecin | rel=r_associated | relid=0 | w=20
  1679. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fowlpox virus vaccine vector
    n1=en:cytarabine | n2=en:fowlpox virus vaccine vector | rel=r_associated | relid=0 | w=20
  1680. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fowlpox-ny-eso-1 vaccine
    n1=en:cytarabine | n2=en:fowlpox-ny-eso-1 vaccine | rel=r_associated | relid=0 | w=20
  1681. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fu-lv regimen
    n1=en:cytarabine | n2=en:fu-lv regimen | rel=r_associated | relid=0 | w=20
  1682. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:fulvestrant
    n1=en:cytarabine | n2=en:fulvestrant | rel=r_associated | relid=0 | w=20
  1683. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:g-idea protocol
    n1=en:cytarabine | n2=en:g-idea protocol | rel=r_associated | relid=0 | w=20
  1684. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:g-quadruplex stabilizer bmvc
    n1=en:cytarabine | n2=en:g-quadruplex stabilizer bmvc | rel=r_associated | relid=0 | w=20
  1685. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:g207
    n1=en:cytarabine | n2=en:g207 | rel=r_associated | relid=0 | w=20
  1686. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gabapentin
    n1=en:cytarabine | n2=en:gabapentin | rel=r_associated | relid=0 | w=20
  1687. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gabapentin enacarbil
    n1=en:cytarabine | n2=en:gabapentin enacarbil | rel=r_associated | relid=0 | w=20
  1688. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gadolinium-chelate
    n1=en:cytarabine | n2=en:gadolinium-chelate | rel=r_associated | relid=0 | w=20
  1689. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:galactomannan derivative
    n1=en:cytarabine | n2=en:galactomannan derivative | rel=r_associated | relid=0 | w=20
  1690. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:galectin inhibitor gr-md-02
    n1=en:cytarabine | n2=en:galectin inhibitor gr-md-02 | rel=r_associated | relid=0 | w=20
  1691. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:galectin-1 inhibitor otx008
    n1=en:cytarabine | n2=en:galectin-1 inhibitor otx008 | rel=r_associated | relid=0 | w=20
  1692. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:galeterone
    n1=en:cytarabine | n2=en:galeterone | rel=r_associated | relid=0 | w=20
  1693. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68 citrate
    n1=en:cytarabine | n2=en:gallium ga 68 citrate | rel=r_associated | relid=0 | w=20
  1694. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68 ops202
    n1=en:cytarabine | n2=en:gallium ga 68 ops202 | rel=r_associated | relid=0 | w=20
  1695. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68-dotatate
    n1=en:cytarabine | n2=en:gallium ga 68-dotatate | rel=r_associated | relid=0 | w=20
  1696. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68-labeled affibody aby-025
    n1=en:cytarabine | n2=en:gallium ga 68-labeled affibody aby-025 | rel=r_associated | relid=0 | w=20
  1697. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68-labeled psma-11
    n1=en:cytarabine | n2=en:gallium ga 68-labeled psma-11 | rel=r_associated | relid=0 | w=20
  1698. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68-labeled-nodaga-mj9
    n1=en:cytarabine | n2=en:gallium ga 68-labeled-nodaga-mj9 | rel=r_associated | relid=0 | w=20
  1699. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68-neb
    n1=en:cytarabine | n2=en:gallium ga 68-neb | rel=r_associated | relid=0 | w=20
  1700. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium ga 68-rgd
    n1=en:cytarabine | n2=en:gallium ga 68-rgd | rel=r_associated | relid=0 | w=20
  1701. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gallium maltolate
    n1=en:cytarabine | n2=en:gallium maltolate | rel=r_associated | relid=0 | w=20
  1702. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:galocitabine
    n1=en:cytarabine | n2=en:galocitabine | rel=r_associated | relid=0 | w=20
  1703. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:galunisertib
    n1=en:cytarabine | n2=en:galunisertib | rel=r_associated | relid=0 | w=20
  1704. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gamma secretase inhibitor pf-03084014
    n1=en:cytarabine | n2=en:gamma secretase inhibitor pf-03084014 | rel=r_associated | relid=0 | w=20
  1705. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gamma-secretase inhibitor ly3039478
    n1=en:cytarabine | n2=en:gamma-secretase inhibitor ly3039478 | rel=r_associated | relid=0 | w=20
  1706. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ganglioside gd2
    n1=en:cytarabine | n2=en:ganglioside gd2 | rel=r_associated | relid=0 | w=20
  1707. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ganitumab
    n1=en:cytarabine | n2=en:ganitumab | rel=r_associated | relid=0 | w=20
  1708. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gap-pomp regimen
    n1=en:cytarabine | n2=en:gap-pomp regimen | rel=r_associated | relid=0 | w=20
  1709. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:garlic extract
    n1=en:cytarabine | n2=en:garlic extract | rel=r_associated | relid=0 | w=20
  1710. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gastrin immunotoxin
    n1=en:cytarabine | n2=en:gastrin immunotoxin | rel=r_associated | relid=0 | w=20
  1711. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine
    n1=en:cytarabine | n2=en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine | rel=r_associated | relid=0 | w=20
  1712. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gd2-car-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:gd2-car-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  1713. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gd2-klh vaccine
    n1=en:cytarabine | n2=en:gd2-klh vaccine | rel=r_associated | relid=0 | w=20
  1714. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gel protein, gelonium multiflorum
    n1=en:cytarabine | n2=en:gel protein, gelonium multiflorum | rel=r_associated | relid=0 | w=20
  1715. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gelatin sponge, absorbable
    n1=en:cytarabine | n2=en:gelatin sponge, absorbable | rel=r_associated | relid=0 | w=20
  1716. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemcitabine
    n1=en:cytarabine | n2=en:gemcitabine | rel=r_associated | relid=0 | w=20
  1717. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemcitabine elaidate
    n1=en:cytarabine | n2=en:gemcitabine elaidate | rel=r_associated | relid=0 | w=20
  1718. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemcitabine hydrochloride
    n1=en:cytarabine | n2=en:gemcitabine hydrochloride | rel=r_associated | relid=0 | w=20
  1719. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemcitabine prodrug ly2334737
    n1=en:cytarabine | n2=en:gemcitabine prodrug ly2334737 | rel=r_associated | relid=0 | w=20
  1720. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemcitabine-cisplatin regimen
    n1=en:cytarabine | n2=en:gemcitabine-cisplatin regimen | rel=r_associated | relid=0 | w=20
  1721. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemcitabine-phosphoramidate hydrochloride nuc-1031
    n1=en:cytarabine | n2=en:gemcitabine-phosphoramidate hydrochloride nuc-1031 | rel=r_associated | relid=0 | w=20
  1722. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gemia protocol
    n1=en:cytarabine | n2=en:gemia protocol | rel=r_associated | relid=0 | w=20
  1723. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:genistein
    n1=en:cytarabine | n2=en:genistein | rel=r_associated | relid=0 | w=20
  1724. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:get acquainted with somebody
    n1=en:cytarabine | n2=en:get acquainted with somebody | rel=r_associated | relid=0 | w=20
  1725. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:get to know somebody
    n1=en:cytarabine | n2=en:get to know somebody | rel=r_associated | relid=0 | w=20
  1726. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ghrelin peptide analogue
    n1=en:cytarabine | n2=en:ghrelin peptide analogue | rel=r_associated | relid=0 | w=20
  1727. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gimatecan
    n1=en:cytarabine | n2=en:gimatecan | rel=r_associated | relid=0 | w=20
  1728. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gimema all 0394
    n1=en:cytarabine | n2=en:gimema all 0394 | rel=r_associated | relid=0 | w=20
  1729. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ginger extract
    n1=en:cytarabine | n2=en:ginger extract | rel=r_associated | relid=0 | w=20
  1730. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:girentuximab
    n1=en:cytarabine | n2=en:girentuximab | rel=r_associated | relid=0 | w=20
  1731. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:givinostat
    n1=en:cytarabine | n2=en:givinostat | rel=r_associated | relid=0 | w=20
  1732. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  1733. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glioma-associated peptide-loaded dendritic cell vaccine sl-701
    n1=en:cytarabine | n2=en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 | rel=r_associated | relid=0 | w=20
  1734. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:globo h-dt vaccine obi-833
    n1=en:cytarabine | n2=en:globo h-dt vaccine obi-833 | rel=r_associated | relid=0 | w=20
  1735. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:globo h-klh immunostimulant opt-822
    n1=en:cytarabine | n2=en:globo h-klh immunostimulant opt-822 | rel=r_associated | relid=0 | w=20
  1736. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine
    n1=en:cytarabine | n2=en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=20
  1737. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:globulin component macrophage-activating factor
    n1=en:cytarabine | n2=en:globulin component macrophage-activating factor | rel=r_associated | relid=0 | w=20
  1738. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glu-ara-c-polylysine
    n1=en:cytarabine | n2=en:glu-ara-c-polylysine | rel=r_associated | relid=0 | w=20
  1739. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glu-ara-c-t70-c(10)
    n1=en:cytarabine | n2=en:glu-ara-c-t70-c(10) | rel=r_associated | relid=0 | w=20
  1740. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glucosamine sulfate/chondroitin sulfate tablet
    n1=en:cytarabine | n2=en:glucosamine sulfate/chondroitin sulfate tablet | rel=r_associated | relid=0 | w=20
  1741. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glufosfamide
    n1=en:cytarabine | n2=en:glufosfamide | rel=r_associated | relid=0 | w=20
  1742. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glutathione
    n1=en:cytarabine | n2=en:glutathione | rel=r_associated | relid=0 | w=20
  1743. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gluten-free compact nutritional supplement drink
    n1=en:cytarabine | n2=en:gluten-free compact nutritional supplement drink | rel=r_associated | relid=0 | w=20
  1744. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gluten-free/fiber-enriched compact nutritional supplement drink
    n1=en:cytarabine | n2=en:gluten-free/fiber-enriched compact nutritional supplement drink | rel=r_associated | relid=0 | w=20
  1745. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glycine
    n1=en:cytarabine | n2=en:glycine | rel=r_associated | relid=0 | w=20
  1746. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:glymidine
    n1=en:cytarabine | n2=en:glymidine | rel=r_associated | relid=0 | w=20
  1747. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gm-csf-encoding oncolytic adenovirus cgtg-102
    n1=en:cytarabine | n2=en:gm-csf-encoding oncolytic adenovirus cgtg-102 | rel=r_associated | relid=0 | w=20
  1748. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gm.cd40l cell vaccine
    n1=en:cytarabine | n2=en:gm.cd40l cell vaccine | rel=r_associated | relid=0 | w=20
  1749. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine
    n1=en:cytarabine | n2=en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine | rel=r_associated | relid=0 | w=20
  1750. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:go well together
    n1=en:cytarabine | n2=en:go well together | rel=r_associated | relid=0 | w=20
  1751. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:go with something
    n1=en:cytarabine | n2=en:go with something | rel=r_associated | relid=0 | w=20
  1752. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gold sodium thiomalate
    n1=en:cytarabine | n2=en:gold sodium thiomalate | rel=r_associated | relid=0 | w=20
  1753. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:golnerminogene pradenovec
    n1=en:cytarabine | n2=en:golnerminogene pradenovec | rel=r_associated | relid=0 | w=20
  1754. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:golotimod
    n1=en:cytarabine | n2=en:golotimod | rel=r_associated | relid=0 | w=20
  1755. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gonadotropin-releasing hormone analog
    n1=en:cytarabine | n2=en:gonadotropin-releasing hormone analog | rel=r_associated | relid=0 | w=20
  1756. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gp100-fowlpox vaccine
    n1=en:cytarabine | n2=en:gp100-fowlpox vaccine | rel=r_associated | relid=0 | w=20
  1757. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gp100:154-162 peptide vaccine
    n1=en:cytarabine | n2=en:gp100:154-162 peptide vaccine | rel=r_associated | relid=0 | w=20
  1758. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gp100:209-217(210m) peptide vaccine
    n1=en:cytarabine | n2=en:gp100:209-217(210m) peptide vaccine | rel=r_associated | relid=0 | w=20
  1759. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410
    n1=en:cytarabine | n2=en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 | rel=r_associated | relid=0 | w=20
  1760. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gpi-0100
    n1=en:cytarabine | n2=en:gpi-0100 | rel=r_associated | relid=0 | w=20
  1761. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:granisetron hydrochloride
    n1=en:cytarabine | n2=en:granisetron hydrochloride | rel=r_associated | relid=0 | w=20
  1762. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:green tea
    n1=en:cytarabine | n2=en:green tea | rel=r_associated | relid=0 | w=20
  1763. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gti-2040
    n1=en:cytarabine | n2=en:gti-2040 | rel=r_associated | relid=0 | w=20
  1764. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gusperimus trihydrochloride
    n1=en:cytarabine | n2=en:gusperimus trihydrochloride | rel=r_associated | relid=0 | w=20
  1765. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gvax pancreatic cancer vaccine
    n1=en:cytarabine | n2=en:gvax pancreatic cancer vaccine | rel=r_associated | relid=0 | w=20
  1766. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:gvax prostate cancer vaccine
    n1=en:cytarabine | n2=en:gvax prostate cancer vaccine | rel=r_associated | relid=0 | w=20
  1767. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:had protocol
    n1=en:cytarabine | n2=en:had protocol | rel=r_associated | relid=0 | w=20
  1768. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:haemophilus influenzae b vaccine
    n1=en:cytarabine | n2=en:haemophilus influenzae b vaccine | rel=r_associated | relid=0 | w=20
  1769. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hat regimen
    n1=en:cytarabine | n2=en:hat regimen | rel=r_associated | relid=0 | w=20
  1770. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hcv dna vaccine ino-8000
    n1=en:cytarabine | n2=en:hcv dna vaccine ino-8000 | rel=r_associated | relid=0 | w=20
  1771. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hcvad protocol
    n1=en:cytarabine | n2=en:hcvad protocol | rel=r_associated | relid=0 | w=20
  1772. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac inhibitor 4sc-202
    n1=en:cytarabine | n2=en:hdac inhibitor 4sc-202 | rel=r_associated | relid=0 | w=20
  1773. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac inhibitor ar-42
    n1=en:cytarabine | n2=en:hdac inhibitor ar-42 | rel=r_associated | relid=0 | w=20
  1774. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac inhibitor chr-3996
    n1=en:cytarabine | n2=en:hdac inhibitor chr-3996 | rel=r_associated | relid=0 | w=20
  1775. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac inhibitor cxd101
    n1=en:cytarabine | n2=en:hdac inhibitor cxd101 | rel=r_associated | relid=0 | w=20
  1776. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac inhibitor shp-141
    n1=en:cytarabine | n2=en:hdac inhibitor shp-141 | rel=r_associated | relid=0 | w=20
  1777. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac protocol
    n1=en:cytarabine | n2=en:hdac protocol | rel=r_associated | relid=0 | w=20
  1778. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hdac/egfr/her2 inhibitor cudc-101
    n1=en:cytarabine | n2=en:hdac/egfr/her2 inhibitor cudc-101 | rel=r_associated | relid=0 | w=20
  1779. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hedgehog inhibitor pf-04449913
    n1=en:cytarabine | n2=en:hedgehog inhibitor pf-04449913 | rel=r_associated | relid=0 | w=20
  1780. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:henatinib maleate
    n1=en:cytarabine | n2=en:henatinib maleate | rel=r_associated | relid=0 | w=20
  1781. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:heparin derivative sst0001
    n1=en:cytarabine | n2=en:heparin derivative sst0001 | rel=r_associated | relid=0 | w=20
  1782. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hepatitis A vaccine
    n1=en:cytarabine | n2=en:hepatitis A vaccine | rel=r_associated | relid=0 | w=20
  1783. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hepatitis a vaccine
    n1=en:cytarabine | n2=en:hepatitis a vaccine | rel=r_associated | relid=0 | w=20
  1784. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hepatitis b vaccine
    n1=en:cytarabine | n2=en:hepatitis b vaccine | rel=r_associated | relid=0 | w=20
  1785. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hepatitis B vaccine
    n1=en:cytarabine | n2=en:hepatitis B vaccine | rel=r_associated | relid=0 | w=20
  1786. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine
    n1=en:cytarabine | n2=en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine | rel=r_associated | relid=0 | w=20
  1787. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:her-2/neu intracellular domain protein
    n1=en:cytarabine | n2=en:her-2/neu intracellular domain protein | rel=r_associated | relid=0 | w=20
  1788. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:her2-targeted liposomal doxorubicin hydrochloride mm-302
    n1=en:cytarabine | n2=en:her2-targeted liposomal doxorubicin hydrochloride mm-302 | rel=r_associated | relid=0 | w=20
  1789. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:herba scutellaria barbata
    n1=en:cytarabine | n2=en:herba scutellaria barbata | rel=r_associated | relid=0 | w=20
  1790. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hexamethylene bisacetamide
    n1=en:cytarabine | n2=en:hexamethylene bisacetamide | rel=r_associated | relid=0 | w=20
  1791. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hexaminolevulinate
    n1=en:cytarabine | n2=en:hexaminolevulinate | rel=r_associated | relid=0 | w=20
  1792. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hexaminolevulinate hydrochloride
    n1=en:cytarabine | n2=en:hexaminolevulinate hydrochloride | rel=r_associated | relid=0 | w=20
  1793. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hi-coap regimen
    n1=en:cytarabine | n2=en:hi-coap regimen | rel=r_associated | relid=0 | w=20
  1794. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:high-selenium baker's yeast
    n1=en:cytarabine | n2=en:high-selenium baker's yeast | rel=r_associated | relid=0 | w=20
  1795. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:high-titer rsv immune globulin ri-001
    n1=en:cytarabine | n2=en:high-titer rsv immune globulin ri-001 | rel=r_associated | relid=0 | w=20
  1796. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:histamine dihydrochloride
    n1=en:cytarabine | n2=en:histamine dihydrochloride | rel=r_associated | relid=0 | w=20
  1797. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:histrelin acetate
    n1=en:cytarabine | n2=en:histrelin acetate | rel=r_associated | relid=0 | w=20
  1798. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine
    n1=en:cytarabine | n2=en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine | rel=r_associated | relid=0 | w=20
  1799. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine
    n1=en:cytarabine | n2=en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=20
  1800. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hla-a*2402-restricted vegfr1 peptide vaccine
    n1=en:cytarabine | n2=en:hla-a*2402-restricted vegfr1 peptide vaccine | rel=r_associated | relid=0 | w=20
  1801. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine
    n1=en:cytarabine | n2=en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine | rel=r_associated | relid=0 | w=20
  1802. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine
    n1=en:cytarabine | n2=en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine | rel=r_associated | relid=0 | w=20
  1803. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hoaap protocol
    n1=en:cytarabine | n2=en:hoaap protocol | rel=r_associated | relid=0 | w=20
  1804. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hoagp protocol
    n1=en:cytarabine | n2=en:hoagp protocol | rel=r_associated | relid=0 | w=20
  1805. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hoap protocol
    n1=en:cytarabine | n2=en:hoap protocol | rel=r_associated | relid=0 | w=20
  1806. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:holmium ho 166 poly(l-lactic acid) microspheres
    n1=en:cytarabine | n2=en:holmium ho 166 poly(l-lactic acid) microspheres | rel=r_associated | relid=0 | w=20
  1807. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:honey
    n1=en:cytarabine | n2=en:honey | rel=r_associated | relid=0 | w=20
  1808. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c
    n1=en:cytarabine | n2=en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c | rel=r_associated | relid=0 | w=20
  1809. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hpv dna plasmids therapeutic vaccine vgx-3100
    n1=en:cytarabine | n2=en:hpv dna plasmids therapeutic vaccine vgx-3100 | rel=r_associated | relid=0 | w=20
  1810. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hpv e6/e7 dna vaccine gx-188e
    n1=en:cytarabine | n2=en:hpv e6/e7 dna vaccine gx-188e | rel=r_associated | relid=0 | w=20
  1811. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hpv-16 e6 peptides vaccine/candida albicans extract
    n1=en:cytarabine | n2=en:hpv-16 e6 peptides vaccine/candida albicans extract | rel=r_associated | relid=0 | w=20
  1812. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin
    n1=en:cytarabine | n2=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | rel=r_associated | relid=0 | w=20
  1813. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hr-1 protocol
    n1=en:cytarabine | n2=en:hr-1 protocol | rel=r_associated | relid=0 | w=20
  1814. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hr-3 protocol
    n1=en:cytarabine | n2=en:hr-3 protocol | rel=r_associated | relid=0 | w=20
  1815. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hsp90 antagonist kw-2478
    n1=en:cytarabine | n2=en:hsp90 antagonist kw-2478 | rel=r_associated | relid=0 | w=20
  1816. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hsp90 inhibitor auy922
    n1=en:cytarabine | n2=en:hsp90 inhibitor auy922 | rel=r_associated | relid=0 | w=20
  1817. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hsp90 inhibitor debio 0932
    n1=en:cytarabine | n2=en:hsp90 inhibitor debio 0932 | rel=r_associated | relid=0 | w=20
  1818. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hsp90 inhibitor ds-2248
    n1=en:cytarabine | n2=en:hsp90 inhibitor ds-2248 | rel=r_associated | relid=0 | w=20
  1819. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hsp90 inhibitor hsp990
    n1=en:cytarabine | n2=en:hsp90 inhibitor hsp990 | rel=r_associated | relid=0 | w=20
  1820. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hsv-1 hf10
    n1=en:cytarabine | n2=en:hsv-1 hf10 | rel=r_associated | relid=0 | w=20
  1821. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:htert vaccine v934/v935
    n1=en:cytarabine | n2=en:htert vaccine v934/v935 | rel=r_associated | relid=0 | w=20
  1822. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:htert/survivin/cmv multipeptide vaccine
    n1=en:cytarabine | n2=en:htert/survivin/cmv multipeptide vaccine | rel=r_associated | relid=0 | w=20
  1823. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine
    n1=en:cytarabine | n2=en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  1824. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hu14.18-il2 fusion protein
    n1=en:cytarabine | n2=en:hu14.18-il2 fusion protein | rel=r_associated | relid=0 | w=20
  1825. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:huachansu
    n1=en:cytarabine | n2=en:huachansu | rel=r_associated | relid=0 | w=20
  1826. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human combinatorial antibody library-based monoclonal antibody vay736
    n1=en:cytarabine | n2=en:human combinatorial antibody library-based monoclonal antibody vay736 | rel=r_associated | relid=0 | w=20
  1827. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human gp100 plasmid dna vaccine
    n1=en:cytarabine | n2=en:human gp100 plasmid dna vaccine | rel=r_associated | relid=0 | w=20
  1828. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human menopausal gonadotrophin
    n1=en:cytarabine | n2=en:human menopausal gonadotrophin | rel=r_associated | relid=0 | w=20
  1829. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human menopausal gonadotropin
    n1=en:cytarabine | n2=en:human menopausal gonadotropin | rel=r_associated | relid=0 | w=20
  1830. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human mhc non-restricted cytotoxic t-cell line tall-104
    n1=en:cytarabine | n2=en:human mhc non-restricted cytotoxic t-cell line tall-104 | rel=r_associated | relid=0 | w=20
  1831. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human monoclonal antibody 216
    n1=en:cytarabine | n2=en:human monoclonal antibody 216 | rel=r_associated | relid=0 | w=20
  1832. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307
    n1=en:cytarabine | n2=en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 | rel=r_associated | relid=0 | w=20
  1833. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine
    n1=en:cytarabine | n2=en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine | rel=r_associated | relid=0 | w=20
  1834. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:human prostate-specific membrane antigen plasmid dna vaccine
    n1=en:cytarabine | n2=en:human prostate-specific membrane antigen plasmid dna vaccine | rel=r_associated | relid=0 | w=20
  1835. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hyaluronic acid-containing topical cream
    n1=en:cytarabine | n2=en:hyaluronic acid-containing topical cream | rel=r_associated | relid=0 | w=20
  1836. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hyb2055
    n1=en:cytarabine | n2=en:hyb2055 | rel=r_associated | relid=0 | w=20
  1837. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hydralazine hydrochloride
    n1=en:cytarabine | n2=en:hydralazine hydrochloride | rel=r_associated | relid=0 | w=20
  1838. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hydrazine sulfate
    n1=en:cytarabine | n2=en:hydrazine sulfate | rel=r_associated | relid=0 | w=20
  1839. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hydrocodone + chlorpheniramine
    n1=en:cytarabine | n2=en:hydrocodone + chlorpheniramine | rel=r_associated | relid=0 | w=20
  1840. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hydrocortisone
    n1=en:cytarabine | n2=en:hydrocortisone | rel=r_associated | relid=0 | w=20
  1841. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hydroxytyrosol
    n1=en:cytarabine | n2=en:hydroxytyrosol | rel=r_associated | relid=0 | w=20
  1842. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hypercvad/hd mtx arac regimen
    n1=en:cytarabine | n2=en:hypercvad/hd mtx arac regimen | rel=r_associated | relid=0 | w=20
  1843. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hyperglycemic agent
    n1=en:cytarabine | n2=en:hyperglycemic agent | rel=r_associated | relid=0 | w=20
  1844. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hyperpolarized carbon c 13 pyruvate
    n1=en:cytarabine | n2=en:hyperpolarized carbon c 13 pyruvate | rel=r_associated | relid=0 | w=20
  1845. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hyperpolarized helium 3
    n1=en:cytarabine | n2=en:hyperpolarized helium 3 | rel=r_associated | relid=0 | w=20
  1846. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:hypoxia-activated prodrug th-302
    n1=en:cytarabine | n2=en:hypoxia-activated prodrug th-302 | rel=r_associated | relid=0 | w=20
  1847. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:i 131 antiferritin immunoglobulin
    n1=en:cytarabine | n2=en:i 131 antiferritin immunoglobulin | rel=r_associated | relid=0 | w=20
  1848. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:i 131 monoclonal antibody f19
    n1=en:cytarabine | n2=en:i 131 monoclonal antibody f19 | rel=r_associated | relid=0 | w=20
  1849. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:i 131 monoclonal antibody lym-1
    n1=en:cytarabine | n2=en:i 131 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=20
  1850. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iap inhibitor hgs1029
    n1=en:cytarabine | n2=en:iap inhibitor hgs1029 | rel=r_associated | relid=0 | w=20
  1851. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iapa-based dendritic cells/cytotoxic t lymphocytes
    n1=en:cytarabine | n2=en:iapa-based dendritic cells/cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=20
  1852. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ibacitabine
    n1=en:cytarabine | n2=en:ibacitabine | rel=r_associated | relid=0 | w=20
  1853. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ibandronate sodium
    n1=en:cytarabine | n2=en:ibandronate sodium | rel=r_associated | relid=0 | w=20
  1854. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ibritumomab tiuxetan
    n1=en:cytarabine | n2=en:ibritumomab tiuxetan | rel=r_associated | relid=0 | w=20
  1855. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ibrutinib
    n1=en:cytarabine | n2=en:ibrutinib | rel=r_associated | relid=0 | w=20
  1856. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ibuprofen injection
    n1=en:cytarabine | n2=en:ibuprofen injection | rel=r_associated | relid=0 | w=20
  1857. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ice protocol 4
    n1=en:cytarabine | n2=en:ice protocol 4 | rel=r_associated | relid=0 | w=20
  1858. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:idh1 inhibitor ag-120
    n1=en:cytarabine | n2=en:idh1 inhibitor ag-120 | rel=r_associated | relid=0 | w=20
  1859. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:idh2 inhibitor ag-221
    n1=en:cytarabine | n2=en:idh2 inhibitor ag-221 | rel=r_associated | relid=0 | w=20
  1860. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ido inhibitor nlg919
    n1=en:cytarabine | n2=en:ido inhibitor nlg919 | rel=r_associated | relid=0 | w=20
  1861. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:idronoxil
    n1=en:cytarabine | n2=en:idronoxil | rel=r_associated | relid=0 | w=20
  1862. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ih636 grape seed proanthocyanidin extract
    n1=en:cytarabine | n2=en:ih636 grape seed proanthocyanidin extract | rel=r_associated | relid=0 | w=20
  1863. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:il-10 immunomodulator mk-1966
    n1=en:cytarabine | n2=en:il-10 immunomodulator mk-1966 | rel=r_associated | relid=0 | w=20
  1864. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:il-12-expressing hsv-1
    n1=en:cytarabine | n2=en:il-12-expressing hsv-1 | rel=r_associated | relid=0 | w=20
  1865. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine
    n1=en:cytarabine | n2=en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine | rel=r_associated | relid=0 | w=20
  1866. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  1867. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ilx-295501
    n1=en:cytarabine | n2=en:ilx-295501 | rel=r_associated | relid=0 | w=20
  1868. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ilx23-7553
    n1=en:cytarabine | n2=en:ilx23-7553 | rel=r_associated | relid=0 | w=20
  1869. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:imatinib mesylate
    n1=en:cytarabine | n2=en:imatinib mesylate | rel=r_associated | relid=0 | w=20
  1870. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:imetelstat sodium
    n1=en:cytarabine | n2=en:imetelstat sodium | rel=r_associated | relid=0 | w=20
  1871. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:imexon
    n1=en:cytarabine | n2=en:imexon | rel=r_associated | relid=0 | w=20
  1872. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:imidazolyl ethanamide pentandioic acid
    n1=en:cytarabine | n2=en:imidazolyl ethanamide pentandioic acid | rel=r_associated | relid=0 | w=20
  1873. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:imisopasem manganese
    n1=en:cytarabine | n2=en:imisopasem manganese | rel=r_associated | relid=0 | w=20
  1874. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immediate-release tablet afuresertib
    n1=en:cytarabine | n2=en:immediate-release tablet afuresertib | rel=r_associated | relid=0 | w=20
  1875. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immunoconjugate ro5479599
    n1=en:cytarabine | n2=en:immunoconjugate ro5479599 | rel=r_associated | relid=0 | w=20
  1876. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immunocytokine nhs-il12
    n1=en:cytarabine | n2=en:immunocytokine nhs-il12 | rel=r_associated | relid=0 | w=20
  1877. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immunocytokine nhs-il2-lt
    n1=en:cytarabine | n2=en:immunocytokine nhs-il2-lt | rel=r_associated | relid=0 | w=20
  1878. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immunomodulator ohr/avr118
    n1=en:cytarabine | n2=en:immunomodulator ohr/avr118 | rel=r_associated | relid=0 | w=20
  1879. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immunomodulators
    n1=en:cytarabine | n2=en:immunomodulators | rel=r_associated | relid=0 | w=20
  1880. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:immunotherapy regimen mkc-1106-mt
    n1=en:cytarabine | n2=en:immunotherapy regimen mkc-1106-mt | rel=r_associated | relid=0 | w=20
  1881. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:imp321
    n1=en:cytarabine | n2=en:imp321 | rel=r_associated | relid=0 | w=20
  1882. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:in 111 folic acid
    n1=en:cytarabine | n2=en:in 111 folic acid | rel=r_associated | relid=0 | w=20
  1883. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:in 111 monoclonal antibody b3
    n1=en:cytarabine | n2=en:in 111 monoclonal antibody b3 | rel=r_associated | relid=0 | w=20
  1884. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:in 111 monoclonal antibody ll2
    n1=en:cytarabine | n2=en:in 111 monoclonal antibody ll2 | rel=r_associated | relid=0 | w=20
  1885. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:in 111 monoclonal antibody lym-1
    n1=en:cytarabine | n2=en:in 111 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=20
  1886. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:inalimarev
    n1=en:cytarabine | n2=en:inalimarev | rel=r_associated | relid=0 | w=20
  1887. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indibulin
    n1=en:cytarabine | n2=en:indibulin | rel=r_associated | relid=0 | w=20
  1888. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indisulam
    n1=en:cytarabine | n2=en:indisulam | rel=r_associated | relid=0 | w=20
  1889. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indium in 111 bevacizumab
    n1=en:cytarabine | n2=en:indium in 111 bevacizumab | rel=r_associated | relid=0 | w=20
  1890. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indium in 111 capromab pendetide
    n1=en:cytarabine | n2=en:indium in 111 capromab pendetide | rel=r_associated | relid=0 | w=20
  1891. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indium in 111 chimeric monoclonal antibody 806
    n1=en:cytarabine | n2=en:indium in 111 chimeric monoclonal antibody 806 | rel=r_associated | relid=0 | w=20
  1892. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indium in 111-dota-biotin
    n1=en:cytarabine | n2=en:indium in 111-dota-biotin | rel=r_associated | relid=0 | w=20
  1893. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indole-3-carbinol
    n1=en:cytarabine | n2=en:indole-3-carbinol | rel=r_associated | relid=0 | w=20
  1894. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule
    n1=en:cytarabine | n2=en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule | rel=r_associated | relid=0 | w=20
  1895. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indoleamine 2,3-dioxygenase peptide vaccine
    n1=en:cytarabine | n2=en:indoleamine 2,3-dioxygenase peptide vaccine | rel=r_associated | relid=0 | w=20
  1896. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:indomethacin
    n1=en:cytarabine | n2=en:indomethacin | rel=r_associated | relid=0 | w=20
  1897. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ingenol mebutate
    n1=en:cytarabine | n2=en:ingenol mebutate | rel=r_associated | relid=0 | w=20
  1898. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ingenol mebutate gel
    n1=en:cytarabine | n2=en:ingenol mebutate gel | rel=r_associated | relid=0 | w=20
  1899. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iniparib
    n1=en:cytarabine | n2=en:iniparib | rel=r_associated | relid=0 | w=20
  1900. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:innate immunostimulator rbbx-01
    n1=en:cytarabine | n2=en:innate immunostimulator rbbx-01 | rel=r_associated | relid=0 | w=20
  1901. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ino-1001
    n1=en:cytarabine | n2=en:ino-1001 | rel=r_associated | relid=0 | w=20
  1902. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:inositol
    n1=en:cytarabine | n2=en:inositol | rel=r_associated | relid=0 | w=20
  1903. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:inotuzumab ozogamicin
    n1=en:cytarabine | n2=en:inotuzumab ozogamicin | rel=r_associated | relid=0 | w=20
  1904. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ins316
    n1=en:cytarabine | n2=en:ins316 | rel=r_associated | relid=0 | w=20
  1905. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:insulin glargine
    n1=en:cytarabine | n2=en:insulin glargine | rel=r_associated | relid=0 | w=20
  1906. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:insulin, regular
    n1=en:cytarabine | n2=en:insulin, regular | rel=r_associated | relid=0 | w=20
  1907. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:interferon alfacon-1
    n1=en:cytarabine | n2=en:interferon alfacon-1 | rel=r_associated | relid=0 | w=20
  1908. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:interleukin-12 gene
    n1=en:cytarabine | n2=en:interleukin-12 gene | rel=r_associated | relid=0 | w=20
  1909. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:interleukin-2 gene
    n1=en:cytarabine | n2=en:interleukin-2 gene | rel=r_associated | relid=0 | w=20
  1910. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:interleukin-4 pe38kdel immunotoxin
    n1=en:cytarabine | n2=en:interleukin-4 pe38kdel immunotoxin | rel=r_associated | relid=0 | w=20
  1911. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:inulin
    n1=en:cytarabine | n2=en:inulin | rel=r_associated | relid=0 | w=20
  1912. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iobenguane i-131
    n1=en:cytarabine | n2=en:iobenguane i-131 | rel=r_associated | relid=0 | w=20
  1913. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 123 anti-cea recombinant diabody t84.66
    n1=en:cytarabine | n2=en:iodine i 123 anti-cea recombinant diabody t84.66 | rel=r_associated | relid=0 | w=20
  1914. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 123 monoclonal antibody 81c6
    n1=en:cytarabine | n2=en:iodine i 123 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=20
  1915. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 124-crgdy-peg-c dots
    n1=en:cytarabine | n2=en:iodine i 124-crgdy-peg-c dots | rel=r_associated | relid=0 | w=20
  1916. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 ethiodized oil
    n1=en:cytarabine | n2=en:iodine i 131 ethiodized oil | rel=r_associated | relid=0 | w=20
  1917. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 monoclonal antibody 81c6
    n1=en:cytarabine | n2=en:iodine i 131 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=20
  1918. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 monoclonal antibody bc8
    n1=en:cytarabine | n2=en:iodine i 131 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=20
  1919. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 monoclonal antibody f16sip
    n1=en:cytarabine | n2=en:iodine i 131 monoclonal antibody f16sip | rel=r_associated | relid=0 | w=20
  1920. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 monoclonal antibody tnt-1/b
    n1=en:cytarabine | n2=en:iodine i 131 monoclonal antibody tnt-1/b | rel=r_associated | relid=0 | w=20
  1921. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 rituximab
    n1=en:cytarabine | n2=en:iodine i 131 rituximab | rel=r_associated | relid=0 | w=20
  1922. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 tenatumomab
    n1=en:cytarabine | n2=en:iodine i 131 tenatumomab | rel=r_associated | relid=0 | w=20
  1923. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 tm-601
    n1=en:cytarabine | n2=en:iodine i 131 tm-601 | rel=r_associated | relid=0 | w=20
  1924. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iodine i 131 tositumomab
    n1=en:cytarabine | n2=en:iodine i 131 tositumomab | rel=r_associated | relid=0 | w=20
  1925. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ioflubenzamide i-131
    n1=en:cytarabine | n2=en:ioflubenzamide i-131 | rel=r_associated | relid=0 | w=20
  1926. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ionomycin
    n1=en:cytarabine | n2=en:ionomycin | rel=r_associated | relid=0 | w=20
  1927. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ipatasertib
    n1=en:cytarabine | n2=en:ipatasertib | rel=r_associated | relid=0 | w=20
  1928. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ipilimumab
    n1=en:cytarabine | n2=en:ipilimumab | rel=r_associated | relid=0 | w=20
  1929. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iratumumab
    n1=en:cytarabine | n2=en:iratumumab | rel=r_associated | relid=0 | w=20
  1930. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:irinotecan hydrochloride
    n1=en:cytarabine | n2=en:irinotecan hydrochloride | rel=r_associated | relid=0 | w=20
  1931. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:irinotecan-eluting beads
    n1=en:cytarabine | n2=en:irinotecan-eluting beads | rel=r_associated | relid=0 | w=20
  1932. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet
    n1=en:cytarabine | n2=en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet | rel=r_associated | relid=0 | w=20
  1933. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:irofulven
    n1=en:cytarabine | n2=en:irofulven | rel=r_associated | relid=0 | w=20
  1934. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iron dextran complex
    n1=en:cytarabine | n2=en:iron dextran complex | rel=r_associated | relid=0 | w=20
  1935. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iron isomaltoside 1000
    n1=en:cytarabine | n2=en:iron isomaltoside 1000 | rel=r_associated | relid=0 | w=20
  1936. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iron sucrose injection
    n1=en:cytarabine | n2=en:iron sucrose injection | rel=r_associated | relid=0 | w=20
  1937. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isavuconazole
    n1=en:cytarabine | n2=en:isavuconazole | rel=r_associated | relid=0 | w=20
  1938. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iseganan hydrochloride
    n1=en:cytarabine | n2=en:iseganan hydrochloride | rel=r_associated | relid=0 | w=20
  1939. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isis 2503
    n1=en:cytarabine | n2=en:isis 2503 | rel=r_associated | relid=0 | w=20
  1940. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iso-fludelone
    n1=en:cytarabine | n2=en:iso-fludelone | rel=r_associated | relid=0 | w=20
  1941. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iso-sulfan blue
    n1=en:cytarabine | n2=en:iso-sulfan blue | rel=r_associated | relid=0 | w=20
  1942. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isoflurane
    n1=en:cytarabine | n2=en:isoflurane | rel=r_associated | relid=0 | w=20
  1943. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isoniazid
    n1=en:cytarabine | n2=en:isoniazid | rel=r_associated | relid=0 | w=20
  1944. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isopréniques
    n1=en:cytarabine | n2=en:isopréniques | rel=r_associated | relid=0 | w=20
  1945. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isoquercetin
    n1=en:cytarabine | n2=en:isoquercetin | rel=r_associated | relid=0 | w=20
  1946. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isosulfan blue
    n1=en:cytarabine | n2=en:isosulfan blue | rel=r_associated | relid=0 | w=20
  1947. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:isotretinoin
    n1=en:cytarabine | n2=en:isotretinoin | rel=r_associated | relid=0 | w=20
  1948. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:iss 1018 cpg oligodeoxynucleotide
    n1=en:cytarabine | n2=en:iss 1018 cpg oligodeoxynucleotide | rel=r_associated | relid=0 | w=20
  1949. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ivac mutanome vaccine
    n1=en:cytarabine | n2=en:ivac mutanome vaccine | rel=r_associated | relid=0 | w=20
  1950. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ivac protocol
    n1=en:cytarabine | n2=en:ivac protocol | rel=r_associated | relid=0 | w=20
  1951. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ivam regimen
    n1=en:cytarabine | n2=en:ivam regimen | rel=r_associated | relid=0 | w=20
  1952. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ixazomib citrate
    n1=en:cytarabine | n2=en:ixazomib citrate | rel=r_associated | relid=0 | w=20
  1953. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak inhibitor incb047986
    n1=en:cytarabine | n2=en:jak inhibitor incb047986 | rel=r_associated | relid=0 | w=20
  1954. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak1 inhibitor incb039110
    n1=en:cytarabine | n2=en:jak1 inhibitor incb039110 | rel=r_associated | relid=0 | w=20
  1955. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak1 inhibitor incb052793
    n1=en:cytarabine | n2=en:jak1 inhibitor incb052793 | rel=r_associated | relid=0 | w=20
  1956. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak2 inhibitor azd1480
    n1=en:cytarabine | n2=en:jak2 inhibitor azd1480 | rel=r_associated | relid=0 | w=20
  1957. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak2 inhibitor bms-911543
    n1=en:cytarabine | n2=en:jak2 inhibitor bms-911543 | rel=r_associated | relid=0 | w=20
  1958. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak2 inhibitor wp1066
    n1=en:cytarabine | n2=en:jak2 inhibitor wp1066 | rel=r_associated | relid=0 | w=20
  1959. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jak2 inhibitor xl019
    n1=en:cytarabine | n2=en:jak2 inhibitor xl019 | rel=r_associated | relid=0 | w=20
  1960. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jeb regimen
    n1=en:cytarabine | n2=en:jeb regimen | rel=r_associated | relid=0 | w=20
  1961. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:jin fu kang
    n1=en:cytarabine | n2=en:jin fu kang | rel=r_associated | relid=0 | w=20
  1962. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:kanglaite
    n1=en:cytarabine | n2=en:kanglaite | rel=r_associated | relid=0 | w=20
  1963. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:kava-based supplement
    n1=en:cytarabine | n2=en:kava-based supplement | rel=r_associated | relid=0 | w=20
  1964. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:key moment
    n1=en:cytarabine | n2=en:key moment | rel=r_associated | relid=0 | w=20
  1965. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:kit/pdgfr inhibitor dcc-2618
    n1=en:cytarabine | n2=en:kit/pdgfr inhibitor dcc-2618 | rel=r_associated | relid=0 | w=20
  1966. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ksp inhibitor arry-520
    n1=en:cytarabine | n2=en:ksp inhibitor arry-520 | rel=r_associated | relid=0 | w=20
  1967. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ksp inhibitor azd4877
    n1=en:cytarabine | n2=en:ksp inhibitor azd4877 | rel=r_associated | relid=0 | w=20
  1968. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:kunecatechins ointment
    n1=en:cytarabine | n2=en:kunecatechins ointment | rel=r_associated | relid=0 | w=20
  1969. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-377,202
    n1=en:cytarabine | n2=en:l-377,202 | rel=r_associated | relid=0 | w=20
  1970. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-6 protocol
    n1=en:cytarabine | n2=en:l-6 protocol | rel=r_associated | relid=0 | w=20
  1971. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement
    n1=en:cytarabine | n2=en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement | rel=r_associated | relid=0 | w=20
  1972. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-carnitine l-tartrate
    n1=en:cytarabine | n2=en:l-carnitine l-tartrate | rel=r_associated | relid=0 | w=20
  1973. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-gossypol
    n1=en:cytarabine | n2=en:l-gossypol | rel=r_associated | relid=0 | w=20
  1974. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-lysine
    n1=en:cytarabine | n2=en:l-lysine | rel=r_associated | relid=0 | w=20
  1975. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-ornithine l-aspartate
    n1=en:cytarabine | n2=en:l-ornithine l-aspartate | rel=r_associated | relid=0 | w=20
  1976. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l-valyl-ara-c
    n1=en:cytarabine | n2=en:l-valyl-ara-c | rel=r_associated | relid=0 | w=20
  1977. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:l19-il2 monoclonal antibody-cytokine fusion protein
    n1=en:cytarabine | n2=en:l19-il2 monoclonal antibody-cytokine fusion protein | rel=r_associated | relid=0 | w=20
  1978. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement
    n1=en:cytarabine | n2=en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement | rel=r_associated | relid=0 | w=20
  1979. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactobacillus fermented extract
    n1=en:cytarabine | n2=en:lactobacillus fermented extract | rel=r_associated | relid=0 | w=20
  1980. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactobacillus plantarum strain 299
    n1=en:cytarabine | n2=en:lactobacillus plantarum strain 299 | rel=r_associated | relid=0 | w=20
  1981. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactobacillus plantarum strain 299v
    n1=en:cytarabine | n2=en:lactobacillus plantarum strain 299v | rel=r_associated | relid=0 | w=20
  1982. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactobacillus rhamnosus gg
    n1=en:cytarabine | n2=en:lactobacillus rhamnosus gg | rel=r_associated | relid=0 | w=20
  1983. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement
    n1=en:cytarabine | n2=en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement | rel=r_associated | relid=0 | w=20
  1984. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lactoferrin-derived lytic peptide ltx-315
    n1=en:cytarabine | n2=en:lactoferrin-derived lytic peptide ltx-315 | rel=r_associated | relid=0 | w=20
  1985. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:laetrile
    n1=en:cytarabine | n2=en:laetrile | rel=r_associated | relid=0 | w=20
  1986. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lai regimen
    n1=en:cytarabine | n2=en:lai regimen | rel=r_associated | relid=0 | w=20
  1987. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lamivudine
    n1=en:cytarabine | n2=en:lamivudine | rel=r_associated | relid=0 | w=20
  1988. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lanreotide acetate
    n1=en:cytarabine | n2=en:lanreotide acetate | rel=r_associated | relid=0 | w=20
  1989. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lanreotide long-acting aqueous gel
    n1=en:cytarabine | n2=en:lanreotide long-acting aqueous gel | rel=r_associated | relid=0 | w=20
  1990. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lapachone
    n1=en:cytarabine | n2=en:lapachone | rel=r_associated | relid=0 | w=20
  1991. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lapatinib ditosylate
    n1=en:cytarabine | n2=en:lapatinib ditosylate | rel=r_associated | relid=0 | w=20
  1992. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lapuleucel-t
    n1=en:cytarabine | n2=en:lapuleucel-t | rel=r_associated | relid=0 | w=20
  1993. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:largetrifoliolious bugbane rhizome supplement
    n1=en:cytarabine | n2=en:largetrifoliolious bugbane rhizome supplement | rel=r_associated | relid=0 | w=20
  1994. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:laromustine
    n1=en:cytarabine | n2=en:laromustine | rel=r_associated | relid=0 | w=20
  1995. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:laronidase
    n1=en:cytarabine | n2=en:laronidase | rel=r_associated | relid=0 | w=20
  1996. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:larotaxel
    n1=en:cytarabine | n2=en:larotaxel | rel=r_associated | relid=0 | w=20
  1997. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:larson regimen
    n1=en:cytarabine | n2=en:larson regimen | rel=r_associated | relid=0 | w=20
  1998. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
    n1=en:cytarabine | n2=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | rel=r_associated | relid=0 | w=20
  1999. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lenvatinib mesylate
    n1=en:cytarabine | n2=en:lenvatinib mesylate | rel=r_associated | relid=0 | w=20
  2000. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:leridistim
    n1=en:cytarabine | n2=en:leridistim | rel=r_associated | relid=0 | w=20
  2001. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lerisetron
    n1=en:cytarabine | n2=en:lerisetron | rel=r_associated | relid=0 | w=20
  2002. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:leucine-enhanced essential amino acid dietary supplement
    n1=en:cytarabine | n2=en:leucine-enhanced essential amino acid dietary supplement | rel=r_associated | relid=0 | w=20
  2003. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:leukemic apoptotic corpse-pulsed autologous dendritic cells
    n1=en:cytarabine | n2=en:leukemic apoptotic corpse-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=20
  2004. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:levamisole hydrochloride
    n1=en:cytarabine | n2=en:levamisole hydrochloride | rel=r_associated | relid=0 | w=20
  2005. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:levocarnitine
    n1=en:cytarabine | n2=en:levocarnitine | rel=r_associated | relid=0 | w=20
  2006. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:levofloxacin
    n1=en:cytarabine | n2=en:levofloxacin | rel=r_associated | relid=0 | w=20
  2007. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:levoleucovorin calcium
    n1=en:cytarabine | n2=en:levoleucovorin calcium | rel=r_associated | relid=0 | w=20
  2008. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lexatumumab
    n1=en:cytarabine | n2=en:lexatumumab | rel=r_associated | relid=0 | w=20
  2009. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lexibulin
    n1=en:cytarabine | n2=en:lexibulin | rel=r_associated | relid=0 | w=20
  2010. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liarozole fumarate
    n1=en:cytarabine | n2=en:liarozole fumarate | rel=r_associated | relid=0 | w=20
  2011. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:licartin
    n1=en:cytarabine | n2=en:licartin | rel=r_associated | relid=0 | w=20
  2012. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lidocaine patch
    n1=en:cytarabine | n2=en:lidocaine patch | rel=r_associated | relid=0 | w=20
  2013. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:linoleyl carbonate-paclitaxel
    n1=en:cytarabine | n2=en:linoleyl carbonate-paclitaxel | rel=r_associated | relid=0 | w=20
  2014. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:linsitinib
    n1=en:cytarabine | n2=en:linsitinib | rel=r_associated | relid=0 | w=20
  2015. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lintuzumab
    n1=en:cytarabine | n2=en:lintuzumab | rel=r_associated | relid=0 | w=20
  2016. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal c-raf antisense oligonucleotide
    n1=en:cytarabine | n2=en:liposomal c-raf antisense oligonucleotide | rel=r_associated | relid=0 | w=20
  2017. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal cytarabine-daunorubicin cpx-351
    n1=en:cytarabine | n2=en:liposomal cytarabine-daunorubicin cpx-351 | rel=r_associated | relid=0 | w=20
  2018. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal daunorubicin citrate
    n1=en:cytarabine | n2=en:liposomal daunorubicin citrate | rel=r_associated | relid=0 | w=20
  2019. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal eribulin mesylate
    n1=en:cytarabine | n2=en:liposomal eribulin mesylate | rel=r_associated | relid=0 | w=20
  2020. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal irinotecan
    n1=en:cytarabine | n2=en:liposomal irinotecan | rel=r_associated | relid=0 | w=20
  2021. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal muc1/pet-lipid a vaccine
    n1=en:cytarabine | n2=en:liposomal muc1/pet-lipid a vaccine | rel=r_associated | relid=0 | w=20
  2022. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal nddp
    n1=en:cytarabine | n2=en:liposomal nddp | rel=r_associated | relid=0 | w=20
  2023. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposomal rhenium re 186
    n1=en:cytarabine | n2=en:liposomal rhenium re 186 | rel=r_associated | relid=0 | w=20
  2024. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94
    n1=en:cytarabine | n2=en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 | rel=r_associated | relid=0 | w=20
  2025. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase
    n1=en:cytarabine | n2=en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase | rel=r_associated | relid=0 | w=20
  2026. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:liraglutide
    n1=en:cytarabine | n2=en:liraglutide | rel=r_associated | relid=0 | w=20
  2027. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lirilumab
    n1=en:cytarabine | n2=en:lirilumab | rel=r_associated | relid=0 | w=20
  2028. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lisdexamfetamine dimesylate
    n1=en:cytarabine | n2=en:lisdexamfetamine dimesylate | rel=r_associated | relid=0 | w=20
  2029. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lisinopril
    n1=en:cytarabine | n2=en:lisinopril | rel=r_associated | relid=0 | w=20
  2030. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:listeria monocytogenes-llo-psa vaccine adxs31-142
    n1=en:cytarabine | n2=en:listeria monocytogenes-llo-psa vaccine adxs31-142 | rel=r_associated | relid=0 | w=20
  2031. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lithium carbonate
    n1=en:cytarabine | n2=en:lithium carbonate | rel=r_associated | relid=0 | w=20
  2032. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:litronesib
    n1=en:cytarabine | n2=en:litronesib | rel=r_associated | relid=0 | w=20
  2033. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:live attenuated measles virus vaccine
    n1=en:cytarabine | n2=en:live attenuated measles virus vaccine | rel=r_associated | relid=0 | w=20
  2034. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:live freeze-dried lactic acid bacteria probiotic
    n1=en:cytarabine | n2=en:live freeze-dried lactic acid bacteria probiotic | rel=r_associated | relid=0 | w=20
  2035. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:live-attenuated listeria encoding human mesothelin vaccine crs-207
    n1=en:cytarabine | n2=en:live-attenuated listeria encoding human mesothelin vaccine crs-207 | rel=r_associated | relid=0 | w=20
  2036. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmb protocol
    n1=en:cytarabine | n2=en:lmb protocol | rel=r_associated | relid=0 | w=20
  2037. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmb-1 immunotoxin
    n1=en:cytarabine | n2=en:lmb-1 immunotoxin | rel=r_associated | relid=0 | w=20
  2038. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmb-7 immunotoxin
    n1=en:cytarabine | n2=en:lmb-7 immunotoxin | rel=r_associated | relid=0 | w=20
  2039. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmb-84 regimen
    n1=en:cytarabine | n2=en:lmb-84 regimen | rel=r_associated | relid=0 | w=20
  2040. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmb89 protocol
    n1=en:cytarabine | n2=en:lmb89 protocol | rel=r_associated | relid=0 | w=20
  2041. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmp-2:419-427 peptide vaccine
    n1=en:cytarabine | n2=en:lmp-2:419-427 peptide vaccine | rel=r_associated | relid=0 | w=20
  2042. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  2043. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lmp2a-specific cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:lmp2a-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  2044. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lnh-92 regimen
    n1=en:cytarabine | n2=en:lnh-92 regimen | rel=r_associated | relid=0 | w=20
  2045. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lometrexol
    n1=en:cytarabine | n2=en:lometrexol | rel=r_associated | relid=0 | w=20
  2046. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lonidamine
    n1=en:cytarabine | n2=en:lonidamine | rel=r_associated | relid=0 | w=20
  2047. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lorlatinib
    n1=en:cytarabine | n2=en:lorlatinib | rel=r_associated | relid=0 | w=20
  2048. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lorvotuzumab mertansine
    n1=en:cytarabine | n2=en:lorvotuzumab mertansine | rel=r_associated | relid=0 | w=20
  2049. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:losoxantrone
    n1=en:cytarabine | n2=en:losoxantrone | rel=r_associated | relid=0 | w=20
  2050. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lovastatin
    n1=en:cytarabine | n2=en:lovastatin | rel=r_associated | relid=0 | w=20
  2051. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lpa97r protocol
    n1=en:cytarabine | n2=en:lpa97r protocol | rel=r_associated | relid=0 | w=20
  2052. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lsa(2)l(2) protocol
    n1=en:cytarabine | n2=en:lsa(2)l(2) protocol | rel=r_associated | relid=0 | w=20
  2053. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lung-targeted immunomodulator qbkpn
    n1=en:cytarabine | n2=en:lung-targeted immunomodulator qbkpn | rel=r_associated | relid=0 | w=20
  2054. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lutetium lu 177 dota-biotin
    n1=en:cytarabine | n2=en:lutetium lu 177 dota-biotin | rel=r_associated | relid=0 | w=20
  2055. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lutetium lu 177 dota-jr11
    n1=en:cytarabine | n2=en:lutetium lu 177 dota-jr11 | rel=r_associated | relid=0 | w=20
  2056. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lutetium lu 177 monoclonal antibody cc49
    n1=en:cytarabine | n2=en:lutetium lu 177 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=20
  2057. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lutetium lu 177 monoclonal antibody j591
    n1=en:cytarabine | n2=en:lutetium lu 177 monoclonal antibody j591 | rel=r_associated | relid=0 | w=20
  2058. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lutetium lu-177 capromab
    n1=en:cytarabine | n2=en:lutetium lu-177 capromab | rel=r_associated | relid=0 | w=20
  2059. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ly2624587
    n1=en:cytarabine | n2=en:ly2624587 | rel=r_associated | relid=0 | w=20
  2060. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ly6k/vegfr1/vegfr2 multipeptide vaccine
    n1=en:cytarabine | n2=en:ly6k/vegfr1/vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=20
  2061. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lymphokine-activated killer cells
    n1=en:cytarabine | n2=en:lymphokine-activated killer cells | rel=r_associated | relid=0 | w=20
  2062. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lyophilized black raspberry lozenge
    n1=en:cytarabine | n2=en:lyophilized black raspberry lozenge | rel=r_associated | relid=0 | w=20
  2063. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lyophilized black raspberry saliva substitute
    n1=en:cytarabine | n2=en:lyophilized black raspberry saliva substitute | rel=r_associated | relid=0 | w=20
  2064. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:lytta vesicatoria preparation
    n1=en:cytarabine | n2=en:lytta vesicatoria preparation | rel=r_associated | relid=0 | w=20
  2065. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:m.d. anderson cancer center protocol
    n1=en:cytarabine | n2=en:m.d. anderson cancer center protocol | rel=r_associated | relid=0 | w=20
  2066. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:m87o-transduced cd34+ peripheral blood stem cells
    n1=en:cytarabine | n2=en:m87o-transduced cd34+ peripheral blood stem cells | rel=r_associated | relid=0 | w=20
  2067. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mac chemotherapy protocol
    n1=en:cytarabine | n2=en:mac chemotherapy protocol | rel=r_associated | relid=0 | w=20
  2068. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mac conditioning regimen
    n1=en:cytarabine | n2=en:mac conditioning regimen | rel=r_associated | relid=0 | w=20
  2069. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mac321
    n1=en:cytarabine | n2=en:mac321 | rel=r_associated | relid=0 | w=20
  2070. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:macho protocol
    n1=en:cytarabine | n2=en:macho protocol | rel=r_associated | relid=0 | w=20
  2071. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:macitentan
    n1=en:cytarabine | n2=en:macitentan | rel=r_associated | relid=0 | w=20
  2072. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mad protocol
    n1=en:cytarabine | n2=en:mad protocol | rel=r_associated | relid=0 | w=20
  2073. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mage-a3 peptide vaccine
    n1=en:cytarabine | n2=en:mage-a3 peptide vaccine | rel=r_associated | relid=0 | w=20
  2074. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mage-a3 reactive t cell receptor-transduced autologous t cells
    n1=en:cytarabine | n2=en:mage-a3 reactive t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=20
  2075. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mage-a3-expressing adenovirus type 5 vaccine
    n1=en:cytarabine | n2=en:mage-a3-expressing adenovirus type 5 vaccine | rel=r_associated | relid=0 | w=20
  2076. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mage-a3/12-specific tcr gene-transduced autologous pbls
    n1=en:cytarabine | n2=en:mage-a3/12-specific tcr gene-transduced autologous pbls | rel=r_associated | relid=0 | w=20
  2077. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mage-a3/hpv 16 peptide vaccine
    n1=en:cytarabine | n2=en:mage-a3/hpv 16 peptide vaccine | rel=r_associated | relid=0 | w=20
  2078. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201
    n1=en:cytarabine | n2=en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 | rel=r_associated | relid=0 | w=20
  2079. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magnesium citrate
    n1=en:cytarabine | n2=en:magnesium citrate | rel=r_associated | relid=0 | w=20
  2080. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magnesium isoglycyrrhizinate
    n1=en:cytarabine | n2=en:magnesium isoglycyrrhizinate | rel=r_associated | relid=0 | w=20
  2081. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magnesium oxide
    n1=en:cytarabine | n2=en:magnesium oxide | rel=r_associated | relid=0 | w=20
  2082. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magnesium sulfate
    n1=en:cytarabine | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=20
  2083. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magnesium sulphate
    n1=en:cytarabine | n2=en:magnesium sulphate | rel=r_associated | relid=0 | w=20
  2084. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magnesium valproate
    n1=en:cytarabine | n2=en:magnesium valproate | rel=r_associated | relid=0 | w=20
  2085. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:magrath regimen
    n1=en:cytarabine | n2=en:magrath regimen | rel=r_associated | relid=0 | w=20
  2086. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:maitake mushroom extract
    n1=en:cytarabine | n2=en:maitake mushroom extract | rel=r_associated | relid=0 | w=20
  2087. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:make a counterpart to something
    n1=en:cytarabine | n2=en:make a counterpart to something | rel=r_associated | relid=0 | w=20
  2088. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:make a pair with something
    n1=en:cytarabine | n2=en:make a pair with something | rel=r_associated | relid=0 | w=20
  2089. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:make somebody 's acquaintance
    n1=en:cytarabine | n2=en:make somebody 's acquaintance | rel=r_associated | relid=0 | w=20
  2090. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:make somebody's acquaintance
    n1=en:cytarabine | n2=en:make somebody's acquaintance | rel=r_associated | relid=0 | w=20
  2091. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mami protocol
    n1=en:cytarabine | n2=en:mami protocol | rel=r_associated | relid=0 | w=20
  2092. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mammaglobin-a dna vaccine
    n1=en:cytarabine | n2=en:mammaglobin-a dna vaccine | rel=r_associated | relid=0 | w=20
  2093. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:manuka honey
    n1=en:cytarabine | n2=en:manuka honey | rel=r_associated | relid=0 | w=20
  2094. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mapatumumab
    n1=en:cytarabine | n2=en:mapatumumab | rel=r_associated | relid=0 | w=20
  2095. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:maribavir
    n1=en:cytarabine | n2=en:maribavir | rel=r_associated | relid=0 | w=20
  2096. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mart-1 reactive cd8+ lymphocytes
    n1=en:cytarabine | n2=en:mart-1 reactive cd8+ lymphocytes | rel=r_associated | relid=0 | w=20
  2097. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mart-1:26-35(27l) peptide vaccine
    n1=en:cytarabine | n2=en:mart-1:26-35(27l) peptide vaccine | rel=r_associated | relid=0 | w=20
  2098. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:masitinib mesylate
    n1=en:cytarabine | n2=en:masitinib mesylate | rel=r_associated | relid=0 | w=20
  2099. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:masoprocol
    n1=en:cytarabine | n2=en:masoprocol | rel=r_associated | relid=0 | w=20
  2100. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:match
    n1=en:cytarabine | n2=en:match | rel=r_associated | relid=0 | w=20
  2101. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:matilde regimen
    n1=en:cytarabine | n2=en:matilde regimen | rel=r_associated | relid=0 | w=20
  2102. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:matuzumab
    n1=en:cytarabine | n2=en:matuzumab | rel=r_associated | relid=0 | w=20
  2103. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:maxzide
    n1=en:cytarabine | n2=en:maxzide | rel=r_associated | relid=0 | w=20
  2104. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mb-triple v protocol
    n1=en:cytarabine | n2=en:mb-triple v protocol | rel=r_associated | relid=0 | w=20
  2105. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mcl-1 inhibitor amg 176
    n1=en:cytarabine | n2=en:mcl-1 inhibitor amg 176 | rel=r_associated | relid=0 | w=20
  2106. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mcp 842 regimen
    n1=en:cytarabine | n2=en:mcp 842 regimen | rel=r_associated | relid=0 | w=20
  2107. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mcpyv tag-specific polyclonal autologous cd8-positive t cells
    n1=en:cytarabine | n2=en:mcpyv tag-specific polyclonal autologous cd8-positive t cells | rel=r_associated | relid=0 | w=20
  2108. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mct/lct/fish oil omega-3 fatty acid lipid emulsion
    n1=en:cytarabine | n2=en:mct/lct/fish oil omega-3 fatty acid lipid emulsion | rel=r_associated | relid=0 | w=20
  2109. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mdx-1379 melanoma vaccine
    n1=en:cytarabine | n2=en:mdx-1379 melanoma vaccine | rel=r_associated | relid=0 | w=20
  2110. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:me-143
    n1=en:cytarabine | n2=en:me-143 | rel=r_associated | relid=0 | w=20
  2111. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mea protocol
    n1=en:cytarabine | n2=en:mea protocol | rel=r_associated | relid=0 | w=20
  2112. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:measles/mumps/rubella vaccine
    n1=en:cytarabine | n2=en:measles/mumps/rubella vaccine | rel=r_associated | relid=0 | w=20
  2113. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mec protocol
    n1=en:cytarabine | n2=en:mec protocol | rel=r_associated | relid=0 | w=20
  2114. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:meca protocol
    n1=en:cytarabine | n2=en:meca protocol | rel=r_associated | relid=0 | w=20
  2115. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:medical marijuana
    n1=en:cytarabine | n2=en:medical marijuana | rel=r_associated | relid=0 | w=20
  2116. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:meet
    n1=en:cytarabine | n2=en:meet | rel=r_associated | relid=0 | w=20
  2117. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mek 1/2 inhibitor as703988/msc2015103b
    n1=en:cytarabine | n2=en:mek 1/2 inhibitor as703988/msc2015103b | rel=r_associated | relid=0 | w=20
  2118. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mek inhibitor ci-1040
    n1=en:cytarabine | n2=en:mek inhibitor ci-1040 | rel=r_associated | relid=0 | w=20
  2119. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mek inhibitor wx-554
    n1=en:cytarabine | n2=en:mek inhibitor wx-554 | rel=r_associated | relid=0 | w=20
  2120. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:melan-a vlp vaccine
    n1=en:cytarabine | n2=en:melan-a vlp vaccine | rel=r_associated | relid=0 | w=20
  2121. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:melanoma antigen recognized by t-cells 1, human
    n1=en:cytarabine | n2=en:melanoma antigen recognized by t-cells 1, human | rel=r_associated | relid=0 | w=20
  2122. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:melphalan hydrochloride
    n1=en:cytarabine | n2=en:melphalan hydrochloride | rel=r_associated | relid=0 | w=20
  2123. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:menadione topical lotion
    n1=en:cytarabine | n2=en:menadione topical lotion | rel=r_associated | relid=0 | w=20
  2124. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mesna
    n1=en:cytarabine | n2=en:mesna | rel=r_associated | relid=0 | w=20
  2125. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  2126. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:met tyrosine kinase inhibitor bms-777607
    n1=en:cytarabine | n2=en:met tyrosine kinase inhibitor bms-777607 | rel=r_associated | relid=0 | w=20
  2127. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:metahexamide
    n1=en:cytarabine | n2=en:metahexamide | rel=r_associated | relid=0 | w=20
  2128. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:methoxsalen
    n1=en:cytarabine | n2=en:methoxsalen | rel=r_associated | relid=0 | w=20
  2129. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:methoxy polyethylene glycol-epoetin beta
    n1=en:cytarabine | n2=en:methoxy polyethylene glycol-epoetin beta | rel=r_associated | relid=0 | w=20
  2130. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:methyl-gag
    n1=en:cytarabine | n2=en:methyl-gag | rel=r_associated | relid=0 | w=20
  2131. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:methylene dimethane sulfonate
    n1=en:cytarabine | n2=en:methylene dimethane sulfonate | rel=r_associated | relid=0 | w=20
  2132. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:metoprine
    n1=en:cytarabine | n2=en:metoprine | rel=r_associated | relid=0 | w=20
  2133. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:metreleptin
    n1=en:cytarabine | n2=en:metreleptin | rel=r_associated | relid=0 | w=20
  2134. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:metronidazole hydrochloride
    n1=en:cytarabine | n2=en:metronidazole hydrochloride | rel=r_associated | relid=0 | w=20
  2135. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mfc protocol
    n1=en:cytarabine | n2=en:mfc protocol | rel=r_associated | relid=0 | w=20
  2136. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:micafungin
    n1=en:cytarabine | n2=en:micafungin | rel=r_associated | relid=0 | w=20
  2137. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:micma protocol
    n1=en:cytarabine | n2=en:micma protocol | rel=r_associated | relid=0 | w=20
  2138. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:micronutrient-fortified probiotic yogurt
    n1=en:cytarabine | n2=en:micronutrient-fortified probiotic yogurt | rel=r_associated | relid=0 | w=20
  2139. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mifamurtide
    n1=en:cytarabine | n2=en:mifamurtide | rel=r_associated | relid=0 | w=20
  2140. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mifap regimen
    n1=en:cytarabine | n2=en:mifap regimen | rel=r_associated | relid=0 | w=20
  2141. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:milatuzumab
    n1=en:cytarabine | n2=en:milatuzumab | rel=r_associated | relid=0 | w=20
  2142. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:milk protein-based energy drink
    n1=en:cytarabine | n2=en:milk protein-based energy drink | rel=r_associated | relid=0 | w=20
  2143. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mine-eshap protocol
    n1=en:cytarabine | n2=en:mine-eshap protocol | rel=r_associated | relid=0 | w=20
  2144. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mini-beam regimen
    n1=en:cytarabine | n2=en:mini-beam regimen | rel=r_associated | relid=0 | w=20
  2145. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mini-beam salvage protocol
    n1=en:cytarabine | n2=en:mini-beam salvage protocol | rel=r_associated | relid=0 | w=20
  2146. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:minocycline-edta
    n1=en:cytarabine | n2=en:minocycline-edta | rel=r_associated | relid=0 | w=20
  2147. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:miracle mouthwash plus hydrocortisone
    n1=en:cytarabine | n2=en:miracle mouthwash plus hydrocortisone | rel=r_associated | relid=0 | w=20
  2148. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mitogen
    n1=en:cytarabine | n2=en:mitogen | rel=r_associated | relid=0 | w=20
  2149. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mitoguazone
    n1=en:cytarabine | n2=en:mitoguazone | rel=r_associated | relid=0 | w=20
  2150. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mk-4280
    n1=en:cytarabine | n2=en:mk-4280 | rel=r_associated | relid=0 | w=20
  2151. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mknk1 inhibitor bay 1143269
    n1=en:cytarabine | n2=en:mknk1 inhibitor bay 1143269 | rel=r_associated | relid=0 | w=20
  2152. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mll-93 protocol
    n1=en:cytarabine | n2=en:mll-93 protocol | rel=r_associated | relid=0 | w=20
  2153. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mnk1/2 inhibitor eft508
    n1=en:cytarabine | n2=en:mnk1/2 inhibitor eft508 | rel=r_associated | relid=0 | w=20
  2154. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mnsod mimetic bmx-001
    n1=en:cytarabine | n2=en:mnsod mimetic bmx-001 | rel=r_associated | relid=0 | w=20
  2155. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:modafinil
    n1=en:cytarabine | n2=en:modafinil | rel=r_associated | relid=0 | w=20
  2156. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:modified citrus pectin supplement
    n1=en:cytarabine | n2=en:modified citrus pectin supplement | rel=r_associated | relid=0 | w=20
  2157. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mogamulizumab
    n1=en:cytarabine | n2=en:mogamulizumab | rel=r_associated | relid=0 | w=20
  2158. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monkey wrench
    n1=en:cytarabine | n2=en:monkey wrench | rel=r_associated | relid=0 | w=20
  2159. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoacetyldiglyceride ec-18
    n1=en:cytarabine | n2=en:monoacetyldiglyceride ec-18 | rel=r_associated | relid=0 | w=20
  2160. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody 11d10 anti-idiotype vaccine
    n1=en:cytarabine | n2=en:monoclonal antibody 11d10 anti-idiotype vaccine | rel=r_associated | relid=0 | w=20
  2161. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody 3622w94
    n1=en:cytarabine | n2=en:monoclonal antibody 3622w94 | rel=r_associated | relid=0 | w=20
  2162. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody a1g4 anti-idiotype vaccine
    n1=en:cytarabine | n2=en:monoclonal antibody a1g4 anti-idiotype vaccine | rel=r_associated | relid=0 | w=20
  2163. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody agent
    n1=en:cytarabine | n2=en:monoclonal antibody agent | rel=r_associated | relid=0 | w=20
  2164. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody cal
    n1=en:cytarabine | n2=en:monoclonal antibody cal | rel=r_associated | relid=0 | w=20
  2165. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody cc49
    n1=en:cytarabine | n2=en:monoclonal antibody cc49 | rel=r_associated | relid=0 | w=20
  2166. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody cc49-streptavidin conjugate
    n1=en:cytarabine | n2=en:monoclonal antibody cc49-streptavidin conjugate | rel=r_associated | relid=0 | w=20
  2167. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody cd19
    n1=en:cytarabine | n2=en:monoclonal antibody cd19 | rel=r_associated | relid=0 | w=20
  2168. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody cep-37250/khk2804
    n1=en:cytarabine | n2=en:monoclonal antibody cep-37250/khk2804 | rel=r_associated | relid=0 | w=20
  2169. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody f19
    n1=en:cytarabine | n2=en:monoclonal antibody f19 | rel=r_associated | relid=0 | w=20
  2170. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody hu3s193
    n1=en:cytarabine | n2=en:monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=20
  2171. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody huhmfg1
    n1=en:cytarabine | n2=en:monoclonal antibody huhmfg1 | rel=r_associated | relid=0 | w=20
  2172. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody huj591
    n1=en:cytarabine | n2=en:monoclonal antibody huj591 | rel=r_associated | relid=0 | w=20
  2173. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody hupam4
    n1=en:cytarabine | n2=en:monoclonal antibody hupam4 | rel=r_associated | relid=0 | w=20
  2174. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody ing-1
    n1=en:cytarabine | n2=en:monoclonal antibody ing-1 | rel=r_associated | relid=0 | w=20
  2175. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody me1-14 f(ab')2
    n1=en:cytarabine | n2=en:monoclonal antibody me1-14 f(ab')2 | rel=r_associated | relid=0 | w=20
  2176. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody mono-dga-rfb4
    n1=en:cytarabine | n2=en:monoclonal antibody mono-dga-rfb4 | rel=r_associated | relid=0 | w=20
  2177. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody rav12
    n1=en:cytarabine | n2=en:monoclonal antibody rav12 | rel=r_associated | relid=0 | w=20
  2178. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:monoclonal antibody sgn-30
    n1=en:cytarabine | n2=en:monoclonal antibody sgn-30 | rel=r_associated | relid=0 | w=20
  2179. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:moplace protocol
    n1=en:cytarabine | n2=en:moplace protocol | rel=r_associated | relid=0 | w=20
  2180. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:motexafin gadolinium
    n1=en:cytarabine | n2=en:motexafin gadolinium | rel=r_associated | relid=0 | w=20
  2181. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mouth off to [sb]
    n1=en:cytarabine | n2=en:mouth off to [sb] | rel=r_associated | relid=0 | w=20
  2182. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:moxetumomab pasudotox
    n1=en:cytarabine | n2=en:moxetumomab pasudotox | rel=r_associated | relid=0 | w=20
  2183. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mps1 kinase inhibitor bay1161909
    n1=en:cytarabine | n2=en:mps1 kinase inhibitor bay1161909 | rel=r_associated | relid=0 | w=20
  2184. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mrc aml 10 protocol
    n1=en:cytarabine | n2=en:mrc aml 10 protocol | rel=r_associated | relid=0 | w=20
  2185. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mtf-1 inhibitor apto-253 hcl
    n1=en:cytarabine | n2=en:mtf-1 inhibitor apto-253 hcl | rel=r_associated | relid=0 | w=20
  2186. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mtor kinase inhibitor azd8055
    n1=en:cytarabine | n2=en:mtor kinase inhibitor azd8055 | rel=r_associated | relid=0 | w=20
  2187. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mtorc1/2 kinase inhibitor bi 860585
    n1=en:cytarabine | n2=en:mtorc1/2 kinase inhibitor bi 860585 | rel=r_associated | relid=0 | w=20
  2188. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:muc-2-globo h-klh conjugate vaccine
    n1=en:cytarabine | n2=en:muc-2-globo h-klh conjugate vaccine | rel=r_associated | relid=0 | w=20
  2189. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:muc-2-klh vaccine
    n1=en:cytarabine | n2=en:muc-2-klh vaccine | rel=r_associated | relid=0 | w=20
  2190. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:muc1 peptide-poly-iclc adjuvant vaccine
    n1=en:cytarabine | n2=en:muc1 peptide-poly-iclc adjuvant vaccine | rel=r_associated | relid=0 | w=20
  2191. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mucoadhesive oral wound rinse
    n1=en:cytarabine | n2=en:mucoadhesive oral wound rinse | rel=r_associated | relid=0 | w=20
  2192. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multicarotenoid supplement mcs-8
    n1=en:cytarabine | n2=en:multicarotenoid supplement mcs-8 | rel=r_associated | relid=0 | w=20
  2193. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multidrug resistance modulator
    n1=en:cytarabine | n2=en:multidrug resistance modulator | rel=r_associated | relid=0 | w=20
  2194. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multifunctional/multitargeted anticancer agent omn54
    n1=en:cytarabine | n2=en:multifunctional/multitargeted anticancer agent omn54 | rel=r_associated | relid=0 | w=20
  2195. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multikinase inhibitor arry614
    n1=en:cytarabine | n2=en:multikinase inhibitor arry614 | rel=r_associated | relid=0 | w=20
  2196. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multikinase inhibitor sar103168
    n1=en:cytarabine | n2=en:multikinase inhibitor sar103168 | rel=r_associated | relid=0 | w=20
  2197. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multipeptide vaccine s-588210
    n1=en:cytarabine | n2=en:multipeptide vaccine s-588210 | rel=r_associated | relid=0 | w=20
  2198. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:multitargeted tyrosine kinase inhibitor jnj-26483327
    n1=en:cytarabine | n2=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | rel=r_associated | relid=0 | w=20
  2199. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:muscadine grape skin extract
    n1=en:cytarabine | n2=en:muscadine grape skin extract | rel=r_associated | relid=0 | w=20
  2200. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:muscle relaxant
    n1=en:cytarabine | n2=en:muscle relaxant | rel=r_associated | relid=0 | w=20
  2201. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mutagen
    n1=en:cytarabine | n2=en:mutagen | rel=r_associated | relid=0 | w=20
  2202. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mycobacterium tuberculosis arabinomannan z-100
    n1=en:cytarabine | n2=en:mycobacterium tuberculosis arabinomannan z-100 | rel=r_associated | relid=0 | w=20
  2203. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:mycophenolic acid
    n1=en:cytarabine | n2=en:mycophenolic acid | rel=r_associated | relid=0 | w=20
  2204. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n-methylformamide
    n1=en:cytarabine | n2=en:n-methylformamide | rel=r_associated | relid=0 | w=20
  2205. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n-squalenoyl-cytarabine
    n1=en:cytarabine | n2=en:n-squalenoyl-cytarabine | rel=r_associated | relid=0 | w=20
  2206. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine-polylysine conjugate
    n1=en:cytarabine | n2=en:n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine-polylysine conjugate | rel=r_associated | relid=0 | w=20
  2207. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-(4-carboxybutyryl)-1-beta-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:n(4)-(4-carboxybutyryl)-1-beta-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  2208. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-chloroacetylcytosine arabinoside
    n1=en:cytarabine | n2=en:n(4)-chloroacetylcytosine arabinoside | rel=r_associated | relid=0 | w=20
  2209. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-hexadecyl-1-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:n(4)-hexadecyl-1-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  2210. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-octadecyl-1-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:n(4)-octadecyl-1-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  2211. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-octadecyl-1-beta-d-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:n(4)-octadecyl-1-beta-d-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  2212. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-oleoyl cytarabine
    n1=en:cytarabine | n2=en:n(4)-oleoyl cytarabine | rel=r_associated | relid=0 | w=20
  2213. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-oleylcytosine arabinoside
    n1=en:cytarabine | n2=en:n(4)-oleylcytosine arabinoside | rel=r_associated | relid=0 | w=20
  2214. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-palmitoyl cytarabine
    n1=en:cytarabine | n2=en:n(4)-palmitoyl cytarabine | rel=r_associated | relid=0 | w=20
  2215. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n(4)-succinyl-1-beta-d-arabinofuranosylcytosine
    n1=en:cytarabine | n2=en:n(4)-succinyl-1-beta-d-arabinofuranosylcytosine | rel=r_associated | relid=0 | w=20
  2216. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n4-(4-carboxybutyryl)-1-arabinofuranosylcytosine-decylenediamine-dextran t70
    n1=en:cytarabine | n2=en:n4-(4-carboxybutyryl)-1-arabinofuranosylcytosine-decylenediamine-dextran t70 | rel=r_associated | relid=0 | w=20
  2217. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:n4se protocol
    n1=en:cytarabine | n2=en:n4se protocol | rel=r_associated | relid=0 | w=20
  2218. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nab-paclitaxel
    n1=en:cytarabine | n2=en:nab-paclitaxel | rel=r_associated | relid=0 | w=20
  2219. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nadolol
    n1=en:cytarabine | n2=en:nadolol | rel=r_associated | relid=0 | w=20
  2220. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nanoparticle-encapsulated doxorubicin hydrochloride
    n1=en:cytarabine | n2=en:nanoparticle-encapsulated doxorubicin hydrochloride | rel=r_associated | relid=0 | w=20
  2221. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:naproxen
    n1=en:cytarabine | n2=en:naproxen | rel=r_associated | relid=0 | w=20
  2222. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nasal saline irrigation solution
    n1=en:cytarabine | n2=en:nasal saline irrigation solution | rel=r_associated | relid=0 | w=20
  2223. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:natalizumab
    n1=en:cytarabine | n2=en:natalizumab | rel=r_associated | relid=0 | w=20
  2224. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:navuridine
    n1=en:cytarabine | n2=en:navuridine | rel=r_associated | relid=0 | w=20
  2225. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ncit antineoplastic agent terminology
    n1=en:cytarabine | n2=en:ncit antineoplastic agent terminology | rel=r_associated | relid=0 | w=20
  2226. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nd-420
    n1=en:cytarabine | n2=en:nd-420 | rel=r_associated | relid=0 | w=20
  2227. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:necitumumab
    n1=en:cytarabine | n2=en:necitumumab | rel=r_associated | relid=0 | w=20
  2228. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nelfinavir mesylate
    n1=en:cytarabine | n2=en:nelfinavir mesylate | rel=r_associated | relid=0 | w=20
  2229. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nelipepimut-s plus gm-csf vaccine
    n1=en:cytarabine | n2=en:nelipepimut-s plus gm-csf vaccine | rel=r_associated | relid=0 | w=20
  2230. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:netazepide
    n1=en:cytarabine | n2=en:netazepide | rel=r_associated | relid=0 | w=20
  2231. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:netupitant
    n1=en:cytarabine | n2=en:netupitant | rel=r_associated | relid=0 | w=20
  2232. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:neuromuscular blocking agents
    n1=en:cytarabine | n2=en:neuromuscular blocking agents | rel=r_associated | relid=0 | w=20
  2233. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:neutrophil activation probe imaging agent
    n1=en:cytarabine | n2=en:neutrophil activation probe imaging agent | rel=r_associated | relid=0 | w=20
  2234. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:new york protocol
    n1=en:cytarabine | n2=en:new york protocol | rel=r_associated | relid=0 | w=20
  2235. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:niacinamide
    n1=en:cytarabine | n2=en:niacinamide | rel=r_associated | relid=0 | w=20
  2236. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nicotine
    n1=en:cytarabine | n2=en:nicotine | rel=r_associated | relid=0 | w=20
  2237. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nicotine lozenge
    n1=en:cytarabine | n2=en:nicotine lozenge | rel=r_associated | relid=0 | w=20
  2238. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nicotine nasal spray
    n1=en:cytarabine | n2=en:nicotine nasal spray | rel=r_associated | relid=0 | w=20
  2239. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nicotine patch
    n1=en:cytarabine | n2=en:nicotine patch | rel=r_associated | relid=0 | w=20
  2240. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nilandron
    n1=en:cytarabine | n2=en:nilandron | rel=r_associated | relid=0 | w=20
  2241. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nilotinib
    n1=en:cytarabine | n2=en:nilotinib | rel=r_associated | relid=0 | w=20
  2242. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nimotuzumab
    n1=en:cytarabine | n2=en:nimotuzumab | rel=r_associated | relid=0 | w=20
  2243. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nintedanib
    n1=en:cytarabine | n2=en:nintedanib | rel=r_associated | relid=0 | w=20
  2244. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nitric oxide-releasing acetylsalicylic acid derivative
    n1=en:cytarabine | n2=en:nitric oxide-releasing acetylsalicylic acid derivative | rel=r_associated | relid=0 | w=20
  2245. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nitroglycerin transdermal patch
    n1=en:cytarabine | n2=en:nitroglycerin transdermal patch | rel=r_associated | relid=0 | w=20
  2246. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nitroglycerin/sodium citrate/ethanol solution
    n1=en:cytarabine | n2=en:nitroglycerin/sodium citrate/ethanol solution | rel=r_associated | relid=0 | w=20
  2247. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nolatrexed dihydrochloride
    n1=en:cytarabine | n2=en:nolatrexed dihydrochloride | rel=r_associated | relid=0 | w=20
  2248. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:norepinephrine, dl-
    n1=en:cytarabine | n2=en:norepinephrine, dl- | rel=r_associated | relid=0 | w=20
  2249. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:notch signaling inhibitor pf-06650808
    n1=en:cytarabine | n2=en:notch signaling inhibitor pf-06650808 | rel=r_associated | relid=0 | w=20
  2250. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:novia protocol
    n1=en:cytarabine | n2=en:novia protocol | rel=r_associated | relid=0 | w=20
  2251. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:novobiocin
    n1=en:cytarabine | n2=en:novobiocin | rel=r_associated | relid=0 | w=20
  2252. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ns-9
    n1=en:cytarabine | n2=en:ns-9 | rel=r_associated | relid=0 | w=20
  2253. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nsc-239336
    n1=en:cytarabine | n2=en:nsc-239336 | rel=r_associated | relid=0 | w=20
  2254. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes
    n1=en:cytarabine | n2=en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes | rel=r_associated | relid=0 | w=20
  2255. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nucleic acid synthesis inhibitors [moa]
    n1=en:cytarabine | n2=en:nucleic acid synthesis inhibitors [moa] | rel=r_associated | relid=0 | w=20
  2256. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nucleoside analog dfp-10917
    n1=en:cytarabine | n2=en:nucleoside analog dfp-10917 | rel=r_associated | relid=0 | w=20
  2257. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nutraceutical tbl-12
    n1=en:cytarabine | n2=en:nutraceutical tbl-12 | rel=r_associated | relid=0 | w=20
  2258. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nutritional supplement drink
    n1=en:cytarabine | n2=en:nutritional supplement drink | rel=r_associated | relid=0 | w=20
  2259. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:nx-1207
    n1=en:cytarabine | n2=en:nx-1207 | rel=r_associated | relid=0 | w=20
  2260. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ny-eso-1 protein vaccine plus montanide isa-51 vg
    n1=en:cytarabine | n2=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | rel=r_associated | relid=0 | w=20
  2261. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  2262. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ny-eso-1/lage-1 peptide vaccine
    n1=en:cytarabine | n2=en:ny-eso-1/lage-1 peptide vaccine | rel=r_associated | relid=0 | w=20
  2263. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine
    n1=en:cytarabine | n2=en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine | rel=r_associated | relid=0 | w=20
  2264. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ny-eso-1b peptide vaccine
    n1=en:cytarabine | n2=en:ny-eso-1b peptide vaccine | rel=r_associated | relid=0 | w=20
  2265. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oap-bleo protocol
    n1=en:cytarabine | n2=en:oap-bleo protocol | rel=r_associated | relid=0 | w=20
  2266. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ocaratuzumab
    n1=en:cytarabine | n2=en:ocaratuzumab | rel=r_associated | relid=0 | w=20
  2267. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ocrelizumab
    n1=en:cytarabine | n2=en:ocrelizumab | rel=r_associated | relid=0 | w=20
  2268. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:octreotide acetate
    n1=en:cytarabine | n2=en:octreotide acetate | rel=r_associated | relid=0 | w=20
  2269. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:odanacatib
    n1=en:cytarabine | n2=en:odanacatib | rel=r_associated | relid=0 | w=20
  2270. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:olanzapine
    n1=en:cytarabine | n2=en:olanzapine | rel=r_associated | relid=0 | w=20
  2271. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:olaparib
    n1=en:cytarabine | n2=en:olaparib | rel=r_associated | relid=0 | w=20
  2272. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:olive oil extract/curcumin-based capsule
    n1=en:cytarabine | n2=en:olive oil extract/curcumin-based capsule | rel=r_associated | relid=0 | w=20
  2273. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:olive oil/soya oil/egg lecithin-based emulsion
    n1=en:cytarabine | n2=en:olive oil/soya oil/egg lecithin-based emulsion | rel=r_associated | relid=0 | w=20
  2274. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion
    n1=en:cytarabine | n2=en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion | rel=r_associated | relid=0 | w=20
  2275. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:olodaterol
    n1=en:cytarabine | n2=en:olodaterol | rel=r_associated | relid=0 | w=20
  2276. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:omalizumab
    n1=en:cytarabine | n2=en:omalizumab | rel=r_associated | relid=0 | w=20
  2277. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:omeprazole
    n1=en:cytarabine | n2=en:omeprazole | rel=r_associated | relid=0 | w=20
  2278. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:onartuzumab
    n1=en:cytarabine | n2=en:onartuzumab | rel=r_associated | relid=0 | w=20
  2279. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oncolytic adenovirus encoding gm-csf
    n1=en:cytarabine | n2=en:oncolytic adenovirus encoding gm-csf | rel=r_associated | relid=0 | w=20
  2280. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:onyx-015
    n1=en:cytarabine | n2=en:onyx-015 | rel=r_associated | relid=0 | w=20
  2281. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:opb-111001
    n1=en:cytarabine | n2=en:opb-111001 | rel=r_associated | relid=0 | w=20
  2282. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:open end wrench
    n1=en:cytarabine | n2=en:open end wrench | rel=r_associated | relid=0 | w=20
  2283. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:open-end wrench
    n1=en:cytarabine | n2=en:open-end wrench | rel=r_associated | relid=0 | w=20
  2284. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:open-ended spanner
    n1=en:cytarabine | n2=en:open-ended spanner | rel=r_associated | relid=0 | w=20
  2285. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:opioid agonist gic-1001
    n1=en:cytarabine | n2=en:opioid agonist gic-1001 | rel=r_associated | relid=0 | w=20
  2286. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oppa regimen
    n1=en:cytarabine | n2=en:oppa regimen | rel=r_associated | relid=0 | w=20
  2287. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oprelvekin
    n1=en:cytarabine | n2=en:oprelvekin | rel=r_associated | relid=0 | w=20
  2288. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oral dosage form product
    n1=en:cytarabine | n2=en:oral dosage form product | rel=r_associated | relid=0 | w=20
  2289. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oral sodium phenylbutyrate
    n1=en:cytarabine | n2=en:oral sodium phenylbutyrate | rel=r_associated | relid=0 | w=20
  2290. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:orantinib
    n1=en:cytarabine | n2=en:orantinib | rel=r_associated | relid=0 | w=20
  2291. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:orteronel
    n1=en:cytarabine | n2=en:orteronel | rel=r_associated | relid=0 | w=20
  2292. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oseltamivir phosphate
    n1=en:cytarabine | n2=en:oseltamivir phosphate | rel=r_associated | relid=0 | w=20
  2293. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oteracil potassium
    n1=en:cytarabine | n2=en:oteracil potassium | rel=r_associated | relid=0 | w=20
  2294. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:over the counter product
    n1=en:cytarabine | n2=en:over the counter product | rel=r_associated | relid=0 | w=20
  2295. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oxitriptan
    n1=en:cytarabine | n2=en:oxitriptan | rel=r_associated | relid=0 | w=20
  2296. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet
    n1=en:cytarabine | n2=en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet | rel=r_associated | relid=0 | w=20
  2297. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oxygen and carbon dioxide mixture
    n1=en:cytarabine | n2=en:oxygen and carbon dioxide mixture | rel=r_associated | relid=0 | w=20
  2298. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:oxymetholone
    n1=en:cytarabine | n2=en:oxymetholone | rel=r_associated | relid=0 | w=20
  2299. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:p-tefb inhibitor bay1143572
    n1=en:cytarabine | n2=en:p-tefb inhibitor bay1143572 | rel=r_associated | relid=0 | w=20
  2300. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:p1-(cortisol-21-yl)-p2-(1-beta-d-arabinofuranosylcytosine-5'-yl)pyrophosphate
    n1=en:cytarabine | n2=en:p1-(cortisol-21-yl)-p2-(1-beta-d-arabinofuranosylcytosine-5'-yl)pyrophosphate | rel=r_associated | relid=0 | w=20
  2301. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:p16_37-63 peptide vaccine
    n1=en:cytarabine | n2=en:p16_37-63 peptide vaccine | rel=r_associated | relid=0 | w=20
  2302. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:p53 peptide vaccine
    n1=en:cytarabine | n2=en:p53 peptide vaccine | rel=r_associated | relid=0 | w=20
  2303. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:p53-synthetic long peptides vaccine
    n1=en:cytarabine | n2=en:p53-synthetic long peptides vaccine | rel=r_associated | relid=0 | w=20
  2304. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pacet protocol
    n1=en:cytarabine | n2=en:pacet protocol | rel=r_associated | relid=0 | w=20
  2305. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:paclitaxel trevatide
    n1=en:cytarabine | n2=en:paclitaxel trevatide | rel=r_associated | relid=0 | w=20
  2306. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pad regimen
    n1=en:cytarabine | n2=en:pad regimen | rel=r_associated | relid=0 | w=20
  2307. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:padre-cmv fusion peptide vaccine
    n1=en:cytarabine | n2=en:padre-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=20
  2308. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pae protocol
    n1=en:cytarabine | n2=en:pae protocol | rel=r_associated | relid=0 | w=20
  2309. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pak4 inhibitor pf-03758309
    n1=en:cytarabine | n2=en:pak4 inhibitor pf-03758309 | rel=r_associated | relid=0 | w=20
  2310. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:palbociclib
    n1=en:cytarabine | n2=en:palbociclib | rel=r_associated | relid=0 | w=20
  2311. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:palivizumab
    n1=en:cytarabine | n2=en:palivizumab | rel=r_associated | relid=0 | w=20
  2312. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:palladium-bacteriopheophorbide
    n1=en:cytarabine | n2=en:palladium-bacteriopheophorbide | rel=r_associated | relid=0 | w=20
  2313. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:palm extract phytonutrient supplement
    n1=en:cytarabine | n2=en:palm extract phytonutrient supplement | rel=r_associated | relid=0 | w=20
  2314. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:palonosetron hydrochloride
    n1=en:cytarabine | n2=en:palonosetron hydrochloride | rel=r_associated | relid=0 | w=20
  2315. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pame protocol
    n1=en:cytarabine | n2=en:pame protocol | rel=r_associated | relid=0 | w=20
  2316. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pamidronate disodium
    n1=en:cytarabine | n2=en:pamidronate disodium | rel=r_associated | relid=0 | w=20
  2317. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pan-her kinase inhibitor ac480
    n1=en:cytarabine | n2=en:pan-her kinase inhibitor ac480 | rel=r_associated | relid=0 | w=20
  2318. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pan-pi3k/mtor inhibitor sf1126
    n1=en:cytarabine | n2=en:pan-pi3k/mtor inhibitor sf1126 | rel=r_associated | relid=0 | w=20
  2319. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pan-selectin antagonist gmi-1070
    n1=en:cytarabine | n2=en:pan-selectin antagonist gmi-1070 | rel=r_associated | relid=0 | w=20
  2320. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:panitumumab
    n1=en:cytarabine | n2=en:panitumumab | rel=r_associated | relid=0 | w=20
  2321. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:panitumumab-irdye800
    n1=en:cytarabine | n2=en:panitumumab-irdye800 | rel=r_associated | relid=0 | w=20
  2322. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pantoprazole sodium
    n1=en:cytarabine | n2=en:pantoprazole sodium | rel=r_associated | relid=0 | w=20
  2323. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:paracetamol
    n1=en:cytarabine | n2=en:paracetamol | rel=r_associated | relid=0 | w=20
  2324. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parathyroid hormone-related protein (1-36)
    n1=en:cytarabine | n2=en:parathyroid hormone-related protein (1-36) | rel=r_associated | relid=0 | w=20
  2325. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parenteral dosage form product
    n1=en:cytarabine | n2=en:parenteral dosage form product | rel=r_associated | relid=0 | w=20
  2326. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parenteral form cytarabine
    n1=en:cytarabine | n2=en:parenteral form cytarabine | rel=r_associated | relid=0 | w=20
  2327. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:paricalcitol
    n1=en:cytarabine | n2=en:paricalcitol | rel=r_associated | relid=0 | w=20
  2328. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:paroxetine hydrochloride
    n1=en:cytarabine | n2=en:paroxetine hydrochloride | rel=r_associated | relid=0 | w=20
  2329. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parp inhibitor azd2461
    n1=en:cytarabine | n2=en:parp inhibitor azd2461 | rel=r_associated | relid=0 | w=20
  2330. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parp inhibitor cep-9722
    n1=en:cytarabine | n2=en:parp inhibitor cep-9722 | rel=r_associated | relid=0 | w=20
  2331. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parp-1/2 inhibitor abt-767
    n1=en:cytarabine | n2=en:parp-1/2 inhibitor abt-767 | rel=r_associated | relid=0 | w=20
  2332. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:parvovirus h-1
    n1=en:cytarabine | n2=en:parvovirus h-1 | rel=r_associated | relid=0 | w=20
  2333. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:patco protocol
    n1=en:cytarabine | n2=en:patco protocol | rel=r_associated | relid=0 | w=20
  2334. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:patritumab
    n1=en:cytarabine | n2=en:patritumab | rel=r_associated | relid=0 | w=20
  2335. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:patupilone
    n1=en:cytarabine | n2=en:patupilone | rel=r_associated | relid=0 | w=20
  2336. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pazopanib hydrochloride
    n1=en:cytarabine | n2=en:pazopanib hydrochloride | rel=r_associated | relid=0 | w=20
  2337. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pbcar3 phosphopeptide-tetanus peptide vaccine
    n1=en:cytarabine | n2=en:pbcar3 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=20
  2338. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pd0325901
    n1=en:cytarabine | n2=en:pd0325901 | rel=r_associated | relid=0 | w=20
  2339. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pdcd-1 knockout autologous t-lymphocytes
    n1=en:cytarabine | n2=en:pdcd-1 knockout autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  2340. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pdgfr alpha/kit mutant-specific inhibitor blu-285
    n1=en:cytarabine | n2=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | rel=r_associated | relid=0 | w=20
  2341. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pdm08
    n1=en:cytarabine | n2=en:pdm08 | rel=r_associated | relid=0 | w=20
  2342. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pediatric nutritional supplement drink
    n1=en:cytarabine | n2=en:pediatric nutritional supplement drink | rel=r_associated | relid=0 | w=20
  2343. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:peg recombinant human megakaryocyte growth and development factor
    n1=en:cytarabine | n2=en:peg recombinant human megakaryocyte growth and development factor | rel=r_associated | relid=0 | w=20
  2344. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative
    n1=en:cytarabine | n2=en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative | rel=r_associated | relid=0 | w=20
  2345. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pegamotecan
    n1=en:cytarabine | n2=en:pegamotecan | rel=r_associated | relid=0 | w=20
  2346. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pegylated anti-gfr antibody fragment
    n1=en:cytarabine | n2=en:pegylated anti-gfr antibody fragment | rel=r_associated | relid=0 | w=20
  2347. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pegylated arginine deiminase
    n1=en:cytarabine | n2=en:pegylated arginine deiminase | rel=r_associated | relid=0 | w=20
  2348. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pegylated granulocyte colony stimulating factor maxy-g34
    n1=en:cytarabine | n2=en:pegylated granulocyte colony stimulating factor maxy-g34 | rel=r_associated | relid=0 | w=20
  2349. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pegylated human recombinant arginase 1 aeb1102
    n1=en:cytarabine | n2=en:pegylated human recombinant arginase 1 aeb1102 | rel=r_associated | relid=0 | w=20
  2350. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pegylated recombinant l-asparaginase erwinia chrysanthemi
    n1=en:cytarabine | n2=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=20
  2351. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:penicillamine
    n1=en:cytarabine | n2=en:penicillamine | rel=r_associated | relid=0 | w=20
  2352. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:penicillin v potassium
    n1=en:cytarabine | n2=en:penicillin v potassium | rel=r_associated | relid=0 | w=20
  2353. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pentamidine
    n1=en:cytarabine | n2=en:pentamidine | rel=r_associated | relid=0 | w=20
  2354. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pentavalent klh conjugate vaccine
    n1=en:cytarabine | n2=en:pentavalent klh conjugate vaccine | rel=r_associated | relid=0 | w=20
  2355. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pentetic acid
    n1=en:cytarabine | n2=en:pentetic acid | rel=r_associated | relid=0 | w=20
  2356. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pentetic acid calcium
    n1=en:cytarabine | n2=en:pentetic acid calcium | rel=r_associated | relid=0 | w=20
  2357. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pentoxifylline
    n1=en:cytarabine | n2=en:pentoxifylline | rel=r_associated | relid=0 | w=20
  2358. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pep-cmv vaccine
    n1=en:cytarabine | n2=en:pep-cmv vaccine | rel=r_associated | relid=0 | w=20
  2359. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:peptide hydrolases
    n1=en:cytarabine | n2=en:peptide hydrolases | rel=r_associated | relid=0 | w=20
  2360. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:peptides hydrolases
    n1=en:cytarabine | n2=en:peptides hydrolases | rel=r_associated | relid=0 | w=20
  2361. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:perflubron
    n1=en:cytarabine | n2=en:perflubron | rel=r_associated | relid=0 | w=20
  2362. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:perflutren
    n1=en:cytarabine | n2=en:perflutren | rel=r_associated | relid=0 | w=20
  2363. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:perflutren protein-a microsphere
    n1=en:cytarabine | n2=en:perflutren protein-a microsphere | rel=r_associated | relid=0 | w=20
  2364. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:perindopril erbumine
    n1=en:cytarabine | n2=en:perindopril erbumine | rel=r_associated | relid=0 | w=20
  2365. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pesticide
    n1=en:cytarabine | n2=en:pesticide | rel=r_associated | relid=0 | w=20
  2366. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pethema all-3-97 protocol
    n1=en:cytarabine | n2=en:pethema all-3-97 protocol | rel=r_associated | relid=0 | w=20
  2367. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:petrolatum-mineral oil-lanolin-ceresin ointment
    n1=en:cytarabine | n2=en:petrolatum-mineral oil-lanolin-ceresin ointment | rel=r_associated | relid=0 | w=20
  2368. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pexidartinib
    n1=en:cytarabine | n2=en:pexidartinib | rel=r_associated | relid=0 | w=20
  2369. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes
    n1=en:cytarabine | n2=en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=20
  2370. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pharmaceutic aids
    n1=en:cytarabine | n2=en:pharmaceutic aids | rel=r_associated | relid=0 | w=20
  2371. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pharmaceutical dosage form
    n1=en:cytarabine | n2=en:pharmaceutical dosage form | rel=r_associated | relid=0 | w=20
  2372. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenethyl isothiocyanate
    n1=en:cytarabine | n2=en:phenethyl isothiocyanate | rel=r_associated | relid=0 | w=20
  2373. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenethyl isothiocyanate-containing watercress juice
    n1=en:cytarabine | n2=en:phenethyl isothiocyanate-containing watercress juice | rel=r_associated | relid=0 | w=20
  2374. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenformin hydrochloride
    n1=en:cytarabine | n2=en:phenformin hydrochloride | rel=r_associated | relid=0 | w=20
  2375. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenobarbital
    n1=en:cytarabine | n2=en:phenobarbital | rel=r_associated | relid=0 | w=20
  2376. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phentolamine mesylate
    n1=en:cytarabine | n2=en:phentolamine mesylate | rel=r_associated | relid=0 | w=20
  2377. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenylephrine + chlorpheniramine + codeine + potassium iodide
    n1=en:cytarabine | n2=en:phenylephrine + chlorpheniramine + codeine + potassium iodide | rel=r_associated | relid=0 | w=20
  2378. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenylephrine + chlorpheniramine + ephedrine + carbetapentane
    n1=en:cytarabine | n2=en:phenylephrine + chlorpheniramine + ephedrine + carbetapentane | rel=r_associated | relid=0 | w=20
  2379. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phenylephrine + promethazine + codeine
    n1=en:cytarabine | n2=en:phenylephrine + promethazine + codeine | rel=r_associated | relid=0 | w=20
  2380. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phosphaplatin pt-112
    n1=en:cytarabine | n2=en:phosphaplatin pt-112 | rel=r_associated | relid=0 | w=20
  2381. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phosphomannopentaose sulfate
    n1=en:cytarabine | n2=en:phosphomannopentaose sulfate | rel=r_associated | relid=0 | w=20
  2382. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phytomenadione
    n1=en:cytarabine | n2=en:phytomenadione | rel=r_associated | relid=0 | w=20
  2383. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:phytonadione
    n1=en:cytarabine | n2=en:phytonadione | rel=r_associated | relid=0 | w=20
  2384. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k alpha inhibitor mln1117
    n1=en:cytarabine | n2=en:pi3k alpha inhibitor mln1117 | rel=r_associated | relid=0 | w=20
  2385. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k delta/gamma inhibitor ipi-145
    n1=en:cytarabine | n2=en:pi3k delta/gamma inhibitor ipi-145 | rel=r_associated | relid=0 | w=20
  2386. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k delta/gamma inhibitor rp6530
    n1=en:cytarabine | n2=en:pi3k delta/gamma inhibitor rp6530 | rel=r_associated | relid=0 | w=20
  2387. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k family kinase inhibitor xl147
    n1=en:cytarabine | n2=en:pi3k family kinase inhibitor xl147 | rel=r_associated | relid=0 | w=20
  2388. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor acp-319
    n1=en:cytarabine | n2=en:pi3k inhibitor acp-319 | rel=r_associated | relid=0 | w=20
  2389. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor ch5132799
    n1=en:cytarabine | n2=en:pi3k inhibitor ch5132799 | rel=r_associated | relid=0 | w=20
  2390. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor gdc-0084
    n1=en:cytarabine | n2=en:pi3k inhibitor gdc-0084 | rel=r_associated | relid=0 | w=20
  2391. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor gdc-0941 bismesylate
    n1=en:cytarabine | n2=en:pi3k inhibitor gdc-0941 bismesylate | rel=r_associated | relid=0 | w=20
  2392. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor gsk1059615
    n1=en:cytarabine | n2=en:pi3k inhibitor gsk1059615 | rel=r_associated | relid=0 | w=20
  2393. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor gsk2126458
    n1=en:cytarabine | n2=en:pi3k inhibitor gsk2126458 | rel=r_associated | relid=0 | w=20
  2394. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor px-866
    n1=en:cytarabine | n2=en:pi3k inhibitor px-866 | rel=r_associated | relid=0 | w=20
  2395. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor wx-037
    n1=en:cytarabine | n2=en:pi3k inhibitor wx-037 | rel=r_associated | relid=0 | w=20
  2396. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k inhibitor zstk474
    n1=en:cytarabine | n2=en:pi3k inhibitor zstk474 | rel=r_associated | relid=0 | w=20
  2397. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k p110beta/delta inhibitor ka2237
    n1=en:cytarabine | n2=en:pi3k p110beta/delta inhibitor ka2237 | rel=r_associated | relid=0 | w=20
  2398. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k-beta inhibitor gsk2636771
    n1=en:cytarabine | n2=en:pi3k-beta inhibitor gsk2636771 | rel=r_associated | relid=0 | w=20
  2399. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k-delta inhibitor incb050465
    n1=en:cytarabine | n2=en:pi3k-delta inhibitor incb050465 | rel=r_associated | relid=0 | w=20
  2400. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k-delta inhibitor tgr-1202
    n1=en:cytarabine | n2=en:pi3k-delta inhibitor tgr-1202 | rel=r_associated | relid=0 | w=20
  2401. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k/mtor inhibitor bez235
    n1=en:cytarabine | n2=en:pi3k/mtor inhibitor bez235 | rel=r_associated | relid=0 | w=20
  2402. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k/mtor kinase inhibitor ds-7423
    n1=en:cytarabine | n2=en:pi3k/mtor kinase inhibitor ds-7423 | rel=r_associated | relid=0 | w=20
  2403. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k/mtor kinase inhibitor pf-04691502
    n1=en:cytarabine | n2=en:pi3k/mtor kinase inhibitor pf-04691502 | rel=r_associated | relid=0 | w=20
  2404. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k/mtor/alk-1/dna-pk inhibitor p7170
    n1=en:cytarabine | n2=en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 | rel=r_associated | relid=0 | w=20
  2405. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901
    n1=en:cytarabine | n2=en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 | rel=r_associated | relid=0 | w=20
  2406. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3kbeta inhibitor azd8186
    n1=en:cytarabine | n2=en:pi3kbeta inhibitor azd8186 | rel=r_associated | relid=0 | w=20
  2407. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pi3kdelta inhibitor incb040093
    n1=en:cytarabine | n2=en:pi3kdelta inhibitor incb040093 | rel=r_associated | relid=0 | w=20
  2408. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:picropodophyllin
    n1=en:cytarabine | n2=en:picropodophyllin | rel=r_associated | relid=0 | w=20
  2409. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pidilizumab
    n1=en:cytarabine | n2=en:pidilizumab | rel=r_associated | relid=0 | w=20
  2410. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pim kinase inhibitor sgi-1776
    n1=en:cytarabine | n2=en:pim kinase inhibitor sgi-1776 | rel=r_associated | relid=0 | w=20
  2411. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pimasertib
    n1=en:cytarabine | n2=en:pimasertib | rel=r_associated | relid=0 | w=20
  2412. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pimecrolimus
    n1=en:cytarabine | n2=en:pimecrolimus | rel=r_associated | relid=0 | w=20
  2413. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pimonidazole
    n1=en:cytarabine | n2=en:pimonidazole | rel=r_associated | relid=0 | w=20
  2414. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pinaverium bromide
    n1=en:cytarabine | n2=en:pinaverium bromide | rel=r_associated | relid=0 | w=20
  2415. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:piperacillin sodium
    n1=en:cytarabine | n2=en:piperacillin sodium | rel=r_associated | relid=0 | w=20
  2416. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:piperazinedione
    n1=en:cytarabine | n2=en:piperazinedione | rel=r_associated | relid=0 | w=20
  2417. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:piritrexim
    n1=en:cytarabine | n2=en:piritrexim | rel=r_associated | relid=0 | w=20
  2418. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pirotinib
    n1=en:cytarabine | n2=en:pirotinib | rel=r_associated | relid=0 | w=20
  2419. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:piroxicam
    n1=en:cytarabine | n2=en:piroxicam | rel=r_associated | relid=0 | w=20
  2420. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pirs2 phosphopeptide-tetanus peptide vaccine
    n1=en:cytarabine | n2=en:pirs2 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=20
  2421. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pivotal moment
    n1=en:cytarabine | n2=en:pivotal moment | rel=r_associated | relid=0 | w=20
  2422. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:plectin-1 targeting agent ptp-01
    n1=en:cytarabine | n2=en:plectin-1 targeting agent ptp-01 | rel=r_associated | relid=0 | w=20
  2423. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pled-based mnsod mimetic
    n1=en:cytarabine | n2=en:pled-based mnsod mimetic | rel=r_associated | relid=0 | w=20
  2424. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pleiotropic pathway modifier cc-122 hydrochloride
    n1=en:cytarabine | n2=en:pleiotropic pathway modifier cc-122 hydrochloride | rel=r_associated | relid=0 | w=20
  2425. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:plevitrexed
    n1=en:cytarabine | n2=en:plevitrexed | rel=r_associated | relid=0 | w=20
  2426. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:plozalizumab
    n1=en:cytarabine | n2=en:plozalizumab | rel=r_associated | relid=0 | w=20
  2427. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:plx73086
    n1=en:cytarabine | n2=en:plx73086 | rel=r_associated | relid=0 | w=20
  2428. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pneumococcal 13-valent conjugate vaccine
    n1=en:cytarabine | n2=en:pneumococcal 13-valent conjugate vaccine | rel=r_associated | relid=0 | w=20
  2429. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pneumococcal polyvalent vaccine
    n1=en:cytarabine | n2=en:pneumococcal polyvalent vaccine | rel=r_associated | relid=0 | w=20
  2430. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pnp-expressing ovine atadenovirus fp253
    n1=en:cytarabine | n2=en:pnp-expressing ovine atadenovirus fp253 | rel=r_associated | relid=0 | w=20
  2431. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pocal protocol
    n1=en:cytarabine | n2=en:pocal protocol | rel=r_associated | relid=0 | w=20
  2432. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pog 8493 protocol
    n1=en:cytarabine | n2=en:pog 8493 protocol | rel=r_associated | relid=0 | w=20
  2433. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pog 8602 protocol
    n1=en:cytarabine | n2=en:pog 8602 protocol | rel=r_associated | relid=0 | w=20
  2434. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pog-8498 protocol
    n1=en:cytarabine | n2=en:pog-8498 protocol | rel=r_associated | relid=0 | w=20
  2435. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pol i inhibitor cx5461
    n1=en:cytarabine | n2=en:pol i inhibitor cx5461 | rel=r_associated | relid=0 | w=20
  2436. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polaprezinc
    n1=en:cytarabine | n2=en:polaprezinc | rel=r_associated | relid=0 | w=20
  2437. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polihexanide solution
    n1=en:cytarabine | n2=en:polihexanide solution | rel=r_associated | relid=0 | w=20
  2438. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polo-like kinase 1 inhibitor nms-1286937
    n1=en:cytarabine | n2=en:polo-like kinase 1 inhibitor nms-1286937 | rel=r_associated | relid=0 | w=20
  2439. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:poly iclc
    n1=en:cytarabine | n2=en:poly iclc | rel=r_associated | relid=0 | w=20
  2440. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:poly-alendronate dextran-guanidine conjugate
    n1=en:cytarabine | n2=en:poly-alendronate dextran-guanidine conjugate | rel=r_associated | relid=0 | w=20
  2441. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:poly-gamma glutamic acid
    n1=en:cytarabine | n2=en:poly-gamma glutamic acid | rel=r_associated | relid=0 | w=20
  2442. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer
    n1=en:cytarabine | n2=en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer | rel=r_associated | relid=0 | w=20
  2443. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polydextrose
    n1=en:cytarabine | n2=en:polydextrose | rel=r_associated | relid=0 | w=20
  2444. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polyethylene glycol
    n1=en:cytarabine | n2=en:polyethylene glycol | rel=r_associated | relid=0 | w=20
  2445. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polyéthylène glycol
    n1=en:cytarabine | n2=en:polyéthylène glycol | rel=r_associated | relid=0 | w=20
  2446. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polyethylene glycol polymer surgical sealant
    n1=en:cytarabine | n2=en:polyethylene glycol polymer surgical sealant | rel=r_associated | relid=0 | w=20
  2447. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polygalacturonic acid-cytarabine
    n1=en:cytarabine | n2=en:polygalacturonic acid-cytarabine | rel=r_associated | relid=0 | w=20
  2448. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polyglutamate camptothecin
    n1=en:cytarabine | n2=en:polyglutamate camptothecin | rel=r_associated | relid=0 | w=20
  2449. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polysaccharide-k
    n1=en:cytarabine | n2=en:polysaccharide-k | rel=r_associated | relid=0 | w=20
  2450. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:polyvinylpyrrolidone-sodium hyaluronate gel
    n1=en:cytarabine | n2=en:polyvinylpyrrolidone-sodium hyaluronate gel | rel=r_associated | relid=0 | w=20
  2451. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pomb-ace protocol
    n1=en:cytarabine | n2=en:pomb-ace protocol | rel=r_associated | relid=0 | w=20
  2452. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pomegranate-extract pill
    n1=en:cytarabine | n2=en:pomegranate-extract pill | rel=r_associated | relid=0 | w=20
  2453. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ponatinib hydrochloride
    n1=en:cytarabine | n2=en:ponatinib hydrochloride | rel=r_associated | relid=0 | w=20
  2454. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ponesimod
    n1=en:cytarabine | n2=en:ponesimod | rel=r_associated | relid=0 | w=20
  2455. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:porcupine inhibitor wnt974
    n1=en:cytarabine | n2=en:porcupine inhibitor wnt974 | rel=r_associated | relid=0 | w=20
  2456. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:posaconazole
    n1=en:cytarabine | n2=en:posaconazole | rel=r_associated | relid=0 | w=20
  2457. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:potassium citrate + citric acid
    n1=en:cytarabine | n2=en:potassium citrate + citric acid | rel=r_associated | relid=0 | w=20
  2458. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:poziotinib
    n1=en:cytarabine | n2=en:poziotinib | rel=r_associated | relid=0 | w=20
  2459. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701
    n1=en:cytarabine | n2=en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 | rel=r_associated | relid=0 | w=20
  2460. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pramipexole dihydrochloride
    n1=en:cytarabine | n2=en:pramipexole dihydrochloride | rel=r_associated | relid=0 | w=20
  2461. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prasterone
    n1=en:cytarabine | n2=en:prasterone | rel=r_associated | relid=0 | w=20
  2462. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pregabalin
    n1=en:cytarabine | n2=en:pregabalin | rel=r_associated | relid=0 | w=20
  2463. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:preimplantation factor pif-1
    n1=en:cytarabine | n2=en:preimplantation factor pif-1 | rel=r_associated | relid=0 | w=20
  2464. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prescription drugs
    n1=en:cytarabine | n2=en:prescription drugs | rel=r_associated | relid=0 | w=20
  2465. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prima-1 analog apr-246
    n1=en:cytarabine | n2=en:prima-1 analog apr-246 | rel=r_associated | relid=0 | w=20
  2466. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prochlorperazine
    n1=en:cytarabine | n2=en:prochlorperazine | rel=r_associated | relid=0 | w=20
  2467. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:proflavine
    n1=en:cytarabine | n2=en:proflavine | rel=r_associated | relid=0 | w=20
  2468. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:proflavine hemisulfate
    n1=en:cytarabine | n2=en:proflavine hemisulfate | rel=r_associated | relid=0 | w=20
  2469. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:progestin
    n1=en:cytarabine | n2=en:progestin | rel=r_associated | relid=0 | w=20
  2470. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prohibitin-targeting peptide 1
    n1=en:cytarabine | n2=en:prohibitin-targeting peptide 1 | rel=r_associated | relid=0 | w=20
  2471. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:promace-cytabom regimen
    n1=en:cytarabine | n2=en:promace-cytabom regimen | rel=r_associated | relid=0 | w=20
  2472. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:promece-cytabom protocol
    n1=en:cytarabine | n2=en:promece-cytabom protocol | rel=r_associated | relid=0 | w=20
  2473. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:prostate health cocktail dietary supplement
    n1=en:cytarabine | n2=en:prostate health cocktail dietary supplement | rel=r_associated | relid=0 | w=20
  2474. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:protein phosphatase 2a inhibitor lb-100
    n1=en:cytarabine | n2=en:protein phosphatase 2a inhibitor lb-100 | rel=r_associated | relid=0 | w=20
  2475. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:protocol 8001
    n1=en:cytarabine | n2=en:protocol 8001 | rel=r_associated | relid=0 | w=20
  2476. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pseudoephedrine + codeine + guaifenesin
    n1=en:cytarabine | n2=en:pseudoephedrine + codeine + guaifenesin | rel=r_associated | relid=0 | w=20
  2477. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pseudomonas aeruginosa preparation
    n1=en:cytarabine | n2=en:pseudomonas aeruginosa preparation | rel=r_associated | relid=0 | w=20
  2478. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:psychopharmacologic agent
    n1=en:cytarabine | n2=en:psychopharmacologic agent | rel=r_associated | relid=0 | w=20
  2479. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:put powder on something
    n1=en:cytarabine | n2=en:put powder on something | rel=r_associated | relid=0 | w=20
  2480. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:put talc on something
    n1=en:cytarabine | n2=en:put talc on something | rel=r_associated | relid=0 | w=20
  2481. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pva microporous hydrospheres/doxorubicin hydrochloride
    n1=en:cytarabine | n2=en:pva microporous hydrospheres/doxorubicin hydrochloride | rel=r_associated | relid=0 | w=20
  2482. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:pyroxamide
    n1=en:cytarabine | n2=en:pyroxamide | rel=r_associated | relid=0 | w=20
  2483. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:quizartinib
    n1=en:cytarabine | n2=en:quizartinib | rel=r_associated | relid=0 | w=20
  2484. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rabusertib
    n1=en:cytarabine | n2=en:rabusertib | rel=r_associated | relid=0 | w=20
  2485. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:racop protocol
    n1=en:cytarabine | n2=en:racop protocol | rel=r_associated | relid=0 | w=20
  2486. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:radioprotective agent
    n1=en:cytarabine | n2=en:radioprotective agent | rel=r_associated | relid=0 | w=20
  2487. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:radiosensitizing agent
    n1=en:cytarabine | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=20
  2488. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:raf kinase inhibitor lgx818
    n1=en:cytarabine | n2=en:raf kinase inhibitor lgx818 | rel=r_associated | relid=0 | w=20
  2489. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:raltitrexed
    n1=en:cytarabine | n2=en:raltitrexed | rel=r_associated | relid=0 | w=20
  2490. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ramipril
    n1=en:cytarabine | n2=en:ramipril | rel=r_associated | relid=0 | w=20
  2491. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ramucirumab
    n1=en:cytarabine | n2=en:ramucirumab | rel=r_associated | relid=0 | w=20
  2492. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rap protocol
    n1=en:cytarabine | n2=en:rap protocol | rel=r_associated | relid=0 | w=20
  2493. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:raralpha agonist irx5183
    n1=en:cytarabine | n2=en:raralpha agonist irx5183 | rel=r_associated | relid=0 | w=20
  2494. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ras peptide cancer vaccine
    n1=en:cytarabine | n2=en:ras peptide cancer vaccine | rel=r_associated | relid=0 | w=20
  2495. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rate protocol
    n1=en:cytarabine | n2=en:rate protocol | rel=r_associated | relid=0 | w=20
  2496. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rebastinib tosylate
    n1=en:cytarabine | n2=en:rebastinib tosylate | rel=r_associated | relid=0 | w=20
  2497. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:receptor tyrosine kinase inhibitor r1530
    n1=en:cytarabine | n2=en:receptor tyrosine kinase inhibitor r1530 | rel=r_associated | relid=0 | w=20
  2498. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand
    n1=en:cytarabine | n2=en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand | rel=r_associated | relid=0 | w=20
  2499. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant adenovirus-hifn-beta
    n1=en:cytarabine | n2=en:recombinant adenovirus-hifn-beta | rel=r_associated | relid=0 | w=20
  2500. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant adenovirus-interferon/syn3
    n1=en:cytarabine | n2=en:recombinant adenovirus-interferon/syn3 | rel=r_associated | relid=0 | w=20
  2501. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant adenovirus-l523s vaccine
    n1=en:cytarabine | n2=en:recombinant adenovirus-l523s vaccine | rel=r_associated | relid=0 | w=20
  2502. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant adenovirus-p53 sch-58500
    n1=en:cytarabine | n2=en:recombinant adenovirus-p53 sch-58500 | rel=r_associated | relid=0 | w=20
  2503. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant bispecific single-chain antibody rm28
    n1=en:cytarabine | n2=en:recombinant bispecific single-chain antibody rm28 | rel=r_associated | relid=0 | w=20
  2504. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant dher2 vaccine
    n1=en:cytarabine | n2=en:recombinant dher2 vaccine | rel=r_associated | relid=0 | w=20
  2505. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant human chorionic gonadotropin
    n1=en:cytarabine | n2=en:recombinant human chorionic gonadotropin | rel=r_associated | relid=0 | w=20
  2506. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant human serum amyloid p/pentraxin 2
    n1=en:cytarabine | n2=en:recombinant human serum amyloid p/pentraxin 2 | rel=r_associated | relid=0 | w=20
  2507. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant interleukin-6
    n1=en:cytarabine | n2=en:recombinant interleukin-6 | rel=r_associated | relid=0 | w=20
  2508. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant mip1-alpha variant eci301
    n1=en:cytarabine | n2=en:recombinant mip1-alpha variant eci301 | rel=r_associated | relid=0 | w=20
  2509. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant oxytocin
    n1=en:cytarabine | n2=en:recombinant oxytocin | rel=r_associated | relid=0 | w=20
  2510. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant thymosin
    n1=en:cytarabine | n2=en:recombinant thymosin | rel=r_associated | relid=0 | w=20
  2511. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:recombinant transforming growth factor-beta 2
    n1=en:cytarabine | n2=en:recombinant transforming growth factor-beta 2 | rel=r_associated | relid=0 | w=20
  2512. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:refametinib
    n1=en:cytarabine | n2=en:refametinib | rel=r_associated | relid=0 | w=20
  2513. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:refills prescribed:num:pt:medication:qn
    n1=en:cytarabine | n2=en:refills prescribed:num:pt:medication:qn | rel=r_associated | relid=0 | w=20
  2514. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:regular insulin
    n1=en:cytarabine | n2=en:regular insulin | rel=r_associated | relid=0 | w=20
  2515. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:remestemcel-l
    n1=en:cytarabine | n2=en:remestemcel-l | rel=r_associated | relid=0 | w=20
  2516. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:reply to
    n1=en:cytarabine | n2=en:reply to | rel=r_associated | relid=0 | w=20
  2517. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:reply to somebody
    n1=en:cytarabine | n2=en:reply to somebody | rel=r_associated | relid=0 | w=20
  2518. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:resistant starch
    n1=en:cytarabine | n2=en:resistant starch | rel=r_associated | relid=0 | w=20
  2519. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:resminostat
    n1=en:cytarabine | n2=en:resminostat | rel=r_associated | relid=0 | w=20
  2520. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:respiratory form tiotropium
    n1=en:cytarabine | n2=en:respiratory form tiotropium | rel=r_associated | relid=0 | w=20
  2521. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:respond
    n1=en:cytarabine | n2=en:respond | rel=r_associated | relid=0 | w=20
  2522. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:respond to
    n1=en:cytarabine | n2=en:respond to | rel=r_associated | relid=0 | w=20
  2523. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:respond to somebody
    n1=en:cytarabine | n2=en:respond to somebody | rel=r_associated | relid=0 | w=20
  2524. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:retinoic acid agent
    n1=en:cytarabine | n2=en:retinoic acid agent | rel=r_associated | relid=0 | w=20
  2525. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rhenium re-186 hydroxyethylidene diphosphonate
    n1=en:cytarabine | n2=en:rhenium re-186 hydroxyethylidene diphosphonate | rel=r_associated | relid=0 | w=20
  2526. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rhenium re-188 ethiodized oil
    n1=en:cytarabine | n2=en:rhenium re-188 ethiodized oil | rel=r_associated | relid=0 | w=20
  2527. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rhubarb/licorice herbal supplement
    n1=en:cytarabine | n2=en:rhubarb/licorice herbal supplement | rel=r_associated | relid=0 | w=20
  2528. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ribociclib
    n1=en:cytarabine | n2=en:ribociclib | rel=r_associated | relid=0 | w=20
  2529. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ribozyme rpi.4610
    n1=en:cytarabine | n2=en:ribozyme rpi.4610 | rel=r_associated | relid=0 | w=20
  2530. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ricin immunoconjugate
    n1=en:cytarabine | n2=en:ricin immunoconjugate | rel=r_associated | relid=0 | w=20
  2531. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rifaximin
    n1=en:cytarabine | n2=en:rifaximin | rel=r_associated | relid=0 | w=20
  2532. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rimiducid
    n1=en:cytarabine | n2=en:rimiducid | rel=r_associated | relid=0 | w=20
  2533. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rintatolimod
    n1=en:cytarabine | n2=en:rintatolimod | rel=r_associated | relid=0 | w=20
  2534. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:risedronate + calcium
    n1=en:cytarabine | n2=en:risedronate + calcium | rel=r_associated | relid=0 | w=20
  2535. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rituximab
    n1=en:cytarabine | n2=en:rituximab | rel=r_associated | relid=0 | w=20
  2536. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rivaroxaban
    n1=en:cytarabine | n2=en:rivaroxaban | rel=r_associated | relid=0 | w=20
  2537. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rk-0202
    n1=en:cytarabine | n2=en:rk-0202 | rel=r_associated | relid=0 | w=20
  2538. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=en:cytarabine | n2=en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=20
  2539. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:romidepsin
    n1=en:cytarabine | n2=en:romidepsin | rel=r_associated | relid=0 | w=20
  2540. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rotavirus vaccine, live, oral
    n1=en:cytarabine | n2=en:rotavirus vaccine, live, oral | rel=r_associated | relid=0 | w=20
  2541. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rucaparib
    n1=en:cytarabine | n2=en:rucaparib | rel=r_associated | relid=0 | w=20
  2542. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rucaparib phosphate
    n1=en:cytarabine | n2=en:rucaparib phosphate | rel=r_associated | relid=0 | w=20
  2543. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:rutin
    n1=en:cytarabine | n2=en:rutin | rel=r_associated | relid=0 | w=20
  2544. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:s-ham protocol
    n1=en:cytarabine | n2=en:s-ham protocol | rel=r_associated | relid=0 | w=20
  2545. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:s1p receptor agonist krp203
    n1=en:cytarabine | n2=en:s1p receptor agonist krp203 | rel=r_associated | relid=0 | w=20
  2546. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sacituzumab govitecan
    n1=en:cytarabine | n2=en:sacituzumab govitecan | rel=r_associated | relid=0 | w=20
  2547. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:salicylic acid + coal tar + sulfur
    n1=en:cytarabine | n2=en:salicylic acid + coal tar + sulfur | rel=r_associated | relid=0 | w=20
  2548. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:salmonella vnp20009
    n1=en:cytarabine | n2=en:salmonella vnp20009 | rel=r_associated | relid=0 | w=20
  2549. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sardomozide
    n1=en:cytarabine | n2=en:sardomozide | rel=r_associated | relid=0 | w=20
  2550. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant
    n1=en:cytarabine | n2=en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant | rel=r_associated | relid=0 | w=20
  2551. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sargramostim plasmid dna melanoma vaccine adjuvant
    n1=en:cytarabine | n2=en:sargramostim plasmid dna melanoma vaccine adjuvant | rel=r_associated | relid=0 | w=20
  2552. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sargramostim plasmid dna sarcoma vaccine
    n1=en:cytarabine | n2=en:sargramostim plasmid dna sarcoma vaccine | rel=r_associated | relid=0 | w=20
  2553. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sdf-1-targeted agent nox-a12
    n1=en:cytarabine | n2=en:sdf-1-targeted agent nox-a12 | rel=r_associated | relid=0 | w=20
  2554. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:semaxanib
    n1=en:cytarabine | n2=en:semaxanib | rel=r_associated | relid=0 | w=20
  2555. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:senna extract
    n1=en:cytarabine | n2=en:senna extract | rel=r_associated | relid=0 | w=20
  2556. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:seribantumab
    n1=en:cytarabine | n2=en:seribantumab | rel=r_associated | relid=0 | w=20
  2557. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:shark cartilage extract ae-941
    n1=en:cytarabine | n2=en:shark cartilage extract ae-941 | rel=r_associated | relid=0 | w=20
  2558. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sheddase inhibitor incb007839
    n1=en:cytarabine | n2=en:sheddase inhibitor incb007839 | rel=r_associated | relid=0 | w=20
  2559. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sheng-mai san
    n1=en:cytarabine | n2=en:sheng-mai san | rel=r_associated | relid=0 | w=20
  2560. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sheng-yu-tang
    n1=en:cytarabine | n2=en:sheng-yu-tang | rel=r_associated | relid=0 | w=20
  2561. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:shu yu wan formula
    n1=en:cytarabine | n2=en:shu yu wan formula | rel=r_associated | relid=0 | w=20
  2562. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine
    n1=en:cytarabine | n2=en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine | rel=r_associated | relid=0 | w=20
  2563. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sildenafil citrate
    n1=en:cytarabine | n2=en:sildenafil citrate | rel=r_associated | relid=0 | w=20
  2564. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sipuleucel-t
    n1=en:cytarabine | n2=en:sipuleucel-t | rel=r_associated | relid=0 | w=20
  2565. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sirpa-fc fusion protein tti-621
    n1=en:cytarabine | n2=en:sirpa-fc fusion protein tti-621 | rel=r_associated | relid=0 | w=20
  2566. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sivifene
    n1=en:cytarabine | n2=en:sivifene | rel=r_associated | relid=0 | w=20
  2567. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:smac mimetic lcl161
    n1=en:cytarabine | n2=en:smac mimetic lcl161 | rel=r_associated | relid=0 | w=20
  2568. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:smokeless tobacco
    n1=en:cytarabine | n2=en:smokeless tobacco | rel=r_associated | relid=0 | w=20
  2569. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:soapstone
    n1=en:cytarabine | n2=en:soapstone | rel=r_associated | relid=0 | w=20
  2570. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sodium butyrate
    n1=en:cytarabine | n2=en:sodium butyrate | rel=r_associated | relid=0 | w=20
  2571. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sodium dibunate
    n1=en:cytarabine | n2=en:sodium dibunate | rel=r_associated | relid=0 | w=20
  2572. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sodium ferric gluconate complex in sucrose
    n1=en:cytarabine | n2=en:sodium ferric gluconate complex in sucrose | rel=r_associated | relid=0 | w=20
  2573. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sodium phenylbutyrate
    n1=en:cytarabine | n2=en:sodium phenylbutyrate | rel=r_associated | relid=0 | w=20
  2574. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sodium selenite
    n1=en:cytarabine | n2=en:sodium selenite | rel=r_associated | relid=0 | w=20
  2575. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:solitomab
    n1=en:cytarabine | n2=en:solitomab | rel=r_associated | relid=0 | w=20
  2576. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:solution
    n1=en:cytarabine | n2=en:solution | rel=r_associated | relid=0 | w=20
  2577. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sonepcizumab
    n1=en:cytarabine | n2=en:sonepcizumab | rel=r_associated | relid=0 | w=20
  2578. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sorafenib tosylate
    n1=en:cytarabine | n2=en:sorafenib tosylate | rel=r_associated | relid=0 | w=20
  2579. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sorghum bicolor supplement
    n1=en:cytarabine | n2=en:sorghum bicolor supplement | rel=r_associated | relid=0 | w=20
  2580. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:source code
    n1=en:cytarabine | n2=en:source code | rel=r_associated | relid=0 | w=20
  2581. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:source text
    n1=en:cytarabine | n2=en:source text | rel=r_associated | relid=0 | w=20
  2582. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:soy isoflavones
    n1=en:cytarabine | n2=en:soy isoflavones | rel=r_associated | relid=0 | w=20
  2583. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:soy protein isolate
    n1=en:cytarabine | n2=en:soy protein isolate | rel=r_associated | relid=0 | w=20
  2584. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:spanner
    n1=en:cytarabine | n2=en:spanner | rel=r_associated | relid=0 | w=20
  2585. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sphingosine kinase-2 inhibitor abc294640
    n1=en:cytarabine | n2=en:sphingosine kinase-2 inhibitor abc294640 | rel=r_associated | relid=0 | w=20
  2586. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:squalamine lactate
    n1=en:cytarabine | n2=en:squalamine lactate | rel=r_associated | relid=0 | w=20
  2587. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sr31747a
    n1=en:cytarabine | n2=en:sr31747a | rel=r_associated | relid=0 | w=20
  2588. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:src/tubulin inhibitor kx02
    n1=en:cytarabine | n2=en:src/tubulin inhibitor kx02 | rel=r_associated | relid=0 | w=20
  2589. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:steatite
    n1=en:cytarabine | n2=en:steatite | rel=r_associated | relid=0 | w=20
  2590. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:strawberry-blackberry-black raspberry-blueberry mixture
    n1=en:cytarabine | n2=en:strawberry-blackberry-black raspberry-blueberry mixture | rel=r_associated | relid=0 | w=20
  2591. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sun's soup
    n1=en:cytarabine | n2=en:sun's soup | rel=r_associated | relid=0 | w=20
  2592. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:sunitinib malate
    n1=en:cytarabine | n2=en:sunitinib malate | rel=r_associated | relid=0 | w=20
  2593. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:surface-active agent
    n1=en:cytarabine | n2=en:surface-active agent | rel=r_associated | relid=0 | w=20
  2594. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:surfactant agent
    n1=en:cytarabine | n2=en:surfactant agent | rel=r_associated | relid=0 | w=20
  2595. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:syk inhibitor hmpl-523
    n1=en:cytarabine | n2=en:syk inhibitor hmpl-523 | rel=r_associated | relid=0 | w=20
  2596. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:t-8801 protocol
    n1=en:cytarabine | n2=en:t-8801 protocol | rel=r_associated | relid=0 | w=20
  2597. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:t1e28z car-expressing autologous cd4-positive t lymphocytes
    n1=en:cytarabine | n2=en:t1e28z car-expressing autologous cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=20
  2598. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ta protocol
    n1=en:cytarabine | n2=en:ta protocol | rel=r_associated | relid=0 | w=20
  2599. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tabalumab
    n1=en:cytarabine | n2=en:tabalumab | rel=r_associated | relid=0 | w=20
  2600. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tacc protocol
    n1=en:cytarabine | n2=en:tacc protocol | rel=r_associated | relid=0 | w=20
  2601. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tad9 protocol
    n1=en:cytarabine | n2=en:tad9 protocol | rel=r_associated | relid=0 | w=20
  2602. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tadop protocol
    n1=en:cytarabine | n2=en:tadop protocol | rel=r_associated | relid=0 | w=20
  2603. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:talazoparib
    n1=en:cytarabine | n2=en:talazoparib | rel=r_associated | relid=0 | w=20
  2604. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:talcum
    n1=en:cytarabine | n2=en:talcum | rel=r_associated | relid=0 | w=20
  2605. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:talcum powder
    n1=en:cytarabine | n2=en:talcum powder | rel=r_associated | relid=0 | w=20
  2606. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:taliglucerase alfa
    n1=en:cytarabine | n2=en:taliglucerase alfa | rel=r_associated | relid=0 | w=20
  2607. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:talimogene laherparepvec
    n1=en:cytarabine | n2=en:talimogene laherparepvec | rel=r_associated | relid=0 | w=20
  2608. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:talmapimod
    n1=en:cytarabine | n2=en:talmapimod | rel=r_associated | relid=0 | w=20
  2609. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tam protocol
    n1=en:cytarabine | n2=en:tam protocol | rel=r_associated | relid=0 | w=20
  2610. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tandutinib
    n1=en:cytarabine | n2=en:tandutinib | rel=r_associated | relid=0 | w=20
  2611. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tanezumab
    n1=en:cytarabine | n2=en:tanezumab | rel=r_associated | relid=0 | w=20
  2612. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tapa protocol
    n1=en:cytarabine | n2=en:tapa protocol | rel=r_associated | relid=0 | w=20
  2613. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tasisulam sodium
    n1=en:cytarabine | n2=en:tasisulam sodium | rel=r_associated | relid=0 | w=20
  2614. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tasquinimod
    n1=en:cytarabine | n2=en:tasquinimod | rel=r_associated | relid=0 | w=20
  2615. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tave protocol
    n1=en:cytarabine | n2=en:tave protocol | rel=r_associated | relid=0 | w=20
  2616. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tc 99m monoclonal antibody 170
    n1=en:cytarabine | n2=en:tc 99m monoclonal antibody 170 | rel=r_associated | relid=0 | w=20
  2617. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc 99m galactosyl human serum albumin
    n1=en:cytarabine | n2=en:technetium tc 99m galactosyl human serum albumin | rel=r_associated | relid=0 | w=20
  2618. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc 99m-3prgd2
    n1=en:cytarabine | n2=en:technetium tc 99m-3prgd2 | rel=r_associated | relid=0 | w=20
  2619. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc-99m
    n1=en:cytarabine | n2=en:technetium tc-99m | rel=r_associated | relid=0 | w=20
  2620. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc-99m ethylenedicysteine-deoxyglucose
    n1=en:cytarabine | n2=en:technetium tc-99m ethylenedicysteine-deoxyglucose | rel=r_associated | relid=0 | w=20
  2621. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc-99m mebrofenin
    n1=en:cytarabine | n2=en:technetium tc-99m mebrofenin | rel=r_associated | relid=0 | w=20
  2622. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc-99m sodium pertechnetate
    n1=en:cytarabine | n2=en:technetium tc-99m sodium pertechnetate | rel=r_associated | relid=0 | w=20
  2623. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:technetium tc-99m-nc100692
    n1=en:cytarabine | n2=en:technetium tc-99m-nc100692 | rel=r_associated | relid=0 | w=20
  2624. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tegafur-gimeracil-oteracil potassium
    n1=en:cytarabine | n2=en:tegafur-gimeracil-oteracil potassium | rel=r_associated | relid=0 | w=20
  2625. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:telomerase-specific type 5 adenovirus obp-301
    n1=en:cytarabine | n2=en:telomerase-specific type 5 adenovirus obp-301 | rel=r_associated | relid=0 | w=20
  2626. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:temsirolimus
    n1=en:cytarabine | n2=en:temsirolimus | rel=r_associated | relid=0 | w=20
  2627. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:teniposide
    n1=en:cytarabine | n2=en:teniposide | rel=r_associated | relid=0 | w=20
  2628. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tenofovir disoproxil fumarate
    n1=en:cytarabine | n2=en:tenofovir disoproxil fumarate | rel=r_associated | relid=0 | w=20
  2629. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:teprotumumab
    n1=en:cytarabine | n2=en:teprotumumab | rel=r_associated | relid=0 | w=20
  2630. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tesetaxel
    n1=en:cytarabine | n2=en:tesetaxel | rel=r_associated | relid=0 | w=20
  2631. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:testosterone gel
    n1=en:cytarabine | n2=en:testosterone gel | rel=r_associated | relid=0 | w=20
  2632. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tetanus toxoid vaccine
    n1=en:cytarabine | n2=en:tetanus toxoid vaccine | rel=r_associated | relid=0 | w=20
  2633. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tetanus-cmv fusion peptide vaccine
    n1=en:cytarabine | n2=en:tetanus-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=20
  2634. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tetracycline hydrochloride
    n1=en:cytarabine | n2=en:tetracycline hydrochloride | rel=r_associated | relid=0 | w=20
  2635. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tgap protocol
    n1=en:cytarabine | n2=en:tgap protocol | rel=r_associated | relid=0 | w=20
  2636. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes
    n1=en:cytarabine | n2=en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=20
  2637. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:thalicarpine
    n1=en:cytarabine | n2=en:thalicarpine | rel=r_associated | relid=0 | w=20
  2638. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic angiotensin-(1-7)
    n1=en:cytarabine | n2=en:therapeutic angiotensin-(1-7) | rel=r_associated | relid=0 | w=20
  2639. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic autologous lymphocytes
    n1=en:cytarabine | n2=en:therapeutic autologous lymphocytes | rel=r_associated | relid=0 | w=20
  2640. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic cortisone
    n1=en:cytarabine | n2=en:therapeutic cortisone | rel=r_associated | relid=0 | w=20
  2641. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic epinephrine
    n1=en:cytarabine | n2=en:therapeutic epinephrine | rel=r_associated | relid=0 | w=20
  2642. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic estrone
    n1=en:cytarabine | n2=en:therapeutic estrone | rel=r_associated | relid=0 | w=20
  2643. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic hydrocortisone
    n1=en:cytarabine | n2=en:therapeutic hydrocortisone | rel=r_associated | relid=0 | w=20
  2644. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:therapeutic testosterone
    n1=en:cytarabine | n2=en:therapeutic testosterone | rel=r_associated | relid=0 | w=20
  2645. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:thiamine
    n1=en:cytarabine | n2=en:thiamine | rel=r_associated | relid=0 | w=20
  2646. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:thiopyrimidine
    n1=en:cytarabine | n2=en:thiopyrimidine | rel=r_associated | relid=0 | w=20
  2647. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:thioureidobutyronitrile
    n1=en:cytarabine | n2=en:thioureidobutyronitrile | rel=r_associated | relid=0 | w=20
  2648. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:thrombopoietin receptor agonist lgd-4665
    n1=en:cytarabine | n2=en:thrombopoietin receptor agonist lgd-4665 | rel=r_associated | relid=0 | w=20
  2649. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tiazofurin
    n1=en:cytarabine | n2=en:tiazofurin | rel=r_associated | relid=0 | w=20
  2650. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tigapotide
    n1=en:cytarabine | n2=en:tigapotide | rel=r_associated | relid=0 | w=20
  2651. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tigatuzumab
    n1=en:cytarabine | n2=en:tigatuzumab | rel=r_associated | relid=0 | w=20
  2652. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tigecycline
    n1=en:cytarabine | n2=en:tigecycline | rel=r_associated | relid=0 | w=20
  2653. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tin sn 117m dtpa
    n1=en:cytarabine | n2=en:tin sn 117m dtpa | rel=r_associated | relid=0 | w=20
  2654. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tiomolibdate diammonium
    n1=en:cytarabine | n2=en:tiomolibdate diammonium | rel=r_associated | relid=0 | w=20
  2655. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tivantinib
    n1=en:cytarabine | n2=en:tivantinib | rel=r_associated | relid=0 | w=20
  2656. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tlr 7/8 agonist medi9197
    n1=en:cytarabine | n2=en:tlr 7/8 agonist medi9197 | rel=r_associated | relid=0 | w=20
  2657. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tlr9 agonist duk-cpg-001
    n1=en:cytarabine | n2=en:tlr9 agonist duk-cpg-001 | rel=r_associated | relid=0 | w=20
  2658. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tlr9 agonist emd 1201081
    n1=en:cytarabine | n2=en:tlr9 agonist emd 1201081 | rel=r_associated | relid=0 | w=20
  2659. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tlr9 agonist sd-101
    n1=en:cytarabine | n2=en:tlr9 agonist sd-101 | rel=r_associated | relid=0 | w=20
  2660. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to answer
    n1=en:cytarabine | n2=en:to answer | rel=r_associated | relid=0 | w=20
  2661. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to answer sb back
    n1=en:cytarabine | n2=en:to answer sb back | rel=r_associated | relid=0 | w=20
  2662. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to be the counterpart of
    n1=en:cytarabine | n2=en:to be the counterpart of | rel=r_associated | relid=0 | w=20
  2663. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to correspond to
    n1=en:cytarabine | n2=en:to correspond to | rel=r_associated | relid=0 | w=20
  2664. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to match
    n1=en:cytarabine | n2=en:to match | rel=r_associated | relid=0 | w=20
  2665. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to meet
    n1=en:cytarabine | n2=en:to meet | rel=r_associated | relid=0 | w=20
  2666. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:to reply to
    n1=en:cytarabine | n2=en:to reply to | rel=r_associated | relid=0 | w=20
  2667. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:toap protocol
    n1=en:cytarabine | n2=en:toap protocol | rel=r_associated | relid=0 | w=20
  2668. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tocilizumab
    n1=en:cytarabine | n2=en:tocilizumab | rel=r_associated | relid=0 | w=20
  2669. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tocotrienol-rich fraction
    n1=en:cytarabine | n2=en:tocotrienol-rich fraction | rel=r_associated | relid=0 | w=20
  2670. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:topical betulinic acid
    n1=en:cytarabine | n2=en:topical betulinic acid | rel=r_associated | relid=0 | w=20
  2671. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:topical pvdf/sirolimus
    n1=en:cytarabine | n2=en:topical pvdf/sirolimus | rel=r_associated | relid=0 | w=20
  2672. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tositumomab
    n1=en:cytarabine | n2=en:tositumomab | rel=r_associated | relid=0 | w=20
  2673. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:total tumor rna-loaded dendritic cell vaccine
    n1=en:cytarabine | n2=en:total tumor rna-loaded dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  2674. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:total-xii protocol
    n1=en:cytarabine | n2=en:total-xii protocol | rel=r_associated | relid=0 | w=20
  2675. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trampco protocol
    n1=en:cytarabine | n2=en:trampco protocol | rel=r_associated | relid=0 | w=20
  2676. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trampcol protocol
    n1=en:cytarabine | n2=en:trampcol protocol | rel=r_associated | relid=0 | w=20
  2677. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tranexamic acid
    n1=en:cytarabine | n2=en:tranexamic acid | rel=r_associated | relid=0 | w=20
  2678. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:transferrin receptor-targeted anti-rrm2 sirna calaa-01
    n1=en:cytarabine | n2=en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 | rel=r_associated | relid=0 | w=20
  2679. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:transgenic lymphocyte immunization vaccine
    n1=en:cytarabine | n2=en:transgenic lymphocyte immunization vaccine | rel=r_associated | relid=0 | w=20
  2680. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trap protocol
    n1=en:cytarabine | n2=en:trap protocol | rel=r_associated | relid=0 | w=20
  2681. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trastuzumab
    n1=en:cytarabine | n2=en:trastuzumab | rel=r_associated | relid=0 | w=20
  2682. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trastuzumab emtansine
    n1=en:cytarabine | n2=en:trastuzumab emtansine | rel=r_associated | relid=0 | w=20
  2683. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trastuzumab vc-seco-duba
    n1=en:cytarabine | n2=en:trastuzumab vc-seco-duba | rel=r_associated | relid=0 | w=20
  2684. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tremelimumab
    n1=en:cytarabine | n2=en:tremelimumab | rel=r_associated | relid=0 | w=20
  2685. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tretinoin
    n1=en:cytarabine | n2=en:tretinoin | rel=r_associated | relid=0 | w=20
  2686. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes
    n1=en:cytarabine | n2=en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=20
  2687. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:triazinate
    n1=en:cytarabine | n2=en:triazinate | rel=r_associated | relid=0 | w=20
  2688. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trivalent live-attenuated influenza vaccine
    n1=en:cytarabine | n2=en:trivalent live-attenuated influenza vaccine | rel=r_associated | relid=0 | w=20
  2689. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:trk inhibitor azd6918
    n1=en:cytarabine | n2=en:trk inhibitor azd6918 | rel=r_associated | relid=0 | w=20
  2690. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tubulin inhibitor alb 109564(a)
    n1=en:cytarabine | n2=en:tubulin inhibitor alb 109564(a) | rel=r_associated | relid=0 | w=20
  2691. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tyroserleutide
    n1=en:cytarabine | n2=en:tyroserleutide | rel=r_associated | relid=0 | w=20
  2692. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:tyrosine kinase inhibitor xl228
    n1=en:cytarabine | n2=en:tyrosine kinase inhibitor xl228 | rel=r_associated | relid=0 | w=20
  2693. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ublituximab
    n1=en:cytarabine | n2=en:ublituximab | rel=r_associated | relid=0 | w=20
  2694. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:uch i protocol
    n1=en:cytarabine | n2=en:uch i protocol | rel=r_associated | relid=0 | w=20
  2695. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:uch ii protocol
    n1=en:cytarabine | n2=en:uch ii protocol | rel=r_associated | relid=0 | w=20
  2696. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ulvwf multimer-targeting agent arc1779
    n1=en:cytarabine | n2=en:ulvwf multimer-targeting agent arc1779 | rel=r_associated | relid=0 | w=20
  2697. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:uracil analog
    n1=en:cytarabine | n2=en:uracil analog | rel=r_associated | relid=0 | w=20
  2698. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:urea/lactic acid-based topical cream
    n1=en:cytarabine | n2=en:urea/lactic acid-based topical cream | rel=r_associated | relid=0 | w=20
  2699. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ustekinumab
    n1=en:cytarabine | n2=en:ustekinumab | rel=r_associated | relid=0 | w=20
  2700. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:uv1 telomerase peptide vaccine
    n1=en:cytarabine | n2=en:uv1 telomerase peptide vaccine | rel=r_associated | relid=0 | w=20
  2701. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:v930 vaccine
    n1=en:cytarabine | n2=en:v930 vaccine | rel=r_associated | relid=0 | w=20
  2702. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vaap regimen
    n1=en:cytarabine | n2=en:vaap regimen | rel=r_associated | relid=0 | w=20
  2703. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vaba protocol
    n1=en:cytarabine | n2=en:vaba protocol | rel=r_associated | relid=0 | w=20
  2704. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vac combination
    n1=en:cytarabine | n2=en:vac combination | rel=r_associated | relid=0 | w=20
  2705. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vad regimen
    n1=en:cytarabine | n2=en:vad regimen | rel=r_associated | relid=0 | w=20
  2706. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vadastuximab talirine
    n1=en:cytarabine | n2=en:vadastuximab talirine | rel=r_associated | relid=0 | w=20
  2707. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vae protocol
    n1=en:cytarabine | n2=en:vae protocol | rel=r_associated | relid=0 | w=20
  2708. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:valerian
    n1=en:cytarabine | n2=en:valerian | rel=r_associated | relid=0 | w=20
  2709. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:valproic acid
    n1=en:cytarabine | n2=en:valproic acid | rel=r_associated | relid=0 | w=20
  2710. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vancomycin
    n1=en:cytarabine | n2=en:vancomycin | rel=r_associated | relid=0 | w=20
  2711. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vandetanib
    n1=en:cytarabine | n2=en:vandetanib | rel=r_associated | relid=0 | w=20
  2712. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vapa protocol
    n1=en:cytarabine | n2=en:vapa protocol | rel=r_associated | relid=0 | w=20
  2713. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vata protocol
    n1=en:cytarabine | n2=en:vata protocol | rel=r_associated | relid=0 | w=20
  2714. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vcl-cb01 vaccine
    n1=en:cytarabine | n2=en:vcl-cb01 vaccine | rel=r_associated | relid=0 | w=20
  2715. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vedolizumab
    n1=en:cytarabine | n2=en:vedolizumab | rel=r_associated | relid=0 | w=20
  2716. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vegfr inhibitor krn951
    n1=en:cytarabine | n2=en:vegfr inhibitor krn951 | rel=r_associated | relid=0 | w=20
  2717. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vegfr/pdgfr tyrosine kinase inhibitor tak-593
    n1=en:cytarabine | n2=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | rel=r_associated | relid=0 | w=20
  2718. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vegfr1-1084 peptide vaccine
    n1=en:cytarabine | n2=en:vegfr1-1084 peptide vaccine | rel=r_associated | relid=0 | w=20
  2719. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:veliparib
    n1=en:cytarabine | n2=en:veliparib | rel=r_associated | relid=0 | w=20
  2720. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:veltuzumab
    n1=en:cytarabine | n2=en:veltuzumab | rel=r_associated | relid=0 | w=20
  2721. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:verteporfin
    n1=en:cytarabine | n2=en:verteporfin | rel=r_associated | relid=0 | w=20
  2722. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:veterinary drugs
    n1=en:cytarabine | n2=en:veterinary drugs | rel=r_associated | relid=0 | w=20
  2723. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:viagenpumatucel-l
    n1=en:cytarabine | n2=en:viagenpumatucel-l | rel=r_associated | relid=0 | w=20
  2724. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vim3-ara c regimen
    n1=en:cytarabine | n2=en:vim3-ara c regimen | rel=r_associated | relid=0 | w=20
  2725. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vinap protocol
    n1=en:cytarabine | n2=en:vinap protocol | rel=r_associated | relid=0 | w=20
  2726. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vinblastine
    n1=en:cytarabine | n2=en:vinblastine | rel=r_associated | relid=0 | w=20
  2727. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vinblastine sulfate
    n1=en:cytarabine | n2=en:vinblastine sulfate | rel=r_associated | relid=0 | w=20
  2728. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vincristine sulfate liposome
    n1=en:cytarabine | n2=en:vincristine sulfate liposome | rel=r_associated | relid=0 | w=20
  2729. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vinflunine
    n1=en:cytarabine | n2=en:vinflunine | rel=r_associated | relid=0 | w=20
  2730. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vinfosiltine
    n1=en:cytarabine | n2=en:vinfosiltine | rel=r_associated | relid=0 | w=20
  2731. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:visilizumab
    n1=en:cytarabine | n2=en:visilizumab | rel=r_associated | relid=0 | w=20
  2732. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vistusertib
    n1=en:cytarabine | n2=en:vistusertib | rel=r_associated | relid=0 | w=20
  2733. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vitamin a compound
    n1=en:cytarabine | n2=en:vitamin a compound | rel=r_associated | relid=0 | w=20
  2734. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vitamin e compound
    n1=en:cytarabine | n2=en:vitamin e compound | rel=r_associated | relid=0 | w=20
  2735. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vitespen
    n1=en:cytarabine | n2=en:vitespen | rel=r_associated | relid=0 | w=20
  2736. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:vmp-ciscf protocol
    n1=en:cytarabine | n2=en:vmp-ciscf protocol | rel=r_associated | relid=0 | w=20
  2737. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:volasertib
    n1=en:cytarabine | n2=en:volasertib | rel=r_associated | relid=0 | w=20
  2738. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:voxtalisib
    n1=en:cytarabine | n2=en:voxtalisib | rel=r_associated | relid=0 | w=20
  2739. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:warfarin
    n1=en:cytarabine | n2=en:warfarin | rel=r_associated | relid=0 | w=20
  2740. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:weight control agent
    n1=en:cytarabine | n2=en:weight control agent | rel=r_associated | relid=0 | w=20
  2741. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:whey protein isolate
    n1=en:cytarabine | n2=en:whey protein isolate | rel=r_associated | relid=0 | w=20
  2742. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:wrench
    n1=en:cytarabine | n2=en:wrench | rel=r_associated | relid=0 | w=20
  2743. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:wt1 124-138 peptide vaccine
    n1=en:cytarabine | n2=en:wt1 124-138 peptide vaccine | rel=r_associated | relid=0 | w=20
  2744. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:wt1 mrna-electroporated autologous dendritic cell vaccine
    n1=en:cytarabine | n2=en:wt1 mrna-electroporated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=20
  2745. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:wt1 protein-derived peptide vaccine dsp-7888
    n1=en:cytarabine | n2=en:wt1 protein-derived peptide vaccine dsp-7888 | rel=r_associated | relid=0 | w=20
  2746. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:xenogeneic tyrosinase dna vaccine
    n1=en:cytarabine | n2=en:xenogeneic tyrosinase dna vaccine | rel=r_associated | relid=0 | w=20
  2747. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:y 90 monoclonal antibody hmfg1
    n1=en:cytarabine | n2=en:y 90 monoclonal antibody hmfg1 | rel=r_associated | relid=0 | w=20
  2748. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:y 90 monoclonal antibody m170
    n1=en:cytarabine | n2=en:y 90 monoclonal antibody m170 | rel=r_associated | relid=0 | w=20
  2749. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:ym598
    n1=en:cytarabine | n2=en:ym598 | rel=r_associated | relid=0 | w=20
  2750. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y 90 daclizumab
    n1=en:cytarabine | n2=en:yttrium y 90 daclizumab | rel=r_associated | relid=0 | w=20
  2751. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y 90 dota anti-cea monoclonal antibody m5a
    n1=en:cytarabine | n2=en:yttrium y 90 dota anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=20
  2752. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y 90 monoclonal antibody hu3s193
    n1=en:cytarabine | n2=en:yttrium y 90 monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=20
  2753. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y 90 monoclonal antibody mn-14
    n1=en:cytarabine | n2=en:yttrium y 90 monoclonal antibody mn-14 | rel=r_associated | relid=0 | w=20
  2754. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y 90-dota-di-hsg peptide imp-288
    n1=en:cytarabine | n2=en:yttrium y 90-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=20
  2755. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y-90 epratuzumab tetraxetan
    n1=en:cytarabine | n2=en:yttrium y-90 epratuzumab tetraxetan | rel=r_associated | relid=0 | w=20
  2756. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:yttrium y-90 ibritumomab tiuxetan
    n1=en:cytarabine | n2=en:yttrium y-90 ibritumomab tiuxetan | rel=r_associated | relid=0 | w=20
  2757. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zalutumumab
    n1=en:cytarabine | n2=en:zalutumumab | rel=r_associated | relid=0 | w=20
  2758. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zanolimumab
    n1=en:cytarabine | n2=en:zanolimumab | rel=r_associated | relid=0 | w=20
  2759. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zidovudine
    n1=en:cytarabine | n2=en:zidovudine | rel=r_associated | relid=0 | w=20
  2760. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zinc gluconate
    n1=en:cytarabine | n2=en:zinc gluconate | rel=r_associated | relid=0 | w=20
  2761. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zinc sulfate
    n1=en:cytarabine | n2=en:zinc sulfate | rel=r_associated | relid=0 | w=20
  2762. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zinc sulphate
    n1=en:cytarabine | n2=en:zinc sulphate | rel=r_associated | relid=0 | w=20
  2763. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zirconium zr 89 bevacizumab
    n1=en:cytarabine | n2=en:zirconium zr 89 bevacizumab | rel=r_associated | relid=0 | w=20
  2764. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zirconium zr 89 df-iab2m
    n1=en:cytarabine | n2=en:zirconium zr 89 df-iab2m | rel=r_associated | relid=0 | w=20
  2765. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zirconium zr 89 girentuximab
    n1=en:cytarabine | n2=en:zirconium zr 89 girentuximab | rel=r_associated | relid=0 | w=20
  2766. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1
    n1=en:cytarabine | n2=en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=20
  2767. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zirconium zr 89-labeled ro5479599
    n1=en:cytarabine | n2=en:zirconium zr 89-labeled ro5479599 | rel=r_associated | relid=0 | w=20
  2768. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zolmitriptan
    n1=en:cytarabine | n2=en:zolmitriptan | rel=r_associated | relid=0 | w=20
  2769. en:cytarabine -- r_associated #0: 20 / 0.25 -> en:zoptarelin doxorubicin
    n1=en:cytarabine | n2=en:zoptarelin doxorubicin | rel=r_associated | relid=0 | w=20
  2770. en:cytarabine -- r_associated #0: 20 / 0.25 -> enzalutamide
    n1=en:cytarabine | n2=enzalutamide | rel=r_associated | relid=0 | w=20
  2771. en:cytarabine -- r_associated #0: 20 / 0.25 -> eplérénone
    n1=en:cytarabine | n2=eplérénone | rel=r_associated | relid=0 | w=20
  2772. en:cytarabine -- r_associated #0: 20 / 0.25 -> éponge de gélatine résorbable
    n1=en:cytarabine | n2=éponge de gélatine résorbable | rel=r_associated | relid=0 | w=20
  2773. en:cytarabine -- r_associated #0: 20 / 0.25 -> érythropoïétine
    n1=en:cytarabine | n2=érythropoïétine | rel=r_associated | relid=0 | w=20
  2774. en:cytarabine -- r_associated #0: 20 / 0.25 -> éthosuximide
    n1=en:cytarabine | n2=éthosuximide | rel=r_associated | relid=0 | w=20
  2775. en:cytarabine -- r_associated #0: 20 / 0.25 -> ézétimibe
    n1=en:cytarabine | n2=ézétimibe | rel=r_associated | relid=0 | w=20
  2776. en:cytarabine -- r_associated #0: 20 / 0.25 -> facteurs biologiques
    n1=en:cytarabine | n2=facteurs biologiques | rel=r_associated | relid=0 | w=20
  2777. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance
    n1=en:cytarabine | n2=faire connaissance | rel=r_associated | relid=0 | w=20
  2778. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance avec
    n1=en:cytarabine | n2=faire connaissance avec | rel=r_associated | relid=0 | w=20
  2779. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance avec [qqn]
    n1=en:cytarabine | n2=faire connaissance avec [qqn] | rel=r_associated | relid=0 | w=20
  2780. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance avec quelqu'un
    n1=en:cytarabine | n2=faire connaissance avec quelqu'un | rel=r_associated | relid=0 | w=20
  2781. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance de
    n1=en:cytarabine | n2=faire connaissance de | rel=r_associated | relid=0 | w=20
  2782. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance de [qqn]
    n1=en:cytarabine | n2=faire connaissance de [qqn] | rel=r_associated | relid=0 | w=20
  2783. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire connaissance de quelqu'un
    n1=en:cytarabine | n2=faire connaissance de quelqu'un | rel=r_associated | relid=0 | w=20
  2784. en:cytarabine -- r_associated #0: 20 / 0.25 -> faire pendant à
    n1=en:cytarabine | n2=faire pendant à | rel=r_associated | relid=0 | w=20
  2785. en:cytarabine -- r_associated #0: 20 / 0.25 -> famitinib
    n1=en:cytarabine | n2=famitinib | rel=r_associated | relid=0 | w=20
  2786. en:cytarabine -- r_associated #0: 20 / 0.25 -> filgrastim
    n1=en:cytarabine | n2=filgrastim | rel=r_associated | relid=0 | w=20
  2787. en:cytarabine -- r_associated #0: 20 / 0.25 -> finastéride
    n1=en:cytarabine | n2=finastéride | rel=r_associated | relid=0 | w=20
  2788. en:cytarabine -- r_associated #0: 20 / 0.25 -> flucytosine
    n1=en:cytarabine | n2=flucytosine | rel=r_associated | relid=0 | w=20
  2789. en:cytarabine -- r_associated #0: 20 / 0.25 -> fludarabine
    n1=en:cytarabine | n2=fludarabine | rel=r_associated | relid=0 | w=20
  2790. en:cytarabine -- r_associated #0: 20 / 0.25 -> fluoro-uracile
    n1=en:cytarabine | n2=fluoro-uracile | rel=r_associated | relid=0 | w=20
  2791. en:cytarabine -- r_associated #0: 20 / 0.25 -> gabapentine
    n1=en:cytarabine | n2=gabapentine | rel=r_associated | relid=0 | w=20
  2792. en:cytarabine -- r_associated #0: 20 / 0.25 -> gemcitabine
    n1=en:cytarabine | n2=gemcitabine | rel=r_associated | relid=0 | w=20
  2793. en:cytarabine -- r_associated #0: 20 / 0.25 -> génistéine
    n1=en:cytarabine | n2=génistéine | rel=r_associated | relid=0 | w=20
  2794. en:cytarabine -- r_associated #0: 20 / 0.25 -> girentuximab
    n1=en:cytarabine | n2=girentuximab | rel=r_associated | relid=0 | w=20
  2795. en:cytarabine -- r_associated #0: 20 / 0.25 -> gluconate de cuivre
    n1=en:cytarabine | n2=gluconate de cuivre | rel=r_associated | relid=0 | w=20
  2796. en:cytarabine -- r_associated #0: 20 / 0.25 -> glutathion
    n1=en:cytarabine | n2=glutathion | rel=r_associated | relid=0 | w=20
  2797. en:cytarabine -- r_associated #0: 20 / 0.25 -> glycol polyéthylénique
    n1=en:cytarabine | n2=glycol polyéthylénique | rel=r_associated | relid=0 | w=20
  2798. en:cytarabine -- r_associated #0: 20 / 0.25 -> gonadotrophine ménopausique humaine
    n1=en:cytarabine | n2=gonadotrophine ménopausique humaine | rel=r_associated | relid=0 | w=20
  2799. en:cytarabine -- r_associated #0: 20 / 0.25 -> hormone gonadotrope ménopausique humaine
    n1=en:cytarabine | n2=hormone gonadotrope ménopausique humaine | rel=r_associated | relid=0 | w=20
  2800. en:cytarabine -- r_associated #0: 20 / 0.25 -> hydrocortisone
    n1=en:cytarabine | n2=hydrocortisone | rel=r_associated | relid=0 | w=20
  2801. en:cytarabine -- r_associated #0: 20 / 0.25 -> hydrocortisones
    n1=en:cytarabine | n2=hydrocortisones | rel=r_associated | relid=0 | w=20
  2802. en:cytarabine -- r_associated #0: 20 / 0.25 -> hydroxytyrosol
    n1=en:cytarabine | n2=hydroxytyrosol | rel=r_associated | relid=0 | w=20
  2803. en:cytarabine -- r_associated #0: 20 / 0.25 -> ibrutinib
    n1=en:cytarabine | n2=ibrutinib | rel=r_associated | relid=0 | w=20
  2804. en:cytarabine -- r_associated #0: 20 / 0.25 -> immuno-modulateurs
    n1=en:cytarabine | n2=immuno-modulateurs | rel=r_associated | relid=0 | w=20
  2805. en:cytarabine -- r_associated #0: 20 / 0.25 -> immunomodulateurs
    n1=en:cytarabine | n2=immunomodulateurs | rel=r_associated | relid=0 | w=20
  2806. en:cytarabine -- r_associated #0: 20 / 0.25 -> indométacine
    n1=en:cytarabine | n2=indométacine | rel=r_associated | relid=0 | w=20
  2807. en:cytarabine -- r_associated #0: 20 / 0.25 -> indométhacine
    n1=en:cytarabine | n2=indométhacine | rel=r_associated | relid=0 | w=20
  2808. en:cytarabine -- r_associated #0: 20 / 0.25 -> inhibiteur d'enzymes
    n1=en:cytarabine | n2=inhibiteur d'enzymes | rel=r_associated | relid=0 | w=20
  2809. en:cytarabine -- r_associated #0: 20 / 0.25 -> inhibiteur des canaux calciques
    n1=en:cytarabine | n2=inhibiteur des canaux calciques | rel=r_associated | relid=0 | w=20
  2810. en:cytarabine -- r_associated #0: 20 / 0.25 -> Inhibiteur enzymatique
    n1=en:cytarabine | n2=Inhibiteur enzymatique | rel=r_associated | relid=0 | w=20
  2811. en:cytarabine -- r_associated #0: 20 / 0.25 -> inhibiteur enzymatique
    n1=en:cytarabine | n2=inhibiteur enzymatique | rel=r_associated | relid=0 | w=20
  2812. en:cytarabine -- r_associated #0: 20 / 0.25 -> inositol
    n1=en:cytarabine | n2=inositol | rel=r_associated | relid=0 | w=20
  2813. en:cytarabine -- r_associated #0: 20 / 0.25 -> insuline glargine
    n1=en:cytarabine | n2=insuline glargine | rel=r_associated | relid=0 | w=20
  2814. en:cytarabine -- r_associated #0: 20 / 0.25 -> insuline normale
    n1=en:cytarabine | n2=insuline normale | rel=r_associated | relid=0 | w=20
  2815. en:cytarabine -- r_associated #0: 20 / 0.25 -> insuline ordinaire
    n1=en:cytarabine | n2=insuline ordinaire | rel=r_associated | relid=0 | w=20
  2816. en:cytarabine -- r_associated #0: 20 / 0.25 -> inuline
    n1=en:cytarabine | n2=inuline | rel=r_associated | relid=0 | w=20
  2817. en:cytarabine -- r_associated #0: 20 / 0.25 -> ionomycine
    n1=en:cytarabine | n2=ionomycine | rel=r_associated | relid=0 | w=20
  2818. en:cytarabine -- r_associated #0: 20 / 0.25 -> ipilimumab
    n1=en:cytarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2819. en:cytarabine -- r_associated #0: 20 / 0.25 -> isavuconazole
    n1=en:cytarabine | n2=isavuconazole | rel=r_associated | relid=0 | w=20
  2820. en:cytarabine -- r_associated #0: 20 / 0.25 -> isoflurane
    n1=en:cytarabine | n2=isoflurane | rel=r_associated | relid=0 | w=20
  2821. en:cytarabine -- r_associated #0: 20 / 0.25 -> isoniazide
    n1=en:cytarabine | n2=isoniazide | rel=r_associated | relid=0 | w=20
  2822. en:cytarabine -- r_associated #0: 20 / 0.25 -> isotrétinoïne
    n1=en:cytarabine | n2=isotrétinoïne | rel=r_associated | relid=0 | w=20
  2823. en:cytarabine -- r_associated #0: 20 / 0.25 -> lamivudine
    n1=en:cytarabine | n2=lamivudine | rel=r_associated | relid=0 | w=20
  2824. en:cytarabine -- r_associated #0: 20 / 0.25 -> langage informatique
    n1=en:cytarabine | n2=langage informatique | rel=r_associated | relid=0 | w=20
  2825. en:cytarabine -- r_associated #0: 20 / 0.25 -> Langage informatique
    n1=en:cytarabine | n2=Langage informatique | rel=r_associated | relid=0 | w=20
  2826. en:cytarabine -- r_associated #0: 20 / 0.25 -> lévofloxacine
    n1=en:cytarabine | n2=lévofloxacine | rel=r_associated | relid=0 | w=20
  2827. en:cytarabine -- r_associated #0: 20 / 0.25 -> lier connaissance avec
    n1=en:cytarabine | n2=lier connaissance avec | rel=r_associated | relid=0 | w=20
  2828. en:cytarabine -- r_associated #0: 20 / 0.25 -> lier connaissance avec [qqn]
    n1=en:cytarabine | n2=lier connaissance avec [qqn] | rel=r_associated | relid=0 | w=20
  2829. en:cytarabine -- r_associated #0: 20 / 0.25 -> lier connaissance avec qn
    n1=en:cytarabine | n2=lier connaissance avec qn | rel=r_associated | relid=0 | w=20
  2830. en:cytarabine -- r_associated #0: 20 / 0.25 -> lier connaissance avec quelqu'un
    n1=en:cytarabine | n2=lier connaissance avec quelqu'un | rel=r_associated | relid=0 | w=20
  2831. en:cytarabine -- r_associated #0: 20 / 0.25 -> liraglutide
    n1=en:cytarabine | n2=liraglutide | rel=r_associated | relid=0 | w=20
  2832. en:cytarabine -- r_associated #0: 20 / 0.25 -> lisinopril
    n1=en:cytarabine | n2=lisinopril | rel=r_associated | relid=0 | w=20
  2833. en:cytarabine -- r_associated #0: 20 / 0.25 -> lovastatine
    n1=en:cytarabine | n2=lovastatine | rel=r_associated | relid=0 | w=20
  2834. en:cytarabine -- r_associated #0: 20 / 0.25 -> macitentan
    n1=en:cytarabine | n2=macitentan | rel=r_associated | relid=0 | w=20
  2835. en:cytarabine -- r_associated #0: 20 / 0.25 -> mal parler à
    n1=en:cytarabine | n2=mal parler à | rel=r_associated | relid=0 | w=20
  2836. en:cytarabine -- r_associated #0: 20 / 0.25 -> médicaments animaux
    n1=en:cytarabine | n2=médicaments animaux | rel=r_associated | relid=0 | w=20
  2837. en:cytarabine -- r_associated #0: 20 / 0.25 -> médicaments vétérinaires
    n1=en:cytarabine | n2=médicaments vétérinaires | rel=r_associated | relid=0 | w=20
  2838. en:cytarabine -- r_associated #0: 20 / 0.25 -> mesna
    n1=en:cytarabine | n2=mesna | rel=r_associated | relid=0 | w=20
  2839. en:cytarabine -- r_associated #0: 20 / 0.25 -> méthoxsalène
    n1=en:cytarabine | n2=méthoxsalène | rel=r_associated | relid=0 | w=20
  2840. en:cytarabine -- r_associated #0: 20 / 0.25 -> mitogène
    n1=en:cytarabine | n2=mitogène | rel=r_associated | relid=0 | w=20
  2841. en:cytarabine -- r_associated #0: 20 / 0.25 -> mitoguazone
    n1=en:cytarabine | n2=mitoguazone | rel=r_associated | relid=0 | w=20
  2842. en:cytarabine -- r_associated #0: 20 / 0.25 -> mitoguazones
    n1=en:cytarabine | n2=mitoguazones | rel=r_associated | relid=0 | w=20
  2843. en:cytarabine -- r_associated #0: 20 / 0.25 -> modafinil
    n1=en:cytarabine | n2=modafinil | rel=r_associated | relid=0 | w=20
  2844. en:cytarabine -- r_associated #0: 20 / 0.25 -> mutagène
    n1=en:cytarabine | n2=mutagène | rel=r_associated | relid=0 | w=20
  2845. en:cytarabine -- r_associated #0: 20 / 0.25 -> myorelaxante
    n1=en:cytarabine | n2=myorelaxante | rel=r_associated | relid=0 | w=20
  2846. en:cytarabine -- r_associated #0: 20 / 0.25 -> nadolol
    n1=en:cytarabine | n2=nadolol | rel=r_associated | relid=0 | w=20
  2847. en:cytarabine -- r_associated #0: 20 / 0.25 -> naproxène
    n1=en:cytarabine | n2=naproxène | rel=r_associated | relid=0 | w=20
  2848. en:cytarabine -- r_associated #0: 20 / 0.25 -> natalizumab
    n1=en:cytarabine | n2=natalizumab | rel=r_associated | relid=0 | w=20
  2849. en:cytarabine -- r_associated #0: 20 / 0.25 -> niacinamide
    n1=en:cytarabine | n2=niacinamide | rel=r_associated | relid=0 | w=20
  2850. en:cytarabine -- r_associated #0: 20 / 0.25 -> nicotinamide
    n1=en:cytarabine | n2=nicotinamide | rel=r_associated | relid=0 | w=20
  2851. en:cytarabine -- r_associated #0: 20 / 0.25 -> nicotine
    n1=en:cytarabine | n2=nicotine | rel=r_associated | relid=0 | w=20
  2852. en:cytarabine -- r_associated #0: 20 / 0.25 -> novobiocine
    n1=en:cytarabine | n2=novobiocine | rel=r_associated | relid=0 | w=20
  2853. en:cytarabine -- r_associated #0: 20 / 0.25 -> ocrelizumab
    n1=en:cytarabine | n2=ocrelizumab | rel=r_associated | relid=0 | w=20
  2854. en:cytarabine -- r_associated #0: 20 / 0.25 -> olanzapine
    n1=en:cytarabine | n2=olanzapine | rel=r_associated | relid=0 | w=20
  2855. en:cytarabine -- r_associated #0: 20 / 0.25 -> olaparib
    n1=en:cytarabine | n2=olaparib | rel=r_associated | relid=0 | w=20
  2856. en:cytarabine -- r_associated #0: 20 / 0.25 -> omalizumab
    n1=en:cytarabine | n2=omalizumab | rel=r_associated | relid=0 | w=20
  2857. en:cytarabine -- r_associated #0: 20 / 0.25 -> oméprazole
    n1=en:cytarabine | n2=oméprazole | rel=r_associated | relid=0 | w=20
  2858. en:cytarabine -- r_associated #0: 20 / 0.25 -> omeprazole
    n1=en:cytarabine | n2=omeprazole | rel=r_associated | relid=0 | w=20
  2859. en:cytarabine -- r_associated #0: 20 / 0.25 -> oxitriptan
    n1=en:cytarabine | n2=oxitriptan | rel=r_associated | relid=0 | w=20
  2860. en:cytarabine -- r_associated #0: 20 / 0.25 -> oxyde de magnésium
    n1=en:cytarabine | n2=oxyde de magnésium | rel=r_associated | relid=0 | w=20
  2861. en:cytarabine -- r_associated #0: 20 / 0.25 -> oxymétholone
    n1=en:cytarabine | n2=oxymétholone | rel=r_associated | relid=0 | w=20
  2862. en:cytarabine -- r_associated #0: 20 / 0.25 -> palbociclib
    n1=en:cytarabine | n2=palbociclib | rel=r_associated | relid=0 | w=20
  2863. en:cytarabine -- r_associated #0: 20 / 0.25 -> patch de nicotine
    n1=en:cytarabine | n2=patch de nicotine | rel=r_associated | relid=0 | w=20
  2864. en:cytarabine -- r_associated #0: 20 / 0.25 -> pénicillamine
    n1=en:cytarabine | n2=pénicillamine | rel=r_associated | relid=0 | w=20
  2865. en:cytarabine -- r_associated #0: 20 / 0.25 -> pentamidine
    n1=en:cytarabine | n2=pentamidine | rel=r_associated | relid=0 | w=20
  2866. en:cytarabine -- r_associated #0: 20 / 0.25 -> pentoxifylline
    n1=en:cytarabine | n2=pentoxifylline | rel=r_associated | relid=0 | w=20
  2867. en:cytarabine -- r_associated #0: 20 / 0.25 -> peptides hydrolases
    n1=en:cytarabine | n2=peptides hydrolases | rel=r_associated | relid=0 | w=20
  2868. en:cytarabine -- r_associated #0: 20 / 0.25 -> pesticide
    n1=en:cytarabine | n2=pesticide | rel=r_associated | relid=0 | w=20
  2869. en:cytarabine -- r_associated #0: 20 / 0.25 -> phénobarbital
    n1=en:cytarabine | n2=phénobarbital | rel=r_associated | relid=0 | w=20
  2870. en:cytarabine -- r_associated #0: 20 / 0.25 -> phylloquinone
    n1=en:cytarabine | n2=phylloquinone | rel=r_associated | relid=0 | w=20
  2871. en:cytarabine -- r_associated #0: 20 / 0.25 -> phytoménadione
    n1=en:cytarabine | n2=phytoménadione | rel=r_associated | relid=0 | w=20
  2872. en:cytarabine -- r_associated #0: 20 / 0.25 -> phytonadione
    n1=en:cytarabine | n2=phytonadione | rel=r_associated | relid=0 | w=20
  2873. en:cytarabine -- r_associated #0: 20 / 0.25 -> pierre à savon
    n1=en:cytarabine | n2=pierre à savon | rel=r_associated | relid=0 | w=20
  2874. en:cytarabine -- r_associated #0: 20 / 0.25 -> Pierre à savon
    n1=en:cytarabine | n2=Pierre à savon | rel=r_associated | relid=0 | w=20
  2875. en:cytarabine -- r_associated #0: 20 / 0.25 -> pimecrolimus
    n1=en:cytarabine | n2=pimecrolimus | rel=r_associated | relid=0 | w=20
  2876. en:cytarabine -- r_associated #0: 20 / 0.25 -> piroxicam
    n1=en:cytarabine | n2=piroxicam | rel=r_associated | relid=0 | w=20
  2877. en:cytarabine -- r_associated #0: 20 / 0.25 -> polydextrose
    n1=en:cytarabine | n2=polydextrose | rel=r_associated | relid=0 | w=20
  2878. en:cytarabine -- r_associated #0: 20 / 0.25 -> polyéthylène glycol
    n1=en:cytarabine | n2=polyéthylène glycol | rel=r_associated | relid=0 | w=20
  2879. en:cytarabine -- r_associated #0: 20 / 0.25 -> ponesimod
    n1=en:cytarabine | n2=ponesimod | rel=r_associated | relid=0 | w=20
  2880. en:cytarabine -- r_associated #0: 20 / 0.25 -> posaconazole
    n1=en:cytarabine | n2=posaconazole | rel=r_associated | relid=0 | w=20
  2881. en:cytarabine -- r_associated #0: 20 / 0.25 -> poudrer
    n1=en:cytarabine | n2=poudrer | rel=r_associated | relid=0 | w=20
  2882. en:cytarabine -- r_associated #0: 20 / 0.25 -> prastérone
    n1=en:cytarabine | n2=prastérone | rel=r_associated | relid=0 | w=20
  2883. en:cytarabine -- r_associated #0: 20 / 0.25 -> préparation d'hydrocortisone
    n1=en:cytarabine | n2=préparation d'hydrocortisone | rel=r_associated | relid=0 | w=20
  2884. en:cytarabine -- r_associated #0: 20 / 0.25 -> préparation de cortisol
    n1=en:cytarabine | n2=préparation de cortisol | rel=r_associated | relid=0 | w=20
  2885. en:cytarabine -- r_associated #0: 20 / 0.25 -> préparation du composé f
    n1=en:cytarabine | n2=préparation du composé f | rel=r_associated | relid=0 | w=20
  2886. en:cytarabine -- r_associated #0: 20 / 0.25 -> préparation du composé F
    n1=en:cytarabine | n2=préparation du composé F | rel=r_associated | relid=0 | w=20
  2887. en:cytarabine -- r_associated #0: 20 / 0.25 -> prochlorpérazine
    n1=en:cytarabine | n2=prochlorpérazine | rel=r_associated | relid=0 | w=20
  2888. en:cytarabine -- r_associated #0: 20 / 0.25 -> produit anesthésiant
    n1=en:cytarabine | n2=produit anesthésiant | rel=r_associated | relid=0 | w=20
  2889. en:cytarabine -- r_associated #0: 20 / 0.25 -> produit démaquillant
    n1=en:cytarabine | n2=produit démaquillant | rel=r_associated | relid=0 | w=20
  2890. en:cytarabine -- r_associated #0: 20 / 0.25 -> proflavine
    n1=en:cytarabine | n2=proflavine | rel=r_associated | relid=0 | w=20
  2891. en:cytarabine -- r_associated #0: 20 / 0.25 -> progestérone
    n1=en:cytarabine | n2=progestérone | rel=r_associated | relid=0 | w=20
  2892. en:cytarabine -- r_associated #0: 20 / 0.25 -> progestine
    n1=en:cytarabine | n2=progestine | rel=r_associated | relid=0 | w=20
  2893. en:cytarabine -- r_associated #0: 20 / 0.25 -> ramipril
    n1=en:cytarabine | n2=ramipril | rel=r_associated | relid=0 | w=20
  2894. en:cytarabine -- r_associated #0: 20 / 0.25 -> ramucirumab
    n1=en:cytarabine | n2=ramucirumab | rel=r_associated | relid=0 | w=20
  2895. en:cytarabine -- r_associated #0: 20 / 0.25 -> relaxant musculaire
    n1=en:cytarabine | n2=relaxant musculaire | rel=r_associated | relid=0 | w=20
  2896. en:cytarabine -- r_associated #0: 20 / 0.25 -> répondre à
    n1=en:cytarabine | n2=répondre à | rel=r_associated | relid=0 | w=20
  2897. en:cytarabine -- r_associated #0: 20 / 0.25 -> répondre à [qqn]
    n1=en:cytarabine | n2=répondre à [qqn] | rel=r_associated | relid=0 | w=20
  2898. en:cytarabine -- r_associated #0: 20 / 0.25 -> répondre à qn
    n1=en:cytarabine | n2=répondre à qn | rel=r_associated | relid=0 | w=20
  2899. en:cytarabine -- r_associated #0: 20 / 0.25 -> répondre à quelqu'un
    n1=en:cytarabine | n2=répondre à quelqu'un | rel=r_associated | relid=0 | w=20
  2900. en:cytarabine -- r_associated #0: 20 / 0.25 -> rituximab
    n1=en:cytarabine | n2=rituximab | rel=r_associated | relid=0 | w=20
  2901. en:cytarabine -- r_associated #0: 20 / 0.25 -> rivaroxaban
    n1=en:cytarabine | n2=rivaroxaban | rel=r_associated | relid=0 | w=20
  2902. en:cytarabine -- r_associated #0: 20 / 0.25 -> rutine
    n1=en:cytarabine | n2=rutine | rel=r_associated | relid=0 | w=20
  2903. en:cytarabine -- r_associated #0: 20 / 0.25 -> rutoside
    n1=en:cytarabine | n2=rutoside | rel=r_associated | relid=0 | w=20
  2904. en:cytarabine -- r_associated #0: 20 / 0.25 -> se joindre
    n1=en:cytarabine | n2=se joindre | rel=r_associated | relid=0 | w=20
  2905. en:cytarabine -- r_associated #0: 20 / 0.25 -> sel d'Epsom
    n1=en:cytarabine | n2=sel d'Epsom | rel=r_associated | relid=0 | w=20
  2906. en:cytarabine -- r_associated #0: 20 / 0.25 -> sel d'epsom
    n1=en:cytarabine | n2=sel d'epsom | rel=r_associated | relid=0 | w=20
  2907. en:cytarabine -- r_associated #0: 20 / 0.25 -> spanner
    n1=en:cytarabine | n2=spanner | rel=r_associated | relid=0 | w=20
  2908. en:cytarabine -- r_associated #0: 20 / 0.25 -> stéatite
    n1=en:cytarabine | n2=stéatite | rel=r_associated | relid=0 | w=20
  2909. en:cytarabine -- r_associated #0: 20 / 0.25 -> sulfate de magnésium
    n1=en:cytarabine | n2=sulfate de magnésium | rel=r_associated | relid=0 | w=20
  2910. en:cytarabine -- r_associated #0: 20 / 0.25 -> sulfate de zinc
    n1=en:cytarabine | n2=sulfate de zinc | rel=r_associated | relid=0 | w=20
  2911. en:cytarabine -- r_associated #0: 20 / 0.25 -> talc
    n1=en:cytarabine | n2=talc | rel=r_associated | relid=0 | w=20
  2912. en:cytarabine -- r_associated #0: 20 / 0.25 -> temsirolimus
    n1=en:cytarabine | n2=temsirolimus | rel=r_associated | relid=0 | w=20
  2913. en:cytarabine -- r_associated #0: 20 / 0.25 -> téniposide
    n1=en:cytarabine | n2=téniposide | rel=r_associated | relid=0 | w=20
  2914. en:cytarabine -- r_associated #0: 20 / 0.25 -> tératogène
    n1=en:cytarabine | n2=tératogène | rel=r_associated | relid=0 | w=20
  2915. en:cytarabine -- r_associated #0: 20 / 0.25 -> texte source
    n1=en:cytarabine | n2=texte source | rel=r_associated | relid=0 | w=20
  2916. en:cytarabine -- r_associated #0: 20 / 0.25 -> Thé noir
    n1=en:cytarabine | n2=Thé noir | rel=r_associated | relid=0 | w=20
  2917. en:cytarabine -- r_associated #0: 20 / 0.25 -> thé noir
    n1=en:cytarabine | n2=thé noir | rel=r_associated | relid=0 | w=20
  2918. en:cytarabine -- r_associated #0: 20 / 0.25 -> thiamine
    n1=en:cytarabine | n2=thiamine | rel=r_associated | relid=0 | w=20
  2919. en:cytarabine -- r_associated #0: 20 / 0.25 -> timbre anti-tabac
    n1=en:cytarabine | n2=timbre anti-tabac | rel=r_associated | relid=0 | w=20
  2920. en:cytarabine -- r_associated #0: 20 / 0.25 -> tocilizumab
    n1=en:cytarabine | n2=tocilizumab | rel=r_associated | relid=0 | w=20
  2921. en:cytarabine -- r_associated #0: 20 / 0.25 -> trastuzumab
    n1=en:cytarabine | n2=trastuzumab | rel=r_associated | relid=0 | w=20
  2922. en:cytarabine -- r_associated #0: 20 / 0.25 -> trétinoïne
    n1=en:cytarabine | n2=trétinoïne | rel=r_associated | relid=0 | w=20
  2923. en:cytarabine -- r_associated #0: 20 / 0.25 -> trioxyde d'arsenic
    n1=en:cytarabine | n2=trioxyde d'arsenic | rel=r_associated | relid=0 | w=20
  2924. en:cytarabine -- r_associated #0: 20 / 0.25 -> ustekinumab
    n1=en:cytarabine | n2=ustekinumab | rel=r_associated | relid=0 | w=20
  2925. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin anti-hépatite A
    n1=en:cytarabine | n2=vaccin anti-hépatite A | rel=r_associated | relid=0 | w=20
  2926. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin anti-hépatite B
    n1=en:cytarabine | n2=vaccin anti-hépatite B | rel=r_associated | relid=0 | w=20
  2927. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin anti-hépatite b
    n1=en:cytarabine | n2=vaccin anti-hépatite b | rel=r_associated | relid=0 | w=20
  2928. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin contre l'hépatite a
    n1=en:cytarabine | n2=vaccin contre l'hépatite a | rel=r_associated | relid=0 | w=20
  2929. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin contre l'hépatite A
    n1=en:cytarabine | n2=vaccin contre l'hépatite A | rel=r_associated | relid=0 | w=20
  2930. en:cytarabine -- r_associated #0: 20 / 0.25 -> Vaccin contre l'hépatite A
    n1=en:cytarabine | n2=Vaccin contre l'hépatite A | rel=r_associated | relid=0 | w=20
  2931. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin contre l'hépatite b
    n1=en:cytarabine | n2=vaccin contre l'hépatite b | rel=r_associated | relid=0 | w=20
  2932. en:cytarabine -- r_associated #0: 20 / 0.25 -> vaccin contre l'hépatite B
    n1=en:cytarabine | n2=vaccin contre l'hépatite B | rel=r_associated | relid=0 | w=20
  2933. en:cytarabine -- r_associated #0: 20 / 0.25 -> Valeriana
    n1=en:cytarabine | n2=Valeriana | rel=r_associated | relid=0 | w=20
  2934. en:cytarabine -- r_associated #0: 20 / 0.25 -> valériane
    n1=en:cytarabine | n2=valériane | rel=r_associated | relid=0 | w=20
  2935. en:cytarabine -- r_associated #0: 20 / 0.25 -> vancomycine
    n1=en:cytarabine | n2=vancomycine | rel=r_associated | relid=0 | w=20
  2936. en:cytarabine -- r_associated #0: 20 / 0.25 -> vedolizumab
    n1=en:cytarabine | n2=vedolizumab | rel=r_associated | relid=0 | w=20
  2937. en:cytarabine -- r_associated #0: 20 / 0.25 -> vinblastine
    n1=en:cytarabine | n2=vinblastine | rel=r_associated | relid=0 | w=20
  2938. en:cytarabine -- r_associated #0: 20 / 0.25 -> vitamine B1
    n1=en:cytarabine | n2=vitamine B1 | rel=r_associated | relid=0 | w=20
  2939. en:cytarabine -- r_associated #0: 20 / 0.25 -> vitamine K1
    n1=en:cytarabine | n2=vitamine K1 | rel=r_associated | relid=0 | w=20
  2940. en:cytarabine -- r_associated #0: 20 / 0.25 -> vitamine k1
    n1=en:cytarabine | n2=vitamine k1 | rel=r_associated | relid=0 | w=20
  2941. en:cytarabine -- r_associated #0: 20 / 0.25 -> Vitamine K1
    n1=en:cytarabine | n2=Vitamine K1 | rel=r_associated | relid=0 | w=20
  2942. en:cytarabine -- r_associated #0: 20 / 0.25 -> warfarine
    n1=en:cytarabine | n2=warfarine | rel=r_associated | relid=0 | w=20
  2943. en:cytarabine -- r_associated #0: 20 / 0.25 -> zidovudine
    n1=en:cytarabine | n2=zidovudine | rel=r_associated | relid=0 | w=20
  2944. en:cytarabine -- r_associated #0: 20 / 0.25 -> zolmitriptan
    n1=en:cytarabine | n2=zolmitriptan | rel=r_associated | relid=0 | w=20
  2945. en:cytarabine -- r_associated #0: 15 / 0.188 -> cytomégalovirus (infection congénitale à )
    n1=en:cytarabine | n2=cytomégalovirus (infection congénitale à ) | rel=r_associated | relid=0 | w=15
  2946. en:cytarabine -- r_associated #0: 5 / 0.063 -> agent antiviral
    n1=en:cytarabine | n2=agent antiviral | rel=r_associated | relid=0 | w=5
  2947. en:cytarabine -- r_associated #0: 5 / 0.063 -> en:medicament
    n1=en:cytarabine | n2=en:medicament | rel=r_associated | relid=0 | w=5
  2948. en:cytarabine -- r_associated #0: 5 / 0.063 -> en:medicine
    n1=en:cytarabine | n2=en:medicine | rel=r_associated | relid=0 | w=5
  2949. en:cytarabine -- r_associated #0: 5 / 0.063 -> en:tablet
    n1=en:cytarabine | n2=en:tablet | rel=r_associated | relid=0 | w=5
  2950. en:cytarabine -- r_associated #0: 5 / 0.063 -> medicament
    n1=en:cytarabine | n2=medicament | rel=r_associated | relid=0 | w=5
  2951. en:cytarabine -- r_associated #0: 5 / 0.063 -> médicaments
    n1=en:cytarabine | n2=médicaments | rel=r_associated | relid=0 | w=5
  2952. en:cytarabine -- r_associated #0: 5 / 0.063 -> pharmacie
    n1=en:cytarabine | n2=pharmacie | rel=r_associated | relid=0 | w=5
≈ 3499 relations entrantes

  1. talc --- r_associated #0: 345 --> en:cytarabine
    n1=talc | n2=en:cytarabine | rel=r_associated | relid=0 | w=345
  2. en:talc --- r_associated #0: 343 --> en:cytarabine
    n1=en:talc | n2=en:cytarabine | rel=r_associated | relid=0 | w=343
  3. fluorouracile --- r_associated #0: 254 --> en:cytarabine
    n1=fluorouracile | n2=en:cytarabine | rel=r_associated | relid=0 | w=254
  4. en:fluorouracil --- r_associated #0: 253 --> en:cytarabine
    n1=en:fluorouracil | n2=en:cytarabine | rel=r_associated | relid=0 | w=253
  5. Vitamine K1 --- r_associated #0: 250 --> en:cytarabine
    n1=Vitamine K1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=250
  6. vitamine K1 --- r_associated #0: 246 --> en:cytarabine
    n1=vitamine K1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=246
  7. vitamine k1 --- r_associated #0: 241 --> en:cytarabine
    n1=vitamine k1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=241
  8. en:haemato fu --- r_associated #0: 239 --> en:cytarabine
    n1=en:haemato fu | n2=en:cytarabine | rel=r_associated | relid=0 | w=239
  9. thé noir --- r_associated #0: 230 --> en:cytarabine
    n1=thé noir | n2=en:cytarabine | rel=r_associated | relid=0 | w=230
  10. en:black tea --- r_associated #0: 227 --> en:cytarabine
    n1=en:black tea | n2=en:cytarabine | rel=r_associated | relid=0 | w=227
  11. hydrocortisones --- r_associated #0: 220 --> en:cytarabine
    n1=hydrocortisones | n2=en:cytarabine | rel=r_associated | relid=0 | w=220
  12. préparation d'hydrocortisone --- r_associated #0: 220 --> en:cytarabine
    n1=préparation d'hydrocortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=220
  13. préparation de cortisol --- r_associated #0: 220 --> en:cytarabine
    n1=préparation de cortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=220
  14. préparation du composé f --- r_associated #0: 220 --> en:cytarabine
    n1=préparation du composé f | n2=en:cytarabine | rel=r_associated | relid=0 | w=220
  15. en:hydrocortisone --- r_associated #0: 216 --> en:cytarabine
    n1=en:hydrocortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=216
  16. cortisol --- r_associated #0: 215 --> en:cytarabine
    n1=cortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=215
  17. hydrocortisone --- r_associated #0: 212 --> en:cytarabine
    n1=hydrocortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=212
  18. vancomycine --- r_associated #0: 210 --> en:cytarabine
    n1=vancomycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=210
  19. en:vancomycin --- r_associated #0: 207 --> en:cytarabine
    n1=en:vancomycin | n2=en:cytarabine | rel=r_associated | relid=0 | w=207
  20. en:cortisol --- r_associated #0: 195 --> en:cytarabine
    n1=en:cortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=195
  21. eau distillée --- r_associated #0: 180 --> en:cytarabine
    n1=eau distillée | n2=en:cytarabine | rel=r_associated | relid=0 | w=180
  22. en:distilled water --- r_associated #0: 179 --> en:cytarabine
    n1=en:distilled water | n2=en:cytarabine | rel=r_associated | relid=0 | w=179
  23. produit anesthésiant --- r_associated #0: 177 --> en:cytarabine
    n1=produit anesthésiant | n2=en:cytarabine | rel=r_associated | relid=0 | w=177
  24. en:anesthetic agent --- r_associated #0: 174 --> en:cytarabine
    n1=en:anesthetic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=174
  25. en:talcum powder --- r_associated #0: 173 --> en:cytarabine
    n1=en:talcum powder | n2=en:cytarabine | rel=r_associated | relid=0 | w=173
  26. en:lamivudine --- r_associated #0: 163 --> en:cytarabine
    n1=en:lamivudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=163
  27. 3TC --- r_associated #0: 162 --> en:cytarabine
    n1=3TC | n2=en:cytarabine | rel=r_associated | relid=0 | w=162
  28. en:steatite --- r_associated #0: 160 --> en:cytarabine
    n1=en:steatite | n2=en:cytarabine | rel=r_associated | relid=0 | w=160
  29. cobalamine --- r_associated #0: 159 --> en:cytarabine
    n1=cobalamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=159
  30. lamivudine --- r_associated #0: 159 --> en:cytarabine
    n1=lamivudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=159
  31. anesthésique --- r_associated #0: 155 --> en:cytarabine
    n1=anesthésique | n2=en:cytarabine | rel=r_associated | relid=0 | w=155
  32. en:biological agent --- r_associated #0: 155 --> en:cytarabine
    n1=en:biological agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=155
  33. en:cobalamin --- r_associated #0: 155 --> en:cytarabine
    n1=en:cobalamin | n2=en:cytarabine | rel=r_associated | relid=0 | w=155
  34. agent biologique --- r_associated #0: 154 --> en:cytarabine
    n1=agent biologique | n2=en:cytarabine | rel=r_associated | relid=0 | w=154
  35. en:soapstone --- r_associated #0: 150 --> en:cytarabine
    n1=en:soapstone | n2=en:cytarabine | rel=r_associated | relid=0 | w=150
  36. immunomodulateurs --- r_associated #0: 150 --> en:cytarabine
    n1=immunomodulateurs | n2=en:cytarabine | rel=r_associated | relid=0 | w=150
  37. phytonadione --- r_associated #0: 150 --> en:cytarabine
    n1=phytonadione | n2=en:cytarabine | rel=r_associated | relid=0 | w=150
  38. pierre à savon --- r_associated #0: 150 --> en:cytarabine
    n1=pierre à savon | n2=en:cytarabine | rel=r_associated | relid=0 | w=150
  39. en:immunomodulators --- r_associated #0: 147 --> en:cytarabine
    n1=en:immunomodulators | n2=en:cytarabine | rel=r_associated | relid=0 | w=147
  40. en:phytonadione --- r_associated #0: 147 --> en:cytarabine
    n1=en:phytonadione | n2=en:cytarabine | rel=r_associated | relid=0 | w=147
  41. préparation du composé F --- r_associated #0: 145 --> en:cytarabine
    n1=préparation du composé F | n2=en:cytarabine | rel=r_associated | relid=0 | w=145
  42. en:human menopausal gonadotropin --- r_associated #0: 141 --> en:cytarabine
    n1=en:human menopausal gonadotropin | n2=en:cytarabine | rel=r_associated | relid=0 | w=141
  43. médicaments animaux --- r_associated #0: 141 --> en:cytarabine
    n1=médicaments animaux | n2=en:cytarabine | rel=r_associated | relid=0 | w=141
  44. en:talcum --- r_associated #0: 140 --> en:cytarabine
    n1=en:talcum | n2=en:cytarabine | rel=r_associated | relid=0 | w=140
  45. en:zidovudine --- r_associated #0: 140 --> en:cytarabine
    n1=en:zidovudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=140
  46. gonadotrophine ménopausique humaine --- r_associated #0: 140 --> en:cytarabine
    n1=gonadotrophine ménopausique humaine | n2=en:cytarabine | rel=r_associated | relid=0 | w=140
  47. phytoménadione --- r_associated #0: 140 --> en:cytarabine
    n1=phytoménadione | n2=en:cytarabine | rel=r_associated | relid=0 | w=140
  48. médicaments vétérinaires --- r_associated #0: 137 --> en:cytarabine
    n1=médicaments vétérinaires | n2=en:cytarabine | rel=r_associated | relid=0 | w=137
  49. zidovudine --- r_associated #0: 137 --> en:cytarabine
    n1=zidovudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=137
  50. en:veterinary drugs --- r_associated #0: 136 --> en:cytarabine
    n1=en:veterinary drugs | n2=en:cytarabine | rel=r_associated | relid=0 | w=136
  51. facteurs biologiques --- r_associated #0: 134 --> en:cytarabine
    n1=facteurs biologiques | n2=en:cytarabine | rel=r_associated | relid=0 | w=134
  52. en:biological factors --- r_associated #0: 133 --> en:cytarabine
    n1=en:biological factors | n2=en:cytarabine | rel=r_associated | relid=0 | w=133
  53. éponge de gélatine résorbable --- r_associated #0: 131 --> en:cytarabine
    n1=éponge de gélatine résorbable | n2=en:cytarabine | rel=r_associated | relid=0 | w=131
  54. phylloquinone --- r_associated #0: 130 --> en:cytarabine
    n1=phylloquinone | n2=en:cytarabine | rel=r_associated | relid=0 | w=130
  55. en:absorbable gelatin sponge --- r_associated #0: 129 --> en:cytarabine
    n1=en:absorbable gelatin sponge | n2=en:cytarabine | rel=r_associated | relid=0 | w=129
  56. citrate de clomifène --- r_associated #0: 125 --> en:cytarabine
    n1=citrate de clomifène | n2=en:cytarabine | rel=r_associated | relid=0 | w=125
  57. en:clomiphene citrate --- r_associated #0: 125 --> en:cytarabine
    n1=en:clomiphene citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=125
  58. en:ethosuximide --- r_associated #0: 125 --> en:cytarabine
    n1=en:ethosuximide | n2=en:cytarabine | rel=r_associated | relid=0 | w=125
  59. en:gelatin sponge, absorbable --- r_associated #0: 125 --> en:cytarabine
    n1=en:gelatin sponge, absorbable | n2=en:cytarabine | rel=r_associated | relid=0 | w=125
  60. en:teratogen --- r_associated #0: 125 --> en:cytarabine
    n1=en:teratogen | n2=en:cytarabine | rel=r_associated | relid=0 | w=125
  61. tératogène --- r_associated #0: 123 --> en:cytarabine
    n1=tératogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=123
  62. sel d'Epsom --- r_associated #0: 122 --> en:cytarabine
    n1=sel d'Epsom | n2=en:cytarabine | rel=r_associated | relid=0 | w=122
  63. éthosuximide --- r_associated #0: 122 --> en:cytarabine
    n1=éthosuximide | n2=en:cytarabine | rel=r_associated | relid=0 | w=122
  64. citrate de clomiphène --- r_associated #0: 121 --> en:cytarabine
    n1=citrate de clomiphène | n2=en:cytarabine | rel=r_associated | relid=0 | w=121
  65. en:magnesium sulfate --- r_associated #0: 119 --> en:cytarabine
    n1=en:magnesium sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=119
  66. anæsthésique --- r_associated #0: 118 --> en:cytarabine
    n1=anæsthésique | n2=en:cytarabine | rel=r_associated | relid=0 | w=118
  67. gluconate de cuivre --- r_associated #0: 117 --> en:cytarabine
    n1=gluconate de cuivre | n2=en:cytarabine | rel=r_associated | relid=0 | w=117
  68. pénicillamine --- r_associated #0: 116 --> en:cytarabine
    n1=pénicillamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=116
  69. acarbose --- r_associated #0: 115 --> en:cytarabine
    n1=acarbose | n2=en:cytarabine | rel=r_associated | relid=0 | w=115
  70. en:copper gluconate --- r_associated #0: 115 --> en:cytarabine
    n1=en:copper gluconate | n2=en:cytarabine | rel=r_associated | relid=0 | w=115
  71. en:magnesium sulphate --- r_associated #0: 115 --> en:cytarabine
    n1=en:magnesium sulphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=115
  72. en:penicillamine --- r_associated #0: 115 --> en:cytarabine
    n1=en:penicillamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=115
  73. immuno-modulateurs --- r_associated #0: 115 --> en:cytarabine
    n1=immuno-modulateurs | n2=en:cytarabine | rel=r_associated | relid=0 | w=115
  74. chlorhydrate de doxorubicine --- r_associated #0: 114 --> en:cytarabine
    n1=chlorhydrate de doxorubicine | n2=en:cytarabine | rel=r_associated | relid=0 | w=114
  75. cimétidine --- r_associated #0: 113 --> en:cytarabine
    n1=cimétidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=113
  76. en:acarbose --- r_associated #0: 113 --> en:cytarabine
    n1=en:acarbose | n2=en:cytarabine | rel=r_associated | relid=0 | w=113
  77. en:doxorubicin hydrochloride --- r_associated #0: 113 --> en:cytarabine
    n1=en:doxorubicin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=113
  78. en:histamine dihydrochloride --- r_associated #0: 112 --> en:cytarabine
    n1=en:histamine dihydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=112
  79. pesticide --- r_associated #0: 112 --> en:cytarabine
    n1=pesticide | n2=en:cytarabine | rel=r_associated | relid=0 | w=112
  80. isoniazide --- r_associated #0: 111 --> en:cytarabine
    n1=isoniazide | n2=en:cytarabine | rel=r_associated | relid=0 | w=111
  81. allergie aux médicaments --- r_associated #0: 110 --> en:cytarabine
    n1=allergie aux médicaments | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  82. en:cimetidine --- r_associated #0: 110 --> en:cytarabine
    n1=en:cimetidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  83. en:drug allergy --- r_associated #0: 110 --> en:cytarabine
    n1=en:drug allergy | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  84. en:isoniazid --- r_associated #0: 110 --> en:cytarabine
    n1=en:isoniazid | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  85. en:pesticide --- r_associated #0: 110 --> en:cytarabine
    n1=en:pesticide | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  86. oméprazole --- r_associated #0: 110 --> en:cytarabine
    n1=oméprazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  87. sulfate de magnésium --- r_associated #0: 110 --> en:cytarabine
    n1=sulfate de magnésium | n2=en:cytarabine | rel=r_associated | relid=0 | w=110
  88. allergie médicamenteuse --- r_associated #0: 109 --> en:cytarabine
    n1=allergie médicamenteuse | n2=en:cytarabine | rel=r_associated | relid=0 | w=109
  89. isotrétinoïne --- r_associated #0: 109 --> en:cytarabine
    n1=isotrétinoïne | n2=en:cytarabine | rel=r_associated | relid=0 | w=109
  90. dichlorhydrate d'histamine --- r_associated #0: 108 --> en:cytarabine
    n1=dichlorhydrate d'histamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=108
  91. en:omeprazole --- r_associated #0: 108 --> en:cytarabine
    n1=en:omeprazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=108
  92. Valeriana --- r_associated #0: 107 --> en:cytarabine
    n1=Valeriana | n2=en:cytarabine | rel=r_associated | relid=0 | w=107
  93. allergie à un médicament --- r_associated #0: 105 --> en:cytarabine
    n1=allergie à un médicament | n2=en:cytarabine | rel=r_associated | relid=0 | w=105
  94. en:isotretinoin --- r_associated #0: 105 --> en:cytarabine
    n1=en:isotretinoin | n2=en:cytarabine | rel=r_associated | relid=0 | w=105
  95. en:valerian --- r_associated #0: 105 --> en:cytarabine
    n1=en:valerian | n2=en:cytarabine | rel=r_associated | relid=0 | w=105
  96. omeprazole --- r_associated #0: 105 --> en:cytarabine
    n1=omeprazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=105
  97. polyéthylène glycol --- r_associated #0: 105 --> en:cytarabine
    n1=polyéthylène glycol | n2=en:cytarabine | rel=r_associated | relid=0 | w=105
  98. en:ipilimumab --- r_associated #0: 104 --> en:cytarabine
    n1=en:ipilimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=104
  99. indométhacine --- r_associated #0: 104 --> en:cytarabine
    n1=indométhacine | n2=en:cytarabine | rel=r_associated | relid=0 | w=104
  100. capsaïcine --- r_associated #0: 103 --> en:cytarabine
    n1=capsaïcine | n2=en:cytarabine | rel=r_associated | relid=0 | w=103
  101. en:capsaicin --- r_associated #0: 103 --> en:cytarabine
    n1=en:capsaicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=103
  102. en:polyethylene glycol --- r_associated #0: 103 --> en:cytarabine
    n1=en:polyethylene glycol | n2=en:cytarabine | rel=r_associated | relid=0 | w=103
  103. mutagène --- r_associated #0: 103 --> en:cytarabine
    n1=mutagène | n2=en:cytarabine | rel=r_associated | relid=0 | w=103
  104. aténolol --- r_associated #0: 101 --> en:cytarabine
    n1=aténolol | n2=en:cytarabine | rel=r_associated | relid=0 | w=101
  105. dextrane --- r_associated #0: 101 --> en:cytarabine
    n1=dextrane | n2=en:cytarabine | rel=r_associated | relid=0 | w=101
  106. ipilimumab --- r_associated #0: 101 --> en:cytarabine
    n1=ipilimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=101
  107. nadolol --- r_associated #0: 101 --> en:cytarabine
    n1=nadolol | n2=en:cytarabine | rel=r_associated | relid=0 | w=101
  108. en:Epsom salt --- r_associated #0: 100 --> en:cytarabine
    n1=en:Epsom salt | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  109. en:atenolol --- r_associated #0: 100 --> en:cytarabine
    n1=en:atenolol | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  110. en:genistein --- r_associated #0: 100 --> en:cytarabine
    n1=en:genistein | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  111. en:indomethacin --- r_associated #0: 100 --> en:cytarabine
    n1=en:indomethacin | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  112. en:mutagen --- r_associated #0: 100 --> en:cytarabine
    n1=en:mutagen | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  113. en:nadolol --- r_associated #0: 100 --> en:cytarabine
    n1=en:nadolol | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  114. insuline ordinaire --- r_associated #0: 100 --> en:cytarabine
    n1=insuline ordinaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  115. lévofloxacine --- r_associated #0: 100 --> en:cytarabine
    n1=lévofloxacine | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  116. valériane --- r_associated #0: 100 --> en:cytarabine
    n1=valériane | n2=en:cytarabine | rel=r_associated | relid=0 | w=100
  117. en:dextran --- r_associated #0: 99 --> en:cytarabine
    n1=en:dextran | n2=en:cytarabine | rel=r_associated | relid=0 | w=99
  118. génistéine --- r_associated #0: 99 --> en:cytarabine
    n1=génistéine | n2=en:cytarabine | rel=r_associated | relid=0 | w=99
  119. niacinamide --- r_associated #0: 99 --> en:cytarabine
    n1=niacinamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=99
  120. pentamidine --- r_associated #0: 99 --> en:cytarabine
    n1=pentamidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=99
  121. phénobarbital --- r_associated #0: 99 --> en:cytarabine
    n1=phénobarbital | n2=en:cytarabine | rel=r_associated | relid=0 | w=99
  122. en:insulin, regular --- r_associated #0: 97 --> en:cytarabine
    n1=en:insulin, regular | n2=en:cytarabine | rel=r_associated | relid=0 | w=97
  123. dobutamine --- r_associated #0: 96 --> en:cytarabine
    n1=dobutamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=96
  124. en:levofloxacin --- r_associated #0: 96 --> en:cytarabine
    n1=en:levofloxacin | n2=en:cytarabine | rel=r_associated | relid=0 | w=96
  125. en:phenobarbital --- r_associated #0: 96 --> en:cytarabine
    n1=en:phenobarbital | n2=en:cytarabine | rel=r_associated | relid=0 | w=96
  126. acitrétine --- r_associated #0: 95 --> en:cytarabine
    n1=acitrétine | n2=en:cytarabine | rel=r_associated | relid=0 | w=95
  127. acénocoumarol --- r_associated #0: 95 --> en:cytarabine
    n1=acénocoumarol | n2=en:cytarabine | rel=r_associated | relid=0 | w=95
  128. en:dobutamine --- r_associated #0: 95 --> en:cytarabine
    n1=en:dobutamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=95
  129. en:niacinamide --- r_associated #0: 95 --> en:cytarabine
    n1=en:niacinamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=95
  130. en:pentamidine --- r_associated #0: 95 --> en:cytarabine
    n1=en:pentamidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=95
  131. cétirizine --- r_associated #0: 93 --> en:cytarabine
    n1=cétirizine | n2=en:cytarabine | rel=r_associated | relid=0 | w=93
  132. en:acenocoumarol --- r_associated #0: 93 --> en:cytarabine
    n1=en:acenocoumarol | n2=en:cytarabine | rel=r_associated | relid=0 | w=93
  133. en:acitretin --- r_associated #0: 93 --> en:cytarabine
    n1=en:acitretin | n2=en:cytarabine | rel=r_associated | relid=0 | w=93
  134. dextran --- r_associated #0: 92 --> en:cytarabine
    n1=dextran | n2=en:cytarabine | rel=r_associated | relid=0 | w=92
  135. en:cetirizine --- r_associated #0: 92 --> en:cytarabine
    n1=en:cetirizine | n2=en:cytarabine | rel=r_associated | relid=0 | w=92
  136. en:apixaban --- r_associated #0: 90 --> en:cytarabine
    n1=en:apixaban | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  137. en:baricitinib --- r_associated #0: 90 --> en:cytarabine
    n1=en:baricitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  138. en:diethylstilbestrol --- r_associated #0: 90 --> en:cytarabine
    n1=en:diethylstilbestrol | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  139. en:macitentan --- r_associated #0: 90 --> en:cytarabine
    n1=en:macitentan | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  140. en:regular insulin --- r_associated #0: 90 --> en:cytarabine
    n1=en:regular insulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  141. inuline --- r_associated #0: 90 --> en:cytarabine
    n1=inuline | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  142. méthoxsalène --- r_associated #0: 90 --> en:cytarabine
    n1=méthoxsalène | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  143. naproxène --- r_associated #0: 90 --> en:cytarabine
    n1=naproxène | n2=en:cytarabine | rel=r_associated | relid=0 | w=90
  144. liraglutide --- r_associated #0: 89 --> en:cytarabine
    n1=liraglutide | n2=en:cytarabine | rel=r_associated | relid=0 | w=89
  145. lovastatine --- r_associated #0: 89 --> en:cytarabine
    n1=lovastatine | n2=en:cytarabine | rel=r_associated | relid=0 | w=89
  146. acétylcystéine --- r_associated #0: 88 --> en:cytarabine
    n1=acétylcystéine | n2=en:cytarabine | rel=r_associated | relid=0 | w=88
  147. en:metronidazole hydrochloride --- r_associated #0: 88 --> en:cytarabine
    n1=en:metronidazole hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=88
  148. en:naproxen --- r_associated #0: 88 --> en:cytarabine
    n1=en:naproxen | n2=en:cytarabine | rel=r_associated | relid=0 | w=88
  149. macitentan --- r_associated #0: 88 --> en:cytarabine
    n1=macitentan | n2=en:cytarabine | rel=r_associated | relid=0 | w=88
  150. novobiocine --- r_associated #0: 88 --> en:cytarabine
    n1=novobiocine | n2=en:cytarabine | rel=r_associated | relid=0 | w=88
  151. antibiotique --- r_associated #0: 87 --> en:cytarabine
    n1=antibiotique | n2=en:cytarabine | rel=r_associated | relid=0 | w=87
  152. apixaban --- r_associated #0: 87 --> en:cytarabine
    n1=apixaban | n2=en:cytarabine | rel=r_associated | relid=0 | w=87
  153. baricitinib --- r_associated #0: 87 --> en:cytarabine
    n1=baricitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=87
  154. en:inulin --- r_associated #0: 87 --> en:cytarabine
    n1=en:inulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=87
  155. en:methoxsalen --- r_associated #0: 87 --> en:cytarabine
    n1=en:methoxsalen | n2=en:cytarabine | rel=r_associated | relid=0 | w=87
  156. arsenic blanc --- r_associated #0: 86 --> en:cytarabine
    n1=arsenic blanc | n2=en:cytarabine | rel=r_associated | relid=0 | w=86
  157. cis-diaminedichloroplatine --- r_associated #0: 86 --> en:cytarabine
    n1=cis-diaminedichloroplatine | n2=en:cytarabine | rel=r_associated | relid=0 | w=86
  158. diéthylstilbestrol --- r_associated #0: 86 --> en:cytarabine
    n1=diéthylstilbestrol | n2=en:cytarabine | rel=r_associated | relid=0 | w=86
  159. en:angiostatin --- r_associated #0: 86 --> en:cytarabine
    n1=en:angiostatin | n2=en:cytarabine | rel=r_associated | relid=0 | w=86
  160. agent antibactérien --- r_associated #0: 85 --> en:cytarabine
    n1=agent antibactérien | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  161. chlorhydrate de métronidazole --- r_associated #0: 85 --> en:cytarabine
    n1=chlorhydrate de métronidazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  162. en:11 epicortisol --- r_associated #0: 85 --> en:cytarabine
    n1=en:11 epicortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  163. en:acetylcysteine --- r_associated #0: 85 --> en:cytarabine
    n1=en:acetylcysteine | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  164. en:antibacterial agent --- r_associated #0: 85 --> en:cytarabine
    n1=en:antibacterial agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  165. en:antibiotic --- r_associated #0: 85 --> en:cytarabine
    n1=en:antibiotic | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  166. en:bevacizumab --- r_associated #0: 85 --> en:cytarabine
    n1=en:bevacizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  167. en:famitinib --- r_associated #0: 85 --> en:cytarabine
    n1=en:famitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  168. en:liraglutide --- r_associated #0: 85 --> en:cytarabine
    n1=en:liraglutide | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  169. en:lovastatin --- r_associated #0: 85 --> en:cytarabine
    n1=en:lovastatin | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  170. en:natalizumab --- r_associated #0: 85 --> en:cytarabine
    n1=en:natalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  171. en:novobiocin --- r_associated #0: 85 --> en:cytarabine
    n1=en:novobiocin | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  172. en:pimecrolimus --- r_associated #0: 85 --> en:cytarabine
    n1=en:pimecrolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  173. glutathion --- r_associated #0: 85 --> en:cytarabine
    n1=glutathion | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  174. mitoguazones --- r_associated #0: 85 --> en:cytarabine
    n1=mitoguazones | n2=en:cytarabine | rel=r_associated | relid=0 | w=85
  175. cannabidiol --- r_associated #0: 84 --> en:cytarabine
    n1=cannabidiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=84
  176. cannabinol --- r_associated #0: 84 --> en:cytarabine
    n1=cannabinol | n2=en:cytarabine | rel=r_associated | relid=0 | w=84
  177. en:arsenic trioxide --- r_associated #0: 84 --> en:cytarabine
    n1=en:arsenic trioxide | n2=en:cytarabine | rel=r_associated | relid=0 | w=84
  178. en:cisplatin --- r_associated #0: 84 --> en:cytarabine
    n1=en:cisplatin | n2=en:cytarabine | rel=r_associated | relid=0 | w=84
  179. modafinil --- r_associated #0: 84 --> en:cytarabine
    n1=modafinil | n2=en:cytarabine | rel=r_associated | relid=0 | w=84
  180. Azadirachta indica --- r_associated #0: 83 --> en:cytarabine
    n1=Azadirachta indica | n2=en:cytarabine | rel=r_associated | relid=0 | w=83
  181. angiostatine --- r_associated #0: 83 --> en:cytarabine
    n1=angiostatine | n2=en:cytarabine | rel=r_associated | relid=0 | w=83
  182. flucytosine --- r_associated #0: 83 --> en:cytarabine
    n1=flucytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=83
  183. pimecrolimus --- r_associated #0: 83 --> en:cytarabine
    n1=pimecrolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=83
  184. cetuximab --- r_associated #0: 82 --> en:cytarabine
    n1=cetuximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=82
  185. digitoxine --- r_associated #0: 82 --> en:cytarabine
    n1=digitoxine | n2=en:cytarabine | rel=r_associated | relid=0 | w=82
  186. en:cortifair --- r_associated #0: 82 --> en:cytarabine
    n1=en:cortifair | n2=en:cytarabine | rel=r_associated | relid=0 | w=82
  187. en:mitoguazone --- r_associated #0: 82 --> en:cytarabine
    n1=en:mitoguazone | n2=en:cytarabine | rel=r_associated | relid=0 | w=82
  188. famitinib --- r_associated #0: 82 --> en:cytarabine
    n1=famitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=82
  189. natalizumab --- r_associated #0: 82 --> en:cytarabine
    n1=natalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=82
  190. anhydride arsénieux --- r_associated #0: 81 --> en:cytarabine
    n1=anhydride arsénieux | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  191. bevacizumab --- r_associated #0: 81 --> en:cytarabine
    n1=bevacizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  192. curcumine --- r_associated #0: 81 --> en:cytarabine
    n1=curcumine | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  193. en:azadirachta indica --- r_associated #0: 81 --> en:cytarabine
    n1=en:azadirachta indica | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  194. en:glutathione --- r_associated #0: 81 --> en:cytarabine
    n1=en:glutathione | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  195. pentoxifylline --- r_associated #0: 81 --> en:cytarabine
    n1=pentoxifylline | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  196. trioxyde d'arsenic --- r_associated #0: 81 --> en:cytarabine
    n1=trioxyde d'arsenic | n2=en:cytarabine | rel=r_associated | relid=0 | w=81
  197. antimétabolite --- r_associated #0: 80 --> en:cytarabine
    n1=antimétabolite | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  198. belimumab --- r_associated #0: 80 --> en:cytarabine
    n1=belimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  199. en:cannabidiol --- r_associated #0: 80 --> en:cytarabine
    n1=en:cannabidiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  200. en:cannabinol --- r_associated #0: 80 --> en:cytarabine
    n1=en:cannabinol | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  201. en:cetuximab --- r_associated #0: 80 --> en:cytarabine
    n1=en:cetuximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  202. en:digitoxin --- r_associated #0: 80 --> en:cytarabine
    n1=en:digitoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  203. en:modafinil --- r_associated #0: 80 --> en:cytarabine
    n1=en:modafinil | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  204. en:pentoxifylline --- r_associated #0: 80 --> en:cytarabine
    n1=en:pentoxifylline | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  205. en:therapeutic hydrocortisone --- r_associated #0: 80 --> en:cytarabine
    n1=en:therapeutic hydrocortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  206. insuline normale --- r_associated #0: 80 --> en:cytarabine
    n1=insuline normale | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  207. peptides hydrolases --- r_associated #0: 80 --> en:cytarabine
    n1=peptides hydrolases | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  208. progestine --- r_associated #0: 80 --> en:cytarabine
    n1=progestine | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  209. ramucirumab --- r_associated #0: 80 --> en:cytarabine
    n1=ramucirumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=80
  210. cisplatine --- r_associated #0: 79 --> en:cytarabine
    n1=cisplatine | n2=en:cytarabine | rel=r_associated | relid=0 | w=79
  211. en:belimumab --- r_associated #0: 79 --> en:cytarabine
    n1=en:belimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=79
  212. en:flucytosine --- r_associated #0: 79 --> en:cytarabine
    n1=en:flucytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=79
  213. en:ramucirumab --- r_associated #0: 79 --> en:cytarabine
    n1=en:ramucirumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=79
  214. en:antimetabolite --- r_associated #0: 78 --> en:cytarabine
    n1=en:antimetabolite | n2=en:cytarabine | rel=r_associated | relid=0 | w=78
  215. en:clarithromycin --- r_associated #0: 78 --> en:cytarabine
    n1=en:clarithromycin | n2=en:cytarabine | rel=r_associated | relid=0 | w=78
  216. en:curcumin --- r_associated #0: 78 --> en:cytarabine
    n1=en:curcumin | n2=en:cytarabine | rel=r_associated | relid=0 | w=78
  217. en:methyl-gag --- r_associated #0: 78 --> en:cytarabine
    n1=en:methyl-gag | n2=en:cytarabine | rel=r_associated | relid=0 | w=78
  218. auranofine --- r_associated #0: 77 --> en:cytarabine
    n1=auranofine | n2=en:cytarabine | rel=r_associated | relid=0 | w=77
  219. en:progestin --- r_associated #0: 77 --> en:cytarabine
    n1=en:progestin | n2=en:cytarabine | rel=r_associated | relid=0 | w=77
  220. en:auranofin --- r_associated #0: 76 --> en:cytarabine
    n1=en:auranofin | n2=en:cytarabine | rel=r_associated | relid=0 | w=76
  221. en:peptides hydrolases --- r_associated #0: 76 --> en:cytarabine
    n1=en:peptides hydrolases | n2=en:cytarabine | rel=r_associated | relid=0 | w=76
  222. clarithromycine --- r_associated #0: 75 --> en:cytarabine
    n1=clarithromycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  223. en:amifampridine --- r_associated #0: 75 --> en:cytarabine
    n1=en:amifampridine | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  224. en:cabergoline --- r_associated #0: 75 --> en:cytarabine
    n1=en:cabergoline | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  225. en:emtricitabine --- r_associated #0: 75 --> en:cytarabine
    n1=en:emtricitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  226. en:filgrastim --- r_associated #0: 75 --> en:cytarabine
    n1=en:filgrastim | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  227. en:polydextrose --- r_associated #0: 75 --> en:cytarabine
    n1=en:polydextrose | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  228. en:posaconazole --- r_associated #0: 75 --> en:cytarabine
    n1=en:posaconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  229. piroxicam --- r_associated #0: 75 --> en:cytarabine
    n1=piroxicam | n2=en:cytarabine | rel=r_associated | relid=0 | w=75
  230. bléomycine sulfate --- r_associated #0: 74 --> en:cytarabine
    n1=bléomycine sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=74
  231. mitoguazone --- r_associated #0: 74 --> en:cytarabine
    n1=mitoguazone | n2=en:cytarabine | rel=r_associated | relid=0 | w=74
  232. amifampridine --- r_associated #0: 73 --> en:cytarabine
    n1=amifampridine | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  233. asparaginase --- r_associated #0: 73 --> en:cytarabine
    n1=asparaginase | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  234. busulfan --- r_associated #0: 73 --> en:cytarabine
    n1=busulfan | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  235. cabergoline --- r_associated #0: 73 --> en:cytarabine
    n1=cabergoline | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  236. cycloleucine --- r_associated #0: 73 --> en:cytarabine
    n1=cycloleucine | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  237. en:isavuconazole --- r_associated #0: 73 --> en:cytarabine
    n1=en:isavuconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  238. en:palbociclib --- r_associated #0: 73 --> en:cytarabine
    n1=en:palbociclib | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  239. inhibiteur enzymatique --- r_associated #0: 73 --> en:cytarabine
    n1=inhibiteur enzymatique | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  240. ionomycine --- r_associated #0: 73 --> en:cytarabine
    n1=ionomycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  241. polydextrose --- r_associated #0: 73 --> en:cytarabine
    n1=polydextrose | n2=en:cytarabine | rel=r_associated | relid=0 | w=73
  242. emtricitabine --- r_associated #0: 72 --> en:cytarabine
    n1=emtricitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  243. en:asparaginase --- r_associated #0: 72 --> en:cytarabine
    n1=en:asparaginase | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  244. en:bleomycin sulfate --- r_associated #0: 72 --> en:cytarabine
    n1=en:bleomycin sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  245. en:ionomycin --- r_associated #0: 72 --> en:cytarabine
    n1=en:ionomycin | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  246. en:piroxicam --- r_associated #0: 72 --> en:cytarabine
    n1=en:piroxicam | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  247. filgrastim --- r_associated #0: 72 --> en:cytarabine
    n1=filgrastim | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  248. posaconazole --- r_associated #0: 72 --> en:cytarabine
    n1=posaconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  249. poudrer --- r_associated #0: 72 --> en:cytarabine
    n1=poudrer | n2=en:cytarabine | rel=r_associated | relid=0 | w=72
  250. E1200 --- r_associated #0: 71 --> en:cytarabine
    n1=E1200 | n2=en:cytarabine | rel=r_associated | relid=0 | w=71
  251. cyclophosphamide --- r_associated #0: 71 --> en:cytarabine
    n1=cyclophosphamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=71
  252. en:busulfan --- r_associated #0: 71 --> en:cytarabine
    n1=en:busulfan | n2=en:cytarabine | rel=r_associated | relid=0 | w=71
  253. ponesimod --- r_associated #0: 71 --> en:cytarabine
    n1=ponesimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=71
  254. E100 --- r_associated #0: 70 --> en:cytarabine
    n1=E100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  255. E100(i) --- r_associated #0: 70 --> en:cytarabine
    n1=E100(i) | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  256. E1521 --- r_associated #0: 70 --> en:cytarabine
    n1=E1521 | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  257. en:Azadirachta indica --- r_associated #0: 70 --> en:cytarabine
    n1=en:Azadirachta indica | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  258. en:axitinib --- r_associated #0: 70 --> en:cytarabine
    n1=en:axitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  259. en:cycloleucine --- r_associated #0: 70 --> en:cytarabine
    n1=en:cycloleucine | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  260. en:daclatasvir --- r_associated #0: 70 --> en:cytarabine
    n1=en:daclatasvir | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  261. en:fludarabine --- r_associated #0: 70 --> en:cytarabine
    n1=en:fludarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  262. en:ponesimod --- r_associated #0: 70 --> en:cytarabine
    n1=en:ponesimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  263. en:put powder on something --- r_associated #0: 70 --> en:cytarabine
    n1=en:put powder on something | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  264. inhibiteur d'enzymes --- r_associated #0: 70 --> en:cytarabine
    n1=inhibiteur d'enzymes | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  265. isavuconazole --- r_associated #0: 70 --> en:cytarabine
    n1=isavuconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  266. palbociclib --- r_associated #0: 70 --> en:cytarabine
    n1=palbociclib | n2=en:cytarabine | rel=r_associated | relid=0 | w=70
  267. carmustine --- r_associated #0: 69 --> en:cytarabine
    n1=carmustine | n2=en:cytarabine | rel=r_associated | relid=0 | w=69
  268. daclatasvir --- r_associated #0: 69 --> en:cytarabine
    n1=daclatasvir | n2=en:cytarabine | rel=r_associated | relid=0 | w=69
  269. en:cyclophosphamide --- r_associated #0: 69 --> en:cytarabine
    n1=en:cyclophosphamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=69
  270. en:dasatinib --- r_associated #0: 69 --> en:cytarabine
    n1=en:dasatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=69
  271. en:enzyme inhibitor --- r_associated #0: 69 --> en:cytarabine
    n1=en:enzyme inhibitor | n2=en:cytarabine | rel=r_associated | relid=0 | w=69
  272. tocilizumab --- r_associated #0: 69 --> en:cytarabine
    n1=tocilizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=69
  273. dasatinib --- r_associated #0: 68 --> en:cytarabine
    n1=dasatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=68
  274. en:carmustine --- r_associated #0: 68 --> en:cytarabine
    n1=en:carmustine | n2=en:cytarabine | rel=r_associated | relid=0 | w=68
  275. axitinib --- r_associated #0: 67 --> en:cytarabine
    n1=axitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=67
  276. en:ceritinib --- r_associated #0: 67 --> en:cytarabine
    n1=en:ceritinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=67
  277. en:rivaroxaban --- r_associated #0: 67 --> en:cytarabine
    n1=en:rivaroxaban | n2=en:cytarabine | rel=r_associated | relid=0 | w=67
  278. ceritinib --- r_associated #0: 66 --> en:cytarabine
    n1=ceritinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=66
  279. fludarabine --- r_associated #0: 66 --> en:cytarabine
    n1=fludarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=66
  280. antienzyme --- r_associated #0: 65 --> en:cytarabine
    n1=antienzyme | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  281. en:olanzapine --- r_associated #0: 65 --> en:cytarabine
    n1=en:olanzapine | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  282. en:put talc on something --- r_associated #0: 65 --> en:cytarabine
    n1=en:put talc on something | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  283. en:temsirolimus --- r_associated #0: 65 --> en:cytarabine
    n1=en:temsirolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  284. en:tocilizumab --- r_associated #0: 65 --> en:cytarabine
    n1=en:tocilizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  285. insuline glargine --- r_associated #0: 65 --> en:cytarabine
    n1=insuline glargine | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  286. rivaroxaban --- r_associated #0: 65 --> en:cytarabine
    n1=rivaroxaban | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  287. vedolizumab --- r_associated #0: 65 --> en:cytarabine
    n1=vedolizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=65
  288. en:abatacept --- r_associated #0: 64 --> en:cytarabine
    n1=en:abatacept | n2=en:cytarabine | rel=r_associated | relid=0 | w=64
  289. olanzapine --- r_associated #0: 64 --> en:cytarabine
    n1=olanzapine | n2=en:cytarabine | rel=r_associated | relid=0 | w=64
  290. temsirolimus --- r_associated #0: 64 --> en:cytarabine
    n1=temsirolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=64
  291. en:insulin glargine --- r_associated #0: 63 --> en:cytarabine
    n1=en:insulin glargine | n2=en:cytarabine | rel=r_associated | relid=0 | w=63
  292. enzalutamide --- r_associated #0: 63 --> en:cytarabine
    n1=enzalutamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=63
  293. oxitriptan --- r_associated #0: 63 --> en:cytarabine
    n1=oxitriptan | n2=en:cytarabine | rel=r_associated | relid=0 | w=63
  294. abatacept --- r_associated #0: 62 --> en:cytarabine
    n1=abatacept | n2=en:cytarabine | rel=r_associated | relid=0 | w=62
  295. en:enzalutamide --- r_associated #0: 62 --> en:cytarabine
    n1=en:enzalutamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=62
  296. en:girentuximab --- r_associated #0: 62 --> en:cytarabine
    n1=en:girentuximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=62
  297. acétaminophène --- r_associated #0: 61 --> en:cytarabine
    n1=acétaminophène | n2=en:cytarabine | rel=r_associated | relid=0 | w=61
  298. en:inositol --- r_associated #0: 61 --> en:cytarabine
    n1=en:inositol | n2=en:cytarabine | rel=r_associated | relid=0 | w=61
  299. en:vedolizumab --- r_associated #0: 61 --> en:cytarabine
    n1=en:vedolizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=61
  300. ramipril --- r_associated #0: 61 --> en:cytarabine
    n1=ramipril | n2=en:cytarabine | rel=r_associated | relid=0 | w=61
  301. zolmitriptan --- r_associated #0: 61 --> en:cytarabine
    n1=zolmitriptan | n2=en:cytarabine | rel=r_associated | relid=0 | w=61
  302. échinomycine --- r_associated #0: 61 --> en:cytarabine
    n1=échinomycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=61
  303. en:acetaminophen --- r_associated #0: 60 --> en:cytarabine
    n1=en:acetaminophen | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  304. en:cisatracurium --- r_associated #0: 60 --> en:cytarabine
    n1=en:cisatracurium | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  305. en:oxitriptan --- r_associated #0: 60 --> en:cytarabine
    n1=en:oxitriptan | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  306. en:ramipril --- r_associated #0: 60 --> en:cytarabine
    n1=en:ramipril | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  307. en:warfarin --- r_associated #0: 60 --> en:cytarabine
    n1=en:warfarin | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  308. girentuximab --- r_associated #0: 60 --> en:cytarabine
    n1=girentuximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  309. warfarine --- r_associated #0: 60 --> en:cytarabine
    n1=warfarine | n2=en:cytarabine | rel=r_associated | relid=0 | w=60
  310. en:echinomycin --- r_associated #0: 59 --> en:cytarabine
    n1=en:echinomycin | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  311. en:hydroxytyrosol --- r_associated #0: 59 --> en:cytarabine
    n1=en:hydroxytyrosol | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  312. en:mitogen --- r_associated #0: 59 --> en:cytarabine
    n1=en:mitogen | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  313. en:ocrelizumab --- r_associated #0: 59 --> en:cytarabine
    n1=en:ocrelizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  314. en:omalizumab --- r_associated #0: 59 --> en:cytarabine
    n1=en:omalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  315. en:zolmitriptan --- r_associated #0: 59 --> en:cytarabine
    n1=en:zolmitriptan | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  316. inositol --- r_associated #0: 59 --> en:cytarabine
    n1=inositol | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  317. trétinoïne --- r_associated #0: 59 --> en:cytarabine
    n1=trétinoïne | n2=en:cytarabine | rel=r_associated | relid=0 | w=59
  318. carbendazime --- r_associated #0: 58 --> en:cytarabine
    n1=carbendazime | n2=en:cytarabine | rel=r_associated | relid=0 | w=58
  319. cisatracurium --- r_associated #0: 58 --> en:cytarabine
    n1=cisatracurium | n2=en:cytarabine | rel=r_associated | relid=0 | w=58
  320. en:carbendazim --- r_associated #0: 58 --> en:cytarabine
    n1=en:carbendazim | n2=en:cytarabine | rel=r_associated | relid=0 | w=58
  321. calmant
    (Nom)
     --- r_associated #0: 57 --> en:cytarabine
    n1=calmant
    (Nom)
    | n2=en:cytarabine | rel=r_associated | relid=0 | w=57
  322. coumaphène --- r_associated #0: 56 --> en:cytarabine
    n1=coumaphène | n2=en:cytarabine | rel=r_associated | relid=0 | w=56
  323. barbe de maïs --- r_associated #0: 55 --> en:cytarabine
    n1=barbe de maïs | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  324. en:citrulline --- r_associated #0: 55 --> en:cytarabine
    n1=en:citrulline | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  325. en:ibrutinib --- r_associated #0: 55 --> en:cytarabine
    n1=en:ibrutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  326. en:tretinoin --- r_associated #0: 55 --> en:cytarabine
    n1=en:tretinoin | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  327. hydroxytyrosol --- r_associated #0: 55 --> en:cytarabine
    n1=hydroxytyrosol | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  328. mitogène --- r_associated #0: 55 --> en:cytarabine
    n1=mitogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  329. ocrelizumab --- r_associated #0: 55 --> en:cytarabine
    n1=ocrelizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  330. omalizumab --- r_associated #0: 55 --> en:cytarabine
    n1=omalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  331. vaccin contre l'hépatite b --- r_associated #0: 55 --> en:cytarabine
    n1=vaccin contre l'hépatite b | n2=en:cytarabine | rel=r_associated | relid=0 | w=55
  332. en:astringent --- r_associated #0: 54 --> en:cytarabine
    n1=en:astringent | n2=en:cytarabine | rel=r_associated | relid=0 | w=54
  333. en:gemcitabine --- r_associated #0: 54 --> en:cytarabine
    n1=en:gemcitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=54
  334. en:al-721 --- r_associated #0: 53 --> en:cytarabine
    n1=en:al-721 | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  335. en:certolizumab --- r_associated #0: 53 --> en:cytarabine
    n1=en:certolizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  336. en:cornsilk --- r_associated #0: 53 --> en:cytarabine
    n1=en:cornsilk | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  337. en:proflavine --- r_associated #0: 53 --> en:cytarabine
    n1=en:proflavine | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  338. en:rutin --- r_associated #0: 53 --> en:cytarabine
    n1=en:rutin | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  339. gemcitabine --- r_associated #0: 53 --> en:cytarabine
    n1=gemcitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  340. ibrutinib --- r_associated #0: 53 --> en:cytarabine
    n1=ibrutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  341. proflavine --- r_associated #0: 53 --> en:cytarabine
    n1=proflavine | n2=en:cytarabine | rel=r_associated | relid=0 | w=53
  342. en:hepatitis B vaccine --- r_associated #0: 52 --> en:cytarabine
    n1=en:hepatitis B vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=52
  343. astringente --- r_associated #0: 51 --> en:cytarabine
    n1=astringente | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  344. citrulline --- r_associated #0: 51 --> en:cytarabine
    n1=citrulline | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  345. en:american ginseng --- r_associated #0: 51 --> en:cytarabine
    n1=en:american ginseng | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  346. en:answer somebody back --- r_associated #0: 51 --> en:cytarabine
    n1=en:answer somebody back | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  347. en:iso-sulfan blue --- r_associated #0: 51 --> en:cytarabine
    n1=en:iso-sulfan blue | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  348. rutine --- r_associated #0: 51 --> en:cytarabine
    n1=rutine | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  349. vaccin contre l'hépatite A --- r_associated #0: 51 --> en:cytarabine
    n1=vaccin contre l'hépatite A | n2=en:cytarabine | rel=r_associated | relid=0 | w=51
  350. certolizumab --- r_associated #0: 50 --> en:cytarabine
    n1=certolizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  351. en:American ginseng --- r_associated #0: 50 --> en:cytarabine
    n1=en:American ginseng | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  352. en:al721 --- r_associated #0: 50 --> en:cytarabine
    n1=en:al721 | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  353. en:dabrafenib --- r_associated #0: 50 --> en:cytarabine
    n1=en:dabrafenib | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  354. en:hepatitis A vaccine --- r_associated #0: 50 --> en:cytarabine
    n1=en:hepatitis A vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  355. en:hepatitis b vaccine --- r_associated #0: 50 --> en:cytarabine
    n1=en:hepatitis b vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  356. en:isosulfan blue --- r_associated #0: 50 --> en:cytarabine
    n1=en:isosulfan blue | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  357. en:ustekinumab --- r_associated #0: 50 --> en:cytarabine
    n1=en:ustekinumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  358. glycol polyéthylénique --- r_associated #0: 50 --> en:cytarabine
    n1=glycol polyéthylénique | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  359. rutoside --- r_associated #0: 50 --> en:cytarabine
    n1=rutoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  360. répondre à qn --- r_associated #0: 50 --> en:cytarabine
    n1=répondre à qn | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  361. répondre à quelqu'un --- r_associated #0: 50 --> en:cytarabine
    n1=répondre à quelqu'un | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  362. ézétimibe --- r_associated #0: 50 --> en:cytarabine
    n1=ézétimibe | n2=en:cytarabine | rel=r_associated | relid=0 | w=50
  363. diéthylstilboestrol --- r_associated #0: 49 --> en:cytarabine
    n1=diéthylstilboestrol | n2=en:cytarabine | rel=r_associated | relid=0 | w=49
  364. en:epsom salt --- r_associated #0: 49 --> en:cytarabine
    n1=en:epsom salt | n2=en:cytarabine | rel=r_associated | relid=0 | w=49
  365. en:hepatitis a vaccine --- r_associated #0: 49 --> en:cytarabine
    n1=en:hepatitis a vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=49
  366. en:finasteride --- r_associated #0: 48 --> en:cytarabine
    n1=en:finasteride | n2=en:cytarabine | rel=r_associated | relid=0 | w=48
  367. en:magnesium oxide --- r_associated #0: 48 --> en:cytarabine
    n1=en:magnesium oxide | n2=en:cytarabine | rel=r_associated | relid=0 | w=48
  368. vinblastine --- r_associated #0: 48 --> en:cytarabine
    n1=vinblastine | n2=en:cytarabine | rel=r_associated | relid=0 | w=48
  369. en:ezetimibe --- r_associated #0: 47 --> en:cytarabine
    n1=en:ezetimibe | n2=en:cytarabine | rel=r_associated | relid=0 | w=47
  370. en:vinblastine --- r_associated #0: 47 --> en:cytarabine
    n1=en:vinblastine | n2=en:cytarabine | rel=r_associated | relid=0 | w=47
  371. répondre à [qqn] --- r_associated #0: 47 --> en:cytarabine
    n1=répondre à [qqn] | n2=en:cytarabine | rel=r_associated | relid=0 | w=47
  372. dabrafenib --- r_associated #0: 46 --> en:cytarabine
    n1=dabrafenib | n2=en:cytarabine | rel=r_associated | relid=0 | w=46
  373. ustekinumab --- r_associated #0: 46 --> en:cytarabine
    n1=ustekinumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=46
  374. Pierre à savon --- r_associated #0: 45 --> en:cytarabine
    n1=Pierre à savon | n2=en:cytarabine | rel=r_associated | relid=0 | w=45
  375. en:lithium carbonate --- r_associated #0: 45 --> en:cytarabine
    n1=en:lithium carbonate | n2=en:cytarabine | rel=r_associated | relid=0 | w=45
  376. en:zinc sulfate --- r_associated #0: 45 --> en:cytarabine
    n1=en:zinc sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=45
  377. finastéride --- r_associated #0: 45 --> en:cytarabine
    n1=finastéride | n2=en:cytarabine | rel=r_associated | relid=0 | w=45
  378. agent tensioactif --- r_associated #0: 44 --> en:cytarabine
    n1=agent tensioactif | n2=en:cytarabine | rel=r_associated | relid=0 | w=44
  379. en:antiviral agent --- r_associated #0: 44 --> en:cytarabine
    n1=en:antiviral agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=44
  380. en:respond to somebody --- r_associated #0: 44 --> en:cytarabine
    n1=en:respond to somebody | n2=en:cytarabine | rel=r_associated | relid=0 | w=44
  381. oxyde de magnésium --- r_associated #0: 44 --> en:cytarabine
    n1=oxyde de magnésium | n2=en:cytarabine | rel=r_associated | relid=0 | w=44
  382. en:2'-f-ara-deoxyuridine --- r_associated #0: 43 --> en:cytarabine
    n1=en:2'-f-ara-deoxyuridine | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  383. en:3'-o-galactopyranosyl-1-4-o-galactopyranosylcytarabine --- r_associated #0: 43 --> en:cytarabine
    n1=en:3'-o-galactopyranosyl-1-4-o-galactopyranosylcytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  384. en:ac regimen --- r_associated #0: 43 --> en:cytarabine
    n1=en:ac regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  385. en:alpha-gal glycosphingolipids --- r_associated #0: 43 --> en:cytarabine
    n1=en:alpha-gal glycosphingolipids | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  386. en:chp-ny-eso-1 peptide vaccine imf-001 --- r_associated #0: 43 --> en:cytarabine
    n1=en:chp-ny-eso-1 peptide vaccine imf-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  387. en:cytembena --- r_associated #0: 43 --> en:cytarabine
    n1=en:cytembena | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  388. en:eculizumab --- r_associated #0: 43 --> en:cytarabine
    n1=en:eculizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  389. en:eltrombopag olamine --- r_associated #0: 43 --> en:cytarabine
    n1=en:eltrombopag olamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  390. en:fu-lv regimen --- r_associated #0: 43 --> en:cytarabine
    n1=en:fu-lv regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  391. en:il-12-expressing hsv-1 --- r_associated #0: 43 --> en:cytarabine
    n1=en:il-12-expressing hsv-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  392. en:mll-93 protocol --- r_associated #0: 43 --> en:cytarabine
    n1=en:mll-93 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  393. en:nitroglycerin/sodium citrate/ethanol solution --- r_associated #0: 43 --> en:cytarabine
    n1=en:nitroglycerin/sodium citrate/ethanol solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  394. en:onartuzumab --- r_associated #0: 43 --> en:cytarabine
    n1=en:onartuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  395. en:sodium dibunate --- r_associated #0: 43 --> en:cytarabine
    n1=en:sodium dibunate | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  396. en:t1e28z car-expressing autologous cd4-positive t lymphocytes --- r_associated #0: 43 --> en:cytarabine
    n1=en:t1e28z car-expressing autologous cd4-positive t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  397. en:tc 99m monoclonal antibody 170 --- r_associated #0: 43 --> en:cytarabine
    n1=en:tc 99m monoclonal antibody 170 | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  398. en:tetracycline hydrochloride --- r_associated #0: 43 --> en:cytarabine
    n1=en:tetracycline hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  399. en:trivalent live-attenuated influenza vaccine --- r_associated #0: 43 --> en:cytarabine
    n1=en:trivalent live-attenuated influenza vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  400. spanner --- r_associated #0: 43 --> en:cytarabine
    n1=spanner | n2=en:cytarabine | rel=r_associated | relid=0 | w=43
  401. Thé noir --- r_associated #0: 42 --> en:cytarabine
    n1=Thé noir | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  402. carbonate lithium --- r_associated #0: 42 --> en:cytarabine
    n1=carbonate lithium | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  403. en:attenuated listeria monocytogenes crs-100 --- r_associated #0: 42 --> en:cytarabine
    n1=en:attenuated listeria monocytogenes crs-100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  404. en:bcl-2 inhibitor bcl201 --- r_associated #0: 42 --> en:cytarabine
    n1=en:bcl-2 inhibitor bcl201 | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  405. en:benazepril hydrochloride --- r_associated #0: 42 --> en:cytarabine
    n1=en:benazepril hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  406. en:blackberry allergenic extract --- r_associated #0: 42 --> en:cytarabine
    n1=en:blackberry allergenic extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  407. en:c-met inhibitor msc2156119j --- r_associated #0: 42 --> en:cytarabine
    n1=en:c-met inhibitor msc2156119j | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  408. en:care protocol --- r_associated #0: 42 --> en:cytarabine
    n1=en:care protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  409. en:cart protocol --- r_associated #0: 42 --> en:cytarabine
    n1=en:cart protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  410. en:centaury preparation --- r_associated #0: 42 --> en:cytarabine
    n1=en:centaury preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  411. en:chlorpheniramine, phenylpropanolamine drug combination --- r_associated #0: 42 --> en:cytarabine
    n1=en:chlorpheniramine, phenylpropanolamine drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  412. en:cholesterol test kit --- r_associated #0: 42 --> en:cytarabine
    n1=en:cholesterol test kit | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  413. en:dach polymer platinate ap5346 --- r_associated #0: 42 --> en:cytarabine
    n1=en:dach polymer platinate ap5346 | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  414. en:efatutazone dihydrochloride --- r_associated #0: 42 --> en:cytarabine
    n1=en:efatutazone dihydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  415. en:glymidine --- r_associated #0: 42 --> en:cytarabine
    n1=en:glymidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  416. en:gold sodium thiomalate --- r_associated #0: 42 --> en:cytarabine
    n1=en:gold sodium thiomalate | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  417. en:human gp100 plasmid dna vaccine --- r_associated #0: 42 --> en:cytarabine
    n1=en:human gp100 plasmid dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  418. en:interleukin-12 gene --- r_associated #0: 42 --> en:cytarabine
    n1=en:interleukin-12 gene | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  419. en:mage-a3 peptide vaccine --- r_associated #0: 42 --> en:cytarabine
    n1=en:mage-a3 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  420. en:melphalan hydrochloride --- r_associated #0: 42 --> en:cytarabine
    n1=en:melphalan hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  421. en:minocycline-edta --- r_associated #0: 42 --> en:cytarabine
    n1=en:minocycline-edta | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  422. en:mrc aml 10 protocol --- r_associated #0: 42 --> en:cytarabine
    n1=en:mrc aml 10 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  423. en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 42 --> en:cytarabine
    n1=en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  424. en:pi3k p110beta/delta inhibitor ka2237 --- r_associated #0: 42 --> en:cytarabine
    n1=en:pi3k p110beta/delta inhibitor ka2237 | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  425. en:polyéthylène glycol --- r_associated #0: 42 --> en:cytarabine
    n1=en:polyéthylène glycol | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  426. en:telomerase-specific type 5 adenovirus obp-301 --- r_associated #0: 42 --> en:cytarabine
    n1=en:telomerase-specific type 5 adenovirus obp-301 | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  427. en:vegfr1-1084 peptide vaccine --- r_associated #0: 42 --> en:cytarabine
    n1=en:vegfr1-1084 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=42
  428. acide tranexamique --- r_associated #0: 41 --> en:cytarabine
    n1=acide tranexamique | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  429. en:2g-1 tcr retroviral vector-transduced lymphocytes --- r_associated #0: 41 --> en:cytarabine
    n1=en:2g-1 tcr retroviral vector-transduced lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  430. en:aminocamptothecin --- r_associated #0: 41 --> en:cytarabine
    n1=en:aminocamptothecin | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  431. en:amrubicin hydrochloride --- r_associated #0: 41 --> en:cytarabine
    n1=en:amrubicin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  432. en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes --- r_associated #0: 41 --> en:cytarabine
    n1=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  433. en:bhac-dmpv protocol --- r_associated #0: 41 --> en:cytarabine
    n1=en:bhac-dmpv protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  434. en:brd4 inhibitor plx51107 --- r_associated #0: 41 --> en:cytarabine
    n1=en:brd4 inhibitor plx51107 | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  435. en:camphor / parachlorophenol --- r_associated #0: 41 --> en:cytarabine
    n1=en:camphor / parachlorophenol | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  436. en:cdki r547 --- r_associated #0: 41 --> en:cytarabine
    n1=en:cdki r547 | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  437. en:chk1 inhibitor gdc-0575 --- r_associated #0: 41 --> en:cytarabine
    n1=en:chk1 inhibitor gdc-0575 | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  438. en:dichloromethotrexate --- r_associated #0: 41 --> en:cytarabine
    n1=en:dichloromethotrexate | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  439. en:erbb-2 inhibitor arry-380 --- r_associated #0: 41 --> en:cytarabine
    n1=en:erbb-2 inhibitor arry-380 | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  440. en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 --- r_associated #0: 41 --> en:cytarabine
    n1=en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  441. en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine --- r_associated #0: 41 --> en:cytarabine
    n1=en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  442. en:lai regimen --- r_associated #0: 41 --> en:cytarabine
    n1=en:lai regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  443. en:lerisetron --- r_associated #0: 41 --> en:cytarabine
    n1=en:lerisetron | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  444. en:micronutrient-fortified probiotic yogurt --- r_associated #0: 41 --> en:cytarabine
    n1=en:micronutrient-fortified probiotic yogurt | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  445. en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand --- r_associated #0: 41 --> en:cytarabine
    n1=en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  446. en:reply to somebody --- r_associated #0: 41 --> en:cytarabine
    n1=en:reply to somebody | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  447. en:sorghum bicolor supplement --- r_associated #0: 41 --> en:cytarabine
    n1=en:sorghum bicolor supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  448. en:thiamine --- r_associated #0: 41 --> en:cytarabine
    n1=en:thiamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  449. en:tositumomab --- r_associated #0: 41 --> en:cytarabine
    n1=en:tositumomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  450. en:zanolimumab --- r_associated #0: 41 --> en:cytarabine
    n1=en:zanolimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  451. sulfate de zinc --- r_associated #0: 41 --> en:cytarabine
    n1=sulfate de zinc | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  452. thiamine --- r_associated #0: 41 --> en:cytarabine
    n1=thiamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  453. vaccin anti-hépatite A --- r_associated #0: 41 --> en:cytarabine
    n1=vaccin anti-hépatite A | n2=en:cytarabine | rel=r_associated | relid=0 | w=41
  454. agent antiviral --- r_associated #0: 40 --> en:cytarabine
    n1=agent antiviral | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  455. créatine phosphate --- r_associated #0: 40 --> en:cytarabine
    n1=créatine phosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  456. en:abarelix --- r_associated #0: 40 --> en:cytarabine
    n1=en:abarelix | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  457. en:ag-024322 --- r_associated #0: 40 --> en:cytarabine
    n1=en:ag-024322 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  458. en:anti-cd38 monoclonal antibody sar650984 --- r_associated #0: 40 --> en:cytarabine
    n1=en:anti-cd38 monoclonal antibody sar650984 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  459. en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate --- r_associated #0: 40 --> en:cytarabine
    n1=en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  460. en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e --- r_associated #0: 40 --> en:cytarabine
    n1=en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  461. en:apoptosis inducer bzl101 --- r_associated #0: 40 --> en:cytarabine
    n1=en:apoptosis inducer bzl101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  462. en:bet inhibitor ten-010 --- r_associated #0: 40 --> en:cytarabine
    n1=en:bet inhibitor ten-010 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  463. en:carboxymethylcellulose / hypromellose --- r_associated #0: 40 --> en:cytarabine
    n1=en:carboxymethylcellulose / hypromellose | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  464. en:ceftobiprole medocaril --- r_associated #0: 40 --> en:cytarabine
    n1=en:ceftobiprole medocaril | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  465. en:chitosan-n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine conjugate --- r_associated #0: 40 --> en:cytarabine
    n1=en:chitosan-n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  466. en:daclizumab --- r_associated #0: 40 --> en:cytarabine
    n1=en:daclizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  467. en:edrecolomab --- r_associated #0: 40 --> en:cytarabine
    n1=en:edrecolomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  468. en:eif4e antisense oligonucleotide isis 183750 --- r_associated #0: 40 --> en:cytarabine
    n1=en:eif4e antisense oligonucleotide isis 183750 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  469. en:fibrin sealant --- r_associated #0: 40 --> en:cytarabine
    n1=en:fibrin sealant | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  470. en:inalimarev --- r_associated #0: 40 --> en:cytarabine
    n1=en:inalimarev | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  471. en:iodine i 131 monoclonal antibody f16sip --- r_associated #0: 40 --> en:cytarabine
    n1=en:iodine i 131 monoclonal antibody f16sip | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  472. en:iodine i 131 monoclonal antibody tnt-1/b --- r_associated #0: 40 --> en:cytarabine
    n1=en:iodine i 131 monoclonal antibody tnt-1/b | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  473. en:l-gossypol --- r_associated #0: 40 --> en:cytarabine
    n1=en:l-gossypol | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  474. en:monoclonal antibody f19 --- r_associated #0: 40 --> en:cytarabine
    n1=en:monoclonal antibody f19 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  475. en:nitroglycerin transdermal patch --- r_associated #0: 40 --> en:cytarabine
    n1=en:nitroglycerin transdermal patch | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  476. en:pdm08 --- r_associated #0: 40 --> en:cytarabine
    n1=en:pdm08 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  477. en:recombinant adenovirus-p53 sch-58500 --- r_associated #0: 40 --> en:cytarabine
    n1=en:recombinant adenovirus-p53 sch-58500 | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  478. en:spanner --- r_associated #0: 40 --> en:cytarabine
    n1=en:spanner | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  479. en:surfactant agent --- r_associated #0: 40 --> en:cytarabine
    n1=en:surfactant agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  480. en:wt1 mrna-electroporated autologous dendritic cell vaccine --- r_associated #0: 40 --> en:cytarabine
    n1=en:wt1 mrna-electroporated autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  481. fluoro-uracile --- r_associated #0: 40 --> en:cytarabine
    n1=fluoro-uracile | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  482. stéatite --- r_associated #0: 40 --> en:cytarabine
    n1=stéatite | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  483. vaccin anti-hépatite b --- r_associated #0: 40 --> en:cytarabine
    n1=vaccin anti-hépatite b | n2=en:cytarabine | rel=r_associated | relid=0 | w=40
  484. ara-c --- r_associated #0: 39 --> en:cytarabine
    n1=ara-c | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  485. en:17-hydroxycorticosterone --- r_associated #0: 39 --> en:cytarabine
    n1=en:17-hydroxycorticosterone | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  486. en:7-cyanoquinocarcinol --- r_associated #0: 39 --> en:cytarabine
    n1=en:7-cyanoquinocarcinol | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  487. en:autologous cd8+ melanoma specific t cells --- r_associated #0: 39 --> en:cytarabine
    n1=en:autologous cd8+ melanoma specific t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  488. en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine --- r_associated #0: 39 --> en:cytarabine
    n1=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  489. en:calcium channel blocker --- r_associated #0: 39 --> en:cytarabine
    n1=en:calcium channel blocker | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  490. en:cocculus/nux vomica/tabacum/petroleum extract --- r_associated #0: 39 --> en:cytarabine
    n1=en:cocculus/nux vomica/tabacum/petroleum extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  491. en:cutemol --- r_associated #0: 39 --> en:cytarabine
    n1=en:cutemol | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  492. en:cytarabine 50 mg/ml [cytosar] --- r_associated #0: 39 --> en:cytarabine
    n1=en:cytarabine 50 mg/ml [cytosar] | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  493. en:dalteparin --- r_associated #0: 39 --> en:cytarabine
    n1=en:dalteparin | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  494. en:dichloroallyl lawsone --- r_associated #0: 39 --> en:cytarabine
    n1=en:dichloroallyl lawsone | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  495. en:docusate --- r_associated #0: 39 --> en:cytarabine
    n1=en:docusate | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  496. en:ellagic acid/annona muricata supplement --- r_associated #0: 39 --> en:cytarabine
    n1=en:ellagic acid/annona muricata supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  497. en:kit/pdgfr inhibitor dcc-2618 --- r_associated #0: 39 --> en:cytarabine
    n1=en:kit/pdgfr inhibitor dcc-2618 | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  498. en:liposomal rhenium re 186 --- r_associated #0: 39 --> en:cytarabine
    n1=en:liposomal rhenium re 186 | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  499. en:mcp 842 regimen --- r_associated #0: 39 --> en:cytarabine
    n1=en:mcp 842 regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  500. en:monoacetyldiglyceride ec-18 --- r_associated #0: 39 --> en:cytarabine
    n1=en:monoacetyldiglyceride ec-18 | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  501. en:pak4 inhibitor pf-03758309 --- r_associated #0: 39 --> en:cytarabine
    n1=en:pak4 inhibitor pf-03758309 | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  502. en:pentetic acid calcium --- r_associated #0: 39 --> en:cytarabine
    n1=en:pentetic acid calcium | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  503. en:phytomenadione --- r_associated #0: 39 --> en:cytarabine
    n1=en:phytomenadione | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  504. en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer --- r_associated #0: 39 --> en:cytarabine
    n1=en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  505. en:surface-active agent --- r_associated #0: 39 --> en:cytarabine
    n1=en:surface-active agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  506. en:tandutinib --- r_associated #0: 39 --> en:cytarabine
    n1=en:tandutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  507. en:technetium tc-99m sodium pertechnetate --- r_associated #0: 39 --> en:cytarabine
    n1=en:technetium tc-99m sodium pertechnetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  508. en:tlr9 agonist sd-101 --- r_associated #0: 39 --> en:cytarabine
    n1=en:tlr9 agonist sd-101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=39
  509. en:akt 1/2 inhibitor bay1125976 --- r_associated #0: 38 --> en:cytarabine
    n1=en:akt 1/2 inhibitor bay1125976 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  510. en:anti-cd33/cd3 bite antibody amg 330 --- r_associated #0: 38 --> en:cytarabine
    n1=en:anti-cd33/cd3 bite antibody amg 330 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  511. en:anti-egfrviii car-transduced allogeneic t-lymphocytes --- r_associated #0: 38 --> en:cytarabine
    n1=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  512. en:anti-icos monoclonal antibody medi-570 --- r_associated #0: 38 --> en:cytarabine
    n1=en:anti-icos monoclonal antibody medi-570 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  513. en:antibody-drug conjugate bay79-4620 --- r_associated #0: 38 --> en:cytarabine
    n1=en:antibody-drug conjugate bay79-4620 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  514. en:aurora kinase/vegfr2 inhibitor cyc116 --- r_associated #0: 38 --> en:cytarabine
    n1=en:aurora kinase/vegfr2 inhibitor cyc116 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  515. en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes --- r_associated #0: 38 --> en:cytarabine
    n1=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  516. en:camphor + menthol + methyl salicylate --- r_associated #0: 38 --> en:cytarabine
    n1=en:camphor + menthol + methyl salicylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  517. en:coxsackievirus a21 --- r_associated #0: 38 --> en:cytarabine
    n1=en:coxsackievirus a21 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  518. en:hydrazine sulfate --- r_associated #0: 38 --> en:cytarabine
    n1=en:hydrazine sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  519. en:l19-il2 monoclonal antibody-cytokine fusion protein --- r_associated #0: 38 --> en:cytarabine
    n1=en:l19-il2 monoclonal antibody-cytokine fusion protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  520. en:multicarotenoid supplement mcs-8 --- r_associated #0: 38 --> en:cytarabine
    n1=en:multicarotenoid supplement mcs-8 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  521. en:nitric oxide-releasing acetylsalicylic acid derivative --- r_associated #0: 38 --> en:cytarabine
    n1=en:nitric oxide-releasing acetylsalicylic acid derivative | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  522. en:pi3k alpha inhibitor mln1117 --- r_associated #0: 38 --> en:cytarabine
    n1=en:pi3k alpha inhibitor mln1117 | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  523. en:pleiotropic pathway modifier cc-122 hydrochloride --- r_associated #0: 38 --> en:cytarabine
    n1=en:pleiotropic pathway modifier cc-122 hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  524. en:ponatinib hydrochloride --- r_associated #0: 38 --> en:cytarabine
    n1=en:ponatinib hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  525. en:sodium selenite --- r_associated #0: 38 --> en:cytarabine
    n1=en:sodium selenite | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  526. en:talazoparib --- r_associated #0: 38 --> en:cytarabine
    n1=en:talazoparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=38
  527. baryte --- r_associated #0: 37 --> en:cytarabine
    n1=baryte | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  528. en:ancitabine --- r_associated #0: 37 --> en:cytarabine
    n1=en:ancitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  529. en:anti-flt3 monoclonal antibody imc-eb10 --- r_associated #0: 37 --> en:cytarabine
    n1=en:anti-flt3 monoclonal antibody imc-eb10 | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  530. en:ashwagandha root powder extract --- r_associated #0: 37 --> en:cytarabine
    n1=en:ashwagandha root powder extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  531. en:atamestane --- r_associated #0: 37 --> en:cytarabine
    n1=en:atamestane | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  532. en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes --- r_associated #0: 37 --> en:cytarabine
    n1=en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  533. en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 37 --> en:cytarabine
    n1=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  534. en:autologous ofa-ilrp rna-transfected dendritic cell vaccine --- r_associated #0: 37 --> en:cytarabine
    n1=en:autologous ofa-ilrp rna-transfected dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  535. en:bp-cx1-platinum complex bp-c1 --- r_associated #0: 37 --> en:cytarabine
    n1=en:bp-cx1-platinum complex bp-c1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  536. en:ceftriaxone sodium --- r_associated #0: 37 --> en:cytarabine
    n1=en:ceftriaxone sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  537. en:checkpoint kinase inhibitor xl844 --- r_associated #0: 37 --> en:cytarabine
    n1=en:checkpoint kinase inhibitor xl844 | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  538. en:chk1 inhibitor pf-477736 --- r_associated #0: 37 --> en:cytarabine
    n1=en:chk1 inhibitor pf-477736 | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  539. en:chlorpheniramine + pseudoephedrine --- r_associated #0: 37 --> en:cytarabine
    n1=en:chlorpheniramine + pseudoephedrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  540. en:clostridium novyi-nt spores --- r_associated #0: 37 --> en:cytarabine
    n1=en:clostridium novyi-nt spores | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  541. en:dc-ova vaccine --- r_associated #0: 37 --> en:cytarabine
    n1=en:dc-ova vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  542. en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine --- r_associated #0: 37 --> en:cytarabine
    n1=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  543. en:e7820 --- r_associated #0: 37 --> en:cytarabine
    n1=en:e7820 | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  544. en:firtecan pegol --- r_associated #0: 37 --> en:cytarabine
    n1=en:firtecan pegol | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  545. en:hydrocodone + chlorpheniramine --- r_associated #0: 37 --> en:cytarabine
    n1=en:hydrocodone + chlorpheniramine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  546. en:imisopasem manganese --- r_associated #0: 37 --> en:cytarabine
    n1=en:imisopasem manganese | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  547. en:isopréniques --- r_associated #0: 37 --> en:cytarabine
    n1=en:isopréniques | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  548. en:laromustine --- r_associated #0: 37 --> en:cytarabine
    n1=en:laromustine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  549. en:larotaxel --- r_associated #0: 37 --> en:cytarabine
    n1=en:larotaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  550. en:n-squalenoyl-cytarabine --- r_associated #0: 37 --> en:cytarabine
    n1=en:n-squalenoyl-cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  551. en:ny-eso-1b peptide vaccine --- r_associated #0: 37 --> en:cytarabine
    n1=en:ny-eso-1b peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  552. en:perflutren protein-a microsphere --- r_associated #0: 37 --> en:cytarabine
    n1=en:perflutren protein-a microsphere | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  553. en:respiratory form tiotropium --- r_associated #0: 37 --> en:cytarabine
    n1=en:respiratory form tiotropium | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  554. en:ricin immunoconjugate --- r_associated #0: 37 --> en:cytarabine
    n1=en:ricin immunoconjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  555. en:thiopyrimidine --- r_associated #0: 37 --> en:cytarabine
    n1=en:thiopyrimidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  556. en:tivantinib --- r_associated #0: 37 --> en:cytarabine
    n1=en:tivantinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  557. en:tranexamic acid --- r_associated #0: 37 --> en:cytarabine
    n1=en:tranexamic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  558. vaccin anti-hépatite B --- r_associated #0: 37 --> en:cytarabine
    n1=vaccin anti-hépatite B | n2=en:cytarabine | rel=r_associated | relid=0 | w=37
  559. ARA-C --- r_associated #0: 36 --> en:cytarabine
    n1=ARA-C | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  560. docusate --- r_associated #0: 36 --> en:cytarabine
    n1=docusate | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  561. en:13-deoxydoxorubicin --- r_associated #0: 36 --> en:cytarabine
    n1=en:13-deoxydoxorubicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  562. en:altiratinib --- r_associated #0: 36 --> en:cytarabine
    n1=en:altiratinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  563. en:alvac-mart-1 vaccine --- r_associated #0: 36 --> en:cytarabine
    n1=en:alvac-mart-1 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  564. en:anti-cd123 monoclonal antibody csl362 --- r_associated #0: 36 --> en:cytarabine
    n1=en:anti-cd123 monoclonal antibody csl362 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  565. en:anti-cea igcd28tcr-transduced autologous t cells --- r_associated #0: 36 --> en:cytarabine
    n1=en:anti-cea igcd28tcr-transduced autologous t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  566. en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine --- r_associated #0: 36 --> en:cytarabine
    n1=en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  567. en:anti-hbegf monoclonal antibody u3-1565 --- r_associated #0: 36 --> en:cytarabine
    n1=en:anti-hbegf monoclonal antibody u3-1565 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  568. en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine --- r_associated #0: 36 --> en:cytarabine
    n1=en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  569. en:cace regimen --- r_associated #0: 36 --> en:cytarabine
    n1=en:cace regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  570. en:chlordiazepoxide, clidinium drug combination --- r_associated #0: 36 --> en:cytarabine
    n1=en:chlordiazepoxide, clidinium drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  571. en:creatine monohydrate --- r_associated #0: 36 --> en:cytarabine
    n1=en:creatine monohydrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  572. en:dec-205/ny-eso-1 fusion protein cdx-1401 --- r_associated #0: 36 --> en:cytarabine
    n1=en:dec-205/ny-eso-1 fusion protein cdx-1401 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  573. en:denileukin diftitox --- r_associated #0: 36 --> en:cytarabine
    n1=en:denileukin diftitox | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  574. en:dt(388)il3 fusion protein sl-401 --- r_associated #0: 36 --> en:cytarabine
    n1=en:dt(388)il3 fusion protein sl-401 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  575. en:gemcitabine-phosphoramidate hydrochloride nuc-1031 --- r_associated #0: 36 --> en:cytarabine
    n1=en:gemcitabine-phosphoramidate hydrochloride nuc-1031 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  576. en:mdx-1379 melanoma vaccine --- r_associated #0: 36 --> en:cytarabine
    n1=en:mdx-1379 melanoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  577. en:micma protocol --- r_associated #0: 36 --> en:cytarabine
    n1=en:micma protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  578. en:nasal saline irrigation solution --- r_associated #0: 36 --> en:cytarabine
    n1=en:nasal saline irrigation solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  579. en:nintedanib --- r_associated #0: 36 --> en:cytarabine
    n1=en:nintedanib | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  580. en:pethema all-3-97 protocol --- r_associated #0: 36 --> en:cytarabine
    n1=en:pethema all-3-97 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  581. en:radioprotective agent --- r_associated #0: 36 --> en:cytarabine
    n1=en:radioprotective agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  582. en:topoisomerase i/ii inhibitor nev-801 --- r_associated #0: 36 --> en:cytarabine
    n1=en:topoisomerase i/ii inhibitor nev-801 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  583. en:total-xii protocol --- r_associated #0: 36 --> en:cytarabine
    n1=en:total-xii protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  584. en:vandetanib --- r_associated #0: 36 --> en:cytarabine
    n1=en:vandetanib | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  585. en:vmp-ciscf protocol --- r_associated #0: 36 --> en:cytarabine
    n1=en:vmp-ciscf protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  586. vaccin contre l'hépatite B --- r_associated #0: 36 --> en:cytarabine
    n1=vaccin contre l'hépatite B | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  587. vaccin contre l'hépatite a --- r_associated #0: 36 --> en:cytarabine
    n1=vaccin contre l'hépatite a | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  588. vitamine B1 --- r_associated #0: 36 --> en:cytarabine
    n1=vitamine B1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=36
  589. arabinosylcytosine --- r_associated #0: 35 --> en:cytarabine
    n1=arabinosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  590. baclofen --- r_associated #0: 35 --> en:cytarabine
    n1=baclofen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  591. baclofène --- r_associated #0: 35 --> en:cytarabine
    n1=baclofène | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  592. clef ouverte --- r_associated #0: 35 --> en:cytarabine
    n1=clef ouverte | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  593. clef à fourche --- r_associated #0: 35 --> en:cytarabine
    n1=clef à fourche | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  594. clef à fourches --- r_associated #0: 35 --> en:cytarabine
    n1=clef à fourches | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  595. clé ouverte --- r_associated #0: 35 --> en:cytarabine
    n1=clé ouverte | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  596. clé à fourche --- r_associated #0: 35 --> en:cytarabine
    n1=clé à fourche | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  597. clé à fourches --- r_associated #0: 35 --> en:cytarabine
    n1=clé à fourches | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  598. désincrustant --- r_associated #0: 35 --> en:cytarabine
    n1=désincrustant | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  599. en:1(beta)-d-arabinofuranosylcytosine-5'-diphosphate prednisolone --- r_associated #0: 35 --> en:cytarabine
    n1=en:1(beta)-d-arabinofuranosylcytosine-5'-diphosphate prednisolone | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  600. en:1,2-carbon c 13-labeled glucose --- r_associated #0: 35 --> en:cytarabine
    n1=en:1,2-carbon c 13-labeled glucose | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  601. en:1-(2-deoxy-2-c-fluoromethylarabinofuranosyl)cytosine --- r_associated #0: 35 --> en:cytarabine
    n1=en:1-(2-deoxy-2-c-fluoromethylarabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  602. en:1-(2-o-methyl-beta-d-arabinofuranosyl)cytosine --- r_associated #0: 35 --> en:cytarabine
    n1=en:1-(2-o-methyl-beta-d-arabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  603. en:[18f]l-fac --- r_associated #0: 35 --> en:cytarabine
    n1=en:[18f]l-fac | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  604. en:abvd regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:abvd regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  605. en:acmp protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:acmp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  606. en:acolbifene hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:acolbifene hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  607. en:act protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:act protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  608. en:adenovirus encoding recombinant human endostatin --- r_associated #0: 35 --> en:cytarabine
    n1=en:adenovirus encoding recombinant human endostatin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  609. en:adenovirus-p53 transduced dendritic cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:adenovirus-p53 transduced dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  610. en:adrtvp-1-transduced prostate cancer cell-based vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:adrtvp-1-transduced prostate cancer cell-based vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  611. en:aee788 --- r_associated #0: 35 --> en:cytarabine
    n1=en:aee788 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  612. en:alk5 inhibitor tew-7197 --- r_associated #0: 35 --> en:cytarabine
    n1=en:alk5 inhibitor tew-7197 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  613. en:all-bfm-90 protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:all-bfm-90 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  614. en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  615. en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo --- r_associated #0: 35 --> en:cytarabine
    n1=en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  616. en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  617. en:alpha-type-1 polarized dendritic cells --- r_associated #0: 35 --> en:cytarabine
    n1=en:alpha-type-1 polarized dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  618. en:alvelestat --- r_associated #0: 35 --> en:cytarabine
    n1=en:alvelestat | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  619. en:aminosyn --- r_associated #0: 35 --> en:cytarabine
    n1=en:aminosyn | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  620. en:ammonia n-13 --- r_associated #0: 35 --> en:cytarabine
    n1=en:ammonia n-13 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  621. en:amolimogene bepiplasmid --- r_associated #0: 35 --> en:cytarabine
    n1=en:amolimogene bepiplasmid | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  622. en:amonafide dihydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:amonafide dihydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  623. en:ancestim --- r_associated #0: 35 --> en:cytarabine
    n1=en:ancestim | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  624. en:anll91 protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:anll91 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  625. en:anti-b4 blocked ricin immunotoxin --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-b4 blocked ricin immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  626. en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  627. en:anti-cd19-dm4 immunoconjugate sar3419 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-cd19-dm4 immunoconjugate sar3419 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  628. en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  629. en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  630. en:anti-ctgf monoclonal antibody fg-3019 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-ctgf monoclonal antibody fg-3019 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  631. en:anti-fgfr3 antibody-drug conjugate ly3076226 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-fgfr3 antibody-drug conjugate ly3076226 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  632. en:anti-gcc antibody-drug conjugate mln0264 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-gcc antibody-drug conjugate mln0264 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  633. en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  634. en:anti-il-4/il-13 combination agent qbx258 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-il-4/il-13 combination agent qbx258 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  635. en:anti-ly6e antibody-drug conjugate dlye5953a --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-ly6e antibody-drug conjugate dlye5953a | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  636. en:anti-masp-2 monoclonal antibody oms721 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-masp-2 monoclonal antibody oms721 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  637. en:anti-mmp-9 monoclonal antibody gs-5745 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-mmp-9 monoclonal antibody gs-5745 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  638. en:anti-neuropilin-1 monoclonal antibody mnrp1685a --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-neuropilin-1 monoclonal antibody mnrp1685a | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  639. en:anti-pd-1 monoclonal antibody bgb-a317 --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-pd-1 monoclonal antibody bgb-a317 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  640. en:anti-tumor necrosis factor alpha drug --- r_associated #0: 35 --> en:cytarabine
    n1=en:anti-tumor necrosis factor alpha drug | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  641. en:antispasmodic agent --- r_associated #0: 35 --> en:cytarabine
    n1=en:antispasmodic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  642. en:aoap protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:aoap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  643. en:apatorsen --- r_associated #0: 35 --> en:cytarabine
    n1=en:apatorsen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  644. en:ara-c 5'-benzoate --- r_associated #0: 35 --> en:cytarabine
    n1=en:ara-c 5'-benzoate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  645. en:ara-c 5'octanoate --- r_associated #0: 35 --> en:cytarabine
    n1=en:ara-c 5'octanoate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  646. en:ara-cdp-cortisol --- r_associated #0: 35 --> en:cytarabine
    n1=en:ara-cdp-cortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  647. en:arabinonucleosides --- r_associated #0: 35 --> en:cytarabine
    n1=en:arabinonucleosides | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  648. en:asulacrine isethionate --- r_associated #0: 35 --> en:cytarabine
    n1=en:asulacrine isethionate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  649. en:atrasentan hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:atrasentan hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  650. en:attenuated chimpanzee adenovirus 5t4 vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:attenuated chimpanzee adenovirus 5t4 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  651. en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  652. en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  653. en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  654. en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  655. en:axl inhibitor tp-0903 --- r_associated #0: 35 --> en:cytarabine
    n1=en:axl inhibitor tp-0903 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  656. en:baclofen --- r_associated #0: 35 --> en:cytarabine
    n1=en:baclofen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  657. en:belinostat --- r_associated #0: 35 --> en:cytarabine
    n1=en:belinostat | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  658. en:beta-elemene --- r_associated #0: 35 --> en:cytarabine
    n1=en:beta-elemene | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  659. en:beta-glucan mm-10-001 --- r_associated #0: 35 --> en:cytarabine
    n1=en:beta-glucan mm-10-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  660. en:bexarotene --- r_associated #0: 35 --> en:cytarabine
    n1=en:bexarotene | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  661. en:bf12 protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:bf12 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  662. en:bfm-86 protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:bfm-86 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  663. en:bgm 84 protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:bgm 84 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  664. en:bi 2536 --- r_associated #0: 35 --> en:cytarabine
    n1=en:bi 2536 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  665. en:bi 831266 --- r_associated #0: 35 --> en:cytarabine
    n1=en:bi 831266 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  666. en:bi 894999 --- r_associated #0: 35 --> en:cytarabine
    n1=en:bi 894999 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  667. en:bi-functional alkylating agent val-083 --- r_associated #0: 35 --> en:cytarabine
    n1=en:bi-functional alkylating agent val-083 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  668. en:bi-layered skin substitute from keratinocytes and fibroblasts --- r_associated #0: 35 --> en:cytarabine
    n1=en:bi-layered skin substitute from keratinocytes and fibroblasts | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  669. en:binetrakin --- r_associated #0: 35 --> en:cytarabine
    n1=en:binetrakin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  670. en:bismuth subsalicylate --- r_associated #0: 35 --> en:cytarabine
    n1=en:bismuth subsalicylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  671. en:bizelesin --- r_associated #0: 35 --> en:cytarabine
    n1=en:bizelesin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  672. en:bms-214662 --- r_associated #0: 35 --> en:cytarabine
    n1=en:bms-214662 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  673. en:brain tumor initiating cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:brain tumor initiating cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  674. en:branched-chain amino acid supplement --- r_associated #0: 35 --> en:cytarabine
    n1=en:branched-chain amino acid supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  675. en:brequinar --- r_associated #0: 35 --> en:cytarabine
    n1=en:brequinar | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  676. en:bryostatin 1 --- r_associated #0: 35 --> en:cytarabine
    n1=en:bryostatin 1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  677. en:calcium carbonate+magnesium carbonate --- r_associated #0: 35 --> en:cytarabine
    n1=en:calcium carbonate+magnesium carbonate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  678. en:camp combination --- r_associated #0: 35 --> en:cytarabine
    n1=en:camp combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  679. en:candelilla wax powder --- r_associated #0: 35 --> en:cytarabine
    n1=en:candelilla wax powder | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  680. en:candesartan cilexetil --- r_associated #0: 35 --> en:cytarabine
    n1=en:candesartan cilexetil | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  681. en:cannabis extract oil sr capsule --- r_associated #0: 35 --> en:cytarabine
    n1=en:cannabis extract oil sr capsule | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  682. en:cantuzumab ravtansine --- r_associated #0: 35 --> en:cytarabine
    n1=en:cantuzumab ravtansine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  683. en:capox regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:capox regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  684. en:caprylyl glucoside --- r_associated #0: 35 --> en:cytarabine
    n1=en:caprylyl glucoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  685. en:captopril, hydrochlorothiazide drug combination --- r_associated #0: 35 --> en:cytarabine
    n1=en:captopril, hydrochlorothiazide drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  686. en:caracemide --- r_associated #0: 35 --> en:cytarabine
    n1=en:caracemide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  687. en:carbetimer --- r_associated #0: 35 --> en:cytarabine
    n1=en:carbetimer | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  688. en:carbon c 14 oxaliplatin --- r_associated #0: 35 --> en:cytarabine
    n1=en:carbon c 14 oxaliplatin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  689. en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  690. en:ccg-0922 apl regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:ccg-0922 apl regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  691. en:ccl21-expressing h1944 cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:ccl21-expressing h1944 cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  692. en:cd4+ cd25+ regulatory t cells --- r_associated #0: 35 --> en:cytarabine
    n1=en:cd4+ cd25+ regulatory t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  693. en:cdc7 inhibitor tak-931 --- r_associated #0: 35 --> en:cytarabine
    n1=en:cdc7 inhibitor tak-931 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  694. en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  695. en:celecoxib/lidocaine/menthol --- r_associated #0: 35 --> en:cytarabine
    n1=en:celecoxib/lidocaine/menthol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  696. en:central nervous system agents --- r_associated #0: 35 --> en:cytarabine
    n1=en:central nervous system agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  697. en:chlorothiazide + reserpine --- r_associated #0: 35 --> en:cytarabine
    n1=en:chlorothiazide + reserpine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  698. en:chlorpheniramine + pyrilamine + phenylephrine --- r_associated #0: 35 --> en:cytarabine
    n1=en:chlorpheniramine + pyrilamine + phenylephrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  699. en:citric acid + magnesium oxide + sodium picosulfate --- r_associated #0: 35 --> en:cytarabine
    n1=en:citric acid + magnesium oxide + sodium picosulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  700. en:clino-san vaginal lubricant --- r_associated #0: 35 --> en:cytarabine
    n1=en:clino-san vaginal lubricant | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  701. en:clomiphen citrate --- r_associated #0: 35 --> en:cytarabine
    n1=en:clomiphen citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  702. en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  703. en:cmvpp65-a*0201 peptide vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:cmvpp65-a*0201 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  704. en:cola --- r_associated #0: 35 --> en:cytarabine
    n1=en:cola | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  705. en:colorectal tumor-associated peptides vaccine ima910 --- r_associated #0: 35 --> en:cytarabine
    n1=en:colorectal tumor-associated peptides vaccine ima910 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  706. en:compound kushen injection --- r_associated #0: 35 --> en:cytarabine
    n1=en:compound kushen injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  707. en:coptis extract --- r_associated #0: 35 --> en:cytarabine
    n1=en:coptis extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  708. en:corticorelin acetate --- r_associated #0: 35 --> en:cytarabine
    n1=en:corticorelin acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  709. en:cortisol-4-ara-c --- r_associated #0: 35 --> en:cytarabine
    n1=en:cortisol-4-ara-c | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  710. en:cortisone-4-ara-c --- r_associated #0: 35 --> en:cytarabine
    n1=en:cortisone-4-ara-c | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  711. en:corynebacterium granulosum p40 --- r_associated #0: 35 --> en:cytarabine
    n1=en:corynebacterium granulosum p40 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  712. en:cp 461 --- r_associated #0: 35 --> en:cytarabine
    n1=en:cp 461 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  713. en:cr2-fh fusion protein tt30 --- r_associated #0: 35 --> en:cytarabine
    n1=en:cr2-fh fusion protein tt30 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  714. en:crystalline genistein formulation axp107-11 --- r_associated #0: 35 --> en:cytarabine
    n1=en:crystalline genistein formulation axp107-11 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  715. en:ctrp terminology --- r_associated #0: 35 --> en:cytarabine
    n1=en:ctrp terminology | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  716. en:cyanocobalamin + folic acid --- r_associated #0: 35 --> en:cytarabine
    n1=en:cyanocobalamin + folic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  717. en:cyclopentolate+phenylephrine --- r_associated #0: 35 --> en:cytarabine
    n1=en:cyclopentolate+phenylephrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  718. en:cyp17 inhibitor cfg920 --- r_associated #0: 35 --> en:cytarabine
    n1=en:cyp17 inhibitor cfg920 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  719. en:cyp17 inhibitor vt-464 --- r_associated #0: 35 --> en:cytarabine
    n1=en:cyp17 inhibitor vt-464 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  720. en:cyproheptadine hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:cyproheptadine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  721. en:cytarabine 5'-methylphosphonate --- r_associated #0: 35 --> en:cytarabine
    n1=en:cytarabine 5'-methylphosphonate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  722. en:cytarabine 50mg injection suspension --- r_associated #0: 35 --> en:cytarabine
    n1=en:cytarabine 50mg injection suspension | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  723. en:cytarabine/daunorubicin/mercaptopurine/prednisolone --- r_associated #0: 35 --> en:cytarabine
    n1=en:cytarabine/daunorubicin/mercaptopurine/prednisolone | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  724. en:cytaramin --- r_associated #0: 35 --> en:cytarabine
    n1=en:cytaramin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  725. en:cytoros --- r_associated #0: 35 --> en:cytarabine
    n1=en:cytoros | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  726. en:daporinad --- r_associated #0: 35 --> en:cytarabine
    n1=en:daporinad | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  727. en:dendritic cell-autologous lung tumor vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:dendritic cell-autologous lung tumor vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  728. en:dendritic cell-cea peptide vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:dendritic cell-cea peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  729. en:dhact regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:dhact regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  730. en:dimethyl sulfoxide --- r_associated #0: 35 --> en:cytarabine
    n1=en:dimethyl sulfoxide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  731. en:dimethylmyleran --- r_associated #0: 35 --> en:cytarabine
    n1=en:dimethylmyleran | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  732. en:diphenhydramine hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:diphenhydramine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  733. en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed --- r_associated #0: 35 --> en:cytarabine
    n1=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  734. en:dmuc4064a --- r_associated #0: 35 --> en:cytarabine
    n1=en:dmuc4064a | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  735. en:dna minor groove binding agent sg2000 --- r_associated #0: 35 --> en:cytarabine
    n1=en:dna minor groove binding agent sg2000 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  736. en:dolastatin 10 --- r_associated #0: 35 --> en:cytarabine
    n1=en:dolastatin 10 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  737. en:dornase alfa --- r_associated #0: 35 --> en:cytarabine
    n1=en:dornase alfa | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  738. en:dova protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:dova protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  739. en:doxercalciferol --- r_associated #0: 35 --> en:cytarabine
    n1=en:doxercalciferol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  740. en:e-selectin antagonist gmi-1271 --- r_associated #0: 35 --> en:cytarabine
    n1=en:e-selectin antagonist gmi-1271 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  741. en:ebselen-containing oral capsule spi-1005 --- r_associated #0: 35 --> en:cytarabine
    n1=en:ebselen-containing oral capsule spi-1005 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  742. en:egfr antagonist hemay022 --- r_associated #0: 35 --> en:cytarabine
    n1=en:egfr antagonist hemay022 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  743. en:egfrviii-specific car-transduced autologous t lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:egfrviii-specific car-transduced autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  744. en:eicosapentaenoic acid-enriched nutritional supplement --- r_associated #0: 35 --> en:cytarabine
    n1=en:eicosapentaenoic acid-enriched nutritional supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  745. en:enzastaurin hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:enzastaurin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  746. en:era36 modulator icaritin --- r_associated #0: 35 --> en:cytarabine
    n1=en:era36 modulator icaritin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  747. en:erk inhibitor mk-8353 --- r_associated #0: 35 --> en:cytarabine
    n1=en:erk inhibitor mk-8353 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  748. en:everolimus --- r_associated #0: 35 --> en:cytarabine
    n1=en:everolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  749. en:exposure as collected domain --- r_associated #0: 35 --> en:cytarabine
    n1=en:exposure as collected domain | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  750. en:fenretinide lipid matrix --- r_associated #0: 35 --> en:cytarabine
    n1=en:fenretinide lipid matrix | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  751. en:flag protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:flag protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  752. en:fluorine f 18 choline --- r_associated #0: 35 --> en:cytarabine
    n1=en:fluorine f 18 choline | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  753. en:gap-pomp regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:gap-pomp regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  754. en:gastrin immunotoxin --- r_associated #0: 35 --> en:cytarabine
    n1=en:gastrin immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  755. en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  756. en:gemcitabine-cisplatin regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:gemcitabine-cisplatin regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  757. en:givinostat --- r_associated #0: 35 --> en:cytarabine
    n1=en:givinostat | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  758. en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  759. en:glu-ara-c-t70-c(10) --- r_associated #0: 35 --> en:cytarabine
    n1=en:glu-ara-c-t70-c(10) | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  760. en:gluten-free/fiber-enriched compact nutritional supplement drink --- r_associated #0: 35 --> en:cytarabine
    n1=en:gluten-free/fiber-enriched compact nutritional supplement drink | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  761. en:golnerminogene pradenovec --- r_associated #0: 35 --> en:cytarabine
    n1=en:golnerminogene pradenovec | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  762. en:hat regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:hat regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  763. en:her2-targeted liposomal doxorubicin hydrochloride mm-302 --- r_associated #0: 35 --> en:cytarabine
    n1=en:her2-targeted liposomal doxorubicin hydrochloride mm-302 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  764. en:hexamethylene bisacetamide --- r_associated #0: 35 --> en:cytarabine
    n1=en:hexamethylene bisacetamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  765. en:hexaminolevulinate hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:hexaminolevulinate hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  766. en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  767. en:hoagp protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:hoagp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  768. en:hsp90 antagonist kw-2478 --- r_associated #0: 35 --> en:cytarabine
    n1=en:hsp90 antagonist kw-2478 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  769. en:hsp90 inhibitor auy922 --- r_associated #0: 35 --> en:cytarabine
    n1=en:hsp90 inhibitor auy922 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  770. en:hu14.18-il2 fusion protein --- r_associated #0: 35 --> en:cytarabine
    n1=en:hu14.18-il2 fusion protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  771. en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 --- r_associated #0: 35 --> en:cytarabine
    n1=en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  772. en:hyaluronic acid-containing topical cream --- r_associated #0: 35 --> en:cytarabine
    n1=en:hyaluronic acid-containing topical cream | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  773. en:hypoxia-activated prodrug th-302 --- r_associated #0: 35 --> en:cytarabine
    n1=en:hypoxia-activated prodrug th-302 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  774. en:idronoxil --- r_associated #0: 35 --> en:cytarabine
    n1=en:idronoxil | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  775. en:in 111 monoclonal antibody ll2 --- r_associated #0: 35 --> en:cytarabine
    n1=en:in 111 monoclonal antibody ll2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  776. en:indium in 111 capromab pendetide --- r_associated #0: 35 --> en:cytarabine
    n1=en:indium in 111 capromab pendetide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  777. en:iobenguane i-131 --- r_associated #0: 35 --> en:cytarabine
    n1=en:iobenguane i-131 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  778. en:iodine i 131 tenatumomab --- r_associated #0: 35 --> en:cytarabine
    n1=en:iodine i 131 tenatumomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  779. en:iodine i 131 tositumomab --- r_associated #0: 35 --> en:cytarabine
    n1=en:iodine i 131 tositumomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  780. en:irinotecan-eluting beads --- r_associated #0: 35 --> en:cytarabine
    n1=en:irinotecan-eluting beads | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  781. en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet --- r_associated #0: 35 --> en:cytarabine
    n1=en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  782. en:iseganan hydrochloride --- r_associated #0: 35 --> en:cytarabine
    n1=en:iseganan hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  783. en:jak2 inhibitor xl019 --- r_associated #0: 35 --> en:cytarabine
    n1=en:jak2 inhibitor xl019 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  784. en:lactobacillus plantarum strain 299v --- r_associated #0: 35 --> en:cytarabine
    n1=en:lactobacillus plantarum strain 299v | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  785. en:lactoferrin-derived lytic peptide ltx-315 --- r_associated #0: 35 --> en:cytarabine
    n1=en:lactoferrin-derived lytic peptide ltx-315 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  786. en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells --- r_associated #0: 35 --> en:cytarabine
    n1=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  787. en:liposomal cytarabine-daunorubicin cpx-351 --- r_associated #0: 35 --> en:cytarabine
    n1=en:liposomal cytarabine-daunorubicin cpx-351 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  788. en:liposomal nddp --- r_associated #0: 35 --> en:cytarabine
    n1=en:liposomal nddp | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  789. en:lmb-7 immunotoxin --- r_associated #0: 35 --> en:cytarabine
    n1=en:lmb-7 immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  790. en:lmp2a-specific cytotoxic t-lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:lmp2a-specific cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  791. en:magnesium valproate --- r_associated #0: 35 --> en:cytarabine
    n1=en:magnesium valproate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  792. en:matilde regimen --- r_associated #0: 35 --> en:cytarabine
    n1=en:matilde regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  793. en:meclocycline sulfosalicylate --- r_associated #0: 35 --> en:cytarabine
    n1=en:meclocycline sulfosalicylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  794. en:methylene dimethane sulfonate --- r_associated #0: 35 --> en:cytarabine
    n1=en:methylene dimethane sulfonate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  795. en:mnk1/2 inhibitor eft508 --- r_associated #0: 35 --> en:cytarabine
    n1=en:mnk1/2 inhibitor eft508 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  796. en:moxetumomab pasudotox --- r_associated #0: 35 --> en:cytarabine
    n1=en:moxetumomab pasudotox | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  797. en:mtf-1 inhibitor apto-253 hcl --- r_associated #0: 35 --> en:cytarabine
    n1=en:mtf-1 inhibitor apto-253 hcl | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  798. en:mucoadhesive oral wound rinse --- r_associated #0: 35 --> en:cytarabine
    n1=en:mucoadhesive oral wound rinse | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  799. en:norepinephrine, dl- --- r_associated #0: 35 --> en:cytarabine
    n1=en:norepinephrine, dl- | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  800. en:novia protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:novia protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  801. en:nsc-239336 --- r_associated #0: 35 --> en:cytarabine
    n1=en:nsc-239336 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  802. en:ny-eso-1/lage-1 peptide vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:ny-eso-1/lage-1 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  803. en:ocaratuzumab --- r_associated #0: 35 --> en:cytarabine
    n1=en:ocaratuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  804. en:olaparib --- r_associated #0: 35 --> en:cytarabine
    n1=en:olaparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  805. en:olive oil/soya oil/egg lecithin-based emulsion --- r_associated #0: 35 --> en:cytarabine
    n1=en:olive oil/soya oil/egg lecithin-based emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  806. en:open-end wrench --- r_associated #0: 35 --> en:cytarabine
    n1=en:open-end wrench | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  807. en:open-ended spanner --- r_associated #0: 35 --> en:cytarabine
    n1=en:open-ended spanner | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  808. en:oxymetholone --- r_associated #0: 35 --> en:cytarabine
    n1=en:oxymetholone | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  809. en:p-tefb inhibitor bay1143572 --- r_associated #0: 35 --> en:cytarabine
    n1=en:p-tefb inhibitor bay1143572 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  810. en:p1-(cortisol-21-yl)-p2-(1-beta-d-arabinofuranosylcytosine-5'-yl)pyrophosphate --- r_associated #0: 35 --> en:cytarabine
    n1=en:p1-(cortisol-21-yl)-p2-(1-beta-d-arabinofuranosylcytosine-5'-yl)pyrophosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  811. en:palm extract phytonutrient supplement --- r_associated #0: 35 --> en:cytarabine
    n1=en:palm extract phytonutrient supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  812. en:parenteral form cytarabine --- r_associated #0: 35 --> en:cytarabine
    n1=en:parenteral form cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  813. en:patco protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:patco protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  814. en:pdgfr alpha/kit mutant-specific inhibitor blu-285 --- r_associated #0: 35 --> en:cytarabine
    n1=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  815. en:pediatric nutritional supplement drink --- r_associated #0: 35 --> en:cytarabine
    n1=en:pediatric nutritional supplement drink | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  816. en:pegamotecan --- r_associated #0: 35 --> en:cytarabine
    n1=en:pegamotecan | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  817. en:pentavalent klh conjugate vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:pentavalent klh conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  818. en:pentetic acid --- r_associated #0: 35 --> en:cytarabine
    n1=en:pentetic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  819. en:pexidartinib --- r_associated #0: 35 --> en:cytarabine
    n1=en:pexidartinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  820. en:phenylephrine + promethazine + codeine --- r_associated #0: 35 --> en:cytarabine
    n1=en:phenylephrine + promethazine + codeine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  821. en:pi3k inhibitor gdc-0941 bismesylate --- r_associated #0: 35 --> en:cytarabine
    n1=en:pi3k inhibitor gdc-0941 bismesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  822. en:pi3k-beta inhibitor gsk2636771 --- r_associated #0: 35 --> en:cytarabine
    n1=en:pi3k-beta inhibitor gsk2636771 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  823. en:pi3k-delta inhibitor incb050465 --- r_associated #0: 35 --> en:cytarabine
    n1=en:pi3k-delta inhibitor incb050465 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  824. en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 --- r_associated #0: 35 --> en:cytarabine
    n1=en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  825. en:pi3kdelta inhibitor incb040093 --- r_associated #0: 35 --> en:cytarabine
    n1=en:pi3kdelta inhibitor incb040093 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  826. en:pimasertib --- r_associated #0: 35 --> en:cytarabine
    n1=en:pimasertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  827. en:plx73086 --- r_associated #0: 35 --> en:cytarabine
    n1=en:plx73086 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  828. en:pocal protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:pocal protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  829. en:polaprezinc --- r_associated #0: 35 --> en:cytarabine
    n1=en:polaprezinc | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  830. en:polihexanide solution --- r_associated #0: 35 --> en:cytarabine
    n1=en:polihexanide solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  831. en:pseudomonas aeruginosa preparation --- r_associated #0: 35 --> en:cytarabine
    n1=en:pseudomonas aeruginosa preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  832. en:radiosensitizing agent --- r_associated #0: 35 --> en:cytarabine
    n1=en:radiosensitizing agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  833. en:rap protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:rap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  834. en:raralpha agonist irx5183 --- r_associated #0: 35 --> en:cytarabine
    n1=en:raralpha agonist irx5183 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  835. en:receptor tyrosine kinase inhibitor r1530 --- r_associated #0: 35 --> en:cytarabine
    n1=en:receptor tyrosine kinase inhibitor r1530 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  836. en:recombinant transforming growth factor-beta 2 --- r_associated #0: 35 --> en:cytarabine
    n1=en:recombinant transforming growth factor-beta 2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  837. en:resminostat --- r_associated #0: 35 --> en:cytarabine
    n1=en:resminostat | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  838. en:rk-0202 --- r_associated #0: 35 --> en:cytarabine
    n1=en:rk-0202 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  839. en:romidepsin --- r_associated #0: 35 --> en:cytarabine
    n1=en:romidepsin | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  840. en:s1p receptor agonist krp203 --- r_associated #0: 35 --> en:cytarabine
    n1=en:s1p receptor agonist krp203 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  841. en:sheng-mai san --- r_associated #0: 35 --> en:cytarabine
    n1=en:sheng-mai san | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  842. en:smac mimetic lcl161 --- r_associated #0: 35 --> en:cytarabine
    n1=en:smac mimetic lcl161 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  843. en:sr31747a --- r_associated #0: 35 --> en:cytarabine
    n1=en:sr31747a | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  844. en:src/tubulin inhibitor kx02 --- r_associated #0: 35 --> en:cytarabine
    n1=en:src/tubulin inhibitor kx02 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  845. en:strawberry-blackberry-black raspberry-blueberry mixture --- r_associated #0: 35 --> en:cytarabine
    n1=en:strawberry-blackberry-black raspberry-blueberry mixture | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  846. en:t4n5 liposomal lotion --- r_associated #0: 35 --> en:cytarabine
    n1=en:t4n5 liposomal lotion | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  847. en:talimogene laherparepvec --- r_associated #0: 35 --> en:cytarabine
    n1=en:talimogene laherparepvec | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  848. en:tam protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:tam protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  849. en:tave protocol --- r_associated #0: 35 --> en:cytarabine
    n1=en:tave protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  850. en:tegafur-gimeracil-oteracil potassium --- r_associated #0: 35 --> en:cytarabine
    n1=en:tegafur-gimeracil-oteracil potassium | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  851. en:teniposide --- r_associated #0: 35 --> en:cytarabine
    n1=en:teniposide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  852. en:tesetaxel --- r_associated #0: 35 --> en:cytarabine
    n1=en:tesetaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  853. en:topical pvdf/sirolimus --- r_associated #0: 35 --> en:cytarabine
    n1=en:topical pvdf/sirolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  854. en:trastuzumab --- r_associated #0: 35 --> en:cytarabine
    n1=en:trastuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  855. en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes --- r_associated #0: 35 --> en:cytarabine
    n1=en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  856. en:tyroserleutide --- r_associated #0: 35 --> en:cytarabine
    n1=en:tyroserleutide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  857. en:tyrosine kinase inhibitor xl228 --- r_associated #0: 35 --> en:cytarabine
    n1=en:tyrosine kinase inhibitor xl228 | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  858. en:uv1 telomerase peptide vaccine --- r_associated #0: 35 --> en:cytarabine
    n1=en:uv1 telomerase peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  859. en:vadastuximab talirine --- r_associated #0: 35 --> en:cytarabine
    n1=en:vadastuximab talirine | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  860. en:valacyclovir --- r_associated #0: 35 --> en:cytarabine
    n1=en:valacyclovir | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  861. en:volasertib --- r_associated #0: 35 --> en:cytarabine
    n1=en:volasertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  862. en:zirconium zr 89 df-iab2m --- r_associated #0: 35 --> en:cytarabine
    n1=en:zirconium zr 89 df-iab2m | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  863. en:zirconium zr 89 girentuximab --- r_associated #0: 35 --> en:cytarabine
    n1=en:zirconium zr 89 girentuximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  864. inhibiteur des canaux calciques --- r_associated #0: 35 --> en:cytarabine
    n1=inhibiteur des canaux calciques | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  865. lier connaissance avec quelqu'un --- r_associated #0: 35 --> en:cytarabine
    n1=lier connaissance avec quelqu'un | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  866. olaparib --- r_associated #0: 35 --> en:cytarabine
    n1=olaparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  867. oxymétholone --- r_associated #0: 35 --> en:cytarabine
    n1=oxymétholone | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  868. trastuzumab --- r_associated #0: 35 --> en:cytarabine
    n1=trastuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  869. téniposide --- r_associated #0: 35 --> en:cytarabine
    n1=téniposide | n2=en:cytarabine | rel=r_associated | relid=0 | w=35
  870. dicumarol --- r_associated #0: 34 --> en:cytarabine
    n1=dicumarol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  871. en:1 beta-arabinofuranosylcytosine 5'-diphosphate-1,2-diolein --- r_associated #0: 34 --> en:cytarabine
    n1=en:1 beta-arabinofuranosylcytosine 5'-diphosphate-1,2-diolein | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  872. en:1-(3-deoxypentofuranosyl)cytosine --- r_associated #0: 34 --> en:cytarabine
    n1=en:1-(3-deoxypentofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  873. en:2'-fluoro-5-bromo-1-beta-d-arabinofuranosylcytosine --- r_associated #0: 34 --> en:cytarabine
    n1=en:2'-fluoro-5-bromo-1-beta-d-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  874. en:4-1bb agonist monoclonal antibody pf-05082566 --- r_associated #0: 34 --> en:cytarabine
    n1=en:4-1bb agonist monoclonal antibody pf-05082566 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  875. en:5-fitc-labeled gi-heptapeptide --- r_associated #0: 34 --> en:cytarabine
    n1=en:5-fitc-labeled gi-heptapeptide | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  876. en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 --- r_associated #0: 34 --> en:cytarabine
    n1=en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  877. en:8-hydroxyquinoline sulfate ointment --- r_associated #0: 34 --> en:cytarabine
    n1=en:8-hydroxyquinoline sulfate ointment | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  878. en:abep protocol 1 --- r_associated #0: 34 --> en:cytarabine
    n1=en:abep protocol 1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  879. en:abve regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:abve regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  880. en:acellular cadaveric dermal matrix --- r_associated #0: 34 --> en:cytarabine
    n1=en:acellular cadaveric dermal matrix | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  881. en:acomla protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:acomla protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  882. en:ad-sig-hmuc-1/ecdcd40l vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:ad-sig-hmuc-1/ecdcd40l vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  883. en:adenovirus 5-cd40 ligand --- r_associated #0: 34 --> en:cytarabine
    n1=en:adenovirus 5-cd40 ligand | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  884. en:aeg35156 --- r_associated #0: 34 --> en:cytarabine
    n1=en:aeg35156 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  885. en:aieop 8803 high-risk all protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:aieop 8803 high-risk all protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  886. en:aieop all protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:aieop all protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  887. en:akt/erk inhibitor onc201 --- r_associated #0: 34 --> en:cytarabine
    n1=en:akt/erk inhibitor onc201 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  888. en:allodepleted t cell immunotherapeutic atir101 --- r_associated #0: 34 --> en:cytarabine
    n1=en:allodepleted t cell immunotherapeutic atir101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  889. en:allogeneic large multivalent immunogen breast cancer vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:allogeneic large multivalent immunogen breast cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  890. en:allogeneic natural killer cell line mg4101 --- r_associated #0: 34 --> en:cytarabine
    n1=en:allogeneic natural killer cell line mg4101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  891. en:allogeneic natural killer cell line nk-92 --- r_associated #0: 34 --> en:cytarabine
    n1=en:allogeneic natural killer cell line nk-92 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  892. en:alpha-galactosylceramide-pulsed autologous dendritic cells --- r_associated #0: 34 --> en:cytarabine
    n1=en:alpha-galactosylceramide-pulsed autologous dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  893. en:alvac-eso-1 vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:alvac-eso-1 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  894. en:amitriptyline hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:amitriptyline hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  895. en:androgen receptor inhibitor epi-506 --- r_associated #0: 34 --> en:cytarabine
    n1=en:androgen receptor inhibitor epi-506 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  896. en:anti-allergic agents --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-allergic agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  897. en:anti-c-kit monoclonal antibody ktn0158 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-c-kit monoclonal antibody ktn0158 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  898. en:anti-ca6-dm4 immunoconjugate sar566658 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-ca6-dm4 immunoconjugate sar566658 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  899. en:anti-cd157 monoclonal antibody men1112 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-cd157 monoclonal antibody men1112 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  900. en:anti-cd19/cd3 tetravalent antibody afm11 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-cd19/cd3 tetravalent antibody afm11 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  901. en:anti-cd20 monoclonal antibody pro131921 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-cd20 monoclonal antibody pro131921 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  902. en:anti-cd25-pbd antibody-drug conjugate adct-301 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-cd25-pbd antibody-drug conjugate adct-301 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  903. en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  904. en:anti-cd37 monoclonal antibody bi 836826 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-cd37 monoclonal antibody bi 836826 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  905. en:anti-egfr monoclonal antibody syn004 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-egfr monoclonal antibody syn004 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  906. en:anti-egfr/c-met bispecific antibody jnj-61186372 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-egfr/c-met bispecific antibody jnj-61186372 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  907. en:anti-enpp3 antibody-drug conjugate ags-16c3f --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-enpp3 antibody-drug conjugate ags-16c3f | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  908. en:anti-etbr/mmae antibody-drug conjugate dedn6526a --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-etbr/mmae antibody-drug conjugate dedn6526a | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  909. en:anti-gpc3-car autologous t lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-gpc3-car autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  910. en:anti-her3 monoclonal antibody ljm716 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-her3 monoclonal antibody ljm716 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  911. en:anti-icos agonist antibody gsk3359609 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-icos agonist antibody gsk3359609 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  912. en:anti-nf-p2x7 antibody ointment bil-010t --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-nf-p2x7 antibody ointment bil-010t | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  913. en:anti-pd-1 monoclonal antibody medi0680 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-pd-1 monoclonal antibody medi0680 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  914. en:anti-psma/cd3 monoclonal antibody mor209/es414 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-psma/cd3 monoclonal antibody mor209/es414 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  915. en:anti-sclu monoclonal antibody ab-16b5 --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-sclu monoclonal antibody ab-16b5 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  916. en:anti-ta-muc1 monoclonal antibody pankomab --- r_associated #0: 34 --> en:cytarabine
    n1=en:anti-ta-muc1 monoclonal antibody pankomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  917. en:antiangiogenic drug combination tl-118 --- r_associated #0: 34 --> en:cytarabine
    n1=en:antiangiogenic drug combination tl-118 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  918. en:antineoplastic agent trx-818 --- r_associated #0: 34 --> en:cytarabine
    n1=en:antineoplastic agent trx-818 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  919. en:antineoplaston as2-1 --- r_associated #0: 34 --> en:cytarabine
    n1=en:antineoplaston as2-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  920. en:apomab --- r_associated #0: 34 --> en:cytarabine
    n1=en:apomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  921. en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells --- r_associated #0: 34 --> en:cytarabine
    n1=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  922. en:aracytidine-5'-hexadecylphosphonophosphate --- r_associated #0: 34 --> en:cytarabine
    n1=en:aracytidine-5'-hexadecylphosphonophosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  923. en:artemether sublingual spray --- r_associated #0: 34 --> en:cytarabine
    n1=en:artemether sublingual spray | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  924. en:arzoxifene hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:arzoxifene hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  925. en:as03-adjuvanted h1n1 pandemic influenza vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:as03-adjuvanted h1n1 pandemic influenza vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  926. en:atn-161 --- r_associated #0: 34 --> en:cytarabine
    n1=en:atn-161 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  927. en:atomoxetine hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:atomoxetine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  928. en:atorvastatin calcium --- r_associated #0: 34 --> en:cytarabine
    n1=en:atorvastatin calcium | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  929. en:aurora b serine/threonine kinase inhibitor tak-901 --- r_associated #0: 34 --> en:cytarabine
    n1=en:aurora b serine/threonine kinase inhibitor tak-901 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  930. en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  931. en:autologous colon cancer cell vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous colon cancer cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  932. en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  933. en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  934. en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  935. en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  936. en:autologous nsclc peptide-specific dendritic cell vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous nsclc peptide-specific dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  937. en:autologous tns9.3.55-transduced cd34-positive cells --- r_associated #0: 34 --> en:cytarabine
    n1=en:autologous tns9.3.55-transduced cd34-positive cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  938. en:bact protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:bact protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  939. en:barium sulfate --- r_associated #0: 34 --> en:cytarabine
    n1=en:barium sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  940. en:bbr 3464 --- r_associated #0: 34 --> en:cytarabine
    n1=en:bbr 3464 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  941. en:bendamustine-containing nanoparticle-based formulation rxdx-107 --- r_associated #0: 34 --> en:cytarabine
    n1=en:bendamustine-containing nanoparticle-based formulation rxdx-107 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  942. en:bendamustine-vorinostat fusion molecule edo-s101 --- r_associated #0: 34 --> en:cytarabine
    n1=en:bendamustine-vorinostat fusion molecule edo-s101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  943. en:bet inhibitor gsk525762 --- r_associated #0: 34 --> en:cytarabine
    n1=en:bet inhibitor gsk525762 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  944. en:bf-9 protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:bf-9 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  945. en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement --- r_associated #0: 34 --> en:cytarabine
    n1=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  946. en:bispecific antibody mdx447 --- r_associated #0: 34 --> en:cytarabine
    n1=en:bispecific antibody mdx447 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  947. en:boanmycin hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:boanmycin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  948. en:boswellia serrata extract --- r_associated #0: 34 --> en:cytarabine
    n1=en:boswellia serrata extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  949. en:braf inhibitor plx8394 --- r_associated #0: 34 --> en:cytarabine
    n1=en:braf inhibitor plx8394 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  950. en:braf(v600e) inhibitor cep-32496 --- r_associated #0: 34 --> en:cytarabine
    n1=en:braf(v600e) inhibitor cep-32496 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  951. en:brivanib --- r_associated #0: 34 --> en:cytarabine
    n1=en:brivanib | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  952. en:broad-spectrum human papillomavirus vaccine v505 --- r_associated #0: 34 --> en:cytarabine
    n1=en:broad-spectrum human papillomavirus vaccine v505 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  953. en:busulfan/melphalan regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:busulfan/melphalan regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  954. en:c-myb antisense oligonucleotide g4460 --- r_associated #0: 34 --> en:cytarabine
    n1=en:c-myb antisense oligonucleotide g4460 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  955. en:calamine --- r_associated #0: 34 --> en:cytarabine
    n1=en:calamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  956. en:calcitonin salmon --- r_associated #0: 34 --> en:cytarabine
    n1=en:calcitonin salmon | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  957. en:calcium saccharate --- r_associated #0: 34 --> en:cytarabine
    n1=en:calcium saccharate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  958. en:calendula preparation --- r_associated #0: 34 --> en:cytarabine
    n1=en:calendula preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  959. en:camptothecin-20(s)-o-propionate hydrate --- r_associated #0: 34 --> en:cytarabine
    n1=en:camptothecin-20(s)-o-propionate hydrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  960. en:cananga odorata extract --- r_associated #0: 34 --> en:cytarabine
    n1=en:cananga odorata extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  961. en:cancell --- r_associated #0: 34 --> en:cytarabine
    n1=en:cancell | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  962. en:carbidopa + entacapone + levodopa --- r_associated #0: 34 --> en:cytarabine
    n1=en:carbidopa + entacapone + levodopa | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  963. en:carbon c 13 lycopene --- r_associated #0: 34 --> en:cytarabine
    n1=en:carbon c 13 lycopene | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  964. en:carbon c 13/nitrogen n 15-labeled valine --- r_associated #0: 34 --> en:cytarabine
    n1=en:carbon c 13/nitrogen n 15-labeled valine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  965. en:carboplatin/etoposide/melphalan regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:carboplatin/etoposide/melphalan regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  966. en:carboxyphenyl retinamide --- r_associated #0: 34 --> en:cytarabine
    n1=en:carboxyphenyl retinamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  967. en:caricotamide/tretazicar --- r_associated #0: 34 --> en:cytarabine
    n1=en:caricotamide/tretazicar | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  968. en:carmustine/cytarabine/etoposide/melphalan --- r_associated #0: 34 --> en:cytarabine
    n1=en:carmustine/cytarabine/etoposide/melphalan | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  969. en:carvedilol --- r_associated #0: 34 --> en:cytarabine
    n1=en:carvedilol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  970. en:cat-g protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:cat-g protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  971. en:catumaxomab --- r_associated #0: 34 --> en:cytarabine
    n1=en:catumaxomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  972. en:cc-1088 --- r_associated #0: 34 --> en:cytarabine
    n1=en:cc-1088 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  973. en:ccg-192p --- r_associated #0: 34 --> en:cytarabine
    n1=en:ccg-192p | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  974. en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  975. en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  976. en:cd19car-cd3zeta-expressing autologous t lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:cd19car-cd3zeta-expressing autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  977. en:cdki at7519 --- r_associated #0: 34 --> en:cytarabine
    n1=en:cdki at7519 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  978. en:cell cycle checkpoint/dna repair antagonist ic83 --- r_associated #0: 34 --> en:cytarabine
    n1=en:cell cycle checkpoint/dna repair antagonist ic83 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  979. en:cerium oxalate --- r_associated #0: 34 --> en:cytarabine
    n1=en:cerium oxalate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  980. en:checkpoint kinase inhibitor azd7762 --- r_associated #0: 34 --> en:cytarabine
    n1=en:checkpoint kinase inhibitor azd7762 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  981. en:chimeric fibril-reactive monoclonal antibody 111f4 --- r_associated #0: 34 --> en:cytarabine
    n1=en:chimeric fibril-reactive monoclonal antibody 111f4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  982. en:chinese herbal formulation phy906 --- r_associated #0: 34 --> en:cytarabine
    n1=en:chinese herbal formulation phy906 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  983. en:chlorpheniramine + ibuprofen + pseudoephedrine --- r_associated #0: 34 --> en:cytarabine
    n1=en:chlorpheniramine + ibuprofen + pseudoephedrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  984. en:chlorpheniramine + pseudoephedrine + dextromethorphan --- r_associated #0: 34 --> en:cytarabine
    n1=en:chlorpheniramine + pseudoephedrine + dextromethorphan | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  985. en:chlorpheniramine + pseudoephedrine + hydrocodone --- r_associated #0: 34 --> en:cytarabine
    n1=en:chlorpheniramine + pseudoephedrine + hydrocodone | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  986. en:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination --- r_associated #0: 34 --> en:cytarabine
    n1=en:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  987. en:choline kinase alpha inhibitor tcd-717 --- r_associated #0: 34 --> en:cytarabine
    n1=en:choline kinase alpha inhibitor tcd-717 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  988. en:cisplatin-e therapeutic implant --- r_associated #0: 34 --> en:cytarabine
    n1=en:cisplatin-e therapeutic implant | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  989. en:clag-m regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:clag-m regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  990. en:clostridium butyricum-containing probiotic --- r_associated #0: 34 --> en:cytarabine
    n1=en:clostridium butyricum-containing probiotic | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  991. en:cmet car-mrna electroporated autologous t lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:cmet car-mrna electroporated autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  992. en:cmv n495 peptide --- r_associated #0: 34 --> en:cytarabine
    n1=en:cmv n495 peptide | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  993. en:codox-m/ivac regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:codox-m/ivac regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  994. en:colloidal gold-bound tumor necrosis factor --- r_associated #0: 34 --> en:cytarabine
    n1=en:colloidal gold-bound tumor necrosis factor | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  995. en:combretastatin a1 diphosphate --- r_associated #0: 34 --> en:cytarabine
    n1=en:combretastatin a1 diphosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  996. en:comla protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:comla protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  997. en:conditionally replicative adenovirus 5/3-delta24 --- r_associated #0: 34 --> en:cytarabine
    n1=en:conditionally replicative adenovirus 5/3-delta24 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  998. en:cp-724,714 --- r_associated #0: 34 --> en:cytarabine
    n1=en:cp-724,714 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  999. en:cridanimod sodium --- r_associated #0: 34 --> en:cytarabine
    n1=en:cridanimod sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1000. en:crisnatol mesylate --- r_associated #0: 34 --> en:cytarabine
    n1=en:crisnatol mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1001. en:crolibulin --- r_associated #0: 34 --> en:cytarabine
    n1=en:crolibulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1002. en:custirsen sodium --- r_associated #0: 34 --> en:cytarabine
    n1=en:custirsen sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1003. en:cyclopentenyl cytosine --- r_associated #0: 34 --> en:cytarabine
    n1=en:cyclopentenyl cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1004. en:cyl-02 plasmid dna --- r_associated #0: 34 --> en:cytarabine
    n1=en:cyl-02 plasmid dna | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1005. en:cytarabine-mitoxantrone regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:cytarabine-mitoxantrone regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1006. en:cytarabine/doxorubicin/prednisone/vincristine --- r_associated #0: 34 --> en:cytarabine
    n1=en:cytarabine/doxorubicin/prednisone/vincristine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1007. en:cytonal --- r_associated #0: 34 --> en:cytarabine
    n1=en:cytonal | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1008. en:d-zapo protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:d-zapo protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1009. en:daflon 500 --- r_associated #0: 34 --> en:cytarabine
    n1=en:daflon 500 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1010. en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins --- r_associated #0: 34 --> en:cytarabine
    n1=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1011. en:delanzomib --- r_associated #0: 34 --> en:cytarabine
    n1=en:delanzomib | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1012. en:dendritic cell-precision multiple antigen t-lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:dendritic cell-precision multiple antigen t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1013. en:dendritic cell-targeting lentiviral vector id-lv305 --- r_associated #0: 34 --> en:cytarabine
    n1=en:dendritic cell-targeting lentiviral vector id-lv305 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1014. en:denibulin hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:denibulin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1015. en:dexa-beam protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:dexa-beam protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1016. en:dianhydrogalactitol --- r_associated #0: 34 --> en:cytarabine
    n1=en:dianhydrogalactitol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1017. en:dicumarol --- r_associated #0: 34 --> en:cytarabine
    n1=en:dicumarol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1018. en:dihydro-5-azacytidine --- r_associated #0: 34 --> en:cytarabine
    n1=en:dihydro-5-azacytidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1019. en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 --- r_associated #0: 34 --> en:cytarabine
    n1=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1020. en:dkk1-neutralizing monoclonal antibody dkn-01 --- r_associated #0: 34 --> en:cytarabine
    n1=en:dkk1-neutralizing monoclonal antibody dkn-01 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1021. en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 --- r_associated #0: 34 --> en:cytarabine
    n1=en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1022. en:durvalumab --- r_associated #0: 34 --> en:cytarabine
    n1=en:durvalumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1023. en:east indian sandalwood oil mouth rinse --- r_associated #0: 34 --> en:cytarabine
    n1=en:east indian sandalwood oil mouth rinse | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1024. en:egfr inhibitor asp8273 --- r_associated #0: 34 --> en:cytarabine
    n1=en:egfr inhibitor asp8273 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1025. en:egfr inhibitor azd3759 --- r_associated #0: 34 --> en:cytarabine
    n1=en:egfr inhibitor azd3759 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1026. en:emitefur --- r_associated #0: 34 --> en:cytarabine
    n1=en:emitefur | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1027. en:entecavir --- r_associated #0: 34 --> en:cytarabine
    n1=en:entecavir | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1028. en:entolimod --- r_associated #0: 34 --> en:cytarabine
    n1=en:entolimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1029. en:enzymatically-hydrolyzed whey protein-based nutritional supplement --- r_associated #0: 34 --> en:cytarabine
    n1=en:enzymatically-hydrolyzed whey protein-based nutritional supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1030. en:eortc gimema aml-10 protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:eortc gimema aml-10 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1031. en:eplerenone --- r_associated #0: 34 --> en:cytarabine
    n1=en:eplerenone | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1032. en:eshap regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:eshap regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1033. en:exenatide --- r_associated #0: 34 --> en:cytarabine
    n1=en:exenatide | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1034. en:ezatiostat hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:ezatiostat hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1035. en:f-18 fluoroethyltyrosine --- r_associated #0: 34 --> en:cytarabine
    n1=en:f-18 fluoroethyltyrosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1036. en:f-machop protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:f-machop protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1037. en:ferrous sulfate --- r_associated #0: 34 --> en:cytarabine
    n1=en:ferrous sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1038. en:fgfr inhibitor asp5878 --- r_associated #0: 34 --> en:cytarabine
    n1=en:fgfr inhibitor asp5878 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1039. en:flang protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:flang protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1040. en:fluciclatide f-18 --- r_associated #0: 34 --> en:cytarabine
    n1=en:fluciclatide f-18 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1041. en:fluorine f 18 dcfpyl --- r_associated #0: 34 --> en:cytarabine
    n1=en:fluorine f 18 dcfpyl | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1042. en:fluzoparib --- r_associated #0: 34 --> en:cytarabine
    n1=en:fluzoparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1043. en:folate receptor-targeted tubulysin conjugate ec1456 --- r_associated #0: 34 --> en:cytarabine
    n1=en:folate receptor-targeted tubulysin conjugate ec1456 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1044. en:fostriecin --- r_associated #0: 34 --> en:cytarabine
    n1=en:fostriecin | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1045. en:fowlpox-ny-eso-1 vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:fowlpox-ny-eso-1 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1046. en:g-idea protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:g-idea protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1047. en:gabapentin enacarbil --- r_associated #0: 34 --> en:cytarabine
    n1=en:gabapentin enacarbil | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1048. en:galectin inhibitor gr-md-02 --- r_associated #0: 34 --> en:cytarabine
    n1=en:galectin inhibitor gr-md-02 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1049. en:gemcitabine hydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:gemcitabine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1050. en:globulin component macrophage-activating factor --- r_associated #0: 34 --> en:cytarabine
    n1=en:globulin component macrophage-activating factor | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1051. en:glufosfamide --- r_associated #0: 34 --> en:cytarabine
    n1=en:glufosfamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1052. en:glycine --- r_associated #0: 34 --> en:cytarabine
    n1=en:glycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1053. en:gm-csf-encoding oncolytic adenovirus cgtg-102 --- r_associated #0: 34 --> en:cytarabine
    n1=en:gm-csf-encoding oncolytic adenovirus cgtg-102 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1054. en:gm.cd40l cell vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:gm.cd40l cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1055. en:gp100:209-217(210m) peptide vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:gp100:209-217(210m) peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1056. en:had protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:had protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1057. en:hdac inhibitor 4sc-202 --- r_associated #0: 34 --> en:cytarabine
    n1=en:hdac inhibitor 4sc-202 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1058. en:high-titer rsv immune globulin ri-001 --- r_associated #0: 34 --> en:cytarabine
    n1=en:high-titer rsv immune globulin ri-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1059. en:histrelin acetate --- r_associated #0: 34 --> en:cytarabine
    n1=en:histrelin acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1060. en:hoaap protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:hoaap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1061. en:hpv dna plasmids therapeutic vaccine vgx-3100 --- r_associated #0: 34 --> en:cytarabine
    n1=en:hpv dna plasmids therapeutic vaccine vgx-3100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1062. en:hpv e6/e7 dna vaccine gx-188e --- r_associated #0: 34 --> en:cytarabine
    n1=en:hpv e6/e7 dna vaccine gx-188e | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1063. en:hsv-1 hf10 --- r_associated #0: 34 --> en:cytarabine
    n1=en:hsv-1 hf10 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1064. en:hyperpolarized helium 3 --- r_associated #0: 34 --> en:cytarabine
    n1=en:hyperpolarized helium 3 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1065. en:ibandronate sodium --- r_associated #0: 34 --> en:cytarabine
    n1=en:ibandronate sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1066. en:ice protocol 4 --- r_associated #0: 34 --> en:cytarabine
    n1=en:ice protocol 4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1067. en:imexon --- r_associated #0: 34 --> en:cytarabine
    n1=en:imexon | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1068. en:immunocytokine nhs-il2-lt --- r_associated #0: 34 --> en:cytarabine
    n1=en:immunocytokine nhs-il2-lt | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1069. en:in 111 folic acid --- r_associated #0: 34 --> en:cytarabine
    n1=en:in 111 folic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1070. en:indium in 111 bevacizumab --- r_associated #0: 34 --> en:cytarabine
    n1=en:indium in 111 bevacizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1071. en:indium in 111-dota-biotin --- r_associated #0: 34 --> en:cytarabine
    n1=en:indium in 111-dota-biotin | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1072. en:indoleamine 2,3-dioxygenase peptide vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:indoleamine 2,3-dioxygenase peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1073. en:ingenol mebutate gel --- r_associated #0: 34 --> en:cytarabine
    n1=en:ingenol mebutate gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1074. en:l-carnitine l-tartrate --- r_associated #0: 34 --> en:cytarabine
    n1=en:l-carnitine l-tartrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1075. en:lapachone --- r_associated #0: 34 --> en:cytarabine
    n1=en:lapachone | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1076. en:licartin --- r_associated #0: 34 --> en:cytarabine
    n1=en:licartin | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1077. en:liposomal daunorubicin citrate --- r_associated #0: 34 --> en:cytarabine
    n1=en:liposomal daunorubicin citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1078. en:lmb-1 immunotoxin --- r_associated #0: 34 --> en:cytarabine
    n1=en:lmb-1 immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1079. en:lmb-84 regimen --- r_associated #0: 34 --> en:cytarabine
    n1=en:lmb-84 regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1080. en:lmb89 protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:lmb89 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1081. en:losoxantrone --- r_associated #0: 34 --> en:cytarabine
    n1=en:losoxantrone | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1082. en:mac321 --- r_associated #0: 34 --> en:cytarabine
    n1=en:mac321 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1083. en:mart-1 reactive cd8+ lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:mart-1 reactive cd8+ lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1084. en:monoclonal antibody a1g4 anti-idiotype vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:monoclonal antibody a1g4 anti-idiotype vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1085. en:monoclonal antibody cal --- r_associated #0: 34 --> en:cytarabine
    n1=en:monoclonal antibody cal | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1086. en:monoclonal antibody rav12 --- r_associated #0: 34 --> en:cytarabine
    n1=en:monoclonal antibody rav12 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1087. en:monoclonal antibody sgn-30 --- r_associated #0: 34 --> en:cytarabine
    n1=en:monoclonal antibody sgn-30 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1088. en:motexafin gadolinium --- r_associated #0: 34 --> en:cytarabine
    n1=en:motexafin gadolinium | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1089. en:muc-2-klh vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:muc-2-klh vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1090. en:mycobacterium tuberculosis arabinomannan z-100 --- r_associated #0: 34 --> en:cytarabine
    n1=en:mycobacterium tuberculosis arabinomannan z-100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1091. en:n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine-polylysine conjugate --- r_associated #0: 34 --> en:cytarabine
    n1=en:n(4)-(4-carboxybutyryl)-1-arabinofuranosylcytosine-polylysine conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1092. en:n(4)-(4-carboxybutyryl)-1-beta-arabinofuranosylcytosine --- r_associated #0: 34 --> en:cytarabine
    n1=en:n(4)-(4-carboxybutyryl)-1-beta-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1093. en:n(4)-octadecyl-1-beta-d-arabinofuranosylcytosine --- r_associated #0: 34 --> en:cytarabine
    n1=en:n(4)-octadecyl-1-beta-d-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1094. en:nd-420 --- r_associated #0: 34 --> en:cytarabine
    n1=en:nd-420 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1095. en:netazepide --- r_associated #0: 34 --> en:cytarabine
    n1=en:netazepide | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1096. en:neutrophil activation probe imaging agent --- r_associated #0: 34 --> en:cytarabine
    n1=en:neutrophil activation probe imaging agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1097. en:nolatrexed dihydrochloride --- r_associated #0: 34 --> en:cytarabine
    n1=en:nolatrexed dihydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1098. en:oap-bleo protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:oap-bleo protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1099. en:octreotide acetate --- r_associated #0: 34 --> en:cytarabine
    n1=en:octreotide acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1100. en:oral dosage form product --- r_associated #0: 34 --> en:cytarabine
    n1=en:oral dosage form product | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1101. en:oteracil potassium --- r_associated #0: 34 --> en:cytarabine
    n1=en:oteracil potassium | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1102. en:parenteral dosage form product --- r_associated #0: 34 --> en:cytarabine
    n1=en:parenteral dosage form product | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1103. en:peg recombinant human megakaryocyte growth and development factor --- r_associated #0: 34 --> en:cytarabine
    n1=en:peg recombinant human megakaryocyte growth and development factor | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1104. en:pegylated arginine deiminase --- r_associated #0: 34 --> en:cytarabine
    n1=en:pegylated arginine deiminase | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1105. en:pegylated granulocyte colony stimulating factor maxy-g34 --- r_associated #0: 34 --> en:cytarabine
    n1=en:pegylated granulocyte colony stimulating factor maxy-g34 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1106. en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes --- r_associated #0: 34 --> en:cytarabine
    n1=en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1107. en:pharmaceutical dosage form --- r_associated #0: 34 --> en:cytarabine
    n1=en:pharmaceutical dosage form | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1108. en:pi3k delta/gamma inhibitor ipi-145 --- r_associated #0: 34 --> en:cytarabine
    n1=en:pi3k delta/gamma inhibitor ipi-145 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1109. en:pimonidazole --- r_associated #0: 34 --> en:cytarabine
    n1=en:pimonidazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1110. en:pirs2 phosphopeptide-tetanus peptide vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:pirs2 phosphopeptide-tetanus peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1111. en:poly-alendronate dextran-guanidine conjugate --- r_associated #0: 34 --> en:cytarabine
    n1=en:poly-alendronate dextran-guanidine conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1112. en:potassium citrate + citric acid --- r_associated #0: 34 --> en:cytarabine
    n1=en:potassium citrate + citric acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1113. en:prasterone --- r_associated #0: 34 --> en:cytarabine
    n1=en:prasterone | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1114. en:prostate health cocktail dietary supplement --- r_associated #0: 34 --> en:cytarabine
    n1=en:prostate health cocktail dietary supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1115. en:rabusertib --- r_associated #0: 34 --> en:cytarabine
    n1=en:rabusertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1116. en:racop protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:racop protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1117. en:rate protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:rate protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1118. en:refametinib --- r_associated #0: 34 --> en:cytarabine
    n1=en:refametinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1119. en:ribozyme rpi.4610 --- r_associated #0: 34 --> en:cytarabine
    n1=en:ribozyme rpi.4610 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1120. en:rotavirus vaccine, live, oral --- r_associated #0: 34 --> en:cytarabine
    n1=en:rotavirus vaccine, live, oral | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1121. en:s-ham protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:s-ham protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1122. en:salmonella vnp20009 --- r_associated #0: 34 --> en:cytarabine
    n1=en:salmonella vnp20009 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1123. en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant --- r_associated #0: 34 --> en:cytarabine
    n1=en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1124. en:sodium phenylbutyrate --- r_associated #0: 34 --> en:cytarabine
    n1=en:sodium phenylbutyrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1125. en:soy isoflavones --- r_associated #0: 34 --> en:cytarabine
    n1=en:soy isoflavones | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1126. en:ta protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:ta protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1127. en:tabalumab --- r_associated #0: 34 --> en:cytarabine
    n1=en:tabalumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1128. en:tapa protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:tapa protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1129. en:technetium tc 99m-3prgd2 --- r_associated #0: 34 --> en:cytarabine
    n1=en:technetium tc 99m-3prgd2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1130. en:tigatuzumab --- r_associated #0: 34 --> en:cytarabine
    n1=en:tigatuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1131. en:topical betulinic acid --- r_associated #0: 34 --> en:cytarabine
    n1=en:topical betulinic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1132. en:trampcol protocol --- r_associated #0: 34 --> en:cytarabine
    n1=en:trampcol protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1133. en:transgenic lymphocyte immunization vaccine --- r_associated #0: 34 --> en:cytarabine
    n1=en:transgenic lymphocyte immunization vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1134. en:vardenafil hydrochloride trihydrate --- r_associated #0: 34 --> en:cytarabine
    n1=en:vardenafil hydrochloride trihydrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1135. en:veliparib --- r_associated #0: 34 --> en:cytarabine
    n1=en:veliparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1136. en:vinflunine --- r_associated #0: 34 --> en:cytarabine
    n1=en:vinflunine | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1137. en:wt1 protein-derived peptide vaccine dsp-7888 --- r_associated #0: 34 --> en:cytarabine
    n1=en:wt1 protein-derived peptide vaccine dsp-7888 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1138. en:y 90 monoclonal antibody hmfg1 --- r_associated #0: 34 --> en:cytarabine
    n1=en:y 90 monoclonal antibody hmfg1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1139. en:yttrium y 90 dota anti-cea monoclonal antibody m5a --- r_associated #0: 34 --> en:cytarabine
    n1=en:yttrium y 90 dota anti-cea monoclonal antibody m5a | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1140. en:yttrium y 90 resin microspheres --- r_associated #0: 34 --> en:cytarabine
    n1=en:yttrium y 90 resin microspheres | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1141. lier connaissance avec qn --- r_associated #0: 34 --> en:cytarabine
    n1=lier connaissance avec qn | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1142. prastérone --- r_associated #0: 34 --> en:cytarabine
    n1=prastérone | n2=en:cytarabine | rel=r_associated | relid=0 | w=34
  1143. en:cleanser --- r_associated #0: 33 --> en:cytarabine
    n1=en:cleanser | n2=en:cytarabine | rel=r_associated | relid=0 | w=33
  1144. en:cytarabine 100mg/ml injection solution 10ml vial --- r_associated #0: 33 --> en:cytarabine
    n1=en:cytarabine 100mg/ml injection solution 10ml vial | n2=en:cytarabine | rel=r_associated | relid=0 | w=33
  1145. en:cytarabine 100mg/vil inj --- r_associated #0: 33 --> en:cytarabine
    n1=en:cytarabine 100mg/vil inj | n2=en:cytarabine | rel=r_associated | relid=0 | w=33
  1146. eplérénone --- r_associated #0: 33 --> en:cytarabine
    n1=eplérénone | n2=en:cytarabine | rel=r_associated | relid=0 | w=33
  1147. en:(99m)tc-n4-(hydrazinonicotinoyl)-1-beta-arabinofuranosyl cytosine --- r_associated #0: 32 --> en:cytarabine
    n1=en:(99m)tc-n4-(hydrazinonicotinoyl)-1-beta-arabinofuranosyl cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1148. en:3-deazauridine --- r_associated #0: 32 --> en:cytarabine
    n1=en:3-deazauridine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1149. en:4'-azidoarabinocytidine --- r_associated #0: 32 --> en:cytarabine
    n1=en:4'-azidoarabinocytidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1150. en:4-amino-1-(5-o-(2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl)arabinofuranosyl)-2(1h)-pyrimidinone --- r_associated #0: 32 --> en:cytarabine
    n1=en:4-amino-1-(5-o-(2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl)arabinofuranosyl)-2(1h)-pyrimidinone | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1151. en:a-triple-v protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:a-triple-v protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1152. en:acodazole --- r_associated #0: 32 --> en:cytarabine
    n1=en:acodazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1153. en:ada protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:ada protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1154. en:adenovirus-mediated human interleukin-12 --- r_associated #0: 32 --> en:cytarabine
    n1=en:adenovirus-mediated human interleukin-12 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1155. en:adipose-derived regenerative cells --- r_associated #0: 32 --> en:cytarabine
    n1=en:adipose-derived regenerative cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1156. en:aie regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:aie regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1157. en:akt inhibitor ly2780301 --- r_associated #0: 32 --> en:cytarabine
    n1=en:akt inhibitor ly2780301 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1158. en:alk/trk inhibitor tsr-011 --- r_associated #0: 32 --> en:cytarabine
    n1=en:alk/trk inhibitor tsr-011 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1159. en:all-82 protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:all-82 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1160. en:amantadine hydrochloride --- r_associated #0: 32 --> en:cytarabine
    n1=en:amantadine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1161. en:aminobenzoate potassium --- r_associated #0: 32 --> en:cytarabine
    n1=en:aminobenzoate potassium | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1162. en:aml-bfm 83 protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:aml-bfm 83 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1163. en:anamorelin hydrochloride --- r_associated #0: 32 --> en:cytarabine
    n1=en:anamorelin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1164. en:androgen antagonist apc-100 --- r_associated #0: 32 --> en:cytarabine
    n1=en:androgen antagonist apc-100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1165. en:angiogenesis inhibitor gt-111 --- r_associated #0: 32 --> en:cytarabine
    n1=en:angiogenesis inhibitor gt-111 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1166. en:anti-alphavbeta3 monoclonal antibody emd 525797 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-alphavbeta3 monoclonal antibody emd 525797 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1167. en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1168. en:anti-cd20-engineered toxin body mt-3724 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-cd20-engineered toxin body mt-3724 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1169. en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1170. en:anti-cd70 monoclonal antibody argx-110 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-cd70 monoclonal antibody argx-110 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1171. en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1172. en:anti-erbb3 monoclonal antibody ktn3379 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-erbb3 monoclonal antibody ktn3379 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1173. en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1174. en:anti-il-13 humanized monoclonal antibody tnx-650 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-il-13 humanized monoclonal antibody tnx-650 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1175. en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1176. en:anti-muc1 car-transduced autologous t-lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-muc1 car-transduced autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1177. en:anti-psma monoclonal antibody mdx1201-a488 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-psma monoclonal antibody mdx1201-a488 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1178. en:anti-tweak monoclonal antibody ro5458640 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-tweak monoclonal antibody ro5458640 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1179. en:anti-vegfr3 monoclonal antibody imc-3c5 --- r_associated #0: 32 --> en:cytarabine
    n1=en:anti-vegfr3 monoclonal antibody imc-3c5 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1180. en:antibiotic sq109 --- r_associated #0: 32 --> en:cytarabine
    n1=en:antibiotic sq109 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1181. en:antibody-drug conjugate sc-003 --- r_associated #0: 32 --> en:cytarabine
    n1=en:antibody-drug conjugate sc-003 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1182. en:apilimod dimesylate capsule --- r_associated #0: 32 --> en:cytarabine
    n1=en:apilimod dimesylate capsule | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1183. en:apoptosis inducer mpc-2130 --- r_associated #0: 32 --> en:cytarabine
    n1=en:apoptosis inducer mpc-2130 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1184. en:ar antagonist odm-201 --- r_associated #0: 32 --> en:cytarabine
    n1=en:ar antagonist odm-201 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1185. en:ara-cdp-1-o-octadecyl-2-o-palmitoyl-sn-glycerol --- r_associated #0: 32 --> en:cytarabine
    n1=en:ara-cdp-1-o-octadecyl-2-o-palmitoyl-sn-glycerol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1186. en:ara-fluorocytosine --- r_associated #0: 32 --> en:cytarabine
    n1=en:ara-fluorocytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1187. en:arginine butyrate --- r_associated #0: 32 --> en:cytarabine
    n1=en:arginine butyrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1188. en:armodafinil --- r_associated #0: 32 --> en:cytarabine
    n1=en:armodafinil | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1189. en:arnebia indigo jade pearl topical cream --- r_associated #0: 32 --> en:cytarabine
    n1=en:arnebia indigo jade pearl topical cream | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1190. en:artichoke whole phytocomplex concentrate --- r_associated #0: 32 --> en:cytarabine
    n1=en:artichoke whole phytocomplex concentrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1191. en:ask1 inhibitor gs-4997 --- r_associated #0: 32 --> en:cytarabine
    n1=en:ask1 inhibitor gs-4997 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1192. en:astuprotimut-r --- r_associated #0: 32 --> en:cytarabine
    n1=en:astuprotimut-r | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1193. en:atezolizumab --- r_associated #0: 32 --> en:cytarabine
    n1=en:atezolizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1194. en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 --- r_associated #0: 32 --> en:cytarabine
    n1=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1195. en:aurora a kinase inhibitor tas-119 --- r_associated #0: 32 --> en:cytarabine
    n1=en:aurora a kinase inhibitor tas-119 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1196. en:aurora b/c kinase inhibitor gsk1070916a --- r_associated #0: 32 --> en:cytarabine
    n1=en:aurora b/c kinase inhibitor gsk1070916a | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1197. en:aurora kinase inhibitor mln8054 --- r_associated #0: 32 --> en:cytarabine
    n1=en:aurora kinase inhibitor mln8054 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1198. en:autologous ad-cd154-transduced cll b cells --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous ad-cd154-transduced cll b cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1199. en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1200. en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1201. en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1202. en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1203. en:autologous heat-shock protein 70 peptide vaccine ag-858 --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous heat-shock protein 70 peptide vaccine ag-858 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1204. en:autologous il-21-modulated cd8+ mart1-specific t cells --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous il-21-modulated cd8+ mart1-specific t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1205. en:autologous interferon-producing killer dendritic cells --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous interferon-producing killer dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1206. en:autologous mesenchymal stem cells apceth_101 --- r_associated #0: 32 --> en:cytarabine
    n1=en:autologous mesenchymal stem cells apceth_101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1207. en:b-raf/vegfr-2 inhibitor raf265 --- r_associated #0: 32 --> en:cytarabine
    n1=en:b-raf/vegfr-2 inhibitor raf265 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1208. en:b16alphagal melanoma vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:b16alphagal melanoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1209. en:b43-pap immunotoxin --- r_associated #0: 32 --> en:cytarabine
    n1=en:b43-pap immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1210. en:bafetinib --- r_associated #0: 32 --> en:cytarabine
    n1=en:bafetinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1211. en:bardoxolone --- r_associated #0: 32 --> en:cytarabine
    n1=en:bardoxolone | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1212. en:bc-819 plasmid/polyethylenimine complex --- r_associated #0: 32 --> en:cytarabine
    n1=en:bc-819 plasmid/polyethylenimine complex | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1213. en:bcg solution --- r_associated #0: 32 --> en:cytarabine
    n1=en:bcg solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1214. en:beetroot juice --- r_associated #0: 32 --> en:cytarabine
    n1=en:beetroot juice | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1215. en:bet inhibitor bms-986158 --- r_associated #0: 32 --> en:cytarabine
    n1=en:bet inhibitor bms-986158 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1216. en:beta-lapachone prodrug arq 761 --- r_associated #0: 32 --> en:cytarabine
    n1=en:beta-lapachone prodrug arq 761 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1217. en:betulinic acid --- r_associated #0: 32 --> en:cytarabine
    n1=en:betulinic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1218. en:bh-ac-amp protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:bh-ac-amp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1219. en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex --- r_associated #0: 32 --> en:cytarabine
    n1=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1220. en:bis(choline)tetrathiomolybdate --- r_associated #0: 32 --> en:cytarabine
    n1=en:bis(choline)tetrathiomolybdate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1221. en:brivudine --- r_associated #0: 32 --> en:cytarabine
    n1=en:brivudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1222. en:brostallicin --- r_associated #0: 32 --> en:cytarabine
    n1=en:brostallicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1223. en:buspirone hydrochloride --- r_associated #0: 32 --> en:cytarabine
    n1=en:buspirone hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1224. en:calamine + zinc oxide --- r_associated #0: 32 --> en:cytarabine
    n1=en:calamine + zinc oxide | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1225. en:calcium channel inhibitor --- r_associated #0: 32 --> en:cytarabine
    n1=en:calcium channel inhibitor | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1226. en:calcium citrate --- r_associated #0: 32 --> en:cytarabine
    n1=en:calcium citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1227. en:cameleon protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:cameleon protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1228. en:camphor / lidocaine / methyl salicylate --- r_associated #0: 32 --> en:cytarabine
    n1=en:camphor / lidocaine / methyl salicylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1229. en:canarypox-hil-12 melanoma vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:canarypox-hil-12 melanoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1230. en:capsaicin/diclofenac --- r_associated #0: 32 --> en:cytarabine
    n1=en:capsaicin/diclofenac | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1231. en:carbogen --- r_associated #0: 32 --> en:cytarabine
    n1=en:carbogen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1232. en:carbon c 11 pbr-28 --- r_associated #0: 32 --> en:cytarabine
    n1=en:carbon c 11 pbr-28 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1233. en:carrageenan-containing gel --- r_associated #0: 32 --> en:cytarabine
    n1=en:carrageenan-containing gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1234. en:casopitant mesylate --- r_associated #0: 32 --> en:cytarabine
    n1=en:casopitant mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1235. en:cb10-277 --- r_associated #0: 32 --> en:cytarabine
    n1=en:cb10-277 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1236. en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 --- r_associated #0: 32 --> en:cytarabine
    n1=en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1237. en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1238. en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc --- r_associated #0: 32 --> en:cytarabine
    n1=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1239. en:cdk inhibitor p276-00 --- r_associated #0: 32 --> en:cytarabine
    n1=en:cdk inhibitor p276-00 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1240. en:cenersen --- r_associated #0: 32 --> en:cytarabine
    n1=en:cenersen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1241. en:cer-cyt protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:cer-cyt protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1242. en:cgp-6809 --- r_associated #0: 32 --> en:cytarabine
    n1=en:cgp-6809 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1243. en:chidamide --- r_associated #0: 32 --> en:cytarabine
    n1=en:chidamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1244. en:cixutumumab --- r_associated #0: 32 --> en:cytarabine
    n1=en:cixutumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1245. en:clag protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:clag protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1246. en:clofarabine --- r_associated #0: 32 --> en:cytarabine
    n1=en:clofarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1247. en:codeine / potassium citrate --- r_associated #0: 32 --> en:cytarabine
    n1=en:codeine / potassium citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1248. en:conb-a protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:conb-a protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1249. en:conium preparation --- r_associated #0: 32 --> en:cytarabine
    n1=en:conium preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1250. en:copper cu 62-atsm --- r_associated #0: 32 --> en:cytarabine
    n1=en:copper cu 62-atsm | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1251. en:cordyceps sinensis preparation --- r_associated #0: 32 --> en:cytarabine
    n1=en:cordyceps sinensis preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1252. en:crop protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:crop protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1253. en:cryoprotective agent --- r_associated #0: 32 --> en:cytarabine
    n1=en:cryoprotective agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1254. en:cyclomethicone --- r_associated #0: 32 --> en:cytarabine
    n1=en:cyclomethicone | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1255. en:cytarabine/prednisone/vincristine --- r_associated #0: 32 --> en:cytarabine
    n1=en:cytarabine/prednisone/vincristine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1256. en:dalbavancin --- r_associated #0: 32 --> en:cytarabine
    n1=en:dalbavancin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1257. en:danusertib --- r_associated #0: 32 --> en:cytarabine
    n1=en:danusertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1258. en:dat-coap regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:dat-coap regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1259. en:depatuxizumab --- r_associated #0: 32 --> en:cytarabine
    n1=en:depatuxizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1260. en:dextroamphetamine-amphetamine --- r_associated #0: 32 --> en:cytarabine
    n1=en:dextroamphetamine-amphetamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1261. en:dhaox protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:dhaox protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1262. en:dhap regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:dhap regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1263. en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1264. en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1265. en:dna-pk inhibitor msc2490484a --- r_associated #0: 32 --> en:cytarabine
    n1=en:dna-pk inhibitor msc2490484a | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1266. en:doap protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:doap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1267. en:donafenib --- r_associated #0: 32 --> en:cytarabine
    n1=en:donafenib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1268. en:drotrecogin alfa (activated) --- r_associated #0: 32 --> en:cytarabine
    n1=en:drotrecogin alfa (activated) | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1269. en:drug products by va class --- r_associated #0: 32 --> en:cytarabine
    n1=en:drug products by va class | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1270. en:dta-h19 plasmid --- r_associated #0: 32 --> en:cytarabine
    n1=en:dta-h19 plasmid | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1271. en:duborimycin --- r_associated #0: 32 --> en:cytarabine
    n1=en:duborimycin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1272. en:egfr/her2 kinase inhibitor tak-285 --- r_associated #0: 32 --> en:cytarabine
    n1=en:egfr/her2 kinase inhibitor tak-285 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1273. en:eicosapentaenoic acid --- r_associated #0: 32 --> en:cytarabine
    n1=en:eicosapentaenoic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1274. en:enocitabine --- r_associated #0: 32 --> en:cytarabine
    n1=en:enocitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1275. en:estradiol/norethindrone acetate tablet --- r_associated #0: 32 --> en:cytarabine
    n1=en:estradiol/norethindrone acetate tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1276. en:evdac regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:evdac regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1277. en:extended release flucytosine --- r_associated #0: 32 --> en:cytarabine
    n1=en:extended release flucytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1278. en:f16-il2 fusion protein --- r_associated #0: 32 --> en:cytarabine
    n1=en:f16-il2 fusion protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1279. en:fermented wheat germ extract --- r_associated #0: 32 --> en:cytarabine
    n1=en:fermented wheat germ extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1280. en:fgfr inhibitor debio 1347 --- r_associated #0: 32 --> en:cytarabine
    n1=en:fgfr inhibitor debio 1347 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1281. en:fgfr inhibitor incb054828 --- r_associated #0: 32 --> en:cytarabine
    n1=en:fgfr inhibitor incb054828 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1282. en:flt3/kit kinase inhibitor akn-028 --- r_associated #0: 32 --> en:cytarabine
    n1=en:flt3/kit kinase inhibitor akn-028 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1283. en:fluorine f 18 ef5 --- r_associated #0: 32 --> en:cytarabine
    n1=en:fluorine f 18 ef5 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1284. en:foretinib --- r_associated #0: 32 --> en:cytarabine
    n1=en:foretinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1285. en:fosbretabulin disodium --- r_associated #0: 32 --> en:cytarabine
    n1=en:fosbretabulin disodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1286. en:fosbretabulin tromethamine --- r_associated #0: 32 --> en:cytarabine
    n1=en:fosbretabulin tromethamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1287. en:gd2-car-expressing autologous t-lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:gd2-car-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1288. en:gimatecan --- r_associated #0: 32 --> en:cytarabine
    n1=en:gimatecan | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1289. en:globo h-klh immunostimulant opt-822 --- r_associated #0: 32 --> en:cytarabine
    n1=en:globo h-klh immunostimulant opt-822 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1290. en:gluten-free compact nutritional supplement drink --- r_associated #0: 32 --> en:cytarabine
    n1=en:gluten-free compact nutritional supplement drink | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1291. en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1292. en:gonadotropin-releasing hormone analog --- r_associated #0: 32 --> en:cytarabine
    n1=en:gonadotropin-releasing hormone analog | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1293. en:hla-a*2402-restricted vegfr1 peptide vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:hla-a*2402-restricted vegfr1 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1294. en:hpv-16 e6 peptides vaccine/candida albicans extract --- r_associated #0: 32 --> en:cytarabine
    n1=en:hpv-16 e6 peptides vaccine/candida albicans extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1295. en:human menopausal gonadotrophin --- r_associated #0: 32 --> en:cytarabine
    n1=en:human menopausal gonadotrophin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1296. en:hypoglycemic agents --- r_associated #0: 32 --> en:cytarabine
    n1=en:hypoglycemic agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1297. en:iap inhibitor hgs1029 --- r_associated #0: 32 --> en:cytarabine
    n1=en:iap inhibitor hgs1029 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1298. en:ibacitabine --- r_associated #0: 32 --> en:cytarabine
    n1=en:ibacitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1299. en:ih636 grape seed proanthocyanidin extract --- r_associated #0: 32 --> en:cytarabine
    n1=en:ih636 grape seed proanthocyanidin extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1300. en:il-10 immunomodulator mk-1966 --- r_associated #0: 32 --> en:cytarabine
    n1=en:il-10 immunomodulator mk-1966 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1301. en:imatinib mesylate --- r_associated #0: 32 --> en:cytarabine
    n1=en:imatinib mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1302. en:immediate-release tablet afuresertib --- r_associated #0: 32 --> en:cytarabine
    n1=en:immediate-release tablet afuresertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1303. en:immunoconjugate ro5479599 --- r_associated #0: 32 --> en:cytarabine
    n1=en:immunoconjugate ro5479599 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1304. en:immunocytokine nhs-il12 --- r_associated #0: 32 --> en:cytarabine
    n1=en:immunocytokine nhs-il12 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1305. en:imp321 --- r_associated #0: 32 --> en:cytarabine
    n1=en:imp321 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1306. en:indium in 111 chimeric monoclonal antibody 806 --- r_associated #0: 32 --> en:cytarabine
    n1=en:indium in 111 chimeric monoclonal antibody 806 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1307. en:ingenol mebutate --- r_associated #0: 32 --> en:cytarabine
    n1=en:ingenol mebutate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1308. en:ioflubenzamide i-131 --- r_associated #0: 32 --> en:cytarabine
    n1=en:ioflubenzamide i-131 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1309. en:ivam regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:ivam regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1310. en:jeb regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:jeb regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1311. en:l-6 protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:l-6 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1312. en:l-valyl-ara-c --- r_associated #0: 32 --> en:cytarabine
    n1=en:l-valyl-ara-c | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1313. en:lactobacillus fermented extract --- r_associated #0: 32 --> en:cytarabine
    n1=en:lactobacillus fermented extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1314. en:lapatinib ditosylate --- r_associated #0: 32 --> en:cytarabine
    n1=en:lapatinib ditosylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1315. en:leucine-enhanced essential amino acid dietary supplement --- r_associated #0: 32 --> en:cytarabine
    n1=en:leucine-enhanced essential amino acid dietary supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1316. en:linsitinib --- r_associated #0: 32 --> en:cytarabine
    n1=en:linsitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1317. en:liposomal irinotecan --- r_associated #0: 32 --> en:cytarabine
    n1=en:liposomal irinotecan | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1318. en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 --- r_associated #0: 32 --> en:cytarabine
    n1=en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1319. en:lisdexamfetamine dimesylate --- r_associated #0: 32 --> en:cytarabine
    n1=en:lisdexamfetamine dimesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1320. en:litronesib --- r_associated #0: 32 --> en:cytarabine
    n1=en:litronesib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1321. en:lonidamine --- r_associated #0: 32 --> en:cytarabine
    n1=en:lonidamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1322. en:lyophilized black raspberry saliva substitute --- r_associated #0: 32 --> en:cytarabine
    n1=en:lyophilized black raspberry saliva substitute | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1323. en:m87o-transduced cd34+ peripheral blood stem cells --- r_associated #0: 32 --> en:cytarabine
    n1=en:m87o-transduced cd34+ peripheral blood stem cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1324. en:mac conditioning regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:mac conditioning regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1325. en:mage-a3/hpv 16 peptide vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:mage-a3/hpv 16 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1326. en:magnesium citrate --- r_associated #0: 32 --> en:cytarabine
    n1=en:magnesium citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1327. en:mami protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:mami protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1328. en:mapatumumab --- r_associated #0: 32 --> en:cytarabine
    n1=en:mapatumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1329. en:methoxy polyethylene glycol-epoetin beta --- r_associated #0: 32 --> en:cytarabine
    n1=en:methoxy polyethylene glycol-epoetin beta | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1330. en:metreleptin --- r_associated #0: 32 --> en:cytarabine
    n1=en:metreleptin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1331. en:mifap regimen --- r_associated #0: 32 --> en:cytarabine
    n1=en:mifap regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1332. en:mine-eshap protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:mine-eshap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1333. en:monoclonal antibody 3622w94 --- r_associated #0: 32 --> en:cytarabine
    n1=en:monoclonal antibody 3622w94 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1334. en:monoclonal antibody cc49-streptavidin conjugate --- r_associated #0: 32 --> en:cytarabine
    n1=en:monoclonal antibody cc49-streptavidin conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1335. en:mtorc1/2 kinase inhibitor bi 860585 --- r_associated #0: 32 --> en:cytarabine
    n1=en:mtorc1/2 kinase inhibitor bi 860585 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1336. en:n(4)-oleylcytosine arabinoside --- r_associated #0: 32 --> en:cytarabine
    n1=en:n(4)-oleylcytosine arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1337. en:nicotine lozenge --- r_associated #0: 32 --> en:cytarabine
    n1=en:nicotine lozenge | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1338. en:nucleoside analog dfp-10917 --- r_associated #0: 32 --> en:cytarabine
    n1=en:nucleoside analog dfp-10917 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1339. en:olive oil extract/curcumin-based capsule --- r_associated #0: 32 --> en:cytarabine
    n1=en:olive oil extract/curcumin-based capsule | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1340. en:opioid agonist gic-1001 --- r_associated #0: 32 --> en:cytarabine
    n1=en:opioid agonist gic-1001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1341. en:p16_37-63 peptide vaccine --- r_associated #0: 32 --> en:cytarabine
    n1=en:p16_37-63 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1342. en:pacet protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:pacet protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1343. en:palivizumab --- r_associated #0: 32 --> en:cytarabine
    n1=en:palivizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1344. en:pan-pi3k/mtor inhibitor sf1126 --- r_associated #0: 32 --> en:cytarabine
    n1=en:pan-pi3k/mtor inhibitor sf1126 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1345. en:pantoprazole sodium --- r_associated #0: 32 --> en:cytarabine
    n1=en:pantoprazole sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1346. en:parp inhibitor azd2461 --- r_associated #0: 32 --> en:cytarabine
    n1=en:parp inhibitor azd2461 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1347. en:pd0325901 --- r_associated #0: 32 --> en:cytarabine
    n1=en:pd0325901 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1348. en:pdcd-1 knockout autologous t-lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:pdcd-1 knockout autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1349. en:phenethyl isothiocyanate --- r_associated #0: 32 --> en:cytarabine
    n1=en:phenethyl isothiocyanate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1350. en:phenformin hydrochloride --- r_associated #0: 32 --> en:cytarabine
    n1=en:phenformin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1351. en:phenylephrine + chlorpheniramine + codeine + potassium iodide --- r_associated #0: 32 --> en:cytarabine
    n1=en:phenylephrine + chlorpheniramine + codeine + potassium iodide | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1352. en:pi3k inhibitor acp-319 --- r_associated #0: 32 --> en:cytarabine
    n1=en:pi3k inhibitor acp-319 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1353. en:pi3kbeta inhibitor azd8186 --- r_associated #0: 32 --> en:cytarabine
    n1=en:pi3kbeta inhibitor azd8186 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1354. en:plectin-1 targeting agent ptp-01 --- r_associated #0: 32 --> en:cytarabine
    n1=en:plectin-1 targeting agent ptp-01 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1355. en:pled-based mnsod mimetic --- r_associated #0: 32 --> en:cytarabine
    n1=en:pled-based mnsod mimetic | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1356. en:plevitrexed --- r_associated #0: 32 --> en:cytarabine
    n1=en:plevitrexed | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1357. en:pog 8602 protocol --- r_associated #0: 32 --> en:cytarabine
    n1=en:pog 8602 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1358. en:pregabalin --- r_associated #0: 32 --> en:cytarabine
    n1=en:pregabalin | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1359. en:recombinant adenovirus-interferon/syn3 --- r_associated #0: 32 --> en:cytarabine
    n1=en:recombinant adenovirus-interferon/syn3 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1360. en:risedronate + calcium --- r_associated #0: 32 --> en:cytarabine
    n1=en:risedronate + calcium | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1361. en:rucaparib --- r_associated #0: 32 --> en:cytarabine
    n1=en:rucaparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1362. en:rucaparib phosphate --- r_associated #0: 32 --> en:cytarabine
    n1=en:rucaparib phosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1363. en:senna extract --- r_associated #0: 32 --> en:cytarabine
    n1=en:senna extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1364. en:sheddase inhibitor incb007839 --- r_associated #0: 32 --> en:cytarabine
    n1=en:sheddase inhibitor incb007839 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1365. en:sheng-yu-tang --- r_associated #0: 32 --> en:cytarabine
    n1=en:sheng-yu-tang | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1366. en:sodium butyrate --- r_associated #0: 32 --> en:cytarabine
    n1=en:sodium butyrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1367. en:sun's soup --- r_associated #0: 32 --> en:cytarabine
    n1=en:sun's soup | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1368. en:tasisulam sodium --- r_associated #0: 32 --> en:cytarabine
    n1=en:tasisulam sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1369. en:technetium tc-99m --- r_associated #0: 32 --> en:cytarabine
    n1=en:technetium tc-99m | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1370. en:testosterone gel --- r_associated #0: 32 --> en:cytarabine
    n1=en:testosterone gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1371. en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes --- r_associated #0: 32 --> en:cytarabine
    n1=en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1372. en:thioureidobutyronitrile --- r_associated #0: 32 --> en:cytarabine
    n1=en:thioureidobutyronitrile | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1373. en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 --- r_associated #0: 32 --> en:cytarabine
    n1=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1374. en:voxtalisib --- r_associated #0: 32 --> en:cytarabine
    n1=en:voxtalisib | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1375. en:yttrium y 90 monoclonal antibody hu3s193 --- r_associated #0: 32 --> en:cytarabine
    n1=en:yttrium y 90 monoclonal antibody hu3s193 | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1376. en:zinc gluconate --- r_associated #0: 32 --> en:cytarabine
    n1=en:zinc gluconate | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1377. hormone gonadotrope ménopausique humaine --- r_associated #0: 32 --> en:cytarabine
    n1=hormone gonadotrope ménopausique humaine | n2=en:cytarabine | rel=r_associated | relid=0 | w=32
  1378. 1-bêta-d-arabinofuranosylcytosine --- r_associated #0: 31 --> en:cytarabine
    n1=1-bêta-d-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1379. E553(iii) --- r_associated #0: 31 --> en:cytarabine
    n1=E553(iii) | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1380. Inhibiteur enzymatique --- r_associated #0: 31 --> en:cytarabine
    n1=Inhibiteur enzymatique | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1381. acide tranéxamique --- r_associated #0: 31 --> en:cytarabine
    n1=acide tranéxamique | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1382. chélateur --- r_associated #0: 31 --> en:cytarabine
    n1=chélateur | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1383. cytarabines --- r_associated #0: 31 --> en:cytarabine
    n1=cytarabines | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1384. en:1 beta-d-arabinofuranosylcytosine-5'-diphosphatecortisol --- r_associated #0: 31 --> en:cytarabine
    n1=en:1 beta-d-arabinofuranosylcytosine-5'-diphosphatecortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1385. en:1-(2-chloro-2-deoxy-d-arabinofuranosyl)cytosine --- r_associated #0: 31 --> en:cytarabine
    n1=en:1-(2-chloro-2-deoxy-d-arabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1386. en:1-(2-deoxy-2-c-hydroxymethylarabinofuranosyl)cytosine --- r_associated #0: 31 --> en:cytarabine
    n1=en:1-(2-deoxy-2-c-hydroxymethylarabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1387. en:18f-labeled mini-peg spacered rgd dimer --- r_associated #0: 31 --> en:cytarabine
    n1=en:18f-labeled mini-peg spacered rgd dimer | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1388. en:2,2'-anhydro-1-(3'-o-acetyl-beta-d-arabinofuranosyl)-5-iodocytosine hydrochloride --- r_associated #0: 31 --> en:cytarabine
    n1=en:2,2'-anhydro-1-(3'-o-acetyl-beta-d-arabinofuranosyl)-5-iodocytosine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1389. en:2-hydroxyoleic acid --- r_associated #0: 31 --> en:cytarabine
    n1=en:2-hydroxyoleic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1390. en:2-methoxyestradiol --- r_associated #0: 31 --> en:cytarabine
    n1=en:2-methoxyestradiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1391. en:7+3 protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:7+3 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1392. en:abiraterone acetate --- r_associated #0: 31 --> en:cytarabine
    n1=en:abiraterone acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1393. en:abt-751 --- r_associated #0: 31 --> en:cytarabine
    n1=en:abt-751 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1394. en:ad5.sstr/tk.rgd --- r_associated #0: 31 --> en:cytarabine
    n1=en:ad5.sstr/tk.rgd | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1395. en:ad5cmv-p53 gene --- r_associated #0: 31 --> en:cytarabine
    n1=en:ad5cmv-p53 gene | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1396. en:adamantoylcytarabine --- r_associated #0: 31 --> en:cytarabine
    n1=en:adamantoylcytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1397. en:adenovirus encoding rat her-2/neu --- r_associated #0: 31 --> en:cytarabine
    n1=en:adenovirus encoding rat her-2/neu | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1398. en:aerosol gemcitabine --- r_associated #0: 31 --> en:cytarabine
    n1=en:aerosol gemcitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1399. en:agatolimod sodium --- r_associated #0: 31 --> en:cytarabine
    n1=en:agatolimod sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1400. en:agerafenib --- r_associated #0: 31 --> en:cytarabine
    n1=en:agerafenib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1401. en:akt inhibitor azd5363 --- r_associated #0: 31 --> en:cytarabine
    n1=en:akt inhibitor azd5363 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1402. en:allogeneic gm-csf-based myeloma cell vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:allogeneic gm-csf-based myeloma cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1403. en:alpha galactosylceramide --- r_associated #0: 31 --> en:cytarabine
    n1=en:alpha galactosylceramide | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1404. en:alpha-1-proteinase inhibitor human --- r_associated #0: 31 --> en:cytarabine
    n1=en:alpha-1-proteinase inhibitor human | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1405. en:ametantrone --- r_associated #0: 31 --> en:cytarabine
    n1=en:ametantrone | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1406. en:amikacin sulfate --- r_associated #0: 31 --> en:cytarabine
    n1=en:amikacin sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1407. en:anaxirone --- r_associated #0: 31 --> en:cytarabine
    n1=en:anaxirone | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1408. en:androgen receptor antagonist arn-509 --- r_associated #0: 31 --> en:cytarabine
    n1=en:androgen receptor antagonist arn-509 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1409. en:angiogenesis inhibitor ji-101 --- r_associated #0: 31 --> en:cytarabine
    n1=en:angiogenesis inhibitor ji-101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1410. en:anti-ags-5 antibody-drug conjugate asg-5me --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-ags-5 antibody-drug conjugate asg-5me | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1411. en:anti-alpha5beta1 integrin antibody mint1526a --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-alpha5beta1 integrin antibody mint1526a | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1412. en:anti-c-fms monoclonal antibody amg 820 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-c-fms monoclonal antibody amg 820 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1413. en:anti-cd20 monoclonal antibody sct400 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-cd20 monoclonal antibody sct400 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1414. en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1415. en:anti-cd27l antibody-drug conjugate amg 172 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-cd27l antibody-drug conjugate amg 172 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1416. en:anti-cd73 monoclonal antibody medi9447 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-cd73 monoclonal antibody medi9447 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1417. en:anti-cd98 monoclonal antibody ign523 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-cd98 monoclonal antibody ign523 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1418. en:anti-csf1r monoclonal antibody fpa008 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-csf1r monoclonal antibody fpa008 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1419. en:anti-dkk1 monoclonal antibody bhq880 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-dkk1 monoclonal antibody bhq880 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1420. en:anti-fgf23 igg1 monoclonal antibody krn23 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-fgf23 igg1 monoclonal antibody krn23 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1421. en:anti-gitr monoclonal antibody gwn 323 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-gitr monoclonal antibody gwn 323 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1422. en:anti-gpc3 monoclonal antibody gc33 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-gpc3 monoclonal antibody gc33 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1423. en:anti-her2 antibody-drug conjugate arx788 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-her2 antibody-drug conjugate arx788 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1424. en:anti-ofa immunotherapeutic bb-mpi-03 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-ofa immunotherapeutic bb-mpi-03 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1425. en:anti-ox40 monoclonal antibody --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-ox40 monoclonal antibody | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1426. en:anti-ox40 monoclonal antibody gsk3174998 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-ox40 monoclonal antibody gsk3174998 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1427. en:anti-pd-l1/tgfbetarii fusion protein msb0011359c --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1428. en:anti-pdgfr alpha monoclonal antibody medi-575 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-pdgfr alpha monoclonal antibody medi-575 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1429. en:anti-pgf monoclonal antibody ro5323441 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-pgf monoclonal antibody ro5323441 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1430. en:anti-rspo3 monoclonal antibody omp-131r10 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-rspo3 monoclonal antibody omp-131r10 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1431. en:anti-sema4d monoclonal antibody vx15/2503 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-sema4d monoclonal antibody vx15/2503 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1432. en:anti-tgf-beta rii monoclonal antibody imc-tr1 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-tgf-beta rii monoclonal antibody imc-tr1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1433. en:anti-vista monoclonal antibody jnj 61610588 --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-vista monoclonal antibody jnj 61610588 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1434. en:anti-von willebrand factor nanobody --- r_associated #0: 31 --> en:cytarabine
    n1=en:anti-von willebrand factor nanobody | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1435. en:antibody-drug conjugate abbv-085 --- r_associated #0: 31 --> en:cytarabine
    n1=en:antibody-drug conjugate abbv-085 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1436. en:antibody-drug conjugate adct-402 --- r_associated #0: 31 --> en:cytarabine
    n1=en:antibody-drug conjugate adct-402 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1437. en:antibody-drug conjugate sc16ld6.5 --- r_associated #0: 31 --> en:cytarabine
    n1=en:antibody-drug conjugate sc16ld6.5 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1438. en:antilipemic agent --- r_associated #0: 31 --> en:cytarabine
    n1=en:antilipemic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1439. en:ar antagonist bms-641988 --- r_associated #0: 31 --> en:cytarabine
    n1=en:ar antagonist bms-641988 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1440. en:ara-cdp-distearin --- r_associated #0: 31 --> en:cytarabine
    n1=en:ara-cdp-distearin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1441. en:asfotase alfa --- r_associated #0: 31 --> en:cytarabine
    n1=en:asfotase alfa | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1442. en:asp4132 --- r_associated #0: 31 --> en:cytarabine
    n1=en:asp4132 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1443. en:autologous anti-psma gene-modified t-lymphocytes --- r_associated #0: 31 --> en:cytarabine
    n1=en:autologous anti-psma gene-modified t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1444. en:autologous dendritic cell-adenovirus ccl21 vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:autologous dendritic cell-adenovirus ccl21 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1445. en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes --- r_associated #0: 31 --> en:cytarabine
    n1=en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1446. en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1447. en:autologous pluripotent aldhbr stem cells ald-451 --- r_associated #0: 31 --> en:cytarabine
    n1=en:autologous pluripotent aldhbr stem cells ald-451 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1448. en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1449. en:azapicyl --- r_associated #0: 31 --> en:cytarabine
    n1=en:azapicyl | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1450. en:azurin:50-77 cell penetrating peptide p28 --- r_associated #0: 31 --> en:cytarabine
    n1=en:azurin:50-77 cell penetrating peptide p28 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1451. en:b-domp protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:b-domp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1452. en:barite --- r_associated #0: 31 --> en:cytarabine
    n1=en:barite | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1453. en:bazedoxifene --- r_associated #0: 31 --> en:cytarabine
    n1=en:bazedoxifene | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1454. en:bcr-abl (b2a2)-derived peptide vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:bcr-abl (b2a2)-derived peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1455. en:bcr-abl (b3a2)-derived peptide vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:bcr-abl (b3a2)-derived peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1456. en:beam protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:beam protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1457. en:belagenpumatucel-l --- r_associated #0: 31 --> en:cytarabine
    n1=en:belagenpumatucel-l | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1458. en:bet bromodomain inhibitor zen-3694 --- r_associated #0: 31 --> en:cytarabine
    n1=en:bet bromodomain inhibitor zen-3694 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1459. en:bet inhibitor bay1238097 --- r_associated #0: 31 --> en:cytarabine
    n1=en:bet inhibitor bay1238097 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1460. en:bh3 mimetic abt-737 --- r_associated #0: 31 --> en:cytarabine
    n1=en:bh3 mimetic abt-737 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1461. en:binimetinib --- r_associated #0: 31 --> en:cytarabine
    n1=en:binimetinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1462. en:bisantrene hydrochloride --- r_associated #0: 31 --> en:cytarabine
    n1=en:bisantrene hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1463. en:blex 404 --- r_associated #0: 31 --> en:cytarabine
    n1=en:blex 404 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1464. en:bmft-all protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:bmft-all protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1465. en:bortezomib --- r_associated #0: 31 --> en:cytarabine
    n1=en:bortezomib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1466. en:brigatinib --- r_associated #0: 31 --> en:cytarabine
    n1=en:brigatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1467. en:calcium carbonate + famotidine + magnesium hydroxide --- r_associated #0: 31 --> en:cytarabine
    n1=en:calcium carbonate + famotidine + magnesium hydroxide | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1468. en:capecitabine --- r_associated #0: 31 --> en:cytarabine
    n1=en:capecitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1469. en:carbon c 13 phytofluene --- r_associated #0: 31 --> en:cytarabine
    n1=en:carbon c 13 phytofluene | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1470. en:carbon c 14 ibrutinib --- r_associated #0: 31 --> en:cytarabine
    n1=en:carbon c 14 ibrutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1471. en:carbon c11 temozolomide --- r_associated #0: 31 --> en:cytarabine
    n1=en:carbon c11 temozolomide | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1472. en:carbon-11 acetate --- r_associated #0: 31 --> en:cytarabine
    n1=en:carbon-11 acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1473. en:cat combination --- r_associated #0: 31 --> en:cytarabine
    n1=en:cat combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1474. en:cathelicidin ll-37 --- r_associated #0: 31 --> en:cytarabine
    n1=en:cathelicidin ll-37 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1475. en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 31 --> en:cytarabine
    n1=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1476. en:cd40 agonist monoclonal antibody cp-870,893 --- r_associated #0: 31 --> en:cytarabine
    n1=en:cd40 agonist monoclonal antibody cp-870,893 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1477. en:cd95 ecd/igg-fc fusion protein apg101 --- r_associated #0: 31 --> en:cytarabine
    n1=en:cd95 ecd/igg-fc fusion protein apg101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1478. en:cdc7 kinase inhibitor bms-863233 --- r_associated #0: 31 --> en:cytarabine
    n1=en:cdc7 kinase inhibitor bms-863233 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1479. en:cef regimen --- r_associated #0: 31 --> en:cytarabine
    n1=en:cef regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1480. en:cenisertib --- r_associated #0: 31 --> en:cytarabine
    n1=en:cenisertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1481. en:cetylpyridinium+menthol --- r_associated #0: 31 --> en:cytarabine
    n1=en:cetylpyridinium+menthol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1482. en:chaste berry extract --- r_associated #0: 31 --> en:cytarabine
    n1=en:chaste berry extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1483. en:chlorpheniramine + carbetapentane --- r_associated #0: 31 --> en:cytarabine
    n1=en:chlorpheniramine + carbetapentane | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1484. en:chlorpheniramine + pseudoephedrine + codeine --- r_associated #0: 31 --> en:cytarabine
    n1=en:chlorpheniramine + pseudoephedrine + codeine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1485. en:chlorpheniramine, ephedrine drug combination --- r_associated #0: 31 --> en:cytarabine
    n1=en:chlorpheniramine, ephedrine drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1486. en:cinobufagin --- r_associated #0: 31 --> en:cytarabine
    n1=en:cinobufagin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1487. en:clove preparation --- r_associated #0: 31 --> en:cytarabine
    n1=en:clove preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1488. en:codeine phosphate --- r_associated #0: 31 --> en:cytarabine
    n1=en:codeine phosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1489. en:comet-a protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:comet-a protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1490. en:copanlisib --- r_associated #0: 31 --> en:cytarabine
    n1=en:copanlisib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1491. en:cord blood-derived expanded natural killer cell infusion pnk-007 --- r_associated #0: 31 --> en:cytarabine
    n1=en:cord blood-derived expanded natural killer cell infusion pnk-007 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1492. en:ctriii --- r_associated #0: 31 --> en:cytarabine
    n1=en:ctriii | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1493. en:cym protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:cym protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1494. en:cytarabine injection --- r_associated #0: 31 --> en:cytarabine
    n1=en:cytarabine injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1495. en:cytosine analog --- r_associated #0: 31 --> en:cytarabine
    n1=en:cytosine analog | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1496. en:cytosine arabinoside palmitate --- r_associated #0: 31 --> en:cytarabine
    n1=en:cytosine arabinoside palmitate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1497. en:cytosine nucleoside --- r_associated #0: 31 --> en:cytarabine
    n1=en:cytosine nucleoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1498. en:d1/3-mage-3-his fusion protein --- r_associated #0: 31 --> en:cytarabine
    n1=en:d1/3-mage-3-his fusion protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1499. en:darinaparsin --- r_associated #0: 31 --> en:cytarabine
    n1=en:darinaparsin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1500. en:dbve-pc regimen --- r_associated #0: 31 --> en:cytarabine
    n1=en:dbve-pc regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1501. en:defined green tea catechin extract --- r_associated #0: 31 --> en:cytarabine
    n1=en:defined green tea catechin extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1502. en:degarelix --- r_associated #0: 31 --> en:cytarabine
    n1=en:degarelix | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1503. en:dendritic cell-gp100-mart-1 antigen vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:dendritic cell-gp100-mart-1 antigen vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1504. en:denosumab --- r_associated #0: 31 --> en:cytarabine
    n1=en:denosumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1505. en:detorubicin --- r_associated #0: 31 --> en:cytarabine
    n1=en:detorubicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1506. en:diaziquone --- r_associated #0: 31 --> en:cytarabine
    n1=en:diaziquone | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1507. en:didox --- r_associated #0: 31 --> en:cytarabine
    n1=en:didox | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1508. en:dienogest --- r_associated #0: 31 --> en:cytarabine
    n1=en:dienogest | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1509. en:dna-pk/tor kinase inhibitor cc-115 --- r_associated #0: 31 --> en:cytarabine
    n1=en:dna-pk/tor kinase inhibitor cc-115 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1510. en:docetaxel formulation ckd-810 --- r_associated #0: 31 --> en:cytarabine
    n1=en:docetaxel formulation ckd-810 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1511. en:dovitinib lactate --- r_associated #0: 31 --> en:cytarabine
    n1=en:dovitinib lactate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1512. en:dr5-targeting tetrameric nanobody agonist tas266 --- r_associated #0: 31 --> en:cytarabine
    n1=en:dr5-targeting tetrameric nanobody agonist tas266 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1513. en:e-z scrub --- r_associated #0: 31 --> en:cytarabine
    n1=en:e-z scrub | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1514. en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 31 --> en:cytarabine
    n1=en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1515. en:elotuzumab --- r_associated #0: 31 --> en:cytarabine
    n1=en:elotuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1516. en:elsamitrucin --- r_associated #0: 31 --> en:cytarabine
    n1=en:elsamitrucin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1517. en:emepepimut-s --- r_associated #0: 31 --> en:cytarabine
    n1=en:emepepimut-s | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1518. en:epinephrine + chlorpheniramine --- r_associated #0: 31 --> en:cytarabine
    n1=en:epinephrine + chlorpheniramine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1519. en:epothilone analog utd1 --- r_associated #0: 31 --> en:cytarabine
    n1=en:epothilone analog utd1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1520. en:esap protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:esap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1521. en:etaracizumab --- r_associated #0: 31 --> en:cytarabine
    n1=en:etaracizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1522. en:ethinyl estradiol --- r_associated #0: 31 --> en:cytarabine
    n1=en:ethinyl estradiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1523. en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 --- r_associated #0: 31 --> en:cytarabine
    n1=en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1524. en:fat emulsion --- r_associated #0: 31 --> en:cytarabine
    n1=en:fat emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1525. en:ferric carboxymaltose solution --- r_associated #0: 31 --> en:cytarabine
    n1=en:ferric carboxymaltose solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1526. en:folate binding protein e39 peptide vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:folate binding protein e39 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1527. en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 --- r_associated #0: 31 --> en:cytarabine
    n1=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1528. en:fowlpox virus vaccine vector --- r_associated #0: 31 --> en:cytarabine
    n1=en:fowlpox virus vaccine vector | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1529. en:gallium ga 68-labeled-nodaga-mj9 --- r_associated #0: 31 --> en:cytarabine
    n1=en:gallium ga 68-labeled-nodaga-mj9 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1530. en:gallium maltolate --- r_associated #0: 31 --> en:cytarabine
    n1=en:gallium maltolate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1531. en:gd2-klh vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:gd2-klh vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1532. en:green tea --- r_associated #0: 31 --> en:cytarabine
    n1=en:green tea | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1533. en:hdac inhibitor cxd101 --- r_associated #0: 31 --> en:cytarabine
    n1=en:hdac inhibitor cxd101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1534. en:hdac inhibitor shp-141 --- r_associated #0: 31 --> en:cytarabine
    n1=en:hdac inhibitor shp-141 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1535. en:hedgehog inhibitor pf-04449913 --- r_associated #0: 31 --> en:cytarabine
    n1=en:hedgehog inhibitor pf-04449913 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1536. en:heparin derivative sst0001 --- r_associated #0: 31 --> en:cytarabine
    n1=en:heparin derivative sst0001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1537. en:hsp90 inhibitor hsp990 --- r_associated #0: 31 --> en:cytarabine
    n1=en:hsp90 inhibitor hsp990 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1538. en:hypercvad/hd mtx arac regimen --- r_associated #0: 31 --> en:cytarabine
    n1=en:hypercvad/hd mtx arac regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1539. en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes --- r_associated #0: 31 --> en:cytarabine
    n1=en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1540. en:ilx23-7553 --- r_associated #0: 31 --> en:cytarabine
    n1=en:ilx23-7553 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1541. en:immunomodulator ohr/avr118 --- r_associated #0: 31 --> en:cytarabine
    n1=en:immunomodulator ohr/avr118 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1542. en:indisulam --- r_associated #0: 31 --> en:cytarabine
    n1=en:indisulam | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1543. en:iniparib --- r_associated #0: 31 --> en:cytarabine
    n1=en:iniparib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1544. en:injection, cytarabine, 100 mg --- r_associated #0: 31 --> en:cytarabine
    n1=en:injection, cytarabine, 100 mg | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1545. en:interferon alfacon-1 --- r_associated #0: 31 --> en:cytarabine
    n1=en:interferon alfacon-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1546. en:interleukin-4 pe38kdel immunotoxin --- r_associated #0: 31 --> en:cytarabine
    n1=en:interleukin-4 pe38kdel immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1547. en:iodine i 123 monoclonal antibody 81c6 --- r_associated #0: 31 --> en:cytarabine
    n1=en:iodine i 123 monoclonal antibody 81c6 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1548. en:iodine i 131 ethiodized oil --- r_associated #0: 31 --> en:cytarabine
    n1=en:iodine i 131 ethiodized oil | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1549. en:isoquercetin --- r_associated #0: 31 --> en:cytarabine
    n1=en:isoquercetin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1550. en:iss 1018 cpg oligodeoxynucleotide --- r_associated #0: 31 --> en:cytarabine
    n1=en:iss 1018 cpg oligodeoxynucleotide | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1551. en:jak2 inhibitor wp1066 --- r_associated #0: 31 --> en:cytarabine
    n1=en:jak2 inhibitor wp1066 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1552. en:jin fu kang --- r_associated #0: 31 --> en:cytarabine
    n1=en:jin fu kang | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1553. en:lactobacillus rhamnosus gg --- r_associated #0: 31 --> en:cytarabine
    n1=en:lactobacillus rhamnosus gg | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1554. en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement --- r_associated #0: 31 --> en:cytarabine
    n1=en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1555. en:levamisole hydrochloride --- r_associated #0: 31 --> en:cytarabine
    n1=en:levamisole hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1556. en:lexibulin --- r_associated #0: 31 --> en:cytarabine
    n1=en:lexibulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1557. en:liposomal eribulin mesylate --- r_associated #0: 31 --> en:cytarabine
    n1=en:liposomal eribulin mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1558. en:liposomal muc1/pet-lipid a vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:liposomal muc1/pet-lipid a vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1559. en:lpa97r protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:lpa97r protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1560. en:macho protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:macho protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1561. en:magrath regimen --- r_associated #0: 31 --> en:cytarabine
    n1=en:magrath regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1562. en:matuzumab --- r_associated #0: 31 --> en:cytarabine
    n1=en:matuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1563. en:mea protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:mea protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1564. en:mec protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:mec protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1565. en:mek inhibitor ci-1040 --- r_associated #0: 31 --> en:cytarabine
    n1=en:mek inhibitor ci-1040 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1566. en:melan-a vlp vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:melan-a vlp vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1567. en:milatuzumab --- r_associated #0: 31 --> en:cytarabine
    n1=en:milatuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1568. en:mnsod mimetic bmx-001 --- r_associated #0: 31 --> en:cytarabine
    n1=en:mnsod mimetic bmx-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1569. en:monoclonal antibody 11d10 anti-idiotype vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:monoclonal antibody 11d10 anti-idiotype vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1570. en:monoclonal antibody ing-1 --- r_associated #0: 31 --> en:cytarabine
    n1=en:monoclonal antibody ing-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1571. en:mtor kinase inhibitor azd8055 --- r_associated #0: 31 --> en:cytarabine
    n1=en:mtor kinase inhibitor azd8055 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1572. en:mycophenolic acid --- r_associated #0: 31 --> en:cytarabine
    n1=en:mycophenolic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1573. en:n(4)-hexadecyl-1-arabinofuranosylcytosine --- r_associated #0: 31 --> en:cytarabine
    n1=en:n(4)-hexadecyl-1-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1574. en:n(4)-octadecyl-1-arabinofuranosylcytosine --- r_associated #0: 31 --> en:cytarabine
    n1=en:n(4)-octadecyl-1-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1575. en:n(4)-succinyl-1-beta-d-arabinofuranosylcytosine --- r_associated #0: 31 --> en:cytarabine
    n1=en:n(4)-succinyl-1-beta-d-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1576. en:nelfinavir mesylate --- r_associated #0: 31 --> en:cytarabine
    n1=en:nelfinavir mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1577. en:nicotine nasal spray --- r_associated #0: 31 --> en:cytarabine
    n1=en:nicotine nasal spray | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1578. en:nilotinib --- r_associated #0: 31 --> en:cytarabine
    n1=en:nilotinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1579. en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion --- r_associated #0: 31 --> en:cytarabine
    n1=en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1580. en:opb-111001 --- r_associated #0: 31 --> en:cytarabine
    n1=en:opb-111001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1581. en:oxygen and carbon dioxide mixture --- r_associated #0: 31 --> en:cytarabine
    n1=en:oxygen and carbon dioxide mixture | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1582. en:pad regimen --- r_associated #0: 31 --> en:cytarabine
    n1=en:pad regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1583. en:padre-cmv fusion peptide vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:padre-cmv fusion peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1584. en:pae protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:pae protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1585. en:pame protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:pame protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1586. en:pamidronate disodium --- r_associated #0: 31 --> en:cytarabine
    n1=en:pamidronate disodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1587. en:panitumumab --- r_associated #0: 31 --> en:cytarabine
    n1=en:panitumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1588. en:pbcar3 phosphopeptide-tetanus peptide vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:pbcar3 phosphopeptide-tetanus peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1589. en:pegylated recombinant l-asparaginase erwinia chrysanthemi --- r_associated #0: 31 --> en:cytarabine
    n1=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1590. en:pep-cmv vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:pep-cmv vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1591. en:pi3k inhibitor gsk1059615 --- r_associated #0: 31 --> en:cytarabine
    n1=en:pi3k inhibitor gsk1059615 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1592. en:picropodophyllin --- r_associated #0: 31 --> en:cytarabine
    n1=en:picropodophyllin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1593. en:pirotinib --- r_associated #0: 31 --> en:cytarabine
    n1=en:pirotinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1594. en:pneumococcal polyvalent vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:pneumococcal polyvalent vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1595. en:pog-8498 protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:pog-8498 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1596. en:poly iclc --- r_associated #0: 31 --> en:cytarabine
    n1=en:poly iclc | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1597. en:poly-gamma glutamic acid --- r_associated #0: 31 --> en:cytarabine
    n1=en:poly-gamma glutamic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1598. en:pomb-ace protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:pomb-ace protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1599. en:preimplantation factor pif-1 --- r_associated #0: 31 --> en:cytarabine
    n1=en:preimplantation factor pif-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1600. en:protocol 8001 --- r_associated #0: 31 --> en:cytarabine
    n1=en:protocol 8001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1601. en:raltitrexed --- r_associated #0: 31 --> en:cytarabine
    n1=en:raltitrexed | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1602. en:recombinant adenovirus-l523s vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:recombinant adenovirus-l523s vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1603. en:recombinant mip1-alpha variant eci301 --- r_associated #0: 31 --> en:cytarabine
    n1=en:recombinant mip1-alpha variant eci301 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1604. en:rhenium re 188 p2045 --- r_associated #0: 31 --> en:cytarabine
    n1=en:rhenium re 188 p2045 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1605. en:rhenium re-188 ethiodized oil --- r_associated #0: 31 --> en:cytarabine
    n1=en:rhenium re-188 ethiodized oil | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1606. en:sardomozide --- r_associated #0: 31 --> en:cytarabine
    n1=en:sardomozide | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1607. en:sargramostim plasmid dna melanoma vaccine adjuvant --- r_associated #0: 31 --> en:cytarabine
    n1=en:sargramostim plasmid dna melanoma vaccine adjuvant | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1608. en:sargramostim plasmid dna sarcoma vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:sargramostim plasmid dna sarcoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1609. en:shu yu wan formula --- r_associated #0: 31 --> en:cytarabine
    n1=en:shu yu wan formula | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1610. en:sildenafil citrate --- r_associated #0: 31 --> en:cytarabine
    n1=en:sildenafil citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1611. en:solitomab --- r_associated #0: 31 --> en:cytarabine
    n1=en:solitomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1612. en:soy protein isolate --- r_associated #0: 31 --> en:cytarabine
    n1=en:soy protein isolate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1613. en:syk inhibitor hmpl-523 --- r_associated #0: 31 --> en:cytarabine
    n1=en:syk inhibitor hmpl-523 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1614. en:t-8801 protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:t-8801 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1615. en:tadop protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:tadop protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1616. en:tetanus toxoid vaccine --- r_associated #0: 31 --> en:cytarabine
    n1=en:tetanus toxoid vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1617. en:therapeutic cortisone --- r_associated #0: 31 --> en:cytarabine
    n1=en:therapeutic cortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1618. en:therapeutic epinephrine --- r_associated #0: 31 --> en:cytarabine
    n1=en:therapeutic epinephrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1619. en:tiazofurin --- r_associated #0: 31 --> en:cytarabine
    n1=en:tiazofurin | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1620. en:tlr9 agonist duk-cpg-001 --- r_associated #0: 31 --> en:cytarabine
    n1=en:tlr9 agonist duk-cpg-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1621. en:tubulin inhibitor alb 109564(a) --- r_associated #0: 31 --> en:cytarabine
    n1=en:tubulin inhibitor alb 109564(a) | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1622. en:uch i protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:uch i protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1623. en:ulvwf multimer-targeting agent arc1779 --- r_associated #0: 31 --> en:cytarabine
    n1=en:ulvwf multimer-targeting agent arc1779 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1624. en:vaap regimen --- r_associated #0: 31 --> en:cytarabine
    n1=en:vaap regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1625. en:vaba protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:vaba protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1626. en:vae protocol --- r_associated #0: 31 --> en:cytarabine
    n1=en:vae protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1627. en:vinblastine sulfate --- r_associated #0: 31 --> en:cytarabine
    n1=en:vinblastine sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1628. en:y 90 monoclonal antibody m170 --- r_associated #0: 31 --> en:cytarabine
    n1=en:y 90 monoclonal antibody m170 | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1629. en:zinc sulphate --- r_associated #0: 31 --> en:cytarabine
    n1=en:zinc sulphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1630. nicotinamide --- r_associated #0: 31 --> en:cytarabine
    n1=nicotinamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=31
  1631. Langage informatique --- r_associated #0: 30 --> en:cytarabine
    n1=Langage informatique | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1632. Vaccin contre l'hépatite A --- r_associated #0: 30 --> en:cytarabine
    n1=Vaccin contre l'hépatite A | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1633. acide docosahexaènoïque --- r_associated #0: 30 --> en:cytarabine
    n1=acide docosahexaènoïque | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1634. agent antinéoplasique --- r_associated #0: 30 --> en:cytarabine
    n1=agent antinéoplasique | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1635. aller ensemble --- r_associated #0: 30 --> en:cytarabine
    n1=aller ensemble | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1636. cancérigène --- r_associated #0: 30 --> en:cytarabine
    n1=cancérigène | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1637. carcinogène --- r_associated #0: 30 --> en:cytarabine
    n1=carcinogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1638. cefpodoxime proxétil --- r_associated #0: 30 --> en:cytarabine
    n1=cefpodoxime proxétil | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1639. clef --- r_associated #0: 30 --> en:cytarabine
    n1=clef | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1640. en:1-(5-deoxy-beta-d-hexofuranosyl)cytosine --- r_associated #0: 30 --> en:cytarabine
    n1=en:1-(5-deoxy-beta-d-hexofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1641. en:18-f-fluoroacetate --- r_associated #0: 30 --> en:cytarabine
    n1=en:18-f-fluoroacetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1642. en:3'-c-ethynylcytidine --- r_associated #0: 30 --> en:cytarabine
    n1=en:3'-c-ethynylcytidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1643. en:5'-palmitoyl cytarabine --- r_associated #0: 30 --> en:cytarabine
    n1=en:5'-palmitoyl cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1644. en:aa2 protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:aa2 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1645. en:ab-triple v protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:ab-triple v protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1646. en:abagovomab --- r_associated #0: 30 --> en:cytarabine
    n1=en:abagovomab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1647. en:absorbable fibrin sealant patch --- r_associated #0: 30 --> en:cytarabine
    n1=en:absorbable fibrin sealant patch | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1648. en:absorbable modified polymer hemostatic powder --- r_associated #0: 30 --> en:cytarabine
    n1=en:absorbable modified polymer hemostatic powder | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1649. en:ad5-ycd/muttk(sr39)rep-adp --- r_associated #0: 30 --> en:cytarabine
    n1=en:ad5-ycd/muttk(sr39)rep-adp | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1650. en:adenovirus 5-human guanylyl cyclase c-padre vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:adenovirus 5-human guanylyl cyclase c-padre vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1651. en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1652. en:afimoxifene --- r_associated #0: 30 --> en:cytarabine
    n1=en:afimoxifene | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1653. en:akt inhibitor sr13668 --- r_associated #0: 30 --> en:cytarabine
    n1=en:akt inhibitor sr13668 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1654. en:alhr88 protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:alhr88 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1655. en:alk inhibitor x-396 --- r_associated #0: 30 --> en:cytarabine
    n1=en:alk inhibitor x-396 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1656. en:alk/ros1 inhibitor pf-06463922 --- r_associated #0: 30 --> en:cytarabine
    n1=en:alk/ros1 inhibitor pf-06463922 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1657. en:allogeneic aml antigen-expressing dendritic cell vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:allogeneic aml antigen-expressing dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1658. en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells --- r_associated #0: 30 --> en:cytarabine
    n1=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1659. en:allogeneic dendritic cell-myeloma idiotype vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:allogeneic dendritic cell-myeloma idiotype vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1660. en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1661. en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 --- r_associated #0: 30 --> en:cytarabine
    n1=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1662. en:alpha-tocopheryloxyacetic acid --- r_associated #0: 30 --> en:cytarabine
    n1=en:alpha-tocopheryloxyacetic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1663. en:alvac-cea b7.1 vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:alvac-cea b7.1 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1664. en:aminocamptothecin colloidal dispersion --- r_associated #0: 30 --> en:cytarabine
    n1=en:aminocamptothecin colloidal dispersion | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1665. en:aml8a protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:aml8a protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1666. en:ammonium glycyrrhizate --- r_associated #0: 30 --> en:cytarabine
    n1=en:ammonium glycyrrhizate | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1667. en:analgesic agent --- r_associated #0: 30 --> en:cytarabine
    n1=en:analgesic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1668. en:androgen receptor antisense oligonucleotide azd5312 --- r_associated #0: 30 --> en:cytarabine
    n1=en:androgen receptor antisense oligonucleotide azd5312 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1669. en:anhydro-araic 3'-acetate --- r_associated #0: 30 --> en:cytarabine
    n1=en:anhydro-araic 3'-acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1670. en:annonaceous acetogenins --- r_associated #0: 30 --> en:cytarabine
    n1=en:annonaceous acetogenins | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1671. en:answer --- r_associated #0: 30 --> en:cytarabine
    n1=en:answer | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1672. en:answer sb back --- r_associated #0: 30 --> en:cytarabine
    n1=en:answer sb back | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1673. en:anti-c-met monoclonal antibody abt-700 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-c-met monoclonal antibody abt-700 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1674. en:anti-cd123/cd3 monoclonal antibody mgd006 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd123/cd3 monoclonal antibody mgd006 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1675. en:anti-cd19-car retroviral vector-transduced autologous t cells --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd19-car retroviral vector-transduced autologous t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1676. en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1677. en:anti-cd20 b9e9 scfv-streptavidin fusion protein --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd20 b9e9 scfv-streptavidin fusion protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1678. en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1679. en:anti-cd44 monoclonal antibody ro5429083 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd44 monoclonal antibody ro5429083 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1680. en:anti-cd70 antibody-drug conjugate mdx-1203 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cd70 antibody-drug conjugate mdx-1203 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1681. en:anti-cea-car autologous t lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-cea-car autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1682. en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1683. en:anti-egfr monoclonal antibody ro5083945 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-egfr monoclonal antibody ro5083945 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1684. en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1685. en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1686. en:anti-fgfr3 monoclonal antibody b-701 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-fgfr3 monoclonal antibody b-701 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1687. en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1688. en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1689. en:anti-hla-dr monoclonal antibody immu-114 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-hla-dr monoclonal antibody immu-114 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1690. en:anti-igf1/2 monoclonal antibody medi-573 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-igf1/2 monoclonal antibody medi-573 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1691. en:anti-inflammatory agents --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-inflammatory agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1692. en:anti-kir monoclonal antibody iph 2101 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-kir monoclonal antibody iph 2101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1693. en:anti-melanin monoclonal antibody pti-6d2 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-melanin monoclonal antibody pti-6d2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1694. en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1695. en:anti-pd-1 monoclonal antibody shr-1210 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-pd-1 monoclonal antibody shr-1210 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1696. en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1697. en:anti-vegf anticalin prs-050-peg40 --- r_associated #0: 30 --> en:cytarabine
    n1=en:anti-vegf anticalin prs-050-peg40 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1698. en:antihypertensive agent --- r_associated #0: 30 --> en:cytarabine
    n1=en:antihypertensive agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1699. en:antineoplastic agent --- r_associated #0: 30 --> en:cytarabine
    n1=en:antineoplastic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1700. en:antrodia cinnamomea supplement --- r_associated #0: 30 --> en:cytarabine
    n1=en:antrodia cinnamomea supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1701. en:apf530 --- r_associated #0: 30 --> en:cytarabine
    n1=en:apf530 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1702. en:aprepitant --- r_associated #0: 30 --> en:cytarabine
    n1=en:aprepitant | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1703. en:ara-cop protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:ara-cop protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1704. en:arginine/omega-3 fatty acids/nucleotides oral supplement --- r_associated #0: 30 --> en:cytarabine
    n1=en:arginine/omega-3 fatty acids/nucleotides oral supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1705. en:artesunate --- r_associated #0: 30 --> en:cytarabine
    n1=en:artesunate | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1706. en:asian ginseng --- r_associated #0: 30 --> en:cytarabine
    n1=en:asian ginseng | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1707. en:asp9853 --- r_associated #0: 30 --> en:cytarabine
    n1=en:asp9853 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1708. en:attenuated corynebacterium parvum --- r_associated #0: 30 --> en:cytarabine
    n1=en:attenuated corynebacterium parvum | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1709. en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1710. en:autologous dendritic cell-based immunotherapeutic av0113 --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous dendritic cell-based immunotherapeutic av0113 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1711. en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1712. en:autologous immunoglobulin idiotype-klh conjugate vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous immunoglobulin idiotype-klh conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1713. en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1714. en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1715. en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1716. en:avn944 --- r_associated #0: 30 --> en:cytarabine
    n1=en:avn944 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1717. en:azd5438 --- r_associated #0: 30 --> en:cytarabine
    n1=en:azd5438 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1718. en:barasertib --- r_associated #0: 30 --> en:cytarabine
    n1=en:barasertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1719. en:bavituximab --- r_associated #0: 30 --> en:cytarabine
    n1=en:bavituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1720. en:bay 56-3722 --- r_associated #0: 30 --> en:cytarabine
    n1=en:bay 56-3722 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1721. en:be a counterpart to something --- r_associated #0: 30 --> en:cytarabine
    n1=en:be a counterpart to something | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1722. en:be the counterpart of --- r_associated #0: 30 --> en:cytarabine
    n1=en:be the counterpart of | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1723. en:belotecan hydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:belotecan hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1724. en:bet inhibitor incb057643 --- r_associated #0: 30 --> en:cytarabine
    n1=en:bet inhibitor incb057643 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1725. en:beta-ara c --- r_associated #0: 30 --> en:cytarabine
    n1=en:beta-ara c | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1726. en:beta-thioguanine deoxyriboside --- r_associated #0: 30 --> en:cytarabine
    n1=en:beta-thioguanine deoxyriboside | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1727. en:bispecific antibody 2b1 --- r_associated #0: 30 --> en:cytarabine
    n1=en:bispecific antibody 2b1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1728. en:bms-817378 --- r_associated #0: 30 --> en:cytarabine
    n1=en:bms-817378 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1729. en:braf/egfr inhibitor bgb-283 --- r_associated #0: 30 --> en:cytarabine
    n1=en:braf/egfr inhibitor bgb-283 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1730. en:c-ham regimen --- r_associated #0: 30 --> en:cytarabine
    n1=en:c-ham regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1731. en:c-met inhibitor jnj-38877605 --- r_associated #0: 30 --> en:cytarabine
    n1=en:c-met inhibitor jnj-38877605 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1732. en:canfosfamide hydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:canfosfamide hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1733. en:carbon c 14 anlotinib hydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:carbon c 14 anlotinib hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1734. en:carboxylesterase-expressing allogeneic neural stem cells --- r_associated #0: 30 --> en:cytarabine
    n1=en:carboxylesterase-expressing allogeneic neural stem cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1735. en:carcinogen --- r_associated #0: 30 --> en:cytarabine
    n1=en:carcinogen | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1736. en:carmustine in ethanol --- r_associated #0: 30 --> en:cytarabine
    n1=en:carmustine in ethanol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1737. en:cc-401 --- r_associated #0: 30 --> en:cytarabine
    n1=en:cc-401 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1738. en:cefpodoxime proxetil --- r_associated #0: 30 --> en:cytarabine
    n1=en:cefpodoxime proxetil | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1739. en:cetearyl alcohol --- r_associated #0: 30 --> en:cytarabine
    n1=en:cetearyl alcohol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1740. en:chelating agent --- r_associated #0: 30 --> en:cytarabine
    n1=en:chelating agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1741. en:chimeric humanized anti-cd47 antibody --- r_associated #0: 30 --> en:cytarabine
    n1=en:chimeric humanized anti-cd47 antibody | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1742. en:chk1 inhibitor gdc-0425 --- r_associated #0: 30 --> en:cytarabine
    n1=en:chk1 inhibitor gdc-0425 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1743. en:chk1 inhibitor mk-8776 --- r_associated #0: 30 --> en:cytarabine
    n1=en:chk1 inhibitor mk-8776 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1744. en:cinacalcet hydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:cinacalcet hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1745. en:cjc-1295 --- r_associated #0: 30 --> en:cytarabine
    n1=en:cjc-1295 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1746. en:ck2-targeting synthetic peptide cigb-300 --- r_associated #0: 30 --> en:cytarabine
    n1=en:ck2-targeting synthetic peptide cigb-300 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1747. en:clematis vitalba flower extract --- r_associated #0: 30 --> en:cytarabine
    n1=en:clematis vitalba flower extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1748. en:clonidine-containing mucoadhesive buccal tablet --- r_associated #0: 30 --> en:cytarabine
    n1=en:clonidine-containing mucoadhesive buccal tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1749. en:clozapine (actavis) --- r_associated #0: 30 --> en:cytarabine
    n1=en:clozapine (actavis) | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1750. en:code --- r_associated #0: 30 --> en:cytarabine
    n1=en:code | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1751. en:codeine / iodinated glycerol --- r_associated #0: 30 --> en:cytarabine
    n1=en:codeine / iodinated glycerol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1752. en:computer language --- r_associated #0: 30 --> en:cytarabine
    n1=en:computer language | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1753. en:copovithane --- r_associated #0: 30 --> en:cytarabine
    n1=en:copovithane | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1754. en:corn tassel --- r_associated #0: 30 --> en:cytarabine
    n1=en:corn tassel | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1755. en:correspond to --- r_associated #0: 30 --> en:cytarabine
    n1=en:correspond to | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1756. en:crl 1005 --- r_associated #0: 30 --> en:cytarabine
    n1=en:crl 1005 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1757. en:cxc chemokine receptor 2 antagonist azd5069 --- r_associated #0: 30 --> en:cytarabine
    n1=en:cxc chemokine receptor 2 antagonist azd5069 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1758. en:cyclosporine ophthalmic emulsion --- r_associated #0: 30 --> en:cytarabine
    n1=en:cyclosporine ophthalmic emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1759. en:cytarabine 100 mg/ml --- r_associated #0: 30 --> en:cytarabine
    n1=en:cytarabine 100 mg/ml | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1760. en:cytarabine 50 mg/ml --- r_associated #0: 30 --> en:cytarabine
    n1=en:cytarabine 50 mg/ml | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1761. en:cytidine analog rx-3117 --- r_associated #0: 30 --> en:cytarabine
    n1=en:cytidine analog rx-3117 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1762. en:decitabine --- r_associated #0: 30 --> en:cytarabine
    n1=en:decitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1763. en:depdc1/mphosh1 peptide vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:depdc1/mphosh1 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1764. en:dextromethorphan hydrobromide --- r_associated #0: 30 --> en:cytarabine
    n1=en:dextromethorphan hydrobromide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1765. en:diindolylmethane --- r_associated #0: 30 --> en:cytarabine
    n1=en:diindolylmethane | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1766. en:dinaciclib --- r_associated #0: 30 --> en:cytarabine
    n1=en:dinaciclib | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1767. en:dn-101 --- r_associated #0: 30 --> en:cytarabine
    n1=en:dn-101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1768. en:docetaxel emulsion anx-514 --- r_associated #0: 30 --> en:cytarabine
    n1=en:docetaxel emulsion anx-514 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1769. en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes --- r_associated #0: 30 --> en:cytarabine
    n1=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1770. en:dopamine-somatostatin chimeric molecule bim-23a760 --- r_associated #0: 30 --> en:cytarabine
    n1=en:dopamine-somatostatin chimeric molecule bim-23a760 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1771. en:dual variable domain immunoglobulin abt-165 --- r_associated #0: 30 --> en:cytarabine
    n1=en:dual variable domain immunoglobulin abt-165 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1772. en:ecromeximab --- r_associated #0: 30 --> en:cytarabine
    n1=en:ecromeximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1773. en:elacytarabine --- r_associated #0: 30 --> en:cytarabine
    n1=en:elacytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1774. en:emricasan --- r_associated #0: 30 --> en:cytarabine
    n1=en:emricasan | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1775. en:epidermal growth factor ointment --- r_associated #0: 30 --> en:cytarabine
    n1=en:epidermal growth factor ointment | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1776. en:exemestane --- r_associated #0: 30 --> en:cytarabine
    n1=en:exemestane | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1777. en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 30 --> en:cytarabine
    n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1778. en:fluorine f 18 galacto-rgd peptide --- r_associated #0: 30 --> en:cytarabine
    n1=en:fluorine f 18 galacto-rgd peptide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1779. en:fluorine f-18 6-fluorodopamine --- r_associated #0: 30 --> en:cytarabine
    n1=en:fluorine f-18 6-fluorodopamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1780. en:fluorine f-18 fluoropaclitaxel --- r_associated #0: 30 --> en:cytarabine
    n1=en:fluorine f-18 fluoropaclitaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1781. en:fluvastatin sodium --- r_associated #0: 30 --> en:cytarabine
    n1=en:fluvastatin sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1782. en:fork wrench --- r_associated #0: 30 --> en:cytarabine
    n1=en:fork wrench | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1783. en:form a pair with something --- r_associated #0: 30 --> en:cytarabine
    n1=en:form a pair with something | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1784. en:gallium ga 68-labeled affibody aby-025 --- r_associated #0: 30 --> en:cytarabine
    n1=en:gallium ga 68-labeled affibody aby-025 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1785. en:gallium ga 68-rgd --- r_associated #0: 30 --> en:cytarabine
    n1=en:gallium ga 68-rgd | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1786. en:get acquainted with somebody --- r_associated #0: 30 --> en:cytarabine
    n1=en:get acquainted with somebody | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1787. en:get to know somebody --- r_associated #0: 30 --> en:cytarabine
    n1=en:get to know somebody | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1788. en:ginger extract --- r_associated #0: 30 --> en:cytarabine
    n1=en:ginger extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1789. en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1790. en:glu-ara-c-polylysine --- r_associated #0: 30 --> en:cytarabine
    n1=en:glu-ara-c-polylysine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1791. en:go well together --- r_associated #0: 30 --> en:cytarabine
    n1=en:go well together | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1792. en:go with something --- r_associated #0: 30 --> en:cytarabine
    n1=en:go with something | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1793. en:gti-2040 --- r_associated #0: 30 --> en:cytarabine
    n1=en:gti-2040 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1794. en:gvax prostate cancer vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:gvax prostate cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1795. en:hdac protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:hdac protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1796. en:her-2/neu intracellular domain protein --- r_associated #0: 30 --> en:cytarabine
    n1=en:her-2/neu intracellular domain protein | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1797. en:hi-coap regimen --- r_associated #0: 30 --> en:cytarabine
    n1=en:hi-coap regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1798. en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1799. en:hoap protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:hoap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1800. en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c --- r_associated #0: 30 --> en:cytarabine
    n1=en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1801. en:human combinatorial antibody library-based monoclonal antibody vay736 --- r_associated #0: 30 --> en:cytarabine
    n1=en:human combinatorial antibody library-based monoclonal antibody vay736 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1802. en:human mhc non-restricted cytotoxic t-cell line tall-104 --- r_associated #0: 30 --> en:cytarabine
    n1=en:human mhc non-restricted cytotoxic t-cell line tall-104 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1803. en:human prostate-specific membrane antigen plasmid dna vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:human prostate-specific membrane antigen plasmid dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1804. en:hyperglycemic agent --- r_associated #0: 30 --> en:cytarabine
    n1=en:hyperglycemic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1805. en:idh2 inhibitor ag-221 --- r_associated #0: 30 --> en:cytarabine
    n1=en:idh2 inhibitor ag-221 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1806. en:imidazolyl ethanamide pentandioic acid --- r_associated #0: 30 --> en:cytarabine
    n1=en:imidazolyl ethanamide pentandioic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1807. en:immunotherapy regimen mkc-1106-mt --- r_associated #0: 30 --> en:cytarabine
    n1=en:immunotherapy regimen mkc-1106-mt | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1808. en:indole-3-carbinol --- r_associated #0: 30 --> en:cytarabine
    n1=en:indole-3-carbinol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1809. en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule --- r_associated #0: 30 --> en:cytarabine
    n1=en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1810. en:ino-1001 --- r_associated #0: 30 --> en:cytarabine
    n1=en:ino-1001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1811. en:iodine i 123 anti-cea recombinant diabody t84.66 --- r_associated #0: 30 --> en:cytarabine
    n1=en:iodine i 123 anti-cea recombinant diabody t84.66 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1812. en:irinotecan hydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:irinotecan hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1813. en:iron dextran complex --- r_associated #0: 30 --> en:cytarabine
    n1=en:iron dextran complex | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1814. en:iron isomaltoside 1000 --- r_associated #0: 30 --> en:cytarabine
    n1=en:iron isomaltoside 1000 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1815. en:isis 2503 --- r_associated #0: 30 --> en:cytarabine
    n1=en:isis 2503 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1816. en:isoflurane --- r_associated #0: 30 --> en:cytarabine
    n1=en:isoflurane | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1817. en:ivac mutanome vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:ivac mutanome vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1818. en:ivac protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:ivac protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1819. en:key moment --- r_associated #0: 30 --> en:cytarabine
    n1=en:key moment | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1820. en:ksp inhibitor azd4877 --- r_associated #0: 30 --> en:cytarabine
    n1=en:ksp inhibitor azd4877 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1821. en:lanreotide long-acting aqueous gel --- r_associated #0: 30 --> en:cytarabine
    n1=en:lanreotide long-acting aqueous gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1822. en:larson regimen --- r_associated #0: 30 --> en:cytarabine
    n1=en:larson regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1823. en:lidocaine patch --- r_associated #0: 30 --> en:cytarabine
    n1=en:lidocaine patch | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1824. en:lisinopril --- r_associated #0: 30 --> en:cytarabine
    n1=en:lisinopril | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1825. en:lutetium lu-177 capromab --- r_associated #0: 30 --> en:cytarabine
    n1=en:lutetium lu-177 capromab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1826. en:lytta vesicatoria preparation --- r_associated #0: 30 --> en:cytarabine
    n1=en:lytta vesicatoria preparation | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1827. en:m.d. anderson cancer center protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:m.d. anderson cancer center protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1828. en:mage-a3-expressing adenovirus type 5 vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:mage-a3-expressing adenovirus type 5 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1829. en:magnesium isoglycyrrhizinate --- r_associated #0: 30 --> en:cytarabine
    n1=en:magnesium isoglycyrrhizinate | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1830. en:maitake mushroom extract --- r_associated #0: 30 --> en:cytarabine
    n1=en:maitake mushroom extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1831. en:make a counterpart to something --- r_associated #0: 30 --> en:cytarabine
    n1=en:make a counterpart to something | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1832. en:make a pair with something --- r_associated #0: 30 --> en:cytarabine
    n1=en:make a pair with something | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1833. en:make somebody 's acquaintance --- r_associated #0: 30 --> en:cytarabine
    n1=en:make somebody 's acquaintance | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1834. en:make somebody's acquaintance --- r_associated #0: 30 --> en:cytarabine
    n1=en:make somebody's acquaintance | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1835. en:mammaglobin-a dna vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:mammaglobin-a dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1836. en:match --- r_associated #0: 30 --> en:cytarabine
    n1=en:match | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1837. en:measles/mumps/rubella vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:measles/mumps/rubella vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1838. en:meet --- r_associated #0: 30 --> en:cytarabine
    n1=en:meet | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1839. en:mek 1/2 inhibitor as703988/msc2015103b --- r_associated #0: 30 --> en:cytarabine
    n1=en:mek 1/2 inhibitor as703988/msc2015103b | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1840. en:mifamurtide --- r_associated #0: 30 --> en:cytarabine
    n1=en:mifamurtide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1841. en:mini-beam salvage protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:mini-beam salvage protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1842. en:modified citrus pectin supplement --- r_associated #0: 30 --> en:cytarabine
    n1=en:modified citrus pectin supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1843. en:monoclonal antibody cc49 --- r_associated #0: 30 --> en:cytarabine
    n1=en:monoclonal antibody cc49 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1844. en:monoclonal antibody hu3s193 --- r_associated #0: 30 --> en:cytarabine
    n1=en:monoclonal antibody hu3s193 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1845. en:monoclonal antibody me1-14 f(ab')2 --- r_associated #0: 30 --> en:cytarabine
    n1=en:monoclonal antibody me1-14 f(ab')2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1846. en:multidrug resistance modulator --- r_associated #0: 30 --> en:cytarabine
    n1=en:multidrug resistance modulator | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1847. en:multipeptide vaccine s-588210 --- r_associated #0: 30 --> en:cytarabine
    n1=en:multipeptide vaccine s-588210 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1848. en:n4-(4-carboxybutyryl)-1-arabinofuranosylcytosine-decylenediamine-dextran t70 --- r_associated #0: 30 --> en:cytarabine
    n1=en:n4-(4-carboxybutyryl)-1-arabinofuranosylcytosine-decylenediamine-dextran t70 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1849. en:nicotine --- r_associated #0: 30 --> en:cytarabine
    n1=en:nicotine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1850. en:olodaterol --- r_associated #0: 30 --> en:cytarabine
    n1=en:olodaterol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1851. en:open end wrench --- r_associated #0: 30 --> en:cytarabine
    n1=en:open end wrench | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1852. en:paclitaxel trevatide --- r_associated #0: 30 --> en:cytarabine
    n1=en:paclitaxel trevatide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1853. en:palladium-bacteriopheophorbide --- r_associated #0: 30 --> en:cytarabine
    n1=en:palladium-bacteriopheophorbide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1854. en:pan-selectin antagonist gmi-1070 --- r_associated #0: 30 --> en:cytarabine
    n1=en:pan-selectin antagonist gmi-1070 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1855. en:panitumumab-irdye800 --- r_associated #0: 30 --> en:cytarabine
    n1=en:panitumumab-irdye800 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1856. en:parp inhibitor cep-9722 --- r_associated #0: 30 --> en:cytarabine
    n1=en:parp inhibitor cep-9722 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1857. en:pazopanib hydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:pazopanib hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1858. en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative --- r_associated #0: 30 --> en:cytarabine
    n1=en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1859. en:pegylated anti-gfr antibody fragment --- r_associated #0: 30 --> en:cytarabine
    n1=en:pegylated anti-gfr antibody fragment | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1860. en:perindopril erbumine --- r_associated #0: 30 --> en:cytarabine
    n1=en:perindopril erbumine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1861. en:pharmacokinetic aspects --- r_associated #0: 30 --> en:cytarabine
    n1=en:pharmacokinetic aspects | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1862. en:phenylephrine + chlorpheniramine + ephedrine + carbetapentane --- r_associated #0: 30 --> en:cytarabine
    n1=en:phenylephrine + chlorpheniramine + ephedrine + carbetapentane | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1863. en:phosphaplatin pt-112 --- r_associated #0: 30 --> en:cytarabine
    n1=en:phosphaplatin pt-112 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1864. en:pi3k delta/gamma inhibitor rp6530 --- r_associated #0: 30 --> en:cytarabine
    n1=en:pi3k delta/gamma inhibitor rp6530 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1865. en:pi3k inhibitor wx-037 --- r_associated #0: 30 --> en:cytarabine
    n1=en:pi3k inhibitor wx-037 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1866. en:pi3k/mtor inhibitor bez235 --- r_associated #0: 30 --> en:cytarabine
    n1=en:pi3k/mtor inhibitor bez235 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1867. en:pi3k/mtor kinase inhibitor pf-04691502 --- r_associated #0: 30 --> en:cytarabine
    n1=en:pi3k/mtor kinase inhibitor pf-04691502 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1868. en:pinaverium bromide --- r_associated #0: 30 --> en:cytarabine
    n1=en:pinaverium bromide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1869. en:piritrexim --- r_associated #0: 30 --> en:cytarabine
    n1=en:piritrexim | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1870. en:pivotal moment --- r_associated #0: 30 --> en:cytarabine
    n1=en:pivotal moment | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1871. en:pneumococcal 13-valent conjugate vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:pneumococcal 13-valent conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1872. en:polysaccharide-k --- r_associated #0: 30 --> en:cytarabine
    n1=en:polysaccharide-k | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1873. en:pomegranate-extract pill --- r_associated #0: 30 --> en:cytarabine
    n1=en:pomegranate-extract pill | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1874. en:pramipexole dihydrochloride --- r_associated #0: 30 --> en:cytarabine
    n1=en:pramipexole dihydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1875. en:prochlorperazine --- r_associated #0: 30 --> en:cytarabine
    n1=en:prochlorperazine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1876. en:pyroxamide --- r_associated #0: 30 --> en:cytarabine
    n1=en:pyroxamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1877. en:ras peptide cancer vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:ras peptide cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1878. en:recombinant interleukin-6 --- r_associated #0: 30 --> en:cytarabine
    n1=en:recombinant interleukin-6 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1879. en:reply to --- r_associated #0: 30 --> en:cytarabine
    n1=en:reply to | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1880. en:respond --- r_associated #0: 30 --> en:cytarabine
    n1=en:respond | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1881. en:rituximab --- r_associated #0: 30 --> en:cytarabine
    n1=en:rituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1882. en:sdf-1-targeted agent nox-a12 --- r_associated #0: 30 --> en:cytarabine
    n1=en:sdf-1-targeted agent nox-a12 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1883. en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1884. en:sipuleucel-t --- r_associated #0: 30 --> en:cytarabine
    n1=en:sipuleucel-t | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1885. en:solution --- r_associated #0: 30 --> en:cytarabine
    n1=en:solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1886. en:sotagliflozin --- r_associated #0: 30 --> en:cytarabine
    n1=en:sotagliflozin | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1887. en:source code --- r_associated #0: 30 --> en:cytarabine
    n1=en:source code | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1888. en:source text --- r_associated #0: 30 --> en:cytarabine
    n1=en:source text | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1889. en:taliglucerase alfa --- r_associated #0: 30 --> en:cytarabine
    n1=en:taliglucerase alfa | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1890. en:tasquinimod --- r_associated #0: 30 --> en:cytarabine
    n1=en:tasquinimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1891. en:tlr 7/8 agonist medi9197 --- r_associated #0: 30 --> en:cytarabine
    n1=en:tlr 7/8 agonist medi9197 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1892. en:to answer sb back --- r_associated #0: 30 --> en:cytarabine
    n1=en:to answer sb back | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1893. en:to be the counterpart of --- r_associated #0: 30 --> en:cytarabine
    n1=en:to be the counterpart of | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1894. en:to correspond to --- r_associated #0: 30 --> en:cytarabine
    n1=en:to correspond to | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1895. en:to match --- r_associated #0: 30 --> en:cytarabine
    n1=en:to match | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1896. en:to meet --- r_associated #0: 30 --> en:cytarabine
    n1=en:to meet | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1897. en:to reply to --- r_associated #0: 30 --> en:cytarabine
    n1=en:to reply to | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1898. en:total tumor rna-loaded dendritic cell vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:total tumor rna-loaded dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1899. en:trap protocol --- r_associated #0: 30 --> en:cytarabine
    n1=en:trap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1900. en:trastuzumab emtansine --- r_associated #0: 30 --> en:cytarabine
    n1=en:trastuzumab emtansine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1901. en:uracil analog --- r_associated #0: 30 --> en:cytarabine
    n1=en:uracil analog | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1902. en:vad regimen --- r_associated #0: 30 --> en:cytarabine
    n1=en:vad regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1903. en:vincristine sulfate liposome --- r_associated #0: 30 --> en:cytarabine
    n1=en:vincristine sulfate liposome | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1904. en:vitespen --- r_associated #0: 30 --> en:cytarabine
    n1=en:vitespen | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1905. en:wrench --- r_associated #0: 30 --> en:cytarabine
    n1=en:wrench | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1906. en:xenogeneic tyrosinase dna vaccine --- r_associated #0: 30 --> en:cytarabine
    n1=en:xenogeneic tyrosinase dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1907. en:yttrium y 90-dota-di-hsg peptide imp-288 --- r_associated #0: 30 --> en:cytarabine
    n1=en:yttrium y 90-dota-di-hsg peptide imp-288 | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1908. en:zalutumumab --- r_associated #0: 30 --> en:cytarabine
    n1=en:zalutumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1909. en:zoptarelin doxorubicin --- r_associated #0: 30 --> en:cytarabine
    n1=en:zoptarelin doxorubicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1910. faire connaissance --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1911. faire connaissance avec --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance avec | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1912. faire connaissance avec [qqn] --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance avec [qqn] | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1913. faire connaissance avec qn --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance avec qn | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1914. faire connaissance avec quelqu'un --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance avec quelqu'un | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1915. faire connaissance de --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance de | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1916. faire connaissance de [qqn] --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance de [qqn] | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1917. faire connaissance de quelqu'un --- r_associated #0: 30 --> en:cytarabine
    n1=faire connaissance de quelqu'un | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1918. faire pendant à --- r_associated #0: 30 --> en:cytarabine
    n1=faire pendant à | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1919. gabapentine --- r_associated #0: 30 --> en:cytarabine
    n1=gabapentine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1920. indométacine --- r_associated #0: 30 --> en:cytarabine
    n1=indométacine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1921. isoflurane --- r_associated #0: 30 --> en:cytarabine
    n1=isoflurane | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1922. langage informatique --- r_associated #0: 30 --> en:cytarabine
    n1=langage informatique | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1923. lier connaissance avec --- r_associated #0: 30 --> en:cytarabine
    n1=lier connaissance avec | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1924. lier connaissance avec [qqn] --- r_associated #0: 30 --> en:cytarabine
    n1=lier connaissance avec [qqn] | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1925. lisinopril --- r_associated #0: 30 --> en:cytarabine
    n1=lisinopril | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1926. myorelaxante --- r_associated #0: 30 --> en:cytarabine
    n1=myorelaxante | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1927. nicotine --- r_associated #0: 30 --> en:cytarabine
    n1=nicotine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1928. prochlorpérazine --- r_associated #0: 30 --> en:cytarabine
    n1=prochlorpérazine | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1929. relaxant musculaire --- r_associated #0: 30 --> en:cytarabine
    n1=relaxant musculaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1930. rituximab --- r_associated #0: 30 --> en:cytarabine
    n1=rituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1931. répondre à --- r_associated #0: 30 --> en:cytarabine
    n1=répondre à | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1932. se joindre --- r_associated #0: 30 --> en:cytarabine
    n1=se joindre | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1933. texte source --- r_associated #0: 30 --> en:cytarabine
    n1=texte source | n2=en:cytarabine | rel=r_associated | relid=0 | w=30
  1934. DOBV --- r_associated #0: 29 --> en:cytarabine
    n1=DOBV | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1935. acide docosahexaénoïque --- r_associated #0: 29 --> en:cytarabine
    n1=acide docosahexaénoïque | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1936. barite --- r_associated #0: 29 --> en:cytarabine
    n1=barite | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1937. clé à molette --- r_associated #0: 29 --> en:cytarabine
    n1=clé à molette | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1938. en:1 beta-d-arabinofuranosylcytosine diphosphate choline --- r_associated #0: 29 --> en:cytarabine
    n1=en:1 beta-d-arabinofuranosylcytosine diphosphate choline | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1939. en:14c bms-275183 --- r_associated #0: 29 --> en:cytarabine
    n1=en:14c bms-275183 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1940. en:16,16-dimethyl prostaglandin e2 --- r_associated #0: 29 --> en:cytarabine
    n1=en:16,16-dimethyl prostaglandin e2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1941. en:2,2'-anhydro-1-(3'-o-acetyl-beta-arabinofuranosyl)-5-iodocytosine hydrochloride --- r_associated #0: 29 --> en:cytarabine
    n1=en:2,2'-anhydro-1-(3'-o-acetyl-beta-arabinofuranosyl)-5-iodocytosine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1942. en:3'-o-galactopyranosylcytarabine --- r_associated #0: 29 --> en:cytarabine
    n1=en:3'-o-galactopyranosylcytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1943. en:4-peptide melanoma vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:4-peptide melanoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1944. en:5-ht3 receptor antagonist --- r_associated #0: 29 --> en:cytarabine
    n1=en:5-ht3 receptor antagonist | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1945. en:7-hydroxystaurosporine --- r_associated #0: 29 --> en:cytarabine
    n1=en:7-hydroxystaurosporine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1946. en:[18f]-labeled substance p antagonist receptor quantifier --- r_associated #0: 29 --> en:cytarabine
    n1=en:[18f]-labeled substance p antagonist receptor quantifier | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1947. en:aaabc protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:aaabc protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1948. en:abcdv protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:abcdv protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1949. en:abr-217620 --- r_associated #0: 29 --> en:cytarabine
    n1=en:abr-217620 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1950. en:activin type 2b receptor fc fusion protein stm 434 --- r_associated #0: 29 --> en:cytarabine
    n1=en:activin type 2b receptor fc fusion protein stm 434 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1951. en:adecatumumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:adecatumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1952. en:adh-1 --- r_associated #0: 29 --> en:cytarabine
    n1=en:adh-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1953. en:afc regimen --- r_associated #0: 29 --> en:cytarabine
    n1=en:afc regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1954. en:afp gene hepatocellular carcinoma vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:afp gene hepatocellular carcinoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1955. en:afp464 --- r_associated #0: 29 --> en:cytarabine
    n1=en:afp464 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1956. en:afuresertib --- r_associated #0: 29 --> en:cytarabine
    n1=en:afuresertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1957. en:agonists --- r_associated #0: 29 --> en:cytarabine
    n1=en:agonists | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1958. en:aieop 8802 standard-risk all protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:aieop 8802 standard-risk all protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1959. en:alefacept --- r_associated #0: 29 --> en:cytarabine
    n1=en:alefacept | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1960. en:alfuzosin hydrochloride --- r_associated #0: 29 --> en:cytarabine
    n1=en:alfuzosin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1961. en:allodepleted haploidentical t cells-expressing inducible caspase 9 --- r_associated #0: 29 --> en:cytarabine
    n1=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1962. en:allogeneic tumor cell vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:allogeneic tumor cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1963. en:allosteric bcr-abl tyrosine kinase inhibitor abl001 --- r_associated #0: 29 --> en:cytarabine
    n1=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1964. en:aloe vera gel --- r_associated #0: 29 --> en:cytarabine
    n1=en:aloe vera gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1965. en:alpha-lipoic acid-palladium/vitamin/mineral supplement --- r_associated #0: 29 --> en:cytarabine
    n1=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1966. en:alvespimycin hydrochloride --- r_associated #0: 29 --> en:cytarabine
    n1=en:alvespimycin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1967. en:amsilarotene --- r_associated #0: 29 --> en:cytarabine
    n1=en:amsilarotene | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1968. en:anti-ags-8 monoclonal antibody ags-8m4 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-ags-8 monoclonal antibody ags-8m4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1969. en:anti-alk-1 monoclonal antibody pf-03446962 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-alk-1 monoclonal antibody pf-03446962 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1970. en:anti-cd123 monoclonal antibody csl360 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd123 monoclonal antibody csl360 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1971. en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1972. en:anti-cd19 monoclonal antibody mdx-1342 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd19 monoclonal antibody mdx-1342 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1973. en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1974. en:anti-cd30 monoclonal antibody mdx-1401 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd30 monoclonal antibody mdx-1401 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1975. en:anti-cd38 monoclonal antibody mor03087 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd38 monoclonal antibody mor03087 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1976. en:anti-cd70 antibody-drug conjugate sgn-cd70a --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cd70 antibody-drug conjugate sgn-cd70a | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1977. en:anti-cea bite monoclonal antibody amg211 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-cea bite monoclonal antibody amg211 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1978. en:anti-ceacam5 antibody-drug conjugate sar408701 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-ceacam5 antibody-drug conjugate sar408701 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1979. en:anti-csf1r monoclonal antibody imc-cs4 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-csf1r monoclonal antibody imc-cs4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1980. en:anti-denatured collagen monoclonal antibody trc093 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-denatured collagen monoclonal antibody trc093 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1981. en:anti-dkk-1 monoclonal antibody ly2812176 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-dkk-1 monoclonal antibody ly2812176 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1982. en:anti-egfr monoclonal antibody mixture sym004 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-egfr monoclonal antibody mixture sym004 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1983. en:anti-egfr monoclonal antibody sct200 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-egfr monoclonal antibody sct200 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1984. en:anti-egfrviii antibody drug conjugate amg 595 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-egfrviii antibody drug conjugate amg 595 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1985. en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1986. en:anti-fucosyl-gm1 monoclonal antibody bms-986012 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-fucosyl-gm1 monoclonal antibody bms-986012 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1987. en:anti-gitr agonistic monoclonal antibody incagn01876 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-gitr agonistic monoclonal antibody incagn01876 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1988. en:anti-gitr monoclonal antibody mk-4166 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-gitr monoclonal antibody mk-4166 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1989. en:anti-gpa33/cd3 monoclonal antibody mgd007 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-gpa33/cd3 monoclonal antibody mgd007 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1990. en:anti-igf-1r recombinant monoclonal antibody biib022 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-igf-1r recombinant monoclonal antibody biib022 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1991. en:anti-lamp1 antibody-drug conjugate sar428926 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-lamp1 antibody-drug conjugate sar428926 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1992. en:anti-met/egfr monoclonal antibody ly3164530 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-met/egfr monoclonal antibody ly3164530 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1993. en:anti-nucleolin aptamer as1411 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-nucleolin aptamer as1411 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1994. en:anti-pd-1 monoclonal antibody regn2810 --- r_associated #0: 29 --> en:cytarabine
    n1=en:anti-pd-1 monoclonal antibody regn2810 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1995. en:antibody-drug conjugate dfrf4539a --- r_associated #0: 29 --> en:cytarabine
    n1=en:antibody-drug conjugate dfrf4539a | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1996. en:antimetabolite ff-10502 --- r_associated #0: 29 --> en:cytarabine
    n1=en:antimetabolite ff-10502 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1997. en:antiperspirant cream f511 --- r_associated #0: 29 --> en:cytarabine
    n1=en:antiperspirant cream f511 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1998. en:antirheumatic agents --- r_associated #0: 29 --> en:cytarabine
    n1=en:antirheumatic agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  1999. en:apaziquone --- r_associated #0: 29 --> en:cytarabine
    n1=en:apaziquone | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2000. en:apc8015f --- r_associated #0: 29 --> en:cytarabine
    n1=en:apc8015f | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2001. en:apricoxib --- r_associated #0: 29 --> en:cytarabine
    n1=en:apricoxib | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2002. en:ara-cdp-1-s-hexadecyl-2-o-palmitoyl-1-thioglycerol --- r_associated #0: 29 --> en:cytarabine
    n1=en:ara-cdp-1-s-hexadecyl-2-o-palmitoyl-1-thioglycerol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2003. en:aurora kinase inhibitor amg 900 --- r_associated #0: 29 --> en:cytarabine
    n1=en:aurora kinase inhibitor amg 900 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2004. en:autologous anti-cd19 car-expressing t lymphocytes --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous anti-cd19 car-expressing t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2005. en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2006. en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2007. en:autologous gm-csf-secreting melanoma vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous gm-csf-secreting melanoma vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2008. en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2009. en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2010. en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2011. en:axl inhibitor bgb324 --- r_associated #0: 29 --> en:cytarabine
    n1=en:axl inhibitor bgb324 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2012. en:b-8801 protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:b-8801 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2013. en:beclomethasone dipropionate --- r_associated #0: 29 --> en:cytarabine
    n1=en:beclomethasone dipropionate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2014. en:berubicin hydrochloride --- r_associated #0: 29 --> en:cytarabine
    n1=en:berubicin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2015. en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion --- r_associated #0: 29 --> en:cytarabine
    n1=en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2016. en:bevacizumab-irdye 800cw --- r_associated #0: 29 --> en:cytarabine
    n1=en:bevacizumab-irdye 800cw | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2017. en:bh-ac-dmp protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:bh-ac-dmp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2018. en:bhac-amp protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:bhac-amp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2019. en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2020. en:bispecific antibody mdx-h210 --- r_associated #0: 29 --> en:cytarabine
    n1=en:bispecific antibody mdx-h210 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2021. en:bl22 immunotoxin --- r_associated #0: 29 --> en:cytarabine
    n1=en:bl22 immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2022. en:blueberry powder supplement --- r_associated #0: 29 --> en:cytarabine
    n1=en:blueberry powder supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2023. en:br96-doxorubicin immunoconjugate --- r_associated #0: 29 --> en:cytarabine
    n1=en:br96-doxorubicin immunoconjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2024. en:braf inhibitor arq 736 --- r_associated #0: 29 --> en:cytarabine
    n1=en:braf inhibitor arq 736 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2025. en:braf(v600e) kinase inhibitor ro5212054 --- r_associated #0: 29 --> en:cytarabine
    n1=en:braf(v600e) kinase inhibitor ro5212054 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2026. en:brivudine phosphoramidate --- r_associated #0: 29 --> en:cytarabine
    n1=en:brivudine phosphoramidate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2027. en:bupropion + naltrexone --- r_associated #0: 29 --> en:cytarabine
    n1=en:bupropion + naltrexone | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2028. en:c-met inhibitor mk2461 --- r_associated #0: 29 --> en:cytarabine
    n1=en:c-met inhibitor mk2461 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2029. en:calcipotriene --- r_associated #0: 29 --> en:cytarabine
    n1=en:calcipotriene | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2030. en:camphor + menthol --- r_associated #0: 29 --> en:cytarabine
    n1=en:camphor + menthol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2031. en:camphor / phenol --- r_associated #0: 29 --> en:cytarabine
    n1=en:camphor / phenol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2032. en:carbinoxamine, dextromethorphan, pseudoephedrine drug combination --- r_associated #0: 29 --> en:cytarabine
    n1=en:carbinoxamine, dextromethorphan, pseudoephedrine drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2033. en:carboxymethyl-beta-glucan-cytarabine --- r_associated #0: 29 --> en:cytarabine
    n1=en:carboxymethyl-beta-glucan-cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2034. en:carcinoembryonic antigen rna-pulsed dc cancer vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2035. en:cationic liposome-encapsulated paclitaxel --- r_associated #0: 29 --> en:cytarabine
    n1=en:cationic liposome-encapsulated paclitaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2036. en:cdk inhibitor sns-032 --- r_associated #0: 29 --> en:cytarabine
    n1=en:cdk inhibitor sns-032 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2037. en:cdk4 inhibitor p1446a-05 --- r_associated #0: 29 --> en:cytarabine
    n1=en:cdk4 inhibitor p1446a-05 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2038. en:cetylpyridinium chloride anhydrous --- r_associated #0: 29 --> en:cytarabine
    n1=en:cetylpyridinium chloride anhydrous | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2039. en:chloroquinoxaline sulfonamide --- r_associated #0: 29 --> en:cytarabine
    n1=en:chloroquinoxaline sulfonamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2040. en:chloroxylenol / pramoxine --- r_associated #0: 29 --> en:cytarabine
    n1=en:chloroxylenol / pramoxine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2041. en:chlorpheniramine + phenylephrine --- r_associated #0: 29 --> en:cytarabine
    n1=en:chlorpheniramine + phenylephrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2042. en:choleretic agent --- r_associated #0: 29 --> en:cytarabine
    n1=en:choleretic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2043. en:chp-her-2 peptide vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:chp-her-2 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2044. en:cngrc peptide-tnf alpha conjugate --- r_associated #0: 29 --> en:cytarabine
    n1=en:cngrc peptide-tnf alpha conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2045. en:cobimetinib --- r_associated #0: 29 --> en:cytarabine
    n1=en:cobimetinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2046. en:cobiprostone --- r_associated #0: 29 --> en:cytarabine
    n1=en:cobiprostone | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2047. en:coccidioides immitis antigen --- r_associated #0: 29 --> en:cytarabine
    n1=en:coccidioides immitis antigen | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2048. en:complement c5 inhibitor alxn1210 --- r_associated #0: 29 --> en:cytarabine
    n1=en:complement c5 inhibitor alxn1210 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2049. en:coriolus versicolor extract --- r_associated #0: 29 --> en:cytarabine
    n1=en:coriolus versicolor extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2050. en:cp-609,754 --- r_associated #0: 29 --> en:cytarabine
    n1=en:cp-609,754 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2051. en:cpg-28 oligodeoxynucleotide --- r_associated #0: 29 --> en:cytarabine
    n1=en:cpg-28 oligodeoxynucleotide | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2052. en:crenolanib besylate --- r_associated #0: 29 --> en:cytarabine
    n1=en:crenolanib besylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2053. en:cyclic ara-cmp --- r_associated #0: 29 --> en:cytarabine
    n1=en:cyclic ara-cmp | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2054. en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2055. en:cytarabine 20 mg/ml injectable solution [cytosar] --- r_associated #0: 29 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml injectable solution [cytosar] | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2056. en:cytarabine-daunorubicin-etoposide regimen --- r_associated #0: 29 --> en:cytarabine
    n1=en:cytarabine-daunorubicin-etoposide regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2057. en:cytomegalovirus pp65-specific cytotoxic t lymphocytes --- r_associated #0: 29 --> en:cytarabine
    n1=en:cytomegalovirus pp65-specific cytotoxic t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2058. en:dam regimen --- r_associated #0: 29 --> en:cytarabine
    n1=en:dam regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2059. en:daniquidone --- r_associated #0: 29 --> en:cytarabine
    n1=en:daniquidone | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2060. en:dcter regimen --- r_associated #0: 29 --> en:cytarabine
    n1=en:dcter regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2061. en:dehydrated human amnion/chorion membrane --- r_associated #0: 29 --> en:cytarabine
    n1=en:dehydrated human amnion/chorion membrane | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2062. en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2063. en:desmopressin acetate --- r_associated #0: 29 --> en:cytarabine
    n1=en:desmopressin acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2064. en:dezaguanine --- r_associated #0: 29 --> en:cytarabine
    n1=en:dezaguanine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2065. en:di-leu16-il2 immunocytokine --- r_associated #0: 29 --> en:cytarabine
    n1=en:di-leu16-il2 immunocytokine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2066. en:dm4-conjugated anti-cripto monoclonal antibody biib015 --- r_associated #0: 29 --> en:cytarabine
    n1=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2067. en:docetaxel-loaded nanopharmaceutical crlx301 --- r_associated #0: 29 --> en:cytarabine
    n1=en:docetaxel-loaded nanopharmaceutical crlx301 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2068. en:dual igf-1r/insr inhibitor bms-754807 --- r_associated #0: 29 --> en:cytarabine
    n1=en:dual igf-1r/insr inhibitor bms-754807 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2069. en:dual pi3 kinase/mtor inhibitor gdc-0980 --- r_associated #0: 29 --> en:cytarabine
    n1=en:dual pi3 kinase/mtor inhibitor gdc-0980 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2070. en:dulanermin --- r_associated #0: 29 --> en:cytarabine
    n1=en:dulanermin | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2071. en:dutasteride --- r_associated #0: 29 --> en:cytarabine
    n1=en:dutasteride | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2072. en:e1m184v peptide vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:e1m184v peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2073. en:eg5 kinesin-related motor protein inhibitor arq 621 --- r_associated #0: 29 --> en:cytarabine
    n1=en:eg5 kinesin-related motor protein inhibitor arq 621 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2074. en:egfr antisense dna --- r_associated #0: 29 --> en:cytarabine
    n1=en:egfr antisense dna | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2075. en:egfr inhibitor abt-414 --- r_associated #0: 29 --> en:cytarabine
    n1=en:egfr inhibitor abt-414 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2076. en:elinafide --- r_associated #0: 29 --> en:cytarabine
    n1=en:elinafide | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2077. en:entinostat --- r_associated #0: 29 --> en:cytarabine
    n1=en:entinostat | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2078. en:eortc gimema aml-13 protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:eortc gimema aml-13 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2079. en:epratuzumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:epratuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2080. en:erastin analogue prlx 93936 --- r_associated #0: 29 --> en:cytarabine
    n1=en:erastin analogue prlx 93936 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2081. en:ex vivo-expanded her2-specific t cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:ex vivo-expanded her2-specific t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2082. en:factor viia inhibitor pci-27483 --- r_associated #0: 29 --> en:cytarabine
    n1=en:factor viia inhibitor pci-27483 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2083. en:fak inhibitor vs-4718 --- r_associated #0: 29 --> en:cytarabine
    n1=en:fak inhibitor vs-4718 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2084. en:fgfr inhibitor tas-120 --- r_associated #0: 29 --> en:cytarabine
    n1=en:fgfr inhibitor tas-120 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2085. en:fiacitabine --- r_associated #0: 29 --> en:cytarabine
    n1=en:fiacitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2086. en:filgrastim-primed peripheral blood progenitor cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:filgrastim-primed peripheral blood progenitor cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2087. en:fluorine f 18 sodium fluoride --- r_associated #0: 29 --> en:cytarabine
    n1=en:fluorine f 18 sodium fluoride | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2088. en:folic acid + pyridoxine + cyanocobalamin --- r_associated #0: 29 --> en:cytarabine
    n1=en:folic acid + pyridoxine + cyanocobalamin | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2089. en:gallium ga 68 ops202 --- r_associated #0: 29 --> en:cytarabine
    n1=en:gallium ga 68 ops202 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2090. en:gallium ga 68-labeled psma-11 --- r_associated #0: 29 --> en:cytarabine
    n1=en:gallium ga 68-labeled psma-11 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2091. en:ganglioside gd2 --- r_associated #0: 29 --> en:cytarabine
    n1=en:ganglioside gd2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2092. en:ganitumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:ganitumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2093. en:gemia protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:gemia protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2094. en:hcvad protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:hcvad protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2095. en:high-selenium baker's yeast --- r_associated #0: 29 --> en:cytarabine
    n1=en:high-selenium baker's yeast | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2096. en:honey --- r_associated #0: 29 --> en:cytarabine
    n1=en:honey | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2097. en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin --- r_associated #0: 29 --> en:cytarabine
    n1=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2098. en:hr-1 protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:hr-1 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2099. en:hr-3 protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:hr-3 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2100. en:htert vaccine v934/v935 --- r_associated #0: 29 --> en:cytarabine
    n1=en:htert vaccine v934/v935 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2101. en:hyperpolarized carbon c 13 pyruvate --- r_associated #0: 29 --> en:cytarabine
    n1=en:hyperpolarized carbon c 13 pyruvate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2102. en:ido inhibitor nlg919 --- r_associated #0: 29 --> en:cytarabine
    n1=en:ido inhibitor nlg919 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2103. en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2104. en:ilx-295501 --- r_associated #0: 29 --> en:cytarabine
    n1=en:ilx-295501 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2105. en:in 111 monoclonal antibody lym-1 --- r_associated #0: 29 --> en:cytarabine
    n1=en:in 111 monoclonal antibody lym-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2106. en:iodine i-125 --- r_associated #0: 29 --> en:cytarabine
    n1=en:iodine i-125 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2107. en:ipatasertib --- r_associated #0: 29 --> en:cytarabine
    n1=en:ipatasertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2108. en:iratumumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:iratumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2109. en:iron sucrose injection --- r_associated #0: 29 --> en:cytarabine
    n1=en:iron sucrose injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2110. en:jak inhibitor incb047986 --- r_associated #0: 29 --> en:cytarabine
    n1=en:jak inhibitor incb047986 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2111. en:jak1 inhibitor incb052793 --- r_associated #0: 29 --> en:cytarabine
    n1=en:jak1 inhibitor incb052793 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2112. en:l-lysine --- r_associated #0: 29 --> en:cytarabine
    n1=en:l-lysine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2113. en:laetrile --- r_associated #0: 29 --> en:cytarabine
    n1=en:laetrile | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2114. en:lanreotide acetate --- r_associated #0: 29 --> en:cytarabine
    n1=en:lanreotide acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2115. en:laronidase --- r_associated #0: 29 --> en:cytarabine
    n1=en:laronidase | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2116. en:leridistim --- r_associated #0: 29 --> en:cytarabine
    n1=en:leridistim | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2117. en:leukemic apoptotic corpse-pulsed autologous dendritic cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:leukemic apoptotic corpse-pulsed autologous dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2118. en:lirilumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:lirilumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2119. en:live attenuated measles virus vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:live attenuated measles virus vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2120. en:live freeze-dried lactic acid bacteria probiotic --- r_associated #0: 29 --> en:cytarabine
    n1=en:live freeze-dried lactic acid bacteria probiotic | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2121. en:lutetium lu 177 monoclonal antibody cc49 --- r_associated #0: 29 --> en:cytarabine
    n1=en:lutetium lu 177 monoclonal antibody cc49 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2122. en:ly6k/vegfr1/vegfr2 multipeptide vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:ly6k/vegfr1/vegfr2 multipeptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2123. en:lymphokine-activated killer cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:lymphokine-activated killer cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2124. en:lyophilized black raspberry lozenge --- r_associated #0: 29 --> en:cytarabine
    n1=en:lyophilized black raspberry lozenge | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2125. en:mad protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:mad protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2126. en:mage-a3 reactive t cell receptor-transduced autologous t cells --- r_associated #0: 29 --> en:cytarabine
    n1=en:mage-a3 reactive t cell receptor-transduced autologous t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2127. en:manuka honey --- r_associated #0: 29 --> en:cytarabine
    n1=en:manuka honey | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2128. en:mart-1:26-35(27l) peptide vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:mart-1:26-35(27l) peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2129. en:mesna --- r_associated #0: 29 --> en:cytarabine
    n1=en:mesna | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2130. en:met tyrosine kinase inhibitor bms-777607 --- r_associated #0: 29 --> en:cytarabine
    n1=en:met tyrosine kinase inhibitor bms-777607 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2131. en:monoclonal antibody agent --- r_associated #0: 29 --> en:cytarabine
    n1=en:monoclonal antibody agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2132. en:mouth off to [sb] --- r_associated #0: 29 --> en:cytarabine
    n1=en:mouth off to [sb] | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2133. en:mps1 kinase inhibitor bay1161909 --- r_associated #0: 29 --> en:cytarabine
    n1=en:mps1 kinase inhibitor bay1161909 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2134. en:multitargeted tyrosine kinase inhibitor jnj-26483327 --- r_associated #0: 29 --> en:cytarabine
    n1=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2135. en:muscle relaxant --- r_associated #0: 29 --> en:cytarabine
    n1=en:muscle relaxant | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2136. en:n(4)-chloroacetylcytosine arabinoside --- r_associated #0: 29 --> en:cytarabine
    n1=en:n(4)-chloroacetylcytosine arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2137. en:n(4)-palmitoyl cytarabine --- r_associated #0: 29 --> en:cytarabine
    n1=en:n(4)-palmitoyl cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2138. en:n-methylformamide --- r_associated #0: 29 --> en:cytarabine
    n1=en:n-methylformamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2139. en:new york protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:new york protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2140. en:nutritional supplement drink --- r_associated #0: 29 --> en:cytarabine
    n1=en:nutritional supplement drink | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2141. en:oppa regimen --- r_associated #0: 29 --> en:cytarabine
    n1=en:oppa regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2142. en:oral sodium phenylbutyrate --- r_associated #0: 29 --> en:cytarabine
    n1=en:oral sodium phenylbutyrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2143. en:oseltamivir phosphate --- r_associated #0: 29 --> en:cytarabine
    n1=en:oseltamivir phosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2144. en:over the counter product --- r_associated #0: 29 --> en:cytarabine
    n1=en:over the counter product | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2145. en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet --- r_associated #0: 29 --> en:cytarabine
    n1=en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2146. en:paracetamol --- r_associated #0: 29 --> en:cytarabine
    n1=en:paracetamol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2147. en:parvovirus h-1 --- r_associated #0: 29 --> en:cytarabine
    n1=en:parvovirus h-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2148. en:peptide hydrolases --- r_associated #0: 29 --> en:cytarabine
    n1=en:peptide hydrolases | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2149. en:phenethyl isothiocyanate-containing watercress juice --- r_associated #0: 29 --> en:cytarabine
    n1=en:phenethyl isothiocyanate-containing watercress juice | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2150. en:phentolamine mesylate --- r_associated #0: 29 --> en:cytarabine
    n1=en:phentolamine mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2151. en:pi3k inhibitor ch5132799 --- r_associated #0: 29 --> en:cytarabine
    n1=en:pi3k inhibitor ch5132799 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2152. en:pi3k inhibitor zstk474 --- r_associated #0: 29 --> en:cytarabine
    n1=en:pi3k inhibitor zstk474 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2153. en:pi3k/mtor kinase inhibitor ds-7423 --- r_associated #0: 29 --> en:cytarabine
    n1=en:pi3k/mtor kinase inhibitor ds-7423 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2154. en:pnp-expressing ovine atadenovirus fp253 --- r_associated #0: 29 --> en:cytarabine
    n1=en:pnp-expressing ovine atadenovirus fp253 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2155. en:polo-like kinase 1 inhibitor nms-1286937 --- r_associated #0: 29 --> en:cytarabine
    n1=en:polo-like kinase 1 inhibitor nms-1286937 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2156. en:polyethylene glycol polymer surgical sealant --- r_associated #0: 29 --> en:cytarabine
    n1=en:polyethylene glycol polymer surgical sealant | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2157. en:polygalacturonic acid-cytarabine --- r_associated #0: 29 --> en:cytarabine
    n1=en:polygalacturonic acid-cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2158. en:polyvinylpyrrolidone-sodium hyaluronate gel --- r_associated #0: 29 --> en:cytarabine
    n1=en:polyvinylpyrrolidone-sodium hyaluronate gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2159. en:poziotinib --- r_associated #0: 29 --> en:cytarabine
    n1=en:poziotinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2160. en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 --- r_associated #0: 29 --> en:cytarabine
    n1=en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2161. en:prescription drugs --- r_associated #0: 29 --> en:cytarabine
    n1=en:prescription drugs | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2162. en:prima-1 analog apr-246 --- r_associated #0: 29 --> en:cytarabine
    n1=en:prima-1 analog apr-246 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2163. en:prohibitin-targeting peptide 1 --- r_associated #0: 29 --> en:cytarabine
    n1=en:prohibitin-targeting peptide 1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2164. en:rar-alpha agonist vtp195183 --- r_associated #0: 29 --> en:cytarabine
    n1=en:rar-alpha agonist vtp195183 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2165. en:recombinant human chorionic gonadotropin --- r_associated #0: 29 --> en:cytarabine
    n1=en:recombinant human chorionic gonadotropin | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2166. en:recombinant human serum amyloid p/pentraxin 2 --- r_associated #0: 29 --> en:cytarabine
    n1=en:recombinant human serum amyloid p/pentraxin 2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2167. en:refills prescribed:num:pt:medication:qn --- r_associated #0: 29 --> en:cytarabine
    n1=en:refills prescribed:num:pt:medication:qn | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2168. en:respond to --- r_associated #0: 29 --> en:cytarabine
    n1=en:respond to | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2169. en:rhenium re-186 hydroxyethylidene diphosphonate --- r_associated #0: 29 --> en:cytarabine
    n1=en:rhenium re-186 hydroxyethylidene diphosphonate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2170. en:sonepcizumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:sonepcizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2171. en:sorafenib tosylate --- r_associated #0: 29 --> en:cytarabine
    n1=en:sorafenib tosylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2172. en:squalamine lactate --- r_associated #0: 29 --> en:cytarabine
    n1=en:squalamine lactate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2173. en:sunitinib malate --- r_associated #0: 29 --> en:cytarabine
    n1=en:sunitinib malate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2174. en:tenofovir disoproxil fumarate --- r_associated #0: 29 --> en:cytarabine
    n1=en:tenofovir disoproxil fumarate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2175. en:teprotumumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:teprotumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2176. en:tgap protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:tgap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2177. en:therapeutic angiotensin-(1-7) --- r_associated #0: 29 --> en:cytarabine
    n1=en:therapeutic angiotensin-(1-7) | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2178. en:toap protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:toap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2179. en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 --- r_associated #0: 29 --> en:cytarabine
    n1=en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2180. en:trk inhibitor azd6918 --- r_associated #0: 29 --> en:cytarabine
    n1=en:trk inhibitor azd6918 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2181. en:v930 vaccine --- r_associated #0: 29 --> en:cytarabine
    n1=en:v930 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2182. en:vac combination --- r_associated #0: 29 --> en:cytarabine
    n1=en:vac combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2183. en:vapa protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:vapa protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2184. en:vata protocol --- r_associated #0: 29 --> en:cytarabine
    n1=en:vata protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2185. en:veltuzumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:veltuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2186. en:visilizumab --- r_associated #0: 29 --> en:cytarabine
    n1=en:visilizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2187. en:vistusertib --- r_associated #0: 29 --> en:cytarabine
    n1=en:vistusertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2188. en:vitamin e compound --- r_associated #0: 29 --> en:cytarabine
    n1=en:vitamin e compound | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2189. en:whey protein isolate --- r_associated #0: 29 --> en:cytarabine
    n1=en:whey protein isolate | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2190. en:ym598 --- r_associated #0: 29 --> en:cytarabine
    n1=en:ym598 | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2191. mesna --- r_associated #0: 29 --> en:cytarabine
    n1=mesna | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2192. patch de nicotine --- r_associated #0: 29 --> en:cytarabine
    n1=patch de nicotine | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2193. sel d'epsom --- r_associated #0: 29 --> en:cytarabine
    n1=sel d'epsom | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2194. timbre anti-tabac --- r_associated #0: 29 --> en:cytarabine
    n1=timbre anti-tabac | n2=en:cytarabine | rel=r_associated | relid=0 | w=29
  2195. capécitabine --- r_associated #0: 28 --> en:cytarabine
    n1=capécitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2196. en:(18f)1-(2'-deoxy-2'-arabinofuranosyl)cytosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:(18f)1-(2'-deoxy-2'-arabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2197. en:1(beta)-arabinofuranosylcytosine 5'-diphosphate-1,2-distearin --- r_associated #0: 28 --> en:cytarabine
    n1=en:1(beta)-arabinofuranosylcytosine 5'-diphosphate-1,2-distearin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2198. en:1-arabinofuranosyl-5-ethynylcytosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:1-arabinofuranosyl-5-ethynylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2199. en:1-beta-4-selenoarabinofuranosyl cytosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:1-beta-4-selenoarabinofuranosyl cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2200. en:2'-deoxy-2'-fluoro-4'-selenoarabinofuranosylcytosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:2'-deoxy-2'-fluoro-4'-selenoarabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2201. en:2'-fluoro-5-methylarabino-furanosylcytosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:2'-fluoro-5-methylarabino-furanosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2202. en:2-methoxyestradiol nanocrystal colloidal dispersion --- r_associated #0: 28 --> en:cytarabine
    n1=en:2-methoxyestradiol nanocrystal colloidal dispersion | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2203. en:5'-chloro-5'-deoxyarabinosylcytosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:5'-chloro-5'-deoxyarabinosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2204. en:5-fluoro-2'-deoxyuridylyl-(3'-5')-arabinocytidine --- r_associated #0: 28 --> en:cytarabine
    n1=en:5-fluoro-2'-deoxyuridylyl-(3'-5')-arabinocytidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2205. en:abexinostat --- r_associated #0: 28 --> en:cytarabine
    n1=en:abexinostat | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2206. en:absorbable adhesion barrier gel --- r_associated #0: 28 --> en:cytarabine
    n1=en:absorbable adhesion barrier gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2207. en:acai berry juice --- r_associated #0: 28 --> en:cytarabine
    n1=en:acai berry juice | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2208. en:acyclovir sodium --- r_associated #0: 28 --> en:cytarabine
    n1=en:acyclovir sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2209. en:ad-hcmv-flt3l --- r_associated #0: 28 --> en:cytarabine
    n1=en:ad-hcmv-flt3l | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2210. en:ad-isf35 --- r_associated #0: 28 --> en:cytarabine
    n1=en:ad-isf35 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2211. en:adenosine a2a receptor antagonist pbf-509 --- r_associated #0: 28 --> en:cytarabine
    n1=en:adenosine a2a receptor antagonist pbf-509 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2212. en:adgmcaix-transduced autologous dendritic cells --- r_associated #0: 28 --> en:cytarabine
    n1=en:adgmcaix-transduced autologous dendritic cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2213. en:ae37 peptide/gm-csf vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:ae37 peptide/gm-csf vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2214. en:afatinib dimaleate --- r_associated #0: 28 --> en:cytarabine
    n1=en:afatinib dimaleate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2215. en:aieop acute lymphoblastic leukemia protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:aieop acute lymphoblastic leukemia protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2216. en:ak 3012 --- r_associated #0: 28 --> en:cytarabine
    n1=en:ak 3012 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2217. en:akt inhibitor mk2206 --- r_associated #0: 28 --> en:cytarabine
    n1=en:akt inhibitor mk2206 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2218. en:aldoxorubicin --- r_associated #0: 28 --> en:cytarabine
    n1=en:aldoxorubicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2219. en:algenpantucel-l --- r_associated #0: 28 --> en:cytarabine
    n1=en:algenpantucel-l | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2220. en:allogeneic cmv/adv-specific cytotoxic t lymphocytes --- r_associated #0: 28 --> en:cytarabine
    n1=en:allogeneic cmv/adv-specific cytotoxic t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2221. en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes --- r_associated #0: 28 --> en:cytarabine
    n1=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2222. en:alpha fetoprotein adenoviral vector vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:alpha fetoprotein adenoviral vector vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2223. en:aminocaproic acid --- r_associated #0: 28 --> en:cytarabine
    n1=en:aminocaproic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2224. en:aml-bfm-87 --- r_associated #0: 28 --> en:cytarabine
    n1=en:aml-bfm-87 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2225. en:aml92 protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:aml92 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2226. en:amnion-derived cellular cytokine solution --- r_associated #0: 28 --> en:cytarabine
    n1=en:amnion-derived cellular cytokine solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2227. en:amphotericin b deoxycholate --- r_associated #0: 28 --> en:cytarabine
    n1=en:amphotericin b deoxycholate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2228. en:amuvatinib --- r_associated #0: 28 --> en:cytarabine
    n1=en:amuvatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2229. en:answer [sb] back --- r_associated #0: 28 --> en:cytarabine
    n1=en:answer [sb] back | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2230. en:anti c-kit antibody-drug conjugate lop628 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti c-kit antibody-drug conjugate lop628 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2231. en:anti-c-met monoclonal antibody argx-111 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-c-met monoclonal antibody argx-111 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2232. en:anti-c-met monoclonal antibody ly2875358 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-c-met monoclonal antibody ly2875358 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2233. en:anti-ca19-9 monoclonal antibody 5b1 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-ca19-9 monoclonal antibody 5b1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2234. en:anti-cd19 monoclonal antibody xmab5574 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd19 monoclonal antibody xmab5574 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2235. en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2236. en:anti-cd200 monoclonal antibody alxn6000 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd200 monoclonal antibody alxn6000 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2237. en:anti-cd22 car-expressing t lymphocytes --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd22 car-expressing t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2238. en:anti-cd47 monoclonal antibody cc-90002 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd47 monoclonal antibody cc-90002 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2239. en:anti-cd47 monoclonal antibody hu5f9-g4 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd47 monoclonal antibody hu5f9-g4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2240. en:anti-cd7 immunotoxin --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cd7 immunotoxin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2241. en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2242. en:anti-dll4 monoclonal antibody medi0639 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-dll4 monoclonal antibody medi0639 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2243. en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2244. en:anti-egfr tap antibody-drug conjugate imgn289 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-egfr tap antibody-drug conjugate imgn289 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2245. en:anti-egfrviii immunotoxin mr1-1 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-egfrviii immunotoxin mr1-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2246. en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2247. en:anti-fgfr2 monoclonal antibody fpa144 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-fgfr2 monoclonal antibody fpa144 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2248. en:anti-ganglioside gm2 monoclonal antibody biw-8962 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2249. en:anti-gnrh vaccine pep223 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-gnrh vaccine pep223 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2250. en:anti-her2 monoclonal antibody ct-p6 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-her2 monoclonal antibody ct-p6 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2251. en:anti-her3 monoclonal antibody gsk2849330 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-her3 monoclonal antibody gsk2849330 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2252. en:anti-human gitr monoclonal antibody trx518 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-human gitr monoclonal antibody trx518 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2253. en:anti-igf-1r monoclonal antibody ave1642 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-igf-1r monoclonal antibody ave1642 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2254. en:anti-lag-3 monoclonal antibody lag525 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-lag-3 monoclonal antibody lag525 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2255. en:anti-muc1 monoclonal antibody bth1704 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-muc1 monoclonal antibody bth1704 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2256. en:anti-napi2b/mmae antibody-drug conjugate dnib0600a --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2257. en:anti-psma/cd3 bite monoclonal antibody mt112 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-psma/cd3 bite monoclonal antibody mt112 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2258. en:anti-tf monoclonal antibody alt-836 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-tf monoclonal antibody alt-836 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2259. en:anti-tim-3 monoclonal antibody mbg453 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-tim-3 monoclonal antibody mbg453 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2260. en:anti-vegfc monoclonal antibody vgx-100 --- r_associated #0: 28 --> en:cytarabine
    n1=en:anti-vegfc monoclonal antibody vgx-100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2261. en:antineoplaston a10 --- r_associated #0: 28 --> en:cytarabine
    n1=en:antineoplaston a10 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2262. en:apomine --- r_associated #0: 28 --> en:cytarabine
    n1=en:apomine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2263. en:asparaginase erwinia chrysanthemi --- r_associated #0: 28 --> en:cytarabine
    n1=en:asparaginase erwinia chrysanthemi | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2264. en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2265. en:autologous dendritic cell-tumor fusion vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous dendritic cell-tumor fusion vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2266. en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2267. en:autologous glioma cell lysate --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous glioma cell lysate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2268. en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2269. en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2270. en:autologous tumor cell vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:autologous tumor cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2271. en:azathioprine sodium --- r_associated #0: 28 --> en:cytarabine
    n1=en:azathioprine sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2272. en:b-triple-v protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:b-triple-v protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2273. en:bcma-specific car-expressing t lymphocytes --- r_associated #0: 28 --> en:cytarabine
    n1=en:bcma-specific car-expressing t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2274. en:beam regimen --- r_associated #0: 28 --> en:cytarabine
    n1=en:beam regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2275. en:benzoylphenylurea --- r_associated #0: 28 --> en:cytarabine
    n1=en:benzoylphenylurea | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2276. en:berberine chloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:berberine chloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2277. en:bet inhibitor cpi-0610 --- r_associated #0: 28 --> en:cytarabine
    n1=en:bet inhibitor cpi-0610 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2278. en:bfm-78 --- r_associated #0: 28 --> en:cytarabine
    n1=en:bfm-78 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2279. en:biomed 101 --- r_associated #0: 28 --> en:cytarabine
    n1=en:biomed 101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2280. en:bivalent hpv16/18 therapeutic cervical cancer vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:bivalent hpv16/18 therapeutic cervical cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2281. en:bmf phase ii protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:bmf phase ii protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2282. en:bms-188797 --- r_associated #0: 28 --> en:cytarabine
    n1=en:bms-188797 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2283. en:bms-275183 --- r_associated #0: 28 --> en:cytarabine
    n1=en:bms-275183 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2284. en:botulinum toxin type a --- r_associated #0: 28 --> en:cytarabine
    n1=en:botulinum toxin type a | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2285. en:brassica vegetable --- r_associated #0: 28 --> en:cytarabine
    n1=en:brassica vegetable | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2286. en:brequinar sodium --- r_associated #0: 28 --> en:cytarabine
    n1=en:brequinar sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2287. en:bromocriptine mesylate --- r_associated #0: 28 --> en:cytarabine
    n1=en:bromocriptine mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2288. en:buparlisib --- r_associated #0: 28 --> en:cytarabine
    n1=en:buparlisib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2289. en:bvam protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:bvam protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2290. en:caffeine/cisplatin/cytarabine --- r_associated #0: 28 --> en:cytarabine
    n1=en:caffeine/cisplatin/cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2291. en:cag protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:cag protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2292. en:calcium-46 chloride aqueous solution --- r_associated #0: 28 --> en:cytarabine
    n1=en:calcium-46 chloride aqueous solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2293. en:carbon c 11 choline --- r_associated #0: 28 --> en:cytarabine
    n1=en:carbon c 11 choline | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2294. en:carbon c 11 n-desmethyl-loperamide --- r_associated #0: 28 --> en:cytarabine
    n1=en:carbon c 11 n-desmethyl-loperamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2295. en:carbon c 14 lenvatinib mesylate --- r_associated #0: 28 --> en:cytarabine
    n1=en:carbon c 14 lenvatinib mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2296. en:carbon c 14 telotristat etiprate --- r_associated #0: 28 --> en:cytarabine
    n1=en:carbon c 14 telotristat etiprate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2297. en:carcinoembryonic antigen-expressing measles virus --- r_associated #0: 28 --> en:cytarabine
    n1=en:carcinoembryonic antigen-expressing measles virus | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2298. en:carmofur --- r_associated #0: 28 --> en:cytarabine
    n1=en:carmofur | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2299. en:caseinate protein isolate --- r_associated #0: 28 --> en:cytarabine
    n1=en:caseinate protein isolate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2300. en:cbp/beta-catenin antagonist pri-724 --- r_associated #0: 28 --> en:cytarabine
    n1=en:cbp/beta-catenin antagonist pri-724 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2301. en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2302. en:cd40 agonist monoclonal antibody ro7009789 --- r_associated #0: 28 --> en:cytarabine
    n1=en:cd40 agonist monoclonal antibody ro7009789 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2303. en:cemadotin hydrochloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:cemadotin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2304. en:cfms tyrosine kinase inhibitor arry-382 --- r_associated #0: 28 --> en:cytarabine
    n1=en:cfms tyrosine kinase inhibitor arry-382 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2305. en:chlorothiazide + methyldopa --- r_associated #0: 28 --> en:cytarabine
    n1=en:chlorothiazide + methyldopa | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2306. en:cirmtuzumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:cirmtuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2307. en:cis-urocanic acid --- r_associated #0: 28 --> en:cytarabine
    n1=en:cis-urocanic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2308. en:clevudine --- r_associated #0: 28 --> en:cytarabine
    n1=en:clevudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2309. en:coffee dietary supplement --- r_associated #0: 28 --> en:cytarabine
    n1=en:coffee dietary supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2310. en:compound sodium lactate solution --- r_associated #0: 28 --> en:cytarabine
    n1=en:compound sodium lactate solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2311. en:conatumumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:conatumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2312. en:copp regimen --- r_associated #0: 28 --> en:cytarabine
    n1=en:copp regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2313. en:crenolanib --- r_associated #0: 28 --> en:cytarabine
    n1=en:crenolanib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2314. en:ctp-37-dt vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:ctp-37-dt vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2315. en:cxcr4 antagonist bl-8040 --- r_associated #0: 28 --> en:cytarabine
    n1=en:cxcr4 antagonist bl-8040 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2316. en:cxcr4 inhibitor x4p-001 --- r_associated #0: 28 --> en:cytarabine
    n1=en:cxcr4 inhibitor x4p-001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2317. en:cytosine arabinoside --- r_associated #0: 28 --> en:cytarabine
    n1=en:cytosine arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2318. en:dab389 epidermal growth factor --- r_associated #0: 28 --> en:cytarabine
    n1=en:dab389 epidermal growth factor | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2319. en:dacetuzumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:dacetuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2320. en:dae protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:dae protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2321. en:darbepoetin alfa --- r_associated #0: 28 --> en:cytarabine
    n1=en:darbepoetin alfa | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2322. en:dat i --- r_associated #0: 28 --> en:cytarabine
    n1=en:dat i | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2323. en:daunorubicin hydrochloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:daunorubicin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2324. en:dha-paclitaxel --- r_associated #0: 28 --> en:cytarabine
    n1=en:dha-paclitaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2325. en:dhact protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:dhact protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2326. en:dher2 vaccine+as15 adjuvant --- r_associated #0: 28 --> en:cytarabine
    n1=en:dher2 vaccine+as15 adjuvant | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2327. en:doconexent --- r_associated #0: 28 --> en:cytarabine
    n1=en:doconexent | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2328. en:dotap:cholesterol-fus1 liposome complex --- r_associated #0: 28 --> en:cytarabine
    n1=en:dotap:cholesterol-fus1 liposome complex | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2329. en:doxorubicin-hpma conjugate --- r_associated #0: 28 --> en:cytarabine
    n1=en:doxorubicin-hpma conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2330. en:e1a lipid complex --- r_associated #0: 28 --> en:cytarabine
    n1=en:e1a lipid complex | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2331. en:edelfosine --- r_associated #0: 28 --> en:cytarabine
    n1=en:edelfosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2332. en:edetate calcium disodium --- r_associated #0: 28 --> en:cytarabine
    n1=en:edetate calcium disodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2333. en:edotecarin --- r_associated #0: 28 --> en:cytarabine
    n1=en:edotecarin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2334. en:eg5 kinesin-related motor protein inhibitor 4sc-205 --- r_associated #0: 28 --> en:cytarabine
    n1=en:eg5 kinesin-related motor protein inhibitor 4sc-205 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2335. en:egfr t790m inhibitor pf-06747775 --- r_associated #0: 28 --> en:cytarabine
    n1=en:egfr t790m inhibitor pf-06747775 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2336. en:elaidic acid-cytarabine --- r_associated #0: 28 --> en:cytarabine
    n1=en:elaidic acid-cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2337. en:elesclomol sodium --- r_associated #0: 28 --> en:cytarabine
    n1=en:elesclomol sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2338. en:enadenotucirev --- r_associated #0: 28 --> en:cytarabine
    n1=en:enadenotucirev | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2339. en:epoetin alfa --- r_associated #0: 28 --> en:cytarabine
    n1=en:epoetin alfa | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2340. en:erk inhibitor ltt462 --- r_associated #0: 28 --> en:cytarabine
    n1=en:erk inhibitor ltt462 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2341. en:esa protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:esa protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2342. en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 --- r_associated #0: 28 --> en:cytarabine
    n1=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2343. en:fidaxomicin --- r_associated #0: 28 --> en:cytarabine
    n1=en:fidaxomicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2344. en:flam regimen --- r_associated #0: 28 --> en:cytarabine
    n1=en:flam regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2345. en:fludap protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:fludap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2346. en:fluorine f 18 alfatide ii --- r_associated #0: 28 --> en:cytarabine
    n1=en:fluorine f 18 alfatide ii | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2347. en:fluorine f 18 feqa --- r_associated #0: 28 --> en:cytarabine
    n1=en:fluorine f 18 feqa | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2348. en:fluoro-uracile --- r_associated #0: 28 --> en:cytarabine
    n1=en:fluoro-uracile | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2349. en:fluoropyrimidine --- r_associated #0: 28 --> en:cytarabine
    n1=en:fluoropyrimidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2350. en:folate binding protein j65 peptide vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:folate binding protein j65 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2351. en:fulvestrant --- r_associated #0: 28 --> en:cytarabine
    n1=en:fulvestrant | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2352. en:galocitabine --- r_associated #0: 28 --> en:cytarabine
    n1=en:galocitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2353. en:galunisertib --- r_associated #0: 28 --> en:cytarabine
    n1=en:galunisertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2354. en:garlic extract --- r_associated #0: 28 --> en:cytarabine
    n1=en:garlic extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2355. en:golotimod --- r_associated #0: 28 --> en:cytarabine
    n1=en:golotimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2356. en:gp100-fowlpox vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:gp100-fowlpox vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2357. en:gp100:154-162 peptide vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:gp100:154-162 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2358. en:gusperimus trihydrochloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:gusperimus trihydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2359. en:hdac inhibitor ar-42 --- r_associated #0: 28 --> en:cytarabine
    n1=en:hdac inhibitor ar-42 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2360. en:hdac/egfr/her2 inhibitor cudc-101 --- r_associated #0: 28 --> en:cytarabine
    n1=en:hdac/egfr/her2 inhibitor cudc-101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2361. en:human monoclonal antibody 216 --- r_associated #0: 28 --> en:cytarabine
    n1=en:human monoclonal antibody 216 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2362. en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2363. en:hydralazine hydrochloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:hydralazine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2364. en:iapa-based dendritic cells/cytotoxic t lymphocytes --- r_associated #0: 28 --> en:cytarabine
    n1=en:iapa-based dendritic cells/cytotoxic t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2365. en:ibuprofen injection --- r_associated #0: 28 --> en:cytarabine
    n1=en:ibuprofen injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2366. en:innate immunostimulator rbbx-01 --- r_associated #0: 28 --> en:cytarabine
    n1=en:innate immunostimulator rbbx-01 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2367. en:ins316 --- r_associated #0: 28 --> en:cytarabine
    n1=en:ins316 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2368. en:iodine i 124-crgdy-peg-c dots --- r_associated #0: 28 --> en:cytarabine
    n1=en:iodine i 124-crgdy-peg-c dots | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2369. en:iodine i 131 monoclonal antibody 81c6 --- r_associated #0: 28 --> en:cytarabine
    n1=en:iodine i 131 monoclonal antibody 81c6 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2370. en:iso-fludelone --- r_associated #0: 28 --> en:cytarabine
    n1=en:iso-fludelone | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2371. en:ksp inhibitor arry-520 --- r_associated #0: 28 --> en:cytarabine
    n1=en:ksp inhibitor arry-520 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2372. en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement --- r_associated #0: 28 --> en:cytarabine
    n1=en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2373. en:largetrifoliolious bugbane rhizome supplement --- r_associated #0: 28 --> en:cytarabine
    n1=en:largetrifoliolious bugbane rhizome supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2374. en:levocarnitine --- r_associated #0: 28 --> en:cytarabine
    n1=en:levocarnitine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2375. en:lexatumumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:lexatumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2376. en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes --- r_associated #0: 28 --> en:cytarabine
    n1=en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2377. en:lometrexol --- r_associated #0: 28 --> en:cytarabine
    n1=en:lometrexol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2378. en:lorlatinib --- r_associated #0: 28 --> en:cytarabine
    n1=en:lorlatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2379. en:lsa(2)l(2) protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:lsa(2)l(2) protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2380. en:lutetium lu 177 dota-biotin --- r_associated #0: 28 --> en:cytarabine
    n1=en:lutetium lu 177 dota-biotin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2381. en:lutetium lu 177 dota-jr11 --- r_associated #0: 28 --> en:cytarabine
    n1=en:lutetium lu 177 dota-jr11 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2382. en:masoprocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:masoprocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2383. en:mb-triple v protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:mb-triple v protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2384. en:mcl-1 inhibitor amg 176 --- r_associated #0: 28 --> en:cytarabine
    n1=en:mcl-1 inhibitor amg 176 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2385. en:mct/lct/fish oil omega-3 fatty acid lipid emulsion --- r_associated #0: 28 --> en:cytarabine
    n1=en:mct/lct/fish oil omega-3 fatty acid lipid emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2386. en:meca protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:meca protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2387. en:medical marijuana --- r_associated #0: 28 --> en:cytarabine
    n1=en:medical marijuana | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2388. en:miracle mouthwash plus hydrocortisone --- r_associated #0: 28 --> en:cytarabine
    n1=en:miracle mouthwash plus hydrocortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2389. en:monkey wrench --- r_associated #0: 28 --> en:cytarabine
    n1=en:monkey wrench | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2390. en:monoclonal antibody cd19 --- r_associated #0: 28 --> en:cytarabine
    n1=en:monoclonal antibody cd19 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2391. en:monoclonal antibody cep-37250/khk2804 --- r_associated #0: 28 --> en:cytarabine
    n1=en:monoclonal antibody cep-37250/khk2804 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2392. en:monoclonal antibody hupam4 --- r_associated #0: 28 --> en:cytarabine
    n1=en:monoclonal antibody hupam4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2393. en:moplace protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:moplace protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2394. en:muc1 peptide-poly-iclc adjuvant vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:muc1 peptide-poly-iclc adjuvant vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2395. en:multifunctional/multitargeted anticancer agent omn54 --- r_associated #0: 28 --> en:cytarabine
    n1=en:multifunctional/multitargeted anticancer agent omn54 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2396. en:nab-paclitaxel --- r_associated #0: 28 --> en:cytarabine
    n1=en:nab-paclitaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2397. en:navuridine --- r_associated #0: 28 --> en:cytarabine
    n1=en:navuridine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2398. en:neuromuscular blocking agents --- r_associated #0: 28 --> en:cytarabine
    n1=en:neuromuscular blocking agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2399. en:nilandron --- r_associated #0: 28 --> en:cytarabine
    n1=en:nilandron | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2400. en:notch signaling inhibitor pf-06650808 --- r_associated #0: 28 --> en:cytarabine
    n1=en:notch signaling inhibitor pf-06650808 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2401. en:ns-9 --- r_associated #0: 28 --> en:cytarabine
    n1=en:ns-9 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2402. en:nutraceutical tbl-12 --- r_associated #0: 28 --> en:cytarabine
    n1=en:nutraceutical tbl-12 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2403. en:ny-eso-1 protein vaccine plus montanide isa-51 vg --- r_associated #0: 28 --> en:cytarabine
    n1=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2404. en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2405. en:odanacatib --- r_associated #0: 28 --> en:cytarabine
    n1=en:odanacatib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2406. en:orantinib --- r_associated #0: 28 --> en:cytarabine
    n1=en:orantinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2407. en:paroxetine hydrochloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:paroxetine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2408. en:penicillin v potassium --- r_associated #0: 28 --> en:cytarabine
    n1=en:penicillin v potassium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2409. en:perflutren --- r_associated #0: 28 --> en:cytarabine
    n1=en:perflutren | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2410. en:pharmaceutic aids --- r_associated #0: 28 --> en:cytarabine
    n1=en:pharmaceutic aids | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2411. en:pi3k family kinase inhibitor xl147 --- r_associated #0: 28 --> en:cytarabine
    n1=en:pi3k family kinase inhibitor xl147 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2412. en:pi3k inhibitor gdc-0084 --- r_associated #0: 28 --> en:cytarabine
    n1=en:pi3k inhibitor gdc-0084 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2413. en:pi3k inhibitor px-866 --- r_associated #0: 28 --> en:cytarabine
    n1=en:pi3k inhibitor px-866 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2414. en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 --- r_associated #0: 28 --> en:cytarabine
    n1=en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2415. en:pidilizumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:pidilizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2416. en:piperacillin sodium --- r_associated #0: 28 --> en:cytarabine
    n1=en:piperacillin sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2417. en:pog 8493 protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:pog 8493 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2418. en:pol i inhibitor cx5461 --- r_associated #0: 28 --> en:cytarabine
    n1=en:pol i inhibitor cx5461 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2419. en:porcupine inhibitor wnt974 --- r_associated #0: 28 --> en:cytarabine
    n1=en:porcupine inhibitor wnt974 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2420. en:proflavine hemisulfate --- r_associated #0: 28 --> en:cytarabine
    n1=en:proflavine hemisulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2421. en:promece-cytabom protocol --- r_associated #0: 28 --> en:cytarabine
    n1=en:promece-cytabom protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2422. en:pva microporous hydrospheres/doxorubicin hydrochloride --- r_associated #0: 28 --> en:cytarabine
    n1=en:pva microporous hydrospheres/doxorubicin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2423. en:raf kinase inhibitor lgx818 --- r_associated #0: 28 --> en:cytarabine
    n1=en:raf kinase inhibitor lgx818 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2424. en:recombinant oxytocin --- r_associated #0: 28 --> en:cytarabine
    n1=en:recombinant oxytocin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2425. en:rifaximin --- r_associated #0: 28 --> en:cytarabine
    n1=en:rifaximin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2426. en:rimiducid --- r_associated #0: 28 --> en:cytarabine
    n1=en:rimiducid | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2427. en:rintatolimod --- r_associated #0: 28 --> en:cytarabine
    n1=en:rintatolimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2428. en:sacituzumab govitecan --- r_associated #0: 28 --> en:cytarabine
    n1=en:sacituzumab govitecan | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2429. en:semaxanib --- r_associated #0: 28 --> en:cytarabine
    n1=en:semaxanib | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2430. en:seribantumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:seribantumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2431. en:smokeless tobacco --- r_associated #0: 28 --> en:cytarabine
    n1=en:smokeless tobacco | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2432. en:sodium ferric gluconate complex in sucrose --- r_associated #0: 28 --> en:cytarabine
    n1=en:sodium ferric gluconate complex in sucrose | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2433. en:talmapimod --- r_associated #0: 28 --> en:cytarabine
    n1=en:talmapimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2434. en:technetium tc-99m ethylenedicysteine-deoxyglucose --- r_associated #0: 28 --> en:cytarabine
    n1=en:technetium tc-99m ethylenedicysteine-deoxyglucose | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2435. en:technetium tc-99m mebrofenin --- r_associated #0: 28 --> en:cytarabine
    n1=en:technetium tc-99m mebrofenin | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2436. en:therapeutic estrone --- r_associated #0: 28 --> en:cytarabine
    n1=en:therapeutic estrone | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2437. en:thrombopoietin receptor agonist lgd-4665 --- r_associated #0: 28 --> en:cytarabine
    n1=en:thrombopoietin receptor agonist lgd-4665 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2438. en:tin sn 117m dtpa --- r_associated #0: 28 --> en:cytarabine
    n1=en:tin sn 117m dtpa | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2439. en:vcl-cb01 vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:vcl-cb01 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2440. en:viagenpumatucel-l --- r_associated #0: 28 --> en:cytarabine
    n1=en:viagenpumatucel-l | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2441. en:vim3-ara c regimen --- r_associated #0: 28 --> en:cytarabine
    n1=en:vim3-ara c regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2442. en:vinfosiltine --- r_associated #0: 28 --> en:cytarabine
    n1=en:vinfosiltine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2443. en:vitamin a compound --- r_associated #0: 28 --> en:cytarabine
    n1=en:vitamin a compound | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2444. en:wt1 124-138 peptide vaccine --- r_associated #0: 28 --> en:cytarabine
    n1=en:wt1 124-138 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2445. en:zirconium zr 89 bevacizumab --- r_associated #0: 28 --> en:cytarabine
    n1=en:zirconium zr 89 bevacizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2446. en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 --- r_associated #0: 28 --> en:cytarabine
    n1=en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2447. produit démaquillant --- r_associated #0: 28 --> en:cytarabine
    n1=produit démaquillant | n2=en:cytarabine | rel=r_associated | relid=0 | w=28
  2448. amifostine --- r_associated #0: 27 --> en:cytarabine
    n1=amifostine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2449. barote --- r_associated #0: 27 --> en:cytarabine
    n1=barote | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2450. cytosine arabinoside --- r_associated #0: 27 --> en:cytarabine
    n1=cytosine arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2451. en:1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin --- r_associated #0: 27 --> en:cytarabine
    n1=en:1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2452. en:1-(2'-deoxy-2'-fluoro-arabinofuranosyl)cytosine --- r_associated #0: 27 --> en:cytarabine
    n1=en:1-(2'-deoxy-2'-fluoro-arabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2453. en:1-(2-o-nitro-beta-d-arabinofuranosyl)cytosine --- r_associated #0: 27 --> en:cytarabine
    n1=en:1-(2-o-nitro-beta-d-arabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2454. en:2'-fluoro-5-chloro-1-beta-d-arabinofuranosylcytosine --- r_associated #0: 27 --> en:cytarabine
    n1=en:2'-fluoro-5-chloro-1-beta-d-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2455. en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide --- r_associated #0: 27 --> en:cytarabine
    n1=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2456. en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2457. en:5'-oleoyl cytarabine --- r_associated #0: 27 --> en:cytarabine
    n1=en:5'-oleoyl cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2458. en:5-methyl ara-c --- r_associated #0: 27 --> en:cytarabine
    n1=en:5-methyl ara-c | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2459. en:6,8-bis(benzylthio)octanoic acid --- r_associated #0: 27 --> en:cytarabine
    n1=en:6,8-bis(benzylthio)octanoic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2460. en:aa3 protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:aa3 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2461. en:abbv-221 --- r_associated #0: 27 --> en:cytarabine
    n1=en:abbv-221 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2462. en:abortifacient agents --- r_associated #0: 27 --> en:cytarabine
    n1=en:abortifacient agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2463. en:adenovector encoding mda7 --- r_associated #0: 27 --> en:cytarabine
    n1=en:adenovector encoding mda7 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2464. en:adenovirus b7-1 --- r_associated #0: 27 --> en:cytarabine
    n1=en:adenovirus b7-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2465. en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 --- r_associated #0: 27 --> en:cytarabine
    n1=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2466. en:aieop 8801 low-risk all protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:aieop 8801 low-risk all protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2467. en:aldesleukin --- r_associated #0: 27 --> en:cytarabine
    n1=en:aldesleukin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2468. en:alectinib --- r_associated #0: 27 --> en:cytarabine
    n1=en:alectinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2469. en:alisertib --- r_associated #0: 27 --> en:cytarabine
    n1=en:alisertib | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2470. en:allogeneic cd56-positive cd3-negative natural killer cells --- r_associated #0: 27 --> en:cytarabine
    n1=en:allogeneic cd56-positive cd3-negative natural killer cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2471. en:allogeneic dendritic cell vaccine combig-dc --- r_associated #0: 27 --> en:cytarabine
    n1=en:allogeneic dendritic cell vaccine combig-dc | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2472. en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2473. en:alpha fetoprotein plasmid dna vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:alpha fetoprotein plasmid dna vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2474. en:alvac-hb7.1 --- r_associated #0: 27 --> en:cytarabine
    n1=en:alvac-hb7.1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2475. en:amatuximab --- r_associated #0: 27 --> en:cytarabine
    n1=en:amatuximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2476. en:amifostine --- r_associated #0: 27 --> en:cytarabine
    n1=en:amifostine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2477. en:aml91 protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:aml91 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2478. en:amonafide l-malate --- r_associated #0: 27 --> en:cytarabine
    n1=en:amonafide l-malate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2479. en:androgen receptor antagonist shr3680 --- r_associated #0: 27 --> en:cytarabine
    n1=en:androgen receptor antagonist shr3680 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2480. en:androgen receptor antisense oligonucleotide ezn-4176 --- r_associated #0: 27 --> en:cytarabine
    n1=en:androgen receptor antisense oligonucleotide ezn-4176 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2481. en:androstane steroid he3235 --- r_associated #0: 27 --> en:cytarabine
    n1=en:androstane steroid he3235 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2482. en:anti-a33 monoclonal antibody krn330 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-a33 monoclonal antibody krn330 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2483. en:anti-c-met monoclonal antibody sait301 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-c-met monoclonal antibody sait301 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2484. en:anti-cd33 antibody-drug conjugate imgn779 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-cd33 antibody-drug conjugate imgn779 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2485. en:anti-cd45 monoclonal antibody bc8 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-cd45 monoclonal antibody bc8 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2486. en:anti-cldn6 monoclonal antibody imab027 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-cldn6 monoclonal antibody imab027 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2487. en:anti-egfr monoclonal antibody gc1118 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-egfr monoclonal antibody gc1118 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2488. en:anti-endosialin monoclonal antibody morab-004 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-endosialin monoclonal antibody morab-004 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2489. en:anti-fgfr2 antibody bay1179470 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-fgfr2 antibody bay1179470 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2490. en:anti-fgfr2 antibody-drug conjugate bay1187982 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-fgfr2 antibody-drug conjugate bay1187982 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2491. en:anti-gd2 monoclonal antibody morab-028 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-gd2 monoclonal antibody morab-028 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2492. en:anti-hgf monoclonal antibody tak-701 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-hgf monoclonal antibody tak-701 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2493. en:anti-human chorionic gonadotropin vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-human chorionic gonadotropin vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2494. en:anti-il-1 alpha monoclonal antibody mabp1 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-il-1 alpha monoclonal antibody mabp1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2495. en:anti-lag-3 monoclonal antibody bms-986016 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-lag-3 monoclonal antibody bms-986016 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2496. en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2497. en:anti-myostatin monoclonal antibody ly2495655 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-myostatin monoclonal antibody ly2495655 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2498. en:anti-nectin 4 antibody-drug conjugate asg-22ce --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-nectin 4 antibody-drug conjugate asg-22ce | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2499. en:anti-ox40 monoclonal antibody medi0562 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-ox40 monoclonal antibody medi0562 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2500. en:anti-pkn3 sirna atu027 --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-pkn3 sirna atu027 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2501. en:anti-psma monoclonal antibody-mmae conjugate --- r_associated #0: 27 --> en:cytarabine
    n1=en:anti-psma monoclonal antibody-mmae conjugate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2502. en:ara-cdp-1-s-octadecyl-2-o-palmitoyl-1-thioglycerol --- r_associated #0: 27 --> en:cytarabine
    n1=en:ara-cdp-1-s-octadecyl-2-o-palmitoyl-1-thioglycerol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2503. en:arac-diphosphate diglyceride --- r_associated #0: 27 --> en:cytarabine
    n1=en:arac-diphosphate diglyceride | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2504. en:asaley --- r_associated #0: 27 --> en:cytarabine
    n1=en:asaley | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2505. en:atiprimod --- r_associated #0: 27 --> en:cytarabine
    n1=en:atiprimod | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2506. en:atr kinase inhibitor azd6738 --- r_associated #0: 27 --> en:cytarabine
    n1=en:atr kinase inhibitor azd6738 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2507. en:atr-101 --- r_associated #0: 27 --> en:cytarabine
    n1=en:atr-101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2508. en:aurora kinase inhibitor bi 811283 --- r_associated #0: 27 --> en:cytarabine
    n1=en:aurora kinase inhibitor bi 811283 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2509. en:aurora kinase inhibitor ttp607 --- r_associated #0: 27 --> en:cytarabine
    n1=en:aurora kinase inhibitor ttp607 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2510. en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2511. en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2512. en:autologous dendritic cell vaccine act2001 --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous dendritic cell vaccine act2001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2513. en:autologous dinitrophenyl-modified ovarian cancer vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous dinitrophenyl-modified ovarian cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2514. en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2515. en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2516. en:autologous sarcoma lysate-pulsed dendritic cell vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2517. en:autologous tumor infiltrating lymphocytes ln-144 --- r_associated #0: 27 --> en:cytarabine
    n1=en:autologous tumor infiltrating lymphocytes ln-144 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2518. en:avitinib maleate --- r_associated #0: 27 --> en:cytarabine
    n1=en:avitinib maleate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2519. en:azimexon --- r_associated #0: 27 --> en:cytarabine
    n1=en:azimexon | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2520. en:banoxantrone --- r_associated #0: 27 --> en:cytarabine
    n1=en:banoxantrone | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2521. en:barium meal --- r_associated #0: 27 --> en:cytarabine
    n1=en:barium meal | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2522. en:batanopride --- r_associated #0: 27 --> en:cytarabine
    n1=en:batanopride | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2523. en:bcr-abl peptide vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:bcr-abl peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2524. en:becatecarin --- r_associated #0: 27 --> en:cytarabine
    n1=en:becatecarin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2525. en:bendamustine hydrochloride --- r_associated #0: 27 --> en:cytarabine
    n1=en:bendamustine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2526. en:berlin-frankfurt-muenster protocol ii --- r_associated #0: 27 --> en:cytarabine
    n1=en:berlin-frankfurt-muenster protocol ii | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2527. en:bet inhibitor ft-1101 --- r_associated #0: 27 --> en:cytarabine
    n1=en:bet inhibitor ft-1101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2528. en:bfm-all 81 protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:bfm-all 81 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2529. en:bicalutamide --- r_associated #0: 27 --> en:cytarabine
    n1=en:bicalutamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2530. en:birinapant --- r_associated #0: 27 --> en:cytarabine
    n1=en:birinapant | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2531. en:black cohosh --- r_associated #0: 27 --> en:cytarabine
    n1=en:black cohosh | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2532. en:blue citrus-based herbal capsule --- r_associated #0: 27 --> en:cytarabine
    n1=en:blue citrus-based herbal capsule | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2533. en:bmvc protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:bmvc protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2534. en:briciclib sodium --- r_associated #0: 27 --> en:cytarabine
    n1=en:briciclib sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2535. en:btk inhibitor gdc-0853 --- r_associated #0: 27 --> en:cytarabine
    n1=en:btk inhibitor gdc-0853 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2536. en:c-kit inhibitor plx9486 --- r_associated #0: 27 --> en:cytarabine
    n1=en:c-kit inhibitor plx9486 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2537. en:c-met inhibitor mk8033 --- r_associated #0: 27 --> en:cytarabine
    n1=en:c-met inhibitor mk8033 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2538. en:cabazitaxel --- r_associated #0: 27 --> en:cytarabine
    n1=en:cabazitaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2539. en:caix inhibitor dtp348 --- r_associated #0: 27 --> en:cytarabine
    n1=en:caix inhibitor dtp348 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2540. en:calamine / pramoxine --- r_associated #0: 27 --> en:cytarabine
    n1=en:calamine / pramoxine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2541. en:calcium aluminosilicate anti-diarrheal --- r_associated #0: 27 --> en:cytarabine
    n1=en:calcium aluminosilicate anti-diarrheal | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2542. en:calcium carbonate + simethicone --- r_associated #0: 27 --> en:cytarabine
    n1=en:calcium carbonate + simethicone | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2543. en:camphor + menthol + phenol --- r_associated #0: 27 --> en:cytarabine
    n1=en:camphor + menthol + phenol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2544. en:cancer stemness kinase inhibitor bbi503 --- r_associated #0: 27 --> en:cytarabine
    n1=en:cancer stemness kinase inhibitor bbi503 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2545. en:cara protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:cara protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2546. en:carbon c 13 acetate --- r_associated #0: 27 --> en:cytarabine
    n1=en:carbon c 13 acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2547. en:carbon c 14 vemurafenib --- r_associated #0: 27 --> en:cytarabine
    n1=en:carbon c 14 vemurafenib | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2548. en:carboxyamidotriazole orotate --- r_associated #0: 27 --> en:cytarabine
    n1=en:carboxyamidotriazole orotate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2549. en:carboxymethylcellulose sodium --- r_associated #0: 27 --> en:cytarabine
    n1=en:carboxymethylcellulose sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2550. en:ccr2 antagonist pf-04136309 --- r_associated #0: 27 --> en:cytarabine
    n1=en:ccr2 antagonist pf-04136309 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2551. en:cd40 agonistic monoclonal antibody apx005m --- r_associated #0: 27 --> en:cytarabine
    n1=en:cd40 agonistic monoclonal antibody apx005m | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2552. en:cdk4/6 inhibitor g1t28 --- r_associated #0: 27 --> en:cytarabine
    n1=en:cdk4/6 inhibitor g1t28 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2553. en:cesium cs-131 --- r_associated #0: 27 --> en:cytarabine
    n1=en:cesium cs-131 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2554. en:chlorambucil-prednisone regimen --- r_associated #0: 27 --> en:cytarabine
    n1=en:chlorambucil-prednisone regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2555. en:choline / dexpanthenol --- r_associated #0: 27 --> en:cytarabine
    n1=en:choline / dexpanthenol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2556. en:ciclopirox olamine lotion --- r_associated #0: 27 --> en:cytarabine
    n1=en:ciclopirox olamine lotion | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2557. en:cisplatin liposomal --- r_associated #0: 27 --> en:cytarabine
    n1=en:cisplatin liposomal | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2558. en:citatuzumab bogatox --- r_associated #0: 27 --> en:cytarabine
    n1=en:citatuzumab bogatox | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2559. en:clioquinol + hydrocortisone + pramoxine hydrochloride --- r_associated #0: 27 --> en:cytarabine
    n1=en:clioquinol + hydrocortisone + pramoxine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2560. en:codeine + pseudoephedrine --- r_associated #0: 27 --> en:cytarabine
    n1=en:codeine + pseudoephedrine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2561. en:concentrated beet crystals --- r_associated #0: 27 --> en:cytarabine
    n1=en:concentrated beet crystals | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2562. en:conjugated estrogens/bazedoxifene --- r_associated #0: 27 --> en:cytarabine
    n1=en:conjugated estrogens/bazedoxifene | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2563. en:cordycepin --- r_associated #0: 27 --> en:cytarabine
    n1=en:cordycepin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2564. en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule --- r_associated #0: 27 --> en:cytarabine
    n1=en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2565. en:cvap-bleo --- r_associated #0: 27 --> en:cytarabine
    n1=en:cvap-bleo | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2566. en:cystemustine --- r_associated #0: 27 --> en:cytarabine
    n1=en:cystemustine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2567. en:cytochlor --- r_associated #0: 27 --> en:cytarabine
    n1=en:cytochlor | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2568. en:cytokine-induced killer cells --- r_associated #0: 27 --> en:cytarabine
    n1=en:cytokine-induced killer cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2569. en:d(a)at protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:d(a)at protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2570. en:dach-platin micelle nc-4016 --- r_associated #0: 27 --> en:cytarabine
    n1=en:dach-platin micelle nc-4016 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2571. en:daep protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:daep protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2572. en:dakins solution --- r_associated #0: 27 --> en:cytarabine
    n1=en:dakins solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2573. en:dcds0780a --- r_associated #0: 27 --> en:cytarabine
    n1=en:dcds0780a | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2574. en:dctp regimen --- r_associated #0: 27 --> en:cytarabine
    n1=en:dctp regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2575. en:dcvp-1-asp protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:dcvp-1-asp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2576. en:deca regimen --- r_associated #0: 27 --> en:cytarabine
    n1=en:deca regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2577. en:delta-tocotrienol --- r_associated #0: 27 --> en:cytarabine
    n1=en:delta-tocotrienol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2578. en:denenicokin --- r_associated #0: 27 --> en:cytarabine
    n1=en:denenicokin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2579. en:dexa-pamb protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:dexa-pamb protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2580. en:diflomotecan --- r_associated #0: 27 --> en:cytarabine
    n1=en:diflomotecan | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2581. en:dna interference oligonucleotide pnt2258 --- r_associated #0: 27 --> en:cytarabine
    n1=en:dna interference oligonucleotide pnt2258 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2582. en:doa protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:doa protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2583. en:docetaxel lipid microspheres --- r_associated #0: 27 --> en:cytarabine
    n1=en:docetaxel lipid microspheres | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2584. en:docosahexaenoic acid --- r_associated #0: 27 --> en:cytarabine
    n1=en:docosahexaenoic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2585. en:egfr inhibitor hm61713 --- r_associated #0: 27 --> en:cytarabine
    n1=en:egfr inhibitor hm61713 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2586. en:egfr/her2 inhibitor ap32788 --- r_associated #0: 27 --> en:cytarabine
    n1=en:egfr/her2 inhibitor ap32788 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2587. en:electrolyte-free parenteral nutrition emulsion --- r_associated #0: 27 --> en:cytarabine
    n1=en:electrolyte-free parenteral nutrition emulsion | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2588. en:elesclomol --- r_associated #0: 27 --> en:cytarabine
    n1=en:elesclomol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2589. en:ep4 receptor antagonist aat-007 --- r_associated #0: 27 --> en:cytarabine
    n1=en:ep4 receptor antagonist aat-007 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2590. en:estriol vaginal gel --- r_associated #0: 27 --> en:cytarabine
    n1=en:estriol vaginal gel | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2591. en:eszopiclone --- r_associated #0: 27 --> en:cytarabine
    n1=en:eszopiclone | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2592. en:ethaselen --- r_associated #0: 27 --> en:cytarabine
    n1=en:ethaselen | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2593. en:ezetimibe/simvastatin --- r_associated #0: 27 --> en:cytarabine
    n1=en:ezetimibe/simvastatin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2594. en:fak inhibitor gsk2256098 --- r_associated #0: 27 --> en:cytarabine
    n1=en:fak inhibitor gsk2256098 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2595. en:fas receptor agonist apo010 --- r_associated #0: 27 --> en:cytarabine
    n1=en:fas receptor agonist apo010 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2596. en:fazarabine --- r_associated #0: 27 --> en:cytarabine
    n1=en:fazarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2597. en:fludarabine phosphate --- r_associated #0: 27 --> en:cytarabine
    n1=en:fludarabine phosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2598. en:fluorine f 18 5-fluoro-2-deoxycytidine --- r_associated #0: 27 --> en:cytarabine
    n1=en:fluorine f 18 5-fluoro-2-deoxycytidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2599. en:g-quadruplex stabilizer bmvc --- r_associated #0: 27 --> en:cytarabine
    n1=en:g-quadruplex stabilizer bmvc | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2600. en:gallium ga 68 citrate --- r_associated #0: 27 --> en:cytarabine
    n1=en:gallium ga 68 citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2601. en:gallium ga 68-dotatate --- r_associated #0: 27 --> en:cytarabine
    n1=en:gallium ga 68-dotatate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2602. en:gallium ga 68-neb --- r_associated #0: 27 --> en:cytarabine
    n1=en:gallium ga 68-neb | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2603. en:gamma secretase inhibitor pf-03084014 --- r_associated #0: 27 --> en:cytarabine
    n1=en:gamma secretase inhibitor pf-03084014 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2604. en:gamma-secretase inhibitor ly3039478 --- r_associated #0: 27 --> en:cytarabine
    n1=en:gamma-secretase inhibitor ly3039478 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2605. en:gastroenteral dosage form product --- r_associated #0: 27 --> en:cytarabine
    n1=en:gastroenteral dosage form product | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2606. en:gel protein, gelonium multiflorum --- r_associated #0: 27 --> en:cytarabine
    n1=en:gel protein, gelonium multiflorum | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2607. en:gemcitabine prodrug ly2334737 --- r_associated #0: 27 --> en:cytarabine
    n1=en:gemcitabine prodrug ly2334737 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2608. en:gimema all 0394 --- r_associated #0: 27 --> en:cytarabine
    n1=en:gimema all 0394 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2609. en:glucosamine sulfate/chondroitin sulfate tablet --- r_associated #0: 27 --> en:cytarabine
    n1=en:glucosamine sulfate/chondroitin sulfate tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2610. en:gpi-0100 --- r_associated #0: 27 --> en:cytarabine
    n1=en:gpi-0100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2611. en:gvax pancreatic cancer vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:gvax pancreatic cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2612. en:henatinib maleate --- r_associated #0: 27 --> en:cytarabine
    n1=en:henatinib maleate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2613. en:herba scutellaria barbata --- r_associated #0: 27 --> en:cytarabine
    n1=en:herba scutellaria barbata | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2614. en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2615. en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2616. en:hsp90 inhibitor debio 0932 --- r_associated #0: 27 --> en:cytarabine
    n1=en:hsp90 inhibitor debio 0932 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2617. en:hsp90 inhibitor ds-2248 --- r_associated #0: 27 --> en:cytarabine
    n1=en:hsp90 inhibitor ds-2248 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2618. en:huachansu --- r_associated #0: 27 --> en:cytarabine
    n1=en:huachansu | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2619. en:i 131 antiferritin immunoglobulin --- r_associated #0: 27 --> en:cytarabine
    n1=en:i 131 antiferritin immunoglobulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2620. en:i 131 monoclonal antibody f19 --- r_associated #0: 27 --> en:cytarabine
    n1=en:i 131 monoclonal antibody f19 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2621. en:ibritumomab tiuxetan --- r_associated #0: 27 --> en:cytarabine
    n1=en:ibritumomab tiuxetan | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2622. en:idh1 inhibitor ag-120 --- r_associated #0: 27 --> en:cytarabine
    n1=en:idh1 inhibitor ag-120 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2623. en:immunology aspects --- r_associated #0: 27 --> en:cytarabine
    n1=en:immunology aspects | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2624. en:indibulin --- r_associated #0: 27 --> en:cytarabine
    n1=en:indibulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2625. en:iodine i 131 monoclonal antibody bc8 --- r_associated #0: 27 --> en:cytarabine
    n1=en:iodine i 131 monoclonal antibody bc8 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2626. en:iodine i 131 rituximab --- r_associated #0: 27 --> en:cytarabine
    n1=en:iodine i 131 rituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2627. en:iodine i 131 tm-601 --- r_associated #0: 27 --> en:cytarabine
    n1=en:iodine i 131 tm-601 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2628. en:irofulven --- r_associated #0: 27 --> en:cytarabine
    n1=en:irofulven | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2629. en:ixazomib citrate --- r_associated #0: 27 --> en:cytarabine
    n1=en:ixazomib citrate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2630. en:kava-based supplement --- r_associated #0: 27 --> en:cytarabine
    n1=en:kava-based supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2631. en:l-377,202 --- r_associated #0: 27 --> en:cytarabine
    n1=en:l-377,202 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2632. en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement --- r_associated #0: 27 --> en:cytarabine
    n1=en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2633. en:lapuleucel-t --- r_associated #0: 27 --> en:cytarabine
    n1=en:lapuleucel-t | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2634. en:lenvatinib mesylate --- r_associated #0: 27 --> en:cytarabine
    n1=en:lenvatinib mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2635. en:liarozole fumarate --- r_associated #0: 27 --> en:cytarabine
    n1=en:liarozole fumarate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2636. en:linoleyl carbonate-paclitaxel --- r_associated #0: 27 --> en:cytarabine
    n1=en:linoleyl carbonate-paclitaxel | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2637. en:lintuzumab --- r_associated #0: 27 --> en:cytarabine
    n1=en:lintuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2638. en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase --- r_associated #0: 27 --> en:cytarabine
    n1=en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2639. en:live-attenuated listeria encoding human mesothelin vaccine crs-207 --- r_associated #0: 27 --> en:cytarabine
    n1=en:live-attenuated listeria encoding human mesothelin vaccine crs-207 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2640. en:lnh-92 regimen --- r_associated #0: 27 --> en:cytarabine
    n1=en:lnh-92 regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2641. en:lung-targeted immunomodulator qbkpn --- r_associated #0: 27 --> en:cytarabine
    n1=en:lung-targeted immunomodulator qbkpn | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2642. en:lutetium lu 177 monoclonal antibody j591 --- r_associated #0: 27 --> en:cytarabine
    n1=en:lutetium lu 177 monoclonal antibody j591 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2643. en:ly2624587 --- r_associated #0: 27 --> en:cytarabine
    n1=en:ly2624587 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2644. en:mage-a3/12-specific tcr gene-transduced autologous pbls --- r_associated #0: 27 --> en:cytarabine
    n1=en:mage-a3/12-specific tcr gene-transduced autologous pbls | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2645. en:masitinib mesylate --- r_associated #0: 27 --> en:cytarabine
    n1=en:masitinib mesylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2646. en:maxzide --- r_associated #0: 27 --> en:cytarabine
    n1=en:maxzide | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2647. en:me-143 --- r_associated #0: 27 --> en:cytarabine
    n1=en:me-143 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2648. en:mechanism of action qualifier --- r_associated #0: 27 --> en:cytarabine
    n1=en:mechanism of action qualifier | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2649. en:melanoma antigen recognized by t-cells 1, human --- r_associated #0: 27 --> en:cytarabine
    n1=en:melanoma antigen recognized by t-cells 1, human | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2650. en:menadione topical lotion --- r_associated #0: 27 --> en:cytarabine
    n1=en:menadione topical lotion | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2651. en:metoprine --- r_associated #0: 27 --> en:cytarabine
    n1=en:metoprine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2652. en:micafungin --- r_associated #0: 27 --> en:cytarabine
    n1=en:micafungin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2653. en:milk protein-based energy drink --- r_associated #0: 27 --> en:cytarabine
    n1=en:milk protein-based energy drink | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2654. en:monoclonal antibody mono-dga-rfb4 --- r_associated #0: 27 --> en:cytarabine
    n1=en:monoclonal antibody mono-dga-rfb4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2655. en:muc-2-globo h-klh conjugate vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:muc-2-globo h-klh conjugate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2656. en:multikinase inhibitor sar103168 --- r_associated #0: 27 --> en:cytarabine
    n1=en:multikinase inhibitor sar103168 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2657. en:nadroparin calcium --- r_associated #0: 27 --> en:cytarabine
    n1=en:nadroparin calcium | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2658. en:nimotuzumab --- r_associated #0: 27 --> en:cytarabine
    n1=en:nimotuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2659. en:nx-1207 --- r_associated #0: 27 --> en:cytarabine
    n1=en:nx-1207 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2660. en:onyx-015 --- r_associated #0: 27 --> en:cytarabine
    n1=en:onyx-015 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2661. en:orteronel --- r_associated #0: 27 --> en:cytarabine
    n1=en:orteronel | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2662. en:palonosetron hydrochloride --- r_associated #0: 27 --> en:cytarabine
    n1=en:palonosetron hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2663. en:pan-her kinase inhibitor ac480 --- r_associated #0: 27 --> en:cytarabine
    n1=en:pan-her kinase inhibitor ac480 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2664. en:patritumab --- r_associated #0: 27 --> en:cytarabine
    n1=en:patritumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2665. en:patupilone --- r_associated #0: 27 --> en:cytarabine
    n1=en:patupilone | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2666. en:pegylated human recombinant arginase 1 aeb1102 --- r_associated #0: 27 --> en:cytarabine
    n1=en:pegylated human recombinant arginase 1 aeb1102 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2667. en:perflubron --- r_associated #0: 27 --> en:cytarabine
    n1=en:perflubron | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2668. en:phosphomannopentaose sulfate --- r_associated #0: 27 --> en:cytarabine
    n1=en:phosphomannopentaose sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2669. en:pi3k inhibitor gsk2126458 --- r_associated #0: 27 --> en:cytarabine
    n1=en:pi3k inhibitor gsk2126458 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2670. en:pim kinase inhibitor sgi-1776 --- r_associated #0: 27 --> en:cytarabine
    n1=en:pim kinase inhibitor sgi-1776 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2671. en:plozalizumab --- r_associated #0: 27 --> en:cytarabine
    n1=en:plozalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2672. en:polyglutamate camptothecin --- r_associated #0: 27 --> en:cytarabine
    n1=en:polyglutamate camptothecin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2673. en:promace-cytabom regimen --- r_associated #0: 27 --> en:cytarabine
    n1=en:promace-cytabom regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2674. en:protein phosphatase 2a inhibitor lb-100 --- r_associated #0: 27 --> en:cytarabine
    n1=en:protein phosphatase 2a inhibitor lb-100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2675. en:pseudoephedrine + codeine + guaifenesin --- r_associated #0: 27 --> en:cytarabine
    n1=en:pseudoephedrine + codeine + guaifenesin | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2676. en:quizartinib --- r_associated #0: 27 --> en:cytarabine
    n1=en:quizartinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2677. en:raloxifene --- r_associated #0: 27 --> en:cytarabine
    n1=en:raloxifene | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2678. en:rebastinib tosylate --- r_associated #0: 27 --> en:cytarabine
    n1=en:rebastinib tosylate | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2679. en:recombinant bispecific single-chain antibody rm28 --- r_associated #0: 27 --> en:cytarabine
    n1=en:recombinant bispecific single-chain antibody rm28 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2680. en:recombinant dher2 vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:recombinant dher2 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2681. en:remestemcel-l --- r_associated #0: 27 --> en:cytarabine
    n1=en:remestemcel-l | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2682. en:resistant starch --- r_associated #0: 27 --> en:cytarabine
    n1=en:resistant starch | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2683. en:retinoic acid agent --- r_associated #0: 27 --> en:cytarabine
    n1=en:retinoic acid agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2684. en:saxagliptin hydrochloride --- r_associated #0: 27 --> en:cytarabine
    n1=en:saxagliptin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2685. en:sivifene --- r_associated #0: 27 --> en:cytarabine
    n1=en:sivifene | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2686. en:sphingosine kinase-2 inhibitor abc294640 --- r_associated #0: 27 --> en:cytarabine
    n1=en:sphingosine kinase-2 inhibitor abc294640 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2687. en:standards characteristics --- r_associated #0: 27 --> en:cytarabine
    n1=en:standards characteristics | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2688. en:tad9 protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:tad9 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2689. en:tanezumab --- r_associated #0: 27 --> en:cytarabine
    n1=en:tanezumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2690. en:tetanus-cmv fusion peptide vaccine --- r_associated #0: 27 --> en:cytarabine
    n1=en:tetanus-cmv fusion peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2691. en:tigapotide --- r_associated #0: 27 --> en:cytarabine
    n1=en:tigapotide | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2692. en:tigecycline --- r_associated #0: 27 --> en:cytarabine
    n1=en:tigecycline | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2693. en:tiomolibdate diammonium --- r_associated #0: 27 --> en:cytarabine
    n1=en:tiomolibdate diammonium | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2694. en:to answer --- r_associated #0: 27 --> en:cytarabine
    n1=en:to answer | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2695. en:tocotrienol-rich fraction --- r_associated #0: 27 --> en:cytarabine
    n1=en:tocotrienol-rich fraction | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2696. en:tremelimumab --- r_associated #0: 27 --> en:cytarabine
    n1=en:tremelimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2697. en:ublituximab --- r_associated #0: 27 --> en:cytarabine
    n1=en:ublituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2698. en:urea/lactic acid-based topical cream --- r_associated #0: 27 --> en:cytarabine
    n1=en:urea/lactic acid-based topical cream | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2699. en:vinap protocol --- r_associated #0: 27 --> en:cytarabine
    n1=en:vinap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2700. en:yttrium y 90 monoclonal antibody mn-14 --- r_associated #0: 27 --> en:cytarabine
    n1=en:yttrium y 90 monoclonal antibody mn-14 | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2701. en:yttrium y-90 epratuzumab tetraxetan --- r_associated #0: 27 --> en:cytarabine
    n1=en:yttrium y-90 epratuzumab tetraxetan | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2702. talquer quelque chose --- r_associated #0: 27 --> en:cytarabine
    n1=talquer quelque chose | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2703. érythropoïétine --- r_associated #0: 27 --> en:cytarabine
    n1=érythropoïétine | n2=en:cytarabine | rel=r_associated | relid=0 | w=27
  2704. citrate de magnésium --- r_associated #0: 26 --> en:cytarabine
    n1=citrate de magnésium | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2705. cytarabine --- r_associated #0: 26 --> en:cytarabine
    n1=cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2706. dapsone --- r_associated #0: 26 --> en:cytarabine
    n1=dapsone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2707. en:1-(2-deoxy-2-fluoro-4-thio-arabinofuranosyl)cytosine --- r_associated #0: 26 --> en:cytarabine
    n1=en:1-(2-deoxy-2-fluoro-4-thio-arabinofuranosyl)cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2708. en:18f-fhbg --- r_associated #0: 26 --> en:cytarabine
    n1=en:18f-fhbg | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2709. en:18f-fluoroazomycin arabinoside --- r_associated #0: 26 --> en:cytarabine
    n1=en:18f-fluoroazomycin arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2710. en:2',5'-arabinosylcytidine monophosphate --- r_associated #0: 26 --> en:cytarabine
    n1=en:2',5'-arabinosylcytidine monophosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2711. en:2'-deoxy-5-fluorouridylyl-(5'-5')-n(4)-octadecyl-1-arabinofuranosylcytosine --- r_associated #0: 26 --> en:cytarabine
    n1=en:2'-deoxy-5-fluorouridylyl-(5'-5')-n(4)-octadecyl-1-arabinofuranosylcytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2712. en:5-fluorouracil/salicylic acid topical solution --- r_associated #0: 26 --> en:cytarabine
    n1=en:5-fluorouracil/salicylic acid topical solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2713. en:80-035 protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:80-035 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2714. en:acalabrutinib --- r_associated #0: 26 --> en:cytarabine
    n1=en:acalabrutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2715. en:acivicin --- r_associated #0: 26 --> en:cytarabine
    n1=en:acivicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2716. en:adefovir dipivoxil --- r_associated #0: 26 --> en:cytarabine
    n1=en:adefovir dipivoxil | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2717. en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 --- r_associated #0: 26 --> en:cytarabine
    n1=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2718. en:akt inhibitor gsk2141795 --- r_associated #0: 26 --> en:cytarabine
    n1=en:akt inhibitor gsk2141795 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2719. en:albuterol sulfate --- r_associated #0: 26 --> en:cytarabine
    n1=en:albuterol sulfate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2720. en:all-bfm-95 protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:all-bfm-95 protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2721. en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2722. en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2723. en:alvocidib hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:alvocidib hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2724. en:anagrelide hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:anagrelide hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2725. en:anagrelide prolonged-release formulation --- r_associated #0: 26 --> en:cytarabine
    n1=en:anagrelide prolonged-release formulation | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2726. en:anhydrovinblastine --- r_associated #0: 26 --> en:cytarabine
    n1=en:anhydrovinblastine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2727. en:aniline mustard --- r_associated #0: 26 --> en:cytarabine
    n1=en:aniline mustard | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2728. en:annamycin liposomal --- r_associated #0: 26 --> en:cytarabine
    n1=en:annamycin liposomal | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2729. en:anthocyanin-rich corn extract --- r_associated #0: 26 --> en:cytarabine
    n1=en:anthocyanin-rich corn extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2730. en:anti-a5b1 integrin monoclonal antibody pf-04605412 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-a5b1 integrin monoclonal antibody pf-04605412 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2731. en:anti-ang2 monoclonal antibody medi-3617 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-ang2 monoclonal antibody medi-3617 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2732. en:anti-cd20 monoclonal antibody tl011 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-cd20 monoclonal antibody tl011 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2733. en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2734. en:anti-cd20/cd3 monoclonal antibody regn1979 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-cd20/cd3 monoclonal antibody regn1979 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2735. en:anti-cd40 monoclonal antibody chi lob 7/4 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-cd40 monoclonal antibody chi lob 7/4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2736. en:anti-cd40 monoclonal antibody sea-cd40 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-cd40 monoclonal antibody sea-cd40 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2737. en:anti-cea/cd3 bispecific antibody ro6958688 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-cea/cd3 bispecific antibody ro6958688 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2738. en:anti-ceacam1 monoclonal antibody cm-24 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-ceacam1 monoclonal antibody cm-24 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2739. en:anti-ctla-4 monoclonal antibody agen1884 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-ctla-4 monoclonal antibody agen1884 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2740. en:anti-egfr monoclonal antibody mixture mm-151 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-egfr monoclonal antibody mixture mm-151 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2741. en:anti-epha2 monoclonal antibody ds-8895a --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-epha2 monoclonal antibody ds-8895a | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2742. en:anti-erbb3 monoclonal antibody av-203 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-erbb3 monoclonal antibody av-203 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2743. en:anti-hb-egf monoclonal antibody khk2866 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-hb-egf monoclonal antibody khk2866 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2744. en:anti-icam-1 monoclonal antibody bi-505 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-icam-1 monoclonal antibody bi-505 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2745. en:anti-il-8 monoclonal antibody humax-il8 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-il-8 monoclonal antibody humax-il8 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2746. en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2747. en:anti-met monoclonal antibody mixture sym015 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-met monoclonal antibody mixture sym015 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2748. en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2749. en:anti-pd-1 fusion protein amp-224 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-pd-1 fusion protein amp-224 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2750. en:anti-pd-l1 monoclonal antibody ly3300054 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-pd-l1 monoclonal antibody ly3300054 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2751. en:anti-plgf monoclonal antibody tb-403 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-plgf monoclonal antibody tb-403 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2752. en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2753. en:anti-prolactin receptor antibody lfa102 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-prolactin receptor antibody lfa102 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2754. en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2755. en:anti-vegf/ang2 nanobody bi 836880 --- r_associated #0: 26 --> en:cytarabine
    n1=en:anti-vegf/ang2 nanobody bi 836880 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2756. en:antibody-drug conjugate abbv-399 --- r_associated #0: 26 --> en:cytarabine
    n1=en:antibody-drug conjugate abbv-399 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2757. en:antibody-drug conjugate sc-002 --- r_associated #0: 26 --> en:cytarabine
    n1=en:antibody-drug conjugate sc-002 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2758. en:antigen-targeted personalized breast cancer vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:antigen-targeted personalized breast cancer vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2759. en:antineoplastic agent combination sm-88 --- r_associated #0: 26 --> en:cytarabine
    n1=en:antineoplastic agent combination sm-88 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2760. en:apatinib --- r_associated #0: 26 --> en:cytarabine
    n1=en:apatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2761. en:atr kinase inhibitor vx-970 --- r_associated #0: 26 --> en:cytarabine
    n1=en:atr kinase inhibitor vx-970 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2762. en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2763. en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2764. en:autologous ebv-ctl cd19car zeta --- r_associated #0: 26 --> en:cytarabine
    n1=en:autologous ebv-ctl cd19car zeta | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2765. en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2766. en:aziridinylbenzoquinone rh1 --- r_associated #0: 26 --> en:cytarabine
    n1=en:aziridinylbenzoquinone rh1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2767. en:bavc protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:bavc protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2768. en:bep regimen --- r_associated #0: 26 --> en:cytarabine
    n1=en:bep regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2769. en:bet bromodomains 2/3/4 inhibitor mk-8628 --- r_associated #0: 26 --> en:cytarabine
    n1=en:bet bromodomains 2/3/4 inhibitor mk-8628 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2770. en:biafine cream --- r_associated #0: 26 --> en:cytarabine
    n1=en:biafine cream | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2771. en:bibx 1382 --- r_associated #0: 26 --> en:cytarabine
    n1=en:bibx 1382 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2772. en:boronophenylalanine-fructose complex --- r_associated #0: 26 --> en:cytarabine
    n1=en:boronophenylalanine-fructose complex | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2773. en:bosutinib --- r_associated #0: 26 --> en:cytarabine
    n1=en:bosutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2774. en:brilacidin oral rinse --- r_associated #0: 26 --> en:cytarabine
    n1=en:brilacidin oral rinse | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2775. en:brivanib alaninate --- r_associated #0: 26 --> en:cytarabine
    n1=en:brivanib alaninate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2776. en:bromelains --- r_associated #0: 26 --> en:cytarabine
    n1=en:bromelains | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2777. en:budesonide/formoterol fumarate dihydrate inhalation aerosol --- r_associated #0: 26 --> en:cytarabine
    n1=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2778. en:bupivacaine hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:bupivacaine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2779. en:caffeine, ergotamine drug combination --- r_associated #0: 26 --> en:cytarabine
    n1=en:caffeine, ergotamine drug combination | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2780. en:calaspargase pegol --- r_associated #0: 26 --> en:cytarabine
    n1=en:calaspargase pegol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2781. en:calcium magnesium potassium carbonate chloride hydroxide --- r_associated #0: 26 --> en:cytarabine
    n1=en:calcium magnesium potassium carbonate chloride hydroxide | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2782. en:capecitabine rapidly disintegrating tablet --- r_associated #0: 26 --> en:cytarabine
    n1=en:capecitabine rapidly disintegrating tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2783. en:carbon c-13 dextromethorphan --- r_associated #0: 26 --> en:cytarabine
    n1=en:carbon c-13 dextromethorphan | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2784. en:carfilzomib --- r_associated #0: 26 --> en:cytarabine
    n1=en:carfilzomib | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2785. en:cdk2/5/9 inhibitor cyc065 --- r_associated #0: 26 --> en:cytarabine
    n1=en:cdk2/5/9 inhibitor cyc065 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2786. en:cebpa-targeting sarna mtl-cebpa liposome --- r_associated #0: 26 --> en:cytarabine
    n1=en:cebpa-targeting sarna mtl-cebpa liposome | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2787. en:cefepime hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:cefepime hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2788. en:chase protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:chase protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2789. en:chewing gum dosage form --- r_associated #0: 26 --> en:cytarabine
    n1=en:chewing gum dosage form | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2790. en:chinese herbal formulation changtai keli --- r_associated #0: 26 --> en:cytarabine
    n1=en:chinese herbal formulation changtai keli | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2791. en:ciclesonide --- r_associated #0: 26 --> en:cytarabine
    n1=en:ciclesonide | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2792. en:cilengitide --- r_associated #0: 26 --> en:cytarabine
    n1=en:cilengitide | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2793. en:ciprofloxacin+dexamethasone --- r_associated #0: 26 --> en:cytarabine
    n1=en:ciprofloxacin+dexamethasone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2794. en:claudiximab --- r_associated #0: 26 --> en:cytarabine
    n1=en:claudiximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2795. en:coa protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:coa protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2796. en:cold contaminant-free iobenguane i-131 --- r_associated #0: 26 --> en:cytarabine
    n1=en:cold contaminant-free iobenguane i-131 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2797. en:controlled substance --- r_associated #0: 26 --> en:cytarabine
    n1=en:controlled substance | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2798. en:ct protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:ct protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2799. en:ctr iii protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:ctr iii protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2800. en:cyclodextrin-based polymer-camptothecin crlx101 --- r_associated #0: 26 --> en:cytarabine
    n1=en:cyclodextrin-based polymer-camptothecin crlx101 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2801. en:cyclophosphamide/dactinomycin/vincristine --- r_associated #0: 26 --> en:cytarabine
    n1=en:cyclophosphamide/dactinomycin/vincristine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2802. en:cyp17 lyase inhibitor asn001 --- r_associated #0: 26 --> en:cytarabine
    n1=en:cyp17 lyase inhibitor asn001 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2803. en:cytarabine liposome 10 mg/ml injection --- r_associated #0: 26 --> en:cytarabine
    n1=en:cytarabine liposome 10 mg/ml injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2804. en:cytarabine-idarubicin regimen --- r_associated #0: 26 --> en:cytarabine
    n1=en:cytarabine-idarubicin regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2805. en:cytarabine/etoposide/mitoxantrone --- r_associated #0: 26 --> en:cytarabine
    n1=en:cytarabine/etoposide/mitoxantrone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2806. en:cytarazid --- r_associated #0: 26 --> en:cytarabine
    n1=en:cytarazid | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2807. en:dactinomycin --- r_associated #0: 26 --> en:cytarabine
    n1=en:dactinomycin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2808. en:dalantercept --- r_associated #0: 26 --> en:cytarabine
    n1=en:dalantercept | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2809. en:dap protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:dap protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2810. en:dapsone --- r_associated #0: 26 --> en:cytarabine
    n1=en:dapsone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2811. en:datv regimen --- r_associated #0: 26 --> en:cytarabine
    n1=en:datv regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2812. en:dc-cholesterol liposome --- r_associated #0: 26 --> en:cytarabine
    n1=en:dc-cholesterol liposome | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2813. en:dcter protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:dcter protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2814. en:delta-8-tetrahydrocannabinol --- r_associated #0: 26 --> en:cytarabine
    n1=en:delta-8-tetrahydrocannabinol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2815. en:dna minor groove binding agent pm060184 --- r_associated #0: 26 --> en:cytarabine
    n1=en:dna minor groove binding agent pm060184 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2816. en:doapp protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:doapp protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2817. en:donepezil + memantine --- r_associated #0: 26 --> en:cytarabine
    n1=en:donepezil + memantine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2818. en:donor lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:donor lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2819. en:drug products by fda established pharmacologic class --- r_associated #0: 26 --> en:cytarabine
    n1=en:drug products by fda established pharmacologic class | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2820. en:drugs, chinese herbal --- r_associated #0: 26 --> en:cytarabine
    n1=en:drugs, chinese herbal | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2821. en:duligotuzumab --- r_associated #0: 26 --> en:cytarabine
    n1=en:duligotuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2822. en:egfr/her2 inhibitor av-412 --- r_associated #0: 26 --> en:cytarabine
    n1=en:egfr/her2 inhibitor av-412 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2823. en:elliptinium acetate --- r_associated #0: 26 --> en:cytarabine
    n1=en:elliptinium acetate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2824. en:enavatuzumab --- r_associated #0: 26 --> en:cytarabine
    n1=en:enavatuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2825. en:ensituximab --- r_associated #0: 26 --> en:cytarabine
    n1=en:ensituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2826. en:enteric-coated trpm8 agonist d-3263 hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:enteric-coated trpm8 agonist d-3263 hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2827. en:eritoran tetrasodium --- r_associated #0: 26 --> en:cytarabine
    n1=en:eritoran tetrasodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2828. en:erk inhibitor cc-90003 --- r_associated #0: 26 --> en:cytarabine
    n1=en:erk inhibitor cc-90003 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2829. en:erk inhibitor gdc-0994 --- r_associated #0: 26 --> en:cytarabine
    n1=en:erk inhibitor gdc-0994 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2830. en:ethylchlorformate vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:ethylchlorformate vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2831. en:etoricoxib --- r_associated #0: 26 --> en:cytarabine
    n1=en:etoricoxib | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2832. en:fap-specific cd8-positive t cells --- r_associated #0: 26 --> en:cytarabine
    n1=en:fap-specific cd8-positive t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2833. en:farletuzumab --- r_associated #0: 26 --> en:cytarabine
    n1=en:farletuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2834. en:fingolimod hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:fingolimod hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2835. en:flaxseed --- r_associated #0: 26 --> en:cytarabine
    n1=en:flaxseed | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2836. en:flu matrix peptide p58-66 --- r_associated #0: 26 --> en:cytarabine
    n1=en:flu matrix peptide p58-66 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2837. en:fluorine f 18 fmdht --- r_associated #0: 26 --> en:cytarabine
    n1=en:fluorine f 18 fmdht | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2838. en:fluorine f 18-av-133 --- r_associated #0: 26 --> en:cytarabine
    n1=en:fluorine f 18-av-133 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2839. en:g207 --- r_associated #0: 26 --> en:cytarabine
    n1=en:g207 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2840. en:gabapentin --- r_associated #0: 26 --> en:cytarabine
    n1=en:gabapentin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2841. en:gadolinium-chelate --- r_associated #0: 26 --> en:cytarabine
    n1=en:gadolinium-chelate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2842. en:galactomannan derivative --- r_associated #0: 26 --> en:cytarabine
    n1=en:galactomannan derivative | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2843. en:galectin-1 inhibitor otx008 --- r_associated #0: 26 --> en:cytarabine
    n1=en:galectin-1 inhibitor otx008 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2844. en:galeterone --- r_associated #0: 26 --> en:cytarabine
    n1=en:galeterone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2845. en:gemcitabine elaidate --- r_associated #0: 26 --> en:cytarabine
    n1=en:gemcitabine elaidate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2846. en:ghrelin peptide analogue --- r_associated #0: 26 --> en:cytarabine
    n1=en:ghrelin peptide analogue | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2847. en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 --- r_associated #0: 26 --> en:cytarabine
    n1=en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2848. en:globo h-dt vaccine obi-833 --- r_associated #0: 26 --> en:cytarabine
    n1=en:globo h-dt vaccine obi-833 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2849. en:granisetron hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:granisetron hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2850. en:haemophilus influenzae b vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:haemophilus influenzae b vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2851. en:hcv dna vaccine ino-8000 --- r_associated #0: 26 --> en:cytarabine
    n1=en:hcv dna vaccine ino-8000 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2852. en:hdac inhibitor chr-3996 --- r_associated #0: 26 --> en:cytarabine
    n1=en:hdac inhibitor chr-3996 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2853. en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2854. en:hexaminolevulinate --- r_associated #0: 26 --> en:cytarabine
    n1=en:hexaminolevulinate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2855. en:holmium ho 166 poly(l-lactic acid) microspheres --- r_associated #0: 26 --> en:cytarabine
    n1=en:holmium ho 166 poly(l-lactic acid) microspheres | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2856. en:htert/survivin/cmv multipeptide vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:htert/survivin/cmv multipeptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2857. en:hyb2055 --- r_associated #0: 26 --> en:cytarabine
    n1=en:hyb2055 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2858. en:hydromorphone hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:hydromorphone hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2859. en:i 131 monoclonal antibody lym-1 --- r_associated #0: 26 --> en:cytarabine
    n1=en:i 131 monoclonal antibody lym-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2860. en:imetelstat sodium --- r_associated #0: 26 --> en:cytarabine
    n1=en:imetelstat sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2861. en:in 111 monoclonal antibody b3 --- r_associated #0: 26 --> en:cytarabine
    n1=en:in 111 monoclonal antibody b3 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2862. en:inotuzumab ozogamicin --- r_associated #0: 26 --> en:cytarabine
    n1=en:inotuzumab ozogamicin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2863. en:interleukin-2 gene --- r_associated #0: 26 --> en:cytarabine
    n1=en:interleukin-2 gene | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2864. en:jak1 inhibitor incb039110 --- r_associated #0: 26 --> en:cytarabine
    n1=en:jak1 inhibitor incb039110 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2865. en:jak2 inhibitor azd1480 --- r_associated #0: 26 --> en:cytarabine
    n1=en:jak2 inhibitor azd1480 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2866. en:jak2 inhibitor bms-911543 --- r_associated #0: 26 --> en:cytarabine
    n1=en:jak2 inhibitor bms-911543 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2867. en:kanglaite --- r_associated #0: 26 --> en:cytarabine
    n1=en:kanglaite | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2868. en:kunecatechins ointment --- r_associated #0: 26 --> en:cytarabine
    n1=en:kunecatechins ointment | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2869. en:l-ornithine l-aspartate --- r_associated #0: 26 --> en:cytarabine
    n1=en:l-ornithine l-aspartate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2870. en:lactobacillus plantarum strain 299 --- r_associated #0: 26 --> en:cytarabine
    n1=en:lactobacillus plantarum strain 299 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2871. en:levoleucovorin calcium --- r_associated #0: 26 --> en:cytarabine
    n1=en:levoleucovorin calcium | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2872. en:liposomal c-raf antisense oligonucleotide --- r_associated #0: 26 --> en:cytarabine
    n1=en:liposomal c-raf antisense oligonucleotide | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2873. en:listeria monocytogenes-llo-psa vaccine adxs31-142 --- r_associated #0: 26 --> en:cytarabine
    n1=en:listeria monocytogenes-llo-psa vaccine adxs31-142 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2874. en:lmb protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:lmb protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2875. en:lmp-2:419-427 peptide vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:lmp-2:419-427 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2876. en:lorvotuzumab mertansine --- r_associated #0: 26 --> en:cytarabine
    n1=en:lorvotuzumab mertansine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2877. en:mac chemotherapy protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:mac chemotherapy protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2878. en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 --- r_associated #0: 26 --> en:cytarabine
    n1=en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2879. en:maribavir --- r_associated #0: 26 --> en:cytarabine
    n1=en:maribavir | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2880. en:mcpyv tag-specific polyclonal autologous cd8-positive t cells --- r_associated #0: 26 --> en:cytarabine
    n1=en:mcpyv tag-specific polyclonal autologous cd8-positive t cells | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2881. en:medication --- r_associated #0: 26 --> en:cytarabine
    n1=en:medication | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2882. en:mek inhibitor wx-554 --- r_associated #0: 26 --> en:cytarabine
    n1=en:mek inhibitor wx-554 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2883. en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2884. en:metahexamide --- r_associated #0: 26 --> en:cytarabine
    n1=en:metahexamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2885. en:mfc protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:mfc protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2886. en:mini-beam regimen --- r_associated #0: 26 --> en:cytarabine
    n1=en:mini-beam regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2887. en:mk-4280 --- r_associated #0: 26 --> en:cytarabine
    n1=en:mk-4280 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2888. en:mknk1 inhibitor bay 1143269 --- r_associated #0: 26 --> en:cytarabine
    n1=en:mknk1 inhibitor bay 1143269 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2889. en:mogamulizumab --- r_associated #0: 26 --> en:cytarabine
    n1=en:mogamulizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2890. en:monoclonal antibody huhmfg1 --- r_associated #0: 26 --> en:cytarabine
    n1=en:monoclonal antibody huhmfg1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2891. en:monoclonal antibody huj591 --- r_associated #0: 26 --> en:cytarabine
    n1=en:monoclonal antibody huj591 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2892. en:multikinase inhibitor arry614 --- r_associated #0: 26 --> en:cytarabine
    n1=en:multikinase inhibitor arry614 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2893. en:muscadine grape skin extract --- r_associated #0: 26 --> en:cytarabine
    n1=en:muscadine grape skin extract | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2894. en:n(4)-oleoyl cytarabine --- r_associated #0: 26 --> en:cytarabine
    n1=en:n(4)-oleoyl cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2895. en:n4se protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:n4se protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2896. en:nanoparticle-encapsulated doxorubicin hydrochloride --- r_associated #0: 26 --> en:cytarabine
    n1=en:nanoparticle-encapsulated doxorubicin hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2897. en:ncit antineoplastic agent terminology --- r_associated #0: 26 --> en:cytarabine
    n1=en:ncit antineoplastic agent terminology | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2898. en:necitumumab --- r_associated #0: 26 --> en:cytarabine
    n1=en:necitumumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2899. en:nelipepimut-s plus gm-csf vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:nelipepimut-s plus gm-csf vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2900. en:netupitant --- r_associated #0: 26 --> en:cytarabine
    n1=en:netupitant | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2901. en:nicotine patch --- r_associated #0: 26 --> en:cytarabine
    n1=en:nicotine patch | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2902. en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes --- r_associated #0: 26 --> en:cytarabine
    n1=en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2903. en:nucleic acid synthesis inhibitors [moa] --- r_associated #0: 26 --> en:cytarabine
    n1=en:nucleic acid synthesis inhibitors [moa] | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2904. en:oncolytic adenovirus encoding gm-csf --- r_associated #0: 26 --> en:cytarabine
    n1=en:oncolytic adenovirus encoding gm-csf | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2905. en:oprelvekin --- r_associated #0: 26 --> en:cytarabine
    n1=en:oprelvekin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2906. en:p53 peptide vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:p53 peptide vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2907. en:p53-synthetic long peptides vaccine --- r_associated #0: 26 --> en:cytarabine
    n1=en:p53-synthetic long peptides vaccine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2908. en:parathyroid hormone-related protein (1-36) --- r_associated #0: 26 --> en:cytarabine
    n1=en:parathyroid hormone-related protein (1-36) | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2909. en:paricalcitol --- r_associated #0: 26 --> en:cytarabine
    n1=en:paricalcitol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2910. en:parp-1/2 inhibitor abt-767 --- r_associated #0: 26 --> en:cytarabine
    n1=en:parp-1/2 inhibitor abt-767 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2911. en:petrolatum-mineral oil-lanolin-ceresin ointment --- r_associated #0: 26 --> en:cytarabine
    n1=en:petrolatum-mineral oil-lanolin-ceresin ointment | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2912. en:pi3k-delta inhibitor tgr-1202 --- r_associated #0: 26 --> en:cytarabine
    n1=en:pi3k-delta inhibitor tgr-1202 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2913. en:piperazinedione --- r_associated #0: 26 --> en:cytarabine
    n1=en:piperazinedione | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2914. en:psychopharmacologic agent --- r_associated #0: 26 --> en:cytarabine
    n1=en:psychopharmacologic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2915. en:recombinant adenovirus-hifn-beta --- r_associated #0: 26 --> en:cytarabine
    n1=en:recombinant adenovirus-hifn-beta | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2916. en:recombinant thymosin --- r_associated #0: 26 --> en:cytarabine
    n1=en:recombinant thymosin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2917. en:rhubarb/licorice herbal supplement --- r_associated #0: 26 --> en:cytarabine
    n1=en:rhubarb/licorice herbal supplement | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2918. en:ribociclib --- r_associated #0: 26 --> en:cytarabine
    n1=en:ribociclib | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2919. en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2920. en:salicylic acid + coal tar + sulfur --- r_associated #0: 26 --> en:cytarabine
    n1=en:salicylic acid + coal tar + sulfur | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2921. en:shark cartilage extract ae-941 --- r_associated #0: 26 --> en:cytarabine
    n1=en:shark cartilage extract ae-941 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2922. en:sirpa-fc fusion protein tti-621 --- r_associated #0: 26 --> en:cytarabine
    n1=en:sirpa-fc fusion protein tti-621 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2923. en:tacc protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:tacc protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2924. en:technetium tc 99m galactosyl human serum albumin --- r_associated #0: 26 --> en:cytarabine
    n1=en:technetium tc 99m galactosyl human serum albumin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2925. en:technetium tc-99m-nc100692 --- r_associated #0: 26 --> en:cytarabine
    n1=en:technetium tc-99m-nc100692 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2926. en:thalicarpine --- r_associated #0: 26 --> en:cytarabine
    n1=en:thalicarpine | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2927. en:therapeutic autologous lymphocytes --- r_associated #0: 26 --> en:cytarabine
    n1=en:therapeutic autologous lymphocytes | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2928. en:therapeutic testosterone --- r_associated #0: 26 --> en:cytarabine
    n1=en:therapeutic testosterone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2929. en:therapeutic use - qualifier --- r_associated #0: 26 --> en:cytarabine
    n1=en:therapeutic use - qualifier | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2930. en:tlr9 agonist emd 1201081 --- r_associated #0: 26 --> en:cytarabine
    n1=en:tlr9 agonist emd 1201081 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2931. en:trampco protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:trampco protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2932. en:trastuzumab vc-seco-duba --- r_associated #0: 26 --> en:cytarabine
    n1=en:trastuzumab vc-seco-duba | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2933. en:triazinate --- r_associated #0: 26 --> en:cytarabine
    n1=en:triazinate | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2934. en:uch ii protocol --- r_associated #0: 26 --> en:cytarabine
    n1=en:uch ii protocol | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2935. en:valproic acid --- r_associated #0: 26 --> en:cytarabine
    n1=en:valproic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2936. en:vegfr inhibitor krn951 --- r_associated #0: 26 --> en:cytarabine
    n1=en:vegfr inhibitor krn951 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2937. en:verteporfin --- r_associated #0: 26 --> en:cytarabine
    n1=en:verteporfin | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2938. en:weight control agent --- r_associated #0: 26 --> en:cytarabine
    n1=en:weight control agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2939. en:yttrium y 90 daclizumab --- r_associated #0: 26 --> en:cytarabine
    n1=en:yttrium y 90 daclizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2940. en:yttrium y-90 ibritumomab tiuxetan --- r_associated #0: 26 --> en:cytarabine
    n1=en:yttrium y-90 ibritumomab tiuxetan | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2941. en:zirconium zr 89-labeled ro5479599 --- r_associated #0: 26 --> en:cytarabine
    n1=en:zirconium zr 89-labeled ro5479599 | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2942. mal parler à --- r_associated #0: 26 --> en:cytarabine
    n1=mal parler à | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2943. progestérone --- r_associated #0: 26 --> en:cytarabine
    n1=progestérone | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2944. préparation pharmaceutique --- r_associated #0: 26 --> en:cytarabine
    n1=préparation pharmaceutique | n2=en:cytarabine | rel=r_associated | relid=0 | w=26
  2945. E553b --- r_associated #0: 25 --> en:cytarabine
    n1=E553b | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2946. artésunate --- r_associated #0: 25 --> en:cytarabine
    n1=artésunate | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2947. chlorhydrate d'hydralazine --- r_associated #0: 25 --> en:cytarabine
    n1=chlorhydrate d'hydralazine | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2948. dianhydro-galactitol --- r_associated #0: 25 --> en:cytarabine
    n1=dianhydro-galactitol | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2949. en:alcohol deterrents --- r_associated #0: 25 --> en:cytarabine
    n1=en:alcohol deterrents | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2950. en:alendronate sodium --- r_associated #0: 25 --> en:cytarabine
    n1=en:alendronate sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2951. en:anguidine --- r_associated #0: 25 --> en:cytarabine
    n1=en:anguidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2952. en:azaribine --- r_associated #0: 25 --> en:cytarabine
    n1=en:azaribine | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2953. en:baby powder --- r_associated #0: 25 --> en:cytarabine
    n1=en:baby powder | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2954. en:bone cements --- r_associated #0: 25 --> en:cytarabine
    n1=en:bone cements | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2955. en:carbenicillin --- r_associated #0: 25 --> en:cytarabine
    n1=en:carbenicillin | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2956. en:cellulose, oxidized --- r_associated #0: 25 --> en:cytarabine
    n1=en:cellulose, oxidized | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2957. en:cesium cs 137 --- r_associated #0: 25 --> en:cytarabine
    n1=en:cesium cs 137 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2958. en:clindamycin phosphate --- r_associated #0: 25 --> en:cytarabine
    n1=en:clindamycin phosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2959. en:clodronate disodium --- r_associated #0: 25 --> en:cytarabine
    n1=en:clodronate disodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2960. en:cytarabine 100 mg/ml injection --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 100 mg/ml injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2961. en:cytarabine 100mg powder for injection solution vial --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 100mg powder for injection solution vial | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2962. en:cytarabine 20 mg/ml --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2963. en:cytarabine 20 mg/ml [alexan] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml [alexan] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2964. en:cytarabine 20 mg/ml [cytosar] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml [cytosar] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2965. en:cytarabine 20 mg/ml [tarabine pfs] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml [tarabine pfs] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2966. en:cytarabine 20 mg/ml injectable solution --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml injectable solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2967. en:cytarabine 20 mg/ml injectable solution [alexan] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml injectable solution [alexan] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2968. en:cytarabine 20 mg/ml injectable solution [tarabine pfs] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml injectable solution [tarabine pfs] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2969. en:cytarabine 20 mg/ml injection --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 20 mg/ml injection | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2970. en:cytarabine 2gm/vil inj --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 2gm/vil inj | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2971. en:cytarabine 5'-carboxypropylphosphate --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 5'-carboxypropylphosphate | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2972. en:cytarabine 50 mg/ml injectable solution --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 50 mg/ml injectable solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2973. en:cytarabine 50 mg/ml injectable solution [cytosar] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 50 mg/ml injectable solution [cytosar] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2974. en:cytarabine 500mg powder for injection solution vial --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine 500mg powder for injection solution vial | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2975. en:cytarabine adverse reaction --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine adverse reaction | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2976. en:cytarabine allergy --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine allergy | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2977. en:cytarabine c:mcnc:pt:ser/plas:qn --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine c:mcnc:pt:ser/plas:qn | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2978. en:cytarabine hydrochloride --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2979. en:cytarabine in parenteral dosage form --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine in parenteral dosage form | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2980. en:cytarabine injectable product --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injectable product | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2981. en:cytarabine injectable solution --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injectable solution | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2982. en:cytarabine injectable solution [alexan] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injectable solution [alexan] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2983. en:cytarabine injectable solution [cytosar] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injectable solution [cytosar] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2984. en:cytarabine injectable solution [tarabine pfs] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injectable solution [tarabine pfs] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2985. en:cytarabine injectable suspension --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injectable suspension | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2986. en:cytarabine injection [depocyt] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine injection [depocyt] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2987. en:cytarabine intrathecal regimen --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine intrathecal regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2988. en:cytarabine liposomal 50mg/5ml injection 5ml vial --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposomal 50mg/5ml injection 5ml vial | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2989. en:cytarabine liposome --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2990. en:cytarabine liposome 10 mg/ml --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome 10 mg/ml | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2991. en:cytarabine liposome 10 mg/ml [depocyt] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome 10 mg/ml [depocyt] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2992. en:cytarabine liposome 10 mg/ml injection [depocyt] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome 10 mg/ml injection [depocyt] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2993. en:cytarabine liposome 100 mg / daunorubicin liposomal 44 mg injection [vyxeos] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome 100 mg / daunorubicin liposomal 44 mg injection [vyxeos] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2994. en:cytarabine liposome injection [depocyt] --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome injection [depocyt] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2995. en:cytarabine liposome, 10 mg administered --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine liposome, 10 mg administered | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2996. en:cytarabine monophosphate prodrug mb07133 --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine monophosphate prodrug mb07133 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2997. en:cytarabine overdose --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine overdose | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2998. en:cytarabine overdose of undetermined intent --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine overdose of undetermined intent | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  2999. en:cytarabine poisoning of undetermined intent --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine poisoning of undetermined intent | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3000. en:cytarabine subcutaneous regimen --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine subcutaneous regimen | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3001. en:cytarabine syndrome --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine syndrome | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3002. en:cytarabine u:mcnc:pt:ser/plas:qn --- r_associated #0: 25 --> en:cytarabine
    n1=en:cytarabine u:mcnc:pt:ser/plas:qn | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3003. en:demeclocycline hydrochloride --- r_associated #0: 25 --> en:cytarabine
    n1=en:demeclocycline hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3004. en:descaler --- r_associated #0: 25 --> en:cytarabine
    n1=en:descaler | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3005. en:get to know sb --- r_associated #0: 25 --> en:cytarabine
    n1=en:get to know sb | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3006. en:gout suppressants --- r_associated #0: 25 --> en:cytarabine
    n1=en:gout suppressants | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3007. en:hematologic agents --- r_associated #0: 25 --> en:cytarabine
    n1=en:hematologic agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3008. en:human varicella zoster immune globulin --- r_associated #0: 25 --> en:cytarabine
    n1=en:human varicella zoster immune globulin | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3009. en:iodine i 124 --- r_associated #0: 25 --> en:cytarabine
    n1=en:iodine i 124 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3010. en:iodine i-123 --- r_associated #0: 25 --> en:cytarabine
    n1=en:iodine i-123 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3011. en:iridium ir 192 --- r_associated #0: 25 --> en:cytarabine
    n1=en:iridium ir 192 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3012. en:meclofenamate sodium --- r_associated #0: 25 --> en:cytarabine
    n1=en:meclofenamate sodium | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3013. en:meet sb --- r_associated #0: 25 --> en:cytarabine
    n1=en:meet sb | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3014. en:meet somebody --- r_associated #0: 25 --> en:cytarabine
    n1=en:meet somebody | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3015. en:metyrosine --- r_associated #0: 25 --> en:cytarabine
    n1=en:metyrosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3016. en:mouth off at [sb] --- r_associated #0: 25 --> en:cytarabine
    n1=en:mouth off at [sb] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3017. en:muc-1 antigen --- r_associated #0: 25 --> en:cytarabine
    n1=en:muc-1 antigen | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3018. en:palladium pd-103 --- r_associated #0: 25 --> en:cytarabine
    n1=en:palladium pd-103 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3019. en:pesticidal --- r_associated #0: 25 --> en:cytarabine
    n1=en:pesticidal | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3020. en:poly au --- r_associated #0: 25 --> en:cytarabine
    n1=en:poly au | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3021. en:powder [sth] --- r_associated #0: 25 --> en:cytarabine
    n1=en:powder [sth] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3022. en:pyrogen --- r_associated #0: 25 --> en:cytarabine
    n1=en:pyrogen | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3023. en:radiopharmaceutical compound --- r_associated #0: 25 --> en:cytarabine
    n1=en:radiopharmaceutical compound | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3024. en:razoxane --- r_associated #0: 25 --> en:cytarabine
    n1=en:razoxane | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3025. en:renal agents --- r_associated #0: 25 --> en:cytarabine
    n1=en:renal agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3026. en:rubidium rb-82 --- r_associated #0: 25 --> en:cytarabine
    n1=en:rubidium rb-82 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3027. en:simethicone --- r_associated #0: 25 --> en:cytarabine
    n1=en:simethicone | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3028. en:thiotepa --- r_associated #0: 25 --> en:cytarabine
    n1=en:thiotepa | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3029. en:to get to know sb --- r_associated #0: 25 --> en:cytarabine
    n1=en:to get to know sb | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3030. en:to meet sb --- r_associated #0: 25 --> en:cytarabine
    n1=en:to meet sb | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3031. en:to return --- r_associated #0: 25 --> en:cytarabine
    n1=en:to return | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3032. en:tocolytic agents --- r_associated #0: 25 --> en:cytarabine
    n1=en:tocolytic agents | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3033. en:toremifene --- r_associated #0: 25 --> en:cytarabine
    n1=en:toremifene | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3034. en:trifluridine --- r_associated #0: 25 --> en:cytarabine
    n1=en:trifluridine | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3035. en:trilostane --- r_associated #0: 25 --> en:cytarabine
    n1=en:trilostane | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3036. en:vitamin K1 --- r_associated #0: 25 --> en:cytarabine
    n1=en:vitamin K1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3037. lilas d'Espagne --- r_associated #0: 25 --> en:cytarabine
    n1=lilas d'Espagne | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3038. nadroparine calcique --- r_associated #0: 25 --> en:cytarabine
    n1=nadroparine calcique | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3039. talquer [qch] --- r_associated #0: 25 --> en:cytarabine
    n1=talquer [qch] | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3040. tchaï --- r_associated #0: 25 --> en:cytarabine
    n1=tchaï | n2=en:cytarabine | rel=r_associated | relid=0 | w=25
  3041. ASF (anglais) --- r_associated #0: 24 --> en:cytarabine
    n1=ASF (anglais) | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3042. BSQV --- r_associated #0: 24 --> en:cytarabine
    n1=BSQV | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3043. acide valproïque --- r_associated #0: 24 --> en:cytarabine
    n1=acide valproïque | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3044. en:cefpodoxim --- r_associated #0: 24 --> en:cytarabine
    n1=en:cefpodoxim | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3045. en:cisplatinum --- r_associated #0: 24 --> en:cytarabine
    n1=en:cisplatinum | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3046. faire pendant --- r_associated #0: 24 --> en:cytarabine
    n1=faire pendant | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3047. moment décisif --- r_associated #0: 24 --> en:cytarabine
    n1=moment décisif | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3048. éthinyl oestradiol --- r_associated #0: 24 --> en:cytarabine
    n1=éthinyl oestradiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=24
  3049. 5 FU --- r_associated #0: 23 --> en:cytarabine
    n1=5 FU | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3050. agent tératogène --- r_associated #0: 23 --> en:cytarabine
    n1=agent tératogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3051. dactinomycine --- r_associated #0: 23 --> en:cytarabine
    n1=dactinomycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3052. décontracturante --- r_associated #0: 23 --> en:cytarabine
    n1=décontracturante | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3053. en:antienzyme --- r_associated #0: 23 --> en:cytarabine
    n1=en:antienzyme | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3054. en:medicinal allergy --- r_associated #0: 23 --> en:cytarabine
    n1=en:medicinal allergy | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3055. sulfate de magnésie --- r_associated #0: 23 --> en:cytarabine
    n1=sulfate de magnésie | n2=en:cytarabine | rel=r_associated | relid=0 | w=23
  3056. Vaccin contre l'hépatite B --- r_associated #0: 22 --> en:cytarabine
    n1=Vaccin contre l'hépatite B | n2=en:cytarabine | rel=r_associated | relid=0 | w=22
  3057. acide éicosapentaénoïque --- r_associated #0: 22 --> en:cytarabine
    n1=acide éicosapentaénoïque | n2=en:cytarabine | rel=r_associated | relid=0 | w=22
  3058. cancérogène --- r_associated #0: 22 --> en:cytarabine
    n1=cancérogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=22
  3059. en:busulphan --- r_associated #0: 22 --> en:cytarabine
    n1=en:busulphan | n2=en:cytarabine | rel=r_associated | relid=0 | w=22
  3060. sulfate de bléomycine --- r_associated #0: 22 --> en:cytarabine
    n1=sulfate de bléomycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=22
  3061. astringent --- r_associated #0: 21 --> en:cytarabine
    n1=astringent | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3062. capsaïsine --- r_associated #0: 21 --> en:cytarabine
    n1=capsaïsine | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3063. carbonate de lithium --- r_associated #0: 21 --> en:cytarabine
    n1=carbonate de lithium | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3064. centranthe --- r_associated #0: 21 --> en:cytarabine
    n1=centranthe | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3065. en:aneurin --- r_associated #0: 21 --> en:cytarabine
    n1=en:aneurin | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3066. en:antienzyme. --- r_associated #0: 21 --> en:cytarabine
    n1=en:antienzyme. | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3067. en:cobalamine --- r_associated #0: 21 --> en:cytarabine
    n1=en:cobalamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3068. en:corn silk --- r_associated #0: 21 --> en:cytarabine
    n1=en:corn silk | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3069. en:nicotinamide --- r_associated #0: 21 --> en:cytarabine
    n1=en:nicotinamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3070. en:powder [sth] with [sth] --- r_associated #0: 21 --> en:cytarabine
    n1=en:powder [sth] with [sth] | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3071. en:to respond to --- r_associated #0: 21 --> en:cytarabine
    n1=en:to respond to | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3072. en:water purified --- r_associated #0: 21 --> en:cytarabine
    n1=en:water purified | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3073. fluoro-5 cytosine --- r_associated #0: 21 --> en:cytarabine
    n1=fluoro-5 cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3074. gonadotrophine de femmes ménopausées --- r_associated #0: 21 --> en:cytarabine
    n1=gonadotrophine de femmes ménopausées | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3075. nicotinique --- r_associated #0: 21 --> en:cytarabine
    n1=nicotinique | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3076. physiopathique (syndrome) --- r_associated #0: 21 --> en:cytarabine
    n1=physiopathique (syndrome) | n2=en:cytarabine | rel=r_associated | relid=0 | w=21
  3077. Acétaminophène --- r_associated #0: 20 --> en:cytarabine
    n1=Acétaminophène | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3078. Rivaroxaban --- r_associated #0: 20 --> en:cytarabine
    n1=Rivaroxaban | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3079. Rutoside --- r_associated #0: 20 --> en:cytarabine
    n1=Rutoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3080. Stéatite --- r_associated #0: 20 --> en:cytarabine
    n1=Stéatite | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3081. Talc --- r_associated #0: 20 --> en:cytarabine
    n1=Talc | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3082. Temsirolimus --- r_associated #0: 20 --> en:cytarabine
    n1=Temsirolimus | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3083. Thiamine --- r_associated #0: 20 --> en:cytarabine
    n1=Thiamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3084. Trastuzumab --- r_associated #0: 20 --> en:cytarabine
    n1=Trastuzumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3085. arabinoside --- r_associated #0: 20 --> en:cytarabine
    n1=arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3086. aracytine --- r_associated #0: 20 --> en:cytarabine
    n1=aracytine | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3087. cytosine-arabinoside --- r_associated #0: 20 --> en:cytarabine
    n1=cytosine-arabinoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3088. dianhydrogalactitol --- r_associated #0: 20 --> en:cytarabine
    n1=dianhydrogalactitol | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3089. en:ancitabine hydrochloride --- r_associated #0: 20 --> en:cytarabine
    n1=en:ancitabine hydrochloride | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3090. en:carcinogenic --- r_associated #0: 20 --> en:cytarabine
    n1=en:carcinogenic | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3091. en:nucleoside metabolic inhibitor [epc] --- r_associated #0: 20 --> en:cytarabine
    n1=en:nucleoside metabolic inhibitor [epc] | n2=en:cytarabine | rel=r_associated | relid=0 | w=20
  3092. paracétamol --- r_associated #0: 16 --> en:cytarabine
    n1=paracétamol | n2=en:cytarabine | rel=r_associated | relid=0 | w=16
  3093. Acide docosahexaénoïque --- r_associated #0: 15 --> en:cytarabine
    n1=Acide docosahexaénoïque | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3094. Agent biologique --- r_associated #0: 15 --> en:cytarabine
    n1=Agent biologique | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3095. Anhydride arsénieux --- r_associated #0: 15 --> en:cytarabine
    n1=Anhydride arsénieux | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3096. Aténolol --- r_associated #0: 15 --> en:cytarabine
    n1=Aténolol | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3097. Auger (effet) --- r_associated #0: 15 --> en:cytarabine
    n1=Auger (effet) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3098. Bartter (syndrome de) --- r_associated #0: 15 --> en:cytarabine
    n1=Bartter (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3099. Beurmann et Gougerot (maladie de) --- r_associated #0: 15 --> en:cytarabine
    n1=Beurmann et Gougerot (maladie de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3100. Bussuquara (virus) --- r_associated #0: 15 --> en:cytarabine
    n1=Bussuquara (virus) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3101. CABV --- r_associated #0: 15 --> en:cytarabine
    n1=CABV | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3102. Cancérigène --- r_associated #0: 15 --> en:cytarabine
    n1=Cancérigène | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3103. Carlens (sonde de) --- r_associated #0: 15 --> en:cytarabine
    n1=Carlens (sonde de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3104. Centranthe --- r_associated #0: 15 --> en:cytarabine
    n1=Centranthe | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3105. Citrate de magnésium --- r_associated #0: 15 --> en:cytarabine
    n1=Citrate de magnésium | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3106. Clara (cellule de) --- r_associated #0: 15 --> en:cytarabine
    n1=Clara (cellule de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3107. Clé à molette --- r_associated #0: 15 --> en:cytarabine
    n1=Clé à molette | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3108. Coats (syndrome de) --- r_associated #0: 15 --> en:cytarabine
    n1=Coats (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3109. Cobalamine --- r_associated #0: 15 --> en:cytarabine
    n1=Cobalamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3110. Curcumine --- r_associated #0: 15 --> en:cytarabine
    n1=Curcumine | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3111. Danon (maladie de) --- r_associated #0: 15 --> en:cytarabine
    n1=Danon (maladie de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3112. DiGeorge (syndrome de) --- r_associated #0: 15 --> en:cytarabine
    n1=DiGeorge (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3113. Dobrava (virus) --- r_associated #0: 15 --> en:cytarabine
    n1=Dobrava (virus) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3114. E345 --- r_associated #0: 15 --> en:cytarabine
    n1=E345 | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3115. E518 --- r_associated #0: 15 --> en:cytarabine
    n1=E518 | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3116. Facteurs biologiques --- r_associated #0: 15 --> en:cytarabine
    n1=Facteurs biologiques | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3117. Flourens (lois de) --- r_associated #0: 15 --> en:cytarabine
    n1=Flourens (lois de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3118. IBIDS (syndrome) --- r_associated #0: 15 --> en:cytarabine
    n1=IBIDS (syndrome) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3119. Olanzapine --- r_associated #0: 15 --> en:cytarabine
    n1=Olanzapine | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3120. Oxyde de magnésium --- r_associated #0: 15 --> en:cytarabine
    n1=Oxyde de magnésium | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3121. Relaxant musculaire --- r_associated #0: 15 --> en:cytarabine
    n1=Relaxant musculaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3122. Rutine --- r_associated #0: 15 --> en:cytarabine
    n1=Rutine | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3123. Sulfate de zinc --- r_associated #0: 15 --> en:cytarabine
    n1=Sulfate de zinc | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3124. aphtose (grande) de Touraine --- r_associated #0: 15 --> en:cytarabine
    n1=aphtose (grande) de Touraine | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3125. cellules dendritiques autologues pulsées avec de l'alpha-galactosylcéramide --- r_associated #0: 15 --> en:cytarabine
    n1=cellules dendritiques autologues pulsées avec de l'alpha-galactosylcéramide | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3126. ciseaux (marche en) --- r_associated #0: 15 --> en:cytarabine
    n1=ciseaux (marche en) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3127. conjugué anticorps-médicament anti-c-kit lop628 --- r_associated #0: 15 --> en:cytarabine
    n1=conjugué anticorps-médicament anti-c-kit lop628 | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3128. cyclope (oeil) --- r_associated #0: 15 --> en:cytarabine
    n1=cyclope (oeil) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3129. cytomégalovirus (infection congénitale à ) --- r_associated #0: 15 --> en:cytarabine
    n1=cytomégalovirus (infection congénitale à ) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3130. eau (intoxication par l') --- r_associated #0: 15 --> en:cytarabine
    n1=eau (intoxication par l') | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3131. en:informatics language --- r_associated #0: 15 --> en:cytarabine
    n1=en:informatics language | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3132. en:medicament --- r_associated #0: 15 --> en:cytarabine
    n1=en:medicament | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3133. en:medicinal product --- r_associated #0: 15 --> en:cytarabine
    n1=en:medicinal product | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3134. en:programming language --- r_associated #0: 15 --> en:cytarabine
    n1=en:programming language | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3135. en:tablet --- r_associated #0: 15 --> en:cytarabine
    n1=en:tablet | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3136. fluorescence induite par la tétracycline (test de) --- r_associated #0: 15 --> en:cytarabine
    n1=fluorescence induite par la tétracycline (test de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3137. medicament --- r_associated #0: 15 --> en:cytarabine
    n1=medicament | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3138. médicament --- r_associated #0: 15 --> en:cytarabine
    n1=médicament | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3139. obéir à --- r_associated #0: 15 --> en:cytarabine
    n1=obéir à | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3140. progéroïde de de Barsy (syndrome) --- r_associated #0: 15 --> en:cytarabine
    n1=progéroïde de de Barsy (syndrome) | n2=en:cytarabine | rel=r_associated | relid=0 | w=15
  3141. 5 fluoro-uracile --- r_associated #0: 10 --> en:cytarabine
    n1=5 fluoro-uracile | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3142. 5FC --- r_associated #0: 10 --> en:cytarabine
    n1=5FC | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3143. Acétylcystéine --- r_associated #0: 10 --> en:cytarabine
    n1=Acétylcystéine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3144. Antimétabolite --- r_associated #0: 10 --> en:cytarabine
    n1=Antimétabolite | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3145. Ara-C --- r_associated #0: 10 --> en:cytarabine
    n1=Ara-C | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3146. Asparaginase --- r_associated #0: 10 --> en:cytarabine
    n1=Asparaginase | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3147. Axitinib --- r_associated #0: 10 --> en:cytarabine
    n1=Axitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3148. Baclofène --- r_associated #0: 10 --> en:cytarabine
    n1=Baclofène | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3149. Barite --- r_associated #0: 10 --> en:cytarabine
    n1=Barite | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3150. Baryte --- r_associated #0: 10 --> en:cytarabine
    n1=Baryte | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3151. Busulfan --- r_associated #0: 10 --> en:cytarabine
    n1=Busulfan | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3152. Cannabidiol --- r_associated #0: 10 --> en:cytarabine
    n1=Cannabidiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3153. Capsaïcine --- r_associated #0: 10 --> en:cytarabine
    n1=Capsaïcine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3154. Capécitabine --- r_associated #0: 10 --> en:cytarabine
    n1=Capécitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3155. Carmustine --- r_associated #0: 10 --> en:cytarabine
    n1=Carmustine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3156. Cimétidine --- r_associated #0: 10 --> en:cytarabine
    n1=Cimétidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3157. Cisplatine --- r_associated #0: 10 --> en:cytarabine
    n1=Cisplatine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3158. Clarithromycine --- r_associated #0: 10 --> en:cytarabine
    n1=Clarithromycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3159. Cortisol --- r_associated #0: 10 --> en:cytarabine
    n1=Cortisol | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3160. Cyclophosphamide --- r_associated #0: 10 --> en:cytarabine
    n1=Cyclophosphamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3161. Cytarabine --- r_associated #0: 10 --> en:cytarabine
    n1=Cytarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3162. Cétirizine --- r_associated #0: 10 --> en:cytarabine
    n1=Cétirizine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3163. Dabrafenib --- r_associated #0: 10 --> en:cytarabine
    n1=Dabrafenib | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3164. Dapsone --- r_associated #0: 10 --> en:cytarabine
    n1=Dapsone | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3165. Dasatinib --- r_associated #0: 10 --> en:cytarabine
    n1=Dasatinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3166. Dieck (méthode de) --- r_associated #0: 10 --> en:cytarabine
    n1=Dieck (méthode de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3167. Digitoxine --- r_associated #0: 10 --> en:cytarabine
    n1=Digitoxine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3168. Diéthylstilbestrol --- r_associated #0: 10 --> en:cytarabine
    n1=Diéthylstilbestrol | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3169. Dobutamine --- r_associated #0: 10 --> en:cytarabine
    n1=Dobutamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3170. Eau distillée --- r_associated #0: 10 --> en:cytarabine
    n1=Eau distillée | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3171. Enzalutamide --- r_associated #0: 10 --> en:cytarabine
    n1=Enzalutamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3172. Fludarabine --- r_associated #0: 10 --> en:cytarabine
    n1=Fludarabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3173. Fluorouracile --- r_associated #0: 10 --> en:cytarabine
    n1=Fluorouracile | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3174. Gabapentine --- r_associated #0: 10 --> en:cytarabine
    n1=Gabapentine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3175. Gardénal --- r_associated #0: 10 --> en:cytarabine
    n1=Gardénal | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3176. Gemcitabine --- r_associated #0: 10 --> en:cytarabine
    n1=Gemcitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3177. Glutathion --- r_associated #0: 10 --> en:cytarabine
    n1=Glutathion | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3178. Hydrocortisone --- r_associated #0: 10 --> en:cytarabine
    n1=Hydrocortisone | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3179. Ibrutinib --- r_associated #0: 10 --> en:cytarabine
    n1=Ibrutinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3180. Indométacine --- r_associated #0: 10 --> en:cytarabine
    n1=Indométacine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3181. Inositol --- r_associated #0: 10 --> en:cytarabine
    n1=Inositol | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3182. Inuline --- r_associated #0: 10 --> en:cytarabine
    n1=Inuline | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3183. Ipilimumab --- r_associated #0: 10 --> en:cytarabine
    n1=Ipilimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3184. Isoniazide --- r_associated #0: 10 --> en:cytarabine
    n1=Isoniazide | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3185. Isotrétinoïne --- r_associated #0: 10 --> en:cytarabine
    n1=Isotrétinoïne | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3186. Lamivudine --- r_associated #0: 10 --> en:cytarabine
    n1=Lamivudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3187. Langage de Programmation --- r_associated #0: 10 --> en:cytarabine
    n1=Langage de Programmation | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3188. Levine-Critchley (syndrome de) --- r_associated #0: 10 --> en:cytarabine
    n1=Levine-Critchley (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3189. Lisfranc (fracture de) --- r_associated #0: 10 --> en:cytarabine
    n1=Lisfranc (fracture de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3190. Lisinopril --- r_associated #0: 10 --> en:cytarabine
    n1=Lisinopril | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3191. Louis-Bar (syndrome de) --- r_associated #0: 10 --> en:cytarabine
    n1=Louis-Bar (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3192. Lovastatine --- r_associated #0: 10 --> en:cytarabine
    n1=Lovastatine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3193. Lévofloxacine --- r_associated #0: 10 --> en:cytarabine
    n1=Lévofloxacine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3194. Macitentan --- r_associated #0: 10 --> en:cytarabine
    n1=Macitentan | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3195. Modafinil --- r_associated #0: 10 --> en:cytarabine
    n1=Modafinil | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3196. Musto (coloration de) --- r_associated #0: 10 --> en:cytarabine
    n1=Musto (coloration de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3197. Mutagène --- r_associated #0: 10 --> en:cytarabine
    n1=Mutagène | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3198. Médicament --- r_associated #0: 10 --> en:cytarabine
    n1=Médicament | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3199. Médicaments vétérinaires --- r_associated #0: 10 --> en:cytarabine
    n1=Médicaments vétérinaires | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3200. Naproxène --- r_associated #0: 10 --> en:cytarabine
    n1=Naproxène | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3201. Natalizumab --- r_associated #0: 10 --> en:cytarabine
    n1=Natalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3202. Nicotinamide --- r_associated #0: 10 --> en:cytarabine
    n1=Nicotinamide | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3203. Okihiro (syndrome de) --- r_associated #0: 10 --> en:cytarabine
    n1=Okihiro (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3204. Omalizumab --- r_associated #0: 10 --> en:cytarabine
    n1=Omalizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3205. Oméprazole --- r_associated #0: 10 --> en:cytarabine
    n1=Oméprazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3206. Pentamidine --- r_associated #0: 10 --> en:cytarabine
    n1=Pentamidine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3207. Pentoxifylline --- r_associated #0: 10 --> en:cytarabine
    n1=Pentoxifylline | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3208. Pestalozzi (anévrysme de) --- r_associated #0: 10 --> en:cytarabine
    n1=Pestalozzi (anévrysme de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3209. Pesticide --- r_associated #0: 10 --> en:cytarabine
    n1=Pesticide | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3210. Phtirius inguinalis (ou pubis ) --- r_associated #0: 10 --> en:cytarabine
    n1=Phtirius inguinalis (ou pubis ) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3211. Phylloquinone --- r_associated #0: 10 --> en:cytarabine
    n1=Phylloquinone | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3212. Phénobarbital --- r_associated #0: 10 --> en:cytarabine
    n1=Phénobarbital | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3213. Piroxicam --- r_associated #0: 10 --> en:cytarabine
    n1=Piroxicam | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3214. Polydextrose --- r_associated #0: 10 --> en:cytarabine
    n1=Polydextrose | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3215. Polyéthylène glycol --- r_associated #0: 10 --> en:cytarabine
    n1=Polyéthylène glycol | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3216. Posaconazole --- r_associated #0: 10 --> en:cytarabine
    n1=Posaconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3217. Progestérone --- r_associated #0: 10 --> en:cytarabine
    n1=Progestérone | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3218. Pénicillamine --- r_associated #0: 10 --> en:cytarabine
    n1=Pénicillamine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3219. Ramipril --- r_associated #0: 10 --> en:cytarabine
    n1=Ramipril | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3220. Ritter-Lyell (syndrome de) --- r_associated #0: 10 --> en:cytarabine
    n1=Ritter-Lyell (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3221. Rivalta (réaction de) --- r_associated #0: 10 --> en:cytarabine
    n1=Rivalta (réaction de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3222. Spanner --- r_associated #0: 10 --> en:cytarabine
    n1=Spanner | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3223. Sulfate de magnésium --- r_associated #0: 10 --> en:cytarabine
    n1=Sulfate de magnésium | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3224. Ter Berg-Bijlsma (syndrome de) --- r_associated #0: 10 --> en:cytarabine
    n1=Ter Berg-Bijlsma (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3225. Thévenard (syndrome de) --- r_associated #0: 10 --> en:cytarabine
    n1=Thévenard (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3226. Trendelenburg (signe de) --- r_associated #0: 10 --> en:cytarabine
    n1=Trendelenburg (signe de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3227. Trioxyde d'arsenic --- r_associated #0: 10 --> en:cytarabine
    n1=Trioxyde d'arsenic | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3228. Trétinoïne --- r_associated #0: 10 --> en:cytarabine
    n1=Trétinoïne | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3229. Tératogène --- r_associated #0: 10 --> en:cytarabine
    n1=Tératogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3230. Vinblastine --- r_associated #0: 10 --> en:cytarabine
    n1=Vinblastine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3231. Vitamine B1 --- r_associated #0: 10 --> en:cytarabine
    n1=Vitamine B1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3232. Ward (triangle de) --- r_associated #0: 10 --> en:cytarabine
    n1=Ward (triangle de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3233. Warfarine --- r_associated #0: 10 --> en:cytarabine
    n1=Warfarine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3234. Zolmitriptan --- r_associated #0: 10 --> en:cytarabine
    n1=Zolmitriptan | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3235. aller bien ensemble --- r_associated #0: 10 --> en:cytarabine
    n1=aller bien ensemble | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3236. analogue de l'hormone de libération des gonadotrophines --- r_associated #0: 10 --> en:cytarabine
    n1=analogue de l'hormone de libération des gonadotrophines | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3237. antagoniste du récepteur A2A de l'adénosine PBF-509 --- r_associated #0: 10 --> en:cytarabine
    n1=antagoniste du récepteur A2A de l'adénosine PBF-509 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3238. antagoniste du récepteur des androgènes ARN-509 --- r_associated #0: 10 --> en:cytarabine
    n1=antagoniste du récepteur des androgènes ARN-509 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3239. antagoniste du récepteur des androgènes SHR3680 --- r_associated #0: 10 --> en:cytarabine
    n1=antagoniste du récepteur des androgènes SHR3680 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3240. barytine --- r_associated #0: 10 --> en:cytarabine
    n1=barytine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3241. bortezomib --- r_associated #0: 10 --> en:cytarabine
    n1=bortezomib | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3242. butyryl-coenzyme A-déshydrogénase --- r_associated #0: 10 --> en:cytarabine
    n1=butyryl-coenzyme A-déshydrogénase | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3243. carbénicilline --- r_associated #0: 10 --> en:cytarabine
    n1=carbénicilline | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3244. clef à molette --- r_associated #0: 10 --> en:cytarabine
    n1=clef à molette | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3245. colatier --- r_associated #0: 10 --> en:cytarabine
    n1=colatier | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3246. crève-coeur --- r_associated #0: 10 --> en:cytarabine
    n1=crève-coeur | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3247. daclizumab --- r_associated #0: 10 --> en:cytarabine
    n1=daclizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3248. diméthylsulfoxyde --- r_associated #0: 10 --> en:cytarabine
    n1=diméthylsulfoxyde | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3249. déchirement --- r_associated #0: 10 --> en:cytarabine
    n1=déchirement | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3250. détartrant --- r_associated #0: 10 --> en:cytarabine
    n1=détartrant | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3251. en:5-fluorocytosine --- r_associated #0: 10 --> en:cytarabine
    n1=en:5-fluorocytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3252. en:Auger's effect --- r_associated #0: 10 --> en:cytarabine
    n1=en:Auger's effect | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3253. en:Behçet's Syndrome --- r_associated #0: 10 --> en:cytarabine
    n1=en:Behçet's Syndrome | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3254. en:Carlens' tube --- r_associated #0: 10 --> en:cytarabine
    n1=en:Carlens' tube | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3255. en:Clara's cell --- r_associated #0: 10 --> en:cytarabine
    n1=en:Clara's cell | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3256. en:Dobrava virus --- r_associated #0: 10 --> en:cytarabine
    n1=en:Dobrava virus | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3257. en:Flourens'laws --- r_associated #0: 10 --> en:cytarabine
    n1=en:Flourens'laws | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3258. en:adjustable spanner --- r_associated #0: 10 --> en:cytarabine
    n1=en:adjustable spanner | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3259. en:adjustable wrench --- r_associated #0: 10 --> en:cytarabine
    n1=en:adjustable wrench | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3260. en:aphtosis --- r_associated #0: 10 --> en:cytarabine
    n1=en:aphtosis | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3261. en:busulphan. --- r_associated #0: 10 --> en:cytarabine
    n1=en:busulphan. | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3262. en:cancer-causing --- r_associated #0: 10 --> en:cytarabine
    n1=en:cancer-causing | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3263. en:clef --- r_associated #0: 10 --> en:cytarabine
    n1=en:clef | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3264. en:congenital infection with cytomegalovirus --- r_associated #0: 10 --> en:cytarabine
    n1=en:congenital infection with cytomegalovirus | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3265. en:cyclops eye --- r_associated #0: 10 --> en:cytarabine
    n1=en:cyclops eye | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3266. en:do as somebody says --- r_associated #0: 10 --> en:cytarabine
    n1=en:do as somebody says | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3267. en:do as somebody tells you --- r_associated #0: 10 --> en:cytarabine
    n1=en:do as somebody tells you | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3268. en:do what somebody says --- r_associated #0: 10 --> en:cytarabine
    n1=en:do what somebody says | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3269. en:erythropoietin --- r_associated #0: 10 --> en:cytarabine
    n1=en:erythropoietin | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3270. en:field [sth] --- r_associated #0: 10 --> en:cytarabine
    n1=en:field [sth] | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3271. en:get acquainted --- r_associated #0: 10 --> en:cytarabine
    n1=en:get acquainted | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3272. en:haematopoietin --- r_associated #0: 10 --> en:cytarabine
    n1=en:haematopoietin | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3273. en:isopréniques. --- r_associated #0: 10 --> en:cytarabine
    n1=en:isopréniques. | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3274. en:medicine --- r_associated #0: 10 --> en:cytarabine
    n1=en:medicine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3275. en:phenobarbitone --- r_associated #0: 10 --> en:cytarabine
    n1=en:phenobarbitone | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3276. en:physiopathic syndrome --- r_associated #0: 10 --> en:cytarabine
    n1=en:physiopathic syndrome | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3277. en:pill --- r_associated #0: 10 --> en:cytarabine
    n1=en:pill | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3278. en:progesterone --- r_associated #0: 10 --> en:cytarabine
    n1=en:progesterone | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3279. en:return [sth] --- r_associated #0: 10 --> en:cytarabine
    n1=en:return [sth] | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3280. en:scissors gait --- r_associated #0: 10 --> en:cytarabine
    n1=en:scissors gait | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3281. en:strike up an acquaintance with sb --- r_associated #0: 10 --> en:cytarabine
    n1=en:strike up an acquaintance with sb | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3282. en:tetracyclin-induced fluorescence test --- r_associated #0: 10 --> en:cytarabine
    n1=en:tetracyclin-induced fluorescence test | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3283. en:to strike up an acquaintance with sb --- r_associated #0: 10 --> en:cytarabine
    n1=en:to strike up an acquaintance with sb | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3284. en:type of endotracheal tube with two lumens --- r_associated #0: 10 --> en:cytarabine
    n1=en:type of endotracheal tube with two lumens | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3285. en:unblocking --- r_associated #0: 10 --> en:cytarabine
    n1=en:unblocking | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3286. en:vitamin B1 --- r_associated #0: 10 --> en:cytarabine
    n1=en:vitamin B1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3287. en:vitamin k1 --- r_associated #0: 10 --> en:cytarabine
    n1=en:vitamin k1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3288. en:water intoxication --- r_associated #0: 10 --> en:cytarabine
    n1=en:water intoxication | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3289. gardénal --- r_associated #0: 10 --> en:cytarabine
    n1=gardénal | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3290. inhibiteur de la thymidylate synthase ciblant le récepteur alpha-folate ONX-0801 --- r_associated #0: 10 --> en:cytarabine
    n1=inhibiteur de la thymidylate synthase ciblant le récepteur alpha-folate ONX-0801 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3291. inhibiteur du récepteur des androgènes EPI-506 --- r_associated #0: 10 --> en:cytarabine
    n1=inhibiteur du récepteur des androgènes EPI-506 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3292. isométrie (règle d') --- r_associated #0: 10 --> en:cytarabine
    n1=isométrie (règle d') | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3293. isotonique (exercice) --- r_associated #0: 10 --> en:cytarabine
    n1=isotonique (exercice) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3294. match --- r_associated #0: 10 --> en:cytarabine
    n1=match | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3295. miel
    (substance)
     --- r_associated #0: 10 --> en:cytarabine
    n1=miel
    (substance)
    | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3296. mot de réponse --- r_associated #0: 10 --> en:cytarabine
    n1=mot de réponse | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3297. médicaments --- r_associated #0: 10 --> en:cytarabine
    n1=médicaments | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3298. oligonucléotide antisens du récepteur des androgènes AZD5312 --- r_associated #0: 10 --> en:cytarabine
    n1=oligonucléotide antisens du récepteur des androgènes AZD5312 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3299. oligonucléotide antisens du récepteur des androgènes EZN-4176 --- r_associated #0: 10 --> en:cytarabine
    n1=oligonucléotide antisens du récepteur des androgènes EZN-4176 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3300. omentum (petit) --- r_associated #0: 10 --> en:cytarabine
    n1=omentum (petit) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3301. peste porcine africaine --- r_associated #0: 10 --> en:cytarabine
    n1=peste porcine africaine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3302. phénacétine (néphrotoxicité de la) --- r_associated #0: 10 --> en:cytarabine
    n1=phénacétine (néphrotoxicité de la) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3303. protéine de fusion Fc du récepteur de type 2B de l'activine STM 434 --- r_associated #0: 10 --> en:cytarabine
    n1=protéine de fusion Fc du récepteur de type 2B de l'activine STM 434 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3304. styptic --- r_associated #0: 10 --> en:cytarabine
    n1=styptic | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3305. timbre à la nicotine --- r_associated #0: 10 --> en:cytarabine
    n1=timbre à la nicotine | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3306. transit baryté --- r_associated #0: 10 --> en:cytarabine
    n1=transit baryté | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3307. van't Hoff-Arrhenius (loi de) --- r_associated #0: 10 --> en:cytarabine
    n1=van't Hoff-Arrhenius (loi de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3308. vitamine b1 --- r_associated #0: 10 --> en:cytarabine
    n1=vitamine b1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3309. Ézétimibe --- r_associated #0: 10 --> en:cytarabine
    n1=Ézétimibe | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3310. éthique (d'un essai randomisé) --- r_associated #0: 10 --> en:cytarabine
    n1=éthique (d'un essai randomisé) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3311. évitement (conduite d') --- r_associated #0: 10 --> en:cytarabine
    n1=évitement (conduite d') | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  3312. Abatacept --- r_associated #0: 5 --> en:cytarabine
    n1=Abatacept | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3313. Acide valproïque --- r_associated #0: 5 --> en:cytarabine
    n1=Acide valproïque | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3314. Apicomplexa --- r_associated #0: 5 --> en:cytarabine
    n1=Apicomplexa | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3315. Apis mellifera --- r_associated #0: 5 --> en:cytarabine
    n1=Apis mellifera | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3316. Apixaban --- r_associated #0: 5 --> en:cytarabine
    n1=Apixaban | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3317. Auranofine --- r_associated #0: 5 --> en:cytarabine
    n1=Auranofine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3318. BVT --- r_associated #0: 5 --> en:cytarabine
    n1=BVT | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3319. Baricitinib --- r_associated #0: 5 --> en:cytarabine
    n1=Baricitinib | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3320. Bevacizumab --- r_associated #0: 5 --> en:cytarabine
    n1=Bevacizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3321. CWV --- r_associated #0: 5 --> en:cytarabine
    n1=CWV | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3322. Cabassou (virus) --- r_associated #0: 5 --> en:cytarabine
    n1=Cabassou (virus) | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3323. Chlorhydrate de doxorubicine --- r_associated #0: 5 --> en:cytarabine
    n1=Chlorhydrate de doxorubicine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3324. Daclatasvir --- r_associated #0: 5 --> en:cytarabine
    n1=Daclatasvir | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3325. Dextrane --- r_associated #0: 5 --> en:cytarabine
    n1=Dextrane | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3326. Emtricitabine --- r_associated #0: 5 --> en:cytarabine
    n1=Emtricitabine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3327. FLT3 gene --- r_associated #0: 5 --> en:cytarabine
    n1=FLT3 gene | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3328. FLT4 gene --- r_associated #0: 5 --> en:cytarabine
    n1=FLT4 gene | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3329. Faire connaissance --- r_associated #0: 5 --> en:cytarabine
    n1=Faire connaissance | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3330. Finastéride --- r_associated #0: 5 --> en:cytarabine
    n1=Finastéride | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3331. Liraglutide --- r_associated #0: 5 --> en:cytarabine
    n1=Liraglutide | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3332. Nicolau et B?lu? (syndrome de) --- r_associated #0: 5 --> en:cytarabine
    n1=Nicolau et B?lu? (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3333. PI 3-kinases --- r_associated #0: 5 --> en:cytarabine
    n1=PI 3-kinases | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3334. Rituximab --- r_associated #0: 5 --> en:cytarabine
    n1=Rituximab | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3335. Répondre à --- r_associated #0: 5 --> en:cytarabine
    n1=Répondre à | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3336. Tocilizumab --- r_associated #0: 5 --> en:cytarabine
    n1=Tocilizumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3337. Vancomycine --- r_associated #0: 5 --> en:cytarabine
    n1=Vancomycine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3338. Zidovudine --- r_associated #0: 5 --> en:cytarabine
    n1=Zidovudine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3339. aphtose bipolaire --- r_associated #0: 5 --> en:cytarabine
    n1=aphtose bipolaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3340. aphtose de Touraine --- r_associated #0: 5 --> en:cytarabine
    n1=aphtose de Touraine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3341. apicolyse --- r_associated #0: 5 --> en:cytarabine
    n1=apicolyse | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3342. apicoplaste --- r_associated #0: 5 --> en:cytarabine
    n1=apicoplaste | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3343. apigénol --- r_associated #0: 5 --> en:cytarabine
    n1=apigénol | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3344. apiol --- r_associated #0: 5 --> en:cytarabine
    n1=apiol | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3345. apiose --- r_associated #0: 5 --> en:cytarabine
    n1=apiose | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3346. augmentation de l'être humain --- r_associated #0: 5 --> en:cytarabine
    n1=augmentation de l'être humain | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3347. augnathe --- r_associated #0: 5 --> en:cytarabine
    n1=augnathe | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3348. butanol --- r_associated #0: 5 --> en:cytarabine
    n1=butanol | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3349. butanol extractible iodine --- r_associated #0: 5 --> en:cytarabine
    n1=butanol extractible iodine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3350. butoconazole --- r_associated #0: 5 --> en:cytarabine
    n1=butoconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3351. butyrobétaïne --- r_associated #0: 5 --> en:cytarabine
    n1=butyrobétaïne | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3352. butyrophénone --- r_associated #0: 5 --> en:cytarabine
    n1=butyrophénone | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3353. butyryl-coenzyme A --- r_associated #0: 5 --> en:cytarabine
    n1=butyryl-coenzyme A | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3354. butée de hanche --- r_associated #0: 5 --> en:cytarabine
    n1=butée de hanche | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3355. butée de l'épaule --- r_associated #0: 5 --> en:cytarabine
    n1=butée de l'épaule | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3356. butée osseuse --- r_associated #0: 5 --> en:cytarabine
    n1=butée osseuse | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3357. carnet de santé --- r_associated #0: 5 --> en:cytarabine
    n1=carnet de santé | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3358. carnet de soins --- r_associated #0: 5 --> en:cytarabine
    n1=carnet de soins | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3359. cellules lymphocytaires T autologues exprimant CAR-CD3zeta-4-1BB anti-CD20 --- r_associated #0: 5 --> en:cytarabine
    n1=cellules lymphocytaires T autologues exprimant CAR-CD3zeta-4-1BB anti-CD20 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3360. clarification hépatocytaire --- r_associated #0: 5 --> en:cytarabine
    n1=clarification hépatocytaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3361. cyclopeptide --- r_associated #0: 5 --> en:cytarabine
    n1=cyclopeptide | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3362. cyclophiline --- r_associated #0: 5 --> en:cytarabine
    n1=cyclophiline | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3363. cyclophorie --- r_associated #0: 5 --> en:cytarabine
    n1=cyclophorie | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3364. cytomorphologie --- r_associated #0: 5 --> en:cytarabine
    n1=cytomorphologie | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3365. cytomorphologique --- r_associated #0: 5 --> en:cytarabine
    n1=cytomorphologique | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3366. cytométrie de flux --- r_associated #0: 5 --> en:cytarabine
    n1=cytométrie de flux | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3367. cytopathie mitochondriale --- r_associated #0: 5 --> en:cytarabine
    n1=cytopathie mitochondriale | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3368. cytopathogène --- r_associated #0: 5 --> en:cytarabine
    n1=cytopathogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3369. cytophile --- r_associated #0: 5 --> en:cytarabine
    n1=cytophile | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3370. cytophilie --- r_associated #0: 5 --> en:cytarabine
    n1=cytophilie | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3371. cytoplasme --- r_associated #0: 5 --> en:cytarabine
    n1=cytoplasme | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3372. cytoplasmique --- r_associated #0: 5 --> en:cytarabine
    n1=cytoplasmique | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3373. cytoponction --- r_associated #0: 5 --> en:cytarabine
    n1=cytoponction | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3374. cytoponction cervicale --- r_associated #0: 5 --> en:cytarabine
    n1=cytoponction cervicale | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3375. cytoprotection --- r_associated #0: 5 --> en:cytarabine
    n1=cytoprotection | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3376. cytosine --- r_associated #0: 5 --> en:cytarabine
    n1=cytosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3377. danse de Saint Guy --- r_associated #0: 5 --> en:cytarabine
    n1=danse de Saint Guy | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3378. danse des hiles --- r_associated #0: 5 --> en:cytarabine
    n1=danse des hiles | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3379. dantrolène --- r_associated #0: 5 --> en:cytarabine
    n1=dantrolène | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3380. dapaglifozine --- r_associated #0: 5 --> en:cytarabine
    n1=dapaglifozine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3381. dexaméthasone (test à la) --- r_associated #0: 5 --> en:cytarabine
    n1=dexaméthasone (test à la) | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3382. digestibilité --- r_associated #0: 5 --> en:cytarabine
    n1=digestibilité | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3383. digestion chlorhydropeptique --- r_associated #0: 5 --> en:cytarabine
    n1=digestion chlorhydropeptique | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3384. digestion des glucides --- r_associated #0: 5 --> en:cytarabine
    n1=digestion des glucides | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3385. digestion des lipides --- r_associated #0: 5 --> en:cytarabine
    n1=digestion des lipides | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3386. digestion des protéines --- r_associated #0: 5 --> en:cytarabine
    n1=digestion des protéines | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3387. digestion entérocytaire --- r_associated #0: 5 --> en:cytarabine
    n1=digestion entérocytaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3388. digestion intraluminale --- r_associated #0: 5 --> en:cytarabine
    n1=digestion intraluminale | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3389. digitaline --- r_associated #0: 5 --> en:cytarabine
    n1=digitaline | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3390. digitalisation de l'avant-bras --- r_associated #0: 5 --> en:cytarabine
    n1=digitalisation de l'avant-bras | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3391. digitalose --- r_associated #0: 5 --> en:cytarabine
    n1=digitalose | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3392. digitations hippocampiques --- r_associated #0: 5 --> en:cytarabine
    n1=digitations hippocampiques | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3393. digitiforme --- r_associated #0: 5 --> en:cytarabine
    n1=digitiforme | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3394. digitonine --- r_associated #0: 5 --> en:cytarabine
    n1=digitonine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3395. digitonoside --- r_associated #0: 5 --> en:cytarabine
    n1=digitonoside | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3396. digitopulpite squameuse --- r_associated #0: 5 --> en:cytarabine
    n1=digitopulpite squameuse | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3397. digitoxigénine --- r_associated #0: 5 --> en:cytarabine
    n1=digitoxigénine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3398. digitoxose --- r_associated #0: 5 --> en:cytarabine
    n1=digitoxose | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3399. eau boriquée --- r_associated #0: 5 --> en:cytarabine
    n1=eau boriquée | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3400. eau conditionnée --- r_associated #0: 5 --> en:cytarabine
    n1=eau conditionnée | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3401. eau de Javel --- r_associated #0: 5 --> en:cytarabine
    n1=eau de Javel | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3402. eau de Labarraque --- r_associated #0: 5 --> en:cytarabine
    n1=eau de Labarraque | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3403. eau de baignade --- r_associated #0: 5 --> en:cytarabine
    n1=eau de baignade | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3404. eau de loisir --- r_associated #0: 5 --> en:cytarabine
    n1=eau de loisir | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3405. eau de piscine --- r_associated #0: 5 --> en:cytarabine
    n1=eau de piscine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3406. eau de source --- r_associated #0: 5 --> en:cytarabine
    n1=eau de source | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3407. eau destinée à la consommation humaine --- r_associated #0: 5 --> en:cytarabine
    n1=eau destinée à la consommation humaine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3408. eau destinée à un usage alimentaire --- r_associated #0: 5 --> en:cytarabine
    n1=eau destinée à un usage alimentaire | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3409. eau déminéralisée --- r_associated #0: 5 --> en:cytarabine
    n1=eau déminéralisée | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3410. en:(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid --- r_associated #0: 5 --> en:cytarabine
    n1=en:(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3411. en:DHA --- r_associated #0: 5 --> en:cytarabine
    n1=en:DHA | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3412. en:address [sth] --- r_associated #0: 5 --> en:cytarabine
    n1=en:address [sth] | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3413. en:carcinogenic agent --- r_associated #0: 5 --> en:cytarabine
    n1=en:carcinogenic agent | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3414. en:cervonic acid --- r_associated #0: 5 --> en:cytarabine
    n1=en:cervonic acid | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3415. flubendazole --- r_associated #0: 5 --> en:cytarabine
    n1=flubendazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3416. fluconazole --- r_associated #0: 5 --> en:cytarabine
    n1=fluconazole | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3417. fluctuation du rythme cardiaque foetal --- r_associated #0: 5 --> en:cytarabine
    n1=fluctuation du rythme cardiaque foetal | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3418. fluctuation quantique --- r_associated #0: 5 --> en:cytarabine
    n1=fluctuation quantique | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3419. fluoro --- r_associated #0: 5 --> en:cytarabine
    n1=fluoro | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3420. lymphocytes CD8+ réactifs au MART-1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes CD8+ réactifs au MART-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3421. lymphocytes T CD4-positifs autologues exprimant le CAR T1E28Z --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T CD4-positifs autologues exprimant le CAR T1E28Z | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3422. lymphocytes T CD8+ autologues spécifiques du mélanome NY-ESO-1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T CD8+ autologues spécifiques du mélanome NY-ESO-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3423. lymphocytes T allogéniques transduits par CAR anti-EGFRvIII --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T allogéniques transduits par CAR anti-EGFRvIII | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3424. lymphocytes T allogéniques transduits par un vecteur rétroviral CAR anti-CD19 FMC63-28z --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T allogéniques transduits par un vecteur rétroviral CAR anti-CD19 FMC63-28z | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3425. lymphocytes T autologues CAR anti-CEA --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues CAR anti-CEA | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3426. lymphocytes T autologues CAR anti-GPC3 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues CAR anti-GPC3 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3427. lymphocytes T autologues avec knockout de PDCD-1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues avec knockout de PDCD-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3428. lymphocytes T autologues exprimant CAR anti-CD19 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CAR anti-CD19 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3429. lymphocytes T autologues exprimant CAR spécifique de CD171-CD28 zeta-4-1-BB-EGFRt --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CAR spécifique de CD171-CD28 zeta-4-1-BB-EGFRt | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3430. lymphocytes T autologues exprimant CAR-CD3zeta-4-1BB ciblant l'EGFR --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CAR-CD3zeta-4-1BB ciblant l'EGFR | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3431. lymphocytes T autologues exprimant CD123CAR-CD28-CD3zeta-EGFRt --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CD123CAR-CD28-CD3zeta-EGFRt | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3432. lymphocytes T autologues exprimant CD19CAR-CD3zeta --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3433. lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3434. lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB électroporés avec de l'ARN --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB électroporés avec de l'ARN | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3435. lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB-CD28 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB-CD28 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3436. lymphocytes T autologues exprimant CD33CAR-CD3zeta-4-1BB --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant CD33CAR-CD3zeta-4-1BB | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3437. lymphocytes T autologues exprimant anti-CD19CAR-4-1BB-CD3zeta-EGFRt --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant anti-CD19CAR-4-1BB-CD3zeta-EGFRt | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3438. lymphocytes T autologues exprimant des récepteurs de cellules T améliorés spécifiques à NY-ESO-1-C259 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant des récepteurs de cellules T améliorés spécifiques à NY-ESO-1-C259 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3439. lymphocytes T autologues exprimant le récepteur d'antigène chimérique CD19-28z --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant le récepteur d'antigène chimérique CD19-28z | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3440. lymphocytes T autologues exprimant un CAR ciblant GD2 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant un CAR ciblant GD2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3441. lymphocytes T autologues exprimant un CAR optimisé pour la charnière, co-stimulateur 41BB, spécifique de l'IL13Ralpha2 et un CD19 tronqué --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues exprimant un CAR optimisé pour la charnière, co-stimulateur 41BB, spécifique de l'IL13Ralpha2 et un CD19 tronqué | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3442. lymphocytes T autologues génétiquement modifiés anti-PSMA --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues génétiquement modifiés anti-PSMA | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3443. lymphocytes T autologues spécifiques du VZV exprimant iC9-GD2-CAR --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues spécifiques du VZV exprimant iC9-GD2-CAR | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3444. lymphocytes T autologues transduits avec CAR spécifique de l'EGFRvIII --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues transduits avec CAR spécifique de l'EGFRvIII | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3445. lymphocytes T autologues transduits par CAR anti-MUC1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues transduits par CAR anti-MUC1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3446. lymphocytes T autologues transduits par CAR iCasp9M28z anti-mésothéline --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues transduits par CAR iCasp9M28z anti-mésothéline | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3447. lymphocytes T autologues transduits par un vecteur lentiviral CAR anti-CD22 M971-BBZ --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues transduits par un vecteur lentiviral CAR anti-CD22 M971-BBZ | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3448. lymphocytes T autologues électroporés avec ARNm CAR-cMET --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T autologues électroporés avec ARNm CAR-cMET | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3449. lymphocytes T cytotoxiques autologues induits par des cellules dendritiques pulsées avec le peptide MUC1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T cytotoxiques autologues induits par des cellules dendritiques pulsées avec le peptide MUC1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3450. lymphocytes T cytotoxiques autologues induits par des cellules dendritiques transfectées avec le gène MUC1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T cytotoxiques autologues induits par des cellules dendritiques transfectées avec le gène MUC1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3451. lymphocytes T cytotoxiques autologues spécifiques du CMV CAR anti-HER2 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T cytotoxiques autologues spécifiques du CMV CAR anti-HER2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3452. lymphocytes T cytotoxiques spécifiques de LMP2A --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T cytotoxiques spécifiques de LMP2A | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3453. lymphocytes T cytotoxiques spécifiques de la pp65 du cytomégalovirus --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T cytotoxiques spécifiques de la pp65 du cytomégalovirus | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3454. lymphocytes T exprimant le CAR anti-CD22 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T exprimant le CAR anti-CD22 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3455. lymphocytes T exprimant un CAR spécifique au BCMA --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T exprimant un CAR spécifique au BCMA | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3456. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3457. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3458. lymphocytes T à antigènes multiples de précision des cellules dendritiques --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes T à antigènes multiples de précision des cellules dendritiques | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3459. lymphocytes autologues du sang périphérique transduits par MTCR anti-thyroglobuline --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes autologues du sang périphérique transduits par MTCR anti-thyroglobuline | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3460. lymphocytes autologues thérapeutiques --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes autologues thérapeutiques | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3461. lymphocytes du donneur --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du donneur | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3462. lymphocytes du sang périphérique autologues co-transduits avec des vecteurs rétroviraux codant pour l'IL-12 inductible et le TCR anti-NY-ESO-1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du sang périphérique autologues co-transduits avec des vecteurs rétroviraux codant pour l'IL-12 inductible et le TCR anti-NY-ESO-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3463. lymphocytes du sang périphérique autologues génétiquement modifiés avec le récepteur des cellules T F5 anti-MART-1 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du sang périphérique autologues génétiquement modifiés avec le récepteur des cellules T F5 anti-MART-1 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3464. lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral CAR anti-HER-2 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral CAR anti-HER-2 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3465. lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral TCR anti-CEA --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral TCR anti-CEA | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3466. lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3467. lymphocytes du sang périphérique transduits par récepteur des cellules T anti-p53 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes du sang périphérique transduits par récepteur des cellules T anti-p53 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3468. lymphocytes t autologues tbi-1201 transduits avec le gène tcr spécifique de mage-a4 --- r_associated #0: 5 --> en:cytarabine
    n1=lymphocytes t autologues tbi-1201 transduits avec le gène tcr spécifique de mage-a4 | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3469. maladie de Beurmann et Gougerot --- r_associated #0: 5 --> en:cytarabine
    n1=maladie de Beurmann et Gougerot | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3470. maladie de Danon --- r_associated #0: 5 --> en:cytarabine
    n1=maladie de Danon | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3471. pI --- r_associated #0: 5 --> en:cytarabine
    n1=pI | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3472. physiothérapie --- r_associated #0: 5 --> en:cytarabine
    n1=physiothérapie | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3473. physique médicale --- r_associated #0: 5 --> en:cytarabine
    n1=physique médicale | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3474. physométrie --- r_associated #0: 5 --> en:cytarabine
    n1=physométrie | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3475. physostigmine --- r_associated #0: 5 --> en:cytarabine
    n1=physostigmine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3476. phytase --- r_associated #0: 5 --> en:cytarabine
    n1=phytase | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3477. phytine --- r_associated #0: 5 --> en:cytarabine
    n1=phytine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3478. phytocénose --- r_associated #0: 5 --> en:cytarabine
    n1=phytocénose | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3479. phytodermatose --- r_associated #0: 5 --> en:cytarabine
    n1=phytodermatose | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3480. phytohémagglutinine --- r_associated #0: 5 --> en:cytarabine
    n1=phytohémagglutinine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3481. phytol --- r_associated #0: 5 --> en:cytarabine
    n1=phytol | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3482. phytooestrogène --- r_associated #0: 5 --> en:cytarabine
    n1=phytooestrogène | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3483. phytophotodermatose --- r_associated #0: 5 --> en:cytarabine
    n1=phytophotodermatose | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3484. phytosphingosine --- r_associated #0: 5 --> en:cytarabine
    n1=phytosphingosine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3485. phytostérol --- r_associated #0: 5 --> en:cytarabine
    n1=phytostérol | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3486. phæohyphomycoses --- r_associated #0: 5 --> en:cytarabine
    n1=phæohyphomycoses | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3487. phæomélanine --- r_associated #0: 5 --> en:cytarabine
    n1=phæomélanine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3488. phæomélanosome --- r_associated #0: 5 --> en:cytarabine
    n1=phæomélanosome | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3489. progéroïde --- r_associated #0: 5 --> en:cytarabine
    n1=progéroïde | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3490. syndrome de Bartter --- r_associated #0: 5 --> en:cytarabine
    n1=syndrome de Bartter | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3491. syndrome de Butler-Albright --- r_associated #0: 5 --> en:cytarabine
    n1=syndrome de Butler-Albright | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3492. syndrome de Coats --- r_associated #0: 5 --> en:cytarabine
    n1=syndrome de Coats | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3493. syndrome de DiGeorge --- r_associated #0: 5 --> en:cytarabine
    n1=syndrome de DiGeorge | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3494. villeuse de la vessie (maladie) --- r_associated #0: 5 --> en:cytarabine
    n1=villeuse de la vessie (maladie) | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3495. Érythropoïétine --- r_associated #0: 5 --> en:cytarabine
    n1=Érythropoïétine | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3496. Éthosuximide --- r_associated #0: 5 --> en:cytarabine
    n1=Éthosuximide | n2=en:cytarabine | rel=r_associated | relid=0 | w=5
  3497. chimie --- r_associated #0: 2 --> en:cytarabine
    n1=chimie | n2=en:cytarabine | rel=r_associated | relid=0 | w=2
  3498. Langage de programmation --- r_associated #0: -5 --> en:cytarabine
    n1=Langage de programmation | n2=en:cytarabine | rel=r_associated | relid=0 | w=-5
  3499. langage de programmation --- r_associated #0: -23 --> en:cytarabine
    n1=langage de programmation | n2=en:cytarabine | rel=r_associated | relid=0 | w=-23
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr